ECR 2013 – Final Programme - myESR.org

March 7–11F inalFinal ProgrammeThe The ECR ECR is is the the annual meeting of of the the European Society of of Radiology.

.artundwork designbüroEmbracing lifethrough better medicalimaging solutions.Better medical imaging solutions for the needs of our customersWe have been committed to delivering outstanding medical imaging solutions over decades. Original solutions,that have grown out of the groups' expertise and technical know-how, providing innovations that meet equallythe Zeitgeist and the needs of our customers and their patients.Visit us at booth 320 in Expo Cand discover “solution stars in radiology”Hitachi Medical Systems Europe Holding AG · Sumpfstrasse 13 · CH-6300 Zugwww.hitachi-medical-systems.eu

Bienvenidosa Viena!!

Timetable14:00 – 15:30 16:00 – 17:30 17:45 – 19:15E³ SessionScientific Sessions(200)Siemens Healthcare SymposiumProfessional Challenges SessionPC 3Mini CourseMC 322Multidisciplinary SessionMS 3Refresher CoursesE³ Session(300)23ESR Radiation Protection SessionOpening CeremonyPresentation of Honorary MembersOpening LectureThursday, March 7Mini CoursesMC 623, MC 628E³ SessionScientific SessionsUpdate Your Skills (Practical Course)(600)ESOR SessionRising Stars Student SessionRising Stars Student WorkshopESR meets E-AHPBANew Horizons SessionNH 7Special Focus SessionsSF 7a, SF 7b, SF 7cCategorical CourseCC 719Mini CoursesMC 722, MC 723, MC 728Refresher CoursesE³ SessionsUpdate Your Skills (Practical Course)(700)67Rising Stars Student SessionFriday, March 8EFRS meets SpainImage Interpretation QuizUpdate Your Skills (Practical Courses)(1000)MIR@ECRHologic SymposiumToshiba SymposiaGE Healthcare Nycomed SymposiumPhilips Healthcare Mini Satellite SymposiumNew Horizons SessionNH 14Special Focus SessionsSF 14a, SF 14b, SF 14cCategorical CoursesCC 1418, CC 1419, CC 1421Refresher CoursesE³ SessionUpdate Your Skills (Practical Course)(1400)Rising StarsStudent Final SessionScientific Sessions(1800)101114Rising Stars14Student Workshop18 18State of the Art SymposiumSA 11Special Focus SessionSF 11Professional Challenges SessionPC 11Categorical CoursesCC 1118, CC 1121Multidisciplinary SessionMS 11Refresher CoursesE³ SessionUpdate Your Skills (Practical Course)(1100)MIR@ECRRising Stars Student WorkshopState of the Art SymposiumSA 15Special Focus SessionsSF 15a, SF 15bCategorical CoursesCC 1518, CC 1519, CC 1521Refresher CoursesE³ SessionUpdate Your Skills (Practical Course)(1500)Special Focus SessionSF 19Refresher Courses(1900)15 1519 19Saturday, March 9Sunday, March 10Monday, March 113

25 th European Congress of RadiologySessions in Joint Sponsorship withCIRSEEFOMPEFRSESCRESERESGARESHNRESMOFIRESNRESOIESPRESSRESTIESUREuroPACSEUSOBIISRRTCongress VenueAustria Center ViennaBruno Kreisky Platz 11220 Vienna, AustriaCongress LanguageEnglishOnsite Opening HoursCardiovascular and Interventional Radiological Society of EuropeEuropean Federation of Organisations for Medical PhysicsEuropean Federation of Radiographer SocietiesEuropean Society of Cardiac RadiologyEuropean Society of Emergency RadiologyEuropean Society of Gastrointestinal and Abdominal RadiologyEuropean Society of Head and Neck RadiologyEuropean Society of Molecular and Functional Imaging in RadiologyEuropean Society of NeuroradiologyEuropean Society of Oncologic ImagingEuropean Society of Paediatric RadiologyEuropean Society of Musculoskeletal RadiologyEuropean Society of Thoracic ImagingEuropean Society of Urogenital RadiologyEuropean Society for the Promotion of Picture Archiving and Communication Systems in MedicineEuropean Society of Breast ImagingInternational Society of Radiographers and Radiological TechnologistsRegistrationWednesday, March 6 12:00–18:00Thursday, March 7 to Monday, March 11 07:00–18:00Preview Centre – EDIPS ECR’s Digital Preview SystemWednesday, March 6 12:00–18:00Thursday, March 7 to Monday, March 11 07:00–18:00EPOS – Scientific ExhibitionThursday, March 7 to Monday, March 11 08:00–18:00Technical ExhibitionEXPO Halls and EXPO Foyer DFriday, March 8 to Sunday, March 10 10:00–18:00Monday, March 11 10:00–14:00First Level (Gallery)Thursday, March 7 14:00–18:00Friday, March 8 to Monday, March 11 10:00–18:00Travel ServiceWednesday, March 6 12:00–18:00Thursday, March 7 to Monday, March 11 07:00–18:00Press Office & Business CentreThursday, March 7 to Monday, March 11 08:00–18:004

Dear collAs president of the European Society of Radiology(ESR), it gives me enormous pleasure to welcomeyou to our society’s scientific meeting, the EuropeanCongress of Radiology (ECR). I would like toextend a special welcome to the numerous youngradiologists joining us in Vienna, especially thosevisiting for the first time and those who are attendingthanks to the support of the Invest in the Youthprogramme.This event is the culmination of almost two yearsof intense planning and hard work, by people whohave brought many years of valuable experience tothe process. I would like to extend not only my congratulations,but my heartfelt thanks, to Prof. Bilbaoand to all the members of the planning committees,for assembling a truly exemplary scientific andeducational programme, as well as to the talentedand dedicated ESR staff who have been involved inputting these plans into action.I wrote in the ECR 2013 Preliminary Programmethat everyone involved in the organisation of ourannual meeting was delighted and very proud thatabstract submission rose again this year. The responseto the call for paper abstracts in the summerwas extremely encouraging, and the continuation ofthat response via the EPOS submission system hasdemonstrated that the radiological community continuesto hold our congress in high regard.Speaking of community, being involved in so manydifferent projects in so many different areas of interestover the past year has also brought me intocontact with a vast number of committed and hardworkingpeople, who are a great source of encouragementfor the future of our discipline. I would liketo thank everyone who has contributed to drivingour society forward over the last twelve months.Sadly, one year is far too short to achieve everythingwe set out to accomplish, but I am satisfied that Ican look back on an exciting and very productiveperiod.The ESR’s main activities this year have focusedvery much on international relations, especiallyon a political level. We have established an office inBrussels so that we can take a proactive approach tomaking our collective voice heard in the EuropeanCommission on topics that affect our profession.The biggest issue on the agenda in this respect is theongoing debate regarding the EMF Directive. At thetime of writing, we are optimistic that we will hearpositive news on this matter by the time we meet atthe ECR.We are also intensifying relations with associate institutionalmembers and other societies outside ofEurope. We have organised an international summitfor representatives of non-European partners,which we hope will help us gain a better understandingof how we can and should work together in thefuture. We are also bringing our institutional membersocieties closer to the fold, by having each onerepresented at ESR committee level by its president.I was delighted with the involvement of so manygroups from all over the world in the first InternationalDay of Radiology (IDoR), which tookplace on November 8. Prompted by the success ofthe European Day of Radiology in 2011, IDoR 2012was introduced to provide the first truly global celebrationof radiology. We were very pleased to see somany radiologists joining us in marking the day andhelping to promote our profession. We are also extremelygrateful to both the Radiological Society ofNorth America and the American College of Radiologyfor their joint role in bringing this event to life.Our efforts to strengthen relations with the manyradiological and partner societies throughout theworld will continue at ECR 2013, in the form ofthe ‘ESR Meets’ programme. This year, along withProf. Bilbao’s home country, Spain, we will have thepleasure of welcoming the national radiologicalsocieties of both Chile and South Africa, as well asthis year’s partner society, the truly multidiscipli-6

WelcomeIt is a great pleasure and a privilege to welcome youto Vienna for the European Congress of Radiology(ECR), the annual meeting of the world’s largestradiological society. The ECR has become one of themost keenly anticipated medical conferences overthe last two decades, not only as a place to come andlearn about the scientific, medical and professionalissues of the day, but to meet our colleagues fromthroughout the world of imaging, to exchange opinions,experience, and knowledge, and to enjoy theinimitable atmosphere of the ECR and its home city,Vienna.I would especially like to address this welcome toour younger attendees, who have been appearingat our congress in increasing numbers in recentyears. It is enormously encouraging to see that newgenerations are not only developing an interest inradiology and radiography, but that they are committedenough to make the trip to Vienna for whatmay well be the most inspiring experience of theirearly careers. I am also personally delighted that we,as a society, are able to make this trip a reality forseveral thousand young people by providing supportthrough the Invest in the Youth programme.Thanks to this very valuable initiative, as well as freeregistration for all students, I am looking forwardto seeing many budding radiologists and radiographersat the Austria Center this year.Each ECR is different from the last; each has its ownunique character and there are always innovationsthat make each congress stand out from its predecessors.But just as important as these differencesare those factors that always remain: the visionand talent that we find within our community andthe enduring appeal of radiological science. This iswhat makes the quality of our scientific and educationalprogramme so exceptionally high, bringingthousands of visitors, who are committed to radiologyand self-improvement, from all over the worldto Vienna each year. On this note, I would like tooffer my sincerest thanks to every member of theProgramme Planning Committee for their fan-tastic work in assembling this programme and tothe extremely capable team at the ESR Office for alltheir support. I am honoured to have played a partin the creation and organisation of this congress,and I hope that every one of you will gain just asmuch pleasure from attending as I will from seeingthe carefully laid plans and hard work of so manypeople come to fruition.This year’s programme offers many sessions, inmany different formats, with the aim of educatingand entertaining at the same time. As usual, someof the most successful and popular sessions willbe repeated from previous congresses, but plentyof others will be new. The congress is constantlyevolving, and the Programme Planning Committeeand ESR Office strive tirelessly to stay ahead of theeducational needs and demands of radiologists andradiographers.Categorical Courses are the heart of our programme,offering the deepest exploration of anytopics at the congress. At ECR 2013 there will bethree of these courses: ‘Never without Arteries’ willbe this year’s contribution to the recently initiated‘Clinical Lessons for Imaging Core Knowledge –CLICK’ series; ‘Oncologic Imaging: Follow-up ofSystemic and Local Therapies’ will summarise themost recent information about how responses totherapy should be evaluated in most oncologic situations;and ‘Urogenital Imaging’ will be a continuationof the ECR 2012 session, covering the latest topics.The programme is always prepared with a strongemphasis on interaction, since the exchange of ideasis a major way to teach and learn. This year the successful‘E 3 – European Excellence in Education’will include fourteen 90-minute sessions, whichwill cover all the major aspects of radiology, withattractive titles such as ‘tips and tricks’ and ‘pitfalls’.The Foundation Course will deal with neuroimagingand, as in previous years, will be followed by aself-assessment test. There will also be two practicalcourses on how to ‘Update your Skills’, which will8

toECR 2013provide interactive demonstrations and opportunitiesfor hands-on experience on ‘How to biopsy’ and‘How to ablate’.Like interaction, multidisciplinarity has becomeone of those words that appear in every conversationabout the ECR. This principle is an increasinglyimportant influence on our work and so it is onlynatural that we try to reflect this at our congress. TheECR 2013 programme includes three MultidisciplinarySessions that will show how experts fromdifferent disciplines within the same institution,interact and decide on the best way to approachspecific clinical situations. In addition, it is my pleasureto welcome the European-African Hepato-Pancreato-Biliary Association (E-AHPBA), a trulymultidisciplinary organisation, to the ECR. They willjoin us as the partner discipline in the ‘ESR Meets’programme, and I am personally looking forward tostrengthening our relationship with this association,from whom I believe we will learn a great deal, interms of both science and professional cooperation.Once again, the ESR has invited three countries toshare their expertise through the ‘ESR Meets’ programme.Chile, South Africa, and Spain will presenttheir most recent scientific developments injoint sessions and bring some international flavourto the entrance hall. For the first time, we will havea new session entitled ‘EFRS meets’, hosted by theEuropean Federation of Radiographers Societies,reflecting the fact that the EFRS recently chose theECR to be their official annual meeting. They havechosen to invite Spain as their first guest, and I ampleased to report that a great many Spanish radiographershave chosen to make their way to Viennafor this occasion. We are of course delighted to offerthe EFRS this platform and we look forward to buildingeven closer relations between our societies andour professions.As well as these few highlights I have mentioned,you will have the opportunity to attend RefresherCourses, Mini Courses, and State-of-the-Art Symposia;learn more about the most recent developmentsin New Horizons Sessions; look into a widevariety of topics in Special Focus Sessions; and hearabout how to tackle some of our greatest issues inProfessional Challenges Session. You will also havethe chance to explore a technical exhibition ofmore than 26,000m 2 in size, and discover the latestproducts and imaging-related services from around300 exhibiting companies from all over the world.And if this is not enough stimulation for you, weare lucky enough to be based in one of the mostamazing cities in the world, boasting so much in theway of art, culture, cuisine and entertainment that ishard to know where to begin.Exactly how to arrange your schedule at the ECR isoften the biggest problem, but however you divideyour time, you can always be certain that it will bewell spent. I look forward to sharing the experiencewith you and wish you all a wonderful congress.José Ignacio BilbaoECR 2013 Congress President9

Committees12 ESR Executive Council12 Congress Committee13 Programme Planning Committee14 Scientific Subcommittees17 Topic Coordinators

ESR Executive CouncilCongress CommitteePresidentGabriel P. Krestin, Rotterdam/NL1 st Vice-PresidentGuy Frija, Paris/FR2 nd Vice-PresidentLorenzo Bonomo, Rome/ITPast-PresidentAndrás Palkó, Szeged/HUCongress Committee ChairmanJosé I. Bilbao, Pamplona/ES1 st Vice-Chairman of the Congress CommitteeValentin Sinitsyn, Moscow/RU2 nd Vice-Chairman of the Congress CommitteeBernd Hamm, Berlin/DEESOR Committee ChairmanNicholas Gourtsoyiannis, Athens/GRPublications Committee ChairmanPaul M. Parizel, Antwerp/BEResearch Committee ChairmanLuis Martí-Bonmatí, Valencia/ESEducation Committee ChairpersonBirgit Ertl-Wagner, Munich/DEProfessional Organisation Committee ChairmanYves Menu, Paris/FRNational Societies Committee ChairmanLuis Donoso, Barcelona/ESSubspecialties and Allied SciencesCommittee ChairmanJim A. Reekers, Amsterdam/NLChairperson (Congress President)J.I. Bilbao; Pamplona/ES1 st Vice-Chairperson(1 st Congress Vice-President)V. Sinitsyn; Moscow/RU2 nd Vice-Chairperson(2 nd Congress Vice-President)B. Hamm; Berlin/DEOrdinary MembersF. Caseiro-Alves; Coimbra/PTK. Åhlström Riklund; Umea/SEV. Vilgrain; Clichy/FRM.I. Argyropoulou; Ioannina/GRESR PresidentG.P. Krestin; Rotterdam/NLESR Executive DirectorP. Baierl; Vienna/ATEx-officio Members:Chairperson of the Finance andInternal Affairs CommitteeB. Brkljačić; Zagreb/HRChairperson of the Publications CommitteeP. M. Parizel; Antwerp/BEFinance and Internal Affairs Committee ChairmanBoris Brkljačić, Zagreb/HRCommunication and External AffairsCommittee ChairmanLorenzo E. Derchi, Genoa/ITStrategic Review Committee ChairmanLorenzo Bonomo, Rome/ITNominations and Awards Committee ChairmanAndrás Palkó, Szeged/HUExecutive DirectorPeter Baierl, Vienna/AT12

Programme Planning CommitteePostgraduate Educational ProgrammeChairman:B. Hamm; Berlin/DEMembers:V.N. Cassar-Pullicino; Oswestry/UKE. de Kerviler; Paris/FRM.H. Fuchsjäger; Graz/ATH.-U. Kauczor; Heidelberg/DEP.C. Maly Sundgren; Lund/SEA. Rossi; Genoa/ITS.A. Taylor; London/UKA. Trojanowska; Lublin/PLA. van der Lugt; Rotterdam/NLScientific PapersChairman:F. Caseiro-Alves; Coimbra/PTMembers:G. Forrai; Budapest/HUM. Raissaki; Iraklion/GRD. Tack; Baudour/BEScientific Exhibition (EPOS)Chairman:K. Åhlström Riklund; Umea/SEMembers:C. Ayuso; Barcelona/ESE.J.R. van Beek; Edinburgh/UKCategorical CoursesT. de Baère; Villejuif/FRL.E. Derchi; Genoa/ITC. Loewe; Vienna/ATE³ – European Excellence in EducationInteractive Teaching SessionsJ. Vilar; Valencia/ESFoundation CourseM.I. Argyropoulou; Ioannina/GRe-LearningD. Caramella; Pisa/ITP. Pokieser; Vienna/ATCases of the DayJ.C. Vilanova; Girona/ESPhysics ProgrammeW.J.M. van der Putten; Galway/IEImage Interpretation QuizD. Vorwerk; Ingolstadt/DEJunior Image Interpretation QuizA. Alguersuari; Sabadell/ESEvaluationD. Weishaupt; Zurich/CHPublications Committee Chairman (until March 2012)A.K. Dixon; Cambridge/UKESR Subspecialties Committee ChairmanJ.A. Reekers; Amsterdam/NLESR Education Committee Chairman (until March 2012)É. Breatnach; Dublin/IEESR Professional Organisation Committee ChairmanY. Menu; Paris/FR13

Scientific SubcommitteesAbdominal and GastrointestinalThe ESR would like to thank ESGAR for their cooperationon this subcommitteeChairmen:B.J. Op de Beeck; Antwerp/BES. Romano; Naples/ITMembers:D. Akata; Ankara/TRC. Ayuso; Barcelona/ESG. Brancatelli; Palermo/ITD.J. Breen; Southampton/UKD. Cano; Pamplona/ESV. Cappendijk; ‘s Hertogenbosch/NLL. Curvo-Semedo; Coimbra/PTE. Danse; Brussels/BEV.J. Goh; London/UKS. Gourtsoyianni; London/UKL. Guimaraes; Porto/PTM. Hellström; Gothenburg/SEC. Hoeffel; Reims/FRG.G. Karmazanovsky; Moscow/RUS. Leschka; St. Gallen/CHO. Lucidarme; Paris/FRM.M. Maher; Cork/IEA. Maier; Vienna/ATT. Mang; Vienna/ATS. Phoa; Amsterdam/NLS. Schmidt; Lausanne/CHS. Stojanovic; Novi Sad/RSC. Stroszczynski; Regensburg/DEJ. Votrubová; Prague/CZBreastThe ESR would like to thank EUSOBI for their cooperationon this subcommitteeChairman:H.M. Dobson; Glasgow/UKMembers:C.S. Balleyguier; Villejuif/FRP.A.T. Baltzer; Jena/DEI. Leconte; Brussels/BEM. Lesaru; Bucharest/ROR.M. Mann; Nijmegen/NLF. Pediconi; Rome/ITK. Pinker-Domenig; Vienna/ATM. Torres-Tabanera; Madrid/ESCardiacThe ESR would like to thank the ESCR for their cooperationon this subcommitteeChairman:M. Garðarsdóttir; Reykjavik/ISMembers:G. Bastarrika; Pamplona/ESF. Cademartiri; Monastier di Treviso/ITB. Graca; Coimbra/PTK. Gruszczynska; Katowice/PLD. Hahn; Würzburg/DES. Katsilouli; Athens/GRE. Mershina; Moscow/RUC. Peebles; Southampton/UKP.K. Vanhoenacker; Aalst/BER. Vliegenthart; Groningen/NLJ. Vymazal; Prague/CZF. Wolf; Vienna/ATChestThe ESR would like to thank ESTI for their cooperationon this subcommitteeChairman:B. Ghaye; Brussels/BEMembers:J. Biederer; Kiel/DEE. Castañer; Sabadell/ESR. Cesar; Ljubljana/SIJ.D. Dodd; Dublin/IEN. Karabulut; Denizli/TRA.P. Parkar; Bergen/NOH. Prosch; Vienna/ATM.-P. Revel; Paris/FRE. Rizzo; Genolier/CHN. Sverzellati; Parma/ITE.J.R. van Beek; Edinburgh/UKJ.E. Wildberger; Maastricht/NLComputer ApplicationsThe ESR would like to thank EuroPACS for their cooperationon this subcommitteeChairman:E. Neri; Pisa/ITMembers:U.W. Engelmann; Dossenheim/DEB. Gibaud; Rennes/FRM. Onu; Bucharest/ROP. Sögner; Feldkirch/ATZ. Tarján; Budapest/HU14

Scientific SubcommitteesMolecular Imaging and Contrast MediaChairman:N. Grenier; Bordeaux/FRMembers:I. Carrió; Barcelona/ESC.C. Cyran; Munich/DEB. Elmståhl; Malmö/SEF.A. Gallagher; Cambridge/UKT. Leiner; Utrecht/NLX. Montet; Geneva/CHF. Stacul; Trieste/ITM. Wozniak; Lublin/PLGenitourinaryThe ESR would like to thank ESUR for their cooperationon this subcommitteeChairman:V. Løgager; Copenhagen/DKMembers:M.-F. Bellin; Le Kremlin-Bicêtre/FRD. Beyersdorff; Berlin/DEF.M. Danza; Rome/ITA. Dimopoulou; Uppsala/SEG. Ivanac; Zagreb/HRP. Leonardou; Athens/GRD. Negru; Iasi/ROM.M. Otero-García; Vigo/ESE. Sala; Cambridge/UKH.C. Thoeny; Berne/CHA.T. Turgut; Ankara/TRD. Yakar; Nijmegen/NLHead and NeckThe ESR would like to thank the ESHNR for their cooperationon this subcommitteeChairman:S. Bisdas; Tübingen/DEMembers:N. Gritzmann; Vienna/ATP. Halimi; Paris/FRC.Z. Karaman; Aydin/TRR. Kohler; Geneva/CHR. Ljumanovic; Amsterdam/NLJ. Olliff; Birmingham/UKS. Petrovic; Nis/RSL. Preda; Milan/ITInterventional RadiologyThe ESR would like to thank CIRSE for their cooperationon this subcommitteeChairman:A. Krajina; Hradec Králové/CZMembers:V. Bérczi; Budapest/HUC. Binkert; Winterthur/CHT.J. Cleveland; Sheffield/UKJ. Luis del Cura; Bilbao/ESL. Lonn; Copenhagen/DKF. Orsi; Milan/ITH. Rousseau; Toulouse/FRM. Schoder; Vienna/ATJ. Tacke; Passau/DEV. Vidjak; Zagreb/HRP. Vilares Morgado; Porto/PTK. Zelenak; Martin/SKMusculoskeletalThe ESR would like to thank the ESSR for their cooperationon this subcommitteeChairman:A.J. Grainger; Leeds/UKMembers:N. Boutry; Lille/FRM. Court-Payen; Copenhagen/DKP.M. Cunningham; Navan/IEC. Glaser; Munich/DEA. Klauser; Innsbruck/ATM. Maas; Amsterdam/NLA. Oktay; Izmir/TRA. Plagou; Athens/GRJ. Raposo; Lisbon/PTL.M. Sconfienza; San Donato Milanese/ITP. Van Dyck; Antwerp/BEJ.C. Vilanova; Girona/ESNeuroThe ESR would like to thank the ESNR for their cooperationon this subcommitteeChairman:J. Van Goethem; Antwerp/BEMembers:N. Bargalló; Barcelona/ESF. Barkhof; Amsterdam/NLM. Bekiesinska-Figatowska; Warsaw/PLB. Ertl-Wagner; Munich/DEZ. Merhemic; Sarajevo/BAM. Muto; Naples/ITY. Özsunar; Aydin/TRM.A. Papathanasiou; Athens/GRI.N. Pronin; Moscow/RUJ.-P. Pruvo; Lille/FRM.M. Thurnher; Vienna/ATT.A. Yousry; London/UK15

Scientific SubcommitteesPaediatricThe ESR would like to thank the ESPR for their cooperationon this subcommitteeChairman:R.R. van Rijn; Amsterdam/NLMembers:G. del Pozo; Madrid/ESC. Fonda; Florence/ITC. Garel; Paris/FRM. Haliloglu; Ankara/TRW. Hirsch; Leipzig/DEP.D. Humphries; London/UKL.-S. Ording-Müller; Tromsø/NOM. Raissaki; Iraklion/GRPhysics in RadiologyThe ESR would like to thank EFOMP for their cooperationon this subcommitteeChairman:J.N. Vassileva; Sofia/BGMembers:T. Beyer; Zurich/CHD. Bor; Ankara/TRO. Ciraj-Bjelac; Belgrade/RSH. Jarvinen; Helsinki/FIR. Padovani; Udine/ITK. Pedersen; Østerås/NOV. Tsapaki; Athens/GRRadiographersThe ESR would like to thank the EFRS and the ISRRT for their cooperationon this subcommitteeChairmen:D. Pekarovic; Ljubljana/SIV. Vilgrain; Clichy/FRMembers:E. Agadakos; Athens/GRK. Haller; Wiener Neustadt/ATC. Malamateniou; London/UKJ. McNulty; Dublin/IEG. Paulo; Coimbra/PTP. Vahtramae; Pärnu/EEVascularThe ESR would like to thank CIRSE for their cooperationon this subcommitteeChairman:K. Malagari; Athens/GRMembers:J.-P. Beregi; Nîmes/FRL. Crocetti; Pisa/ITE. Esteban; Alzira/ESK.A. Hausegger; Klagenfurt/ATT. Jargiello; Lublin/PLA. Keeling; Dublin/IES. Müller-Hülsbeck; Flensburg/DER. Uberoi; Oxford/UKOncologic ImagingChairman:R.G.H. Beets-Tan; Maastricht/NLMembers:M. Bellomi; Milan/ITP. Brader; Vienna/ATF. Caseiro-Alves; Coimbra/PTL. Martí-Bonmatí; Valencia/ESC. Matos; Brussels/BEA.G. Rockall; London/UKH.-P. Schlemmer; Heidelberg/DEM.R Torkzad; Stockholm/SEEmergency RadiologyChairman:U. Linsenmaier; Munich/DEMembers:I. Arkhipova; Moscow/RUO. Chan; London/UKD.R. Kool; Nijmegen/NLS. Koskinen; Helsinki/FIP.-A. Poletti; Geneva/CHG. Schueller; Bülach/CHM. Stajgis; Poznan/PLM. Zins; Paris/FR16

Topic CoordinatorsCategorical CoursesCLICK (Clinical Lessons for Imaging Core Knowledge):Never without ArteriesC. Loewe; Vienna/ATOncologic Imaging: Follow-up of Systemic and LocalTherapiesT. de Baère; Villejuif/FRUrogenital ImagingL.E. Derchi; Genoa/ITMini CoursesOrgans from A to Z: HeartK. Nikolaou; Munich/DEControversies in Breast ImagingF. Sardanelli; Milan/ITThe Beauty of Basic Knowledge: Head and NeckA. Borges; Lisbon/PTThe Beauty of Basic Knowledge: Musculoskeletal ImagingK. Wörtler; Munich/DEJoint Course of ESR and RSNA(Radiological Society of North America):Essentials in oncologic imaging:what radiologists need to knowR.L. Baron; Chicago, IL/USC.J. Herold; Vienna/ATH. Hricak; New York, NY/USY. Menu; Paris/FRD.M. Panicek; New York, NY/USM.F. Reiser; Munich/DEMultidisciplinary SessionsManaging Patients with CancerJ.I. Bilbao; Pamplona/ESB. Hamm; Berlin/DEB. Sangro; Pamplona/ESV. Vilgrain; Clichy/FRE³ – European Excellence in EducationFoundation Course: NeuroimagingM.I. Argyropoulou; Ioannina/GRInteractive Teaching SessionsJ. Vilar; Valencia/ESUpdate Your Skills (Practical Courses)How to Biopsy with US GuidanceG. Mostbeck; Vienna/ATImage-Guided Tumour Ablation: How to do itD.J. Breen; Southampton/UKM.H. Fuchsjäger; Graz/AT6 th Post-Processing Face-Off SessionA. Graser; Munich/DE17

Dignitaries20 Honorary Member George Simpson Bisset III22 Honorary Member Tarek A. El-Diasty24 Honorary Member Gary Glazer †26 Gold Medallist José Cáceres28 Gold Medallist Johannes Lammer30 Gold Medallist Maximilian F. Reiser32 Opening Lecturer Jesús Prieto34 Honorary Lecturer Carlo Catalano36 Honorary Lecturer Jean-François ‘Jeff’ Geschwind38 Honorary Lecturer Luis Martí-Bonmatí

George Simpson Bisset IIIHouston, TX/USHonorary MemberIn recognition of hisgroundbreaking work in thefield of diagnostic radiologyand his dedication toeducating the nextgeneration of radiologists,Professor George SimpsonBisset III will be awardedHonorary Membership ofthe European Society ofRadiology at ECR 2013.20

ESR DignitariesGeorge Simpson Bisset III serves as chief of paediatric radiologyat Texas Children’s Hospital and Edward B. Singleton Professorof Radiology at Baylor College of Medicine.Prof. Bisset began his studies at the University of Tennessee,before returning to his native Florida, where he received hismedical degree from the University of South Florida in 1975.He then went on to complete his residency in paediatrics at theChildren’s Hospital Medical Center, Cincinnati, Ohio, where helater carried out a fellowship in cardiology, a residency in radiology,and a fellowship in paediatric radiology. Before taking uphis current post, Prof. Bisset had already built up a great dealof experience during his career, having not only worked as aradiologist in a number of hospitals, but also as a consultantcardiologist.As a result of his work in paediatric cardiology and radiology,Prof. Bisset has received a number of honours during his career.At the International Pediatric Radiology Congress in 2001, hismanuscript received the John A. Caffey Award. He has also beenappointed a Fellow of the American College of Radiology, anHonorary Member of the American Association of Physicists inMedicine, and an honorary member of both German and Austriannational radiological societies.During his career, Prof. Bisset has shown a great deal of dedicationto research and the development of his discipline. Witha total of 125 articles published in peer-reviewed journals andmore than 20 book chapters, he has written and researchedextensively on the subjects of paediatrics, cardiology andradiology.Prof. Bisset is an active member of many radiological societies,including the American College of Radiologists and theSociety for Pediatric Radiology. He is a long-time member ofthe Radiological Society of North America and is the immediatepast president of the society. In 2012, as RSNA President,he strengthened the society’s focus on patient care, choosing‘patients first’ as the theme of the society’s most recentcongress.21

Tarek A. El-DiastyMansoura/EGHonorary MemberIn recognition ofachievements throughouthis career, his outstandingcontributions to thedevelopment of radiologyin Egypt and his dedicationto fostering internationalcooperation, Professor TarekEl-Diasty will be awardedHonorary Membership ofthe European Society ofRadiology at ECR 2013.22

ESR DignitariesTarek El-Diasty is professor of radiology and chairman of theradiology department at the Urology and Nephrology Centre,Mansoura University, Egypt.Born in Egypt in 1955, Prof. El-Diasty received his medicaldegree from the Medical Faculty of Mansoura University, Egypt,in 1979. He then completed his internship and residency periodsat the same institution, receiving his master’s degree in 1986and doctorate in 1990. Throughout his long and distinguishedcareer, he has focused on improving urological care in Egyptand he has dedicated much of his time and effort to establishingEgypt’s first uroradiology department.An ardent supporter of international cooperation andexchange, Prof. El-Diasty has worked hard to build closer tiesbetween the Egyptian Society of Radiology and other radiologicalsocieties around the world. As an ambassador forEgyptian radiology, he has helped to build bridges with theEuropean Society of Radiology and the Radiological Societyof North America, to name but a few of the societies he hasestablished links with.In addition to his clinical work, Prof. El-Diasty has also publishedextensively, with more than 100 peer-reviewed papers andsix book chapters to his name. He has also delivered 55 invitedlectures and served as chairman of the European Society ofUrogenital Radiology (ESUR) Symposium, which took place inCairo in 2006. He has actively participated in every EuropeanCongress of Radiology since 1995, as well as every ESUR meetingsince 1992.A dedicated teacher, Prof. El-Diasty has, to date, supervisedmore than 50 postgraduate medical students in the field ofradiology during his time at Mansoura University.23

Gary Glazer †Stanford, CA/USHonorary MemberIn recognition of hismajor contributions to theimprovement of oncologicimaging as well as his yearsof work to create one of theworld’s foremost imagingcentres, the late ProfessorGary Glazer will be awardedHonorary Membership ofthe European Society ofRadiology at ECR 2013.24

ESR DignitariesGary Glazer served as chairman of the department of radiologyat the Stanford University School of Medicine, California, formore than 20 years. He was also the Emma Pfeiffer Merner Professorof the Medical Sciences at the same institution. On October16, 2011, Glazer passed away, at the age of 61, after a longfight with prostate cancer.Born in Cleveland, Ohio, in 1950, Prof. Glazer was born into afamily of healthcare professionals, his father being a paediatricradiologist and founding member of the Society of PaediatricRadiology, while his mother worked as a nurse.At the University of Michigan, Prof. Glazer studied cellular biologybefore moving on to receive his medical degree from CaseWestern University. He carried out his internship, residency andfellowship training in radiology at the University of California,San Francisco (UCSF). He worked for a short time at UCSF,before he returned to the University of Michigan to work as anassistant professor. Six years later he was full professor of radiologyand serving as director of magnetic resonance imaging.In 1989, Prof. Glazer became chair of the department of radiologyat the Stanford University School of Medicine, and underhis chairmanship the department underwent a number ofmajor expansions and improvements, making it one of themost sophisticated imaging centres in the world. He workedto introduce a more patient-centred approach to his department,as he sought to increase the radiologist’s interactionwith patients.Over the course of his long and distinguished career, Prof.Glazer carried out a great deal of important and influentialresearch. His work in the fields of computed tomography andmagnetic resonance imaging led to the development of standardsfor distinguishing liver and adrenal tumours and stagingtumours in lung cancer. These standards remain vital to treatmentand are still used routinely today. He also published morethan 150 peer-reviewed articles, three books and served as consultanteditor for a range of highly reputable scientific journalsincluding the New England Journal of Medicine and Radiology.During his career, Prof. Glazer received widespread recognitionfor his work, which is evidenced by the many awards andhonours he received, including Gold Medals from both theRadiological Society of North America and the Association ofUniversity Radiologists. He was also an Honorary Member ofthe French, German and Japanese national radiological societiesand served as president of the International Society for StrategicStudies in Radiology from 2003 to 2005.Gary Glazer is survived by his wife Diane and two sons Danieland David.25

José CáceresBarcelona/ESGold MedallistIn recognition of hismany years of dedicationto radiological educationand training, as well as histireless efforts to promotethe discipline of radiologyin Europe and aroundthe world, Professor JoséCáceres will be awarded theGold Medal of the EuropeanSociety of Radiology atECR 2013.26

ESR DignitariesJosé Cáceres is a professor and former head of diagnostic radiologyat H.G.U. Vall d’Hebron Universidad Autonoma, Barcelona,Spain. He is also a long-standing member of the ESR andis well-known for his series on the ESR blog, ‘Cáceres’ Corner,’in which he and his puppet colleague challenge radiologists tosolve specific cases and take away some important lessons.Prof. Cáceres was born in Seville, Spain in 1940. He studiedmedicine at the University of Seville from 1957 to 1964, beforemoving to the United States in 1965. In the US, he completed aninternship at Cook County Hospital in Chicago and later servedhis residency at the University of Cincinnati from 1966 to 1969,followed by a one-year fellowship in diagnostic radiology. Hewent on to serve as assistant professor of radiology at the Universityof Kentucky before returning to Spain in 1971.Back in his home country, Prof. Cáceres built up a wealth ofclinical and academic experience. He served as head of departmentand professor in a number of institutions in Madrid, Val-ladolid and Barcelona. In 1996, he took up the posts of professorof radiology and head of diagnostic radiology at the H.G.U. Valld’Hebron Autonomous University of Barcelona, where he serveduntil his retirement in 2010.A valued and distinguished member of the international radiologicalcommunity, Prof. Cáceres is a member of a number ofscientific societies including, the Radiological Society of NorthAmerica, the Spanish Society of Radiology, the Spanish Societyof Thoracic Imaging (SEIT) and the European Society of ThoracicImaging (ESTI). He has served as president of both ESTIand the SEIT, and at ECR 2011 he delivered the Josef LissnerHonorary Lecture.Over the course of his career, Prof. Cáceres has published extensivelyand has 87 peer-reviewed articles, 12 book chapters anda book to his name. He has also served as chest section editorfor the European Journal of Radiology and editor-in-chief of theSpanish radiological publication, Radiología.27

Johannes LammerVienna/ATGold MedallistIn recognition of hisscientific achievementsand his dedication tointernational exchange andcooperation in the fieldof radiology, ProfessorJohannes Lammer will beawarded the Gold Medalof the European Society ofRadiology at ECR 2013.28

ESR DignitariesJohannes Lammer is vice-chairman of the department of radiologyand director of cardiovascular and interventional radiologyat the Medical University of Vienna, Austria.Born in Vienna, Prof. Lammer studied at the University ofVienna Medical School, where he graduated in 1975, beforemoving on to work as an intern at hospitals in Bregenz andFeldkirch. He then went to Graz, to complete his residencyin radiology at Karl Franzens University. In 1982, he travelledto the United States, where he held visiting fellowships at thedepartment of radiology, University of Pennsylvania, Philadelphia,the MD Anderson Hospital and Tumor Institute at theUniversity of Texas in Houston, and the department of radiologyat the University of California in San Francisco. In 1984,he took up the post of associate professor of radiology at KarlFranzens University, Graz. In 1990, he became head of thedepartment of angiography and interventional radiology at theUniversity of Vienna.On top of this impressive academic and clinical career, Prof.Lammer has also been very active in the field of internationalscientific collaboration and exchange. From 1996 to 1997, heserved as president of the International Society of Hepato-Biliary-PancreaticRadiology, followed by presidency of the AustrianSociety of Angiology, from 1999 to 2000. A long-standing,active and highly valued member of the Cardiovascular andInterventional Radiological Society of Europe, he has servedas its treasurer, secretary and president, which exemplifies hisdedication to promoting international cooperation within thefield of interventional radiology.As an author, Prof. Lammer has published more than 300 articlesin peer-reviewed journals such as Radiology, Circulation,The Lancet and the New England Journal of Medicine. He hasalso written a number of abstracts and book chapters, as wellas a book, Praxis der Interventionellen Radiologie (The Practiceof Interventional Radiology). His research interests include CTand MR angiography of coronary and peripheral arteries, IRtreatment of peripheral vascular and aortic diseases, as well asHCC and liver metastases.As a result of his work, Prof. Lammer has received a numberof awards and honours throughout his career, including honorarymembership of the Austrian Society of Radiology, theAustrian Society of Interventional Radiology, the HungarianSociety of Interventional Radiology and the Turkish Societyof Radiology. He has also received Honorary Fellowship ofthe British Society of Interventional Radiology and the GoldMedal of the Cardiovascular and Interventional RadiologicalSociety of Europe.29

Maximilian F. ReiserMunich/DEGold MedallistIn recognition of yearsof groundbreaking workin clinical radiology andhis devotion to fosteringcooperation on a Europeanand international level,Professor Maximilian Reiserwill be awarded the GoldMedal of the EuropeanSociety of Radiologyat ECR 2013.30

ESR DignitariesMaximilian F. Reiser is professor of radiology, chairman of thedepartment of clinical radiology, and dean of medicine at LudwigMaximilians University of Munich.In 1973, Prof. Reiser received his medical degree from the LudwigMaximilians University of Munich, the same institution henow heads. He then completed his residency at the diagnosticradiology department of the Technical University of Munichin 1983. He later served as an assistant professor at the sameinstitute, before moving on to become an associate professor atthe University of Münster in 1986. He then went on to take upthe post of professor and chairman of radiology at the Universityof Bonn in 1989, where he worked until he returned to hisalma mater in 1993. He has served as professor and chairman ofLudwig Maximilians University’s department of radiology since1993, and in 2008 he was appointed dean of medicine.A well-known figure within the international radiological community,Prof. Reiser has taken an active interest in promotingand furthering the interests of his discipline. A long-time andactive member of the European Society of Radiology, he servedas president of the Society’s congress in 2008, and went onto serve as president of the society in 2010–2011. He has alsoserved as president of the German Radiological Society, theEuropean Society of Musculoskeletal Radiology and the jointcongress of the German Radiological Society and AustrianRadiological Society in 2001.With more than 500 original publications to his name, Prof.Reiser has authored extensively throughout his distinguished clinicaland academic career. His main research interests includeskeletal radiology, magnetic resonance imaging, abdominal andcardiac imaging, as well as oncologic interventions. Among themany awards he has received throughout his career are HonoraryFellowship of the Royal College of Radiologists and the AmericanCollege of Radiology. He was also awarded the Holthusen RingAward of the German Radiological Society. Prof. Reiser is alsoan honorary member of many national radiological societies,including those of Austria, France, Switzerland, Korea, Greece,Japan, India and Iran, as well as being an honorary member ofthe Radiological Society of North America. He has also receivedhonorary membership of the Leopoldina, the German NationalAcademy of Science, as well as an honorary doctorate from theveterinary faculty of Ludwig Maximilians University and TiflisState University. He was also made Foreign Associate of the NationalAcademy of Science (USA) Institute of Medicine (IOM).31

Jesús PrietoPamplona/ESOpening LecturerIn recognition ofhis expertise andgroundbreaking workin the field of primarybiliary cirrhosis and genetherapy of liver diseases,the European Society ofRadiology has invitedProfessor Jesús Prietoto deliver the OpeningLecture, entitled ‘Promisesand facts of liver-directedgene therapy’, at ECR 2013.32

ESR DignitariesJesús Prieto is professor of medicine and director of the departmentof hepatology and gene therapy at the Centre for AppliedMedical Research at the University of Navarra, Spain. He alsoserves as a consultant internist at the University of NavarraClinic.An expert in the field of hepatology, Prof. Prieto is considered tobe a pioneer of gene therapy in Europe. His research has focusedmainly on understanding the underlying mechanisms of liverdisease and on the development of new therapies for acute andchronic liver damage. He is credited with contributing to theunravelling of the pathogenesis of primary biliary cirrhosis,where he showed that a defect in bicarbonate transport inducesboth bile duct injury and immune dysfunction.Through his research, Prof. Prieto has analysed the role of IGF-Ideficiency in the progression of liver cirrhosis and has producedclinical and experimental data to show that IGF-I replacementtherapy can induce regression of liver fibrosis and a reductionof portal pressure, along with a significant improvement in liverfunction. In addition, he has identified cardiotrophin-1 as amolecule with potent hepatoprotective properties, making it anatural defence against apoptosis and a potential therapy forpatients with acute, severe liver damage.A member of many national and international societies dedicatedto the study of the liver, Prof. Prieto has served as presidentof the Spanish Association for the Study of the Liver and on theScientific Committee of the European Association for the Studyof the Liver. He was made Doctor Honoris Causa by the Universityof Porto (Portugal) and the University Austral of BuenosAires (Argentina).Prof. Prieto has authored more than 300 articles, which haveappeared in many prestigious peer-reviewed journals such as theNew England Journal of Medicine, Journal of Experimental Medicine,Journal of Clinical Investigation, Cell Metabolism, PNAS,Gastroenterology, Journal of Clinical Oncology and many others.33

Carlo CatalanoRome/ITHonorary LecturerIn recognition of hisresearch and work in theareas of cardiovascularimaging and interventionalradiology, Professor CarloCatalano has been invitedto present the Josef LissnerHonorary Lecture, entitled‘MR-guided focusedultrasound: a new string tothe radiologist’s bow’,at ECR 2013.34

ESR DignitariesCarlo Catalano is professor of radiology and head of the departmentof diagnostic radiology at La Sapienza University of RomeHospital.Born in Rome in 1965, Prof. Catalano received his medicaldegree from La Sapienza University of Rome in 1990 beforecompleting his residency at the University of L’Aquila in 1994.Up until 1999, he worked as a staff radiologist in the departmentof radiology and the department of emergency radiologyat La Sapienza University of Rome. During this time he focusedmainly on CT and MR body imaging along with cardiovascularimaging and interventional procedures. In 1999, he becameassistant professor of radiology at La Sapienza, as well as assistantprofessor at the Campus Bio-Medico University, Rome.Throughout his career, Prof. Catalano has dedicated much ofhis time to research and education. He became full professor ofradiology at La Sapienza University of Rome in 2010, after eightyears of teaching and research as associate professor. He servesas the Italian delegate to the European Society of Radiology’sEducation Committee and has served as a member of the EuropeanSchool of Radiology’s faculty for its Teach-the-Teachersprogramme in Italy, which reflects his experience and passionfor the field of radiological education and training.Prof. Catalano has been an active member of the ESR since thebeginning of his career, participating as a panellist and as anorganiser for the Junior Film Reading Session at ECR 1999. Furthermore,during his career he has shown great dedication todeveloping relations with less developed countries, with the aimof sharing radiological knowledge.A prolific author and researcher, Prof. Catalano has authoredmore than 170 scientific papers, six books and upwards of 50book chapters. On top of this, he has delivered more than 150invited lectures at national and international conferences.35

Jean-François ‘Jeff’GeschwindBaltimore, MD/USHonorary LecturerIn recognition of his work incancer research and his effortsto further the developmentof oncologic imaging andinterventional oncology,Professor Jean-FrançoisGeschwind has been invitedby the European Societyof Radiology to deliver theWilhelm Conrad RöntgenHonorary Lecture, entitled‘Interventional oncology:the era of molecular targetedtherapy’ at ECR 2013.36

ESR DignitariesJean-François Geschwind is professor of radiology, surgery, andoncology, and director of the division of vascular and interventionalradiology at the Johns Hopkins University School ofMedicine in Baltimore, Maryland/US. He is also director of theInterventional Radiology Center and chief of interventionalradiology research at the Johns Hopkins Hospital.Originally from France, Prof. Geschwind began his early medicaltraining at the University of Paris School of Medicine andsubsequently moved to the United States, where he studied atthe University of Pennsylvania and then completed his medicaldegree at Boston University School of Medicine in Massachusetts.He completed his residency training in diagnosticradiology as a research scholar (sponsored by the NationalInstitutes of Health) at the University of California, San Franciscoin 1996. He went on to complete his two-year trainingin vascular and interventional radiology at the Johns HopkinsUniversity School of Medicine, before joining the faculty thereas an assistant professor. In 2002, he was appointed directorof the division of vascular and interventional radiology andthe Interventional Radiology Center at Johns Hopkins Hospital,and in 2007 he was promoted to professor of radiology,surgery and oncology at the Johns Hopkins University Schoolof Medicine.A leading figure in the field of liver cancer, Prof. Geschwind hasfocused most of his research on hepatic cancer. He has receivednumerous grants from foundations, industry and the federalgovernment for his research in the field.Prof. Geschwind has authored or co-authored more than 350 scientificarticles and abstracts on interventional radiology and, morespecifically, the treatment of liver cancer. As lead or co-investigatoron more than 40 clinical trials, Prof. Geschwind’s research hasbeen published in highly rated peer-reviewed journals, includingthe Journal of Clinical Oncology, Clinical Cancer Research, Radiology,European Radiology, Gastroenterology and Annals of Surgery.He has also won numerous national and international awardsin recognition of his research accomplishments. In addition tohaving co-authored the first book dedicated to interventionalradiology, entitled Interventional Oncology: Principles and Practice,Prof. Geschwind is currently co-editing the book, AbramsAngiography: Interventional Radiology with Dr. Michael Dake.A prolific speaker and lecturer, both nationally and internationally,Prof. Geschwind has delivered over 200 keynote speechesat scientific assemblies, annual meetings and symposia. He hasalso served as visiting professor at many prestigious institutionsthroughout the world.37

Luis Martí-BonmatíValencia/ESHonorary LecturerIn recognition of hisdedication to scientificresearch and development,Professor Luis Martí-Bonmatí has been invitedby the European Societyof Radiology to presentthe Santiago Ramón yCajal Honorary Lecture,‘Research and science: fromindividuals to societies – theRamón y Cajal background,’at ECR 2013.38

ESR DignitariesLuis Martí-Bonmatí is director of medical imaging at La Fe Universityand Polytechnic University Hospital, and chief of radiologyat Quirón Hospital, Valencia, Spain. He is also professor ofradiology at Valencia University.After completing his undergraduate medical training at theUniversity of Valencia in 1983, Prof. Martí-Bonmatí worked asa resident at La Fe University Hospital Valencia until 1987. Hethen began work on his Ph.D. thesis, ‘MRI in the study and characterisationof focal liver lesions’, which earned him a doctoratewith excellence from the University of Valencia in 1990.As a researcher, Prof. Martí-Bonmatí’s interests lie mainly in thefields of liver MR and CT, abdominal and pelvic MRI, contrastagents, image processing, and imaging biomarkers. With morethan 200 articles listed in PubMed and 55 book chapters to hisname, he is an established scientific author. As an editor he hascontributed to eight books. He has also supervised twenty-twoPh.D. students, and has delivered hundreds of presentations atscientific meetings, symposia, and international conferences.On top of his work as a clinician and academic, Prof. Martí-Bonmatí has also been engaged in strengthening internationalties within the field of radiology. He is an active member ofmany European scientific societies and has served as presidentof the Spanish Society of Radiology, the European Society forMagnetic Resonance in Medicine and Biology and the SpanishSociety of Abdominal Imaging. In addition to these presidencies,he has served as vice-president of the European Society ofGastrointestinal and Abdominal Radiology.He is a long-time member of the European Society of Radiologyand currently serves as chairman of the society’s ResearchCommittee.39

Customiseyour congress!Plan and personalise your ECR 2013 experiencewith the Interactive Programme Planner.The IPP offers a great, convenient way to explore the whole ECR programmeonline and create a custom timetable. You can search or browse for sessionsand posters, read full abstracts, create a personal calendar, and even print your ownpersonalised Book of Abstracts. It’s also optimised for mobile devices, meaning you cankeep every detail that’s important to you exactly where you need it – right in your hand.Plan your own personalised congress and you’ll never lose track again ...ipp.myESR.org

GeneralInformation42 Information from A to Z50 CME at ECR 201352 ESR Meets Sessions53 EFRS Meets Session55 Plenary Sessions56 Social Media Guide59 Image Interpretation Quizzes61 MIR@ECR62 EPOS – Scientific Exhibition65 eLearning Tools66 Special Exhibition67 Cafés & Restaurants67 Free Publications71 ECR 2013 welcomes its industry partners73 ESR Journals75 Underground Map

General InformationInformation from A to ZArts & CultureDelegates are encouraged to visit the Arts & Culture Desk in theentrance hall for information on Vienna’s cultural events such asexclusive opera performances, delightful concerts, and the fascinatingexhibitions in Vienna’s most important and remarkablemuseums. Pick up your personal Arts & Culture Brochure atthis counter to find descriptions of all cultural places.BadgesFor organisational and security reasons, badges must be wornat the congress venue. Access to the different areas will only begranted upon presentation of an appropriate badge.Please note that in order to obtain CME credits, it is mandatory toaffix your Personal ID stickers to the evaluation forms available ineach scientific session, and to drop these into the dedicated boxes.Lost or Forgotten BadgesIn the case of loss, a replacement badge will only be provided onfull payment of the applicable onsite registration fee.Forgotten badges will be replaced against a deposit of the fullonsite fee.Book of Abstracts – ‘Insights into Imaging(Supplement 1 to Volume 4)’Professional delegates will find a complimentary copy in theircongress bag.Please note that in accordance with the ESR members’ wishes, theprint version of the Book of Abstracts contains Scientific Sessionsonly. The extended version of the Book of Abstracts, includingthe Postgraduate Educational Programme and Satellite Symposiacan be accessed at www.i3-journal.org/articles.You can also create your own personal Book of Abstracts withthe help of the popular ECR Interactive Programme Planner(ipp.myESR.org).Abstracts of EPOS presentations no longer appear in the Bookof Abstracts. Each full EPOS presentation can instead be citedby a Digital Object Identifier (DOI), which appears with thepresentation at www.myESR.org/EPOS.Broadcast RoomsFor the second time, the ECR features specific Broadcast Rooms,where you can listen to sessions and view the corresponding presentationmaterial in a relaxed atmosphere when the actual lecturerooms are overcrowded. Broadcast Rooms/Zones are located nextto room B (2 nd level), rooms L/M and N/O (1 st level), rooms E1and F2 (entrance level) and rooms G/H and I/K (lower level).See Floor Plans on pages 78–84.Business CentreThe Press Office & Business Centre, located on the entrance level,offers copy and fax facilities for a small charge.Opening hours:Thursday, March 7 to Monday, March 11: 08:00–18:00Cafés & RestaurantsIf you are looking for an ideal meeting point, or if you just wantto take a short break, try one of the various foyer cafés and restaurants.They are situated throughout the whole congress venueand on all levels of the building, offering a variety of tasty hotand cold snacks.To offer you the broadest possible variety of Austrian and internationaldelicacies, each café and restaurant has its own theme,from Austrian specialties to Italian treats and Asian delights.See page 67.Please see the ‘coffee-cup’ signs on the floor plans on pages 78–84of this programme to locate the various foyer cafés.Cases of the DayFrom Thursday to Sunday, five Cases of the Day covering differentsections of radiology are shown on computer stations inthe EPOS classroom on the 2 nd level. Participants are invited tosubmit their diagnoses. The winners will be announced on theESR website.We would like to acknowledge the contribution of the followingauthors to the Cases of the Day:Thursday:Case 1: R. Basilico, E. Rodolfino, L. Migliorato, V. Calamita,A.R. Ferri, A.R. Cotroneo; ItalyCase 2: P. Belli, M. Di Matteo, M. Giuliani; ItalyCase 3: M.B. Damasio, F. Rizzo, C. Mattiuz, G.M. Magnano; ItalyCase 4: R. Viguer, F. Aparici, F. Mas, L. Martí-Bonmati; SpainCase 5: M.P. García-Peña, L. Cadavid Álvarez; SpainFriday:Case 1: P.I. Davydenko, G.G. Karmazanovsky; RussiaCase 2: K. Gruszczynska, P. Ulbrych, K.S. Gołba, J. Biernat,J. Baron; PolandCase 3: E. Fisci, A. Tagliafico; ItalyCase 4: G.C. Colleran, M.J. Shelly, B.D Murphy, H.M. Fenlon,E.C. Kavanagh; IrelandCase 5: C.A. Acevedo, I. Delgado, A. Sanchez-Montanez,E. Vazquez; SpainSaturday:Case 1: P.L. Di Paolo, H.A. Vargas, O. Akin, H. Hricak;Italy/United StatesCase 2: K.-F. Kreitner, N. Abegunewardene; GermanyCase 3: I.I. Reidsma, M. Reijnierse; NetherlandsCase 4: I.G. Lupescu, G.A. Popa, C.A. Nicolae; RomaniaCase 5: S. Speca, C. Borelli, G. Soglia, L. Bonomo; ItalySunday:Case 1: E. Astrinakis, N. Courcoutsakis, A. Karayiannakis,P.K. Prassopoulos; GreeceCase 2: M.-P. Revel, B. Fedida; FranceCase 3: M.J. Shelly, G.C. Colleran, B.D. Murphy, H.M. Fenlon;IrelandCase 4: L. Holzer-Frühwald, M. Pones, C. Kölblinger,M.M. Thurnher; AustriaCase 5: M. Teodorescu, E. Coche, B. Ghaye; Belgium42

General InformationInformation from A to ZCategorical CoursesThere are two new Categorical Courses, entitled ‘Oncologic Imaging:Follow-up of Systemic and Local Therapies’ and ‘CLICK(Clinical Lessons for Imaging Core Knowledge): Never withoutArteries’ at ECR 2013. The Categorical Course ‘Urogenital Imaging’is repeated from ECR 2012. The latter and the CLICK Courseare interactive courses with electronic voting/self assessment. Forboth courses, voluntary self-assessment tests will be available afterthe last session is finished. Tests can be accessed online (assessment.myESR.org)as well as via the EPOS classroom.Places on each course are allocated on a first-come, first-servedbasis. Please refer to pages 109–111 for the course programmes.Churches and Religious Communities in ViennaVienna is a multi-denominational, multi-cultural city. We willbe pleased to provide you with information on local religiouscommunities and places of worship at the Travel Service Desk.CME Accreditation SystemPlease make sure you pick up an evaluation form, which is providedat the entrance of each room. Then affix one of your PersonalID stickers to the evaluation form and drop it into thededicated box in front of each room. This is mandatory in orderto obtain CME credits.See pages 50–51.Coat CheckThe coat check services are located on the entrance level, in FoyersE and F, as well as on the lower level next to Room D1.Communication AreasIf you are looking for the perfect place to meet and talk withfriends or just to relax and browse through ECR Today, ECR2013 offers two areas perfectly equipped for communicationand recreation; the ESR Welcome Lounge right in the middleof the entrance hall and the EPOS Lounge on the 2 nd level ofthe congress venue.Confirmation of Payment and Attendance /CME AccreditationCongress-related confirmation will be available during and afterthe congress from the ESR website (www.myESR.org) via theMyUserArea (login with your last name and your Personal ID asprinted on your badge). Internet access is provided at the registrationterminals (from Saturday, March 9, afternoon onwards) aswell as at the internet points (see floor plans) and W-LAN areas,which are available throughout the congress venue.Congress LanguageEnglishCongress VenueAustria Center ViennaBruno Kreisky Platz 11220 Vienna, AustriaPhone: (+43 1) 533 40 64–0To reach the ACV by public transport from the city centre(Stephansplatz) take the U1 underground line (red line, directionLeopoldau). Get off at Vienna International Centre/Kaisermühlenand take the exit marked Schüttaustraße.Travelling time: approximately eight minutes.‘ECR Live’After last year’s success, the ESR is once again providing a livestreaming service for ECR 2013, under the name ECR Live, in aneffort to bring the ECR to everyone. The majority of ECR sessionsare being broadcast live via the ESR website, with Facebookand Twitter options integrated into the web interface to providea fully interactive experience.ECR Live is kindly supported by Siemens.Link: live.myESR.orgECR TodayECR Today, the popular daily newspaper of the congress, is publishedfrom Thursday to Monday (with a special issue dedicatedto the European Diploma in Radiology on Wednesday) and distributedin the entrance hall of the congress venue and in theentrance area of the Technical Exhibition.ECR 2013 Smartphone AppThe ECR 2013 App gives iPhoneand Android users a new way toexperience the congress. The app ispacked with features, including generalcongress information, scientificand educational programme details,top news stories from ECR Today, fullabstracts, and even floor plans of theAustria Center. You can download theapp from iTunes or via the QR codeto the right.The ECR 2013 App is kindly supported by Bracco.EDIPS – ECR’s Digital Preview SystemSee Preview Centre.EFOMP (European Federation of Organisations forMedical Physics) WorkshopThis workshop is the 15 th in the series of EFOMP Workshops on‘New Technology in Diagnostic Radiology’. This year’s workshopfocuses on ‘New frontiers in imaging of the lung’. It has beenorganised by EFOMP in collaboration with the ESR to addressthe current and future technological requirements for radiologyimaging equipment (please refer to page 135).43

General InformationInformation from A to Z‘EFRS Meets’ SessionAt ECR 2013 the relationship between the ESR and the EuropeanFederation of Radiographer Societies (EFRS) will reach a newlevel of cooperation. The EFRS is hosting the session ‘EFRS meetsSpain’, underlining the essential role of radiographers in medicalimaging. Please refer to page 53 for the programme of the session.EIBIR BoothVisit the EIBIR Booth in the entrance hall for the most recentnews on the European Institute for Biomedical Imaging Research.EIBIR presents IMAGINEAfter last year’s success, EIBIR again presents the IMAGINEWorkshop. The sessions will feature research institutes, universitygroups and research departments of industrial companies, presentingnovel and exciting technological developments in the fieldof diagnostic and interventional radiology. See pages 142–143.Emergency Information/First AidFor fire, medical or police assistance, please contact ACV Informationor the nearest available ECR or ACV staff member. Amedical specialist trained in emergency medicine will be presentfor the duration of the congress.EPOS – Scientific ExhibitionThe ECR 2013 electronic scientific exhibition is open Thursdayto Monday from 08:00 to 18:00. The EPOS Area, consisting of aclassroom with 80 workstations and a lounge, is located in FoyerA on the 2 nd level.A wireless internet network is available in the EPOS Lounge(name ‘EPOS WiFi’), through which the poster exhibition canbe accessed as if from within the classroom.At ECR 2013, EPOS is again offering discussions on hot topicsin radiology, where authors of the highest-scored posters in eachfield will discuss them with a moderator.Note: On Saturday, March 9, 12:15–13:15, the EPOS classroomwill be closed for the self-assessment test for the participants ofthe Foundation Course on Neuroimaging.EPOS is kindly supported by Hewlett-Packard.See pages 62–63.ESOR BoothVisit the ESOR Booth in the entrance hall for the latest news onthe European School of Radiology. In addition, there is an ESORInfo Desk in the Rising Stars Lounge.‘ESR Meets’ SessionsThe purpose of ‘ESR meets’ is to forge closer ties between theESR and its guest societies. The three guest nations of this year’sECR are Chile, South Africa and the Congress President’s homecountry, Spain. There are dedicated sessions for the radiologicalcommunities of these nations to demonstrate the excellence ofradiology in their countries.In addition, ECR 2013 again features special activities focusingon a partner discipline, providing a platform to establish closerties. This year’s guest in the series will be the European-AfricanHepato-Pancreato-Biliary Association.Places at these sessions are allocated on a first-come, first-servedbasis. Please refer to pages 52–53 for the programme of thesessions.ESR Welcome LoungeVisit the ESR Welcome Lounge in the entrance hall! Whetheryou are looking for an ideal meeting point or just want to take ashort break – the ESR Welcome Lounge will suit your needs. Freewireless LAN is provided for your convenience.Watch out for artistic performances from the ‘ESR meets’ countriesduring the lunch breaks!European Diploma in Radiology (EDiR)An examination for the European Diploma in Radiology is beingheld at ECR 2013. The electronic-based written examinationtakes place on Wednesday, March 6, in the EPOS Area on the2 nd level, whereas the case-based oral examinations take place onThursday, March 7, and Friday, March 8, in various rooms closeto the EPOS Area.Success in the examination certifies a standard of radiologicalknowledge deemed appropriate by the ESR for independentpractise in General Radiology.Make sure you grab the special EDiR edition of ECR Today onWednesday.www.myESR.org/diploma‘European Radiology’Visit the booth of the ESR’s flagship journal, European Radiology,in the entrance hall.See page 73.EURORADEURORAD is the largest peer-reviewed radiological teachingdatabase on the internet, accessible free of charge to all ESRmembers. Please visit the EURORAD booth in the entrance hall.Expo GalleryOpening hours:Thursday, March 7: 14:00–18:00Friday, March 8 to Monday, March 11: 10:00–18:00Visit the additional technical exhibition area on the 1 st level ofthe congress venue!44

General InformationInformation from A to ZFace-Off SessionSee Post-Processing Face-Off Session.Foundation CourseThis basic teaching course, which takes place under the headingof E³ – European Excellence in Education, in room E2 on theentrance level, is designed to be suitable for trainees and for thosewho wish to refresh their knowledge. The motto of the course is‘All you need to know about neuroimaging in 18 easy lessons.This course answers your questions!’The course concludes with a self-assessment test in the EPOSArea on Saturday, March 9, 12:15–13:15.Course places are allocated on a first-come, first-served basis.Please refer to page 136 for the course programme.Free PublicationsThe ESR again presents the ‘Free Publications’ Booth on the 2 ndlevel, integrated into the EPOS Lounge. Pick up free copies ofradiology journals and magazines and get free access to onlineradiology journals. Free bags are provided for your convenience.Future Meetings DeskThis area – located on the lower level next to Rooms D1 andD2 – offers you an overview of future meetings in the field ofradiology and related disciplines, from all over the world. Feelfree to contribute flyers and posters to promote your own meetingsand courses.Hands-On WorkshopsSee Update Your Skills (Practical Courses).IMAGINESee EIBIR presents IMAGINE.‘Insights into Imaging’Insights into Imaging is the ESR’s journal for education and guidelines.It is open access and PubMed indexed. A special printedissue of Insights into Imaging has been placed in all students’and residents’ congress bags. Free copies are also available at theInsights into Imaging booth in the entrance hall.See page 73.Industry Hands-On WorkshopsAt ECR 2013 there are various Industry Hands-On Workshopsscheduled, organised by Hologic and Siemens Healthcare.See page 153 for details.Interactive Programme PlannerThe ESR is again proud to present this popular interactive toolfor ECR 2013. The IPP provides a convenient way to explore andcustomise the congress programme online, in both traditionalbrowser and mobile device versions.Featuring various search and browse functions for sessions as wellas posters, the IPP also includes a ‘basket’ option, which enablesusers to collate items from the programme to create their own personalcalendar and even print a personalised Book of Abstracts.The IPP 2013 is kindly supported by Siemens.Link: ipp.myESR.orgInteractive Teaching SessionsUnder the heading of E 3 – European Excellence in Education,ECR 2013 presents 14 interactive teaching sessions dealing withspecific topics of common radiological problems, emergencies,imaging of cancer and infections, establishing a two-way interactionbetween the presenters and the participants.The material is presented in an interactive way, with audienceparticipation and self assessment through the use of an electronicvoting system (key-pads).Places are allocated on a first-come, first-served basis.Please refer to page 137 for the programme of the sessions.Internet PointsComputer terminals with internet connections are available onthe 1 st level and in Extension Expo A, and can be used for variouspurposes. Delegates can compile their personal session itinerariesusing the Interactive Programme Planner, send e-mails andbrowse the internet.(Junior) Image Interpretation QuizThe Image Interpretation Quizzes are two traditional highlightsof every ECR. This year’s themes are ‘Radiology is global’ and‘Golden Eye’ (see page 59).LiabilityESR and the Austria Center Vienna are free from all liabilitiesthat may arise from the delegates’ and presenters’ participationin ECR 2013 and its activities.Lost and FoundLost and found articles may be picked up or handed in at theACV Information Desk located in the entrance area.Meditation & Prayer RoomThe Meditation & Prayer Room is located on the lower level inFoyer G/H. You will find it marked on the floor plan.Meeting RoomsMeeting rooms at ECR 2013 are to be found on:3 rd Level Meeting Rooms 1–92 nd Level Meeting Rooms 10–131 st Level Meeting Room 14Lower Level Meeting Rooms 15–16You will find them marked on the floor plan.Please contact the Info Service Desk on the 3 rd level for access toand onsite booking of meeting rooms.MembershipFor membership application and renewal, please go to the registrationdesks in the entrance hall.45

General InformationInformation from A to ZMini CoursesECR 2013 features three new Mini Courses, ‘Controversies inBreast Imaging’, ‘The Beauty of Basic Knowledge: Head and Neck’and ‘The Beauty of Basic Knowledge: Musculoskeletal Imaging’.The joint course of the ESR and RSNA ‘Essentials in OncologicImaging: What Radiologists Need to Know’ is repeated from lastyear. The ‘Organs from A to Z’ series, introduced at ECR 2010,will this year focus on the heart.The ‘Organs from A to Z’ course, the course on breast imaging andthe ESR/RSNA course sessions will be interactive with electronicvoting/self assessment.Places for all courses are allocated on a first-come, first-servedbasis.The ‘Organs from A to Z’ course is accompanied by a voluntaryself-assessment test that will be available after the last session isfinished. Tests can be accessed online (assessment.myESR.org)as well as via the EPOS classroom.Please refer to pages 112–114 for the courses’ programmes.MIR@ECRAfter last year’s success, the ESR Subcommittee on Managementin Radiology has again organised a special session at the ECR oncore managerial issues and supportive methods and techniques.It takes place on Saturday, March 9, 13:00–17:30 in Room Q.See page 61.Mobile GuideGet the ECR on your smartphone and always stay up to date! TheECR Mobile Guide brings ECR 2013 to the palm of your hand.Find out all about sessions/lectures, abstracts, exhibitors, floorplans and places to be.Link: m.myESR.orgMultidisciplinary Sessions:Managing Patients with CancerThese sessions are intended to promote a multidisciplinaryapproach to cancer detection and treatment, by bringing togetherradiologists, surgeons and oncologists to share their expertise.The topics that are covered this year are: colorectal liver metastases,hepatocellular carcinoma and cholangiocarcinoma.Please refer to page 108 for the programme of the sessions.New Horizons SessionsThe aim of the New Horizons Sessions is to provide practitionerswith an overview of the new developments in a specific areaof practice e.g. specialty, technique, or disease. These developmentsmay become routine within a few years, or may indicatea new direction for research and clinical application. There arethree New Horizons Sessions, entitled ‘Cartilage imaging’, ‘MR/PET: a marriage made in heaven or hell?’ and ‘Imaging of themind’, at ECR 2013. Session places are allocated on a first-come,first-served basis. Please refer to page 100 for the programmeof the sessions.Plenary SessionsSee page 55.Post-Processing Face-Off SessionThe ‘Workstation Face-Off ’ session takes place in Room B onFriday, March 8, 08:30–10:00.The aim of this session is to simulate a realistic ‘reading room’atmosphere and to give an impression of how different workstationsperform in a clinical scenario. We would like to cordiallyinvite you to attend this exciting tournament of post-processing(see page 139).PressThe ECR 2013 Opening Press Conference takes place on Thursday,March 7, at 09:30 at the Austria Center Vienna, MeetingRoom 14 (1 st level). For press accreditation, please contact thePress Office & Business Centre on the entrance level. To obtaina press badge, you must present an international press ID or aconfirmation letter from the relevant medium.Delegates and exhibitors may display their press kits in the PressOffice & Business Centre. There are also several publicly availablecomputer terminals as well as workspace and plug points for youto work with your personal laptop.Opening hours:Thursday, March 7 to Monday, March 11: 08:00–18:00Preview Centre – EDIPSEDIPS, the ECR’s digital preview system, allows for fast and easypresenter identification through badge scanning. Large screensin the waiting area display the names of the presenters who areasked to proceed to the Check-In counter, where they can handin their presentations. At the Preview Stations, presenters have theopportunity to do a final check on their presentations. This year,presenters were offered the option of submitting their materialprior to the congress.The Preview Centre is located on the 1 st level, next to Room N/O.Opening hours:Wednesday, March 6: 12:00–18:00Thursday, March 7 to Monday, March 11: 07:00–18:00Please note that only digital material will be allowed for oralpresentations.The material must be in English and must be provided on CD-ROM, DVD, ZIP disk or USB devices so that it can be transferredto a central server onsite. It is mandatory that the data carriersare delivered to the audiovisual preview centre 2 hours prior tothe session, at the latest. Computers connected to data projectorsare provided in each lecture room for the speaker to retrievethe saved data.The material remains the property of the speakers.Professional Challenges SessionsThese sessions are intended to communicate and exchange issueson radiological training and education, research networking,radiological management and professional developments. Thisyear’s topics are ‘Bringing radiology to medical undergraduates’,‘The visibility of the radiologist’, ‘Personalised radiology’, ‘Legalmatters related to multimodality techniques’ and ‘The radiologist,the clinician and the patient: an impossible trio?’.Places are allocated on a first-come, first-served basis. Please referto page 107 for the sessions’ programme.46

General InformationInformation from A to ZPublic TransportTickets for public transportation are available at the registrationdesks in the entrance area.Special ECR Ticket:6 days (valid from March 6–11): € 20.00Underground map; see page 75.Publishers Row (1 st level) & Partner Publishers(entrance level)Opening hours:Thursday, March 7: 14:00–18:00Friday, March 8 to Monday, March 11: 10:00–17:30Browse through a wide range of scientific publications displayedby the most important publishers in the field of medicine.Radiology Trainees Forum (RTF)The RTF promotes and coordinates the efforts of radiology traineesat a European level in order to improve the progress of radiologyand related sciences. One of the RTF’s most important goalsis to provide an equal level of radiological knowledge and skillsfor radiology trainees all over Europe.Highlighted Lectures organised by the RTF will be given onSunday, March 10, 10:30–12:00 in Room Q (see page 141).The RTF General Assembly takes place on Sunday, March 10,14:30–16:00, in Meeting Room 9 (3 rd level). For more detailedinformation please visit the RTF Meeting Point in the RisingStars Lounge (Foyer B, 2 nd Level).Recording / PhotographyVideo or audio recording of presentations is not allowed withoutthe speaker’s/exhibitor’s and ECR’s prior permission. Flash photographyis not permitted during presentations. Interviews musttake place outside the lecture room. For queries, please contactthe ESR Press Office.Refresher Courses75 Refresher Courses have been organised by the various scientificsubcommittees for ECR 2013. Based on the topic of thesession, some refresher courses are presented in an ‘integrated’format with an organised panel discussion, similar to SpecialFocus Sessions.Places are allocated on a first-come, first-served basis.Please refer to pages 115–134 for the programme of the sessions.Registration Opening HoursWednesday, March 6: 12:00–18:00Thursday, March 7: 07:00–18:00Friday, March 8: 07:00–18:00Saturday, March 9: 07:00–18:00Sunday, March 10: 07:00–18:00Monday, March 11: 07:00–18:00Restaurant ReservationsOur staff at the Dining & Shopping Desk in the entrance hall willbe pleased to recommend places to eat close to your hotel or neara certain theatre, and will be happy to reserve a table for you.Rising Stars Lounge / Residents & Students LoungeThe Rising Stars Lounge for residents and students is locatedon the 2 nd level, Foyer B. In the lounge you will find informationon the European School of Radiology, the European Diploma ofRadiology and the Radiology Trainees Forum.Rising Stars ProgrammeSee pages 144–145.Satellite SymposiaIndustrial Satellite Symposia are presented by international companies.CME credits can be claimed for attendance of these symposiaon condition that the relevant completed evaluation formhas been received by the organisation. Places are allocated on afirst-come, first-served basis.See pages 149–152 for details.Scientific Presentation AwardsThe authors of the best scientific papers and scientific/educationalexhibits will be presented with a certificate and given free ECR2014 registration.Scientific Papers: The award will be assigned to the best paperpresentation of each topic based on the evaluation by sessionmoderators, subcommittee members and session participants.Selection criteria comprise quality of presentation, scientific contentand overall impression of the performance.The award winners will be informed after the congressand will be published on the ESR website.Scientific/educational exhibits: See page 62 (Scientific ExhibitionAwards).Security / SafetyThe safety of all congress attendees is of utmost importance tothe European Society of Radiology. The Austria Center Viennaand the ESR have taken security precautions to ensure the maximumpossible safety for all ECR participants. Please inform ourstaff, especially our room attendants, immediately if securityproblems occur.The ESR reserves the right to check your identification uponadmission to the congress centre and/or inside the building. Youmay be asked at any time to present adequate proof of identityby showing your passport, driver’s licence, national or militaryidentification, or student ID, all with photograph and signature.SmokingSmoking is not permitted inside the Austria Center Vienna. TheECR is a non-smoking congress. Outside the building, we kindlyask you to use the ashtrays provided. In addition, there is a dedicatedsmokers’ area on the right side of the main building. Pleasenote that smoking is prohibited in front of the main entrance.Society BoothsUp to 50 national and international radiological societies presenttheir meetings and societies in the society booths area, which islocated on the entrance level, next to the registration desks andthe coat checks.47

BOOSTYOURCAREER.TAKE THE EUROPEANDIPLOMA IN RADIOLOGY (EDiR)EXAM DATES:June 6–8, 2013, Wroclaw/PL(Congress of the Polish Medical Society of Radiology)October 18–22, 2013, Paris/FR (JFR)October 28 – November 2, Antalya/TR (TURKRAD 2013)www.myESR.org/diploma

General InformationInformation from A to ZSpecial AssistanceDelegates with special needs may park on the lower level withdirect elevator access to the ACV. All lecture rooms are accessibleby wheelchair.Special ExhibitionIn compliance with the ECR’s tradition of offering its delegatesan ambitious supporting programme at the annual congress, theECR is again proud to present an exhibition by Prof. Vogel fromHamburg/DE, in cooperation with the German Röntgenmuseum.This year’s exhibit is entitled X-Rays: Evidence and Threat andis presented on the 2 nd level, next to the EPOS Lounge.See page 66.Special Focus SessionsSpecial Focus Sessions deal with a topic at the cutting edge ofdevelopment and clinical application. The topics of these sessionsare presented so as to promote debate and to give an in-depthanalysis. The chairman introduces each aspect of the topic and thepanellists then discuss their different perspectives and opinions.The audience is also given the opportunity to discuss their ideaswith the lecturers. Places are allocated on a first-come, firstservedbasis. Please refer to pages 102–106 for the programmeof the sessions.State of the Art SymposiaThese sessions are intended to inform the audience about the ‘realstate of the art’ of a given subject. Each of the lecturers is an experton the topic as a whole or on some specific aspect of the topic,which will be the subject of the respective session. The presentationsare followed by a discussion conducted by the panellists, ledby the chairman. Places are allocated on a first-come, first-servedbasis. Please refer to page 101 for the programme of the sessions.Students’ SessionsAt ECR 2013, students have the chance to present their ownabstracts in front of a huge audience. The submitters of the best20 abstracts have been invited to Vienna to present their workin dedicated sessions.See pages 144–145.TaxiThere is a taxi stand outside the main entrance.Technical ExhibitionOpening hours:EXPO Halls and EXPO Foyer DFriday, March 8 to Sunday, March 10: 10:00–18:00Monday, March 11: 10:00–14:00Travel ServiceThe ESR and ECR are proud to offer their delegates services thatshould facilitate their travel arrangements and make their stayin Vienna as pleasant as possible. The ESR’s Travel Service Deskis located on the entrance level of the Austria Center Vienna.Next to it you can find the ECR’s official travel agency Mondial.Opening hours:Wednesday, March 6: 12:00–18:00Thursday, March 7 to Monday, March 11: 07:00–18:00Air TravelThe Austrian Airlines desk in the entrance area offers the followingservices for Austrian Airlines and Star Alliance flights:Ticket office & Check-in services:Friday, March 8 to Monday, March 11: 09:00–18:00• Check-in for Star Alliance flights• Issue of boarding passesAt Vienna Airport• Check-in for Star Alliance flights with hand-baggage only;deadline: latest passengers to show up at the respective boardinggate at Vienna Airport according to boarding time shownon boarding pass• Check-in for Star Alliance flights (except flights to Tel-Avivand USA) with baggage; deadline: latest passenger to show upwith baggage at the Baggage Drop Off Counters / Terminal 1at Vienna Airport 45 minutes before departure.Update Your Skills (Practical Courses)The following Update Your Skills (Practical Courses) are presentedat ECR 2013:– How to biopsy with US guidance– Image-guided tumour ablation: How to do itThe number of participants of each workshop is restricted. Pleaserefer to pages 146–147 for the course programmes.Wireless LANFree wireless LAN access is available throughout the congressvenue. The public WiFi ‘ECR’ requires a login. Please log in withthe following data:Username: ecrPassword: ecr2013In addition, every lecture room is equipped with a dedicated WiFinetwork. Login data will be provided onsite.First Level (Gallery)Thursday, March 7: 14:00–18:00Friday, March 8 to Monday, March 11: 10:00–18:00Detailed information on the Technical Exhibition can be found inthe ‘On-Show exhibition guide – Exhibitor Directory and ProductInformation’, which is distributed together with the congress bags.49

General InformationCME at ECR 2013General InformationEach ECR delegate receives confirmation of all activities attended(CME confirmation – Record of attendance). The approximatemaximum number of hours of scientific activity attendance is 40(please note that this number differs from the maximum numberof UEMS/EACCME credits).CME AccreditationEuropeThe following European countries accept the ECR 2013 CMEaccreditation:■■Austria*■■Azerbaijan■■Belgium■■Bulgaria■■Croatia■■Cyprus■■Czech Republic■■Denmark■■Estonia■■Finland■■France■■Georgia■■Germany**■■Greece■■Hungary■■Iceland■■Ireland■■Italy■■Latvia■■Lithuania■■Luxembourg■■Malta■■Netherlands■■Norway■■Poland■■Portugal■■Romania■■Slovakia■■Slovenia■■Spain■■Sweden■■Switzerland***■■Turkey■■United Kingdom* The ESR is an accredited CME provider of the Austrian Medical Chamber.The Austrian Medical Chamber has granted a maximum of 40 DFP (Diplom-Fortbildungs-Programm der Österreichischen Akademie der Ärzte) credits forECR 2013.** The German Society of Radiology (DRG) has granted a minimum of 27 Category1-credits for ECR 2013. The actual number of credits granted will depend onthe respective German State Chamber of Physicians (Landesärztekammer) andcan be accordingly higher.*** The Swiss Society of Radiology (SGR-SSR) has granted a maximum of 40Category 1-credits for ECR 2013.UEMSThe ESR – European Society of Radiology is accredited by theEuropean Accreditation Council for Continuing Medical Education(EACCME) to provide the following CME activity for medicalspecialists. The EACCME is an institution of the EuropeanUnion of Medical Specialists (UEMS).The ECR 2013 is designated for a maximum of 27 hours ofEuropean external CME credits. Each medical specialist shouldclaim only those hours of credit that he/she actually spent in theeducational activity. European Accreditation is granted by theEACCME in order to allow participants to validate the creditsobtained at this activity in their home European Country.USADue to an agreement of mutual recognition the American MedicalAssociation (AMA) will convert European continuing medicaleducation (CME) credits to AMA PRA Category 1 Credits. Forfurther information about the conversion of European credits intoAMA PRA Category 1 credits, please contact the AMA at pra@ama-assn.org or visit the AMA website.WorldwideCME claimed at the ECR are accepted by almost all national CMEauthorities worldwide.CME Acquisition ProcedureCME (continuing medical education) credits will only beawarded, if• the questionnaire provided at the entrance of each session isfully completed,• your unique personal CME sticker, which you will receivetogether with your badge, is affixed,• and the form is dropped into the provided box immediatelyafter the relevant scientific session.• The combined participation and evaluation questionnaireconsiderably helps the next organising committee to selectsubjects for future ECRs. Evaluation sheets differ dependingon the types of the scientific event.• Please note that confirmation of any additional attendance ofthe scientific programme, for which you have not submittedan evaluation form during the congress, cannot be claimed ata later date as late requests cannot be processed and can thusnot be included in your record of attendance.GuidanceConfirmation of participation in the scientific programme is tobe obtained as follows:Scientific Sessions1. Participate in the event of your interest.2. Personalise the relevant questionnaire (evaluation form) usingyour CME sticker, since otherwise it is not possible to sort outthe forms afterwards and to provide confirmation.3. Fill in this form completely during the session.4. Drop the completed form into the box provided at the exit ofthe room when leaving the session.50

General InformationScientific ExhibitionAttendance and evaluation are recorded online in EPOS.1. Enter EPOS (Electronic Presentation Online System) andview the posters of your interest. When logging out fromEPOS, you will be asked to complete the evaluation form.2. Fill in this form completely and press the ‘Submit’ button.A maximum of 3 hours of attendance at the scientific exhibition(SE) will be listed if the participant has completed and submittedthe online SE evaluation form using EPOS (Electronic PresentationOnline System).CME ConfirmationsEvery participant will be able to view and print his/her personalrecord of attendance from the internet at the MyUserArea on thecondition that the above mentioned procedures have been accomplished.This service is already available onsite at the numerouscomputer terminals and at the registration desk. Please note thatyour Personal ID, printed on your badge, is required for login.The printout of your record will be recognised by the nationalaccreditation society upon submission. Please note that the recordof attendance will be issued only to the participant. It will notbe supplied to any accreditation agency or other organisation/health authority.After the congress CME certificates will still be available online.To show and print your CME certificates after the congress, pleaselog into the MyUserArea with your last name and Personal ID.Although participants may partially attend multiple concurrentsessions, the total number of hours printed at the end of the listlimits the credit to the equivalent of a single session during thattime slot.For further information, please contact the ECR CME Supportat cme@myESR.org.

General InformationESR Meets SessionsFriday, March 8, 10:30–12:00, Room BESR meets SpainEM 1: Imaging: essential tool fromdiagnosis to treatmentWelcome by the ESR PresidentG.P. Krestin; Rotterdam/NLPresiding: C. Ayuso; Barcelona/ESJ.I. Bilbao; Pamplona/ES• Introduction [A-111]C. Ayuso; Barcelona/ES• Ischaemic stroke [A-112]J. Macho; Barcelona/ES• Interlude: Spanish radiologists:open to the world [A-113]E. Fraile Moreno; Madrid/ES• Aortic aneurisms [A-114]J.J. Martínez Rodrigo; Valencia/ES• Interlude: Radiologists and Spanish wines [A-115]L. Martí-Bonmatí; Valencia/ES• Hepatocellular carcinoma: the BCLC approach [A-116]M. Burrel; Barcelona/ES• Panel discussion:Is the multidisciplinary environment the natural way todevelop excellence and leadership in clinical imaging?Friday, March 8, 16:00–17:30, Room BESR meets E-AHPBA(European-African Hepato-Pancreato-Biliary Association)EM 2: Pancreatic cystic neoplasms 2013Welcome by the ESR PresidentG.P. Krestin; Rotterdam/NLSaturday, March 9, 10:25–12:00, Room BESR meets South AfricaEM 3: Imaging HIV and TBWelcome by the ESR PresidentG.P. Krestin; Rotterdam/NLPresiding: J.I. Bilbao; Pamplona/ESC.W. Sperryn; Cape Town/ZA• ‘Big Five’ video• Introduction [A-256]C.W. Sperryn; Cape Town/ZA• HIV-related cerebrovascular disease:the South African experience [A-257]V. Mngomezulu; Johannesburg/ZA• Interlude: Radiology training in South AfricaZ. Lockhat; Pretoria/ZA• New concepts in the pathogenesis of cerebral TB [A-258]P. Janse van Rensburg; Stellenbosch/ZA• Interlude: South Africa: the country, its people,its diversity and its attractions [A-259]Z. Lockhat; Pretoria/ZA• Spinal tuberculosis in children [A-260]T. Kilborn; Cape Town/ZA• Chronic chest radiographic changes in a cohortof HIV-infected South African children [A-261]R. Pitcher; Cape Town/ZA• Panel discussion:HIV and TB: What impact do they have onhealth care workers?Presiding: J.I. Bilbao; Pamplona/ESP.-A. Clavien; Zurich/CH• Introduction [A-144]P.-A. Clavien; Zurich/CHK. Conlon; Dublin/IE• Classification/pathology [A-145]C. Verbeke; Stockholm/SE• Radiological diagnosis [A-146]S. Skehan; Dublin/IE• Current role of endoscopic ultrasonography [A-147]P. Bauerfeind; Zurich/CH• How aggressive should the surgeon be? [A-148]K. Conlon; Dublin/IE• Panel discussion52

General InformationESR/EFRS Meets SessionsSunday, March 10, 10:30–12:00, Room BESR meets ChileEM 4: Topics of ongoing radiological researchfrom the AndesWelcome by the ESR PresidentG.P. Krestin; Rotterdam/NLPresiding: J.I. Bilbao; Pamplona/ESM.A. Pinochet; Santiago/CL• Introduction:Radiology in Chile: reality and challenges [A-403]P. Soffia; Santiago/CLM.A. Pinochet; Santiago/CL• TI-RADS: a US classification of thyroid nodulesrelated to cancer risk [A-404]E. Horvath; Santiago/CL• Interlude: Chile, land of geographical andcultural contrasts [A-405]G. Soto Giordani; Santiago/CL• Neuroimaging in epilepsy:in search of invisible lesions [A-406]M. Galvez; Santiago/CL• Interlude: Chile, land of wine and poets [A-407]G. Soto Giordani; Santiago/CL• MDCT patterns in mesenteric ischaemia:usefulness in predicting clinical outcome [A-408]A. Huete; Santiago/CL• Panel discussion:Creating networks between Latin American andEuropean radiology: a unique opportunity forcollaborative research projectsSaturday, March 9, 14:00–15:30, Room BEFRS meets Spain(European Federation of Radiographer Societies)EM 5: Knowledge development as a tool forradiographers’ professional improvementPresiding: G. Paulo; Coimbra/PTC. Ruiz Blanco; Madrid/ES• Introduction [A-284]G. Paulo; Coimbra/PTC. Ruiz Blanco; Madrid/ES• The Spanish radiographer’s role in advancedMRI research [A-285]E. Alfayate Sáez; Madrid/ES• The radiographer’s specialisation in ultrasound:two decades of experience in a public hospital [A-286]M.P. Peña Fernández; Madrid/ES• Interlude: Radiology and Spanish art [A-287]C. Ruiz Blanco; Madrid/ES• The radiographer as the interface between patientand technology in promoting safety in radiationprotection [A-288]J.A. Sória Jerez; Madrid/ES• Educational status of radiographers in Spain:comparison with the EU [A-289]M.R. Soto García; Barcelona/ES• Panel discussion:Could a transnational and multi-professional combinedstatement contribute to professional development?53

myESRWhen you‘ve checked in to ECR 2013 on .catch up with the latest #ECR2013 news on .become a fan and post us a photo on .and then check out our videos on .’ECR 2013' on 4sq - twitter.com/myESR - facebook.com/myESR - youtube.com/myESR

PlenaryPlenary SessionsSessionsThursday, March 7, 17:45–19:15, Room AOpening CeremonyMusical entertainment by Janoska Ensemble & FriendsWelcome AddressesGabriel P. Krestin; Rotterdam/NLESR PresidentJosé Ignacio Bilbao; Pamplona/ESECR 2013 Congress PresidentPresentation of ESR Honorary MembershipPresentation of ESR Honorary Membership toGeorge S. Bisset III; Houston, TX/USTarek A. El-Diasty; Mansoura/ETGary M. Glazer; Stanford, CA/US†Opening LecturePromises and facts of liver-directed gene therapyJesus Prieto; Pamplona/ESFriday, March 8, 12:15–13:15, Room APresentation of the ESR Gold Medal AwardPresentation of the ESR Gold Medal Award toJosé Cáceres; Barcelona/ESJohannes Lammer; Vienna/ATMaximilian F. Reiser; Munich/DEJosef Lissner Honorary LectureMR-guided focused ultrasound: a new string to the radiologist’s bowCarlo Catalano; Rome/ITSaturday, March 9, 12:15–12:45, Room AWilhelm Conrad Röntgen Honorary LectureInterventional oncology: the era of molecular targeted therapyJean-François Geschwind; Baltimore, MD/USSaturday, March 9, 14:00–15:30, Room AImage Interpretation QuizRadiology is globalModerator: Dierk Vorwerk; Ingolstadt/DESunday, March 10, 12:15–12:45, Room ASantiago Ramón y Cajal Honorary LectureResearch and science: from individuals to societies – the Ramón y Cajal backgroundLuis Martí-Bonmatí; Valencia/ESSunday, March 10, 13:00–14:00, Room AJunior Image Interpretation QuizGolden EyeModerator: Anna Alguersuari; Sabadell/ESCo-Moderator: Ernest Belmonte; Barcelona/ES55

General InformationInformation from A to ZSocial Media GuidemyESR, @myESR & #ECR2013myESR Facebook Page | facebook.com/myESRFull congress coverage, daily photo uploads, daily news, competitions and much more.If you have photos or tips for the myESR community, post them on our wall!ECR 2013 Facebook EventSince you’re attending ECR 2013, it’s time to update your Facebook Timeline and RSVPto the official Facebook event.myESR Twitter | twitter.com/myESRGet the latest and hottest news live from the congress. Follow @myESR and tweet at us tolet us know you’re here.Tweeting about ECR? Using Google+? Taking pictures with Instagram?Here are the official hashtags:General: #ECR2013 | ESR Rising Stars: #ESRRisingStarsTweeting about a particular session or room?Add the room name to the hashtag: #ECR2013A, #ECR2013B, #ECR2013Studio, etc. You can alsoadd a simplified presentation or session number: e.g.: A-123 ‣ #A123 or SF 4 ‣ #SF4Other useful hashtags:ECR 2013 Party: #ECRPartyCheck in at ECR 2013: Facebook Places & FoursquareLook out for the official venues and check in!Communication at ECR 2013Bring all your ECR 2013 social media activity together in one place by using our ECR Social Media Wall.The wall will collect posts and tweets in one convenient stream, which will be visible to participantsthroughout the congress venue. But you can also access it from anywhere, whether you’re at thecongress venue, in your hotel, at home, using your laptop or smartphone, or at our internet terminals.ECR LiveYour colleagues can also join you at the ECR, online and live via our video and social media stream.Sessions will be streamed for free: just visit the myESR.org homepage and look out for ECR Live.And don’t forget to subscribe to our YouTube channel: www.youtube.com/myESRWant more? Add our other pages to your stream:ESR Rising Stars: facebook.com/ESRRisingStarsInsights into Imaging: facebook.com/insights.into.imagingEuropean Radiology: facebook.com/EurRadiolEuropean Diploma in Radiology: facebook.com/EuropeanDiplomainRadiologyESOR: facebook.com/EuropeanSchoolofRadiologyThe whole ECR in your hand: ECR 2013 AppBrowse through the programme, schedule your favourite sessions and download yourpersonal book of abstracts. No need to carry all those congress booklets with you ...

General InformationInformation from A to Z

Activities 2013Visiting SchoolsVisiting SeminarsVisiting Scholarship ProgrammesExchange Programmes for FellowshipsTeach-the-Teachers ProgrammeVisiting Professorship Programme

General Information(Junior) ImageInterpretation QuizzesThe Image Interpretation sessions, two traditional highlightsof every ECR, provide both education and entertainment. Twopanels of distinguished radiologists will share their knowledgeand diagnosis strategies with you.The slogan for this year’s ‘senior’ quiz is ‘Radiology is global’.Radiologists will challenge each other in an enjoyable and excitingcompetition where they will face some tricky cases. Thesession will be presented interactively and e-voting units willbe provided to the audience.In the ‘junior’ quiz, with its theme ‘Golden Eye’, the panellistswill compete with each other in teams. While solving a varietyof cases, the moderator will guarantee a scientifically challengingand entertaining session.Saturday, March 9, 14:00–15:30, Room AImage Interpretation Quiz:Radiology is globalModerator: D. Vorwerk; Ingolstadt/DEReferee: A. Agrawal; Delhi/INPanellists:Team 1:A.R. Gillams; London/UKT. Leiner; Utrecht/NLA. Oikonomou; Alexandroupolis/GRC.W. Sperryn; Cape Town/ZATeam 2:F.M. Danza; Rome/ITH.B. Eggesbø; Oslo/NOP. Rogalla; Toronto, ON/CAM. Studniarek; Gdansk/PLSunday, March 10, 13:00–14:00, Room AJunior Image Interpretation Quiz:Golden EyeModerator: A. Alguersuari; Sabadell/ESCo-Moderator: E. Belmonte; Barcelona/ESPanellists:G. Gherarducci; Pisa/ITC. Sayer; Brighton/UKC.M. Sommer; Heidelberg/DEL. Tzarouchi; Ioannina/GRA. Vanrossomme; Brussels/BE= Interactive session with electronic voting/self assessment59

EIBIR SUMMER SCHOOLon Neurology ImagingAugust 26–30, 2013, Dubrovnik /HRGOALThe EIBIR Summer School on Neurology Imagingis a multidisciplinary summer school, uniting 50young researchers coming from a variety ofbackgrounds. The high scientific level and therelaxed atmosphere invite a close and fruitfulinteraction between everybody present, bothparticipants and staff.TOPICSImaging modalities (MR, PET, CT), quantitativeimage analysis, (open-source) tools for imageanalysis, neuro- and population imaging andimage analysis in clinical practice, validation andopen-source databases, atlases, applications inthe clinic, small animals and clinical trials.FACULTYDirk LoeckxWiro NiessenSébastien OurselinDaniel RueckertXavier GolayRoger Gunn (tbc)Nick Fox (tbc)Aad Van der Lugt (tbc)Julia SchnabelAlex HammersDue to the greatsuccess in 2011,we proudlypresent thethird edition ofthe EIBIRSummer School.Registration and more info on www.eibir.org/school

MIR@ECRManagement inRadiologySaturday, March 9, 13:00–17:30, Room QAfter its great success at ECR 2012, MIR (Management in Radiology), a subcommittee of the ESRProfessional Organisation Committee, will again coordinate a session on core managerial issues aswell as supportive methods and techniques.Session 1: Innovation managementand the future of radiologyand radiologistsSession 2: Radiology in modern times:challenges by telemedicine,eHealth, appropriatenessand safetyChairmen:Yves Menu; Paris/FRPeter Mildenberger; Mainz/DEChairmen:Guy Frija; Paris/FRJan Schillebeeckx; Bonheiden/BE13:0013:1013:4013:4513:5013:5514:00Welcome by the chairsImaging innovation and the futurepractice of radiologyBruce Hillman; Charlottesville, VA/USResident training: preparing youngradiologists for the futureBirgit Ertl-Wagner; Munich/DEResearch, EIBIR, HTALuis Donoso; Barcelona/ESHealth technology assessment: can weshow that radiology is value for money?Jane Adam; London/UKLeadership and personal developmentYves Menu; Paris/FRNew imaging methodsMoshe Graif; Tel Aviv/IL15:1515:3515:5516:1516:3516:55 DiscussionThe radiologist's perspective:report on the development of anESR White Paper for TeleradiologyEric Ranschaert; s’Hertogenbosch/NLThe requirements of citizens and therole of patients using telemedicineKarim Berkouk; Brussels/BEImaging referral guidelines in Europe:impetus, innovations and initiativesDenis Remedios; Harrow/UKFactors affecting safety of patients:workload, reporting speed, etc.Richard FitzGerald; Wolverhampton/UKEvidence Based Radiology:The math of decision in radiologyUtku Senol; Antalya/TR14:0514:1014:45–15:15Radiology 2020:residents’ and fellows’ perspectivesMyriam Edjlali-Goujon; Tours/FRDebate on innovation managementand requirements of radiologyCoffee Break17:15 Closing remarks 61

General InformationEPOS – Scientific ExhibitionOpening HoursThursday, March 7 to Monday, March 11: 08:00–18:00The staff of the EPOS Service Desk will be glad to assist youduring these times.LocationFoyer A, 2 nd levelNote:On Saturday, March 9, 12:15–13:15, EPOS will be closed for aself assessment test for the participants of the foundation courseon neuroimaging.Thank you for your understanding!WiFi in the EPOS LoungeECR delegates can access all posters of ECR 2013 at the computerterminals in the EPOS classroom. In addition, a dedicated wirelessinternet network is available in the EPOS Lounge (name ‘EPOSWiFi’), through which the poster exhibition can be accessed as iffrom within the classroom. Connect your mobile device to thenetwork and open your internet browser, which will direct youto EPOS. (Please note that this dedicated network only allowsaccess to EPOS).What’s in EPOS at ECR 2013?• Over 2,600 new scientific and educational exhibits and scientificpaper presentations• 20 new Cases-of-the-Day (five new cases each day)• 4 Self-Assessment modules on ECR 2013 courses:––Categorical Course ‘CLICK (Clinical Lessons for ImagingCore Knowledge): Never without Arteries’––Categorical Course ‘Urogenital Imaging’––Mini Course ‘Organs from A to Z: Heart’––Foundation Course ‘Neuroimaging’• EURORAD – Europe’s largest radiological case databaseScientific Exhibition AwardsA jury of European radiologists has judged all scientific andeducational exhibits with regard to their scientific content, educationalvalue, originality and visual impression. Taking advantageof EPOS, the rating was carried out online, prior to the congress,enabling a detailed and considered assessment. On this basis, theScientific Exhibition Committee has awarded the best posterswith Magna Cum Laude, Cum Laude and Certificate of Merits.Awardees can pick up their certificates at the EPOS Service Desk.Each of the Magna Cum Laude awardees will also be granted freeECR 2014 registration.All awarded posters are flagged in EPOS and will be publishedon the ESR website and on myESR.org/eposEPOS DiscussionsTo enhance interaction, discussions on hot topics in radiologyhave been arranged, where authors of the selected and best-scoredposters in each field will discuss them with a moderator.All discussions take place in the EPOS Area in Foyer A (2 nd level)and ECR delegates are welcome to join, listen, and discuss withthe experts. The discussion rounds will be:Friday, March 8, 10:00–10:30Imaging of the scrotum: why considering MR?Moderator: Lorenzo E. Derchi; Genoa/ITFriday, March 8, 12:30–13:00Paediatric neuroimagingModerator: Andrea Rossi; Genoa/ITFriday, March 8, 15:30–16:00Plaque imaging and myocardial characterisationModerator: Valentin Sinitsyn; Moscow/RUSaturday, March 9, 10:00–10:30CT and MRI diagnosis of focal liver masses:when to use what?Moderator: Pablo Ros; Cleveland, OH/USSaturday, March 9, 15:30–16:00Paediatric chest and heart:state of the art imaging of the young patientModerator: Rick R. van Rijn; Amsterdam/NLSunday, March 10, 12:30–13:00Vascular imaging: CT, MR – or something completelydifferent?Challenges in imaging peripheral arteryocclusive diseaseModerator: Christian Loewe; Vienna/ATAttendance (CME) and EvaluationAttendance of the scientific exhibition is recorded online inEPOS:1. Enter EPOS and view the posters of your interest. Whenlogging out, you will be asked to complete the evaluation form.2. Fill in this form and press the ‘Submit’ button.The evaluation of the electronic scientific exhibition is veryimportant for future planning and your opinion and commentswill be highly appreciated.For those who login and submit completed evaluation forms,a maximum of 3 hours attendance at the scientific exhibitionwill be listed in the record of attendance (CME confirmation).EPOS at ECR 2013 is kindly supported by Hewlett-Packard.62

General InformationEPOS – Scientific ExhibitionESR thanks all reviewersWe cordially thank the members of theScientific Exhibition Committee and theEPOS Reviewers who reviewed abstractsand graded electronic posters in the pastmonths, establishing the basis for presentingthe awards.(in alphabetical order)E. Ada; Izmir/TRH.C. Addley; Cambridge/UKH. Ahmadzadehfar; Bonn/DEA. Alberich-Bayarri; Valencia/ESH. Alkadhi; Zurich/CHG.C. Anselmetti; Candiolo/ITI. Arkhipova; Moscow/RUN. Bargalló Alabart; Barcelona/ESI. Bargellini; Pisa/ITA. Barile; L’Aquila/ITT.V. Bartolotta; Palermo/ITG. Bastarrika; Pamplona/EST. Baumann; Freiburg/DEA.J. Beer; Munich/DEM.-F. Bellin; Villejuif/FRK.S.S. Bhatia; Hampton/UKA. Blandino; Contemplazione, Messina/ITJ.G. Blickman; Rochester/USE. Blumfield; New York/USA. Bozzao; Rome/ITF. Cademartiri; Monastier di Treviso/ITC. Calli; Izmir/TRF. Calliada; Pavia/ITR.S.D. Campbell; Liverpool/UKD. Caramella; Pisa/ITN.M. Caserta; Campinas/BRW. Chamroonrat; Philadelphia/UST.M. Cunha; Lisbon/PTJ. Damilakis; Iraklion/GRA.I.B. De Backer; Ghent/BEA. de Roos; Leiden/NLS. Delorme; Heidelberg/DEV. Dialani; Boston/USO. Ekberg; Malmö/SEB.B. Ertl-Wagner; Munich/DEY. Fargeaudou; Clichy/FRE.F.C. Fleury; Sao Paulo/BRR. Forstner; Salzburg/ATA. Fotiadou; Huntingdon/UKF. Frauscher; Innsbruck/ATS. Freeman; Cambridge/UKM.T.G. Gaskarth; Cambridge/UKJ.-T. Geitung; Bergen/NOA. Ghiatas; Ekali-Athens/GRS. Gourtsoyianni; London/UKA. Guermazi; Boston/USB. Hansson; Stockholm/SEC. Herzog; Munich/DEJ. Heverhagen; Marburg/DEJ. Hodel; Paris/FRA. Jackson; Manchester/UKT. Jakobs; Munich/DEJ.A. Jakobsen; Oslo/NOC. Kahn; Milwaukee/USN. Kalyvas; Athens/GRA. Kassarjian; Majadahonda (Madrid)/ESF. Knollmann; Pittsburgh/USE. Kotter; Freiburg/DEK.-F. Kreitner; Mainz/DEM. Krokidis; Cambridge/UKA. Laghi; Latina/ITJ. Laissy; Paris/FRM. Lemmerling; Beervelde/BED. Litmanovich; Boston/USE. Llopis; Alzira/ESR. Llorens; Valencia/ESI.G. Lupescu; Bucharest/ROM.G. Mack; Baierbrunn/DEA. Mahnken; Marburg/DEL. Mannelli; Seattle/USR. Manns; Telford/UKK. Marten-Engelke; Göttingen/DEC. Matos; Brussels/BEJ. McHugo; Birmingham/UKE. Mershina; Moscow/RUP. Mildenberger; Mainz/DEM. Minami; Ibaraki/JPG. Morana; Treviso/ITP.L. Moyle; Cambridge/UKV.F. Muglia; Ribeirao Preto/BRK. Nikolaou; Munich/DEM. Notohamiprodjo; Munich/DES. Nougaret; St. Clement de Riviere/FRA. Offiah; Sheffield/UKA. Oikonomou; Alexandroupolis/GRY. Oishi Tanaka; Tsukuba/JPM. Onu; Bucharest/ROL. Pallwein-Prettner; Linz/ATV. Panebianco; Rome/ITG. Pärtan; Vienna/ATA. Paterson; Belfast/IEL.J. Pina Insausti; Pamplona/ESK. Pinker-Domenig; Vienna/ATT.J. Popiela; Krakow/PLP.K. Prassopoulos; Alexandroupolis/GRL. Preda; Milan/ITS. Puig; Vienna/ATE. Quaia; Trieste/ITD. Regge; Candiolo-Torino/ITA. Righini; Milan/ITP. Rinaldi; Rome/ITS. Robinson; Vienna/ATJ. Romero; Boston/USA. Rovira-Canellas; Barcelona/ESR. Rzanny; Jena/DER. Sanz-Requena; Valencia/ESG. Savino; Rome/ITM. Scharitzer; Vienna/ATK. Schürmann; Aachen/DET.C. See; Cambridge/UKM.J. Shelly; Dublin/IEP. Sijens; Groningen/NLG.N. Simao; Ribeirao Preto/BRW.H. Sommer; Munich/DES. Steens; Nijmegen/NLW. Stiller; Heidelberg/DEM. Sumi; Nagasaki/JPD. Tack; Braine-L’Alleud/BEA. Taibbi; Palermo/ITS.A. Taylor; London/UKG. Thornbury; Belfast/UKM. Toepker; Vienna/ATM. Torkzad; Sollentuna/SED. Tsetis; Iraklion/GRA. Tsili; Ioannina/GRS. Ulmer; Kiel/DEE.J.R. van Beek; Edinburgh/UKW.J.M. van der Putten; Galway/IEM.I. Vargas; Geneva/CHB. Verbist; Leiden/NLJ.A. Verschakelen; Leuven/BEM.G. Wallis; Cambridge/UKA. Wibmer; Vienna/ATD. Wormanns; Berlin/DEK. Wörtler; Munich/DEX. Wortsman; Santiago/CLP. Wunderlich; Radebeul/DE63

Visit the EPOS TM Area on the second level.Browse through thousandsof electronic posters fromECR 2003–2013 and other congresses.www.myESR.org/eposTRADEMARK OF

General InformationeLearning ToolsEPOS – Electronic Presentation Online SystemLet’s celebrate the 10 th anniversary of EPOS TM !In 2003, ECR introduced an all-electronic scientific exhibitionusing EPOS, the Electronic Presentation Online System,thus setting new standards in the medical meeting industry.EPOS contains over 16,000 electronic exhibits fromECR 2003–2013 and from other congresses:Online at www.myESR.org/epos or in the EPOS Area on the2 nd level.EPOS at ECR 2013 is kindly supported by Hewlett-Packard.www.myESR.org/eposEURORAD – Radiological Case DatabaseThe largest peer-reviewed teaching database of radiology onthe internet offers free access to a wealth of medical informationand imaging data, whose accuracy and quality have beenvalidated by some of the most experienced radiologists inEurope. Submitting to and publishing in EURORAD is anexclusive benefit of ESR membership.EURORAD contains case reports for medical students (simplecases), residents in radiology (everyday cases) and senior radiologists(complex cases) in all radiological specialties.For easy retrieval of required cases, the website offers a powerfulsearch engine as well as multi-lingual navigation (English /Spanish / French). EURORAD allows you to download, save,and print the cases as PDF documents, or e-mail them via theweb-based e-mail client. All EURORAD cases are registeredwith a unique DOI (Digital Object Identifier), which makes allcases citable.www.eurorad.org65

General InformationECR 2013SPECIALEXHIBITIONX-RAyS: EvidEncE And ThREATA notably popular feature at the European Congress of Radiology is the specialexhibition, initiated and compiled by Prof. Hermann Vogel from Hamburg, Germany,in cooperation with the Deutsches Röntgenmuseum, which has been part of theannual meeting for years. This year’s exhibit is entitled:X-Rays: Evidence and Threat.This year’s exhibition covers a wide variety of instances where imaging has beenused, from the outlandish to the downright gruesome. It includes images of injuriessustained from terrorist attacks, accidents and torture. It also demonstrates howimaging has been used to detect drugs and explosives hidden inside the humanbody, as well as some other more benign cosmetic implants.This exhibition provides a unique insight into the physical aftermath of manytragic incidents while also delving into some non-medical imaging applications.It promises to be an eye-opening experience for all.Prof. Hermann Vogel is head physician at the Albers-Schönberg-Institute, thedepartment of radiology at St. Georg Hospital in Hamburg. The new exhibition,which will be shown for the first time at ECR 2013, again features more than20 posters with partly provocative images.The exhibition is presented on the 2 nd level of the congress venuenext to the EPOS Area.U. HennigDeutsches Röntgen-MuseumH. and B. VogelInstitut für Rechtsmedizin66

Cafés & Restaurantsat ECR 2013Want to take a short break? Looking for the right place to eat? –The best spots to relax and enjoy tasty hot and cold snacks are ourvarious foyer cafés and restaurants. They are situated throughoutthe whole congress venue and across all levels of the building.To offer you the broadest variety of Austrian and internationaldelicacies, each café and restaurant has its own theme, fromAustrian specialties and Italian treats to Mediterranean pleasuresand Asian delights.Lower level, Expo Foyer DItalian Snack LoungeLower level, Foyer G/H (next to Room G/H)Mediterranean CornerLower level, Foyer I/K (next to Room I/K)Asian Delights – authentic Asian cuisineEntrance level (next to the main entrance)Café Accademia: Accademia del Caffè1 st level, within EDIPS – Preview CentreVital Lounge2 nd level, Foyer A (in the EPOS Area)Viennese Snacks & Pastries2 nd level, Foyer B (in the Rising Stars Lounge)Snack LoungeFree Publicationsat ECR 2013Broaden your horizons withFree Publications at ECR 2013General InformationThe Free Publications initiative will run for the seventh consecutiveyear after attracting increasing levels of attention at ECR 2012.The Free Publications booth will be located on the second level ofthe ACV next to the EPOS Area. The booth will be richly stockedwith a galaxy of fascinating reading material from many of ourassociated organisations and publishing houses from around theworld, such as Globetech, Diagnostic Imaging, MindByte andEuropean Hospital.In addition to a broad library of print media, internet terminalswill also be installed nearby, providing access to a wide varietyof online publications.About 20 publishers will provide more than 30 different titles forthis initiative, ranging from copies of the ESR’s flagship journalsEuropean Radiology and Insights into Imaging, to issues from asfar afield as Lebanon, many of which will also be available online.Interested delegates can peruse La Radiologia Medica, pick up acopy of International Hospital and browse the online ImagingManagement, among others. It is a rare chance to learn from somany diverse medical imaging communities from around theglobe, and in this case it is something you can take away withyou, with free bags provided to help you make the very best ofthe opportunity.We are of course enormously grateful for the enthusiasm of ourfriends in the publishing industry for making the Free Publicationsinitiative possible, and allowing us to provide ECR participantswith the chance to pick up some literature and broadentheir medical imaging horizons.Free Publications Booth: 2 nd level, next to the EPOS Area.2 nd level, Foyer C (next to Room C)Italian RestaurantExpo CCafé Vienna: Austrian SpecialtiesExpo EBar XXLExpo Extension ASnack Café67

EnjoyVienna‘sculturalhighlightsVisit the Arts & Culture Desk in the entrance hall

Friedensreich Hundertwasser, The Large Path, 1955© 2012 Namida AG, Glarus, Switzerland

Visit the Technical Exhibition!And learn all about the most recentdevelopments in healthcare technology.Opening hours:EXPO Halls and EXPO Foyer DFriday, March 8 to Sunday, March 10: 10:00–18:00Monday, March 11: 10:00–14:00First Level (Gallery)Thursday, March 7: 14:00–18:00Friday, March 8 to Monday, March 11: 10:00–18:00

General InformationECR 2013 welcomes itsindustry partners4 star levelLogo and logotype overviewFile namesProfessional printingBHC_Logo_4c_100801.epsBHC_Logo_Pant_100801.epsBHC_Logo_Blk_100801.epsBHC_Logo_Wht_100801.epsScreenBHC_Logo_RGB_100801.pngBHC_Logo_Wht_100801.pngBHC_Logo_Blk_100801.pngBHC_Logo_RGB_100801.emfBHC_Logo_Wht_100801.emfBHC_Logo_Blk_100801.emfProfessional printingBHC_Logo_Cent_4c_100801.epsBHC_Logo_Cent_Pant_100801.epsBHC_Logo_Cent_Blk_100801.epsBHC_Logo_Cent_Wht_100801.epsAbbreviationsBHC Bayer HealthCareCent Centered4c CMYK (Euroscale)Pant PantoneBlk Black (Lineart)Wht WhiteRGB Red Green Blue (screen).eps encapsulated postscript file.emf enhanced meta file.png portable network graphicsPlease Note!The .emf files are only for use withPC Computers and MicrosoftOffice 2003 (Windows, PowerPoint)!ColorsCMYKGreen 65C /100YBlue 100C /10M /10KGray 70KBlack 100KThe ESR welcomes its Supporting MembersThe ESR gives a warm welcome to all its existing and newly joinedsupporting membership companies!As the ECR puts a special focus on innovation and keeping up todate with recent developments in the field, a close cooperationwith the industry leaders is indispensable.The companies contribute with their active involvement to thesuccess of the society and its congress with their continuoussupport for the cause of radiology in Europe.© Bayer AG, August 1, 2010Pantone 158CR-245G-128B-37ScreenBHC_Logo_Cent_RGB_100801.pngBHC_Logo_Cent_Wht_100801.pngBHC_Logo_Cent_Blk_100801.pngBHC_Logo_Cent_RGB_100801.emfBHC_Logo_Cent_Wht_100801.emfBHC_Logo_Cent_Blk_100801.emfProfessional printingBHC_Logotype_4c_100801.epsBHC_Logotype_Pant_100801.epsBHC_Logotype_Blk_100801.epsBHC_Logotype_Wht_100801.epsScreenBHC_Logotype_RGB_100801.pngBHC_Logotype_Wht_100801.pngBHC_Logotype_Blk_100801.pngBHC_Logotype_RGB_100801.emfBHC_Logotype_Wht_100801.emfBHC_Logotype_Blk_100801.emfPantoneGreen 368Blue Process BlueGray Cool Gray 11Black BlackESR Supporting Members:4-star: Agfa HealthCareBayer HealthCareBracco ImagingCanon EuropeCarestream HealthCovidien – MallinckrodtEsaoteFujifilm EuropeGE HealthcareGuerbetHitachi Medical Systems EuropeHologicPhilips HealthcareSamsung MedisonSiemens Healthcare Sector3-Star: Shenzhen Mindray Bio-Medical ElectronicsTeraRecon2-Star: Cerner CorporationNovarad CorporationParamed Medical SystemsShimadzu EuropaSwissray MedicalThank you for your involvement!3 star level2 star level‘ESR meets’ countriesEach year the ECR places a special focus on its ‘ESR meets’ countries– in 2013 namely Spain, South Africa and Chile – withparticular emphasis on their scientific and technological developments.The ESR, industry companies and the national societieswork closely together to highlight these countries.Additionally, we are proud to present you the ‘ESR meets’ partnerdiscipline; E-AHPBA (European-African Hepato-Pancreato-Biliary Association).71

Top radiologists read more than just images

General InformationESR JournalsEuropean RadiologyEuropean Radiology at your fingertips!Carry Europe’s leading radiology journal with you wherever yougo – with the European Radiology App – download the app fromiTunes or via the QR code below.European Radiology is the official journal of the ESR and officialorgan of numerous subspecialty organisations. It acts as a flagship,publishing original scientific papers in the radiological field withan Impact Factor of 3.222 for 2011.Full access to the online version of European Radiology is includedin the ESR membership fee. ESR members can also arrange subscriptionsfor the printed version at special rates in the MyUserArea(www.myESR.org/MyUserArea under ‘MyJournals’)!Insights into ImagingThe clearest insights … for all to see!Insights into Imaging is the ESR journal for education and strategiesin radiology. Besides excellent review articles, it publishesarticles on professional issues, several official documents andpolitical statements.Insights into Imaging is an Open Access journal on the SpringerOpenplatform – therefore all articles published are freelyavailable. As benefit for ESR members, ESR covers the ArticleProcessing Charges for all its active members!As a reminder of the valuable content and its importance to everyradiologist’s daily practice, a special printed issue of Insights intoImaging has been placed in all Students and Residents congressbags!Free copies of this booklet are available from the journal’s boothin the entrance hall.Links to the journalswww.european-radiology.orgwww.i3-journal.org73

Insights into ImagingEducation and strategies in European radiologyThe clearest insights… for all to see!Now Open Access – Read Insights into Imagingwithout subscription and without restrictionswww.i3-journal.orgFull articles at www.i3-journal.org/articles

General InformationUnderground MapU-BahnECR STOP:Kaisermühlen /Vienna Int. Centre© Wiener Linien, November 2012ACVUnderground Line (U-Bahn)Commuter Train (S-Bahn)City Airport TrainUrban Train (Lokalbahn)Vienna International BusterminalCustomer Service Centre(U3 Erdberg)InfopointsTicket SalesPark & Ride75

Johannes Krisch in Der Alpenkönig und der Menschenfeind by Ferdinand Raimund© Reinhard Werner / BurgtheaterMore about theatres in Vienna:www.myESR.org/arts_culture

Floor Plans78 U2 – Lower Level79 U2 – Lower Level EXPO80 OE – Entrance Level81 OE – Entrance Level EXPO82 O1 – First Level83 O2 – Second Level84 O3 – Third Level

Floor PlansU2 – Lower LevelU2 - LOWER LEVELMeditation & Prayer RoomBroadcast Room G/H21RESTAURANTRoomG/HRoomI/K1545RESTAURANTMeeting Room 15Broadcast Room I/KCOAT CHECK 3COAT CHECK 4RoomD16TOEXPO ERoomD2AREASMOKING163EXPO FOYER DFuture MeetingsMeeting Room 16TO EXPOB/C/EEXPO E1. Meditation & Prayer Room2. Broadcast Room G/H3. Meeting Room 16EXPO B4. Meeting Room 155. Broadcast Room I/K6. Future MeetingsEXPO C78

Meditation & Prayer RoomU2 - LOWER LEVELFloor PlansU2 – Lower Level EXPOMeeting Room 15Broadcast Room G/H15Broadcast Room I/KRESTAURANTRoomG/HRoomI/KRESTAURANTCOAT CHECK 3COAT CHECK 4RoomD12TOEXPO ERoomD2AREASMOKING161EXPO FOYER DFuture MeetingsMeeting Room 16TO EXPOB/C/EEXPO EEXPO CEXPO B1. Meeting Room 162. Future Meetings79

Floor PlansOE – Entrance LevelOE - ENTRANCE LEVELCONGRESSOFFICECOATCHECK 18RoomE2Partner PublishersPartner PublishersRoomF1COATCHECK 267Photo CompetitionBroadcast Zone E1/E2Society BoothsRoomE1SocietyBoothsREGISTRATIONWaterSociety BoothsESR MEETSSociety BoothsREGISTRATION5 5RoomF2SocietyBoothsSociety BoothsBroadcast Zone F1/F2BAGSESRWELCOMELOUNGEBAGSSMOKINGAREAPRESS OFFICE ANDBUSINESS CENTRESIEMENSExperience LoungeIndustry Hands-OnWorkshopExpo Servicesand Exhibitors’RegistrationECRInfoACVInfoAustrianAirlines12 34MondialTravel ServiceArts & CultureRestaurantReservations= CASH DISPENSER / ATMMAIN ENTRANCEPHILIPS1. Mondial2. Travel Service3. Arts & Culture4. Restaurant ReservationsEXPO A5. Registration6. Broadcast Zone F1/F27. Photo Competition8. Broadcast Zone E1/E2EXTENSION EXPO ATO / FROM UNDERGROUND80RECREATIONAREAINTERNETTERMINALS

COATCHECK 1CONGRESSOFFICEFloor PlansOE – Entrance Room Level EXPORoomE2Partner PublishersPartner PublishersF1COATCHECK 2Photo CompetitioBroadcast Zone E1/E2Society BoothsRoomE1REGISTRATIONWaterSociety BoothsESR MEETSSociety BoothsREGISTRATIONRoomF2Society BoothsBroadcast Zone F1/F2SocietyBoothsSocietyBoothsBAGSESRWELCOMELOUNGEBAGSSMOKINGAREAPRESS OFFICE ANDBUSINESS CENTRESIEMENSExperience LoungeIndustry Hands-OnWorkshopExpo Servicesand Exhibitors’RegistrationECRInfoACVInfoAustrianAirlinesMondialTravel ServiceArts & CultureRestaurantReservations= CASH DISPENSER / ATMMAIN ENTRANCEPHILIPSTO / FROM UNDERGROUNDEXPO AEXTENSION EXPO ARECREATIONAREAINTERNETTERMINALS81

Floor PlansO1 – First LevelO1 - FIRST LEVELInternet TerminalsPREVIEW CENTREEDIPSRoomPBroadcast Zone L/MRoomL/M1EXPO GALLERY3RoomN/OBroadcast Zone N/OHologicIndustry Hands-OnWorkshop Room42Studio 2013RoomYRoomXRoomQ1. Broadcast Zone L/M2. Hologic Industry Hands-On Workshop Room3. Broadcast Zone N/O4. Meeting Room 1482

Floor PlansO2 – Second LevelO2 - SECOND LEVELMeeting Room 13113Rising StarsLoungeRoomBRoomCRESTAURANTBroadcast Room B/C2Meeting Room 12Meeting Room 11Meeting Room 10Special Exhibition312411105RoomAEDiR Examination AreaEPOS Discussions CornerRoomZ6EPOS TMRoomU9EIBIR IMAGINE TheatreeHealth and Imaging Informatics7 8Free Publications1. Meeting Room 132. Broadcast Room B/C3. Meeting Room 124. Meeting Room 115. Meeting Room 106. Special Exhibition7. EPOS Discussions Corner8. eHealth and Imaging Informatics9. EIBIR IMAGINE Theatre83

Floor PlansO3 – Third LevelO3 - THIRD LEVELMeeting Room 7Meeting Room 87 7 8 8OFFICES 1–17OFFICES 21– 339 9Meeting Room 9Meeting Room 6Meeting Room 5Past Presidents Circle6655PRESIDENTS’OFFICE12341234Meeting Room 1Meeting Room 2Meeting Room 3Meeting Room 4Info Service Desk1. Meeting Room 12. Meeting Room 23. Meeting Room 34. Meeting Room 45. Meeting Room 56. Meeting Room 67. Meeting Room 78. Meeting Room 89. Meeting Room 910. Info Service Desk11. Past Presidents Circle84

Free ECR Student RegistrationStudents and radiographers-in-training under the age of 30,without any academic degree, can register for free.Rising Stars LoungeWe want all students and residents to feel at home at the ECR, which is why we haveprovided the exclusive Rising Stars Lounge, located on the 2 nd level in Foyer B.Basic Sessions for Students, Residentsand Radiographers-in-trainingStudent SessionsStudent Hands-On Workshops on UltrasoundSee pages 144–145 for more detailsFind more information on myESR.org/RisingStars andbecome a Rising Star on Facebook: facebook.com/ESRRisingStars

ProgrammeOverviews88 Thursday, March 790 Friday, March 892 Saturday, March 994 Sunday, March 1096 Monday, March 11

Programme OverviewThursday, March 7Room/TimeA2 nd LevelB2 nd LevelC2 nd LevelD1Lower LevelD2Lower LevelE1Entrance LevelE2Entrance LevelF1Entrance LevelF2Entrance LevelG/HLower Level08:3009:0009:3010:0010:3011:00SS 103CardiacCT and MRI inpreoperativeand postoperativeevaluation(p. 214)SS 111NeuroFrom structureto function)(p. 214)SS 104ChestLung cancer:from tissuecharacterisationto treatment(p. 215)SS 109InterventionalRadiologyChemoembolisationandradioembolisationof liver tumours(p. 215)SS 110MusculoskeletalShoulder andhand(p. 216)SS 101aGI TractAcute boweldiseases:challenges andsolutions(p. 216)SS 116OncologicImagingPerfusion CTand MRI: readyfor clinicalpractice(p. 217)SS 102BreastBreast MRI:improvingaccuracy andtissue characterisation(p. 217)SS 107GenitourinaryProstateimaging(p. 218)11:3012:0012:3013:00SY 2SuperSonicImagineSatelliteSymposium(p. 149)13:3014:0014:3015:00E³ 220InteractiveTeachingSessionLung cancer(p. 156)SS 208Head andNeckHead and neckcancer: functionalimagingand hybridmodalities(p. 221)SS 204ChestAirways andinfiltrative lungdiseases(p. 222)SS 209InterventionalRadiologyAblation andbiopsy of theprostate andthe kidney(p. 222)SS 210MusculoskeletalLower limb:tricks for improvedimaging(p. 223)SS 201aGI TractBowel imaging:protocol optimisationandintervention(p. 223)SS 216OncologicImagingNewbiomarkersfor tumourquantification(p. 224)SS 202BreastImprovementsin preoperativestaging ofbreast cancer(p. 224)SS 211NeuroInfection andinflammation(p. 225)15:3016:0016:3017:00E³ 320InteractiveTeachingSessionMalignantpancreatictumours(p. 156)RC 301GI TractStaging andrestaging ofrectal and analcancer(p. 156)RC 303CardiacCardiac imaging:the cuttingedge(p. 157)RC 306MolecularImagingMolecularimaging inoncology(p. 157)MS 3MultidisciplinarySessions:ManagingPatients withCancerColorectal livermetastases(p. 157)PC 3ProfessionalChallengesSessionBringing radiologyto medicalundergraduates(p. 157)RC 302BreastFunctionalimaging of thebreast(p. 158)RC 307GenitourinaryRenal and adrenaltumours(p. 158)17:3017:45-19:15 Room A: Opening Ceremony / Presentation of Honorary Members / Opening Lecture [p. 160]Registration: Wednesday, March 6: 12:00–18:00 / Thursday, March 7 to Monday, March 11: 07:00–18:0088

Programme OverviewThursday, March 7I/KLower LevelL/M1 st LevelN/O1 st LevelP1 st LevelQ1 st LevelX1 st LevelY1 st LevelZ2 nd LevelStudio 20131 st LevelEPOS2 nd LevelRoom/Time08:3009:0009:3010:00SS 101bAbdominalVisceraLiver fibrosisand cirrhosis:elastographyand biomarkers(p. 218)SS 113Physics inRadiologyMulti modalityimaging and MRsafety(p. 219)SS 115VascularCarotid plaqueevaluation(p. 219)SS 117EmergencyRadiologyAn update onemergencythoraco-abdominalimaging(p. 220)SS 114RadiographersImportance ofeducation inpractice(p. 220)SS 105ComputerApplicationsIT infrastructure,learningsupport andteleradiology(p. 221)SY 1SiemensHealthcareSatelliteSymposium(p. 149)10:3011:0011:30SY 3Bayer Health-Care SatelliteSymposium(p. 149)MC 24AThe Beautyof BasicKnowledge:Head and NeckA taste of the oralcavity and salivaryglands(p. 156)MC 25AThe Beautyof BasicKnowledge:MusculoskeletalImagingTrauma(p. 156)SY 4SiemensHealthcareSatelliteSymposium(p. 149)12:0012:3013:0013:30SS 201bAbdominalVisceraHepatocellularcarcinoma:diagnosis andmanagement(p. 225)SS 213Physics inRadiologyInnovations inCT technologyand data processing(p. 226)SS 215VascularMajor vesselimaging(p. 226)SS 203CardiacPlanningcardiac interventions(p. 227)SS 214RadiographersManagingquality anddose in CT(p. 227)SS 205ComputerApplicationsQuantitativeimage analysisand optimisation(p. 228)SY 5SiemensHealthcareSatelliteSymposium(p. 149)14:0014:3015:0015:30RC 304ChestHow I report(p. 158)MC 322Organs fromA to Z: HeartTechnical andanatomicalfundamentalsfor imaging theheart(p. 159)RC 309InterventionalRadiologyPercutaneoustreatmentof chronicback pain andsciatica(p. 159)RC 315VascularVascularimaging inischaemicstroke(p. 159)RC 305ComputerApplicationsNew PACSarchitecture:decouplingimagemanagementfrom imagenavigation(p. 159)ESR RadiationProtectionSessionSecurity scannersat airports:are they safe?(p. 160)16:0016:3017:0017:30Technical Exhibition: EXPO First Level (Gallery): 14:00–18:00EPOS – Scientific Exhibition: 08:00–18:0089

Programme OverviewFriday, March 8Room/TimeA2 nd LevelB2 nd LevelC2 nd LevelD1Lower LevelD2Lower LevelE1Entrance LevelE2Entrance LevelF1Entrance LevelF2Entrance LevelG/HLower Level08:3009:0009:30RC 401AbdominalVisceraPitfalls ininterpretationof pancreaticimaging(p. 161)6 th PostProcessingFace-OffSession(p. 139)RC 416OncologicImagingMR imaging forprostate cancermanagement:the essentialguide for radiologists(p. 161)MC 423Controversiesin BreastImagingOverdiagnosisfrom screeningmammography:should we careabout it?(p. 161)RC 417EmergencyRadiologyER: basic principles(p. 161)SA 4State of theArt SymposiumDiffusion-weightedimaging(DWI) of theabdomen(p. 162)E³ 420FoundationCourse:NeuroimagingThe orbit, thepetrous boneand the sella(p. 162)MS 4MultidisciplinarySessions:ManagingPatients withCancerHepatocellularcarcinoma(p. 162)SF 4aSpecial FocusSession„MRI of the lung:to go?“(p. 163)RC 411NeuroThe paediatricbrain: not just asmall brain(p. 163)10:0010:3011:00E³ 520aInteractiveTeachingSessionPitfalls in abdominalimaging(p. 165)EM 1ESR meetsSpainImaging:essential toolfrom diagnosis totreatment(p. 165)E³ 520bInteractiveTeachingSessionPitfalls inhead and neckimaging(p. 166)SS 504ChestLung nodules(p. 229)SS 509InterventionalRadiologyNeurovascularand spine interventions(p. 229)SS 510MusculoskeletalTendon, muscleand tissuecomposition(p. 230)E³ 520cFoundationCourse:NeuroimagingPaediatric(p. 166)SS 516OncologicImagingCutting edgeimaging inoncology: whenand how?(p. 230)SS 502BreastElastography andother advancesin breastultrasound(p. 231)SS 507GenitourinaryNew frontiers inGU imaging(p. 231)11:3012:0012:3013:0012:15–12:45Gold MedalAwards(p. 55)12:45–13:15HonoraryLecture 1(p. 167)12:15–13:30SY 6Bayer Health-Care SatelliteSymposium(p. 149)SY 7BraccoSatelliteSymposium(p. 150)13:3014:0014:3015:00SS 607GenitourinaryFemale pelvisimaging(p. 234)SS 611NeuroAlzheimer‘sand Parkinson‘s(p. 234)SS 603aCardiacCT and MRI:risk stratification(p. 235)MC 623Controversiesin BreastImagingPreoperativeMRI in newlydiagnosed breastcancer: to do ornot to do?(p. 167)SS 609aInterventionalRadiologyOncologic ablationand guidedinterventions(p. 235)SS 610aMusculoskeletalMusculoskeletaltumours(p. 236)E³ 620FoundationCourse:NeuroimagingTrauma andvascularity(p. 167)SS 601AbdominalVisceraLiver steatosis:imaging andquantification(p. 236)SS 602BreastBreast imagingafter neoadjuvanttherapyand surgery(p. 237)SS 603bCardiacCardiomyopathyand fibrosis(p. 237)15:3016:0016:3017:00E³ 720aInteractiveTeachingSessionNeurologicalemergencies(p. 168)EM 2ESR meetsE-AHPBAPancreaticcystic neoplasms2013(p. 168)NH 7New HorizonsSessionCartilageimaging(p. 168)MC 723Controversiesin BreastImagingShould we addultrasound tomammographicscreening ofdense breasts?(p. 169)CC 719OncologicImaging:Follow-upof Systemicand LocalTherapiesImaging aftersystemic therapies:the standards(p. 169)RC 710MusculoskeletalPeripheral nerveimaging: MRIand US(p. 169)E³ 720bFoundationCourse:NeuroimagingInfection andinflammation(p. 169)SF 7aSpecial FocusSessionRadiographersand ultrasonographyinEurope(p. 170)SF 7bSpecial FocusSessionImaging andradiotherapy:all you need toknow(p. 170)RC 707GenitourinaryDiagnosis andmanagementof GU tracttrauma(p. 170)17:30Registration: 07:00–18:00 EPOS – Scientific Exhibition: 08:00–18:0090

Programme OverviewFriday, March 8I/KLower LevelL/M1 st LevelN/O1 st LevelP1 st LevelQ1 st LevelX1 st LevelY1 st LevelZ2 nd LevelStudio 20131 st LevelEPOS2 nd LevelRoom/TimeMC 428Joint Course ofESR and RSNA(RadiologicalSociety ofNorth America)Essentials in oncologicimaging: whatradiologists need toknow (part 1)(p. 163)MC 422Organs from Ato Z: HeartNon-ischaemicheart disease(p. 164)EIBIR/EORTCJoint WorkshopA radiologist witha ruler in his handis a dangerousperson: seekingstandardisationin multicenterimaging trials(p. 164)PC 4ProfessionalChallengesSessionThe visibility ofthe radiologist(p. 164)SF 4bSpecial FocusSessionJustifying CTin paediatricradiology(p. 165)StudentWorkshop 1(p. 145)SK 427Image-GuidedTumourAblation(p. 147)Rising StarsBasic 1(p. 144)08:3009:0009:3010:00MC 528Joint Course ofESR and RSNA(RadiologicalSociety ofNorth America)Essentials in oncologicimaging: whatradiologists need toknow (part 2)(p. 166)SS 511NeuroStroke-relatedarterial disease(p. 232)SS 515VascularNovel toolsfor blood flowevaluation(p. 232)SS 503CardiacAdvances incoronary CTangiography(p. 233)SS 514RadiographersTheradiographer‘srole as healthcare teammember(p. 233)SK 527Image-GuidedTumourAblation(p. 147)Rising StarsBasic 2(p. 144)10:3011:0011:3012:00SY 8GEHealthcareSatelliteSymposium(p. 150)SY 9SiemensHealthcareSatelliteSymposium(p. 150)MC 25BThe Beauty ofBasic Knowledge:MusculoskeletalImagingDegenerativedisorders(p. 166)MC 24BThe Beauty ofBasic Knowledge:Head and NeckThe infrahyoid neckand lymph nodes(p. 167)EPOSdiscussionPaediatric neuroimaging(p. 62)12:3013:0013:30MC 628Joint Course ofESR and RSNA(RadiologicalSociety ofNorth America)Essentials in oncologicimaging: whatradiologists need toknow (part 3)(p. 167)SS 608Head and NeckTechnical innovations,TMJ diseaseand rare entities(p. 238)SS 610bMusculoskeletalCartilage: advancedimaging(p. 238)SS 609bInterventionalRadiologyGynaecologicaland obstetricinterventions(p. 239)ESOR SessionFostering futureresearchers(p. 139)StudentWorkshop 2(p. 145)SK 627Image-GuidedTumourAblation(p. 147)SS 606MolecularImagingMR/PET andPET/CT(p. 239)StudentSession 1(p. 144)14:0014:3015:00EPOS discussionPlaque imaging and myocardialcharacterisation(p. 62)15:30MC 728Joint Course ofESR and RSNA(RadiologicalSociety ofNorth America)Essentials in oncologicimaging: whatradiologists need toknow (part 4)(p. 171)MC 722Organs from Ato Z: HeartIschaemic heartdisease(p. 171)RC 709InterventionalRadiologyExpanding therole of interventionalradiologyin hepatocellularcarcinoma(p. 171)RC 714RadiographersClinical audit:from EURATOMto the clinicalenvironment(p. 172)SF 7cSpecial FocusSessionImaging inintensive carepatients(p. 172)SK 727Image-GuidedTumourAblation(p. 147)RC 715VascularDialysis fistula(p. 173)StudentSession 2(p. 144)16:0016:3017:0017:30Technical Exhibition: EXPO First Level (Gallery): 10:00–18:00Technical Exhibition: EXPO Halls and EXPO Foyer D:10:00–18:0091

Programme OverviewSaturday, March 9Room/TimeA2 nd LevelB2 nd LevelC2 nd LevelD1Lower LevelD2Lower LevelE1Entrance LevelE2Entrance LevelF1Entrance LevelF2Entrance LevelG/HLower Level08:3009:0009:30E³ 820aInteractiveTeachingSessionPitfalls in heartimaging(p. 175)SF 8aSpecial FocusSessionIs diagnosticcatheterangiographystill useful inneuroimaging?(p. 175)NH 8New HorizonsSessionMR/PET: amarriage madein heaven orhell?(p. 175)CC 818CLICK (ClinicalLessons forImaging CoreKnowledge):Never withoutArteriesHow old areyou in reality?Vascular age andclinical events(p. 175)CC 819OncologicImaging:Follow-upof Systemicand LocalTherapiesImaging aftersystemic therapies:advancedtechniques(p. 176)RC 817EmergencyRadiologyPolytrauma:redefining imagingissues formanagementpriorities(p. 176)E³ 820bFoundationCourse:NeuroimagingMetabolic andneurodegenerativedisorders(p. 176)RC 802BreastClinicalchallenges inbreast MRI(p. 177)SF 8bSpecial FocusSessionGI imaging:technologicaladvancesand clinicalapplications(p. 177)EF 1EFOMPWorkshopLung and chestimaging: newapproaches(p. 177)10:0010:3011:00E³ 920aInteractiveTeachingSessionTips andtricks in chestimaging(p. 179)10:25–12:00EM 3ESR meetsSouth AfricaImaging HIVand TB(p. 179)SS 911NeuroNew insightsinto braingliomas(p. 241)SS 904ChestImage qualityand dosereduction(p. 241)SS 909InterventionalRadiologyThoracic interventions(p. 242)SS 910MusculoskeletalSpine: advancingthe use of CT andMRI(p. 242)E³ 920bFoundationCourse:NeuroimagingTumours andphacomatosis(p. 180)SS 916OncologicImagingWhole-bodyimaging: howto do it(p. 243)SS 902BreastIncreasedrisk of breastcancer(p. 243)EF 2EFOMPWorkshopLung imaging:multidisciplinaryscenario(p. 180)11:3012:0012:3013:0012:15–12:45HonoraryLecture 2(p. 181)SY 10SiemensHealthcareand BayerHealthCareJoint SatelliteSymposium(p. 150)SY 11BraccoSatelliteSymposium(p. 150)SY 12SiemensHealthcareSatelliteSymposium(p. 150)SY 13GEHealthCareSatelliteSymposium(p. 150)SY 14GuerbetSatelliteSymposium(p. 151)13:3014:0014:3015:00IIQImageInterpretationQuiz(p. 140)EM 5EFRS meetsSpainKnowledgedevelopmentas a tool forradiographers‘professionalimprovement(p. 181)SY 17HologicSatelliteSymposium(p. 151)SY 18ToshibaSatelliteSymposium(p. 151)SY 19ToshibaSatelliteSymposium(p. 151)15:3016:0016:3017:00E³ 1120InteractiveTeachingSessionBreast cancer(p. 182)SA 11State ofthe ArtSymposiumEvaluation ofresponse inhaematologicalmalignancy(p. 182)CC 1121UrogenitalImagingStones:diagnosis andintervention(p. 182)CC 1118CLICK (ClinicalLessons forImaging CoreKnowledge):Never withoutArteriesStroke(p. 182)RC 1108Head andNeckSkull base lesions:imagingstudies anddifferentialdiagnosis(p. 183)RC 1110MusculoskeletalThe knee(p. 183)MS 11MultidisciplinarySessions:ManagingPatients withCancerCholangiocarcinoma(p. 183)SF 11Special FocusSessionAdults withcongenitalheart disease(GUCH)(p. 184)PC 11ProfessionalChallengesSessionPersonalisedradiology(p. 184)RC 1111NeuroBrain tumours:advancedimaging techniquesin dailypractice - dowe really needthem?(p. 185)17:30Registration: 07:00–18:00 EPOS – Scientific Exhibition: 08:00–18:0092

Programme OverviewSaturday, March 9I/KLower LevelL/M1 st LevelN/O1 st LevelP1 st LevelQ1 st LevelX1 st LevelY1 st LevelZ2 nd LevelStudio 20131 st LevelEPOS2 nd LevelRoom/TimeRC 804ChestPatterns inchest radiology:are theresubtype patternsof groundglass opacity(GGO)?(p. 178)RC 815VascularHow I report(p. 178)RC 809InterventionalRadiologyWhat shouldevery radiologistknow about theendovasculartreatment ofabdominal aorticaneurysms?(p. 178)RC 803CardiacPracticalapproach tocardiovascularrisk stratificationwith CTand MRI(p. 178)RC 812PaediatricImaging thepaediatricspine(p. 179)SK 826How tobiopsy with USguidance(p. 146)StudentSession 3(p. 145)08:3009:0009:3010:00SS 901AbdominalVisceraCross-sectionalpancreaticimaging andbiomarkers(p. 244)Standards andAudit SessionAssessmentof radiologists‘professionalperformance(p. 180)SS 903CardiacMyocardial perfusionand coronaryartery disease(p. 244)SS 912PaediatricPaediatric bodyand bones(p. 245)SS 914RadiographersDose optimisationas dailychallenge(p. 245)SK 926How toBiopsy with USGuidance(p. 146)SK 927Image-GuidedTumourAblation(p. 147)SS 905ComputerApplicationsComputer-aideddiagnosis(p. 246)StudentSession 4(p. 145)EPOS discussionCT and MRI diagnosis offocal liver masses:when to use what?(p. 62)10:3011:0011:30SY 15PhilipsHealthcareSatelliteSymposium(p. 151)SY 16PhilipsHealthcareSatelliteSymposium(p. 151)SY 20GE HealthcareNycomedSatelliteSymposium(p. 152)MC 24CThe Beauty ofBasic Knowledge:Head and NeckMain pipelines ofthe neck: pharynxand larynx(p. 181)MSY 1Philips HealthcareMini SatelliteSymposium(p. 151)MC 25CThe Beauty ofBasic Knowledge:MusculoskeletalImagingInflammatory/infectiousdisorders(p. 181)13:00–14:45MIR@ECRInnovationmanagementand the futureof radiology andradiologists(p. 61)SK 1026How toBiopsy with USGuidance(p. 146)SK 1027Image-GuidedTumourAblation(p. 147)12:45–14:15EIBIR Session(p. 140)12:15-13:15FC SelfAssessmentTest(p. 136)12:0012:3013:0013:3014:0014:30RC 1104ChestPulmonary infections:the old andthe new(p. 185)RC 1113Physics inRadiologyCone-beamimaging(p. 185)RC 1109InterventionalRadiologyUpdate on biliaryinterventions(p. 185)RC 1114RadiographersHot topics in magneticresonanceimaging(p. 186)15:15–17:30MIR@ECRRadiology inmodern times:challenges bytelemedicine,eHealth, appropriatenessandsafety(p. 61)16:00–18:00StudentWorkshop 3(p. 145)SK 1127Image-GuidedTumourAblation(p. 147)Euro-BioImagingSession(p. 141)EPOS discussionPaediatric chest and heart:state of the art imaging ofthe young patient(p. 62)15:0015:3016:0016:3017:0017:30Technical Exhibition: EXPO First Level (Gallery): 10:00–18:00Technical Exhibition: EXPO Halls and EXPO Foyer D:10:00–18:0093

Programme OverviewSunday, March 10Room/TimeA2 nd LevelB2 nd LevelC2 nd LevelD1Lower LevelD2Lower LevelE1Entrance LevelE2Entrance LevelF1Entrance LevelF2Entrance LevelG/HLower Level08:3009:0009:30E³ 1220InteractiveTeachingSessionPitfalls in brainimaging(p. 187)RC 1201GI TractHow I report(p. 187)CC 1221UrogenitalImagingRetroperitonealanatomy, variantsand diseases(p. 187)CC 1218CLICK (ClinicalLessons forImaging CoreKnowledge):Never withoutArteriesChest pain: vascularnon-cardiac causes(p. 187)CC 1219OncologicImaging:Follow-up ofSystemic andLocal TherapiesAssessing HCCresponse(p. 188)RC 1210MusculoskeletalOveruse injuries insport: a multimodalityapproach(p. 188)RC 1211NeuroStroke: is theprognosis gettingany better?(p. 188)SF 12Special FocusSessionQuantitativeimaging biomarkersin cardiacradiology(p. 188)RC 1202BreastMulti-modalitybreast imaging(p. 189)RC 1207GenitourinaryHow I report(p. 189)10:0010:3011:0011:30SS 1316OncologicImagingRectal cancerimaging: the nextstep(p. 247)EM 4ESR meetsChileTopics of ongoingradiologicalresearch from theAndes(p. 191)CC 1321UrogenitalImagingThe female pelvis(p. 192)SS 1304ChestCTPA techniquesin lung perfusionand pulmonaryhypertension(p. 247)SS 1309InterventionalRadiologySkeletal andendocrinologicinterventions(p. 248)SS 1310MusculoskeletalArthritis andmetabolic bonedisease(p. 248)SS 1303CardiacTowards improvedimage quality anddetection(p. 249)SS 1311NeuroBrain tumours:imaging andtherapy(p. 249)SS 1302BreastHow to get morefrom breast imagingmodalities(p. 250)SS 1307GenitourinaryThe bladder andbelow(p. 250)12:0012:3013:0013:3012:15–12:45HonoraryLecture 3(p. 192)JIIQJunior ImageInterpretationQuiz(p. 141)SY 21GEHealthcareSatelliteSymposium(p. 152)SY 22SamsungSatelliteSymposium(p. 152)14:0014:3015:00E³ 1420InteractiveTeachingSessionCommon anduncommon errorsin plain film andCT imaging ofthe chest: howto improve yourperformance(p. 193)NH 14New HorizonsSessionImaging of themind(p. 193)CC 1421UrogenitalImagingThe male genitalsystem(p. 193)CC 1418CLICK (ClinicalLessons forImaging CoreKnowledge):Never withoutArteriesAngina, nonocclusivemesentericischaemia (NOMI)and friends: vascularcauses of acuteabdomen(p. 194)CC 1419OncologicImaging:Follow-up ofSystemic andLocal TherapiesFollow-up ofthermal ablation(part I)(p. 194)RC 1410MusculoskeletalHow I report(p. 194)RC 1416OncologicImagingThe essentialsof lymph nodeimaging of solidtumours: whatthe radiologistneeds to know(p. 194)SF 14aSpecial FocusSessionPalliativeinterventionaltechniques incancer(p. 195)RC 1402BreastHow I report(p. 195)SF 14bSpecial FocusSessionComprehensiveCT cardiothoracicimaging: a newchallenge forradiologists(p. 195)15:3016:0016:3017:00E³ 1520InteractiveTeachingSessionThoracicemergencies(p. 198)RC 1501GI TractCT colonography:when the‚new‘ becomes‚ordinary‘(p. 198)CC 1521UrogenitalImagingPaediatrics(p. 198)CC 1518CLICK (ClinicalLessons forImaging CoreKnowledge):Never withoutArteriesWhen every stepcounts: imaging andmanagement ofperipheral arterialocclusive disease(PAOD)(p. 199)CC 1519Oncologicmaging:Follow-upof Systemicand LocalTherapiesFollow-up ofthermal ablation(part II)(p. 199)RC 1517EmergencyRadiologyER: comprehensiveimaging ofnon-traumaticabdominalemergencies(p. 199)SA 15State ofthe ArtSymposiumImagingimpingementsyndromes(p. 199)SF 15aSpecial FocusSessionTraumatic braininjury(p. 200)SF 15bSpecial FocusSessionDigital breasttomosynthesis(p. 200)RC 1511NeuroEpilepsy:a lack ofknowledge canbe dangerous(p. 201)17:30Registration: 07:00–18:00 EPOS – Scientific Exhibition: 08:00–18:0094

Programme OverviewSunday, March 10I/KLower LevelL/M1 st LevelN/O1 st LevelP1 st LevelQ1 st LevelX1 st LevelY1 st LevelZ2 nd LevelStudio 20131 st LevelEPOS2 nd LevelRoom/TimeRC 1204ChestLung cancerstaging in 2013(p. 189)RC 1213Physics inRadiologyRisk assessmentand risk communication(p. 190)RC 1209InterventionalRadiologyGynaecologicaland obstetricalhaemorrhagicemergencies(p. 190)RC 1214RadiographersDose optimisationin computedtomography(p. 190)RC 1212PaediatricOncologicimaging: how toimage, follow upand report(p. 191)PC 12ProfessionalChallengesSessionLegal mattersrelated tomultimodalitytechniques(p. 191)Rising StarsBasic 3(p. 144)08:3009:0009:3010:00SS 1301AbdominalVisceraAbdominal CT:dose reductionand technicalimprovements(p. 251)SS 1308Head and NeckAdvanced imagingof the ear, orbitand glands(p. 251)SS 1317EmergencyRadiologyTechnicalissues and clinicalresults(p. 252)SS 1312PaediatricChest, heartand radiationawareness(p. 252)TF 1RTF - RadiologyTrainees ForumHighlightedLectures(p. 192)SK 1326How toBiopsy with USGuidance(p. 146)SK 1327Image-GuidedTumourAblation(p. 147)SS 1306Contrast MediaNew agents andprotocols(p. 253)PC 13ProfessionalChallengesSessionThe radiologist,the clinician andthe patient: animpossible trio?(p. 107)10:3011:0011:3012:00SY 23Philips HealthcareSatelliteSymposium(p. 152)SY 24Bracco SatelliteSymposium(p. 152)MC 25DThe Beauty ofBasic Knowledge:MusculoskeletalImagingNeoplastic/nonneoplasticlesions(p. 192)MC 24DThe Beauty of BasicKnowledge: Headand NeckThe suprahyoidneck: anatomy anddiagnostic algorithm ofthe neck mass(p. 193)EPOS discussionVascular imaging: CT,MR - or somethingcompletely different?Challenges in imagingperipheral arteryocclusive disease(p. 62)12:3013:0013:30RC 1407GenitourinaryContrast mediasafety: update(p. 196)RC 1413Physics inRadiologyHybrid imagingsystems(p. 196)RC 1408Head andNeckLaryngealcancer andradiology(p. 196)RC 1414RadiographersTowardsadvancing anddevelopingthe role ofradiographers(p. 197)RC 1412PaediatricPaediatricemergencies(p. 197)SK 1427Image-GuidedTumourAblation(p. 147)SF 14cSpecial FocusSessionAdvances in forensicradiology(p. 197)Student FinalSession(p. 145)14:0014:3015:0015:30RC 1503CardiacCardiac CT andMRI in difficultpatients: whatto do?(p. 201)RC 1513Physics inRadiologyNovel developmentsin CT andtheir impact ondose(p. 201)RC 1508Head and NeckPerforming andreporting headand neck examinations:howshould I do it?(p. 201)RC 1514RadiographersHybrid imagingtechnologies(p. 202)RC 1512PaediatricPaediatric MSKradiology: what isimportant?(p. 202)16:00–18:00StudentWorkshop 4(p. 145)SK 1527Image-GuidedTumourAblation(p. 147)16:0016:3017:0017:30Technical Exhibition: EXPO First Level (Gallery): 10:00–18:00Technical Exhibition: EXPO Halls and EXPO Foyer D:10:00–18:0095

Programme OverviewMonday, March 11Room/Time08:3009:0009:30A2 nd LevelE³ 1620InteractiveTeachingSessionAcute abdominalinflammatorydisorders(p. 203)B2 nd LevelSF 16aSpecial FocusSessionMy most beautifulmistakes in paediatricradiology(p. 203)C2 nd LevelCC 1621UrogenitalImagingThe usual, theunusual and thedangerous(p. 203)D1Lower LevelCC 1618CLICK (ClinicalLessons forImaging CoreKnowledge):Never withoutArteriesThe fast and thefurious: vasculartrauma resultingfrom trafficaccidents(p. 203)D2Lower LevelCC 1619OncologicImaging:Follow-up ofSystemic andLocal TherapiesFollow-up of localtreatments ofbreast cancer(p. 204)E1Entrance LevelRC 1601aGI TractDiagnosis andstaging of esophagealcancer(p. 204)E2Entrance LevelRC 1616OncologicImagingComplications ofcancer treatmentand the detectionof recurrences(p. 204)F1Entrance LevelRC 1601bAbdominalViscera/GI TractAbdominal MRI:standard and advancedprotocolsin clinical settings(p. 205)F2Entrance LevelESR GeneralAssemblyG/HLower LevelRC 1611NeuroSpine: update onpostoperativeimaging andminimally invasiveprocedures(p. 205)10:0010:3011:00E³ 1720bInteractiveTeachingSessionMusculoskeletalemergencies(p. 207)E³ 1720aInteractiveTeachingSessionPitfalls in pelvicimaging(p. 208)SS 1711NeuroBrain ischaemia:perfusionand diffusion(p. 255)SS 1704ChestTechnologicalrefinements:from x-rays tomicro-imaging(p. 255)SS 1709InterventionalRadiologyAbdominalinterventions:from TIPS tobile ducts(p. 256)SS 1710MusculoskeletalHip: CT and MRIapplications(p. 256)SS 1701aGI TractCT/MR colonography:technical issuesand clinicalstudies(p. 257)SS 1716OncologicImagingResponseevaluation inoncology:beyond RECIST(p. 257)SS 1702BreastTomosynthesis:a role in clinicalpractice?(p. 258)SS 1707GenitourinaryHints onhaematuriaand adrenalsfor all(p. 258)11:3012:0012:3013:0013:3014:0014:30SS 1811aNeuroLatest developmentsinneuroimaging(p. 262)SS 1811bNeuroSpinal imaging(p. 262)SS 1803CardiacCardiac imaging:into the future(p. 263)SS 1809InterventionalRadiologyNew approachesto aortic andperipheralinterventions(p. 263)SS 1810MusculoskeletalKnee: newhorizons(p. 264)SS 1801aGI TractColorectalcancer: diagnosticbiomarkers andresponse assessment(p. 264)SS 1802aBreastNewer techniquesin breast imagingand therapy(p. 265)SS 1802bBreastMaximising cancerdetection inbreast screening(p. 265)SS 1807GenitourinaryMixed modalitiesin GU imaging(p. 266)15:0015:3016:0016:3017:00RC 1901GI TractCross-sectionalimaging of colitis(p. 208)RC 1906Contrast MediaHow I optimisecontrast mediaadministration(p. 208)RC 1910MusculoskeletalIntra-articularimaging(p. 209)RC 1916OncologicImagingGastro-enteropancreaticneuroendocrinetumours(GEP-NET):a multidisciplinaryupdate(p. 209)SF 19Special FocusSessionTablet-computersin radiology:friend or foe?(p. 209)RC 1902BreastBreast ultrasound(p. 210)RC 1911NeuroMultiple sclerosis:2013 update(p. 210)17:30Registration: 07:00–18:00Technical Exhibition: EXPO Halls and EXPO Foyer D:10:00–14:0096

Programme OverviewMonday, March 11I/KLower LevelL/M1 st LevelN/O1 st LevelP1 st LevelQ1 st LevelX1 st LevelY1 st LevelZ2 nd LevelStudio 20131 st LevelEPOS2 nd LevelRoom/TimeRC 1604ChestPulmonary embolism:guidelinesand best practicethroughoutEurope(p. 205)SF 16cSpecial FocusSessionMaking homogeneousHCCreadings(p. 205)SF 16bSpecial FocusSessionHead and neckcancer battle: thepower of imagingstudies(p. 206)RC 1603CardiacHow I report(p. 206)RC 1605ComputerApplicationsImproving workflowefficiencyand quality(p. 207)Joint Sessionof the ESR andEFSUMBAdvances indiagnostic ultrasound:betterresults throughcooperation(p. 207)08:3009:0009:3010:00SS 1701bAbdominalVisceraDWI in pancreaticand hepatobiliarydiseases(p. 259)SS 1713Physics inRadiologyBreast imagingand novel CTtechniques(p. 259)SS 1703CardiacBiomarkers, tissuecharacterisationand remodelling(p. 260)SS 1712PaediatricFoetal and neonatalimaging(p. 260)SS 1714RadiographersMammography(p. 261)SS 1706MolecularImagingMolecular imagingin cancer anddegenerativediseases(p. 261)10:3011:0011:30SS 1801bAbdominalVisceraLiver volume,function and focallesions(p. 266)SS 1813Physics inRadiologyPatient dosemanagement anddose surveys(p. 267)MC 24EThe Beauty of BasicKnowledge: Headand NeckTemporal bone: sobeautiful, yet socomplicated(p. 208)SS 1815VascularVascular research(p. 267)MC 25EThe Beauty ofBasic Knowledge:MusculoskeletalImagingMetabolic/endocrinedisease(p. 208)SS 1812PaediatricPaediatric brain(p. 268)SS 1814RadiographersChallenges ofdifferent imagingtechniques(p. 268)SS 1806Contrast MediaFunctional studiesand safety(p. 269)12:0012:3013:0013:3014:0014:3015:0015:30RC 1904ChestPhenotypes inobstructive airwaydisease: howshould I image,analyse andreport?(p. 210)RC 1908Head and NeckTemporal bone:imaging the mostcommon symptomsand signs(p. 210)RC 1915VascularLower extremityvenous insufficiency(p. 211)RC 1912PaediatricNormal variantsin paediatricimaging: not tobe confused withdisease(p. 211)16:0016:3017:0017:30Technical Exhibition: EXPO First Level (Gallery): 10:00–18:0097

Programmeby Topic100 New Horizons Sessions101 State of the Art Symposia102 Special Focus Sessions107 Professional Challenges Session108 Multidisciplinary SessionsManaging Patients with Cancer109 Categorical Courses109 CLICK (Clinical Lessons for ImagingCore Knowledge):Never without Arteries110 Oncologic Imaging: Follow-up ofSystemic and Local Therapies111 Urogential Imaging112 Mini Courses112 Organs from A to Z: Heart112 Controversies in Breast Imaging113 The Beauty of Basic Knowledge:Head and Neck113 The Beauty of Basic Knowledge:Musculoskeletal Imaging114 Joint Course of ESR and RSNA115 Refresher Courses / Scientific Sessions115 Abdominal and Gastrointestinal117 Breast118 Cardiac120 Chest121 Computer Applications122 Molecular Imaging and ContrastMedia122 Genitourinary123 Head and Neck124 Interventional Radiology126 Musculoskeletal127 Neuro129 Paediatric130 Physics in Radiology131 Radiographers132 Vascular133 Oncologic Imaging134 Emergency Radiology135 EFOMP Workshop136 E 3 – European Excellence in Education136 Foundation Course: Neuroimaging137 Interactive Teaching Sessions139 Accompanying Sessions139 ESR Radiation Protection Session139 6 th Post-Processing Face-OffSession139 EIBIR/EORTC Symposium139 ESOR Session140 Standards and Audit Session140 EIBIR/EuroAIM Session140 EIBIR Session / Horizon 2020140 Image Interpretation Quiz141 Euro-BioImaging141 RTF Highlighted Lectures141 Junior Image Interpretation Quiz141 Joint Session ESR/EFSUMB142 EIBIR presents IMAGINE144 Rising Stars Programme146 Update Your Skills (Practical Courses)146 How to biopsy with US guidance147 Image-guided tumor ablation149 Satellite Symposia153 Industry Hands-on WorkshopsEspecially marked for ANCED and IOR radiologists or suitable for= Interactive session with electronic voting/self assessment= Session broadcast live at myESR.org

New Horizons SessionsFriday, March 8, 16:00–17:30, Room CNH 7: Cartilage imaging• Chairman’s Introduction [A-149]V.N. Cassar-Pullicino; Oswestry/UK• Sodium imaging [A-150]S. Trattnig; Vienna/AT• dGEMRIC (delayed gadolinium-enhanced MR imagingof cartilage) [A-151]G. Welsch; Erlangen/DE• Diffusion tensor imaging [A-152]C. Glaser; Munich/DE• CEST (chemical exchange saturation transfer) [A-153]B. Schmitt; Vienna/AT• Panel discussion: What are the envisaged future advancesin these cartilage imaging techniques and can we expectto introduce them into clinical practice?Saturday, March 9, 08:30–10:00, Room CNH 8: MR/PET: a marriage made in heavenor hell?• Chairman’s Introduction [A-207]B. Hamm; Berlin/DE• MR/PET in neuroimaging: nuclear medicine [A-208]O. Sabri; Leipzig/DE• MR/PET in neuroimaging: radiology [A-209]B.R. Rosen; Charlestown, MA/US• MR/PET in oncologic imaging: nuclear medicine [A-210]O. Ratib; Geneva/CH• MR/PET in oncologic imaging: radiology [A-211]H.-P. Schlemmer; Heidelberg/DE• Panel discussion: What benefits and risks should weexpect in terms of basic research, clinical service, andeconomics?Sunday, March 10, 14:00–15:30, Room BNH 14: Imaging of the mind• Chairman’s introduction: New insights into the state ofconsciousness through neuroimaging [420]S. Sunaert; Leuven/BE• Brain wiring: resting state fMRI [A-421]F. Barkhof; Amsterdam/NL• fMRI in disorders of consciousness: diagnostic and legalchallenges [A-422]C. Di Perri; Liège/BE• fMRI of cognitive functions: discriminating normalaging, minimal cognitive impairment and Alzheimer’sdisease [A-423]A. Falini; Milan/IT• Panel discussion: New insights into the state ofconsciousness through neuroimaging. Where are we andwhere should we go?100

State of the Art SymposiaFriday, March 8, 08:30–10:00, Room E1SA 4: Diffusion-weighted imaging (DWI)of the abdomen• Chairman’s Introduction [A-068]Y. Menu; Paris/FR• DWI of the abdomen: a tutorial for beginners [A-069]H.C. Thoeny; Berne/CH• Liver and pancreas: answering burning questions [A-070]F. Caseiro-Alves; Coimbra/PT• DWI of abdominal lymph nodes: PET competitive or justpseudo? [A-071]S. Gourtsoyianni; London/UK• Clinical casesSaturday, March 9, 16:00–17:30, Room BSA 11: Evaluation of response inhaematological malignancy• Chairman’s Introduction [A-298]E. de Kerviler; Paris/FR• Opportunities and limitations of PET, CT and MRIanswering the haematologist’s questions [A-299]T.C. Kwee; Utrecht/NL• Evaluation of response in multiple myeloma [A-300]J. Hillengass; Heidelberg/DE• Evaluation of response in lymphoma with PET/CT[A-301]S.F. Barrington; London/UK• Panel discussion: Is it time for biomarker responsecriteria in haematological malignancies?Sunday, March 10, 16:00–17:30, Room E2SA 15: Imaging impingement syndromes• Chairman’s Introduction [A-496]C.W.A. Pfirrmann; Zurich/CH• Shoulder [A-497]P. Robinson; Leeds/UK• Ankle [A-498]M. Maas; Amsterdam/NL• Hip [A-499]K. Wörtler; Munich/DE• Panel discussion: Form or function: is impingement aclinical or imaging diagnosis?101

Special Focus SessionsFriday, March 8, 08:30–10:00, Room F2SF 4a: ‘MRI of the lung: to go?‘• Chairman’s introduction: ‘Apéritif ’ [A-080]H. Kauczor; Heidelberg/DE• ‘The sequence buffet’ [A-081]J.M. Wild; Sheffield/UK• ‘Preparing your menu’ [A-082]J. Biederer; Heidelberg/DE• ‘Bon appétit! Starters’: cystic fibrosis, pneumonia andpulmonary embolism [A-083]M.U. Puderbach; Heidelberg/DE• ‘Bon appétit! Main course’: pulmonary and mediastinalneoplasms [A-084]E.J.R. van Beek; Edinburgh/UK• Panel discussion: ‘Bon appétit! Dessert’: what are thebenefits of MRI of the lung in clinical workflow anddecision-making?Friday, March 8, 08:30–10:00, Room QSF 4b: Justifying CT in paediatric radiology• Chairman’s Introduction [A-105]C. Owens; London/UK• How should CT be optimised? [A-106]W.A. Kalender; Erlangen/DE• When, how, and why I perform CT [A-107]C. Owens; London/UK• Why and when CT does not need to be performed[A-108]M. Claudon; Vandoeuvre-les-Nancy/FR• Panel discussion: Do we have guidelines for paediatricCT? Do we have alternatives?Friday, March 8, 16:00–17:30, Room F1SF 7a: Radiographers and ultrasonographyin Europe• Chairmen’s Introduction [A-167]D. Pekarovic; Ljubljana/SIV. Vilgrain; Clichy/FR• Levels of training and competencies across Europe[A-169]M. Stanton; Dublin/IE• The role and impact of the radiographer conducted US inPortugal [A-169]R. Ribeiro; Lisbon/PT• Evolution of radiography education for US in theNetherlands since 1990, and its influence on their role[A-170]G. Plug; Haarlem/NL• Panel discussion: What are the challenges and barriersfacing role extension?102

Special Focus SessionsFriday, March 8, 16:00–17:30, Room F2SF 7b: Imaging and radiotherapy:all you need to know• Chairman’s Introduction [A-171]V.J. Goh; London/UK• Modern radiotherapy: what are the new technologies?[A-172]V. Valentini; Rome/IT• PET/CT for radiotherapy planning: how does it assistIMRT? [A-173]A. Loft; Copenhagen/DK• Response evaluation and treatment adaptation [A-174]K. Haustermans; Leuven/BE• MR imaging biomarkers for response evaluation [A-175]R.G.H. Beets-Tan; Maastricht/NL• Panel discussion: How can imaging improve outcomes inradiotherapy?Friday, March 8, 16:00–17:30, Room QSF 7c: Imaging in intensive care patients• Chairman’s Introduction [A-193]A. Palkó; Szeged/HU• Value of MRI for intensive care coma patients withunclear brain pathology [A-194]P.C. Maly Sundgren; Lund/SE• Computed tomography of pathologic lung conditionscomplicating intensive care treatment [A-195]C.M. Schaefer-Prokop; Amersfoort/NL• Point-of-care versus diagnostic ultrasound in theintensive care unit [A-196]E. Danse; Brussels/BE• Imaging in polyTrauma [A-197]U. Linsenmaier; Munich/DE• Panel discussion: What training and special skills areradiologists expected to have in order to work withintensive care units? How should we manage the clinicaland technical challenges posed by this very specificenvironment?Saturday, March 9, 08:30–10:00, Room BSF 8a: Is diagnostic catheter angiography stilluseful in neuroimaging?• Chairman’s Introduction [A-203]M. Essig; Erlangen/DE• What can we expect from vascular diagnostic procedures?[A-204]R. Siemund; Lund/SE• Can non-invasive techniques as CTA and MRA replacecatheter angio for diagnostic work-up? [A-205]L. Van den Hauwe; Brasschaat/BE• Diagnostic catheter angiography is not dead: currentindications and advantages over the non-invasivetechniques [A-206]T. Engelhorn; Erlangen/DE• Panel discussion: The pros and cons of diagnostic catheterangiography in neuroimagingSaturday, March 9, 08:30–10:00, Room F2SF 8b: GI imaging: technological advances andclinical applications• Chairman’s Introduction [A-229]S.A. Jackson; Plymouth/UK• CEUS of the bowel wall: when and how [A-230]F. Maccioni; Rome/IT• Dual-energy (spectral) CT: GI applications [A-231]P. Rogalla; Toronto, ON/CA• MR imaging of GI tract motility [A-232]S.A. Taylor; London/UK• Panel discussion: When should we integrate thesetechnological advances into our routine practice?Saturday, March 9, 16:00–17:30, Room F1SF 11: Adults with congenital heart disease(GUCH)• Chairman’s introduction: Why should a radiologistgather information on GUCH patients? [A-321]M. Gutberlet; Leipzig/DE• A list of typical surgical procedures: the top ten in GUCH[A-322]M. Hübler; Zurich/CH• ‘Adults are not just big children’: differences betweenchildren and adults [A-323]A.M. Taylor; London/UK• Which modality, for which patient? MRI or CT, that’s thequestion [A-324]J. Bremerich; Basle/CH• Panel discussion: Can we now get all the information weneed to treat GUCH patients, non-invasively?103

Special Focus SessionsSunday, March 10, 08:30–10:00, Room F1SF 12: Quantitative imaging biomarkers incardiac radiology• Chairman’s Introduction [A-368]A. van der Lugt; Rotterdam/NL• Imaging biomarkers [A-369]J.-P. Vallée; Geneva/CH• Imaging biomarkers for myocardial function [A-370]J. Bogaert; Leuven/BE• Imaging biomarkers of myocardial viability [A-371]P. Croisille; Saint-Etienne/FR• Imaging biomarkers of myocardial ischaemia [A-372]L. Natale; Sesto Fiorentino/IT• Panel discussion: How should we implement quantitativebiomarkers in clinical practice?Sunday, March 10, 14:00–15:30, Room F1SF 14a: Palliative interventional techniquesin cancer• Chairman’s Introduction [A-441]K.A. Hausegger; Klagenfurt/AT• Cementoplasty of lytic bone metastasis [A-442]A. Gangi; Strasbourg/FR• Pleural drainage, pleurodesis [A-443]F. Gleeson; Oxford/UK• Percutaneous nephrostomy (PCN) and ureteral stenting[A-444]F. Orsi; Milan/IT• Biliary procedures [A-445]M. Krokidis; Cambridge/UK• Panel discussion: How invasive can palliation be? Whento say no to palliative treatment?Sunday, March 10, 14:00–15:30, Room G/HSF 14b: Comprehensive CT cardiothoracicimaging:a new challenge for radiologists• Chairman’s Introduction [A-449]L. Bonomo; Rome/IT• How to optimise integrated cardiothoracic imaging withCT [A-450]U.J. Schoepf; Charleston, SC/US• Coronary artery imaging from a chest CT examination:when and how [A-451]R. Marano; Rome/IT• Cardiopulmonary functional imaging from a chest CTexamination: when and how [A-452]E.J.R. van Beek; Edinburgh/UK• Panel discussion: Is a single CT scan technique andprotocol feasible for all the cardiothoracic problems?Sunday, March 10, 14:00–15:30, Room ZSF 14c: Advances in forensic radiology• Chairman’s Introduction [A-471]G. Guglielmi; Foggia/IT• Imaging in forensic medicine [A-472]M. Thali; Zurich/CH• Advances in post-mortem CT angiography [A-473]S. Grabherr; Lausanne/CH• Virtual anthropology and forensic identification usingMDCT [A-474]F. Dedouit; Toulouse/FR• Forensic MR imaging [A-475]T. Ruder; Zurich/CH• Panel discussion: Which imaging technique for whichforensic scenario?Sunday, March 10, 16:00–17:30, Room F1SF 15a: Traumatic brain injury• Chairman’s Introduction [A-500]A. Rovira-Cañellas; Barcelona/ES• Acute brain trauma: CT vs MRI [A-501]M. Muto; Naples/IT• New imaging techniques in the detection andquantification of brain damage [A-502]S. Sunaert; Leuven/BE• Advanced imaging of brain trauma: outcome prediction[A-503]D. Galanaud; Paris/FR• Cerebrovascular trauma: diagnosis and therapy [A-504]T. Krings; Toronto, ON/CA• Panel discussion: Role of neuroimaging in traumaticbrain injury in 2013Sunday, March 10, 16:00–17:30, Room F2SF 15b: Digital breast tomosynthesis• Chairman’s Introduction [A-505]G. Gennaro; Padua/IT• Optimisation of image acquisition and reconstruction inDBT [A-506]M.J. Yaffe; Toronto, ON/CA• Current role of DBT in diagnostic imaging [A-507]S. Zackrisson; Malmö/SE• Clinical aspects of computer aided detection anddiagnosis in DBT [A-508]H.-P. Chan; Ann Arbor, MI/US• Panel discussion: Digital breast tomosynthesis: replacingor just supporting standard mammography?104

Special Focus SessionsMonday, March 11, 08:30–10:00, Room BSF 16a: My most beautiful mistakes inpaediatric radiology• Chairman’s Introduction [A-530]P. Tomà; Rome/IT• Abdomen [A-531]S.G.F. Robben; Maastricht/NL• CNS [A-532]B. Bernardi; Rome/IT• Musculoskeletal [A-533]K. Rosendahl; Bergen/NO• Panel discussion: How have you changed or improvedyourself after recognising your mistakes?Monday, March 11, 08:30–10:00, Room N/OSF 16b: Head and neck cancer battle:the power of imaging studies• Chairman’s Introduction [A-568]V. Vandecaveye; Leuven/BE• Building blocks for locoregional staging of head and necktumours [A-569]F.A. Pameijer; Utrecht/NL• Detection of tumour recurrence in head and neck cancer:challenges and pitfalls [A-570]M. Becker; Geneva/CH• Locoregional treatment failure in head and neck cancer:causes and clinical implications [A-571]R. Maroldi; Brescia/ITP. Nicolai; Brescia/IT• Panel discussion: Advanced imaging in clinical practice:how does it help the patient?105

Special Focus SessionsMonday, March 11, 08:30–10:00, Room L/MSF 16c: Making homogeneous HCC readings• Chairman’s Introduction [A-563]C. Bartolozzi; Pisa/IT• HCC diagnosis: how to report ‘typical’ findings [A-564]C. Ayuso; Barcelona/ES• How to interpret and report ‘atypical’ findings [A-565]C.J. Zech; Basle/CH• How to evaluate tumour response to therapies [A-566]J. Ricke; Magdeburg/DE• Information technology: the practical impact on themanagement of HCC patients [A-567]I. Bargellini; Pisa/IT• Panel discussion: Case-based discussion: a practicaldemonstration of how interpretation and reporting affectpatient managementMonday, March 11, 16:00–17:30, Room F1SF 19: Tablet computers in radiology:friend or foe?• Chairman’s Introduction [A-605]E. Neri; Pisa/IT• Tablet computers: a technical overview [A-606]J. Fernandez-Bayó; Sabadell/ES• Radiological features of the tablet computer [A-607]L. Faggioni; Pisa/IT• Reading DICOM images on the tablet [A-608]O. Ratib; Geneva/CH• Mobile teleradiology with tablet computers:a critical appraisal [A-609]E.R. Ranschaert; ‘s-Hertogenbosch/NL• Panel discussion: Are we ready and confident enough touse tablet computers in clinical practice? How and when?106

Professional Challenges SessionsThursday, March 7, 16:00–17:30, Room F1PC 3: Bringing radiology to medicalundergraduates• Chairman’s introduction: why does it matter? [A-022]S.J. Golding; Oxford/UK• Establishing a radiological presence in the undergraduatecurriculum [A-023]R.N. Gibson; Melbourne, VIC/AU• Finding the time and resources in the radiologydepartment [A-024]J.L. del Cura; Bilbao/ES• Involving the undergraduate with the radiologydepartment [A-025]K. Verstraete; Gent/BE• How to ensure teachers are suitably trained [A-026]E. Szabó; Szeged/HU• Panel discussion: What needs to be done to overcome theconstraints on radiologists?Friday, March 8, 08:30–10:00, Room PPC 4: The visibility of the radiologist• Chairman’s introduction [A-100]J.A. Reekers; Amsterdam/NL• How to optimise the visibility of the radiologydepartment [A-101]J.A. Reekers; Amsterdam/NL• Start early with radiological visibility [A-102]M. Maas; Amsterdam/NL• Clinical radiology puts you in the spotlight: taking overthe clinical responsibility [A-103]E. de Kerviler; Paris/FR• Radiology in the 21st century: time to come out of thedark? [A-104]A. Adam; London/UK• Panel discussion: Should we improve the visibility of theradiologist? And if yes, how?Sunday, March 10, 08:30–10:00, Room ZPC 12: Legal matters related tomultimodality techniques• Chairman’s introduction [A-398]K. Åhlström Riklund; Umea/SE• Radiological legal matters in eastern Europe [A-399]M. Studniarek; Gdansk/PL• Legal matters in nuclear medicine [A-400]G.K. von Schulthess; Zurich/CH• Legal matters in Scandinavia [A-401]K. Åhlström Riklund; Umea/SE• International, regional, national and local frameworkrequirements [A-402]A. Perkins; Nottingham/UK• Panel discussion: A discussion with questions from theaudience about the differences across EuropeSunday, March 10, 10:30–12:00, Studio 2013PC 13: The radiologist, the clinician and thepatient: an impossible trio?Chairman: C.D. Claussen; Tübingen/DEModerator: W. Wagner; Vienna/ATThe aim of this session is to initiate an open and frankdiscussion among different stakeholders about the current roleof the radiologist in relation to the patient, other cliniciansand the public. Which procedures are efficient? Which areinefficient? What should be changed in future and whatis manageable during clinical routine? As the participantsrepresent various disciplines, we hope to come to a realisticoutlook.Participants:• A. Adam; London/UK (Radiologist)• G. Marckmann; Munich/DE (Medical Ethicist)• M. Peck-Radosavljevic; Vienna/AT (Internal Medicine Doctor)• J.A. Reekers; Amsterdam/NL (Radiologist)Saturday, March 9, 16:00–17:30, Room F2PC 11: Personalised radiology• Chairman’s introduction [A-325]G.P. Krestin; Rotterdam/NL• Personalised medicine: hope or hype? [A-326]O. Golubnitschaja; Bonn/DE• Imaging for disease prediction [A-327]M. Vernooij; Rotterdam/NL• Molecular imaging: a solution for personalised diagnosisand treatment? [A-328]F.M.A. Kiessling; Aachen/DE• Role of imaging in personalised therapy monitoring[A-329]A.R. Padhani; Northwood/UK• Panel discussion: Is imaging providing an added value tothe ‘omics’ of personalised medicine?107

Multidisciplinary SessionsManaging Patients with CancerThursday, March 7, 16:00–17:30, Room E2MS 3: Colorectal liver metastases• Chairman’s introduction [A-017]V. Vilgrain; Clichy/FR• Role of imaging in the pretreatment assessment [A-018]V. Vilgrain; Clichy/FR• Surgical resection of liver metastases: when and how[A-019]J. Belghiti; Clichy/FR• Chemotherapy and novel therapy in colorectal livermetastases: rationale, indications and results [A-020]S. Faivre; Clichy/FR• Role of image-guided treatment in colorectal livermetastases [A-021]M. Abdel Rehim; Clichy/FR• Case presentation and discussionFriday, March 8, 08:30–10:00, Room F1MS 4: Hepatocellular carcinoma• Chairman’s introduction [A-075]B. Sangro; Pamplona/ES• Abdominal radiology [A-076]A. Benito; Pamplona/ES• Interventional radiology [A-077]J.I. Bilbao; Pamplona/ES• Surgery [A-078]F. Pardo; Pamplona/ES• Hepatology/oncology [A-079]B. Sangro; Pamplona/ES• Case presentation and discussionSaturday, March 9, 16:00–17:30, Room E2MS 11: Cholangiocarcinoma• Chairman’s introduction [A-316]B. Hamm; Berlin/DE• Surgery of hilar and extrahepatic cholangiocarcinoma[A-317]P. Neuhaus; Berlin/DE• Radiology – diagnostics and portal vein embolisation inhilar and extrahepatic cholangiocarcinoma [A-318]T. Denecke; Berlin/DE• Medical treatment of cholangiocarcinomas [A-319]H. Riess; Berlin/DE• Radiology – diagnostics and image guided therapies inintrahepatic cholangiocarcinomas [A-320]B. Gebauer; Berlin/DE• Case presentation (part 1): hilar cholangiocarcinoma• Case presentation (part 2): CCC multimodal treatment108

Categorical CoursesCLICK (Clinical Lessons for Imaging Core Knowledge): Never without ArteriesSaturday, March 9, 08:30–10:00, Room D1CC 818: How old are you in reality?Vascular age and clinical eventsModerator: L. Lonn; Copenhagen/DKA. Clinical considerations [A-212]E. Minar; Vienna/ATB. Imaging techniques and typical findings [A-213]H.J. Lamb; Leiden/NLC. Interactive case discussion: how to deal with the results?[A-214]A. van der Lugt; Rotterdam/NLSaturday, March 9, 16:00–17:30, Room D1CC 1118: StrokeModerator: M.M. Thurnher; Vienna/ATA. Clinical considerations [A-306]P.M. Parizel; Antwerp/BEB. Imaging techniques and typical findings [A-307]J. Vymazal; Prague/CZC. Interactive case discussion: what is next after diffusionand perfusion? [A-308]A. Dörfler; Erlangen/DESunday, March 10, 08:30–10:00, Room D1CC 1218: Chest pain:vascular non-cardiac causesModerator: E. Brountzos; Athens/GRA. Clinical considerations [A-355]R. Iezzi; Rome/ITB. Imaging techniques and typical findings [A-356]F. Wolf; Vienna/ATC. Interactive case discussion: what is really important?[A-357]T.R.C. Johnson; Munich/DESunday, March 10, 14:00–15:30, Room D1CC 1418: Angina, non-occlusive mesentericischaemia (NOMI) and friends:vascular causes of acute abdomenModerator: O. Chan; London/UKA. Clinical considerations [A-428]P. Rogalla; Toronto, ON/CAB. Imaging techniques and typical findings [A-429]M. Prokop; Nijmegen/NLC. Interactive case discussion: how to proceed? [A-430]A. Palkó; Szeged/HUSunday, March 10, 16:00–17:30, Room D1CC 1518: When every step counts: imaging andmanagement of peripheral arterialocclusive disease (PAOD)Moderator: J.F.M. Meaney; Dublin/IEA. Clinical considerations [A-486]M. Schillinger; Vienna/ATB. Imaging techniques and typical findings [A-487]T. Leiner; Utrecht/NLC. Interactive case discussion: how to deal with the results?Typical cases, pitfalls, and what is next? [A-488]L.P. Lawler; Dublin/IEMonday, March 11, 08:30–10:00, Room D1CC 1618: The fast and the furious: vasculartrauma resulting from traffic accidentsModerator: U. Linsenmaier; Munich/DEA. Clinical considerations [A-538]H. Hoppe; Berne/CHB. Imaging techniques and typical findings [A-539]H. Alkadhi; Zurich/CHC. Interactive case discussion [A-540]R. Morgan; London/UK= Interactive session with electronic voting/self assessment109

Categorical CoursesOncologic Imaging: Follow-up of Systemic and Local TherapiesFriday, March 8, 16:00–17:30, Room D2CC 719: Imaging after systemic therapies:the standardsModerator: E.L. van Persijn van Meerten; Leiden/NLA. RECIST criteria [A-157]Y. Menu; Paris/FRB. PERCIST: evolving considerations for PET responsecriteria in solid tumours [A-158]T.F. Hany; Zurich/CHC. Evaluation of brain tumours [A-159]C. Majós; L’Hospitalet de Llobregat/ESSaturday, March 9, 08:30–10:00, Room D2CC 819: Imaging after systemic therapies:advanced techniquesModerator: D.-M. Koh; Sutton/UKA. What can we expect from biomarkers [A-215]B. Van Beers; Clichy/FRB. MRI biomarkers: from acquisition to post-processing[A-216]O. Lucidarme; Paris/FRC. Assessing the precision and accuracy of biomarkerimaging: is it reproducible? [A-217]C.B. Sirlin; San Diego, CA/USSunday, March 10, 08:30–10:00, Room D2CC 1219: Assessing HCC responseModerator: R. Lencioni; Pisa/ITA. Systemic therapies [A-358]V. Vilgrain; Clichy/FRB. Endovascular therapies [A-359]R. Salem; Chicago, IL/USC. Ablative therapies [A-360]C. Ayuso; Barcelona/ESSunday, March 10, 14:00–15:30, Room D2CC 1419: Follow-up of thermal ablation (part I) Moderator: W. Prevoo; Amsterdam/NLA. The zone of cell death and collateral phenomena oncross-sectional imaging: from histopathology to thestandardisation of terms [A-431]A. Denys; Lausanne/CHB. PET/CT for the evaluation of ablative therapy: Who?Where? When? Does it help? [A-432]D. Deandreis; Villejuif/FRC. Everyday practice: MR and CT for evaluating response tothermal ablation [A-433]C. Dromain; Villejuif/FRSunday, March 10, 16:00–17:30, Room D2CC 1519: Follow-up of thermal ablation (part II) Moderator: P.L. Pereira; Heilbronn/DEA. Follow-up imaging of thermal ablative therapies for lungtumours [A-489]A.R. Gillams; London/UKB. Follow-up imaging of percutaneous local treatment ofbone tumours [A-490]F. Deschamps; Villejuif/FRC. Follow-up imaging of thermal ablative therapies forkidney tumours [A-491]D.J. Breen; Southampton/UKMonday, March 11, 08:30–10:00, Room D2CC 1619: Follow-up of local treatments ofbreast cancerModerator: M.H. Fuchsjäger; Graz/ATA. MRI-guided HIFU therapies in the breast [A-541]M. Sklair-Levy; Tel Aviv/ILB. Pre- and post- imaging appearance of breast lesionexcision system (BLES) lesions [A-542]S. Allen; Sutton/UKC. Common features and pitfalls in imaging the treatedbreast [A-543]J. Camps Herrero; Valencia/ES110

Categorical CoursesUrogential ImagingSaturday, March 9, 16:00–17:30, Room CCC 1121: Stones: diagnosis and interventionModerator: N.C. Cowan; Oxford/UKA. Imaging patients with renal colic [A-302]G. Heinz-Peer; St. Pölten/ATB. Percutaneous treatment of renal stones [A-303]S. Moussa; Edinburgh/UKC. Intervention in ureteral obstruction and ureteral trauma[A-304]A. Magnusson; Uppsala/SED. Interactive case discussion [A-305]N.C. Cowan; Oxford/UKSunday, March 10, 08:30–10:00, Room CCC 1221: Retroperitoneal anatomy, variantsand diseasesModerator: U.G. Mueller-Lisse; Munich/DEA. Retroperitoneal anatomy: an embryology based approach[A-351]F.M. Danza; Rome/ITB. Anatomical variants and benign diseases [A-352]S. Merran; Paris/FRC. Malignant tumours [A-353]R.H. Oyen; Leuven/BED. Interactive case discussion [A-354]U.G. Mueller-Lisse; Munich/DESunday, March 10, 10:30–12:00, Room CCC 1321: The female pelvisModerator: E. Sala; New York, NY/USA. Imaging congenital anomalies of the female genitalsystem [A-409]K. Kinkel; Chêne-Bougeries/CHB. Benign ovarian masses [A-410]R. Forstner; Salzburg/ATC. Imaging the infertile couple [A-411]J. McHugo; Birmingham/UKD. Interactive case discussion [A-412]E. Sala; New York, NY/USSunday, March 10, 14:00–15:30, Room CCC 1421: The male genital systemModerator: J.O. Barentsz; Nijmegen/NLA. Imaging of prostate cancer: an update [A-424]J.J. Fütterer; Nijmegen/NLB. Scrotal tumours [A-425]P.S. Sidhu; London/UKC. The penis [A-426]M. Bertolotto; Trieste/ITD. Interactive case discussion [A-427]J.O. Barentsz; Nijmegen/NLSunday, March 10, 16:00–17:30, Room CCC 1521: PaediatricsModerator: M. Claudon; Vandoeuvre-les-Nancy/FRA. Imaging strategies for children: urinary tract infectionand vesico-ureteral reflux [A-482]M. Riccabona; Graz/ATB. Paediatric adrenal tumours [A-483]P.-H. Vivier; Rouen/FRC. Prenatal detection of GU diseases [A-484]F.E. Avni; Lille/FRD. Interactive case discussion [A-485]M. Claudon; Vandoeuvre-les-Nancy/FRMonday, March 11, 08:30–10:00, Room CCC 1621: The usual, the unusualand the dangerousModerator: S.K. Morcos; Sheffield/UKA. Imaging of renal Trauma [A-534]V. Logager; Copenhagen/DKB. Postoperative anatomy and complications after GUinterventions [A-535]H.C. Thoeny; Berne/CHC. GU complications in patients with spinal cord damage[A-536]S. Agarwal; Wrexham/UKD. Interactive case discussion [A-537]S.K. Morcos; Sheffield/UK= Interactive session with electronic voting/self assessment111

Mini CoursesOrgans from A to Z: HeartThursday, March 7, 16:00–17:30, Room L/MMC 322: Technical and anatomicalfundamentals for imaging the heartModerator: A. de Roos; Leiden/NLA. Anatomy: too many details in cardiac imaging? [A-036]A.J.B.S Madureira; Porto/PTB. Examination protocols for imaging the heart: CT [A-037]H. Alkadhi; Zurich/CHC. Examination protocols for imaging the heart: MRI[A-038]N.L. Kelekis; Athens/GR• Interactive case discussion [A-039]A. de Roos; Leiden/NLFriday, March 8, 08:30–10:00, Room L/MMC 422: Non-ischaemic heart diseaseModerator: V.E. Sinitsyn; Moscow/RUA. Congenital heart disease [A-091]M. Gutberlet; Leipzig/DEB. Valvular disease [A-092]J. Bogaert; Leuven/BEC. Cardiomyopathies [A-093]P. Sipola; Kuopio/FI• Interactive case discussion [A-094]V.E. Sinitsyn; Moscow/RUFriday, March 8, 16:00–17:30, Room L/MMC 722: Ischaemic heart diseaseModerator: C. Catalano; Rome/ITA. Imaging of the coronary arteries: the Holy Grail [A-182]G. Roditi; Glasgow/UKB. The ischaemic myocardium: what to do? [A-183]C. Loewe; Vienna/ATC. The ischaemic heart after treatment: still alive? [A-184]G. Bastarrika; Pamplona/ES• Interactive case discussion [A-185]C. Catalano; Rome/ITControversies in Breast ImagingFriday, March 8, 08:30–10:00, Room D1MC 423: Overdiagnosis from screeningmammography:should we care about it?Moderator: T.H. Helbich; Vienna/ATTeaser: H.J. de Koning; Rotterdam/NLA. The risk of overdiagnosis from screening mammography[A-062]E. Paci; Florence/ITB. How breast radiologists should control the risk ofoverdiagnosis [A-063]U. Bick; Berlin/DE• Discussion [A-064]T.H. Helbich; Vienna/ATH.J. de Koning; Rotterdam/NLFriday, March 8, 14:00–15:30, Room D1MC 623: Preoperative MRI in newly diagnosedbreast cancer: to do or not to do?Moderator: F. Sardanelli; Milan/ITTeaser: N. Houssami; Sydney/AUA. Why we should do preoperative MRI [A-128]W.A. Kaiser; Jena/DEB. Reasons not to do preoperative MRI [A-129]M.G. Wallis; Cambridge/UK• Discussion [A-130]F. Sardanelli; Milan/ITN. Houssami; Sydney/AUFriday, March 8, 16:00–17:30, Room D1MC 723: Should we add ultrasound tomammographic screening ofdense breasts?Moderator: F.J. Gilbert; Cambridge/UKTeaser: A. Tardivon; Paris/FRA. We can reduce the interval cancer rate [A-154]W. Berg; Pittsburgh, PA/USB. Do we have enough radiologists to do it? Alternatives toultrasound to reduce interval cancers [A-155]A. Frigerio; Turin/IT• Discussion [A-156]F.J. Gilbert; Cambridge/UKA. Tardivon; Paris/FR= Interactive session with electronic voting/self assessment112

The Beauty of Basic Knowledge:Head and NeckThursday, March 7, 12:30–13:30, Room N/OMC 24A: A taste of the oral cavity andsalivary glands [A-001]A. Borges; Lisbon/PTFriday, March 8, 12:30–13:30, Room QMC 24B: The infrahyoid neck and lymph nodes[A-126]M.G. Mack; Munich/DESaturday, March 9, 12:30–13:30, Room N/OMC 24C: Main pipelines of the neck:pharynx and larynx [A-274]M. Becker; Geneva/CHSunday, March 10, 12:30–13:30, Room QMC 24D: The suprahyoid neck: anatomy anddiagnostic algorithm of the neck mass[A-418]A. Trojanowska; Lublin/PLMonday, March 11, 12:30–13:30, Room N/OMC 24E: Temporal bone: so beautiful, yetso complicated [A-588]B. De Foer; Antwerp/BEMini CoursesThe Beauty of Basic Knowledge:Musculoskeletal ImagingThursday, March 7, 12:30–13:30, Room PMC 25A: Trauma [A-002]A. Kassarjian; Majadahonda/ESFriday, March 8, 12:30–13:30, Room PMC 25B: Degenerative disorders [A-125]T.M. Link; San Francisco, CA/USSaturday, March 9, 12:30–13:30, Room PMC 25C: Inflammatory/infectious disorders[A-275]V.N. Cassar-Pullicino; Oswestry/UKSunday, March 10, 12:30–13:30, Room PMC 25D: Neoplastic/non-neoplastic lesions[A-417]F.M.H.M. Vanhoenacker; Antwerp/BEMonday, March 11, 12:30–13:30, Room PMC 25E: Metabolic/endocrine disease [A-589]J. Freyschmidt; Bremen/DE113

Mini CoursesJoint Course of ESR and RSNA (Radiological Society of North America)Friday, March 8, 08:30–10:00, Room I/KMC 428: Essentials in oncologic imaging:what radiologists need to know (part 1)Moderator: D.M. Panicek; New York, NY/USA. Principles of oncologic imaging and reporting [A-088]D.M. Panicek; New York, NY/USB. Lung cancers (primary, metastases) [A-089]C.J. Herold; Vienna/ATC. Colon cancer [A-090]R.M. Gore; Evanston, IL/US• QuestionsFriday, March 8, 10:30–12:00, Room I/KMC 528: Essentials in oncologic imaging:what radiologists need to know (part 2)Moderator: H. Hricak; New York, NY/USA. Pancreatic cancer [A-122]F. Caseiro-Alves; Coimbra/PTB. Kidney cancer [A-123]E.K. Fishman; Baltimore, MD/USC. Ovarian cancer [A-124]H. Hricak; New York, NY/US• QuestionsFriday, March 8, 14:00–15:30, Room I/KMC 628: Essentials in oncologic imaging:what radiologists need to know (part 3)Moderator: Y. Menu; Paris/FRA. Oncologic imaging: terminology, definitions andbuzzwords [A-134]Y. Menu; Paris/FRB. Liver cancers (primary, metastases) [A-135]R.L. Baron; Chicago, IL/USC. Prostate cancer [A-136]J.O. Barentsz; Nijmegen/NL• QuestionsFriday, March 8, 16:00–17:30, Room I/KMC 728: Essentials in oncologic imaging: whatradiologists need to know (part 4)Moderator: M.F. Reiser; Munich/DEA. Lymphoma [A-179]H. Schoder; New York, NY/USB. Musculoskeletal neoplasms [A-180]M.F. Reiser; Munich/DEC. Chemo- and radiation therapy-induced toxicity [A-181]H.-U. Kauczor; Heidelberg/DE• Questions= Interactive session with electronic voting/self assessment114

Refresher Courses / Scientific SessionsAbdominal and GastrointestinalThursday, March 7, 10:30–12:00, Room E2SS 101a: Acute bowel diseases: challengesand solutions [B-0051 – B-0060]Moderators: J.B. Dormagen; Oslo/NOS. Leschka; St. Gallen/CHThursday, March 7, 10:30–12:00, Room I/KSS 101b: Liver fibrosis and cirrhosis:elastography and biomarkers[B-0091 – B-0100]Moderators: R. Faschingbauer; Innsbruck/ATT.J. Kroencke; Berlin/DEThursday, March 7, 14:00–15:30, Room E2SS 201a: Bowel imaging: protocol optimisationand intervention [B-0190 – B-0199]Moderators: V. Cantisani; Rome/ITP. Popovic; Ljubljana/SIThursday, March 7, 14:00–15:30, Room I/KSS 201b: Hepatocellular carcinoma:diagnosis and management[B-0230 – B-0239]Moderators: G. Brancatelli; Palermo/ITM. Bruegel; Munich/DEThursday, March 7, 16:00–17:30, Room CRC 301: Staging and restaging of rectal andanal cancer• Chairman’s introduction [A-007]R.G.H. Beets-Tan; Maastricht/NLA. Local staging of anal and rectal cancer and impact oninitial therapeutic strategy [A-008]S. Gourtsoyianni; London/UKB. Assessment of rectal cancer response [A-009]L. Curvo-Semedo; Coimbra/PTC. Assessment of anal cancer response [A-010]V.J. Goh; London/UK• Panel discussion: What clinicians expect from us in rectaland anal cancer staging and re-staging? How should weimage patients?Friday, March 8, 08:30–10:00, Room ARC 401: Pitfalls in interpretation ofpancreatic imagingModerator: H.-J. Brambs; Ulm/DEA. Pancreatic cancer or pancreatitis? [A-055]B.J. Op de Beeck; Antwerp/BEB. How can we differentiate cystic neoplasms frompseudocysts? [A-056]T. Denecke; Berlin/DEC. How to manage incidental findings [A-057]C. Triantopoulou; Athens/GRFriday, March 8, 14:00–15:30, Room F1SS 601: Liver steatosis: imagingand quantification [B-0440 – B-0449]Moderators: I. Bargellini; Pisa/ITB. Van Beers; Clichy/FRSaturday, March 9, 10:30–12:00, Room I/KSS 901: Cross-sectional pancreatic imagingand biomarkers [B-0570 – B-0579]Moderators: B. Marincek; Cleveland, OH/USG. Zamboni; Verona/ITSunday, March 10, 08:30–10:00, Room BRC 1201: How I reportModerator: G.A. Rollandi; Genoa/ITA. MDCT in the post-operative abdomen [A-348]D.J.M. Tolan; Leeds/UKB. MDCT in a patient with small bowel ischaemia [A-349]S. Romano; Naples/ITC. MDCT in a patient with small bowel obstruction [A-350]P. Taourel; Montpellier/FRSunday, March 10, 10:30–12:00, Room I/KSS 1301: Abdominal CT: dose reductionand technical improvements[B-0699 – B-0708]Moderators: D. Tack; Baudour/BEA. Taibbi; Palermo/ITSunday, March 10, 16:00–17:30, Room BRC 1501: CT colonography: when the ’new‘becomes ’ordinary‘• Chairman’s introduction [A-478]A. Laghi; Latina/ITA. State-of-the-art techniques in 2013 [A-479]T. Mang; Vienna/ATB. How to set up a service [A-480]P. Lefere; Roeselare/BEC. Interaction with gastroenterologists: friends or enemies?[A-481]A. Graser; Munich/DEC. Hassan; Rome/IT• Panel discussion: How to create an efficient CTC team?115

Refresher Courses / Scientific SessionsAbdominal and GastrointestinalMonday, March 11, 08:30–10:00, Room E1RC 1601a: Diagnosis and staging ofesophageal cancer• Chairman’s introduction [A-544]Z. Tarján; Budapest/HUA. Diagnosis [A-545]M. Krokidis; CambridgeUKB. Staging [A-546]V. Válek; Brno/CZC. Treatment response [A-547]B. Mahon; Birmingham/UK• Panel discussion: Cross-sectional techniques: developingan integrated imaging algorithm in oesophageal cancerMonday, March 11, 08:30–10:00, Room F1RC 1601b: Abdominal MRI: standardand advanced protocols inclinical settingsModerator: M.A. Patak; Zurich/CHA. Fistula in ano [A-552]A. Gupta; London/UKB. Pelvic floor disease [A-553]M. Bazot; Paris/FRC. Suspected biliary tumour [A-554]C. Matos; Brussels/BEMonday, March 11, 10:30–12:00, Room E2SS 1701a: CT/MR colonography: technical issuesand clinical studies [B-0789 – B-0798]Moderators: D. Cano; Pamplona/ESD.Z. Saranovic; Belgrade/RSMonday, March 11, 14:00–15:30, Room E2SS 1801a: Colorectal cancer: diagnosticbiomarkers and response assessment[B-0939 – B-0948]Moderators: A. Filippone; Chieti/ITJ. Husty; Brno/CZMonday, March 11, 14:00–15:30, Room I/KSS 1801b: Liver volume, function andfocal lesions [B-0979 – B-0988]Moderators: B.I. Choi; Seoul/KRC. Nyhsen; Sunderland/UKMonday, March 11, 16:00–17:30, Room CRC 1901: Cross-sectional imaging of colitis• Chairman’s introduction [A-590]S.A. Taylor; London/UKA. What protocol to use? [A-591]S. Schmidt; Lausanne/CHB. Differentiating between the causes of colitis [A-592]B. Gallix; Montpellier/FRC. The role of cross-sectional imaging in colonicinflammatory bowel disease [A-593]J. Rimola; Barcelona/ES• Panel discussion: The role of cross-sectional imaging inthe diagnosis and follow-up of colitisMonday, March 11, 10:30–12:00, Room I/KSS 1701b: DWI in pancreatic andhepatobiliary diseases [B-0829 – B-0838]Moderators: G.J. Munneke; London/UKD. Weishaupt; Zurich/CH116

Refresher Courses / Scientific SessionsBreastThursday, March 7, 10:30–12:00, Room F2SS 102: Breast MRI: improving accuracyand tissue characterisation[B-0071 – B-0080]Moderators: R. Schulz-Wendtland; Erlangen/DEM. Telesca; Rome/ITThursday, March 7, 14:00–15:30, Room F2SS 202: Improvements in preoperative stagingof breast cancer [B-0210 – B-0219]Moderators: R.A. Kubik-Huch; Baden/CHA. Zytoon; Shebin El-Kom/EGThursday, March 7, 16:00–17:30, Room F2RC 302: Functional imaging of the breastModerator: G. Esen; Istanbul/TRA. Contrast-enhanced mammography [A-027]C.S. Balleyguier; Villejuif/FRB. Ultrasound elastography [A-028]A. Athanasiou; Paris/FRC. MRI diffusion, perfusion and spectroscopy [A-029]P.A.T. Baltzer; Jena/DEFriday, March 8, 10:30–12:00, Room F2SS 502: Elastography and other advances inbreast ultrasound [B-0330 – B-0339]Moderators: D. Djilas-Ivanovic; Sremska Kamenica/RSP. Skaane; Oslo/NOFriday, March 8, 14:00–15:30, Room F2SS 602: Breast imaging after neoadjuvanttherapy and surgery [B-0450 – B-0459]Moderators: G. Gennaro; Padua/ITP. Martinez-Miravete; Zaragoza/ESSaturday, March 9, 08:30–10:00, Room F1RC 802: Clinical challenges in breast MRI• Chairman’s introduction [A-225]F.J. Gilbert; Cambridge/UKA. High risk patients: establishing clinical protocols [A-226]J. Veltman; Almelo/NLB. Non-mass like enhancement (NMLE): when to biopsy?[A-227]C.K. Kuhl; Aachen/DEC. Monitoring response to neo-adjuvant chemotherapy[A-228]T.H. Helbich; Vienna/AT• Panel discussion: how can the specificity and sensitivityof breast MRI in these indeterminate clinical and imagingscenarios be maximised?Saturday, March 9, 10:30–12:00, Room F2SS 902: Increased risk of breast cancer[B-0559 – B-0569]Moderators: L.A. Carbonaro; San Donato Milanese/ITL. Ollivier; Paris/FRSunday, March 10, 08:30–10:00, Room F2RC 1202: Multi-modality breast imaging• Chairman’s introduction [A-373]M. Lesaru; Bucharest/ROA. Conventional, functional and interventional lymph nodeassessment [A-374]P.D. Britton; Cambridge/UKB. Multi-modality assessment of the breast followingoncoplastic Surgery [A-375]M. Torres-Tabanera; Madrid/ESC. Image guided therapy in breast lesions: indications andtechniques [A-376]G. Manenti; Rome/IT• Panel discussion: how is the evolution of multi-modalitybreast imaging changing the nature of the multidisciplinarymeeting (MDM)?Sunday, March 10, 10:30–12:00, Room F2SS 1302: How to get more from breast imagingmodalities [B-0679 – B-0688]Moderators: N. Houssami; Sydney/AUM. Nadrljanski; Belgrade/RSSunday, March 10, 14:00–15:30, Room F2RC 1402: How I reportModerator: A. Tardivon; Paris/FRA. Mammography [A-446]E. Azavedo; Stockholm/SEB. Breast US [A-447]J. Camps Herrero; Valencia/ESC. Breast MRI [A-448]R.M. Mann; Nijmegen/NL117

Refresher Courses / Scientific SessionsBreastCardiacMonday, March 11, 10:30–12:00, Room F2SS 1702: Tomosynthesis: a role in clinicalpractice? [B-0809 – B-0818]Moderators: S. Allen; Sutton/UKE.M. Jung; Regensburg/DEMonday, March 11, 14:00–15:30, Room F1SS 1802a: Newer techniques in breast imagingand therapy [B-0949 – B-0958]Moderators: F. Chamming’s; Paris/FRM. Sklair-Levy; Tel Aviv/ILMonday, March 11, 14:00–15:30, Room F2SS 1802b: Maximising cancer detection inbreast screening [B-0959 – B-0968]Moderators: M. Álvarez-Benito; Córdoba/ESE. Szabó; Szeged/HUMonday, March 11, 16:00–17:30, Room F2RC 1902: Breast ultrasoundModerator: M. Müller-Schimpfle; Frankfurt a. Main/DEA. Physics and practical aspects of high-quality hand-heldand automated breast US [A-610]M.H. Fuchsjäger; Graz/ATB. Complicated cysts and complex-cystic lesions:differentiation and management [A-611]C.F. Weismann; Salzburg/ATC. The use of ultrasound in the evaluation of the nippleareolarcomplex [A-612]R. Salvador; Barcelona/ESThursday, March 7, 10:30–12:00, Room BSS 103: CT and MRI in preoperativeand postoperative evaluation[B-0001 – B-0010]Moderators: G.A. Krombach; Giessen/DER. Sanz-Requena; Valencia/ESThursday, March 7, 14:00–15:30, Room PSS 203: Planning cardiac interventions[B-0260 – B-0269]Moderators: I. Arkhipova; Moscow/RUP. Mildenberger; Mainz/DEThursday, March 7, 16:00–17:30, Room D2RC 303: Cardiac imaging: the cutting edgeModerator: E. Di Cesare; L’Aquila/ITA. Cardiac MRI: do we need more than 1.5T? [A-011]B.J. Wintersperger; Toronto, ON/CAB. Cardiac CT: technique in 2020; where to next? [A-012]K. Nikolaou; Munich/DEC. Cardiac hybrid imaging: “One-Stop-Shop” [A-013]P.A. Kaufmann; Zurich/CHFriday, March 8, 10:30–12:00, Room PSS 503: Advances in coronary CT angiography[B-0370 – B-0379]Moderators: S. Bohata; Brno/CZL. Natale; Sesto Fiorentino/ITFriday, March 8, 14:00–15:30, Room CSS 603a: CT and MRI: risk stratification[B-0410 – B-0419]Moderators: E. Mershina; Moscow/RUM.R. Rees; Gwynedd/UKFriday, March 8, 14:00–15:30, Room G/HSS 603b: Cardiomyopathy and fibrosis[B-0460 – B-0469]Moderators: P. Donato; Coimbra/PTR. Maksimović; Belgrade/RS118

Refresher Courses / Scientific SessionsCardiacSaturday, March 9, 08:30–10:00, Room PRC 803: Practical approach to cardiovascularrisk stratification with CT and MRIModerator: C. Peebles; Southampton/UKA. Modern views on value of coronary calcium scoring forrisk assessment [A-248]A. Stadler; Vienna/ATB. Coronary CTA: from detection of stenosis to prognosis[A-249]N.R. Mollet; Turnhout/BEC. Myocardial perfusion and viability for risk scoring[A-250]A. de Roos; Leiden/NLSaturday, March 9, 10:30–12:00, Room N/OSS 903: Myocardial perfusion and coronaryartery disease [B-0580 – B-0589]Moderators: F. Cademartiri; Monastier di Treviso/ITG.I. Kirova-Nedialkova; Sofia/BGSunday, March 10, 10:30–12:00, Room E2SS 1303: Towards improved image qualityand detection [B-0660 – B-0669]Moderators: G. Feuchtner; Innsbruck/ATC. Herzog; Munich/DEMonday, March 11, 08:30–10:00, Room PRC 1603: How I reportModerator: R. Vliegenthart; Groningen/NLA. Chest x-ray in cardiac disease [A-572]M. Rubens; London/UKB. Coronary CTA [A-573]F. Wolf; Vienna/ATC. Cardiac MRI in ischaemic heart disease [A-574]J. Bremerich; Basle/CHMonday, March 11, 10:30–12:00, Room N/OSS 1703: Biomarkers, tissue characterisationand remodelling [B-0849 – B-0858]Moderators: M. Das; Maastricht/NLK. Gruszczynska; Katowice/PLMonday, March 11, 14:00–15:30, Room D1SS 1803: Cardiac imaging: into the future[B-0909 – B-0918]Moderators: R.W. Bauer; Frankfurt/DEE. Canet Soulas; Bron/FRSunday, March 10, 16:00–17:30, Room I/KRC 1503: Cardiac CT and MRI in difficultpatients: what to do?• Chairman’s introduction [A-512]M. Hamilton; Bristol/UKA. Coronary CTA in patients with severe arrhythmias andhigh heart rate [A-513]C. Loewe; Vienna/ATB. Severe coronary calcinosis and stents:tips and tricks in image acquisition and interpretation[A-514]F. Pugliese; London/UKC. Cardiac MRI: possible problems and how to avoid them[A-515]E. Mershina; Moscow/RU• Panel discussion: When to scan and when not to? Howcan we make the best of what we have?119

Refresher Courses / Scientific SessionsChestThursday, March 7, 10:30–12:00, Room D1SS 104: Lung cancer: from tissuecharacterisation to treatment[B-0021 – B-0030]Moderators: E. Castañer; Sabadell/ESN. Tacelli; Brussels/BEThursday, March 7, 14:00–15:30, Room D1SS 204: Airways and infiltrative lung diseases[B-0160 – B-0169]Moderators: G.R. Ferretti; Grenoble/FRC. Mueller-Mang; Vienna/ATThursday, March 7, 16:00–17:30, Room I/KRC 304: How I reportModerator: J. Cáceres; Barcelona/ESA. Bedside chest radiography [A-033]R. Eibel; Schwerin/DEB. CTA and MRA of the pulmonary arteries [A-034]J.E. Wildberger; Maastricht/NLC. PET/CT [A-035]C. Keyzer; Brussels/BEFriday, March 8, 10:30–12:00, Room D1SS 504: Lung nodules[B-0290 – B-0299]Moderators: S. Diederich; Düsseldorf/DEN. Karabulut; Denizli/TRSaturday, March 9, 08:30–10:00, Room I/KRC 804: Patterns in chest radiology: are theresubtype patterns of ground glassopacity (GGO)?• Chairman’s introduction [A-237]A. Oikonomou; Alexandroupolis/GRA. Ground glass opacification: why do we see it and whatdoes it mean? [A-238]S.R. Desai; London/UKB. Inflammatory and infectious GGO [A-239]K. Marten-Engelke; Göttingen/DEC. GGO in dysplasia and neoplasia [A-240]G.R. Ferretti; Grenoble/FR• Panel discussion: How should we report and manageground glass opacity?Saturday, March 9, 16:00–17:30, Room I/KRC 1104: Pulmonary infections:the old and the newModerator: F. Gleeson; Oxford/UKA. Mycobacterial infections [A-333]C. Beigelman; Lausanne/CHB. Infectious disease in immuno-compromised patients[A-334]C.P. Heussel; Heidelberg/DEC. Emerging infections [A-335]T. Franquet; Barcelona/ESSunday, March 10, 08:30–10:00, Room I/KRC 1204: Lung cancer staging in 2013• Chairman’s introduction:the latest TNM classification [A-380]J. Biederer; Heidelberg/DEA. Local tumour staging [A-381]L. Bonomo; Rome/ITB. Lymph node staging [A-382]W.F.M. De Wever; Leuven/BEC. Distant metastasis and whole body imaging [A-383]G. Antoch; Düsseldorf/DE• Panel discussion: Facts and controversies in lung cancerstagingSunday, March 10, 10:30–12:00, Room D1SS 1304: CTPA techniques in lung perfusionand pulmonary hypertension[B-0630 – B-0639]Moderators: I. Hartmann; Rotterdam/NLE.J. Stern; Seattle, WA/USSaturday, March 9, 10:30–12:00, Room D1SS 904: Image quality and dose reduction[B-0519 – B-0528]Moderators: P.A. Grenier; Paris/FRJ. Vlahos; London/UK120

ChestRefresher Courses / Scientific SessionsComputer ApplicationsMonday, March 11, 08:30–10:00, Room I/KRC 1604: Pulmonary embolism: guidelines andbest practice throughout Europe• Chairman’s introduction [A-559]M. Rémy-Jardin; Lille/FRA. Pioped 1-2-3: what have we learned so far? [A-560]C. Engelke; Göttingen/DEB. PE in oncologic patients [A-561]B. Ghaye; Brussels/BEC. PE during pregnancy and puerperium [A-562]M.-P. Revel; Paris/FR• Panel discussion: Pulmonary embolism work-up in 2013Monday, March 11, 10:30–12:00, Room D1SS 1704: Technological refinements:from x-rays to micro-imaging[B-0759 – B-0768]Moderators: A.P. Parkar; Bergen/NOC.M. Schaefer-Prokop; Amersfoort/NLMonday, March 11, 16:00–17:30, Room I/KRC 1904: Phenotypes in obstructive airwaydisease: how should I image, analyseand report?Moderator: P.A. Gevenois; Brussels/BEA. Asthma and associated conditions [A-616]P.-Y. Brillet; Bobigny/FRB. Chronic obstructive pulmonary disease (COPD) [A-617]N. Sverzellati; Parma/ITC. Cystic fibrosis and other bronchiectatic diseases [A-618]M.U. Puderbach; Heidelberg/DEThursday, March 7, 10:30–12:00, Room ZSS 105: IT infrastructure, learning supportand teleradiology [B-0141 – B-0149]Moderators: B. Gibaud; Rennes/FRA. Simisker; Tartu/EEThursday, March 7, 14:00–15:30, Room ZSS 205: Quantitative image analysisand optimisation [B-0280 – B-0289]Moderators: L. Faggioni; Pisa/ITM. Fatehi; Tehran/IRThursday, March 7, 16:00–17:30, Room QRC 305: New PACS architecture: decouplingimage management fromimage navigation• Chairman’s introduction [A-047]H.U. Lemke; Berlin/DEA. Image navigation and new PACS architecture [A-048]J. Reponen; Raahe/FIB. Intraoperative imaging for surgeons [A-049]A. Pietrabissa; Pavia/ITC. Dismantling PACS: separating image viewing from thedata storage and sharing [A-050]B. Gibaud; Rennes/FR• Panel discussion: How should we manage our imagestoday?Saturday, March 9, 10:30–12:00, Room ZSS 905: Computer-aided diagnosis[B-0610 – B-0619]Moderators: T. Mang; Vienna/ATD. Regge; Turin/ITMonday, March 11, 08:30–10:00, Room QRC 1605: Improving workflow efficiencyand quality• Chairman’s introduction [A-575]D. Caramella; Pisa/ITA. Improving quality and efficiency of computerised orderentry through decision support [A-576]P. Mildenberger; Mainz/DEB. Improving quality and efficiency of reporting by structureand templates [A-577]N. Dugar; Doncaster/UKC. Improving quality and efficiency of dose managementthrough exchange between modalities and registries[A-578]E. Vaño; Madrid/ES• Panel discussion: Will novel IT tools really improvequality and efficiency in daily radiological practice?121

Refresher Courses / Scientific SessionsMolecular Imaging and Contrast Media GenitourinaryThursday, March 7, 16:00–17:30, Room E1RC 306: Molecular imaging in oncologyModerator: O. Clément; Paris/FRA. New PET-tracers for oncology [A-014]P.L. Choyke; Bethesda, MD/USB. Potential of MRI for molecular imaging in oncology[A-015]F.A. Gallagher; Cambridge/UKC. Emerging molecular imaging techniques [A-016]F.M.A. Kiessling; Aachen/DEFriday, March 8, 14:00–15:30, Room ZSS 606: MR/PET and PET/CT [B-0500 – B-0508]Moderators: N. Belcari; Pisa/ITP.R. Ros; Cleveland, OH/USSunday, March 10, 10:30–12:00, Room ZSS 1306: New agents and protocols[B-0739 – B-0748]Moderators: L. Grazioli; Brescia/ITT.C. Lauenstein; Essen/DEMonday, March 11, 10:30–12:00, Room ZSS 1706: Molecular imaging in cancerand degenerative diseases[B-0879 – B-0888]Moderators: J. Hakumäki; Kuopio/FIE. Lopci; Rozzano/ITMonday, March 11, 14:00–15:30, Room ZSS 1806: Functional studies and safety[B-1029 – B-1038]Moderators: T. Gleeson; Wexford/UKE.M. Merkle; Basle/CHMonday, March 11, 16:00–17:30, Room D2RC 1906: How I optimise contrastmedia administrationModerator: W. Semmler; Heidelberg/DEA. CT [A-594]P. Leander; Malmö/SEB. MRI [A-595]G.M. Bongartz; Basle/CHC. PET/CT [A-596]X. Montet; Geneva/CHThursday, March 7, 10:30–12:00, Room G/HSS 107: Prostate imaging [B-0081 – B-0090]Moderators: S. Morozov; Moscow/RUJ. Richenberg; Brighton/UKThursday, March 7, 16:00–17:30, Room G/HRC 307: Renal and adrenal tumoursModerator: B. Brkljačić; Zagreb/HRA. Adrenal masses, a practical approach [A-030]G. Heinz-Peer; St. Pölten/ATB. Staging renal cancer [A-031]R. Pozzi-Mucelli; Verona/ITC. How to deal with small indeterminate renal masses[A-032]O. Hélénon; Paris/FRFriday, March 8, 10:30–12:00, Room G/HSS 507: New frontiers in GU imaging[B-0340 – B-0349]Moderators: G. Hagen; Oslo/NOC.M.A. Hoeks; Nijmegen/NLFriday, March 8, 14:00–15:30, Room ASS 607: Female pelvis imaging[B-0390 – B-0399]Moderators: L.S. Fournier; Paris/FRA.G. Rockall; London/UKFriday, March 8, 16:00–17:30, Room G/HRC 707: Diagnosis and management ofGU tract traumaModerator: A. Magnusson; Uppsala/SEA. Imaging the kidney and ureter [A-176]M.-F. Bellin; Le Kremlin-Bicêtre/FRB. Imaging the bladder and urethra [A-177]U.G. Mueller-Lisse; Munich/DEC. Interventional radiology for GU Trauma [A-178]B. Peynircioglu; Ankara/TR122

GenitourinaryRefresher Courses / Scientific SessionsHead and NeckSunday, March 10, 08:30–10:00, Room G/HRC 1207: How I reportModerator: G.M. Villeirs; Gent/BEA. Female pelvis MRI [A-377]A.G. Rockall; London/UKB. Prostate MRI [A-378]J.J. Fütterer; Nijmegen/NLC. CT urography [A-379]N.C. Cowan; Oxford/UKSunday, March 10, 10:30–12:00, Room G/HSS 1307: The bladder and below[B-0689 – B-0698]Moderators: M. Baramia; Tbilisi/GER.H. Oyen; Leuven/BESunday, March 10, 14:00–15:30, Room I/KRC 1407: Contrast media safety: update• Chairman’s introduction [A-453]P. Reimer; Karlsruhe/DEA. Acute non-renal reactions to contrast media: newconcepts [A-454]O. Clément; Paris/FRB. Nephrogenic systemic fibrosis: from pathophysiology torecommendations [A-455]H.S. Thomsen; Herlev/DKC. Contrast medium-induced nephropathy and newguidelines [A-456]F. Stacul; Trieste/IT• Panel discussion: What is the most appropriateradiological approach to patients with falling eGFR andwhen should contrast media be administered and whenshould it not?Monday, March 11, 10:30–12:00, Room G/HSS 1707: Hints on haematuria and adrenals forall [B-0819 – B-0828]Moderators: O. Nikolic; Novi Sad/RSK. Sugimura; Kobe/JPMonday, March 11, 14:00–15:30, Room G/HSS 1807: Mixed modalities in GU imaging[B-0969 – B-0978]Moderators: A.J. Beer; Munich/DEI. Vivas; Pamplona/ESThursday, March 7, 14:00–15:30, Room CSS 208: Head and neck cancer: functionalimaging and hybrid modalities[B-0150 – B-0159]Moderators: N. Abolmaali; Dresden/DES. Steens; Nijmegen/NLFriday, March 8, 14:00–15:30, Room L/MSS 608: Technical innovations, TMJ disease andrare entities [B-0470 – B-0479]Moderators: J. Frühwald-Pallamar; Vienna/ATJ. Widelec; Brussels/BESaturday, March 9, 16:00–17:30, Room D2RC 1108: Skull base lesions: imaging studiesand differential diagnosisModerator: L. Grzycka-Kowalczyk; Lublin/PLA. Anterior cranial fossa with special emphasis on olfactoryapparatus lesions [A-309]T.P.J. Duprez; Brussels/BEB. Middle cranial fossa pathologies [A-310]A. Borges; Lisbon/PTC. Posterior cranial fossa pathologies [A-311]H. Tanghe; Rotterdam/NLSunday, March 10, 10:30–12:00, Room L/MSS 1308: Advanced imaging of the ear, orbitand glands [B-0709 – B-0718]Moderators: R. Elias; Rotterdam/NLB.F. Schuknecht; Zurich/CHSunday, March 10, 14:00–15:30, Room N/ORC 1408: Laryngeal cancer and radiology• Chairman’s introduction [A-460]J.E. Kabala; Bristol/UKA. Staging of laryngeal cancer: pearls and pitfalls [A-461]R. Maroldi; Brescia/ITB. Evaluation after surgery and non-surgical treatment:expected findings [A-462]S. Bisdas; Tübingen/DEC. Cancer recurrence: how to address clinical dilemmas[A-463]B. Verbist; Leiden/NL• Panel discussion: Diagnostic algorithms for diagnosisand follow-up of laryngeal cancer123

Refresher Courses / Scientific SessionsHead and NeckInterventional RadiologySunday, March 10, 16:00–17:30, Room N/ORC 1508: Performing and reporting head andneck examinations: how should I do it?Moderator: K. Surlan Popovič; Ljubljana/SIA. Sinonasal CT scans: technique and evaluation [A-519]H.B. Eggesbø; Oslo/NOB. Temporal bone: CT and MRI [A-520]M.M. Lemmerling; Gent/BEC. CT and MRI of the neck: how to address key clinicalquestions [A-521]D. Farina; Brescia/ITMonday, March 11, 16:00–17:30, Room N/ORC 1908: Temporal bone: imaging the mostcommon symptoms and signsModerator: T. Beale; London/UKA. Conductive hearing loss: what’s behind it? [A-619]A. Trojanowska; Lublin/PLB. Sensorineural hearing loss: a challenge for radiologists[A-620]J.W. Casselman; Bruges/BEC. Tinnitus and vertigo: diagnostic algorithm [A-621]R.B.-J. de Bondt; Zwolle/NLThursday, March 7, 10:30–12:00, Room D2SS 109: Chemoembolisation andradioembolisation of liver tumours[B-0031 – B-0040]Moderators: A. Denys; Lausanne/CHP. Paprottka; Munich/DEThursday, March 7, 14:00–15:30, Room D2SS 209: Ablation and biopsy of the prostate andthe kidney [B-0170 – B-0179]Moderators: J.J. Fütterer; Nijmegen/NLJ. Kettenbach; Berne/CHThursday, March 7, 16:00–17:30, Room N/ORC 309: Percutaneous treatment of chronicback pain and sciatica• Chairman’s introduction [A-040]A.D. Kelekis; Athens/GRA. Sacroiliac joint syndrome [A-041]D.J. Wilson; Oxford/UKB. Facet syndrome [A-042]M. Gallucci; L’Aquila/ITC. Intervertebral disc syndromes [A-043]A. Gangi; Strasbourg/FR• Panel discussion: How can imaging methods separatecandidates for percutaneous therapy and surgery?Friday, March 8, 10:30–12:00, Room D2SS 509: Neurovascular and spine interventions[B-0300 – B-0309]Moderators: E.R. Gizewski; Innsbruck/ATL. Pierot; Reims/FRFriday, March 8, 14:00–15:30, Room D2SS 609a: Oncologic ablation andguided interventions [B-0420 – B-0429]Moderators: P. Almeida; Coimbra/PTA. Basile; Catania/ITFriday, March 8, 14:00–15:30, Room PSS 609b: Gynaecological andobstetric interventions[B-0490 – B-0499]Moderators: P.E. Andersen; Odense/DKR. Nijenhuis; Maastricht/NL124

Refresher Courses / Scientific SessionsInterventional RadiologyFriday, March 8, 16:00–17:30, Room N/ORC 709: Expanding the role of interventionalradiology in hepatocellular carcinoma• Chairman’s introduction [A-186]V. Válek; Brno/CZA. RF ablation [A-187]J.L. del Cura; Bilbao/ESB. Intra-arterial procedures [A-188]F. Orsi; Milan/ITC. Portal vein embolisation before Surgery [A-189]A. Denys; Lausanne/CH• Panel discussion: How to allow for more patients withHCC to be treated?Saturday, March 9, 08:30–10:00, Room N/ORC 809: What should every radiologist knowabout the endovascular treatment ofabdominal aortic aneurysms?• Chairman’s introduction [A-244]H. Rousseau; Toulouse/FRA. Pre-therapeutic radiological evaluation [A-245]J. Raupach; Hradec Kralove/CZB. EVAR techniques and results [A-246]F. Fanelli; Rome/ITC. Imaging follow-up and treatment of complications[A-247]R. Morgan; London/UK• Panel discussion: What are the best imaging methods forfollow-up?Saturday, March 9, 10:30–12:00, Room D2SS 909: Thoracic interventions[B-0529 – B-0538]Moderators: J. Tacke; Passau/DEK. Zelenak; Martin/SKSunday, March 10, 08:30–10:00, Room N/ORC 1209: Gynaecological and obstetricalhaemorrhagic emergencies• Chairman’s introduction [A-388]A.-M. Belli; London/UKA. Etiology and treatment of gynaecological benign andmalignant causes of massive bleeding [A-389]A. Keeling; Dublin/IEB. Can we prevent post-partum haemorrhage in high-riskpatients? [A-390]J.-P. Pelage; Caen/FRC. Treatment of post-partum haemorrhage [A-391]M. Szczerbo-Trojanowska; Lublin/PL• Panel discussion: How to reduce the radiation doses ofthese methods?Sunday, March 10, 10:30–12:00, Room D2SS 1309: Skeletal and endocrinologicinterventions [B-0640 – B-0649]Moderators: L. Crocetti; Pisa/ITD.K. Tsetis; Iraklion/GRMonday, March 11, 10:30–12:00, Room D2SS 1709: Abdominal interventions:from TIPS to bile ducts[B-0769 – B-0778]Moderators: R.F. Dondelinger; Liège/BEB. Sekovski; Split/HRMonday, March 11, 14:00–15:30, Room D2SS 1809: New approaches to aorticand peripheral interventions[B-0919 – B-0928]Moderators: S. Kudrnova; Budapest/HUR. Morgan; London/UKSaturday, March 9, 16:00–17:30, Room N/ORC 1109: Update on biliary interventions• Chairman’s introduction [A-339]M. Krokidis; Cambridge/UKA. Fistula and benign stenosis [A-340]M. Bezzi; Rome/ITB. Interventions after liver transplantation [A-341]P. Goffette; Brussels/BEC. In tandem with endoscopy [A-342]D.F. Martin; Manchester/UK• Panel discussion: Are there new possibilities in the area ofbiliary interventions?125

Refresher Courses / Scientific SessionsMusculoskeletalThursday, March 7, 10:30–12:00, Room E1SS 110: Shoulder and hand [B-0041 – B-0050]Moderators: C. Schüller-Weidekamm; Vienna/ATM. Shahabpour; Brussels/BEThursday, March 7, 14:00–15:30, Room E1SS 210: Lower limb: tricks for improved imaging[B-0180 – B-0189]Moderators: A. Klauser; Innsbruck/ATL.M. Sconfienza; San Donato Milanese/ITFriday, March 8, 10:30–12:00, Room E1SS 510: Tendon, muscle and tissue composition[B-0310 – B-0319]Moderators: J. Healy; London/UKA. Mileto; Durham, NC/USFriday, March 8, 14:00–15:30, Room E1SS 610a: Musculoskeletal tumours[B-0430 – B-0439]Moderators: R. Lalam; Oswestry/UKE. Quaia; Trieste/ITFriday, March 8, 14:00–15:30, Room N/OSS 610b: Cartilage: advanced imaging[B-0480 – B-0489]Moderators: A. Karpenko; St. Petersburg/RUP. Omoumi; Brussels/BEFriday, March 8, 16:00–17:30, Room E1RC 710: Peripheral nerve imaging: MRI and US• Chairman’s introduction [A-160]J. Renoux; Paris/FRA. Applied radiological anatomy and pathology of thebrachial plexus [A-161]S. Gerevini; Milan/ITB. Upper limb nerve entrapment [A-162]D. Weishaupt; Zurich/CHC. Lower limb nerve entrapment [A-163]C. Martinoli; Genoa/IT• Panel discussion: Which on-going technological advancesin MRI and US could influence the way we imageperipheral nerves in the future?Saturday, March 9, 10:30–12:00, Room E1SS 910: Spine: advancing the use of CT and MRI[B-0539 – B-0548]Moderators: P.M. Cunningham; Navan/IEJ. Labuscagne; Bunbury, WA/AUSaturday, March 9, 16:00–17:30, Room E1RC 1110: The knee• Chairman’s introduction [A-312]F.M.H.M. Vanhoenacker; Antwerp/BEA. Patterns of injury [A-313]P. Van Dyck; Antwerp/BEB. Inflammatory disease [A-314]A. Cotten; Lille/FRC. Soft tissue tumours/tumour-like lesions [A-315]J.C. Vilanova; Girona/ES• Panel discussion: What are the remaining clinicalquestions that imaging currently cannot answer and howcan we answer them in the future?Sunday, March 10, 08:30–10:00, Room E1RC 1210: Overuse injuries in sport:a multimodality approachModerator: E. Llopis; Valencia/ESA. Overuse injuries in the footballer’s ankle [A-361]S.J. Eustace; Dublin/IEB. Overuse injuries in the gymnast’s spine [A-362]M.C. De Jonge; Amsterdam/NLC. Upper limb overuse injuries in golfers [A-363]P.J. O’Connor; Leeds/UKSunday, March 10, 10:30–12:00, Room E1SS 1310: Arthritis and metabolic bone disease[B-0650 – B-0659]Moderators: A.J. Grainger; Leeds/UKA. Plagou; Athens/GRSunday, March 10, 14:00–15:30, Room E1RC 1410: How I reportModerator: M. Padrón; Madrid/ESA. Soft tissue mass: US/MR [A-434]C. van Rijswijk; Leiden/NLB. MR of vertebral body collapse [A-435]R. Lalam; Oswestry/UKC. MR of the unstable shoulder [A-436]M. Zanetti; Zurich/CH126

MusculoskeletalRefresher Courses / Scientific SessionsNeuroMonday, March 11, 10:30–12:00, Room E1SS 1710: Hip: CT and MRI applications[B-0779 – B-0788]Moderators: M.H. Maurer; Berlin/DEA. Vieira; Porto/PTMonday, March 11, 14:00–15:30, Room E1SS 1810: Knee: new horizons[B-0929 – B-0938]Moderators: M.P. Aparisi Gomez; Valencia/ESA. Cotten; Lille/FRMonday, March 11, 16:00–17:30, Room E1RC 1910: Intra-articular imaging• Chairman’s introduction [A-597]A.H. Karantanas; Iraklion/GRA. Standard MR techniques [A-598]C. Faletti; Turin/ITB. CT arthrography [A-599]C.W.A. Pfirrmann; Zurich/CHC. MR arthrography [A-600]J. Kramer; Linz/AT• Panel discussion: Which imaging technique for whichclinical scenario?Thursday, March 7, 10:30–12:00, Room CSS 111: From structure to function[B-0011 – B-0020]Moderators: S.J. Bakke; Oslo/NOB. Ertl-Wagner; Munich/DEThursday, March 7, 14:00–15:30, Room G/HSS 211: Infection and inflammation[B-0220 – B-0229]Moderators: E. Marco de Lucas; Santander/ESG. Schroth; Berne/CHFriday, March 8, 08:30–10:00, Room G/HRC 411: The paediatric brain:not just a small brainModerator: C. Venstermans; Antwerp/BEA. Neurocutaneous syndromes: more thanneurofibromatosis [A-085]B. Ertl-Wagner; Munich/DEB. Patterns of white matter disease in children [A-086]A. Rossi; Genoa/ITC. Paediatric brain tumours [A-087]C. Hoffmann; Tel Hashomer/ILFriday, March 8, 10:30–12:00, Room L/MSS 511: Stroke-related arterial disease[B-0350 – B-0359]Moderators: E. Avdagic; Sarajevo/BAP. Barsi; Budapest/HUFriday, March 8, 14:00–15:30, Room BSS 611: Alzheimer’s and Parkinson’s[B-0400 – B-0409]Moderators: B. Góraj; Nijmegen/NLT. Meindl; Landshut/DE127

Refresher Courses / Scientific SessionsNeuroSaturday, March 9, 10:30–12:00, Room CSS 911: New insights into brain gliomas[B-0509 – B-0518]Moderators: L.C. Tzarouchi; Ioannina/GRP. Vilela; Almada/PTSaturday, March 9, 16:00–17:30, Room G/HRC 1111: Brain tumours: advanced imagingtechniques in daily practice – do wereally need them?Moderator: Z. Merhemic; Sarajevo/BAA. Diffusion-weighted imaging (DWI) and diffusion tensorimaging (DTI) [A-330]M. Law; Los Angeles, CA/USB. Perfusion imaging [A-331]Y. Özsunar; Aydin/TRC. Follow-up after treatment [A-332]P.C. Maly Sundgren; Lund/SESunday, March 10, 08:30–10:00, Room E2RC 1211: Stroke: is the prognosis getting anybetter?• Chairman’s introduction [A-364]J.-P. Pruvo; Lille/FRA. Initial imaging work-up: CT or MR? [A-365]P.M. Parizel; Antwerp/BEB. Stroke: is there really any therapy? [A-366]V. Mendes Pereira; Geneva/CHC. Stenting: does it prevent stroke? [A-367]P. Vilela; Almada/PT• Panel discussion: What is the future of stroke preventionand treatment?Sunday, March 10, 10:30–12:00, Room F1SS 1311: Brain tumours: imaging and therapy[B-0670 – B-0678]Moderators: X. Golay; London/UKA. Zimny; Wroclaw/PLSunday, March 10, 16:00–17:30, Room G/HRC 1511: Epilepsy: a lack of knowledge canbe dangerousModerator: M.A. Papathanasiou; Athens/GRA. Anatomy of the limbic system [A-509]T.A. Yousry; London/UKB. Temporal lobe epilepsy [A-510]I.N. Pronin; Moscow/RUC. fMRI in epilepsy [A-511]N. Bargalló; Barcelona/ESMonday, March 11, 08:30–10:00, Room G/HRC 1611: Spine: update on postoperativeimaging and minimallyinvasive procedures• Chairman’s introduction [A-555]J. Van Goethem; Antwerp/BEA. Postoperative spine [A-556]L. Van den Hauwe; Brasschaat/BEB. Indications for vertebroplasty [A-557]A. Gangi; Strasbourg/FRC. Percutaneous treatment of spinal diseases [A-558]M. Muto; Naples/IT• Panel discussion: Minimally invasive spinal procedures:the radiologist’s future role?Monday, March 11, 10:30–12:00, Room CSS 1711: Brain ischaemia: perfusionand diffusion [B-0749 – B-0758]Moderators: L. Oleaga Zufiría; Barcelona/ESM. Vernooij; Rotterdam/NLMonday, March 11, 14:00–15:30, Room BSS 1811a: Latest developmentsin neuroimaging [B-0889 – B-0898]Moderators: S. Haller; Geneva/CHE. Papadaki; Iraklion/GRMonday, March 11, 14:00–15:30, Room CSS 1811b: Spinal imaging [B-0899 – B-0908]Moderators: M. Buruian; Targu-Mures/ROA. Cianfoni; Lugano/CHMonday, March 11, 16:00–17:30, Room G/HRC 1911: Multiple sclerosis: 2013 updateModerator: E.T. Tali; Ankara/TRA. Differential diagnosis of multiple T2-HI white matterlesions [A-613]A. Rovira-Cañellas; Barcelona/ESB. New developments in the diagnosis of multiple sclerosis[A-614]F. Barkhof; Amsterdam/NLC. Imaging of MS treatment-related complications [A-615]M.M. Thurnher; Vienna/AT128

Refresher Courses / Scientific SessionsPaediatricSaturday, March 9, 08:30–10:00, Room QRC 812: Imaging the paediatric spineModerator: C.J. Kellenberger; Zurich/CHA. Craniocervical junction abnormalities [A-251]B. Ozgen Mocan; Ankara/TRB. Inflammation, infection and tumours: the role of imaging[A-252]M.I. Argyropoulou; Ioannina/GRC. Imaging spinal trauma in childhood [A-253]M. Maas; Amsterdam/NLSaturday, March 9, 10:30–12:00, Room PSS 912: Paediatric body and bones[B-0590 – B-0599]Moderators: K.J. Johnson; Birmingham/UKL.-S. Ording-Müller; Tromsø/NOSunday, March 10, 08:30–10:00, Room QRC 1212: Oncologic imaging: how to image,follow up and report• Chairman’s introduction [A-394]D. Roebuck; London/UKA. Renal and adrenal tumours in children [A-395]A.M.J.B. Smets; Amsterdam/NLB. Paediatric liver malignancies [A-396]D. Roebuck; London/UKC. Oncologic imaging in the paediatric brain [A-397]G. Hahn; Dresden/DE• Panel discussion: How far should the radiologist goin suggesting tumour recurrence or post-treatmentcomplications?Sunday, March 10, 10:30–12:00, Room PSS 1312: Chest, heart and radiation awareness[B-0729 – B-0738]Moderators: W. Hirsch; Leipzig/DEP.D. Humphries; London/UKSunday, March 10, 16:00–17:30, Room QRC 1512: Paediatric MSK radiology:what is important? Moderator: M. Raissaki; Iraklion/GRA. Scoliosis: what the radiologist needs to know [A-525]J.-F. Chateil; Bordeaux/FRB. Benign bone tumours and pseudotumours in children:the pitfalls [A-526]K.J. Johnson; Birmingham/UKC. Congenital bone dysplasias [A-527]A.C. Offiah; Sheffield/UKMonday, March 11, 10:30–12:00, Room PSS 1712: Foetal and neonatal imaging[B-0859 – B-0868]Moderators: N. De Graaf; Rotterdam/NLH. Ringertz; Linköping/SEMonday, March 11, 14:00–15:30, Room PSS 1812: Paediatric brain [B-1010 – B-1018]Moderators: M.A. Lucic; Sremska Kamenica/RSM. Stenzel; Jena/DEMonday, March 11, 16:00–17:30, Room QRC 1912: Normal variants in paediatric imaging:not to be confused with diseaseModerator: Ø.E. Olsen; London/UKA. Brain [A-626]A. Rossi; Genoa/ITB. Chest and abdomen [A-627]S.G.F. Robben; Maastricht/NLC. Musculoskeletal [A-628]F. Saez; Barakaldo/ESSunday, March 10, 14:00–15:30, Room QRC 1412: Paediatric emergencies Moderator: V. Donoghue; Dublin/IEA. The acute non-traumatic neurological patient: CT orMRI? [A-468]E. Vázquez; Barcelona/ESB. Imaging of acute chest pain and/or distress in children[A-469]C.E. de Lange; Oslo/NOC. The role of the interventional radiologist in paediatricTrauma [A-470]J.B. Karani; London/UK129

Refresher Courses / Scientific SessionsPhysics in RadiologyThursday, March 7, 10:30–12:00, Room L/MSS 113: Multi modality imaging and MR safety[B-0101 – B-0110]Moderators: O. Ciraj-Bjelac; Belgrade/RSO. Speck; Magdeburg/DEThursday, March 7, 14:00–15:30, Room L/MSS 213: Innovations in CT technology anddata processing [B-0240 – B-0249]Moderators: C. Leidecker; Forchheim/DER. Padovani; Udine/ITSaturday, March 9, 16:00–17:30, Room L/MRC 1113: Cone-beam imagingModerators: O. Ciraj-Bjelac; Belgrade/RSA. Trianni; Udine/ITA. Fundamentals of cone-beam imaging [A-336]M. Kachelrieß; Heidelberg/DEB. Medical applications of CB imaging [A-337]M. Grass; Hamburg/DEC. 3D dentomaxillofacial imaging [A-338]K. Horner; Manchester/UKSunday, March 10, 08:30–10:00, Room L/MRC 1213: Risk assessment andrisk communicationSunday, March 10, 16:00–17:30, Room L/MRC 1513: Novel developments in CTand their impact on doseModerators: M. Prokop; Nijmegen/NLV. Tsapaki; Athens/GRA. Patient dose assessment in CT [A-516]P.C. Shrimpton; Didcot/UKB. New frontiers in CT: functional and spectral imaging[A-517]N. Pelc; Stanford, CA/USC. New image reconstruction techniques [A-518]J. Sijbers; Antwerp/BEMonday, March 11, 10:30–12:00, Room L/MSS 1713: Breast imaging and novelCT techniques [B-0839 – B-0848]Moderators: N. Karssemeijer; Nijmegen/NLM. Koutalonis; Colchester/UKMonday, March 11, 14:00–15:30, Room L/MSS 1813: Patient dose management anddose surveys [B-0989 – B-0998]Moderators: H. Bosmans; Leuven/BEW. Stiller; Heidelberg/DE• Chairmen’s introduction [A-384]M.M. Rehani; Vienna/ATP. Vock; Berne/CHA. Radiation risks for patients and staff [A-385]E. Vaño; Madrid/ESB. Risk in MRI [A-386]R. Peeters; Leuven/BEC. Communication of risk to patients and public [A-387]G. Gamhewage; Geneva/CH• Panel discussion: How to communicate risk to patientsand the public?Sunday, March 10, 14:00–15:30, Room L/MRC 1413: Hybrid imaging systemsModerators: D.G. Sutton; Dundee/UKJ. Votrubová; Prague/CZA. Clinical SPECT/CT and PET/CT [A-457]T. Beyer; Zurich/CHB. Clinical MR/PET [A-458]G. Antoch; Düsseldorf/DEC. Preclinical hybrid imaging [A-459]N. Belcari; Pisa/IT130

Refresher Courses / Scientific SessionsRadiographersThursday, March 7, 10:30–12:00, Room QSS 114: Importance of education in practice[B-0131 – B-0140]Moderators: R. Ribeiro; Lisbon/PTT. Roding; Haarlem/NLThursday, March 7, 14:00–15:30, Room QSS 214: Managing quality and dose in CT[B-0270 – B-0279]Moderators: E. Agadakos; Athens/GRA. Yule; Cardiff/UKFriday, March 8, 10:30–12:00, Room QSS 514: The radiographer’s role as health careteam member [B-0380 – B-0389]Moderators: V. Syrgiamiotis; Athens/GRC. Vandulek; Kaposvár/HUFriday, March 8, 16:00–17:30, Room PRC 714: Clinical audit: from EURATOM to theclinical environmentModerators: E.J. Adam; London/UKD. Pronk-Larive; Middelburg/NLA. Clinical audit: from the EURATOM treaty to EUguidelines: clinical audit RP 159 [A-190]P. Wood; Helsinki/FIB. Implementation in practice: a comparison of differentmodels [A-191]S. Geers-van Gemeren; Utrecht/NLC. A perspective on the impact and benefits of clinical audit[A-192]S. O’Connor; Dublin/IESaturday, March 9, 10:30–12:00, Room QSS 914: Dose optimisation as daily challenge[B-0600 – B-0609]Moderators: P. Blackburn Andersen; Kolding/DKA. Petakovic; Novo Mesto/SISaturday, March 9, 16:00–17:30, Room PRC 1114: Hot topics in magneticresonance imagingModerators: K. Haller; Wiener Neustadt/ATL. Martí-Bonmatí; Valencia/ESA. New trends in MR safety [A-343]P. Bauer; Vienna/ATB. MR spectroscopy: the role of radiographers in dataoptimisation [A-344]J. McNulty; Dublin/IEC. Challenges and opportunities in paediatric MR [A-345]V. Syrgiamiotis; Athens/GRSunday, March 10, 08:30–10:00, Room PRC 1214: Dose optimisation incomputed tomographyModerators: G. Frija; Paris/FRD. Pekarovic; Ljubljana/SIA. Innovations in dose optimisation [A-392]S. Foley; Dublin/IEB. Developing patient specific examination protocols[A-393]H. Precht; Odense/DKSunday, March 10, 14:00–15:30, Room PRC 1414: Towards advancing and developingthe role of radiographers• Chairmen’s introduction [A-464]S. Mathers; Aberdeen/UKD. Tscholakoff; Vienna/ATA. The current status: a clinical perspective [A-465]C. McLaren; London/UKB. The importance of evidence-based practice for the futureof advanced practice in radiography [A-466]A. England; Liverpool/UKC. The view from the European level [A-467]G. Paulo; Coimbra/PT• Panel discussion: How to use the EFRS guidancedocument on role developmentSunday, March 10, 16:00–17:30, Room PRC 1514: Hybrid imaging technologiesModerators: C.D. Claussen; Tübingen/DEC. Malamateniou; London/UKA. Recent developments [A-522]S. Rep; Ljubljana/SIB. Clinical applications [A-523]T. Lindner; Ternitz/ATC. Trends in radiography education [A-524]P. Hogg; Manchester/UKMonday, March 11, 10:30–12:00, Room QSS 1714: Mammography [B-0869 – B-0878]Moderators: S.J. Foley; Dublin/IEP. Vahtramae; Pärnu/EEMonday, March 11, 14:00–15:30, Room QSS 1814: Challenges of differentimaging techniques [B-1019 – B-1028]Moderators: H.H. Hjemly; Oslo/NOJ. McNulty; Dublin/IE131

Refresher Courses / Scientific SessionsVascularThursday, March 7, 10:30–12:00, Room N/OSS 115: Carotid plaque evaluation[B-0111 – B-0120]Moderators: M.A. Aschauer; Graz/ATD. Filippiadis; Athens/GRThursday, March 7, 14:00–15:30, Room N/OSS 215: Major vessel imaging[B-0250 – B-0259]Moderators: W.R. Jaschke; Innsbruck/ATO. Pellerin; Paris/FRThursday, March 7, 16:00–17:30, Room PRC 315: Vascular imaging in ischaemic strokeModerator: J. Hendrikse; Utrecht/NLA. Intracranial atherosclerotic disease of carotid arteries[A-044]T. Jargiello; Lublin/PLB. Vertebrobasilar atherosclerotic disease [A-045]L. Valvassori; Milan/ITC. Dissection and vasculitis of intracranial and extracranialarteries [A-046]H.R. Jäger; London/UKFriday, March 8, 10:30–12:00, Room N/OSS 515: Novel tools for blood flow evaluation[B-0361 – B-0369]Moderators: J. Barkhausen; Lübeck/DEF.G. Garaci; Rome/ITSaturday, March 9, 08:30–10:00, Room L/MRC 815: How I reportModerator: D. Bilecen; Basle/CHA. CTA and MRA of supra-aortic arteries [A-241]J.H. Gillard; Cambridge/UKB. CTA and MRA of thoracic and abdominal aorta [A-242]H.J. Michaely; Mannheim/DEC. CTA and MRA of peripheral arteries [A-243]T. Leiner; Utrecht/NLMonday, March 11, 14:00–15:30, Room N/OSS 1815: Vascular research [B-0999 – B-1008]Moderators: S. Kuribayashi; Tokyo/JPA. Pellegrin; Trento/ITMonday, March 11, 16:00–17:30, Room PRC 1915: Lower extremity venous insufficiency• Chairman’s introduction [A-622]D.J. West; Stoke-on-Trent/UKA. Venous anatomy and ultrasound [A-623]H. Moschouris; Piraeus/GRB. Rare venous diseases of the lower extremities [A-624]M. Greiner; Neuilly sur Seine/FRC. CT venography and MR venography [A-625]G. O’Sullivan; Galway/IE• Panel discussion: Which imaging modality is best forplanning endovascular management?Friday, March 8, 16:00–17:30, Room ZRC 715: Dialysis fistulaModerator: H. Deutschmann; Graz/ATA. Preoperative mapping [A-198]L. Turmel-Rodrigues; Tours/FRB. Screening for problems [A-199]D. Vorwerk; Ingolstadt/DEC. Evaluation of malfunction [A-200]R. Uberoi; Oxford/UK132

Refresher Courses / Scientific SessionsOncologic ImagingThursday, March 7, 10:30–12:00, Room F1SS 116: Perfusion CT and MRI: ready forclinical practice [B-0061 – B-0070]Moderators: S. Delorme; Heidelberg/DEF.A. Gallagher; Cambridge/UKThursday, March 7, 14:00–15:30, Room F1SS 216: New biomarkers fortumour quantification [B-0200 – B-0209]Moderators: C.J. Herold; Vienna/ATC. Keyzer; Brussels/BEFriday, March 8, 08:30–10:00, Room CRC 416: MR imaging for prostate cancermanagement: the essential guidefor radiologists• Chairman’s introduction [A-058]H.-P. Schlemmer; Heidelberg/DEA. Clinical challenges: how to treat prostate cancer [A-059]B.A. Hadaschik; Heidelberg/DEB. The radiologist’s contribution: how to detect andcharacterise a tumour [A-060]A.R. Padhani; Northwood/UKC. The radiologist’s influence on management. Stagingprostate cancer: how it impacts on treatment selection[A-061]H. Hricak; New York, NY/US• Panel discussion: Is MRI an integral part of the clinicalroutine?Friday, March 8, 10:30–12:00, Room F1SS 516: Cutting edge imaging in oncology: whenand how? [B-0320 – B-0329]Moderators: K. Coenegrachts; Bruges/BEE.J. Rummeny; Munich/DESaturday, March 9, 10:30–12:00, Room F1SS 916: Whole-body imaging: how to do it[B-0549 – B-0558]Moderators: T.F. Hany; Zurich/CHD. Lambregts; Maastricht/NLSunday, March 10, 10:30–12:00, Room ASS 1316: Rectal cancer imaging: the next step[B-0620 – B-0629]Moderators: L. Curvo-Semedo; Coimbra/PTC. Hoeffel; Reims/FRSunday, March 10, 14:00–15:30, Room E2RC 1416: The essentials of lymph node imagingof solid tumours: what the radiologistneeds to know• Chairman’s introduction [A-437]R.G.H. Beets-Tan; Maastricht/NLA. The current criteria for nodal involvement on CT/MRI[A-438]W. Schima; Vienna/ATB. DWI MR: what does it contribute? [A-439]H.C. Thoeny; Berne/CHC. Nuclear medicine: PET and other nuclear medicinetechniques [A-440]P.L. Choyke; Bethesda, MD/US• Panel discussion: When and how could imaging makediagnostic biopsy unnecessary?Monday, March 11, 08:30–10:00, Room E2RC 1616: Complications of cancer treatmentand the detection of recurrences• Chairman’s introduction [A-548]M. Laniado; Dresden/DEA. Head and neck cancer [A-549]L. Oleaga Zufiría; Barcelona/ESB. Liver and pancreatic cancer [A-550]C. Catalano; Rome/ITC. Rectal cancer [A-551]L.C.O. Blomqvist; Stockholm/SE• Panel discussion: How to differentiate between treatmentsequelae and active diseaseMonday, March 11, 10:30–12:00, Room F1SS 1716: Response evaluation in oncology:beyond RECIST [B-0799 – B-0808]Moderators: T. Denecke; Berlin/DEM.I. Furmanek; Warsaw/PLMonday, March 11, 16:00–17:30, Room E2RC 1916: Gastro-entero-pancreaticneuro-endocrine tumours (GEP-NET):a multidisciplinary update• Chairman’s introduction [A-601]C. Matos; Brussels/BEA. Tumour biology, pathogenesis and classification [A-602]B. Wiedenmann; Berlin/DEB. The current role of nuclear medicine techniques [A-603]C. Deroose; Leuven/BEC. Anatomical imaging: transabdominal US, endoscopic US,MDCT and MRI. What is the most appropriate imagingapproach? [A-604]V. Vilgrain; Clichy/FR• Panel discussion: The future of hybrid imaging?133

Refresher Courses / Scientific SessionsEmergency RadiologyThursday, March 7, 10:30–12:00, Room PSS 117: An update on emergency thoracoabdominalimaging [B-0121 – B-0130]Moderators: B. Feragalli; Chieti/ITA. Huete; Santiago/CLFriday, March 8, 08:30–10:00, Room D2RC 417: ER: basic principlesModerator: P. Valdés Solís; Marbella/ESA. Logistics and organisation of an emergency radiologydepartment [A-065]M. Körner; Munich/DEB. Advanced trauma life support: basic knowledge forradiologists [A-066]D.R. Kool; Nijmegen/NLC. Mechanism of injury and MDCT protocols: choosing theright protocol for the right patient [A-067]S. Voelckel; Innsbruck/ATSaturday, March 9, 08:30–10:00, Room E1RC 817: Polytrauma: redefining imaging issuesfor management priorities• Chairman’s introduction: advanced imaging, logisticsand management priorities in patients after polytrauma[A-218]H. Alkadhi; Zurich/CHA. Vascular Trauma [A-219]G. Schueller; Bülach/CHB. Chest and abdomen [A-220]M. Scaglione; Castel Volturno/ITC. Extremities [A-221]U. Linsenmaier; Munich/DE• Panel discussion: How to speed up your diagnoses?Sunday, March 10, 10:30–12:00, Room N/OSS 1317: Technical issues and clinical results[B-0719 – B-0728]Moderators: M. Brink; Nijmegen/NLG. Schueller; Bülach/CHSunday, March 10, 16:00–17:30, Room E1RC 1517: ER: comprehensive imaging ofnon-traumatic abdominal emergencies• Chairman’s introduction: logistics and management ofcritical patients with abdominal complaints [A-492]S. Wirth; Munich/DEA. Imaging of the most frequent emergencies of the upperabdomen [A-493]C.J. Zech; Basle/CHB. Imaging of the most frequent emergencies of thegastrointestinal tract [A-494]M. Zins; Paris/FRC. Imaging of the most frequent emergencies of thegenitourinary tract [A-495]L.E. Derchi; Genoa/IT• Panel discussion: How to speed up your diagnoses?134

Organising Committee:EFOMP WorkshopNew technology in diagnostic radiology:new frontiers in imaging of the lungChairman: P. Sharp; Aberdeen/UKMembers: A. Torresin; Milan/ITW.J.M. van der Putten; Galway/IEJ. Vassileva; Sofia/BGSaturday, March 9, 08:30–10:00, Room G/HEF 1: Lung and chest imaging:new approachesModerators: P. Sharp; Aberdeen/UKW.J.M. van der Putten; Galway/IE• Welcome address [A-233]J.I. Bilbao; Pamplona/ESP. Sharp; Aberdeen/UK• Radiologist’s point of view:clinical and technical requirements for imagingof the lung [A-234]H.-U. Kauczor; Heidelberg/DE• Respiratory motion correction in lung imaging [A-235]J. Schnabel; Oxford/UK• Role of tomosynthesis in lung imaging [A-236]M. Båth; Gothenburg/SESaturday, March 9, 10:30–12:00, Room G/HEF 2: Lung imaging:multidisciplinary scenarioModerators: A. Torresin; Milan/ITJ. Vassileva; Sofia/BG• Pulmonary nodule detection using CAD [A-266]A. Retico; Pisa/IT• Optimisation in lung imaging of children [A-267]C. Owens; London/UK• Lung imaging: developments in role of PET [A-268]M.-E. Meyer; Amiens/FR• Lung imaging: developments in role of MR [A-269]J.M. Wild; Sheffield/UK135

E 3 – European Excellence in EducationFoundation Course: NeuroimagingFriday, March 8, 08:30–10:00, Room E2E³ 420: The orbit, the petrous bone andthe sellaModerator: B. De Foer; Antwerp/BEA. Imaging of the orbit: the globe and conal lesions [A-072]P.C. Maly Sundgren; Lund/SEB. The petrous bone [A-073]F. Veillon; Strasbourg/FRC. Sella and parasellar pathology [A-074]R. Gasparotti; Brescia/ITFriday, March 8, 10:30–12:00, Room E2E³ 520c: PaediatricModerator: D. Prayer; Vienna/ATA. Neonatal hypoxic-ischaemic brain injury [A-119]M.I. Argyropoulou; Ioannina/GRB. Spine and spinal cord malformations [A-120]A. Rossi; Genoa/ITC. Imaging of the foetal brain [A-121]C. Garel; Paris/FRFriday, March 8, 14:00–15:30, Room E2E³ 620: Trauma and vascularityModerator: A. Molyneux; Oxford/UKA. CNS Trauma [A-131]P.M. Parizel; Antwerp/BEB. Cerebral ischaemia and infarction [A-132]L. Pierot; Reims/FRC. Vascular malformations of the spinal cord [A-133]D.A. Rüfenacht; Zurich/CHSaturday, March 9, 08:30–10:00, Room E2E³ 820b: Metabolic andneurodegenerative disordersModerator: S. Lehéricy; Paris/FRA. Dementia [A-222]B. Gómez-Ansón; Barcelona/ESB. Movement disorders [A-223]T.A. Yousry; London/UKC. Metabolic disorders [A-224]J.F. Schneider; Basle/CHSaturday, March 9, 10:30–12:00, Room E2E³ 920b: Tumours and phacomatosisModerator: N. Girard; Marseille/FRA. Brain tumours [A-263]M.M. Thurnher; Vienna/ATB. Tumours of the spinal cord [A-264]J. Van Goethem; Antwerp/BEC. Phacomatosis [A-265]M.A. Papathanasiou; Athens/GRSaturday, March 9, 12:15–13:15, EPOS AreaSelf assessment testModerator: M.I. Argyropoulou; Ioannina/GR• Interactive computer evaluation of course learningFriday, March 8, 16:00–17:30, Room E2E³ 720b: Infection and inflammationModerator: A.D. Gouliamos; Athens/GRA. Infection [A-164]E.T. Tali; Ankara/TRB. Multiple sclerosis [A-165]F. Barkhof; Amsterdam/NLC. Mimics of multiple sclerosis [A-166]V. Dousset; Bordeaux/FR136

E 3 – European Excellence in EducationInteractive Teaching SessionsThursday, March 7, 14:00–15:30, Room BE³ 220: Lung cancerA. Detection [A-003]S. Diederich; Düsseldorf/DEB. Follow-up [A-004]F. Gleeson; Oxford/UKThursday, March 7, 16:00–17:30, Room BE³ 320: Malignant pancreatic tumoursA. Solid tumours [A-005]W. Schima; Vienna/ATB. Cystic tumours [A-006]G. Morana; Treviso/ITFriday, March 8, 10:30–12:00, Room AE³ 520a: Pitfalls in abdominal imagingA. Liver [A-109]V. Vilgrain; Clichy/FRB. Pancreas and bile ducts [A-110]R. Manfredi; Verona/ITFriday, March 8, 10:30–12:00, Room CE³ 520b: Pitfalls in head and neck imagingA. Pitfalls in neck imaging [A-117]F.A. Pameijer; Utrecht/NLB. Pitfalls in maxillofacial and skull base imaging [A-118]R. Hermans; Leuven/BEFriday, March 8, 16:00–17:30, Room AE³ 720a: Neurological emergenciesA. Non-traumatic [A-142]C. Ozdoba; Berne/CHB. Traumatic [A-143]M. Stajgis; Poznan/PLSaturday, March 9, 08:30–10:00, Room AE³ 820a: Pitfalls in heart imagingA. CT [A-201]G. Bastarrika; Pamplona/ESB. MRI [A-202]M. Francone; Rome/ITSaturday, March 9, 10:30–12:00, Room AE³ 920a: Tips and tricks in chest imagingA. Plain radiography [A-254]J. Cáceres; Barcelona/ESB. CT [A-255]J. Vilar; Valencia/ESSaturday, March 9, 16:00–17:30, Room AE³ 1120: Breast cancerA. Detection [A-296]C.S. Balleyguier; Villejuif/FRB. Follow-up [A-297]G. Forrai; Budapest/HUSunday, March 10, 08:30–10:00, Room AE³ 1220: Pitfalls in brain imagingA. CT [A-346]L. Van den Hauwe; Brasschaat/BEB. MRI [A-347]M. Essig; Erlangen/DESunday, March 10, 14:00–15:30, Room AE³ 1420: Common and uncommon errors in plainfilm and CT imaging of the chest: howto improve your performanceD. Tack; Baudour/BE [A-419]N. Howarth; Chêne-Bougeries/CHSunday, March 10, 16:00–17:30, Room AE³ 1520: Thoracic emergenciesA. Vascular [A-476]E. Castañer; Sabadell/ESB. Pulmonary [A-477]C.M. Schaefer-Prokop; Amersfoort/NLMonday, March 11, 08:30–10:00, Room AE³ 1620: Acute abdominalinflammatory disordersA. Colitis and enterocolitis [A-528]D.J.M. Tolan; Leeds/UKB. Liver and bile ducts [A-529]C.D. Becker; Geneva/CHMonday, March 11, 10:30–12:00, Room BE³ 1720a: Pitfalls in pelvic imagingA. Pitfalls in MRI of the pelvis [A-586]E. Sala; New York, NY/USB. Pitfalls in pelvic ultrasound [A-587]K. Kinkel; Chêne-Bougeries/CHMonday, March 11, 10:30–12:00, Room AE³ 1720b: Musculoskeletal emergenciesA. Axial skeleton [A-584]E. Llopis; Valencia/ESB. Peripheral skeleton [A-585]V.N. Cassar-Pullicino; Oswestry/UK= Interactive session with electronic voting/self assessment137

Gustav Klimt, Design Drawing Tree, 1910/11© MAK/Georg MayerMore about museums and exhibitions in Vienna:www.myESR.org/arts_culture

Accompanying SessionsThursday, March 7, 16:00–17:30, Room ZESR Radiation Protection SessionSecurity scanners at airports: are they safe?Moderators: J. Damilakis; Iraklion/GRP. Vock; Berne/CH• X-ray backscatter security scanners: principles,performance and potential health risks [A-051]J. Damilakis; Iraklion/GR• Cumulative low-level x-ray radiation exposure: is itharmful? [A-052]P. Vock; Berne/CH• Security scanners using non-ionising radiation: currentstatus and trends for development [A-053]M. Kemp; Cambridge/UKFriday, March 8, 08:30–10:00, Room B6 th Post-Processing Face-Off SessionChairman: A. Graser; Munich/DECo-chairmen: M. D’Anastasi; Munich/DEF. Schwarz; Munich/DEAfter the great success in the last years, ECR 2013 will, for thesixth time, feature a ‘Workstation Face-Off ’ session. Continuousrapid technical advances in CT require state-of-the-art postprocessingtools and workstations. Currently, most solutionsare based on a thin client-server architecture which significantlyspeeds up loading times and workflow.In the 21 st century, radiologists are required to interpret 3D datasetsand to handle very large data volumes. For several clinicalapplications, dedicated post-processing workflows are now available.All major vendors offer a variety of hardware and software,and it is often difficult to recognise the individual strengths andweaknesses of different systems. Our 6 th annual Post-ProcessingFace-Off Session will allow you to get an impression of the3D capabilities and large data volume handling provided bythe latest workstation technology.Several workstations from different vendors (aycan,GE Healthcare, Philips Healthcare, Siemens, TeraRecon,Vital Images) will be set up on stage next to each other, andtwo cases provided by the ESR will be demonstrated by expertusers. This year, one of the cases is a cardiac case involving CTAof the coronary arteries and functional MRI with rest and stressperfusion imaging. The second case will be an oncology patientwith a metastasised malignant melanoma. Tasks will includedetection of lung nodules with CAD and segmentation of lesionsover time assessing response.The aim of this session is to simulate a realistic ‘reading room’atmosphere and to give an impression of how different workstationsperform in a clinical scenario. We cordially invite you toattend this exciting ‘tournament’ of post-processing.Friday, March 8, 08:30–10:00, Room N/OEIBIR/EORTC (European Organisation forResearch and Treatment of Cancer) SymposiumA radiologist with a ruler in his hand is adangerous person: seeking standardisation inmulticentre imaging trialsModerators: P. Brader; Vienna/ATY. Liu; Brussels/BE• Introduction: Who, what, why, outcome at the end of thesymposium [A-095]P. Brader; Vienna/ATY. Liu; Brussels/BE• Setting up clinical trials with functional imaging endpoints:trials and tribulations [A-096]N. deSouza; Sutton/UK• Challenges, problems on key imaging techniques [A-097]B. van Beers; Clichy/FR• Advanced MR neuroimaging in multicentre trials:experience from the EORTC Brain Tumour Group[A-098]M. Smits; Rotterdam/NL• Presentation of LUNG study: from the beginning untiltoday [A-099]U. Nestle; Freiburg/DE• Discussion, Questions and AnswersFriday, March 8, 14:00–15:30, Room QESOR SessionFostering future researchersModerators: N. Gourtsoyiannis; Athens/GRG.P. Krestin; Rotterdam/NLDuring this session, the European School of Radiology (ESOR)will give participants an insight into the variety of its trainingprogrammes and opportunities. Crucial and evolving obstacles toresearch training in radiology will be put forward for discussion.• IntroductionG.P. Krestin; Rotterdam/NL• ESOR in action 2013N. Gourtsoyiannis; Athens/GR• Research training for residentsL. Martí-Bonmatí; Valencia/ES• PhD in residency programmesS. Trattnig; Vienna/AT• Preparing research trialsR.G.H. Beets-Tan; Maastricht/NL• AwardsDuring the session, scholars and fellows will be awardedcertificates for successfully completing the 2012 ESORScholarship and Fellowship Programmes.139

Accompanying SessionsSaturday, March 9, 10:30–12:00, Room L/MStandards and Audit SessionAssessment of radiologists’professional performanceModerator: E.J. Adam; London/UK• Radiologists’ performance: assessment using peer review[A-270]G. Boland; Wellesley, MA/US• Radiologists’ individual performance: use of standardisedtest images [A-271]A.G. Gale; Loughborough/UK• Radiologists’ performance: referrers’ view [A-272]J.M.L. Bosmans; Gent/BESaturday, March 9, 10:30–12:00,Meeting Room 14, 1 st LevelEIBIR/EuroAIM SessionEvidence-based radiologyModerators: F. Sardanelli; Milan/ITM.G.M. Hunink; Rotterdam/NL• Systematic reviews and meta-analyses in radiologyG. Di Leo; Milan/IT• Guidelines in radiologyL.M. Sconfienza; Milan/IT• Clinical decision support for the safe and effective use ofimaging testsM.G.M. Hunink; Rotterdam/NL• Preoperative breast MRI: the MIPA studyR.M. Trimboli; Milan/IT• DiscussionSaturday, March 9, 12:45–14:15, Room ZEIBIR SessionHorizon 2020 – Setting the scene forEurope’s next research programmeModerators: G.P. Krestin; Rotterdam/NLJ. Hennig; Freiburg/DE• Horizon 2020: setting the scene – insight intoHorizon 2020 health priorities, including the researchinfrastructure perspectiveK. Berkouk; Brussels/BE• IMI – How to speed up the development of better andsafer medicines for patientsE. Vaudano; Brussels/BE• Public private partnerships as a booster for research andeconomic growth in the futureN. Denjoy; Brussels/BE• The role of imaging in health research in the era ofPersonalised MedicineL. Martí-Bonmatí; Valencia/ES• How EIBIR supports biomedical imaging scientists intheir grant applications and research managementJ. Hennig; Freiburg/DE• Questions/AnswersSaturday, March 9, 14:00–15:30, Room AImage Interpretation Quiz: Radiology is globalModerator: D. Vorwerk; Ingolstadt/DEReferee: A. Agrawal, Delhi/INPanellists:Team 1:A.R. Gillams; London/UKT. Leiner; Utrecht/NLA. Oikonomou; Alexandroupolis/GRC.W. Sperryn; Cape Town/ZATeam 2:F.M. Danza; Rome/ITH.B. Eggesbø; Oslo/NOP. Rogalla; Toronto, ON/CAM. Studniarek; Gdansk/PL140= Interactive session with electronic voting/self assessment

Accompanying SessionsSaturday, March 9, 16:00–17:30, Room ZEuro-BioImagingTowards implementation of apan-European imaging infrastructureModerator: J. Hennig; Freiburg/DE• Euro-BioImaging – Towards implementation of aEuropean open access imaging research infrastructureJ. Hennig; Freiburg/DE• Making the case: development of a node for UHF-MRIO. Speck; Magdeburg/DEJ. Hennig; Freiburg /DE• Potential of Phase-Contrast Imaging as a node withinEuro-BioImagingF. Bamberg; Munich/DE• DiscussionSunday, March 10, 10:30–12:00, Room QRadiology Trainees ForumRTF Highlighted LecturesModerators: D. Bulja; Sarajevo/BAV.H. Koen; Harleem/NL• Emergency radiology management in patientswith polytrauma [A-413]U. Linsenmaier; Munich/DE• Imaging of non-traumatic intracranial haemorrhage[A-414]Z. Merhemic; Sarajevo/BA• Case-based learning in radiology [A-415]P. Pokieser; Vienna/ATSunday, March 10, 13:00–14:00, Room AJunior Image Interpretation Quiz: Golden EyeModerator: A. Alguersuari; Sabadell/ESCo-Moderator: E. Belmonte; Barcelona/ESPanellists:G. Gherarducci; Pisa/ITC. Sayer; Brighton/UKC.M. Sommer; Heidelberg/DEL. Tzarouchi; Ioannina/GRA. Vanrossomme; Brussels/BEMonday, March 11, 08:30–10:00, Room ZJoint Session of the ESR and EFSUMB(European Federation of Societies for Ultrasoundin Medicine and Biology)Advances in diagnostic ultrasound: betterresults through cooperationModerators: L.E. Derchi; Genoa/ITF. Piscaglia; Bologna/IT• Introducing the EFSUMB: the world’s largest ultrasoundsociety [A-579]N. Gritzmann; Vienna/AT• ESR/EFSUMB collaboration: a newly establishedplatform for joint development of ultrasound inradiology and clinical specialties [A-580]L.E. Derchi; Genoa/IT• Image fusion and intervention [A-581]T. Lorentzen; Herlev/DK• The EFSUMB non-liver CEUS guidelines [A-582]F. Piscaglia; Bologna/IT• The EFSUMB/WFUMB liver-CEUS guidelines [A-583]M. Claudon; Vandœuvre-les-Nancy/FR141

EIBIR presents IMAGINEThursday March 7 to Sunday March 10Novel technology that shapes radiology:EIBIR presents IMAGINEIMAGINE aims to stimulate interaction between imaging researchers and radiologists. Internationally leading academic and industrialresearch groups present their latest developments in medical image analysis and image-guided interventions. During the interactivesoftware demonstration sessions the visitors get hands-on experience with developed techniques and tools.EIBIR IMAGINE committeeto chair the oral presentations:Chair & coordinator:Marleen de Bruijne,Erasmus MC; Rotterdam/NL & University of Copenhagen;Copenhagen/DK;EIBIR IMAGINE committee:Mari Cruz Villa,Universitat Pompeu Fabra – CISTIB Computional Imaging;Barcelona/ESSune Darkner,Københavns Universitet – Datalogisk Institut (DIKU-NC);Copenhagen/DKJan Klein,Fraunhofer MEVIS – Institute for Medical Image Computing;Bremen/DEEmanuele Neri,University of Pisa/Diagnostic and Interventional Radiology;Pisa/ITChristine Tanner,Computer Vision Laboratory / ETH Zurich; Zurich/CHEva van Rikxoort,Radboud University Nijmegen – Medical Center, DiagnosticImage Analysis Group; Nijmegen/NLSetting:• One lecture (oral presentation) per topic (90 minutes)• Two software demonstration sessions per topic:hands-on experience of the techniques and tools.The first session is right after the oral presentation(60 minutes); a second session is held the next day at12:00–13:00.Programme/Schedule:Thursday, March 7, 16:30–17:30, Room UNovel technology that shapes radiology:EIBIR presents IMAGINE Scientific exchangeget-togetherOncological image analysisThursday, March 7, 14:00–15:30,EIBIR IMAGINE Theatre, Room UOral presentationsModerators: EIBIR IMAGINE committee• Quantifying response to CRT in colorectal cancerpatients from dynamic imagingM. Bhushan; Oxford /UK• Efficient workflows and reporting for RECIST and otherquantitative imaging standards in cancer research andclinical practiceM. Baumhauer; Heidelberg/DEM. Seitel; Heidelberg/DE• IMBIS: Imaging biomarkers information system formedical images post-processing and structured reportingA. Alberich-Bayarri; Valencia/ES• Fully automatic estimation of film-based breastpercentage density separate out postmenopausalhormone replacement treatment effects as well as expert’sestimationK. Petersen; Frederiksberg/DK• CT colonography: Accurate registration of prone andsupine endoluminal surfaces of the colonT.E. Hampshire; London/UK• Optimised workflow for low dose thoracic CT lungcancer screening: automated detection, measurement,temporal matching and volumetry and mass analysis,individualised prediction of cancer risk, structuredreporting with follow-up recommendationC. Jacobs; Nijmegen/NLSoftware demonstrations‘Oncological image analysis’Thursday, March 7, 15:30–16:30, Room UFriday, March 8, 12:00–13:00, Room U142

EIBIR presents IMAGINEQuantitative image analysisFriday, March 8, 14:00–15:30,EIBIR IMAGINE Theatre, Room UOral presentationsModerators: EIBIR IMAGINE committee• An automatic system for segmentation, matching,anatomical labelling and measurement of airways fromCT imagesJ. Petersen; Copenhagen/DK• New algorithms for quantitative image analysis inspiredby functional brain mechanismsB.M. Ter Haar Romeny; Eindhoven/NL• Patterns in radiology: spatio-temporal image analysis inresearch and clinical applicationR. Donner; Vienna/AT• QuantaVita for clinical practice: fully-automatedquantitative MRI with normative rangesA. Cherubini; Catanzaro/IT• BrainCON: graph theory based multimodal brainconnectivity analysis and visualisation software;BrainMOD: multi-purpose software for 4-dimensionalmultimodal medical image analysisT. Spisák; Debrecen/HU• The 3DSlicer open-source platform for segmentation,registration, quantitative imaging and 3D visualisation ofbiomedical image dataS. Pujol; Boston, MA/USSoftware demonstrations‘Quantitative image analysis’Friday, March 8, 15:30–16:30, Room USaturday March 9, 12:00–13:00, Room UImage guided interventionsand computer aided diagnosisSaturday, March 9, 14:00–15:30,EIBIR IMAGINE Theatre, Room UOral presentationsModerators: EIBIR IMAGINE committee• Markerlessly tracking lung tumours during radiotherapytreatment using Align RT optical surrogate and motionmodel built from cone-beam CT on day of treatmentJ. McClelland; London/UK• FUSIMO: A prototype for patient-specific prediction offocused ultrasound surgery in moving organsJ. Strehlow; Bremen/DE• SlicerRT – 3D Slicer based open-source toolkit forradiation therapy researchC. Pinter; Kingston, ON/CA• MRI guided prostate biopsy: a multiparametric,multireader, registration assisted, template basedworkflowT. Penzkofer; Bosten, MA/US• BRIC1936: software package for lesion assessment:segmentation, progression and intensity analysis, inmagnetic resonance imagingM.C. Valdés Hernández; Edinburgh/UK• Automated labelling framework applied on full andpartial spine CT scansJ. Hladuvka; Vienna/ATSoftware demonstrations ‘Image guidedinterventions and computer aided diagnosis’Saturday, March 9, 15:30–16:30, Room USunday, March 10, 12–13, Room U143

Rising Stars ProgrammeBasic SessionsFriday, March 8, 08:30–10:00, Studio 2013Basic Session on Cardiac Radiology• Imaging of myocardial infarction and viabilityM. Francone; Rome/IT• Acute aortic syndromeA.J.B.S. Madureira; Porto/PT• Cardiac CT in the Workup of Coronary Heart DiseaseU.J. Schoepf; Charleston, SC/USFriday, March 8, 10:30–12:00, Studio 2013Basic Session on Neuroradiology• Aging, degeneration, and inflammation in the brain: animaging perspectiveB. Gómez-Ansón; Barcelona/ES• Is the Circle of Willis a circle?H.R. Jäger; London/UK• CNS InfectionsM.M. Thurnher; Vienna/ATSunday, March 10, 08:30–10:00, Studio 2013Basic Session on Interventional Radiology• Management of aortic aneurysm and dissectionR. Morgan; London/UK• Overview of the development of interventionalradiology techniquesB. Ganai; Newcastle/UK• Embolisation of liver malignanciesM.A.A.J. van den Bosch; Utrecht/NLStudent SessionsFriday, March 8, 14:00–15:30, Studio 2013Student Session 1• Provisional reporting – maintaining high standardsin radiologyF. Seker; Mannheim/DE• Provisional reporting – radiology versus emergencydoctorsR. Coroiu; Covasna/RO• Provisional reporting – The key for diagnosis ofpolytrauma patientsJ. Lee; Seoul/KR• With the patient; let us establish a rapportK. Song; Seoul/KR• Theory and practice in medical educationM. Aleksandrova-Moiseja; Riga/LVFriday, March 8, 16:00–17:30, Studio 2013Student Session 2• Theory vs. practiceV. Nechaev; Moscow/RU• The imaging professional of the future: how can tasks bedistributed?Z. Demeter; Nyíregyháza/HU• Theory and practice – supposed dichotomy –exemplifying the practical role of MRI in diagnosing kneeinjuriesC.G. Iacoban; Baia Mare/RO• MRI contrast agents: what radiographers-in-trainingneed to knowC. Fraga Piñeiro; Vigo/ES• Radiographer students’ role in large-scale researchprojects of the European community:my educational perspectiveM. Breikss; Riga/LV144

Rising Stars ProgrammeSaturday, March 9, 08:30–10:00, Studio 2013Student Session 3• CT, MRI, US or x-rays for blunt trauma in pregnancyJ. Bojarovska; Riga/LV• Cervical trauma: is plain x-ray still necessary?H.A. Hanelore; Bistrita/RO• Utilisation of radiological examinations in patients withtraumaE. Dappa; Pfungstadt/DE• Can the anatomy of the heart be taught usingreconstructed CT images? A pilot studyM. Kolossvary; Budapest/HU• Scaphoid and cervical spine fractures: are plain x-raysreally enough?D. Grant; Aylesbury/UKSaturday, March 9, 10:30–12:00, Studio 2013Student Session 4• New algorithm for treatment of trauma patients required:considering total body imaging instead of plain x-ray asinitial managementH. Emich; Mannheim/DE• Post-mortem CT characteristics and its influence onvirtual autopsyJ.H. van Mourik; Amsterdam/NL• Implementing student to student mentorship in theFaculty of Medicine from ‘Grigore T. Popa’ University ofMedicine and Pharmacy, IasiG.-E. Gilca; Iasi/RO• Peer teaching for sonographic and orthopaedicassessment of the large jointsB.J. Neubauer; Vienna/AT• Occupational exposure in interventional procedures: doactive dosimeters influence professional behaviour?C. Paulo; Coimbra/PTStudent Hands-on Workshops on UltrasoundIn cooperation with Sono4YouAfter last year’s success, hands-on workshops exclusively forstudents will again be held at ECR 2013.An expert team of tutors will lead the students through theworkshops, which will include six different workstations togive every participant the chance to familiarise themselves withthe wide range of possibilities with ultrasound.• Workshop 1: Friday, March 8, 10:00–12:00• Workshop 2: Friday, March 8, 14:00–16:00• Workshop 3: Saturday, March 9, 16:00–18:00• Workshop Advanced: Sunday, March 10, 16:00–18:00Suitable for advanced students and residents.All workshops take place in Room X (1 st level).Registration:These workshops are fully booked. Places may become availableat short notice onsite.Sunday, March 10, 14:00–15:00, Studio 2013Final Student SessionThe four best student presenters will be awarded by the ESRduring this session.145

Update Your Skills(Practical Courses)How to biopsy with US guidanceCoordinator: G. Mostbeck; Vienna/ATSpeakers: J.-M. Correas; Paris/FRG. Mostbeck; Vienna/ATW. Pokieser; Vienna/ATL. Solbiati; Busto Arsizio/ITInstructors: F. Deschamps; Villejuif/FRH. Kopf; Vienna/ATG. Mauri; Busto Arsizio/ITW. Pokieser; Vienna/ATH. Schuster; Vienna/ATThis practical course teaches participants the fundamentals ofUS-guided biopsy. US-guided biopsy is faster, less invasive andless expensive than surgical biopsy and technically less demandingcompared to CT und MR guidance. Tissue acquisition isperformed with aspiration needles and/or automated large-coreneedles and biopsy guns. The choice of the needle depends onthe lesion type as well as the pre-test probability of a specificmalignancy. This practical course reviews indications, patientpreparation, techniques, material preparation and contraindicationsof US-guided biopsy.Participants will work on phantoms to learn the device-relatedtechnical aspects of the performance, how to prepare the patientand percutaneous biopsy device, and how to adequately approacha lesion. State-of-the-art equipment, including different automatedlarge core needles and/or guns will be available. Thepractical training courses are organised to allow time for eachparticipant to perform interventions under expert supervision.It is recommended to follow the introductory lectures beforeentering the practical training courses.Learning objectives1. To know the indications and contraindications and the technicalrequirements to perform US-guided biopsy procedures.2. To know requirements for patient preparation, selection ofmaterial and specimen preparation for optimal results as wellas management of complications.3. To become familiar with the handling of needles, scan-headsand biopsy guns.Introductory lectures• Introduction: why choose US for biopsy guidance?G. Mostbeck; Vienna/AT• All you need to know: protocols, patient preparation andconsent, needles and guns, aspiration vs. core, indicationsand contraindicationsJ.-M. Correas; Paris/FR• Do we always need the pathologist onsite? What is‘enough’ material? Specimen preparation and handlingW. Pokieser; Vienna/AT• Image fusion: when do we need it?L. Solbiati; Busto Arsizio/ITScheduleSaturday, March 9SK 826 08:30-10:00 Introductory Lectures(Room Z, 2 nd level)SK 926 10:30-12:00 Practical Training CourseSK 1026 14:00-15:30 Practical Training CourseSunday, March 10SK 1326 10:30-12:00 Practical Training CourseAll courses take place in Room X (1 st level).RegistrationThe number of participants for each course is limited.Pre-registration has been arranged according to the order inwhich applications were received. Registration will be possibleonsite if seats are still available. Please register in front of Room X,20 minutes before the start of the course. Please note that an extrafee of €50 per participant is charged for this course.Attendance of the lecture session on Monday morning is mandatoryin order to participate in the pre-registered practical trainingcourses.146

Update Your Skills(Practical Courses)Image-Guided Tumour Ablation: How to do itCoordinators: D.J. Breen; Southampton/UK,M.H. Fuchsjäger; Graz/ATSpeakers: Liver AblationD.J. Breen; Southampton/UKL. Crocetti; Pisa/ITT. Helmberger; Munich/DEP.L. Pereira; Heilbronn/DEBreast AblationB. Brkljačić; Zagreb/HRE. Cossu; Rome/ITM.H. Fuchsjäger; Graz/ATInstructors: Liver AblationD. Alcorn; Glasgow/UK,P. Almeida; Coimbra/PT,E.M. Anderson; Oxford/UK,R. Bale; Innsbruck/AT,D.J. Breen; Southampton/UK,X. Buy; Strasbourg/FR,R. Illing; London/UK,J. Tacke; Passau/DEBreast AblationE. Bonanno; Rome/IT,E. Cossu; Rome/IT,M.H. Fuchsjäger; Graz/AT,G. Ivanac; Zagreb/HR,A. Malich; Nordhausen/DEH. Schöllnast; Graz/ATThis practical course reviews indications, advantages, limitationsand controversial issues in percutaneous image-guidedablation of liver and breast lesions under multimodality imagingguidance. Participants will work on phantoms not only to learnthe device-related technical aspects of the performance but alsohow to choose the adequate guidance method, how to preparethe patient and the percutaneous ablation device, and how toadequately approach the lesion. Oncological as well as qualityassurance aspects will be emphasised. State-of-the-art equipment,including different ablation devices (Radio-frequency-,microwave-, cryo-Ablation, irreversible electroporation), is available;the practical courses are organised to allow time for eachparticipant to perform interventions under expert supervision.Participants are required to attend the complete practical course(lectures and practical course).Learning objectives1. To understand the range of ablation technologies currentlyon offer, their surgical properties, merits and limitations.2. To comprehend the indications and limitations of percutaneousimage-guided tumour ablation.3. To achieve appropriate case selection and understand theinterface with resection and chemo/radio-embolisation.4. To learn how to plan an appropriate treatment strategy toachieve optimal clinical results.5. To plan appropriate follow-up and participate fully inmulti-disciplinary patient management.6. To perform image-guided tumour ablation under ultrasoundand guidance in accordance to international standards.RegistrationThe number of participants for each course is limited.Pre-registration has been arranged according to the order inwhich applications were received. Registration will be possibleonsite if seats are still available. Please register in front of RoomY, 20 minutes before the start of the course. Please note that anextra fee of €50 per participant is charged for this course.Attendance of the lecture sessions on Friday morning is mandatoryin order to participate in the pre-registered practical trainingcourses.Introductory lecturesTheoretical introduction: liver ablation• Understanding ablation devices and treatment strategiesD.J. Breen; Southampton/UK• Optimised outcomes in hepatocellular carcinoma ablationL. Crocetti; Pisa/IT• Optimised outcomes in ablation of colorectal metastasesT. Helmberger; Munich/DE• Outcomes: making the case for image-guided ablation inthe multidisciplinary patient managementP.L. Pereira; Heilbronn/DETheoretical introduction: breast ablation• Indications, patient selection and limitations forimaging-guided breast ablationB. Brkljačić; Zagreb/HR• Technical considerations: guidance modalities,treatment devicesM. Fuchsjäger; Graz/AT• Practical considerations: multidisciplinary patientmanagementE. Cossu; Rome/ITScheduleFriday, March 8SK 427 08:30–10:00 Introductory Lectures(liver ablation; Room Z)SK 527 10:30–12:00 Introductory Lectures(breast ablation; Room Z)SK 627 14:00–15:30 Liver ablationSK 727 16:00–17:30 Breast ablationSaturday, March 9SK 927 10:30–12:00 Liver ablationSK 1027 14:00–15:30 Breast ablationSK 1127 16:00–17:30 Liver ablationSunday, March 10SK 1327 10:30–12:00 Breast ablationSK 1427 14:00–15:30 Liver ablationSK 1527 16:00–17:30 Breast ablationAll practical training courses will take place in Room Y (1 st level).147

Florian Boesch in Radamisto by Georg Friedrich Händel© Monika RittershausMore about opera in Vienna:www.myESR.org/arts_culture

Satellite SymposiaThursday, March 7, 10:30–11:30, Studio 2013Satellite Symposium organised bySiemens HealthcareSY 1: Advanced multimodality breast image readingModerator: T. Hartley; Erlangen/DE• Place of digital breast tomosynthesis in diagnosticinvestigation of breast lesions: old and new paradigmsC. Van Ongeval; Leuven/BE• Place of breast MRI in diagnostic investigation ofbreast lesionsE. Wenkel; Erlangen/DE• Panel DiscussionThursday, March 7, 12:30–13:30, Room G/HSatellite Symposium organised bySuperSonic ImagineSY 2: The benefits UltraFast TM imagingbrings to ultrasoundModerator: J. Souquet; Aix-en-Provence/FR• Advantages and limitations of ShearWave TM elastographyfor imaging prostate cancer and guiding biopsyP.S. Zoumpoulis; Athens/GR• Benefits of UltraFastTM Doppler in the clinical workflowG. Ivanac; Zagreb/HR• Experiences with the Aixplorer and ShearWave TMelastography for the staging of liver fibrosesV. Vilgrain; Clichy/FR• Advances in breast imaging with ShearWave TMelastographyF.K.W. Schäfer; Kiel/DEThursday, March 7, 12:30–13:30, Room I/KSatellite Symposium organised by Bayer HealthCareSY 3: New insight in breast cancer imagingModerator: J. Camps Herrero; Valencia/ES• Breast MRI for screening breast cancer, why, who andwhen?L. Umutlu; Essen/DE• Overtreatment due to breast MRI – a threat, a myth, orboth?C.K. Kuhl; Aachen/DE• MIPA study: study design, goals, rolloutF. Sardanelli; Milan/ITThursday, March 7, 12:00–13:30, Studio 2013Satellite Symposium organised bySiemens HealthcareSY 4: Challenges in breast imagingModerator: J. Barkhausen; Lübeck/DE• 3D automated breast ultrasound: accuracy and diagnosticpotentialsM.J.C.M. Rutten; s’Hertogenbosch/NL• High image quality with lower dose mammographyD. Uhlenbrock; Dortmund/DE• Breast imaging from a pathologist’s perspectiveA. Hartmann; Erlangen/DE• MR breast in clinical routineW.A. Kaiser; Jena/DE• Panel discussionThursday, March 7, 14:00–15:30, Studio 2013Satellite Symposium organised bySiemens HealthcareSY 5: Chances with digital breast tomosynthesis(DBT)Moderator: T.H. Helbich; Vienna/AT• Physical challenges with digital breast tomosynthesisH. Bosmans; Leuven/BE• Experiences with digital breast tomosynthesis inscreeningS. Zachrisson; Malmö/SE• Value of tomosynthesis for the assessment of screendetectedabnormalitiesS.H. Heywang-Köbrunner; Munich/DE• Clinical experiences with digital breast tomosynthesis infollow up diagnosticsF. Taşkın; Aydin/TR• The future of breast tomosynthesisT.H. Helbich; Vienna/AT• Panel DiscussionFriday, March 8, 12:15–13:30, Room D1Satellite Symposium organised by Bayer HealthCareSY 6: 25 years of contrast-enhanced MRI: there is moreto see!Moderator: F. Caseiro-Alves; Coimbra/PT• Contrast enhanced MRI: illuminating the shadowsF. Caseiro-Alves; Coimbra/PT• Optimising MRI in CNS for treatment planningJ. Provenzale; Durham, NC/US• The role of contrast in breast MRIF. Pediconi; Rome/IT• Cardiovascular MR – assessment of viability todayand tomorrowJ. Schulz-Menger; Berlin/DE• Primovist®-enhanced MRI in the preoperative assessmentof liver functionJ.M. Lee; Seoul/KR149

Satellite SymposiaFriday, March 8, 12:30–13:30, Room G/HSatellite Symposium organised by BraccoSY 7: Breast MRI: where are we, and where are wegoing?Moderator: T.H. Helbich; Vienna/AT• Current and future role of breast MRIC.K. Kuhl; Aachen/DE• Challenges to contrast-enhanced breast MRI:pros and consT.H. Helbich; Vienna/AT• Contrast protocolsF. Sardanelli; Milan/ITFriday, March 8, 12:30–13:30, Room I/KSatellite Symposium organised by GE HealthcareSY 8: Evidence of avant-garde MRModerator: D. Pickuth; Saarbrücken/DE• Sharing GE MR vision and futureR. Hausmann; Waukesha, WI/US• Innovativ technology:the clinical application of silent MRA. van der Lugt; Rotterdam/NL• Getting closer to metallic implantsM. Padrón; Madrid/ESFriday, March 8, 12:30–13:30, Room L/MSatellite Symposium organised bySiemens HealthcareSY 9: Pioneering futures in ultrasoundModerator: P.S. Sidhu; London/UK• Strain imaging in the breast – with a focus on the newVTIQ technologyC.S. Balleyguier; Villejuif/FR• Ultrasound study of the pancreas with CPS (CEUS)and ARFI (elastography): improving the diagnosis ofpancreatic tumoursM. D’Onofrio; Verona/IT• Image fusion: is this something we need?A. Nilsson; Uppsala/SESaturday, March 9, 12:30–13:30, Room D1Satellite Symposium jointly organised bySiemens Healthcare and Bayer HealthCareSY 10: Synergies in CT for better patient care: cuttingedge CT and optimised contrast media applicationModerator: J.E. Wildberger; Maastricht/NL• Clinical benefits of a new fully integrated CT detectorH. Alkadhi; Zurich/CH• Optimise your CT results from scan to contrast mediaapplicationJ.E. Wildberger; Maastricht/NL• Protocol optimisation in cutting edge CTA.H. Mahnken; Marburg/DESaturday, March 9, 12:30–13:30, Room E1Satellite Symposium organised by BraccoSY 11: Personalised CT imaging: a patient centricapproachModerator: M. Prokop; Nijmegen/NL• Tailoring CT exams: when and how?C. Loewe; Vienna/AT• How to balance radiation dose and diagnostic yield?H.-C. Becker; Munich/DE• What if the patient is at risk?M.-F. Bellin; Le Kremlin-Bicêtre/FRSaturday, March 9, 12:30–13:30, Room E2Satellite Symposium organised bySiemens HealthcareSY 12: Leading. With MAGNETOM.Moderator: T.J. Vogl; Frankfurt a. Main/DE• Leading. With MAGNETOM.N. Bolle; Erlangen/DE• Novel imaging techniques in abdominal imagingH.J. Michaely; Mannheim/DE• Sustainability in a complex healthcare environmentT.J. Vogl; Frankfurt a. Main/DESaturday, March 9, 12:30–13:30, Room F2Satellite Symposium organised by GE HealthcareSY 13: Developing innovative breast care solutions toimprove clinical confidenceModerator: R.C. Sigal; Velizy/FR• Case clarification with digital breast tomosynthesisversus mammography special viewsA. Stork; Düsseldorf/DE• Contrast enhanced spectral mammography versus breastMRI: clinical experienceE.M. Fallenberg; Berlin/DE• New frontiers of advanced breast ultrasoundA. Mundinger; Osnabrück/DE• Role of MR DWI in breast cancer: correlation withhistopathologyV. Martinez de Vega; Madrid/ES150

Satellite SymposiaSaturday, March 9, 12:30–13:30, Room G/HSatellite Symposium organised by GuerbetSY 14: Combining high tolerance with high diagnosticperformance in contrast enhanced MRIModerator: S.O. Schönberg; Mannheim/DE• IntroductionS.O. Schönberg; Mannheim/DE• Tolerance of MR contrast agent in at risk patientsG. Deray; Paris/FR• Optimal gadolinium concentration with high diagnosticaccuracyM. Lell; Erlangen/DE• MRI follow-up after kidney cancer cryoablationE. de Kerviler; Paris/FR• Questions and conclusionS.O. Schönberg; Mannheim/DESaturday, March 9, 12:30–13:30, Room I/KSatellite Symposium organised by Philips HealthcareSY 15: Transforming healthcare through innovative MRtechnologyModerator: J. van den Heuvel; Eindhoven/NL• Imaging in cancer: multi-parametric whole-body andprostate imagingS. Punwani; London/UK• New MR imaging approaches in assessing the aging brainM.A. van Buchem; Leiden/NLSaturday, March 9, 12:30–13:30, Room L/MSatellite Symposium organised by Philips HealthcareSY 16: News in mammography:spectral imaging in mammography screeningModerator: M. Danielsson; Solna/SE• Experiences of MicroDose in tailored breast cancerscreening program including women between 40-49 yearsP. Panizza; Milan/IT• Latest development in mammography:non-invasive single-shot spectral imagingS. Suryanarayanan; Andover, MA/US• Spectral lesion evaluation: will it be possible todistinguish cysts from solid masses on thescreening mammogram?M.G. Wallis; Cambridge/UK• QuestionsSaturday, March 9, 14:00-14:30, Room N/OMini Satellite Symposium organised byPhilips HealthcareMSY 1: Transforming healthcare with CTModerator: L. De Vries; Amsterdam/NL• Clinical outcomes of novel CT reconstruction techniquesE.E.J.G. Coche; Brussels/BESaturday, March 9, 14:00–15:30, Room CSatellite Symposium organised by HologicSY 17: Celebrating the evolution of breast tomosynthesis:from research to large-scale, population-basedscreening programs, to advanced applicationsModerator: A. Smith; Bedford, MA/US• A review of the evolution of breast tomosynthesisA. Smith; Bedford, MA/US• The Oslo clinical tomosynthesis screening experienceP. Skaane; Oslo/NO• Initial experience with tomosynthesis biopsyD. Bernardi; Trento/ITSaturday, March 9, 14:00–15:30, Room E1Satellite Symposium organised by ToshibaSY 18: Clinical advances in multimodality applications –new perspectives in perfusion and fusion imagingModerator: B. Hamm; Berlin/DE• The impact of smart fusion on the diagnostic outcomeT. Fischer; Berlin/DE• CEUS of the kidney: from new technology to patientmanagement improvementJ.-M. Correas; Paris/FR• Liver and pancreatic perfusion usingAquilion ONE visionJ. Hermans; Nijmegen/NLSaturday, March 9, 14:00–15:30, Room F2Satellite Symposium organised by ToshibaSY 19: Multimodal imaging for neuro applicationsModerator: P.A. Brouwer; Leiden/NL• Neuro applications using Aquilion ONEP.A. Brouwer; Leiden/NL• Advanced neuroimaging at 3T with a 32ch head coilT. Okada; Kyoto/JP• Neurological interventions using Toshiba InfinixH. Fransen; Gent/BE151

Satellite SymposiaSaturday, March 9, 14:00–15:30, Room L/MSatellite Symposium organised byGE Healthcare NycomedSY 20: CT and MR diagnostic capabilities and safety:new tendencyModerators: V.N. Kornienko; Moscow/RUI.E. Tyurin; Moscow/RU• Low-dose and low-iodine CT coronary angiographyV.E. Sinitsyn; Moscow/RU• MRI safety – actual issuesE. Mershina; Moscow/RU• Brain – heart – axisR. Rienmüller; Graz/AT• Russian radiology best practice – clinical experiencesharingA. Lukianchenko; Moscow/RU• GE Healthcare innovative solutions for modernhealthcareV.I. Grischenko; Moscow/RUSunday, March 10, 12:30–13:30, Room CSatellite Symposium organised by GE HealthcareSY 21: Patient care and image quality: at the forefront ofCT innovations and contrast mediaModerator: V.E. Sinitsyn; Moscow/RU• Key properties of isosmolar contrast mediaR.P. Franke; Ulm/DE• Optimising image quality and patient care in cardiac CTD. Andreini; Milan/IT• Spectral imaging: clinical breakthrough in oncologyP. Ardies; Malle/BESunday, March 10, 12:30–13:30, Room G/HSatellite Symposium organised by SamsungSY 22: A new tool for detecting and diagnosing breastcancer: ultrasound ElastoScanModerator: W. van de Vooren; Delft/NL• Introduction to ElastoScanW. van de Vooren; Delft/NL• The positive influence of ElastoScan on early breastcancer detectionV.F. Duda; Marburg/DE• Has ElastoScan positively influenced the way of breastsurgery?C. Kohler; Marburg/DESunday, March 10, 12:30–13:30, Room L/MSatellite Symposium organised by Philips HealthcareSY 23: Transforming healthcare with ultrasoundModerator: S.T. Elliott; Newcastle upon Tyne/UK• Opening• Sonoelastography of the liver: the clinical point of viewC. Filice; Pavia/IT• Results with ElastPQ in the assessment ofdiffuse liver diseaseG. Ferraioli; Pavia/IT• Fusion imaging with contrast enhanced ultrasoundin the abdomenA. Martegani; Como/IT• Innovation in high resolution breast ultrasoundD.A. Clevert; Munich/DE• Questions and answersSunday, March 10, 12:30–13:30, Room N/OSatellite Symposium organised by BraccoSY 24: Cost-effectiveness and improvement of patientmanagement with contrast enhanced ultrasound(CEUS)Moderator: G.H. Mostbeck; Vienna/AT• Implementation of CEUS in the daily practice of theimaging centerM. Wüstner; Trier/DE• CEUS in interventional radiology: clinical outcomes andimpact on patient managementE.M. Jung; Regensburg/DE• Clinical and cost effectiveness of CEUS for liver imaging:the NICE diagnostics guidanceT. Hoare; Newcastle Upon Tyne/UK152

Industry Hands-on WorkshopsThursday, March 7 to Sunday, March 10,Siemens Experience Lounge, Entrance LevelIndustry Hands-on Workshops organised bySiemens HealthcareClinical experts will demonstrate how to better use andfurther benefit from our solutions for advancedmultimodality reading. A special focus will be placed onthe imaging software syngo.via. Benefit from experts’ experienceand receive an update on state-of-the-art techniques in computedtomography, magnetic resonance, molecular imaging and breastimaging. As a registered attendee for ECR 2013 these workshopsare free of charge.Thursday, March 7:14:00–15:30: MRI breast reading and reportingW.A. Kaiser; Jena/DE16:00–17:30: Digital breast tomosynthesisJ. Barkhausen; Lübeck/DEFriday, March 8:10:00–11:30: CT ColonographyT. Mang; Vienna/AT12:00–13:30: Digital breast tomosynthesisJ. Barkhausen; Lübeck/DE14:00–15:30: Advanced orthopaedic hip and knee MRIR. Sutter; Zurich/CH16:00–17:30: CT oncologyA. Graser; Munich/DESaturday, March 9:10:00–11:30: Multimodal prostate MRIM. Röthke; Heidelberg/DE12:00–13:30: MRI and CT for imaging acute strokeKarl-Olof Loevblad, GenevaP. Schramm; Göttingen/DE14:00–15:30: Hybrid imaging in daily routine: SPECT-CT and PET-CT in orthopaedics andoncologyC. von Gall; Erlangen/DE16:00–17:30: Digital breast tomosynthesisJ. Barkhausen; Lübeck/DESunday, March 10:10:00–11:30: CT Dual EnergyM. Kerl; Frankfurt/DE12:00–13:30: Hybrid imaging in daily routine:SPECT-CT and PET-CT in orthopaedicsand oncologyC. von Gall; Erlangen/DE14:00–15:30: CT cardiacR. Bauer; Frankfurt/DE16:00–17:30: MRI breast reading and reportingW.A. Kaiser; Jena/DEThursday, March 7 to Sunday, March 10,Hologic Hands-on Workshop Room, 1 st LevelIndustry Hands-on Workshopsorganised by HologicHologic is offering a series of 75-minute educational sessions forradiologists throughout the congress. The workshops includehands-on experience reading 3D breast tomosynthesis imagesin combination with conventional and synthesised 2D images.Brief lectures will provide an overview of the technologies priorto the hands-on. This programme is intended for radiologistsinterested in learning more about this breast cancer screeningand diagnosis technology.Hologic Breast Tomosynthesis Hands-on WorkshopsScheduleThursday, March 7:13:00–14:1515:00–16:15Friday, March 8:10:15–11:3013:45–15:0015:30–16:45Saturday, March 9:10:15–11:30Sunday, March 10:10:15–11:3013:45–15:0015:30–16:45153

Zubin Mehta at the Musikverein© www.flonthego.comMore about concerts in Vienna:www.myESR.org/arts_culture

PostgraduateEducationalProgrammeSession numbers are prefixed by CC, E 3 , EF, EM, HL,MC, MS, NH, OL, PC, RC, SA, SF, TFPresentation numbers are prefixed by the letter AKey to AbbreviationsCC Categorical CourseE 3 European Excellence in EducationEF EFOMP WorkshopEM ESR meets SessionHLMCMSNHOLPCRCSASFTFHonorary LectureMini CourseMultidisciplinary SessionNew Horizons SessionOpening LectureProfessional Challenges SessionRefresher CourseState of the Art SymposiumSpecial Focus SessionRadiology Trainees Forum

Postgraduate Educational ProgrammeA-001 – A-01012:30–13:30 Room N/OThe Beauty of Basic Knowledge:Head and NeckMC 24A A taste of the oral cavityand salivary glands12:30A-001 A taste of the oral cavity and salivary glandsA. Borges; Lisbon/PTLearning Objectives:1. To become familiar with the anatomy of the oral cavity and salivaryglands.2. To learn how to tailor imaging approaches to the patient’s clinicalpresentation.3. To appreciate the main pathologic processes of the oral cavity andsalivary glands.12:30–13:30 Room PThe Beauty of Basic Knowledge:Musculoskeletal ImagingMC 25A Trauma12:30A-002 TraumaA. Kassarjian; Majadahonda/ESLearning Objectives:1. To learn about the basic mechanisms of musculoskeletal trauma.2. To become familiar with typical musculoskeletal injuries and injurypatterns.3. To understand the impact of different radiological methods in thetrauma setting.14:00–15:30 Room BInteractive Teaching SessionE³ 220 Lung cancer14:00A-003 A. DetectionS. Diederich; Düsseldorf/DELearning Objectives:1. To learn which imaging techniques are appropriate for detecting lungcancer.2. To learn about the most relevant imaging findings in lung cancer.3. To understand the behaviour of lung cancer related to imaging.14:45A-004 B. Follow-upF. Gleeson; Oxford/UKLearning Objectives:1. To know the common features of lung cancer recurrence.2. To learn how to establish follow-up protocols after treatment of lungcancer.16:00–17:30 Room BInteractive Teaching SessionsE³ 320 Malignant pancreatic tumours16:00A-005 A. Solid tumoursW. Schima; Vienna/ATLearning Objectives:1. To learn how to differentiate tumours from other non-tumouralpathology.2. To understand how to choose the proper imaging technology.3. To appreciate how to determine resectability and extension of thetumour.16:45A-006 B. Cystic tumoursG. Morana; Treviso/ITLearning Objectives:1. To learn how to choose the proper imaging modality.2. To understand the criteria of malignancy and benignity.3. To learn how to follow-up the lesions.16:00–17:30 Room CGI TractRC 301Staging and restaging of rectaland anal cancer16:00A-007 Chairman‘s introductionR.G.H. Beets-Tan; Maastricht/NL16:05A-008 A. Local staging of anal and rectal cancer and impact oninitial therapeutic strategyS. Gourtsoyianni; London/UKLearning Objectives:1. To learn about optimised MR techniques for rectal and anal cancerstaging.2. To become familiar with the role of endorectal ultrasound inanorectal cancer staging.3. To understand basic TNM staging and assessment of the CRM onimaging.4. To understand how imaging findings influence the initial therapeuticapproach.16:35A-009 B. Assessment of rectal cancer responseL. Curvo-Semedo; Coimbra/PTLearning Objectives:1. To learn the rationale for following-up on patients after neoadjuvantchemoradiation.2. To understand conventional imaging criteria for assessing tumourresponse.3. To learn about new techniques for assessing response, includingdiffusion MRI and PET/CT.16:55A-010 C. Assessment of anal cancer responseV.J. Goh; London/UKLearning Objectives:1. To learn the rationale for restaging after therapy.2. To know how to assess the tumour response with conventionalimaging criteria.3. To learn about new techniques for assessing response in anal cancer,including diffusion MRI and PET/CT.Panel discussion:17:15 What clinicians expect from us in rectal and anal cancerstaging and restaging? How should we image patients?156

Postgraduate Educational Programme16:00–17:30 Room D2CardiacRC 303Cardiac imaging: the cutting edgeModerator: E. Di Cesare; L‘Aquila/IT16:00A-011 A. Cardiac MRI: do we need more than 1.5T?B.J. Wintersperger; Toronto, ON/CALearning Objectives:1. To learn about the differences between 1.5T and 3T cardiac MRI.2. To understand the clinical applications of high-field cardiac MRI.3. To become familiar with the problems of using high-field cardiacMRI in daily routine.16:30A-012 B. Cardiac CT: technique in 2020; where to next?K. Nikolaou; Munich/DELearning Objectives:1. To learn about the latest technical developments in state-of-the-artcardiac CT.2. To explore what new developments will influence cardiac CT over thenext few years.3. To understand if what you need is a lot of rows, tubes or both foroptimal cardiac CT.17:00A-013 C. Cardiac hybrid imaging: „One-Stop-Shop“P.A. Kaufmann; Zurich/CHLearning Objectives:1. To understand the principles of cardiac hybrid imaging.2. To learn about the diagnostic value of hybrid imaging.3. To know about possible indications for performing hybrid imaging.16:00–17:30 Room E1Molecular ImagingRC 306 Molecular imaging in oncologyModerator: O. Clément; Paris/FR16:00A-014 A. New PET-tracers for oncologyP.L. Choyke; Bethesda, MD/USLearning Objectives:1. To learn about the new specific tracers that can be used in oncologicpatients.2. To become familiar with their possible impact on patientmanagement.3. To understand their potential and limitations for practice.16:30A-015 B. Potential of MRI for molecular imaging in oncologyF.A. Gallagher; Cambridge/UKLearning Objectives:1. To become familiar with the different approaches to molecularimaging with MRI.2. To understand the role of molecular imaging in oncology.3. To learn about emerging MRI techniques for molecular imaging.17:00A-016 C. Emerging molecular imaging techniquesF.M.A. Kiessling; Aachen/DELearning Objectives:1. To become familiar with optical imaging techniques and probes.2. To learn about the potential of targeted US contrast agents.3. To appreciate emerging hybrid imaging techniques.16:00–17:30 Room E2Multidisciplinary Session: ManagingPatients with CancerMS 3 Colorectal liver metastases16:00A-017 Chairman‘s introductionV. Vilgrain; Clichy/FRSession Objectives:1. To learn about the prognostic factors of colorectal liver metastases.2. To become familiar with the most common therapeutic strategies.3. To understand the role of the multidisciplinary team in patients withcolorectal liver metastases.16:05A-018 Role of imaging in the pretreatment assessmentV. Vilgrain; Clichy/FRLearning Objectives:1. To become familiar with imaging findings indicating surgicalresectability.2. To understand the role of CT and MR imaging in staging livermetastases.3. To learn about the role of new imaging techniques in staging livermetastases.16:20A-019 Surgical resection of liver metastases: when and howJ. Belghiti; Clichy/FRLearning Objectives:1. To become familiar with surgical indications of liver metastases.2. To understand treatment planning strategies.3. To learn about prognostic factors for surgical candidates.16:35A-020 Chemotherapy and novel therapy in colorectal livermetastases: rationale, indications and resultsS. Faivre; Clichy/FRLearning Objectives:1. To appreciate the rationale behind chemotherapy and novel therapy.2. To learn about the most common protocols of chemotherapy andnovel therapy.3. To consolidate knowledge in treatment efficacy.16:50A-021 Role of image-guided treatment in colorectal livermetastasesM. Abdel Rehim, A. Sibert, V. Barrau, Z. Ben Lakhdar, V. Vilgrain; Clichy/FRLearning Objectives:1. To learn about the most common image-guided treatments.2. To understand advantages and drawbacks of each treatment.3. To become familiar with the role of image-guided treatments.17:05 Case presentation and discussion16:00–17:30 Room F1Professional Challenges SessionPC 3 Bringing radiology to medicalundergraduates16:00A-022 Chairman‘s introduction: why does it matter?S.J. Golding; Oxford/UKSession Objectives:1. To understand why radiologists need to make undergraduateteaching a priority.2. To become familiar with the effect of teaching undergraduates on thestudent and the institution.3. To appreciate the objectives with which the undergraduate should betaught.A-011 – A-022Thursday157

Postgraduate Educational ProgrammeA-023 – A-03416:05A-023 Establishing a radiological presence in the undergraduatecurriculumR.N. Gibson; Melbourne/AULearning Objectives:1. To understand the importance of radiology‘s undergraduate profile.2. To understand the effect of a presence throughout the curriculum oneducation.3. To become familiar with the ways in which radiology‘s curricularpresence may be achieved at individual stages.16:20A-024 Finding the time and resources in the radiologydepartmentJ. del Cura; Bilbao/ESLearning Objectives:1. To be aware of the competing demands on departmental resources.2. To understand the available methods for creating time for teaching.3. To understand the physical resources that aid effective and efficientteaching.16:35A-025 Involving the undergraduate with the radiologydepartmentK.L.A. Verstraete; Gent/BELearning Objectives:1. To understand the effect of involvement in radiology on learning.2. To become familiar with the potential methods of undergraduateinvolvement.3. To understand the value and management of short-term and longtermattachments to the radiology department.16:50A-026 How to ensure teachers are suitably trainedE. Szabó, Z. Morvay, E. Nagy, I. Mátéka; Szeged/HULearning Objectives:1. To learn that teaching is a psychomotor skill with its own trainingrequirements.2. To understand the importance of course design and methods ofassessment to learning.3. To understand the ways in which radiological teachers may obtaintraining appropriate to their needs.Panel discussion:17:05 What needs to be done to overcome the constraints onradiologists?16:00–17:30 Room F2BreastRC 302Functional imaging of the breastModerator: G. Esen; Istanbul/TR16:00A-027 A. Contrast-enhanced mammographyC.S. Balleyguier 1 , E. Fallenberg 2 , S. Canale 1 , C. Dromain 1 ; 1 Villejuif/FR, 2 Berlin/DELearning Objectives:1. To understand the underlying physical principles of contrastenhancedmammography (CEM).2. To become familiar with different protocols.3. To appreciate the potential impact of CEM on every day clinicalpractice.16:30A-028 B. Ultrasound elastographyA. Athanasiou; Paris/FRLearning Objectives:1. To understand the basic principles of US elastography.2. To learn about the difference between strain and shear waveelastography and their respective results.3. To appreciate the additional value of US elastography to B-mode US.17:00A-029 C. MRI diffusion, perfusion and spectroscopyP.A.T. Baltzer; Vienna/ATLearning Objectives:1. To understand the diagnostic value of diffusion weighted imaging(DWI) in its present clinical applications.2. To learn about the technical basics and potential use of MRIperfusion in the breast.3. To understand promises and challenges of MR spectroscopy inclinical practice.16:00–17:30 Room G/HGenitourinaryRC 307 Renal and adrenal tumoursModerator: B. Brkljacic; Zagreb/HR16:00A-030 A. Adrenal masses, a practical approachG. Heinz-Peer; St. Pölten/ATLearning Objectives:1. To become familiar with the different imaging appearances of adrenalmasses including pathological relation.2. To learn the different imaging techniques to improve evaluation ofbenign versus malignant adrenal masses.3. To understand the impact of imaging given the information that thepatient has/has not a known malignancy.16:30A-031 B. Staging renal cancerR. Pozzi-Mucelli; Verona/ITLearning Objectives:1. To recognise the CT/MRI/US findings for staging.2. To learn about the optimal imaging protocol for the diagnosis andstaging of renal cancer.3. To understand treatment options and implications.17:00A-032 C. How to deal with small indeterminate renal massesO. Hélénon; Paris/FRLearning Objectives:1. To become familiar with the various appearances of smallindeterminate renal masses.2. To learn about the respective roles of US, CT and MR imaging ininvestigating small renal masses.3. To learn the main pitfalls in assessing small renal masses.16:00–17:30 Room I/KChestRC 304How I reportModerator: J. Cáceres; Barcelona/ES16:00A-033 A. Bedside chest radiographyR. Eibel; Schwerin/DELearning Objectives:1. To learn a structured reporting approach.2. To understand key imaging findings in different clinical settings.3. To improve confidence by linking pattern recognition, interpretationand diagnosis.16:30A-034 B. CTA and MRA of the pulmonary arteriesJ.E. Wildberger; Maastricht/NLLearning Objectives:1. To learn more about recent improvements in CTand MR angiography.2. To learn a structured approach to reporting CTA or MRA.3. To become familiar with the role of CT angiography in comparisonto MR angiography.158

Postgraduate Educational Programme17:00A-035 C. PET/CTC. Keyzer; Brussels/BELearning Objectives:1. To understand the basic principles of PET/CT using FDG.2. To become familiar with physiologic FDG uptakeand frequent pitfalls.3. To learn about FDG PET/CT in non-oncologic and oncologicdisorders and how to report.16:00–17:30 Room L/MOrgans from A to Z: HeartMC 322 Technical and anatomicalfundamentals for imaging the heartModerator: A. de Roos; Leiden/NL16:00A-036 A. Anatomy: too many details in cardiac imaging?A.J.B.S. Madureira; Porto/PTLearning Objectives:1. To learn about the detailed anatomy of the heart.2. To learn about the anatomy of the thoracic vasculature and greatvessels.3. To get an overview of important incidental findings in cardiacimaging.16:20A-037 B. Examination protocols for imaging the heart: CTH. Alkadhi; Zurich/CHLearning Objectives:1. To get an overview of different examination protocols.2. To learn about various strategies in radiation dose optimisation.3. To identify suitable clinical indications for cardiac CT.16:40A-038 C. Examination protocols for imaging the heart: MRIN.L. Kelekis; Athens/GRLearning Objectives:1. To get an overview of different examination protocols.2. To learn about typical cardiac MR artefacts and pitfalls.3. To identify suitable clinical indications for cardiac MRI.17:00A-039 Interactive case discussionA. de Roos; Leiden/NL16:00–17:30 Room N/OInterventional RadiologyRC 309 Percutaneous treatment of chronicback pain and sciatica16:00A-040 Chairman‘s introductionA.D. Kelekis; Athens/GR16:05A-041 A. Sacroiliac joint syndromeD.J. Wilson; Oxford/UKLearning Objectives:1. To learn about relevant anatomy and clinical presentations of thesyndrome.2. To know more about the available treatments.3. To learn about clinical results and possible further developments.16:28A-042 B. Facet syndromeM. Gallucci; L‘Aquila/ITLearning Objectives:1. To understand the difference between facet joint and disc disease.2. To learn about different treatment options for facet disease.3. To learn how to manage patients.16:51A-043 C. Intervertebral disc syndromesA. Gangi, J. Garnon, G. Tsoumakidou, I. Enescu; Strasbourg/FRLearning Objectives:1. To understand possible treatment techniques for disc disease.2. To know more about clinical and imaging findings in treatment.3. To learn about published results on percutaneous disc treatment.Panel discussion:17:14 How can imaging methods separate candidates forpercutaneous therapy and surgery?16:00–17:30 Room PVascularRC 315Vascular imaging in ischaemic strokeModerator: J. Hendrikse; Utrecht/NL16:00A-044 A. Intracranial atherosclerotic disease of carotid arteriesT. Jargiello; Lublin/PLLearning Objectives:1. To become familiar with appropriate imaging protocols for allimaging modalities and the pros and cons of each modality.2. To learn about imaging signs of atherosclerotic disease in the carotidartery territory.3. To learn about the classification of lesions and indications fortreatment.16:30A-045 B. Vertebrobasilar atherosclerotic diseaseL. Valvassori, M. Piano; Milan/ITLearning Objectives:1. To learn about the appropriate imaging protocol and the imagingsigns of extracranial and intracranial atherosclerosis.2. To learn about the epidemiology, symptomatology and naturalhistory.3. To learn about the classification of lesions and indications fortreatment.17:00A-046 C. Dissection and vasculitis of intracranial and extracranialarteriesH.R. Jäger; London/UKLearning Objectives:1. To learn the imaging signs of dissection and different types of large/medium vessel vasculitis.2. To learn about lesion morphology and haemodynamic consequencesof dissection and vasculitis.3. To learn about imaging protocols for detection of dissection andlarge/medium vessel vasculitis.16:00–17:30 Room QComputer ApplicationsRC 305 New PACS architecture: decouplingimage management from imagenavigation16:00A-047 Chairman‘s introductionH.U. Lemke; Berlin/DESession Objectives:1. To introduce models of image management and workflow.2. To present the evolution of image management outside of radiology(surgery, interventions etc.).3. To discuss the technical requirements for better image sharing anddistribution.A-035 – A-047Thursday159

Postgraduate Educational ProgrammeA-048 – A-05416:05A-048 A. Image navigation and new PACS architectureJ. Reponen; Raahe/FILearning Objectives:1. To learn about recent changes in PACS design and infrastructure.2. To understand the role of data management in PACS architecture.3. To become acquainted with different PACS architectures.4. To understand technical, workflow and legal aspects of innovativetechnologies.16:28A-049 B. Intraoperative imaging for surgeonsA. Pietrabissa 1 , L. Pugliese 1 , A. Peri 1 , F.P. Tinozzi 1 , V. Ferrari 2 ; 1 Pavia/IT, 2 Pisa/ITLearning Objectives:1. To understand why surgeons need more intraoperative guidance.2. To learn about the role of robotics and augmented reality in generalsurgery.3. To become familiar with patient-specific simulation.4. To appreciate the place of surgical training and accreditation.16:51A-050 C. Dismantling PACS: separating image viewing from thedata storage and sharingB. Gibaud; Rennes/FRLearning Objectives:1. To learn about strategic issues of generic image archiving anddistribution.2. To understand new concepts of independent ‚front ends‘ of PACS.3. To become familiar with new examples of PACS implementationbased on component architecture.4. To appreciate new strategies of PACS architecture and migration.18:30–18:50 Room APlenary SessionOL Opening LecturePresiding:J.I. Bilbao; Pamplona/ES18:30A-054 Promises and facts of liver-directed gene therapyJ.M. Prieto; Pamplona/ESLearning Objectives:1. To learn about novel therapeutic approaches in hepatology.2. To understand principles and applications of liver-directed genetherapy.3. To appreciate flexibility, potential and limitations of the procedure.4. To become familiar with gene therapy vectors and their clinical use.5. To consolidate knowledge of novel approaches to treat liver diseases.Panel discussion:17:14 How should we manage our images today?16:00–17:30 Room ZESR Radiation Protection SessionSecurity scanners at airports: are they safe?Moderators: J. Damilakis; Iraklion/GR, P. Vock; Berne/CH16:00A-051 X-ray backscatter security scanners: principles,performance and potential health risksJ. Damilakis; Iraklion/GRLearning Objectives:1. To become familiar with the technological principles of securityscanners.2. To learn about the detection performance of x-ray security scanners.3. To understand the radiation doses and risks from x-ray backscattersecurity scanners.16:30A-052 Cumulative low-level x-ray radiation exposure: is itharmful?P. Vock; Berne/CHLearning Objectives:1. To learn about risks of x-ray exposure in relation to age.2. To appreciate the difference between individual and collectiveradiogenic risks.3. To understand issues related to cumulative radiation doses andpossible risks from medical x-ray screening procedures.17:00A-053 Security scanners using non-ionising radiation: currentstatus and trends for developmentM. Kemp; Cambridge/UKLearning Objectives:1. To understand the current status of non-ionising radiationtechnology for the detection of explosives and other threats.2. To learn about trends for development of millimetre-wave andterahertz technology.3. To learn about the challenges and limitations of these technologies.160

Postgraduate Educational Programme08:30–10:00 Room AAbdominal VisceraRC 401 Pitfalls in interpretation ofpancreatic imagingModerator: H.-J. Brambs; Ulm/DE08:30A-055 A. Pancreatic cancer or pancreatitis?B.J. Op de Beeck, A. Snoeckx, M. Spinhoven, R. Salgado, P.M. Parizel; Antwerp/BELearning Objectives:1. To become familiar with the common benign mimickers ofpancreatic malignancy.2. To learn how to differentiate between benign and malignant lesions.3. To know the limitations and complementary roles of CT and MR.09:00A-056 B. How can we differentiate cystic neoplasms frompseudocysts?T. Denecke; Berlin/DELearning Objectives:1. To learn the most common cystic lesions of the pancreas.2. To know typical imaging findings of pseudocysts and cystic tumours.3. To become familiar with imaging elements that help differentiatebetween cystic lesions.09:30A-057 C. How to manage incidental findingsC. Triantopoulou; Athens/GRLearning Objectives:1. To learn how to differentiate between benign and malignant cysticlesions.2. To know the correct management of unclassified cystic lesionsthrough imaging.3. To become familiar with the reference imaging criteria suggestingtreatment.08:30–10:00 Room COncologic ImagingRC 416 MR imaging for prostate cancermanagement: the essential guidefor radiologists08:30A-058 Chairman‘s introductionH.-P. Schlemmer; Heidelberg/DE08:35A-059 A. Clinical challenges: how to treat prostate cancerB.A. Hadaschik; Heidelberg/DELearning Objectives:1. To understand how diagnosis is established through PSA evaluationand biopsy.2. To learn about different treatment options.08:58A-060 B. The radiologist‘s contribution: how to detect andcharacterise a tumourA.R. Padhani; Northwood/UKLearning Objectives:1. To understand how multiparametric MRI detects prostate cancer.2. To learn how to perform, interpret and communicate multiparametric MRIs.3. To learn how to support image guided biopsy.4. To understand the need for the standardisation of MRI protocols andreports.09:21A-061 C. The radiologist‘s influence on management. Stagingprostate cancer: how it impacts on treatment selectionH. Hricak; New York, NY/USLearning Objectives:1. To learn how advanced MR techniques improve staging.2. To learn how imaging impacts on clinical management (treatmentselection and response monitoring).3. To understand the need for the implementation of MRI in clinicalpractice and clinical trials.4. To understand the need for specialised training of radiologists inprostate cancer imaging.Panel discussion:09:44 Is MRI an integral part of the clinical routine?08:30–10:00 Room D1Controversies in Breast ImagingMC 423 Overdiagnosis from screeningmammography:should we care about it?Moderator: T.H. Helbich; Vienna/ATTeaser: H.J. de Koning; Rotterdam/NL08:30A-062 A. The risk of overdiagnosis from screeningmammographyE. Paci, D. Puliti; Florence/IT08:55A-063 B. How breast radiologists should control the risk ofoverdiagnosisU. Bick; Berlin/DE09:20A-064 DiscussionT.H. Helbich 1 , H.J. de Koning 2 ; 1 Vienna/AT, 2 Rotterdam/NL08:30–10:00 Room D2Emergency RadiologyRC 417 ER: basic principlesModerator: P. Valdés Solís; Marbella/ES08:30A-065 A. Logistics and organisation of an emergency radiologydepartmentM. Körner; Landshut/DELearning Objectives:1. To understand how an emergency radiology department should beorganised.2. To become familiar with the logistics, staffing and technicalequipment of an ER department operating 24/7.09:00A-066 B. Advanced trauma life support: basic knowledge forradiologistsD.R. Kool; Nijmegen/NLLearning Objectives:1. To understand the relationship between ATLS and emergencyradiology.2. To know more about the rational use of CR, US and CT according topatient priorities in the emergency setting.3. To become familiar with priority-oriented reporting of findings.09:30A-067 C. Mechanism of injury and MDCT protocols: choosing theright protocol for the right patientS. Voelckel 1 , M. Rieger 2 ; 1 Innsbruck/AT, 2 Hall in Tirol/ATLearning Objectives:1. To understand mechanisms of traumatic injuries.2. To become familiar with established whole body MDCT protocolsand their possible relation to injuries.3. To know the impact of MDCT findings on patient management.A-055 – A-067Friday161

Postgraduate Educational ProgrammeA-068 – A-07808:30–10:00 Room E1State of the Art SymposiumSA 4 Diffusion-weighted imaging (DWI)of the abdomen08:30A-068 Chairman‘s introductionY. Menu; Paris/FRSession Objectives:1. To understand DWI principles.2. To learn about appropriate protocols for DWI of the abdomen.3. To learn how to analyse and report DWI images.4. To understand the clinical value of DWI for detection,characterisation and prognostic evaluation.08:35A-069 DWI of the abdomen: a tutorial for beginnersH.C. Thoeny; Berne/CHLearning Objectives:1. To understand the principles of DWI.2. To learn the different acquisition protocols (optimal b values, optimalsequences) and their advantages and disadvantages.3. To learn how DWI can be integrated into acquisition protocols, andwhether it precludes the need for other sequences.4. To learn how to interpret ADC maps and values.08:55A-070 Liver and pancreas: answering burning questionsF. Caseiro-Alves; Coimbra/PTLearning Objectives:1. To understand the images observed in the main focal liver andpancreatic diseases.2. To learn if DWI can provide useful information concerning tissuecharacterisation.3. To understand the clinical circumstances in which DWI is mosthelpful.4. To learn if DWI helps in the evaluation of diffuse liver diseases andhow iron and fat could be misleading issues.09:15A-071 DWI of abdominal lymph nodes: PET competitive or justpseudo?S. Gourtsoyianni; London/UKLearning Objectives:1. To understand the signal of lymph nodes on DWI sequences, and toidentify the correlation between histological changes and DWI signalin benign and malignant lymph nodes involvement.2. To learn whether or not ADC value is helpful for characterisation.3. To compare DWI and PET and understand their respective roles.4. To open the door to the future combination of PET and MRI.09:35 Clinical cases08:30–10:00 Room E2Foundation Course: NeuroimagingE³ 420 The orbit, the petrous boneand the sellaModerator: B. De Foer; Antwerp/BE08:30A-072 A. Imaging of the orbit: the globe and conal lesionsP.C. Maly Sundgren; Lund/SELearning Objectives:1. To understand the embryology and imaging findings of the mostcommon malformations of the orbit.2. To learn about space occupying lesions and the differential diagnosisof tumours and inflammatory conditions.3. To become familiar with the role of conventional and advanced MRsequences in the diagnostic approach of lesions in the orbit.09:00A-073 B. The petrous boneF. Veillon; Strasbourg/FRLearning Objectives:1. To understand the normal imaging anatomy.2. To learn about the role of CT and MRI in the evaluation of congenitalmalformations.3. To become familiar with the most common acquired lesions of themiddle and inner ear.09:30A-074 C. Sella and parasellar pathologyR. Gasparotti; Brescia/ITLearning Objectives:1. To consolidate knowledge about the normal anatomy and the agerelated patterns of the normal pituitary gland.2. To learn how to evaluate congenital and acquired lesions of the sellaand parasellar region.3. To become familiar with imaging protocols.08:30–10:00 Room F1Multidisciplinary Session:Managing Patients with CancerMS 4 Hepatocellular carcinoma08:30A-075 Chairman‘s introductionB. Sangro; Pamplona/ESSession Objectives:1. To learn the current management of HCC as laid out in scientificguidelines.2. To identify those areas of uncertainty, where multidisciplinary teamsare needed most.3. To understand the basis of personalised care for HCC patients andthe need for multidisciplinary teams.08:35A-076 Abdominal radiologyA. Benito; Pamplona/ESLearning Objectives:1. To learn which imaging procedures should be considered standardof care for staging HCC and which are potential improvements thatawait confirmation.2. To understand the limitations of imaging in the diagnosis andevaluation of response to locoregional and antiangiogenic therapies.3. To learn about the scientific evidence supporting the use ofpercutaneous ablation procedures other than radiofrequency.08:50A-077 Interventional radiologyJ.I. Bilbao; Pamplona/ESLearning Objectives:1. To learn about locoregional intraarterial therapies currently beingused for HCC and the rationale behind their use.2. To become familiar with patient selection for embolising proceduresprior to and after angiographic evaluation.3. To learn some tips that may help reduce side effects and preventcomplications of transarterial therapies.4. To understand how IRs can help patients with unresectable tumoursbeing evaluated for resection.09:05A-078 SurgeryF. Pardo; Pamplona/ESLearning Objectives:1. To learn about the main factors behind the resectability of HCC.2. To learn about the evolving criteria for liver transplantation.3. To understand the potential role of radiologists in the intraoperativeor postoperative management of HCC.4. To learn about complications of locoregional therapies (percutaneousablation or intraarterial therapies) that could complicate resection ortransplantation.162

Postgraduate Educational Programme09:20A-079 Hepatology/oncologyB. Sangro; Pamplona/ESLearning Objectives:1. To learn the basis of tumour staging in HCC and the generaltreatment paradigm.2. To learn about the discrepancies between different treatmentguidelines and clinical practice.3. To become familiar with systemic anticancer agents and their impacton locoregional and surgical treatment of HCC.09:35 Case presentation and discussion08:30–10:00 Room F2Special Focus SessionSF 4a „MRI of the lung: to go?“08:30A-080 Chairman‘s introduction: „ApéritifH.-U. Kauczor; Heidelberg/DESession Objectives:1. To learn how to do MRI of the lung in clinical routine.2. To understand the rationales and potential clinical applications ofMRI of the lung.3. To understand the prerequisites for acceptance of MRI of the lung byour clinical colleagues.08:33A-081 The sequence buffetJ.M. Wild; Sheffield/UKLearning Objectives:1. To learn about the basic physics of MR imaging of protons in thelung.2. To understand the role of different magnetic field strengths andparallel receiver coils.3. To appreciate the potential of fast imaging sequences for imaging thelung.08:48A-082 Preparing your menuJ. Biederer; Heidelberg/DELearning Objectives:1. To learn how to combine MR sequences with a comprehensiveimaging protocol.2. To become familiar with the different diagnostic scopes of theprotocol components.3. To learn how to apply protocol variations for specific clinicalquestions.4. To learn when to use IV contrast-enhanced series.09:03A-083 Bon appétit! Starters“: cystic fibrosis, pneumonia andpulmonary embolismM.U. Puderbach; Heidelberg/DELearning Objectives:1. To understand the application of MRI to morphological andfunctional imaging of airway diseases.2. To appreciate the potential of MRI for imaging pulmonaryembolisms using different morphological and functional MRtechniques.09:23A-084 Bon appétit! Main course“: pulmonary and mediastinalneoplasmsE.J.R. van Beek; Edinburgh/UKLearning Objectives:1. To understand the application of MRI sequences to the staging oflung cancer.2. To become familiar with the role of MRI in lung cancer work-ups.3. To learn about the limitations of MRI in chest tumours.08:30–10:00 Room G/HNeuroRC 411The paediatric brain:not just a small brainModerator: C. Venstermans; Edegem/BE08:30A-085 A. Neurocutaneous syndromes: more thanneurofibromatosisB. Ertl-Wagner; Munich/DELearning Objectives:1. To become familiar with the typical clinical presentations ofneurocutaneous syndromes.2. To consolidate knowledge of the typical imaging patterns of themajor neurocutaneous syndromes.3. To become familiar with some less common features ofneurocutaneous syndromes.09:00A-086 B. Patterns of white matter disease in childrenA. Rossi; Genoa/ITLearning Objectives:1. To become familiar with the most common white matter diseases inchildren.2. To learn how to differentiate between white matter diseases inchildren.3. To consolidate knowledge of appropriate imaging protocols for MRIof children with white matter disease.09:30A-087 C. Paediatric brain tumoursC. Hoffmann; Tel Hashomer/ILLearning Objectives:1. To learn about the difference between paediatric and adult braintumours.2. To understand the imaging strategy for the paediatric population.3. To recognise the most common paediatric brain tumours.08:30–10:00 Room I/KJoint Course of ESR and RSNA(Radiological Society of North America)MC 428 Essentials in oncologic imaging: whatradiologists need to know (part 1)Moderator: D.M. Panicek; New York, NY/US08:30A-088 A. Principles of oncologic imaging and reportingD.M. Panicek; New York, NY/USLearning Objectives:1. To review general principles of oncologic imaging.2. To understand the critical importance of clinical context duringinterpretation of oncologic exams.3. To evaluate ways to ensure that our reports provide added value andreflect the radiologist’s role as consultant.08:55A-089 B. Lung cancers (primary, metastases)C.J. Herold; Vienna/ATLearning Objectives:1. To review the strengths and limitations of radiologic techniquessuitable for detecting and characterising primary and metastaticlesions in the lungs.2. To understand the imaging findings relevant for lung cancer T, Nand M staging, and appraise the implications of the new IASLC lungcancer staging system.3. To evaluate the imaging findings used to assess response toconventional and new therapies for lung cancers.A-079 – A-089FridayPanel discussion:09:43 „Bon appétit! Dessert“: what are the benefits of MRI of thelung in clinical workflow and decision-making?163

Postgraduate Educational ProgrammeA-090 – A-10409:25A-090 C. Colon cancerR.M. Gore, R. Silvers; Evanston, IL/USLearning Objectives:1. To get an overview of current recommendations for the diagnosis ofcolorectal cancer.2. To understand the specific role of MDCT, MR imaging, endoscopicultrasound, and PET/CT in the staging of colorectal cancer inoptimising patient management.3. To learn the utility of imaging in assessing tumour response totherapy and in the general follow-up of patients with colorectalcancer.09:50 Questions08:30–10:00 Room L/MOrgans from A to Z: HeartMC 422 Non-ischaemic heart diseaseModerator: V.E. Sinitsyn; Moscow/RU08:30A-091 A. Congenital heart diseaseM. Gutberlet; Leipzig/DELearning Objectives:1. To understand the value of available imaging modalities in congenitalheart disease.2. To get an overview of common cases of congenital heart failure.3. To learn how to read post-surgical cases in patients with congenitalheart disease.08:50A-092 B. Valvular diseaseJ. Bogaert; Leuven/BELearning Objectives:1. To learn about various imaging modalities available for imaging thecardiac valves.2. To get an overview of various types of valvular diseases.3. To understand myocardial changes caused by valvular pathologies.09:10A-093 C. CardiomyopathiesP. Sipola; Kuopio/FILearning Objectives:1. To get an overview of different types of cardiomyopathies.2. To differentiate typical imaging findings in various cardiomyopathies.09:30A-094 Interactive case discussionV.E. Sinitsyn; Moscow/RU08:30–10:00 Room N/OEIBIR/EORTC Joint WorkshopA radiologist with a ruler in his hand isa dangerous person: seeking standardisation inmulticenter imaging trialsModerators: P. Brader; Vienna/AT, Y. Liu; Brussels/BE08:30A-095 Introduction: imaging and the future of cancer therapyP. Brader 1 , Y. Liu 2 ; 1 Vienna/AT, 2 Brussels/BELearning Objectives:1. To seek standardisation of imaging biomarkers in multicenter cancerclinical trials.2. To demonstrate examples of imaging implementation in optimisedstudy design.3. To explore future collaboration between EORTC and EIBIR.08:40A-096 Setting up clinical trials with functional imaging endpoints:trials and tribulationsN.M. deSouza; Sutton/UKLearning Objective:1. To understand the processes involved in incorporating functionalimaging end points into clinical trials and appreciate the limitations.09:00A-097 Challenges, problems on key imaging techniquesB. Van Beers; Clichy/FR09:20A-098 Advanced MR neuroimaging in multicentre trials:experience from the EORTC Brain Tumour GroupM. Smits; Rotterdam/NL09:40A-099 Presentation of LUNG study: from the beginning untiltodayU. Nestle; Freiburg/DE08:30–10:00 Room PProfessional Challenges SessionPC 4 The visibility of the radiologist08:30A-100 Chairman‘s introductionJ.A. Reekers; Amsterdam/NLSession Objectives:1. To learn how the visibility of the radiologist can be increased.2. To understand that radiology needs to play a central role in diagnosisand treatment.3. To learn from the experts and increase understanding through Q &A.08:33A-101 How to optimise the visibility of the radiology departmentJ.A. Reekers; Amsterdam/NLLearning Objectives:1. To learn how to organise a radiology department within a hospital.2. To learn how to optimise contact with clinical partners.3. To learn how to create an open radiology department.08:45A-102 Start early with radiological visibilityM. Maas; Amsterdam/NLLearning Objectives:1. To learn how to set up an undergraduate teaching programme forradiology.2. To learn how to overcome the barriers of a traditional curriculum.3. To learn about the results of an undergraduate teaching programmefor radiology.09:05A-103 Clinical radiology puts you in the spotlight: taking overthe clinical responsibilityE. de Kerviler; Paris/FRLearning Objectives:1. To learn how to become more clinically involved.2. To learn about the requirements of clinical radiology.3. To learn how to manage the clinical problems of others.09:25A-104 Radiology in the 21st century: time to come out of thedark?A. Adam; London/UKLearning Objectives:1. To learn about the role of the radiologist as quality controller.2. To learn how to become proactive and drive patient pathways ratherthan simply responding to requests.3. To learn about improved visibility through improved service.164Panel discussion:09:45 Should we improve the visibility of the radiologist?And if yes, how?

Postgraduate Educational Programme08:30–10:00 Room QSpecial Focus SessionSF 4b Justifying CT in paediatric radiology08:30A-105 Chairman‘s introductionC. Owens; London/UKSession Objectives:1. To become familiar with the importance of CT justification andoptimisation.2. To understand the evidence base for concern.3. To become familiar with realistic alternatives to CT.08:34A-106 How should CT be optimised?W.A. Kalender; Erlangen/DELearning Objectives:1. To become familiar with the dose levels currently encountered inpaediatric CT.2. To become familiar with new developments towards dose reductionin CT.3. To learn about tools for assessing organ dose and effective dosevalues.08:56A-107 When, how, and why I perform CTC. Owens; London/UKLearning Objectives:1. To become familiar with the concept of CT ‘fit for purpose’.2. To appreciate the role of CT in paediatric body imaging.3. To become familiar with suggested parameters for use of CT incardiothoracic imaging, describing risks and benefits.09:18A-108 Why and when CT does not need to be performedM. Claudon; Vandoeuvre-les-Nancy/FRLearning Objectives:1. To become familiar with alternative imaging methods to replace CT.2. To appreciate the advantages and disadvantages of these alternativemethods of imaging.3. To become familiar with a practical model for CEUS and MRI inbody imaging.Panel discussion:09:40 Do we have guidelines for paediatric CT?Do we have alternatives?10:30–12:00 Room AInteractive Teaching SessionE³ 520a Pitfalls in abdominal imaging10:30A-109 A. LiverV. Vilgrain, M. Ronot, A. Kerbaol, O. Bruno; Clichy/FRLearning Objectives:1. To learn about morphologic changes in the liver observed in noncirrhoticdiseases.2. To understand imaging features enabling distinction between intraand extrahepatic tumours.3. To become familiar with liver lesions mimicking liver tumours.11:15A-110 B. Pancreas and bile ductsR. Manfredi; Verona/ITLearning Objectives:1. To understand the MRI technique for evaluating the pancreaticparenchyma, the pancreatic duct system and the biliary tree, thefunctional assessment following secretin stimulation.2. To appreciate the signs in MR imaging of the pancreas and bile ducts.3. To understand the diagnostic imaging criteria useful for differentialdiagnosis.10:30–12:00 Room BESR meets SpainEM 1 Imaging: essential tool fromdiagnosis to treatmentWelcome by the ESR President:G.P. Krestin; Rotterdam/NLPresiding:C. Ayuso; Barcelona/ESJ.I. Bilbao; Pamplona/ES10:30A-111 IntroductionC. Ayuso; Barcelona/ESSession Objectives:1. To discuss the role of imaging techniques in different clinicalscenarios where radiologists are key, from diagnosis to treatment.2. To present technical imaging innovations that assist the diagnosis,treatment and follow-up in three different clinical scenarios:ischaemic stroke, aortic aneurism and hepatocellular carcinoma.3. To present specific clinical advantages and results of themultimodality approach.10:35A-112 Ischaemic strokeJ. Macho; Barcelona/ESLearning Objectives:1. To discuss the clinical and neuroradiologic implications of an earlydiagnosis. Evaluation of CT and MR diffusion/perfusion in patientselection for endoarterial treatment.2. To understand the rationale behind mechanical endoarterialreperfusion of acute vascular occlusion.3. To analyse the short and medium term results of a regionalprogramme for acute stroke treatment after three years.10:55A-113 Interlude: Spanish radiologists: open to the worldE. Fraile Moreno; Madrid/ES11:00A-114 Aortic aneurismsJ.J. Martínez Rodrigo; Valencia/ESLearning Objectives:1. To understand the role of imaging modalities in diagnosis andendovascular treatment of aortic aneurisms.2. To learn about the role of 3D imaging techniques to assist theendovascular treatment of aortic aneurisms.3. To appreciate the role of imaging modalities in evaluating thecomplications of endovascular aortic repair.11:20A-115 Interlude: Radiologists and Spanish winesL. Martí-Bonmatí; Valencia/ESLearning Objectives:1. To understand the influence of the country, the climate and thesituation in the quality of wines.2. To learn about Spain‘s characteristics that influence the wine quality.3. To appreciate why the soil (and by extension the terroir) is soimportant.11:25A-116 Hepatocellular carcinoma: the BCLC approachM. Burrel; Barcelona/ESLearning Objectives:1. To understand the clinical implications of an early diagnosis, whenthe lesion is small and asymptomatic.2. To learn about the rationale behind the current guidelines for modeltreatment options.3. To appreciate the spectrum of locoregional therapies for HCC frompercutaneous to intravascular approaches.Panel discussion:11:45 Is the multidisciplinary environment the natural way todevelop excellence and leadership in clinical imaging?A-105 – A-116Friday165

Postgraduate Educational ProgrammeA-117 – A-12510:30–12:00 Room CInteractive Teaching SessionsE³ 520b Pitfalls in head and neck imaging10:30A-117 A. Pitfalls in neck imagingF.A. Pameijer; Utrecht/NLLearning Objectives:1. To understand the variations of normal anatomy in the neck thatshould not be interpreted as abnormal.2. To become familiar with the incidental findings that are frequentlyencountered when searching for neck disease.3. To recognise suboptimal neck studies, or technique related problemsand understand how these may influence interpretation.11:15A-118 B. Pitfalls in maxillofacial and skull base imagingR. Hermans; Leuven/BELearning Objectives:1. To understand the basic requirements for an optimal imaging studyof the skull base and maxillofacial region.2. To become familiar with anatomical variants, potentially mimickingdisease.3. To learn to appreciate incidental findings, avoiding unnecessaryconcern while recognising relevant pathology.10:30–12:00 Room E2Foundation Course: NeuroimagingE³ 520c PaediatricModerator: D. Prayer; Vienna/AT10:30A-119 A. Neonatal hypoxic-ischaemic brain injuryM.I. Argyropoulou; Ioannina/GRLearning Objectives:1. To understand gestational age-related patterns of brain injury.2. To understand the role of ultrasound and MRI for the initialdiagnosis and follow-up of these patients.3. To understand when and how to use advanced MRI techniques fordelineation of lesions and for prognosis.11:00A-120 B. Spine and spinal cord malformationsA. Rossi; Genoa/ITLearning Objectives:1. To understand the embryology underlying the different categories ofmalformations.2. To learn the key morphological features.3. To learn how to use a simplified diagnostic imaging approach.11:30A-121 C. Imaging of the foetal brainC. Garel; Paris/FRLearning Objectives:1. To become familiar with the normal appearance of the developingbrain.2. To learn about the protocols and the limitations of foetal imaging.3. To gain knowledge about the imaging findings of the most commonbrain abnormalities.10:30–12:00 Room I/KJoint Course of ESR and RSNA(Radiological Society of North America)MC 528 Essentials in oncologic imaging: whatradiologists need to know (part 2)Moderator: H. Hricak; New York, NY/US10:30A-122 A. Pancreatic cancerF. Caseiro-Alves; Coimbra/PTLearning Objectives:1. To understand current pathologic concepts for the classification ofpancreatic tumours.2. To learn about imaging findings used for tumour detection, staging,and restaging after adjuvant therapy.3. To understand the role of functional and molecular informationprovided by PET/CT, DWI and perfusion imaging when assessingpancreatic tumours.10:55A-123 B. Kidney cancerE.K. Fishman; Baltimore, MD/USLearning Objectives:1. To understand the diagnostic implications of minimally invasivetreatments of renal cancer.2. To review the genetic causes of renal cancer and the radiologicappearances of specific histologic subtypes.3. To review the potential role of molecular imaging in the managementof advanced renal cancer.11:20A-124 C. Ovarian cancerH. Hricak; New York, NY/USLearning Objectives:1. To get an overview of the essential imaging findings incharacterisation and staging of ovarian cancer.2. To learn the key imaging findings that affect management of ovariancancer.3. To understand the changes in imaging armamentarium in ovariancancer, and learn the best practice in proper image utilisation.11:50 Questions12:30–13:30 Room PThe Beauty of Basic Knowledge:Musculoskeletal ImagingMC 25B Degenerative disorders12:30A-125 Degenerative disordersT.M. Link; San Francisco, CA/USLearning Objectives:1. To understand the basic pathophysiology of degenerative processes inperipheral joints and in the spine.2. To become familiar with typical imaging findings of osteoarthritisand degenerative changes in the spine.3. To learn about the differential diagnosis of degenerative disorders.166

Postgraduate Educational Programme12:30–13:30 Room QThe Beauty of Basic Knowledge:Head and NeckMC 24B The infrahyoid neck and lymph nodes12:30A-126 The infrahyoid neck and lymph nodesM.G. Mack; Munich/DELearning Objectives:1. To become familiar with the different anatomic compartments of theinfrahyoid neck.2. To understand lymph node classification and level system.3. To learn about the best imaging approach to an IHN mass.4. To be able to localise and provide a useful differential diagnosis.12:45–13:15 Room APlenary SessionHL 1 Josef Lissner Honorary LecturePresiding: J.I. Bilbao; Pamplona/ES12:45A-127 MR guided focused ultrasound: a new string to theradiologist‘s bowC. Catalano; Rome/ITLearning Objectives:1. To learn about the technical and physical principles of MR guidedfocused ultrasound.2. To understand the advantages of MR guidance.3. To become familiar with the approved clinical applications and theongoing clinical trials.4. To learn the research activities and the possible future applications inthe fields of drug delivery and gene therapy.14:00–15:30 Room D1Controversies in Breast ImagingMC 623 Preoperative MRI in newly diagnosedbreast cancer: to do or not to do?Moderator: F. Sardanelli; Milan/ITTeaser: N. Houssami; Sydney/AU14:00A-128 A. Why we should do preoperative MRIW.A. Kaiser; Jena/DE14:25A-129 B. Reasons not to do preoperative MRIM.G. Wallis; Cambridge/UK14:50A-130 DiscussionF. Sardanelli 1 , N. Houssami 2 ; 1 Milan/IT, 2 Sydney/AU14:00–15:30 Room E2Foundation Course: NeuroimagingE³ 620 Trauma and vascularityModerator: A. Molyneux; Oxford/UK14:00A-131 A. CNS traumaP.M. Parizel, C. Venstermans, F. De Belder, T. Van der Zijden, L. van den Hauwe, M.Voormolen, J. Van Goethem; Antwerp/BELearning Objectives:1. To become familiar with the different types of intracranial injury andthe appropriate imaging patterns.2. To learn about the imaging characteristics of intracranialhaemorrhage by CT and MR.3. To be able to recognise imaging findings that are critical for thepatient‘s prognosis.14:30A-132 B. Cerebral ischaemia and infarctionL. Pierot; Reims/FRLearning Objectives:1. To consolidate knowledge of CT findings and conventional MRIfindings.2. To become familiar with the imaging findings and diagnostic role ofdiffusion and perfusion MRI.3. To be informed of the indications and techniques for endovascularstroke treatment.15:00A-133 C. Vascular malformations of the spinal cordD.A. Rüfenacht, I. Wanke; Zurich/CHLearning Objectives:1. To understand the pathophysiology of vascular anomalies.2. To become familiar with imaging protocols.3. To be informed of the indications of interventional therapeuticprocedures.14:00–15:30 Room I/KJoint Course of ESR and RSNA(Radiological Society of North America)MC 628 Essentials in oncologic imaging: whatradiologists need to know (part 3)Moderator: Y. Menu; Paris/FR14:00A-134 A. Oncologic imaging: terminology, definitions andbuzzwordsY. Menu; Paris/FRLearning Objectives:1. To get an overview and precise explanation of current cancer-relatedterminology, definitions and „buzz“ words used in everyday practice.2. To understand why and how this terminology should ensure andsimplify communication with all specialists involved in cancermanagement, including clinicians, researchers as well as otherradiologists.3. To learn common tricks and traps in providing a radiology report,illustrated with clinical cases.14:20A-135 B. Liver cancers (primary, metastases)R.L. Baron; Chicago, IL/USLearning Objectives:1. To get an overview of the AASLD/EASL imaging criteria fornoninvasive diagnosis of hepatocellular carcinoma.2. To learn about best practice CT/MR/US imaging techniques thatoptimise characterisation, detection and staging of primary andmetastatic liver tumours.3. To understand the key role specific findings reported by radiologistshave in determining patient treatment options for hepatocellularcarcinoma.14:55A-136 C. Prostate cancerJ.O. Barentsz; Nijmegen/NLLearning Objectives:1. To learn the key clinical indications for MR imaging in prostatecancer.2. To get an overview of essential MR imaging techniques in detection,characterisation, localisation and staging of prostate cancer.3. To understand how MR imaging influences therapeutic decisions andhow best to provide a value added MR report.15:20 QuestionsA-126 – A-136Friday167

Postgraduate Educational ProgrammeA-142 – A-15316:00–17:30 Room AInteractive Teaching SessionE³ 720a Neurological emergencies16:00A-142 A. Non-traumaticC. Ozdoba; Berne/CHLearning Objectives:1. To learn which imaging modality to use.2. To understand how to identify early ischaemia.3. To be able to select patients for treatment.16:45A-143 B. TraumaticM. Stajgis; Poznan/PLLearning Objectives:1. To understand the proper imaging protocols for trauma patients.2. To become familiar with imaging findings in acute head trauma.3. To learn about the imaging findings in spinal cord trauma.16:00–17:30 Room BESR meets E-AHPBAEM 2 Pancreatic cystic neoplasms 2013Welcome by the ESR President:G.P. Krestin; Rotterdam/NLPresiding:J.I. Bilbao; Pamplona/ESP.-A. Clavien; Zurich/CH16:00A-144 IntroductionP.-A. Clavien 1 , K. Conlon 2 ; 1 Zurich/CH, 2 Dublin/IESession Objectives:1. To understand the importance of the recent WHO classification andits relevance to therapy.2. To become familiar with the radiological work-up for patients withpancreatic cystic tumours.3. To appreciate the current role of endoscopic ultrasonography indiagnosis and management.4. To become familiar with the indications for surgical intervention andthe role of organ-sparing therapies.16:03A-145 Classification/pathologyC. Verbeke; Stockholm/SELearning Objectives:1. To understand the morphological classification of pancreatic cysticlesions based on the distinction between neoplastic/non-neoplasticand epithelial/non-epithelial cysts.2. To become familiar with the key distinctive macroscopic featuresof the various cyst entities and to understand the basic microscopicdiagnostic features.3. To appreciate the considerable variation in macroscopic appearancesand the potential overlap between certain entities.4. To become familiar with the macroscopic features of malignanttransformation within primarily benign cystic lesions.16:21A-146 Radiological diagnosisS. Skehan; Dublin/IELearning Objectives:1. To become familiar with the optimal imaging modalities for cysticpancreatic lesions.2. To learn about the characteristic imaging features of cystic pancreaticlesions and to describe how imaging can contribute to preoperativediagnosis.3. To discuss the appropriate imaging surveillance of selected cysticpancreatic lesions.16:39A-147 Current role of endoscopic ultrasonographyP. Bauerfeind; Zurich/CHLearning Objectives:1. To appreciate the technical aspects, performance characteristics andlimitations of EUS and EUS-FNA in PCNs.2. To understand how EUS and EUS-guided FNA help to establish adiagnosis in PCNs.3. To appreciate the added information that EUS brings in staging premalignantand malignant PCNs and in orientating surgical decisionmaking.16:57A-148 How aggressive should the surgeon be?K. Conlon; Dublin/IELearning Objectives:1. To understand the clinical indications for surgical intervention.2. To appreciate the rationale for deciding on a particular procedure.3. To discuss the outcomes of observation versus surgery.Panel discussion:17:15 The multidisciplinary assessment and management ofpancreatic cystic neoplasia16:00–17:30 Room CNew Horizons SessionNH 7 Cartilage imaging16:00A-149 Chairman‘s introductionV.N. Cassar-Pullicino; Oswestry/UKSession Objectives:1. To review the basics of articular cartilage physiology.2. To introduce the quantitative MR tools used to assess collagen andproteoglycan depletion.3. To learn about the problems arising from the avascular nature ofarticular cartilage.16:03A-150 Sodium imagingS. Trattnig; Vienna/ATLearning Objectives:1. To get familiar with the basic principles of sodium imaging.2. To understand technical challenges of sodium imaging and how tohandle them.3. To learn about clinical applications of sodium imaging in cartilage,cartilage repair and other MSK structures.16:21A-151 dGEMRIC (delayed gadolinium-enhanced MR imaging ofcartilage)G. Welsch 1 , S. Trattnig 2 ; 1 Erlangen/DE, 2 Vienna/ATLearning Objectives:1. To learn the basic principles of dGEMRIC and the current usedtechniques for clinical imaging.2. To learn about the current clinical applications of dGEMRIC.3. To get an overview of future uses of dGEMRIC in therapeutic studies.16:39A-152 Diffusion tensor imagingC. Glaser; Munich/DELearning Objectives:1. To discuss basic principles of diffusion imaging in MSK.2. To review technical challenges and current achievements.3. To look into potential future directions.16:57A-153 CEST (chemical exchange saturation transfer)B. Schmitt; Vienna/ATLearning Objectives:1. To understand basic principles of CEST imaging.2. To learn about the current status of gagCEST imaging.3. To become aware of technical pitfalls and future approaches.168

Postgraduate Educational ProgrammePanel discussion:17:15 What are the envisaged future advances in these cartilageimaging techniques and can we expect to introduce them intoclinical practice?16:00–17:30 Room D1Controversies in Breast ImagingMC 723 Should we add ultrasound tomammographic screening ofdense breasts?Moderator: F.J. Gilbert; Cambridge/UKTeaser: A. Tardivon; Paris/FR16:00A-154 A. We can reduce the interval cancer rateW.A. Berg; Pittsburgh, PA/US16:25A-155 B. Do we have enough radiologists to do it? Alternativesto ultrasound to reduce interval cancersA. Frigerio; Turin/IT16:50A-156 DiscussionF.J. Gilbert 1 , A. Tardivon 2 ; 1 Cambridge/UK, 2 Paris/FR16:00–17:30 Room D2Oncologic Imaging: Follow-up of Systemicand Local TherapiesCC 719 Imaging after systemic therapies:the standardsModerator: E.L. van Persijn van Meerten; Leiden/NL16:00A-157 A. RECIST criteriaY. Menu; Paris/FRLearning Objectives:1. To consolidate knowledge of evaluation of solid tumour response.2. To learn about tips and tricks to help bring RECIST to everydaypractice.3. To understand advantages and limitations of RECIST.16:30A-158 B. PERCIST: evolving considerations for PET responsecriteria in solid tumoursT.F. Hany; Zurich/CHLearning Objectives:1. To learn about the evaluation of solid tumours through metabolicimaging.2. To understand the benefits of metabolic imaging.17:00A-159 C. Evaluation of brain tumoursC. Majós; L‘Hospitalet de Llobregat/ESLearning Objectives:1. To learn about evaluation criteria for brain tumours.2. To become familiar with the evaluation of brain tumours aftertreatment with various therapies.16:00–17:30 Room E1MusculoskeletalRC 710 Peripheral nerve imaging: MRI and US16:00A-160 Chairman‘s introductionJ. Renoux; Paris/FR16:05A-161 A. Applied radiological anatomy and pathology of thebrachial plexusS. Gerevini; Milan/ITLearning Objectives:1. To understand the anatomy of the brachial plexus as demonstratedwith MRI.2. To appreciate the range of pathology seen at the brachial plexus.3. To become familiar with the MRI findings of brachial plexuspathology.16:28A-162 B. Upper limb nerve entrapmentD. Weishaupt; Zurich/CHLearning Objectives:1. To become familiar with the strengths and weaknesses of US andMRI for assessing upper limb nerves.2. To appreciate the imaging findings of upper limb nerve entrapment.16:51A-163 C. Lower limb nerve entrapmentC. Martinoli, A. Tagliafico; Genoa/ITLearning Objectives:1. To become familiar with the strengths and weaknesses of US andMRI for assessing lower limb nerves.2. To appreciate the imaging findings of lower limb nerve entrapment.Panel discussion:17:14 Which on-going technological advances in MRI and US couldinfluence the way we image peripheral nerves in the future?16:00–17:30 Room E2Foundation Course: NeuroimagingE³ 720b Infection and inflammationModerator: A. Gouliamos; Athens/GR16:00A-164 A. InfectionE.T. Tali; Ankara/TRLearning Objectives:1. To understand the concept of ‚leaky vessels‘ in the infectiousmeningeal, parenchymal and ventricular involvement.2. To learn how to proceed with imaging when ‚time is of the essence‘.3. To become familiar with the specific imaging patterns of bacterial,viral, fungal, parasitic and prion infections.16:30A-165 B. Multiple sclerosisF. Barkhof; Amsterdam/NLLearning Objectives:1. To learn about the role of MRI in detecting focal and diffuse multiplesclerosis pathology.2. To consolidate knowledge of lesion distribution, signal intensitycharacteristics and patterns of contrast enhancement.3. To be able to apply the 2010 McDonald criteria to the diagnosis ofMS.17:00A-166 C. Mimics of multiple sclerosisV. Dousset; Bordeaux/FRLearning Objectives:1. To be aware of the top ten mimics of multiple sclerosis.2. To become familiar with the imaging findings suggestive of otherdisorders.3. To be informed of the importance of imaging the spinal cord for thedifferential diagnosis of MS/MS mimics.A-154 – A-166Friday169

Postgraduate Educational ProgrammeA-167 – A-17716:00–17:30 Room F1Special Focus SessionSF 7a Radiographers and ultrasonography inEurope16:00A-167 Chairmen‘s introductionD. Pekarovic 1 , V. Vilgrain 2 ; 1 Ljubljana/SI, 2 Clichy/FRSession Objectives:1. To understand why ultrasound continues to be a growth area indiagnostic imaging.2. To identify the challenges posed by the growth of this field.3. To understand the challenges faced by radiographers carrying out USacross Europe.16:05A-168 Levels of training and competencies across EuropeM.T. Stanton; Dublin/IELearning Objectives:1. To appreciate the similarities between radiographer competenciesacross Europe.2. To become familiar with the regulations for radiographers to trainand practice in Europe.3. To understand an expert-derived consensus of educational standardsfor radiographer in Europe.16:28A-169 The role and impact of the radiographer conducted US inPortugalR.T. Ribeiro; Lisbon/PTLearning Objectives:1. To become familiar with the radiographers’ role in the context of aprofessional progression framework.2. To understand the synergies at play in interprofessional relationshipsand team-work.3. To learn the benefits of having radiographers in the management andoptimisation of health systems.16:51A-170 Evolution of radiography education for US in theNetherlands since 1990, and its influence on their roleG. Plug; Haarlem/NLLearning Objectives:1. To learn about US education over an entire four year bachelorprogramme.2. To understand the role of the radiographers as a result of thisbachelor programme.3. To appreciate changes in the education programme following changesin the role of the radiographers.Panel discussion:17:14 What are the challenges and barriers facing role extension?16:00–17:30 Room F2Special Focus SessionSF 7b Imaging and radiotherapy:all you need to know16:00A-171 Chairman‘s introductionV.J. Goh; London/UKSession Objectives:1. To understand the principles of modern radiotherapy.2. To learn how functional and metabolic imaging have been integratedinto radiotherapy planning, adaptation and response evaluation.3. To become familiar with imaging findings after radiotherapy.4. To understand how imaging affects radiotherapy outcomes.16:05A-172 Modern radiotherapy: what are the new technologies?V. Valentini; Rome/ITLearning Objectives:1. To become familiar with 3D conformal radiotherapy and intensitymodulated radiation therapy (IMRT) and intensity modulatedradiosurgery (IMRS).2. To learn about brachytherapy and intraoperative radiotherapy(IORT) and its indications.3. To understand how IMRT contributes to better treatment outcomesas compared with conventional radiotherapy.16:23A-173 PET/CT for radiotherapy planning: how does it assistIMRT?A. Loft; Copenhagen/DKLearning Objectives:1. To learn about anatomical imaging risk compartments that definegross tumour volume (GTV).2. To understand how PET/CT assists in delineating the GTV.3. To understand the role of PET/CT guided IMRT and how it can leadto treatment adaptation.16:41A-174 Response evaluation and treatment adaptationK. Haustermans; Leuven/BELearning Objectives:1. To understand the molecular tumour microenvironment (tumourhypoxia, -apoptosis and -proliferation) that may impact response toradiation treatment.2. To learn how tumour heterogeneity, reflecting tumourmicroenvironment, influences dose distribution in IMRT.3. To learn how response assessment during IMRT leads to adaptationand tailoring of radiation treatment.16:59A-175 MR imaging biomarkers for response evaluationR.G.H. Beets-Tan; Maastricht/NLLearning Objectives:1. To learn about the range of MR imaging biomarkers that can be usedfor markers of tumor microenvironment and heterogeneity.2. To understand the role and accuracy of diffusion and perfusion (MR)imaging for evaluation of response during and after radiotherapy.3. To become familiar with the MR imaging findings after radiotherapyand understand the pitfalls and interpretation difficulties.Panel discussion:17:17 How can imaging improve outcomes in radiotherapy?16:00–17:30 Room G/HGenitourinaryRC 707 Diagnosis and management of GU tracttraumaModerator: A. Magnusson; Uppsala/SE16:00A-176 A. Imaging the kidney and ureterM.-F. Bellin; Le Kremlin-Bicêtre/FRLearning Objectives:1. To learn the indications, advantages and disadvantages of imagingmodalities after trauma.2. To learn the appropriate diagnostic imaging studies and imagingfindings of different types of trauma.3. To be able to identify a kidney that is in danger after trauma.16:30A-177 B. Imaging the bladder and urethraU.G. Mueller-Lisse; Munich/DELearning Objectives:1. To be able to identify patients requiring urgent cysto-urethrography.2. To learn to identify bladder and urethral injury.3. To learn the imaging techniques necessary for accurate initialevaluation of the urethra in cases of complicated pelvic trauma.170

Postgraduate Educational Programme17:00A-178 C. Interventional radiology for GU traumaB. Peynircioglu; Ankara/TRLearning Objectives:1. To be able to determine which cases deserve management byinterventional radiology.2. To understand the techniques to manage fistulas and ruptures of theureter and urethra.3. To appreciate the vascular and non-vascular interventionaltechniques in kidney trauma.16:00–17:30 Room I/KJoint Course of ESR and RSNA (RadiologicalSociety of North America)MC 728 Essentials in oncologic imaging: whatradiologists need to know (part 4)Moderator: M.F. Reiser; Munich/DE16:00A-179 A. LymphomaH. Schoder; New York, NY/USLearning Objectives:1. To get a practical, clinically relevant summary of key imaging issuesin Hodgkin and non-Hodgkin lymphoma.2. To learn how imaging, especially PET and PET-CT can optimallyassess and measure tumour treatment response, providing a valueaddedradiology report.16:30A-180 B. Musculoskeletal neoplasmsM.F. Reiser; Munich/DELearning Objectives:1. To become familiar with the imaging modalities which enable todetect and differentiate benign and malignant bone neoplasms.2. To consolidate knowledge of radiographic, CT and MRI findingswhich enable to classify and stage bone tumours.3. To understand the potential role of PET-CT and whole body MRI.4. To learn the signs indicative of favourable and poor response topreoperative chemotherapy and for recurrence of malignant bonetumours.16:55A-181 C. Chemo- and radiation therapy-induced toxicityH.-U. Kauczor; Heidelberg/DELearning Objectives:1. To get an overview of organ-specific toxicity and other adverse effectsof chemo- and radiotherapy.2. To review the key imaging findings of therapy-induced organ toxicityand adverse effects.3. To understand how to differentiate inflammatory, infectious, fibrotic,and necrotic changes from tumour recurrence.17:20 Questions16:00–17:30 Room L/MOrgans from A to Z: HeartMC 722 Ischaemic heart diseaseModerator: C. Catalano; Rome/IT16:00A-182 A. Imaging of the coronary arteries: the Holy GrailG. Roditi; Glasgow/UKLearning Objectives:1. To learn about the meaning of CT coronary calcium screening forrisk assessment.2. To identify suitable modalities and challenges for non-invasivecoronary angiography.3. To understand the potential of coronary plaque imaging beyondcalcium.16:20A-183 B. The ischaemic myocardium: what to do?C. Loewe; Vienna/ATLearning Objectives:1. To learn how to evaluate the function of the ischaemic myocardium.2. To identify methods of assessing the viability of the ischaemicmyocardium.3. To get an overview of the therapeutic consequences depending onimaging findings.16:40A-184 C. The ischaemic heart after treatment: still alive?G. Bastarrika; Toronto, ON/CALearning Objectives:1. To learn how to analyse cardiac images following bypass grafting.2. To understand the value of cardiac imaging after coronaryinterventions (PTA and stenting).3. To assess potential therapeutic consequences.17:00A-185 Interactive case discussionC. Catalano; Rome/IT16:00–17:30 Room N/OInterventional RadiologyRC 709 Expanding the role of interventionalradiology in hepatocellular carcinoma16:00A-186 Chairman‘s introductionV. Válek; Brno/CZ16:05A-187 A. RF ablationJ. del Cura; Bilbao/ESLearning Objectives:1. To understand the indications for RF ablation.2. To learn about the technique and devices for RF ablation.3. To learn about results, complications and follow-up strategies.16:28A-188 B. Intra-arterial proceduresF. Orsi; Milan/ITLearning Objectives:1. To become familiar with the indications for intra-arterial treatmentof HCC.2. To learn the techniques of intra-arterial treatment.3. To learn about results, complications and follow-up strategies.16:51A-189 C. Portal vein embolisation before surgeryA. Denys, P. Bize; Lausanne/CHLearning Objectives:1. To become familiar with imaging strategies and indications forembolisation.2. To understand embolisation methods.3. To learn about results, complications and follow-up strategies.Panel discussion:17:14 How to allow for more patients with HCC to be treated?A-178 – A-189Friday171

Postgraduate Educational ProgrammeA-190 – A-19716:00–17:30 Room PRadiographersRC 714 Clinical audit: from EURATOM to theclinical environmentModerators: E.J. Adam; London/UK, D. Pronk-Larive; Middelburg/NL16:00A-190 A. Clinical audit: from the EURATOM treaty to EUguidelines: clinical audit RP 159P. Wood; Helsinki/FILearning Objectives:1. To understand the background to the publication of RP 159 alongwith its purpose and scope.2. To become familiar with the principles and prerequisites of clinicalaudit as outlined by RP 159.3. To become familiar with the relationship between clinical audit andregulatory controls.4. To gain an insight into potential national, regional and internationalissues associated with clinical audit.16:30A-191 B. Implementation in practice:a comparison of different modelsS. Geers-van Gemeren; Utrecht/NLLearning Objectives:1. To understand the key components required to allow clinical audit tobe implemented in practice.2. To gain an insight into different implementation models.3. To be informed about the key considerations that must be made priorto implementing an audit model: organisation, auditors, process,financing, the roles of professional bodies, and outcomes.17:00A-192 C. A perspective on the impact andbenefits of clinical auditS. O‘Connor; Dublin/IELearning Objectives:1. To gain an insight into the use of clinical audit from the perspectiveof a clinical audit lead in an international diagnostic imaging serviceprovider.2. To become familiar with the challenges that may be encounteredwhen undertaking clinical audit.3. To understand the significant impact that clinical audit can have fromthe perspective of the patient, the healthcare team and on servicedelivery.16:00–17:30 Room QSpecial Focus SessionSF 7c Imaging in intensive care patients16:00A-193 Chairman‘s introductionA. Palkó; Szeged/HUSession Objectives:1. To understand the importance of imaging diagnostics in the uniqueand challenging clinical setting of the intensive care units.2. To learn about the technical and methodological considerations to betaken into account with this patient group.3. To learn more about the most important conditions and the imagingfindings as well as the diagnostic imaging algorithms to be used inthe intensive care environment.16:05A-194 Value of MRI for intensive care coma patients withunclear brain pathologyP.C. Maly Sundgren; Lund/SELearning Objectives:1. To understand the importance of magnetic resonance imaging incases of unclear brain pathology causing severe dysfunction of thecentral nervous system.2. To understand the significance of imaging in the evaluation of brainfunction and potential outcome following anesthesia, injuries andhypoxia.3. To become familiar with the imaging signs and their predictive valueand accuracy regarding brain death, and future role of imaging indecisions concerning the termination of intensive treatment.16:23A-195 Computed tomography of pathologic lung conditionscomplicating intensive care treatmentC.M. Schaefer-Prokop; Amersfoort/NLLearning Objectives:1. To understand the spectrum of pathological lung conditions, whichcomplicate intensive care treatment.2. To learn about the role of diagnostic imaging and its technicaldifficulties and requirements in the intensive care environment.3. To become familiar with the most important imaging signs andsymptoms of tracheobronchial and lung conditions, influencing thetreatment and survival of the intensive care patient.16:41A-196 Point-of-care versus diagnostic ultrasound in theintensive care unitE. Danse, P.-F. Laterre, L. Jacquet, A. Dragean, I. Nica, P. Trefois, L. Annet; Brussels/BELearning Objectives:1. To understand the concept and role of point-of-care ultrasound andits technical and training requirements.2. To become familiar with the role and tasks of diagnostic ultrasoundversus point-of-care ultrasound in the most common pathologicconditions in intensive care.3. To learn more about typical ultrasound findings and theirsignificance in the diagnosis, differential diagnosis and therapy ofintensive care patients.16:59A-197 Imaging in polytraumaU. Linsenmaier; Munich/DELearning Objectives:1. To appreciate the clinical significance of conditions characterisedby multiple severe injuries and their systemic and multi-organcomplications.2. To explain the special role of imaging, the diagnostic algorithmand the technical, organisational and training requirements for thediagnosis and follow-up of polytrauma patients.3. To consolidate knowledge of imaging signs and symptoms and theirdiagnostic value in patients with polytrauma.Panel discussion:17:17 What training and special skills are radiologists expected tohave in order to work with intensive care units? How shouldwe manage the clinical and technical challenges posed by thisvery specific environment?172

Postgraduate Educational Programme16:00–17:30 Room ZVascularRC 715Dialysis fistulaModerator: H.A. Deutschmann; Graz/AT16:00A-198 A. Preoperative mappingL. Turmel-Rodrigues; Tours/FRLearning Objectives:1. To become familiar with the indications and techniques for preoperativearterial venous mapping.2. To learn about the venous anatomy.3. To become familiar with the potential pitfalls of preoperativemapping.16:30A-199 B. Screening for problemsD. Vorwerk; Ingolstadt/DELearning Objectives:1. To understand the spectrum of problems with dialysis fistula.2. To learn about screening protocols and the results of screening.3. To learn about the most common problems and how to detect them.17:00A-200 C. Evaluation of malfunctionR. Uberoi; Oxford/UKLearning Objectives:1. To understand the main indications and results of angioplasty.2. To learn about thrombectomy and aspiration.3. To become familiar with the indications for stenting.A-198 – A-200Friday173

Postgraduate Educational Programme174

Postgraduate Educational Programme08:30–10:00 Room AInteractive Teaching SessionE³ 820a Pitfalls in heart imaging08:30A-201 A. CTG. Bastarrika; Toronto, ON/CALearning Objectives:1. To learn about practical aspects of postprocessing, reading andreporting non-invasive cardiac CT examinations.2. To learn how to improve reading of results by recognising technicalcauses for various artifacts in cardiac CT.3. To become familiar with approaches to reducing false inaccuraciesand misinterpretations when assessing coronary artery stenosis.09:15A-202 B. MRIM. Francone; Rome/ITLearning Objectives:1. To learn about common pitfalls in MRI evaluation of the heart.2. To become familiar with cardiac anatomical variants, potentiallymimicking disease.08:30–10:00 Room BSpecial Focus SessionSF 8a Is diagnostic catheter angiography stilluseful in neuroimaging?08:30A-203 Chairman‘s introductionM. Essig; Erlangen/DESession Objectives:1. To become familiar with the current debate on the need fordiagnostic catheter angio.2. To learn about the pros and cons of diagnostic catheter angio.3. To learn about the pros and cons of alternative non-invasiveangiography techniques.08:35A-204 What can we expect from vascular diagnostic procedures?R. Siemund; Lund/SELearning Objectives:1. To learn about the expectations from vascular diagnostic proceduresin the diagnostic work-up.2. To become familiar with the expectations from vascular diagnosticprocedures in therapy planning and therapeutic procedures.3. To learn about the expectations from vascular diagnostic proceduresin the follow-up assessments.08:58A-205 Can non-invasive techniques as CTA and MRA replacecatheter angio for diagnostic work-up?L. van den Hauwe, M. Voormolen, T. van der Zijden, R. Salgado, J.W. Van Goethem,P.M. Parizel; Antwerp/BELearning Objectives:1. To become familiar with the diagnostic potential of CTA and MRA.2. To understand the current proved clinical indications where CTAand MRA can replace catheter angio.3. To learn about safety issues in non-invasive procedures.09:21A-206 Diagnostic catheter angiography is not dead: currentindications and advantages over the non-invasivetechniquesT. Engelhorn; Erlangen/DELearning Objectives:1. To learn about the current indications for diagnostic catheterangiography.2. To become familiar with complication rates of selective catheterangiography in high volume centers.3. To appreciate some technical innovations for diagnostic catheterangiography.Panel discussion:09:44 The pros and cons of diagnostic catheter angiography inneuroimaging08:30–10:00 Room CNew Horizons SessionNH 8 MR/PET:a marriage made in heaven or hell?08:30A-207 Chairman‘s introductionB. Hamm; Berlin/DESession Objectives:1. To introduce the potential of this new imaging modality.2. To appreciate a new opportunity for cooperation between radiologyand nuclear medicine.08:33A-208 MR/PET in neuroimaging: nuclear medicineO. Sabri; Leipzig/DELearning Objectives:1. To learn about what we are able to do now.2. To understand the nuclear aspect of neuroimaging.3. To learn about the possibilities and limitations of neuroimaging.08:51A-209 MR/PET in neuroimaging: radiologyB.R. Rosen; Charlestown, MA/USLearning Objectives:1. To demonstrate the value of this hybrid technique.2. To understand the radiological aspect of neuroimaging.3. To learn about the possibilities and limitations of neuroimaging.09:09A-210 MR/PET in oncologic imaging: nuclear medicineO. Ratib; Geneva/CHLearning Objectives:1. To learn about what we are able to do now.2. To understand the nuclear aspect of oncologic imaging.3. To learn about the possibilities and limitations of oncologic imaging.09:27A-211 MR/PET in oncologic imaging: radiologyH.-P. Schlemmer; Heidelberg/DELearning Objectives:1. To demonstrate the value of this hybrid technique.2. To become familiar with the radiologic aspect of oncologic imaging.3. To learn about possibilities and limitations of oncologic imaging.Panel discussion:09:45 What benefits and risks should we expect in terms of basicresearch, clinical service, and economics?08:30–10:00 Room D1CLICK (Clinical Lessons for Imaging CoreKnowledge): Never without ArteriesCC 818 How old are you in reality? Vascularage and clinical eventsModerator: L. Lonn; Copenhagen/DK08:30A-212 A. Clinical considerationsE. Minar; Vienna/ATLearning Objectives:1. To learn about the frequency and importance of vascular diseases.2. To become familiar with clinical risk stratification strategies.3. To learn about the possibility of reducing cardiovascular risk.A-201 – A-212Saturday175

Postgraduate Educational ProgrammeA-213 – A-22409:00A-213 B. Imaging techniques and typical findingsH.J. Lamb; Leiden/NLLearning Objectives:1. To learn about the imaging modalities used for the assessment ofcardiovascular risk.2. To learn how to select the right test for the right patient.3. To become familiar with the newest innovations and newestguidelines in non-invasive cardiovascular risk assessment.09:30A-214 C. Interactive case discussion: how to deal with theresults?A. van der Lugt; Rotterdam/NLLearning Objectives:1. To understand the strength of non-invasive risk stratification inproperly selected patient populations.2. To consolidate knowledge of the selection of the appropriateimaging technique, image interpretation and image-based treatmentrecommendation.3. To learn about the risks of the inappropriate use of such riskstratification tests (Ca-scoring) in symptomatic patients.2. To become familiar with alternative imaging modalities such as US,DSA and MR.3. To learn about typical and atypical imaging findings.09:00A-220 B. Chest and abdomenM. Scaglione; Castel Volturno/ITLearning Objectives:1. To become familiar with the most important imaging findings andtheir impact on patient management.2. To understand common classification systems, trauma scoringsystems and their impact on patient management.3. To learn about typical and atypical imaging findings.09:20A-221 C. ExtremitiesU. Linsenmaier, L.L. Geyer; Munich/DELearning Objectives:1. To become familiar with imaging strategies, the role of CR, CT andMR.2. To understand common classification systems and their impact onpatient management.3. To learn about typical and atypical imaging findings.08:30–10:00 Room D2Oncologic Imaging: Follow-up ofSystemic and Local TherapiesCC 819 Imaging after systemic therapies:advanced techniquesModerator: D.-M. Koh; Sutton, Surrey/UK08:30A-215 A. What can we expect from biomarkersB. Van Beers; Clichy/FRLearning Objectives:1. To become familiar with biomarkers.2. To consolidate knowledge of various biomarkers and their utility.09:00A-216 B. MRI biomarkers: from acquisition to post-processingO. Lucidarme, M. Wagner, C. Pellot Barakat, F. Frouin; Paris/FRLearning Objectives:1. To become familiar with MRI biomarkers.2. To learn about tips and tricks for MRI biomarker evaluation.09:30A-217 C. Assessing the precision and accuracy of biomarkerimaging: is it reproducible?C.B. Sirlin; San Diego, CA/USLearning Objectives:1. To understand imaging biomarker precision (repeatability andreproducibility) and accuracy and how it is evaluated.2. To understand how to interpret biomarker precision and accuracy inthe context of the biomarker‘s intended use.08:30–10:00 Room E1Emergency RadiologyRC 817 Polytrauma: redefining imaging issuesfor management priorities08:30A-218 Chairman‘s introduction: advanced imaging, logistics andmanagement priorities in patients after polytraumaH. Alkadhi; Zurich/CH08:40A-219 A. Vascular traumaG. Schueller; Bülach/CHLearning Objectives:1. To become familiar with the use of dedicated MDCT protocols,classification of vascular injuries and treatment options.Panel discussion:09:40 How to speed up your diagnoses?08:30–10:00 Room E2Foundation Course: NeuroimagingE³ 820b Metabolic and neurodegenerativedisordersModerator: S. Lehéricy; Paris/FR08:30A-222 A. DementiaB. Gómez-Ansón; Barcelona/ESLearning Objectives:1. To understand when and why you should image dementia.2. To become familiar with the imaging findings of the most commonprimary degenerative and secondary vascular dementias.3. To understand how to recognise normal pressure hydrocephalus asan underlying cause of subcortical dementia.09:00A-223 B. Movement disordersT.A. Yousry; London/UKLearning Objectives:1. To learn the typical imaging findings, their anatomic substrate andthe limitations of conventional MRI.2. To understand the contribution of advanced imaging techniques suchas DTI, SWI and high field imaging as well as quantitative MR postprocessingtechniques.3. To understand the role of MR in the diagnosis and differentialdiagnosis of movement disorders.09:30A-224 C. Metabolic disordersJ.F. Schneider; Basle/CHLearning Objectives:1. To become familiar with the imaging findings of the most importantinnate metabolic defects affecting CNS.2. To learn how to recognise patterns of gray and white matterinvolvement.3. To learn about specific discriminating imaging findings.176

Postgraduate Educational Programme08:30–10:00 Room F1BreastRC 802Clinical challenges in breast MRI08:30A-225 Chairman‘s introductionF.J. Gilbert; Cambridge/UK08:35A-226 A. High risk patients: establishing clinical protocolsJ. Veltman; Almelo/NLLearning Objectives:1. To become familiar with the literature on the role of breast MRI inscreening of high risk patients.2. To understand current protocols in clinical practice.3. To appreciate the challenges of breast MRI imaging in this patientgroup.08:58A-227 B. Non-mass like enhancement (NMLE): when to biopsy?C.K. Kuhl; Aachen/DELearning Objectives:1. To learn about the clinical significance of NMLE.2. To understand differential diagnosis for NMLE.3. To become familiar with a work-up algorithm of NMLE cases.09:21A-228 C. Monitoring response to neo-adjuvant chemotherapyT.H. Helbich; Vienna/ATLearning Objectives:1. To understand the clinical aspects of neo-adjuvant chemotherapy.2. To appreciate evidence-based protocols for imaging in this clinicalsetting.3. To learn about particular imaging challenges of assessing response toneo-adjuvant chemotherapy.Panel discussion:09:44 How can the specificity and sensitivity of breast MRI in theseindeterminate clinical and imaging scenarios be maximised?08:30–10:00 Room F2Special Focus SessionSF 8b GI imaging: technological advancesand clinical applications08:30A-229 Chairman‘s introductionS.A. Jackson; Plymouth/UKSession Objectives:1. To review the significant recent advances in GI imaging.2. To understand the place of these advances in the clinical imaging ofpatients.3. To summarise the future directions of GI radiology in the 21stcentury.08:35A-230 CEUS of the bowel wall: when and howF. Maccioni; Rome/ITLearning Objectives:1. To review the relevant clinical indications for CEUS of the bowel.2. To learn how to optimally perform a CEUS examination of the bowelwall.3. To appreciate important findings in patients with IBD and learn howto evaluate inflammatory activityof the bowel wall.08:58A-231 Dual-energy (spectral) CT: GI applicationsP. Rogalla; Toronto, ON/CALearning Objectives:1. To review the concept and technique of dual-energy CT.2. To understand the clinical application of dual-energy CT in GIimaging.3. To appreciate the additional benefits of the technique in routineclinico-radiological practice.09:21A-232 MR imaging of GI tract motilityS.A. Taylor; London/UKLearning Objectives:1. To learn about the MRI protocols that can best assess bowel motility.2. To understand the various software approaches to quantifying bowelmotility.3. To become familiar with how motility MRI can be used in clinicalpractice.Panel discussion:09:44 When should we integrate these technological advances intoour routine practice?08:30–10:00 Room G/HEFOMP WorkshopNew technology in diagnostic radiology:new frontiers in imaging of the lungEF 1 Lung and chest imaging: newapproachesModerators: P. Sharp; Aberdeen/UK, W.J.M. van der Putten; Galway/IE08:30A-233 Welcome addressJ.I. Bilbao 1 , P. Sharp 2 ; 1 Pamplona/ES, 2 Aberdeen/UK08:40A-234 Radiologist’s point of view: clinical and technicalrequirements for imaging of the lungH.-U. Kauczor; Heidelberg/DELearning Objectives:1. To comprehend the new approaches towards functional andmolecular lung imaging.2. To understand their potential in comprehensive and quantitative lungimaging.3. To become familiar with new applications of structural functionaland molecular imaging in lung disease.09:10A-235 Respiratory motion correction in lung imagingJ.A. Schnabel; Oxford/UKLearning Objectives:1. To comprehend the problem of motion corruption and difference inbreath holds in lung imaging.2. To become familiar with state-of-the-art motion correction methodsin single- and multi-modality lung imaging.3. To understand the concept of modelling complex sliding motion ofthe lungs.09:35A-236 Role of tomosynthesis in lung imagingM. Båth; Gothenburg/SELearning Objectives:1. To understand the technical principles of chest tomosynthesis.2. To become familiar with the results of the latest clinical evaluations ofchest tomosynthesis.A-225 – A-236Saturday177

Postgraduate Educational ProgrammeA-237 – A-24808:30–10:00 Room I/KChestRC 804Patterns in chest radiology: are theresubtype patterns of ground glassopacity (GGO)?08:30A-237 Chairman‘s introductionA. Oikonomou; Alexandroupolis/GRSession Objectives:1. To learn about the prevalence and low specificity of GGO.2. To appreciate the need for definition of GGO subtypes to improveradiological diagnoses.08:35A-238 A. Ground glass opacification: why do we see it and whatdoes it mean?S.R. Desai; London/UKLearning Objectives:1. To appreciate the different physiological conditions which causeGGO pattern.2. To learn about the associations and reversibility of physiology-relatedGGO.08:58A-239 B. Inflammatory and infectious GGOK. Marten-Engelke; Göttingen/DELearning Objectives:1. To learn more about the inflammatory conditions which cause GGO.2. To appreciate the histopathological correlates of inflammatory andinfectious GGO.3. To become familiar with GGO in autoimmune and infectious lungdisease.09:21A-240 C. GGO in dysplasia and neoplasiaG.R. Ferretti, S. Lantuejoul; Grenoble/FRLearning Objectives:1. To learn more about the dysplastic and neoplastic conditions causingGGO.2. To appreciate the histopathological correlates of dysplastic andneoplastic GGO.3. To understand how to estimate malignancy on the basis of GGOpattern.Panel discussion:09:44 How should we report and manage ground glass opacity?08:30–10:00 Room L/MVascularRC 815How I reportModerator: D. Bilecen; Basle/CH08:30A-241 A. CTA and MRA of supra-aortic arteriesJ.H. Gillard; Cambridge/UKLearning Objectives:1. To learn about a structured reporting approach to angiographicstudies of supra-aortic arteries.2. To understand the role of post-processing techniques andquantitative analysis of arterial stenosis.3. To be able to answer specific clinical questions about supra-aorticarterial occlusive diseases.09:00A-242 B. CTA and MRA of thoracic and abdominal aortaH.J. Michaely; Mannheim/DELearning Objectives:1. To learn about a structured reporting approach to aneurysmal andobstructive diseases.2. To learn the classifications of aneurysmatic aortic diseases.3. To understand the role of post-processing techniques in aorticdiseases.4. To be able to answer specific clinical questions about aortic diseases.09:30A-243 C. CTA and MRA of peripheral arteriesT. Leiner; Utrecht/NLLearning Objectives:1. To learn about a structured reporting approach to peripheral arterialobstructive diseases.2. To understand the importance of quantitative analysis of peripheralarterial obstructions and how to report these analyses.3. To be able to answer specific clinical questions about peripheralarterial diseases.08:30–10:00 Room N/OInterventional RadiologyRC 809 What should every radiologist knowabout the endovascular treatment ofabdominal aortic aneurysms?08:30A-244 Chairman‘s introductionH. Rousseau, J. Auriol, C. Lions, F. Mokrane; Toulouse/FR08:35A-245 A. Pre-therapeutic radiological evaluationJ. Raupach, O. Renc, P. Hoffmann, J. Zizka; Hradec Kralove/CZLearning Objectives:1. To learn about the best pretreatment imaging modality.2. To understand planning and sizing of appropriate stent-graft.3. To become familiar with critical criteria and vessel morphology.08:58A-246 B. EVAR techniques and resultsF. Fanelli; Rome/ITLearning Objectives:1. To understand indications and contraindications for EVAR.2. To know more about advantages of different types of stent-graft.3. To become familiar with percutaneous vascular access.4. To learn about the latest trials.09:21A-247 C. Imaging follow-up and treatment of complicationsR. Morgan; London/UKLearning Objectives:1. To learn about available imaging methods for follow-up.2. To become familiar with complications and failure of EVAR.3. To understand how to treat endoleaks.Panel discussion:09:44 What are the best imaging methods for follow-up?08:30–10:00 Room PCardiacRC 803Practical approach to cardiovascularrisk stratification with CT and MRIModerator: C. Peebles; Southampton/UK08:30A-248 A. Modern views on value of coronary calcium scoring forrisk assessmentA. Stadler; Vienna/ATLearning Objectives:1. To understand what kind of information calcium scoring can deliverand the appropriate indications.2. To become familiar with its role in an asymptomatic and in asymptomatic population.3. To learn about the current data and guidelines supporting its use forassessment of cardiac risk.178

Postgraduate Educational Programme09:00A-249 B. Coronary CTA: from detection of stenosis to prognosisN.R. Mollet 1 , F. Cademartiri 2 ; 1 Turnhout/BE, 2 Rotterdam/NLLearning Objectives:1. To understand the accuracy of CTA in the diagnosis of coronarydisease.2. To become familiar with the strengths and limitations of the variousquantification techniques.3. To appreciate the prognostic value of CTA in coronary disease.09:30A-250 C. Myocardial perfusion and viability for risk scoringA. de Roos; Leiden/NLLearning Objectives:1. To become familiar with the current status of CT and MRI forevaluation of myocardial perfusion and viability.2. To understand the accuracy of myocardial perfusion in identifyingischaemia and its role in risk assessment.3. To learn the prognostic value of viability imaging in ichaemic heartdisease.08:30–10:00 Room QPaediatricRC 812 Imaging the paediatric spineModerator: C.J. Kellenberger; Zurich/CH08:30A-251 A. Craniocervical junction abnormalitiesB. Ozgen Mocan; Ankara/TRLearning Objectives:1. To learn about normal cervical junction development and anatomy.2. To understand congenital cervical junction anomalies.3. To appreciate acquired cervical junction pathology.09:00A-252 B. Inflammation, infection and tumours: the role ofimagingM.I. Argyropoulou; Ioannina/GRLearning Objectives:1. To learn about the etiologies and the imaging findings of infectious,para-infectious and autoimmune disorders.2. To appreciate the role of spinal MRI in the differential diagnosis ofmultiple sclerosis vs its mimics.3. To become familiar with the imaging findings of primary andmetastatic tumours.4. To learn about the indications of whole spine MRI with presence ofbrain tumours.09:30A-253 C. Imaging spinal trauma in childhoodM. Maas; Amsterdam/NLLearning Objectives:1. To understand how best to investigate suspected spinal trauma in achild.2. To appreciate the imaging findings.3. To consolidate knowledge about the differences between paediatricand adult spinal trauma.10:30–12:00 Room AInteractive Teaching SessionE³ 920a Tips and tricks in chest imaging10:30A-254 A. Plain radiographyJ. Cáceres; Barcelona/ESLearning Objectives:1. To become familiar with useful signs in the diagnosis of chestdisorders in the chest radiograph.2. To learn about common pitfalls in plain radiography of the chest.3. To understand the mechanisms that cause errors in imageinterpretation of chest radiographs.11:15A-255 B. CTJ. Vilar; Valencia/ESLearning Objectives:1. To become familiar with useful signs in the diagnosis of chestdisorders in CT.2. To learn about common pitfalls in CT of the chest.3. To understand the mechanisms that cause errors in imageinterpretation of chest CT.10:25–12:00 Room BESR meets South AfricaEM 3 Imaging HIV and TBWelcome by the ESR President:G.P. Krestin; Rotterdam/NLPresiding:J.I. Bilbao; Pamplona/ESC. Sperryn; Cape Town/ZA10:30A-256 IntroductionC. Sperryn; Cape Town/ZASession Objectives:1. To learn about cerebrovascular disease in HIV infected patients inSouth Africa.2. To understand the pathogenesis of TB meningitis and its implicationsfor treatment.3. To become familiar with the MR imaging of spinal TB in childrenand possible differential diagnoses.4. To consolidate knowledge of chest radiograph reporting in HIVinfectedchildren.5. To appreciate South Africa, the country, its diversity and how itsradiologists are trained.10:35A-257 HIV-related cerebrovascular disease: the South AfricanexperienceV. Mngomezulu; Johannesburg/ZALearning Objectives:1. To learn about the clinical and imaging spectrum of cerebrovasculardisease in HIV infected patients in South Africa.2. To appreciate the role of other co-factors in the pathogenesis of HIVrelated cerebrovascular disease.3. To become familiar with the challenges and technical strategies in themedical and interventional management of these conditions.10:50A-258 Interlude: Radiology training in South AfricaZ. Lockhat; Pretoria/ZA10:55A-259 New concepts in the pathogenesis of cerebral TBP. Janse van Rensburg, R. Hewlett; Stellenbosch/ZALearning Objectives:1. To learn more about the morphological spectrum of tuberculousmeningoencephalitis as shown on contrast MRI.2. To understand the pathogenesis of TBM and its implications fordisease progression and treatment.3. To appreciate the importance of imaging-pathologic correlation.4. To become familiar with imaging of TBM.5. To consolidate knowledge of neurotuberculosis.11:10A-260 Interlude: South Africa: the country, its people, itsdiversity and its attractionsZ. Lockhat; Pretoria/ZA11:15A-261 Spinal tuberculosis in childrenT. Kilborn; Cape Town/ZALearning Objectives:1. To learn about the spectrum of tuberculous infection of the spine inchildren namely; intramedullary spinal tuberculomas, tuberculousspondylitis and rarely tuberculous epidural abscess.A-249 – A-261Saturday179

Postgraduate Educational ProgrammeA-262 – A-2702. To appreciate the incidence of tuberculous arachnoiditis andtuberculomas in patients presenting with tuberculous meningitis andits implications for management.3. To become familiar with MR imaging of spinal TB and possibledifferential diagnoses.4. To discuss the role of ultrasound and CT in the imaging algorithm.5. To understand the importance of accurate and timely radiologicaldiagnosis for guiding management.11:30A-262 Chronic chest radiographic changes in a cohort of HIVinfectedSouth African childrenR. Pitcher, C. Lombard, M. Cotton, S. Beningfield, H. Zar; Cape Town/ZALearning Objectives:1. To learn about the level of chronic chest radiographic changesencountered in HIV-infected children who do not have access toHAART.2. To better understand the clinical and immunological correlates ofchest radiographic changes in HAART-naïve HIV-infected children.3. To appreciatea. the burden of paediatric pulmonary disease on resource-limitedhealthcare environment with a high prevalence of paediatric HIVinfection.b. the impact of HAART on chest radiographic changes in HIV-infectedchildren.c. the importance of the early initiation of HAART in HIV-infectedchildren.d. the challenges to healthcare delivery in a resource-limited healthcareenvironment.4. To become familiar with standardised chest radiographic reportingtechniques utilised for research in paediatric pulmonary radiology.5. To consolidate knowledge of paediatric chest radiograph reporting,with particular emphasis on:i. The impact of technical factorsii. The importance of standardised terminologyiii. Paediatric-specific normal variantsiv. Useful chest radiographic signsPanel discussion:11:45 HIV and TB: What impact do they have on health care workers?10:30–12:00 Room E2Foundation Course: NeuroimagingE³ 920b Tumours and phacomatosisModerator: N. Girard; Marseille/FR10:30A-263 A. Brain tumoursM.M. Thurnher; Vienna/ATLearning Objectives:1. To learn about the imaging findings and the limitations ofconventional MRI in the evaluation of brain tumours.2. To become familiar with new MRI techniques available for advancedbrain tumour imaging.3. To learn about the potential of ‚functional imaging‘ (fMRI, PET,SPECT) in tumour characterisation, treatment decisions, and followup.11:00A-264 B. Tumours of the spinal cordJ. Van Goethem, C. Venstermans, F. De Belder, L. van den Hauwe, P. Parizel;Antwerp/BELearning Objectives:1. To become familiar with the imaging findings of primary andmetastatic tumours of the spinal cord.2. To be able to recognise metastatic disease in the extradural, epidural,subdural and paraspinal compartments.3. To learn how best to use imaging and create the appropriate protocol.11:30A-265 C. PhacomatosisM.A. Papathanasiou; Athens/GRLearning Objectives:1. To learn how and when you should image.2. To consolidate knowledge about conventional neuroimaging findingsof the more common phacomatoses.3. To be informed of the possible applications of advancedneuroimaging techniques.18010:30–12:00 Room G/HPhysics in RadiologyEFOMP WorkshopNew technology in diagnostic radiology:new frontiers in imaging of the lungEF 2 Lung imaging: multidisciplinaryscenarioModerators: A. Torresin; Milan/IT, J.N. Vassileva; Sofia/BG10:30A-266 Pulmonary nodule detection using CADA. Retico; Pisa/ITLearning Objectives:1. To comprehend the basic steps to design a CAD system for lungnodule detection in CT scans.2. To be aware of the possible usage of CAD as second reader in theclinical practice.3. To understand how the impact of CAD on the reader sensitivity isevaluated.10:50A-267 Optimisation in lung imaging of childrenC. Owens; London/UKLearning Objectives:1. To understand the importance of a dynamic team approach tooptimisation of local CT techniques in all hospitals.2. To appreciate the iterative nature and concept of sharing protocolsacross sites.3. To become familiar with the techniques, tips and tricks to perform ‚aslow as reasonably achievable‘ CT imaging that is ‚fit for purpose‘.4. To consolidate knowledge of low dose acquisition of CT imagesand post-processing techniques to optimise images using images toillustrate.11:10A-268 Lung imaging: developments in role of PETM.-E. Meyer, P. Bailly, J. Daouk; Amiens/FRLearning Objectives:1. To learn about respiratory motion management in PET acquisitions.2. To understand techniques of respiratory motion compensation or fullmotion correction to prevent inappropriate attenuation correctionand errors in quantification.3. To consolidate knowledge of adaptive treatment and advancedfollow-up: optimisation of radiotherapy planning.11:35A-269 Lung imaging: developments in role of MRJ.M. Wild; Sheffield/UKLearning Objectives:1. To comprehend the basic MR physics of imaging protons andhyperpolarised gases in the lungs.2. To understand the techniques that are in use in clinical lung andpulmonary vascular MRI.3. To become familiar with established and future clinical applicationsof MRI in lung and pulmonary vascular disease.10:30–12:00 Room L/MStandards and Audit SessionAssessment of radiologists‘ professionalperformanceModerator: E.J. Adam; London/UK10:30A-270 Radiologists‘ performance: assessment using peer reviewG. Boland; Wellesley, MA/USLearning Objectives:1. To comprehend the importance of peer review to education, clinicalcare, research, best practices and cost.2. To understand how to implement an effective peer review program.3. To become familiar with the differing peer review tools includingelectronic decision support.

Postgraduate Educational Programme11:00A-271 Radiologists‘ individual performance: use of standardisedtest imagesA.G. Gale; Loughborough/UKLearning Objectives:1. To understand the use of standardised test sets.2. To comprehend the advantages and limitations of using test sets tomeasure the radiological performance.11:30A-272 Radiologists‘ performance: referrers‘ viewJ.M.L. Bosmans; Gent/BELearning Objectives:1. To become familiar with the views and expectatations of referringclinicians concerning communication with the radiologist and morespecifically regarding the radiology report.2. To understand the different needs of particular subgroups ofreferrers.3. To become familiar with the views and expectations of referrersregarding structured reporting and its potential effect on productivityand training.12:15–12:45 Room APlenary SessionHL 2 Wilhelm Conrad Röntgen HonoraryLecturePresiding: J.I. Bilbao; Pamplona/ES12:15A-273 Interventional oncology: the era of molecular targetedtherapyJ.-F. Geschwind; Baltimore, MD/USLearning Objectives:1. To learn about basic principles of cancer biology.2. To understand the importance of tumour metabolism and recogniseits role in cancer growth.3. To appreciate the growing impact of image-guided therapies forcancer.12:30–13:30 Room N/OThe Beauty of Basic Knowledge:Head and NeckMC 24C Main pipelines of the neck: pharynxand larynx12:30A-274 Main pipelines of the neck: pharynx and larynxM. Becker; Geneva/CHLearning Objectives:1. To become familiar with the anatomy of the pharynx and larynx.2. To learn how to choose and tailor imaging techniques according toclinical presentation.3. To appreciate the most common pathologies affecting thesestructures.4. To be able to provide a useful differential diagnosis of pharyngeal andlaryngeal lesions.12:30–13:30 Room PThe Beauty of Basic Knowledge:Musculoskeletal ImagingMC 25C Inflammatory/infectious disorders12:30A-275 Inflammatory/infectious disordersV.N. Cassar-Pullicino; Oswestry/UKLearning Objectives:1. To understand the pathophysiology of inflammatory conditions ofthe musculoskeletal system.2. To learn about the basic imaging criteria for the diagnosis of arthritis,osteomyelitis, and spondylitis.3. To become familiar with the differential diagnosis of the mostcommon inflammatory diseases.14:00–15:30 Room BEFRS meets SpainEM 5 Knowledge development as a toolfor radiographers’ professionalimprovementPresiding: G. Paulo; Coimbra/PT, C. Ruiz Blanco; Madrid/ES14:00A-284 IntroductionG. Paulo 1 , C. Ruiz Blanco 2 ; 1 Coimbra/PT, 2 Madrid/ESSession Objectives:1. To understand Spanish radiographers‘ education and professionalstatus and its comparison with other European countries.2. To learn about the role of radiographer within the framework of theSpanish health system.3. To learn about areas of professional development for radiographersin Spain.14:05A-285 The Spanish radiographer‘s role in advanced MRI researchE. Alfayate Sáez; Madrid/ESLearning Objectives:1. To understand the role of radiographer in a MRI research centre.2. To understand the daily activity in a MRI research center and thecontinuous professional development related to it.3. To learn about the potential areas of research development in MRI.14:23A-286 The radiographer‘s specialisation in ultrasound: twodecades of experience in a public hospitalM.P. Peña Fernández; Getafe/ESLearning Objectives:1. To understand the role of the radiographer in ultrasound.2. To learn about inter-professional relations in ultrasound.3. To appreciate the advantages of a radiographer in ultrasound forradiology department outcomes and for the quality of patient care.14:41A-287 Interlude: Radiology and Spanish artC. Ruiz Blanco; Madrid/ES14:46A-288 The radiographer as the interface between patient andtechnology in promoting safety in radiation protectionJ.A. Soria Jerez; Madrid/ESLearning Objectives:1. To learn how to enhance patient safety in radiation protection.2. To learn about radiographers‘ role in optimising procedures.3. To understand the continuous professional developmentrequirements needed to maintain high standards in patient safety.A-271 – A-288Saturday181

Postgraduate Educational ProgrammeA-289 – A-30615:04A-289 Educational status of radiographers in Spain: comparisonwith the EUM.R. Soto García; Barcelona/ESLearning Objectives:1. To understand the Spanish radiography education model.2. To learn about the limitations of Spanish education on freemovement on professionals in Europe.3. To learn about solutions for education-model development regardingprofessional harmonisation.Panel discussion:15:22 Could a transnational and multi-professional combinedstatement contribute to professional development?16:00 -17:30 Room A16:00–17:30 Room AInteractive Teaching SessionE³ 1120 Breast cancer16:00A-296 A. DetectionC.S. Balleyguier; Villejuif/FRLearning Objectives:1. To understand the respective role of each imaging technique in thediagnosis of breast cancer.2. To learn about common pitfalls in the diagnosis of breast cancer.16:45A-297 B. Follow-upG. Forrai; Budapest/HULearning Objectives:1. To understand the common features of recurrent breast cancer.2. To learn how to establish imaging follow-up protocols or breastcancer.16:00–17:30 Room BState of the Art SymposiumSA 11 Evaluation of response inhaematological malignancy16:00A-298 Chairman‘s introductionE. de Kerviler; Paris/FRSession Objectives:1. To become reacquainted with the standard criteria for therapeuticresponse in myeloma and lymphoma.2. To demonstrate the role of CT, MRI and PET in the assessment oftherapeutic response.3. To show that functional imaging is now essential for patientevaluation at baseline and follow-up.4. To consider future imaging biomarkers in the assessment of response.16:05A-299 Opportunities and limitations of PET, CT and MRI answering thehaematologist‘s questionsT.C. Kwee; Utrecht/NLLearning Objectives:1. To learn the various imaging features of lymphoma.2. To learn the advantages and limitations of CT, PET, and MRI in theevaluation of lymphoma.3. To understand the importance of and opportunities provided by(new) functional imaging methods for staging and follow-up oflymphoma.16:28A-300 Evaluation of response in multiple myelomaJ. Hillengass; Heidelberg/DELearning Objectives:1. To understand the pathophysiologic mechanisms of multiplemyeloma.2. To be able to compare the significance of imaging and serologicalmarkers for response evaluation in myeloma.3. To assess the significance of the depth of response to systemictreatment.16:51A-301 Evaluation of response in lymphoma with PET/CTS.F. Barrington; London/UKLearning Objectives:1. To understand the role of interim PET/CT in the evaluation ofmetabolic response to lymphoma.2. To become aware of proposed reporting criteria developed forassessment of interim PET/CT.3. To get an overview of current clinical trials exploring the role ofresponse adapted therapy according to PET/CT.Panel discussion:17:14 Is it time for biomarker response criteria in haematologicalmalignancies?16:00–17:30 Room CUrogenital ImagingCC 1121 Stones: diagnosis and interventionModerator: N.C. Cowan; Oxford/UK16:00A-302 A. Imaging patients with renal colicG. Heinz-Peer; St. Pölten/ATLearning Objectives:1. To learn about imaging approaches to patients with renal colic.2. To become familiar with the strengths and limitations of variousimaging techniques.3. To learn about the management of patients with renal colic.16:20A-303 B. Percutaneous treatment of renal stonesS. Moussa; Edinburgh/UKLearning Objectives:1. To appreciate the importance of imaging, stone selection andplanning for percutaneous nephron-lithotomy (PCNL).2. To become familiar with the technical aspects and differentapproaches to PCNL.3. To appreciate the importance of recognising and avoidingcomplications.16:40A-304 C. Intervention in ureteral obstruction and ureteral traumaA. Magnusson; Uppsala/SELearning Objectives:1. To learn how to manage a patient with ureteral obstruction.2. To understand when and how to treat a patient with ureteral trauma.3. To learn more about how to perform a nephrostomy.17:00A-305 D. Interactive case discussionN.C. Cowan; Birmingham/UK16:00–17:30 Room D1CLICK (Clinical Lessons for Imaging CoreKnowledge): Never without ArteriesCC 1118StrokeModerator: M.M. Thurnher; Vienna/AT16:00A-306 A. Clinical considerationsP.M. Parizel, P. Cras, T. Menovsky, T. Van der Zijden, M. Voormolen; Antwerp/BELearning Objectives:1. To become familiar with the frequency and causes of stroke.2. To learn about the most important risk factors and predisposingdiseases.3. To learn about the importance of imaging for treatment decisionmakingand planning.182

Postgraduate Educational Programme16:30A-307 B. Imaging techniques and typical findingsJ. Vymazal; Prague/CZLearning Objectives:1. To learn about state-of-the art imaging in cases of suspected stroke.2. To discuss potential pros and cons of using MR and CT.3. To become familiar with most recent innovations in stroke imaging.17:00A-308 C. Interactive case discussion: what is next after diffusionand perfusion?A. Dörfler; Erlangen/DELearning Objectives:1. To become familiar with typical cases demonstrating the crucialrole of imaging modalities in the diagnosis and treatment decisionmakingin ischaemic stroke.2. To consolidate knowledge of the selection of the appropriateimaging technique, image interpretation and image based treatmentrecommendation.3. To learn about the importance of imaging for treatment decisionsand planning.16:00–17:30 Room D2Head and NeckRC 1108 Skull base lesions: imaging studiesand differential diagnosisModerator: L. Grzycka-Kowalczyk; Lublin/PL16:00A-309 A. Anterior cranial fossa with special emphasis onolfactory apparatus lesionsT.P.J. Duprez; Brussels/BELearning Objectives:1. To learn the imaging techniques of the anterior skull base with anemphasis on the olfactory apparatus.2. To become familiar with the imaging findings.3. To understand how to differentiate between lesions in the anteriorskull base.16:30A-310 B. Middle cranial fossa pathologiesA. Borges; Lisbon/PTLearning Objectives:1. To become familiar with imaging strategies for the middle cranialfossa.2. To know more about imaging findings of common lesions.3. To learn how to differentiate between the lesions in middle cranialfossa.17:00A-311 C. Posterior cranial fossa pathologiesH. Tanghe; Rotterdam/NLLearning Objectives:1. To learn the imaging techniques in the posterior cranial fossa.2. To become familiar with the imaging findings of common posteriorcranial fossa pathologies.3. To understand how to differentiate between the lesions in theposterior cranial fossa.16:00–17:30 Room E1MusculoskeletalRC 1110 The knee16:00A-312 Chairman‘s introductionF.M.H.M. Vanhoenacker; Antwerp/BE16:05A-313 A. Patterns of injuryP. Van Dyck; Antwerp/BELearning Objectives:1. To know more about the imaging appearances of soft tissue andosteoarticular injury.2. To become familiar with the patterns of bone and soft tissue injury inthe knee.16:28A-314 B. Inflammatory diseaseA. Cotten; Lille/FRLearning Objectives:1. To know more about the imaging appearances of soft tissue andosteoarticular inflammation.2. To become familiar with imaging findings of specific inflammatoryconditions.16:51A-315 C. Soft tissue tumours/tumour-like lesionsJ.C. Vilanova; Girona/ESLearning Objectives:1. To know more about the spectrum of intra and para-articular softtissue tumours, and soft tissue tumour-like lesions.2. To become familiar with US and MRI findings of specific soft tissuelesions.Panel discussion:17:14 What are the remaining clinical questions that imagingcurrently cannot answer and how can we answer them in thefuture?16:00–17:30 Room E2Multidisciplinary Session: ManagingPatients with CancerMS 11 Cholangiocarcinoma16:00A-316 Chairman‘s introductionB. Hamm; Berlin/DESession Objectives:1. To learn about state-of-the-art diagnosis of cholangiocarcinoma.2. To understand the value of surgical and systemic strategies in therapy.3. To appreciate image-guided interventional treatment.16:05A-317 Surgery of hilar and extrahepatic cholangiocarcinomaP. Neuhaus; Berlin/DELearning Objectives:1. To become familiar with prognosis depending on the evolution ofsurgical approach.2. To become familiar with surgical decision making: left/right liverresection, hilar resection, pancreatic head resection.3. To become familiar with technique of extended righthemihepatectomy.4. To become familiar with liver function, volume.5. To become familiar with biliary decompression left/right, internal/external.A-307 – A-317Saturday183

Postgraduate Educational ProgrammeA-318 – A-32916:20A-318 Radiology - diagnostics and portal vein embolisation inhilar and extrahepatic cholangiocarcinomaT. Denecke; Berlin/DELearning Objectives:1. To learn about diagnosis/differential diagnosis.2. To learn about surgical planning through imaging: bile ducts,vascular system, hyperplasia induction, liver function testing.16:35A-319 Medical treatment of cholangiocarcinomasH. Riess; Berlin/DELearning Objectives:1. To become familiar with chemotherapy of extrahepaticcholangiocarcinoma.2. To become familiar with treatment concepts for intrahepaticcholangiocarcinomas.3. To become familiar with systemic vs. intra-arterial chemotherapy.16:50A-320 Radiology - diagnostics and image guided therapies inintrahepatic cholangiocarcinomasB. Gebauer; Berlin/DELearning Objectives:1. To learn about image guided therapy decisions.2. To learn about local ablation in non-surgical candidates (RFA, CTbrachytherapy).3. To learn about intra-arterial port implantation.4. To learn about transarterial radioembolisation.17:05 Case presentation (part 1): hilar cholangiocarcinoma17:17 Case presentation (part 2): CCC multimodal treatment16:00–17:30 Room F1Special Focus SessionSF 11 Adults with congenital heart disease(GUCH)16:00A-321 Chairman‘s introduction: Why should a radiologist gatherinformation on GUCH patients?M. Gutberlet; Leipzig/DESession Objectives:1. To learn about the increasing number of GUCH patients.2. To appreciate the importance of lifelong imaging follow-ups.3. To become familiar with the need for specialised GUCH centres.16:05A-322 A list of typical surgical procedures: the top ten in GUCHM. Hübler, D. Hitendu, M. Schweiger, M. Greutmann; Zurich/CHLearning Objectives:1. To become familiar with the most common surgical procedures incongenital heart disease (CHD).2. To know more about the typical postoperative problems in GUCHpatients.3. To learn about how imaging can help the cardiac surgeon.16:30A-323 ‚Adults are not just big children‘: differences betweenchildren and adultsA.M. Taylor; London/UKLearning Objectives:1. To understand the age dependency in the selection of imagingmodalities.2. To learn about radiation exposure issues in GUCH patients.3. To understand what the difference between imaging of children andadults.16:55A-324 Which modality, for which patient? MRI or CT, that‘s thequestionJ. Bremerich; Basle/CHLearning Objectives:1. To learn about the pros and cons of different imaging modalities forGUCH patients.2. To become familiar with imaging of the most common entities inGUCH.3. To consolidate knowledge of imaging protocols after surgicalcorrection of CHD.Panel discussion:17:20 Can we now get all the information we need to treat GUCHpatients, non-invasively?16:00–17:30 Room F2Professional Challenges SessionPC 11 Personalised radiology16:00A-325 Chairman‘s introductionG.P. Krestin; Rotterdam/NLSession Objectives:1. To understand the concept of personalised radiology.2. To get an overview of the role of imaging in personalised medicine.3. To learn about the concept of personalised medicine andpersonalised healthcare.16:06A-326 Personalised medicine: hope or hype?O. Golubnitschaja; Bonn/DELearning Objectives:1. To understand the definition of personalised medicine.2. To learn about some of the successful examples of personalisedhealthcare.3. To understand the present limitations in adapting personalisedmedicine.16:22A-327 Imaging for disease predictionM. Vernooij; Rotterdam/NLLearning Objectives:1. To learn about population imaging.2. To become familiar with the role of imaging in disease prediction.3. To understand the need for validated imaging biomarkers.16:38A-328 Molecular imaging: a solution for personalised diagnosisand treatment?F.M.A. Kiessling; Aachen/DELearning Objectives:1. To become familiar with the role of molecular imaging for diseaselocalisation and characterisation, patient selection to therapy andtherapy monitoring.2. To learn about individualised image-guided drug delivery systems.3. To understand the concept of theranostics: the combination oftargeted imaging and targeted therapy.16:54A-329 Role of imaging in personalised therapy monitoringA.R. Padhani; Northwood/UKLearning Objectives:1. To become familiar with the general role of imaging in treatmentmonitoring and drug development.2. To understand the requirements of imaging biomarker developmentfor treatment monitoring in personalised medicine.3. To understand how to develop the evidence base so that imagingbiomarkers can be used for personalised therapeutic approaches.Panel discussion:17:10 Is imaging providing an added value to the ‚omics‘ ofpersonalised medicine?184

Postgraduate Educational Programme16:00–17:30 Room G/HNeuroRC 1111Brain tumours: advanced imagingtechniques in daily practice -do we really need them?Moderator: Z. Merhemic; Sarajevo/BA16:00A-330 A. Diffusion-weighted imaging (DWI) and diffusion tensorimaging (DTI)M. Law; Los Angeles, CA/USLearning Objectives:1. To appreciate DWI in the characterisation of focal brain lesions.2. To understand how to differentiate between tumoural and nontumouraldisease using DWI.3. To consolidate knowledge on how to combine DWI with otheradvanced MRI tools.4. To find out if DTI is really useful in the clinical setting or merely amathematical algorithm of the tensor.16:30A-331 B. Perfusion imagingY. Özsunar; Aydin/TRLearning Objectives:1. To appreciate the value of perfusion imaging.2. To understand why perfusion imaging is needed.3. To become familiar with principles, applications, and pitfalls ofvarious perfusion imaging techniques.4. To consolidate knowledge of perfusion imaging of various brainmasses that can be encountered in daily practice.17:00A-332 C. Follow-up after treatmentP.C. Maly Sundgren; Lund/SELearning Objectives:1. To understand the present traditional model for the follow-up andmonitoring of brain tumour treatment.2. To become familiar with different imaging biomarkers for earlyassessment of brain tumour treatment response.3. To consolidate presently available knowledge and ideas on braintumour imaging follow-up for future brain tumour treatment andmonitoring of response.16:00–17:30 Room I/KChestRC 1104Pulmonary infections:the old and the newModerator: F. Gleeson; Oxford/UK16:00A-333 A. Mycobacterial infectionsC. Beigelman; Lausanne/CHLearning Objectives:1. To appreciate the imaging features of primary and post-primaryinfections in TB.2. To learn about the similarities and differences between TB and non-TB mycobacterial infections.3. To understand the radiologist‘s role in diagnosis.16:30A-334 B. Infectious disease in immuno-compromised patientsC.-P. Heussel; Heidelberg/DELearning Objectives:1. To appreciate the various types of immuno-deficiencies and theirrelated infections.2. To become familiar with the role of the radiologist in immunocompromisedpatients.3. To learn how to follow pulmonary infections in immunocompromisedpatients.17:00A-335 C. Emerging infectionsT. Franquet; Barcelona/ESLearning Objectives:1. To learn more about emerging infections.2. To become familiar with radiological patterns and conditions whichsuggest viral infections.3. To learn how to improve diagnostic accuracy.16:00–17:30 Room L/MPhysics in RadiologyRC 1113 Cone-beam imagingModerators: O. Ciraj-Bjelac; Belgrade/RS, A. Trianni; Udine/IT16:00A-336 A. Fundamentals of cone-beam imagingM. Kachelrieß; Heidelberg/DELearning Objectives:1. To understand the principles of volumetric image formation with flatdetectors.2. To understand the difference between CBCT and MSCT.3. To learn about reconstruction techniques and image processing.4. To become acquainted with the important image quality parameters.16:30A-337 B. Medical applications of CB imagingM. Grass; Hamburg/DELearning Objectives:1. To become acquainted with the applications of CB imaging.2. To learn about systems design and parameters.3. To understand image quality characteristics.4. To learn how to use cone beam images in image guided interventions.17:00A-338 C. 3D dentomaxillofacial imagingK. Horner; Manchester/UKLearning Objectives:1. To become acquainted with CBCT systems for dentomaxillofacialimaging.2. To learn about image quality characteristics and patient dosecompared to other techniques.3. To learn how to access CB images and influence the clinical outcome.16:00–17:30 Room N/OInterventional RadiologyRC 1109 Update on biliary interventions16:00A-339 Chairman‘s introductionM. Krokidis 1 , A.A. Hatzidakis 2 ; 1 Cambridge/UK, 2 Iraklion/GRSession Objective:1. To review the various interventional techniques for the treatment ofcomplex biliary diseases.16:05A-340 A. Fistula and benign stenosisM. Bezzi; Rome/ITLearning Objectives:1. To know about the etiology of fistulas and benign stenoses.2. To become familiar with the various imaging modalities and findingsin benign fistulas and stenoses.3. To understand the techniques, results, and complications ofinterventional treatments.A-330 – A-340Saturday185

Postgraduate Educational ProgrammeA-341 – A-34516:28A-341 B. Interventions after liver transplantationP.P. Goffette; Brussels/BELearning Objectives:1. To know about the appropriate imaging algorithm for the detectionof biliary complications after liver transplantation.2. To become familiar with the techniques of interventional treatmentof biliary complications after liver transplantion.3. To understand the results and complications in comparison withsurgical management.16:51A-342 C. In tandem with endoscopyD.F. Martin; Manchester/UKLearning Objectives:1. To be aware of the indications for tandem use of percutaneous andendoscopic approach.2. To learn the tips and tricks of tandem technique.3. To learn about the results and complications of tandem treatment.Panel discussion:17:14 Are there new possibilities in the area of biliary interventions?16:00–17:30 Room PRadiographersRC 1114 Hot topics in magnetic resonanceimagingModerators: K. Haller; Wiener Neustadt/AT, L. Martí-Bonmatí; Valencia/ES16:00A-343 A. New trends in MR safetyP. Bauer; Vienna/ATLearning Objectives:1. To become familiar with the standard MRI safety measures (metalcheck and SAR limits).2. To understand the new challenges for MRI safety given thetechnological advances in high-field magnets, faster gradients coils,hybrid MR imaging and new contrast agents.3. To learn about updated MRI safety guidelines with reference torecent literature, white papers and accredited MRI safety websites.4. To appreciate the MRI safety implications for pregnant women,neonates and the general paediatric population.16:30A-344 B. MR spectroscopy: the role of radiographers in dataoptimisationJ. McNulty; Dublin/IELearning Objectives:1. To learn about the basic principles of MR spectroscopy contrastingthem to the basic principles of MR imaging.2. To understand the benefits of using MRS in clinical practice.3. To appreciate how image quality is defined in MRS, to highlight theparameters which affect image quality in MRS and how these can bemodified by the radiographer.4. To become familiar with examples of common MRS artefacts andhow these can be corrected by the radiographer.17:00A-345 C. Challenges and opportunities in paediatric MRV. Syrgiamiotis; Athens/GRLearning Objectives:1. To learn about the basic anatomical/physiological differences withinthe paediatric population, contrasting it with the general adultpopulation.2. To understand the MRI scan parameter modifications required toaccommodate these differences and their trade-offs.3. To become familiar with examples of improved, optimised imagingprotocols against standard, preset, commercially available adultimaging protocols.4. To consolidate knowledge on the optimal use of equipment to achievea successful and clinically useful paediatric MRI exam.186

Postgraduate Educational Programme08:30–10:00 Room AInteractive Teaching SessionE³ 1220 Pitfalls in brain imaging08:30A-346 A. CTL. van den Hauwe 1 , S. Pugliese 2 , J.W. Van Goethem 1 , C. Venstermans 1 , F. De Belder 1 ,T. van der Zijden 1 , M. Voormolen 1 , P.M. Parizel 1 ; 1 Antwerp/BE, 2 Rome/ITLearning Objectives:1. To learn about common pitfalls in CT evaluation of the brain.2. To become familiar with anatomical variants, potentially mimickingdisease.09:15A-347 B. MRIM. Essig; Erlangen/DELearning Objectives:1. To learn about common pitfalls in MRI evaluation of the brain.2. To become familiar with anatomical variants, potentially mimickingdisease.08:30–10:00 Room BGI TractRC 1201How I reportModerator: G.A. Rollandi; Genoa/IT08:30A-348 A. MDCT in the post-operative abdomenD.J.M. Tolan; Leeds/UKLearning Objectives:1. To become familiar with an optimised MDCT protocol for thedetection of post-operative complications.2. To learn the normal post-operative appearance of common surgicalmaterial including mesh, packing and sutures.3. To understand the expected findings of peritoneal air, fluid and boweldilatation in the immediate post operative course.4. To learn the most common causes of clinical deterioration in thepost-operative state and their imaging findings.09:00A-349 B. MDCT in a patient with small bowel ischaemiaS. Romano; Naples/ITLearning Objectives:1. To understand the patho-physiologic mechanism leading to arterial,venous or low-flow state vascular injury.2. To learn how to differentiate different stages of disease from earlypotentially transient ischaemia to late infarction.3. To become familiar with reperfusion damage of the intestine.4. To understand the accuracy of the various radiological signs of bowelischaemia.09:30A-350 C. MDCT in a patient with small bowel obstructionP. Taourel; Montpellier/FRLearning Objectives:1. To understand a simple classification for the causes of bowelobstruction.2. To become familiar with CT protocols.3. To learn a structured approach to the reporting of CT.4. To understand the accuracy of the various radiological signs of bowelobstruction.08:30–10:00 Room CUrogenital ImagingCC 1221 Retroperitoneal anatomy, variants anddiseasesModerator: U.G. Mueller-Lisse; Munich/DE08:30A-351 A. Retroperitoneal anatomy: an embryology basedapproachF.M. Danza; Rome/ITLearning Objectives:1. To understand the development of the retroperitoneum duringthe embryo development, introducing the concept of a uniquesubperitoneal space.2. To understand the importance of fascial planes in determining thepattern of diffusion of diseases.3. To apply these new concepts signs during routine diagnostic work.08:50A-352 B. Anatomical variants and benign diseasesS. Merran; Paris/FRLearning Objectives:1. To learn about the most important variants of retroperitoneal vesselsand about renal anomalies.2. To understand the role of radiology in patients with retroperitonealfibrosis and infections.3. To become familiar with benign retroperitoneal tumours and learnabout the clues for differential diagnosis.09:10A-353 C. Malignant tumoursR.H. Oyen, F. Claus, D. Hompes, L. De Wever; Leuven/BELearning Objectives:1. To learn about the spectrum of malignant retroperitoneal neoplasms.2. To understand the role of preoperative cytology/histology by needleaspiration/biopsy.3. To learn about the predictors for survival after resection ofretroperitoneal sarcoma.09:30A-354 D. Interactive case discussionU.G. Mueller-Lisse; Munich/DE08:30–10:00 Room D1CLICK (Clinical Lessons for Imaging CoreKnowledge): Never without ArteriesCC 1218 Chest pain: vascular non-cardiaccausesModerator: E. Brountzos; Athens/GR08:30A-355 A. Clinical considerationsR. Iezzi; Rome/ITLearning Objectives:1. To become familiar with clinical diagnostic algorithms in cases ofnon-cardiac acute chest pain.2. To learn about the constituents of acute aortic syndrome.3. To become familiar with prognosis, treatment and outcome and learnabout the influence of imaging on treatment decisions in acute chestpain.09:00A-356 B. Imaging techniques and typical findingsF. Wolf; Vienna/ATLearning Objectives:1. To learn about state-of-the-art CT angiographic imaging in acutechest pain (after ruling out MI).2. To become familiar with the techniques and advantages of ECGgating in CT angiographies of acute chest pain.3. To discuss the potential role of additional MR angiography.A-346 – A-356Sunday187

Postgraduate Educational ProgrammeA-357 – A-36809:30A-357 C. Interactive case discussion: what is really important?T.R.C. Johnson; Munich/DELearning Objectives:1. To become familiar with typical cases illustrating the role of imagingmodalities in the diagnosis and differential diagnosis of acute chestpain.2. To consolidate knowledge of the selection of the appropriateimaging technique, image interpretation and image based treatmentrecommendation.3. To understand the most important information urgently needed fortreatment decisions and planning.08:30–10:00 Room D2Oncologic Imaging: Follow-up of Systemicand Local TherapiesCC 1219 Assessing HCC responseModerator: R. Lencioni; Pisa/IT08:30A-358 A. Systemic therapiesV. Vilgrain, M. Ronot, M. Zappa, S. Faivre, E. Raymond; Clichy/FRLearning Objectives:1. To learn about difficulties in HCC assessment with local therapy.2. To become familiar with various evaluation criteria of HCC.09:00A-359 B. Endovascular therapiesR. Salem; Chicago, IL/USLearning Objectives:1. To appreciate the value of different imaging techniques forassessment of intra-arterial therapies of HCC.2. To become familiar with post-treatment imaging after intra-arterialtherapies according to type of therapy.09:30A-360 C. Ablative therapiesC. Ayuso; Barcelona/ESLearning Objectives:1. To learn about the value of different imaging techniques for theassessment of ablative therapies of HCC.2. To become familiar with post-treatment imaging after ablativetherapies according to type of therapy.08:30–10:00 Room E1MusculoskeletalRC 1210 Overuse injuries in sport: amultimodality approachModerator: E. Llopis; Valencia/ES08:30A-361 A. Overuse injuries in the footballer‘s ankleS.J. Eustace; Dublin/IELearning Objectives:1. To learn the spectrum of overuse injuries sustained by footballers atthe ankle joint.2. To understand the mechanisms by which these injuries occur.3. To become familiar with the imaging findings seen in overuseinjuries at the ankle.09:00A-362 B. Overuse injuries in the gymnast‘s spineM.C. De Jonge; Amsterdam/NLLearning Objectives:1. To become familiar with the types of chronic injuries seen in thegymnast‘s spine.2. To understand the strengths and weaknesses of different imagingmodalities for imaging these injuries.09:30A-363 C. Upper limb overuse injuries in golfersP.J. O‘Connor; Leeds/UKLearning Objectives:1. To understand the types and mechanisms of overuse injuries seen inthe upper limb in golfers.2. To understand the advantages and disadvantages of different imagingmodalities.3. To become familiar with the imaging findings seen in overuseinjuries of the upper limb.08:30–10:00 Room E2NeuroRC 1211Stroke: is the prognosis gettingany better?08:30A-364 Chairman‘s introductionJ.-P. Pruvo; Lille/FR08:35A-365 A. Initial imaging work-up: CT or MR?P.M. Parizel, T. Van der Zijden, F. De Belder, C. Venstermans, L. van den Hauwe, R.Salgado, J. Van Goethem, M. Voormolen; Antwerp/BELearning Objectives:1. To become familiar with a comprehensive imaging protocol inpatients with suspected stroke.2. To know the advantages and disadvantages of CT and MR in theinitial work-up of stroke patients.3. To recognise the different imaging patterns in stroke.08:58A-366 B. Stroke: is there really any therapy?V. Mendes Pereira, K.-O. Lovblad; Geneva/CHLearning Objectives:1. To learn the natural evolution of untreated stroke.2. To understand the advantages and disadvantages of the differenttherapeutic options in stroke patients.3. To recognise imaging patterns that may determine therapy in strokepatients.09:21A-367 C. Stenting: does it prevent stroke?P. Vilela; Almada/PTLearning Objectives:1. To understand the natural history of extracranial and intracranialcarotid and vertebral artery atherosclerotic and non-atheroscleroticdiseases.2. To become familiar with the endovascular treatment indications ofextracranial and intracranial arterial disorders.3. To understand the endovascular treatment strategies aimed at strokeprevention.4. To recognise the present and future challenges for PTA and stentingof extracranial and intracranial arteries.Panel discussion:09:44 What is the future of stroke prevention and treatment?08:30–10:00 Room F1Special Focus SessionSF 12 Quantitative imaging biomarkers incardiac radiology08:30A-368 Chairman‘s introductionA. van der Lugt; Rotterdam/NLSession Objectives:1. To appreciate the increasing role of imaging biomarkers inradiological research and clinical practice.2. To understand the importance of quantification and standardisationof imaging biomarkers.3. To become familiar with the spectrum of quantitative imagingbiomarkers in cardiac radiology188

Postgraduate Educational Programme08:33A-369 Imaging biomarkersJ.-P. Vallée; Geneva/CHLearning Objectives:1. To understand the concept of imaging biomarkers.2. To learn about the different types of biomarkers (anatomical/functional/molecular).3. To understand the different applications of imaging biomarkers(detection, prediction, response).4. To learn about the standardisation and validation of imagingbiomarkers.08:45A-370 Imaging biomarkers for myocardial functionJ. Bogaert; Leuven/BELearning Objectives:To become familiar with the quantitative imaging biomarkers of:1) cardiac mass (MRI/CT)2) ventricular volume (MRI/CT)3) ventricular function (MRI/CT)09:05A-371 Imaging biomarkers of myocardial viabilityP. Croisille; Saint-Etienne/FRLearning Objectives:To become familiar with the quantitative imaging biomarkers of:1) infarct size using delayed enhancement (MRI/CT)2) areas at risk in myocardial infarction using T2w MRI3) cardiac contractility using cine or tag MRI after low dosedobutamine challenge09:25A-372 Imaging biomarkers of myocardial ischaemiaL. Natale; Rome/ITLearning Objectives:To become familiar with the quantitative imaging biomarkers of:1) myocardial perfusion (MRI/CT),2) cardiac contraction after high dose dobutamine challenge (MRI)3) coronary atherosclerosis (CT)Panel discussion:09:45 How should we implement quantitative biomarkers in clinicalpractice?08:30–10:00 Room F2BreastRC 1202Multi-modality breast imaging08:30A-373 Chairman‘s introductionM. Lesaru; Bucharest/RO08:35A-374 A. Conventional, functional and interventional lymph nodeassessmentP.D. Britton; Cambridge/UKLearning Objectives:1. To learn about normal lymph node morphology.2. To understand criteria suggestive of morphological abnormality.3. To become familiar with factors affecting overall sensitivity of preoperativelymph node assessment.08:58A-375 B. Multi-modality assessment of the breast followingoncoplastic surgeryM. Torres-Tabanera, S. Perez-Rodrigo; Madrid/ESLearning Objectives:1. To learn about the range of oncoplastic breast procedures in currentclinical practice.2. To become familiar with imaging features resulting from oncoplasticsurgery.3. To appreciate the potential pitfalls encountered while imaging suchcases.09:21A-376 C. Image guided therapy in breast lesions: indications andtechniquesG. Manenti, G. Simonetti; Rome/ITLearning Objectives:1. To understand indications for therapeutic interventions in malignantand benign lesions.2. To learn about current image guided therapeutic techniques inmalignant and benign lesions.3. To appreciate possible future developments of therapeuticinterventions.Panel discussion:09:44 How is the evolution of multi-modality breast imagingchanging the nature of the multi-disciplinary meeting (MDM)?08:30–10:00 Room G/HGenitourinaryRC 1207 How I reportModerator: G.M. Villeirs; Gent/BE08:30A-377 A. Female pelvis MRIA.G. Rockall; London/UKLearning Objectives:1. To learn a structured reporting approach to MR imaging.2. To learn a structured reporting approach to uterine and cervicalcancer staging.3. To learn a structured reporting approach to adnexal masses.09:00A-378 B. Prostate MRIJ.J. Fütterer; Nijmegen/NLLearning Objectives:1. To learn a structured reporting approach to MR imaging.2. To learn the most essential points and details to be reported inprostate cancer patients.3. To understand the major weaknesses of a prostate MR report.09:30A-379 C. CT urographyN.C. Cowan; Birmingham/UKLearning Objectives:1. To learn how to read and report CT urography.2. To understand how to optimise CT urography for haematuria andurothelial cancer.3. To report specimen cases and self-assess your own performance.08:30–10:00 Room I/KChestRC 1204 Lung cancer staging in 201308:30A-380 Chairman‘s introduction: the latest TNM classificationJ. Biederer; Heidelberg/DE08:35A-381 A. Local tumour stagingL. Bonomo; Rome/ITLearning Objectives:1. To learn about the T staging of lung cancer.2. To become familiar with the current state of the different imagingtechnique to assess the T stage.3. To appreciate limitations and pitfalls.A-369 – A-381Sunday189

Postgraduate Educational ProgrammeA-382 – A-39308:58A-382 B. Lymph node stagingW.F.M. De Wever; Leuven/BELearning Objectives:1. To learn about N staging in lung cancer.2. To learn the current state of endobronchial ultrasound forintrathoracic intervention.3. To become familiar with limitations and pitfalls.09:21A-383 C. Distant metastasis and whole body imagingG. Antoch; Düsseldorf/DELearning Objectives:1. To appreciate the role of PET/CT and whole-body MRI.2. To learn about the sensitivity and specificity.3. To become familiar with the role of imaging in early responseevaluation and in follow-up.Panel discussion:09:44 Facts and controversies in lung cancer staging08:30–10:00 Room L/MPhysics in RadiologyRC 1213 Risk assessment and riskcommunication08:30A-384 Chairmen‘s introductionM.M. Rehani 1 , P. Vock 2 ; 1 Vienna/AT, 2 Berne/CHSession Objectives:1. To learn about risk, risk estimation, risk perception andcommunication.2. To become familiar with radiation risk: past and present.3. To appreciate why we need to inform patients and the public aboutthe risks and how.4. To understand what referring doctors should know about risk.08:35A-385 A. Radiation risks for patients and staffE. Vaño; Madrid/ESLearning Objectives:1. To get the latest information on stochastic risks in radiology.2. To understand the risks for children compared to adults.3. To get the latest information on tissue reaction to medicalprocedures.4. To learn about radiation cataract and its dose dependence.08:58A-386 B. Risk in MRIR.R. Peeters; Leuven/BELearning Objectives:1. To learn about the risks for patients from MRI procedures.2. To be informed about the contraindications for MRI scan.3. To learn about risks for staff in an MRI department.09:21A-387 C. Communication of risk to patients and publicG. Gamhewage; Geneva/CHLearning Objectives:1. To become familiar with communicating risk according to theimaging modality.2. To become familiar with important rules in communication.3. To understand the relationship between threat/hazard and perceptionof parents regarding imaging for their child.4. To learn how to select an appropriate risk communications strategysuited to parents and children.Panel discussion:09:44 How to communicate risk to patients and the public?08:30–10:00 Room N/OInterventional RadiologyRC 1209 Gynaecological and obstetricalhaemorrhagic emergencies08:30A-388 Chairman‘s introductionA.-M. Belli; London/UK08:35A-389 A. Etiology and treatment of gynaecological benign andmalignant causes of massive bleedingA. Keeling; Dublin/IELearning Objectives:1. To know more about causes of massive bleeding due togynaecological disorders.2. To learn about diagnostic imaging and therapeutic embolisation.3. To review published results obtained through embolisation.08:58A-390 B. Can we prevent post-partum haemorrhage in high-riskpatients?J.-P. Pelage; Caen/FRLearning Objectives:1. To learn how to identify a high-risk patient.2. To become familiar with preventive measures and medication.3. To know more about techniques for invasive prevention.4. To learn about the results obtained through preventive techniques.09:21A-391 C. Treatment of post-partum haemorrhageM. Szczerbo-Trojanowska; Lublin/PLLearning Objectives:1. To learn about clinical evaluation of post-partum haemorrhage.2. To become familiar with relevant anatomy.3. To understand catheterisation and embolisation techniques.4. To become familiar with results of embolisation.Panel discussion:09:44 How to reduce the radiation doses of these methods?08:30–10:00 Room PRadiographersRC 1214 Dose optimisation in computedtomographyModerators: G. Frija; Paris/FR, D. Pekarovic; Ljubljana/SI08:30A-392 A. Innovations in dose optimisationS. Foley; Dublin/IELearning Objectives:1. To consolidate knowledge in the area.2. To become familiar with recent developments based on scannerdesign features and to be aware of the evidence base that supportsthese developments.3. To become familiar with recent developments based on non-scannerbased approaches such as shielding and to be aware of the evidencebase that supports these approaches.4. To learn more about the potential for future developments in thearea.09:15A-393 B. Developing patient specific examination protocolsH. Precht; Odense/DKLearning Objectives:1. To understand the importance of employing patient specificexamination protocols in computed tomography by exploring thebenefits of such protocols.2. To understand the categories of patients for which specificallytailored protocols must always be employed.190

Postgraduate Educational Programme3. To appreciate the potential impact of patient specific protocols onimage quality and patient dose through the use of sample cases.4. To discover a simple framework which could assist radiographersin introducing patient specific examination protocols to theirdepartments.08:30–10:00 Room QPaediatricRC 1212 Oncologic imaging: how to image,follow up and report08:30A-394 Chairman‘s introductionD. Roebuck; London/UK08:35A-395 A. Renal and adrenal tumours in childrenA.M.J.B. Smets; Amsterdam/NLLearning Objectives:1. To appreciate the role of US, CT, MRI and scintigraphy.2. To become familiar with the imaging findings and the maindifferential diagnoses.3. To learn about the imaging strategies for diagnosis and staging.08:58A-396 B. Paediatric liver malignanciesD. Roebuck; London/UKLearning Objectives:1. To understand the role of US, CT and MRI.2. To become familiar with the imaging findings and the maindifferential diagnoses.3. To learn the imaging strategies for diagnosis and in staging.09:21A-397 C. Oncologic imaging in the paediatric brainG. Hahn; Dresden/DELearning Objectives:1. To understand the role of CT, MRI and MRS.2. To become familiar with the imaging findings and the maindifferential diagnoses.3. To learn about the imaging findings of post-chemo/radiation therapyconditions and complications.Panel discussion:09:44 How far should the radiologist go in suggesting tumourrecurrence or post-treatment complications?08:30–10:00 Room ZProfessional Challenges SessionPC 12 Legal matters related tomultimodality techniques08:30A-398 Chairman‘s introductionK. Åhlström Riklund; Umea/SESession Objectives:1. To learn about legal matters in multimodality imaging in differentparts of Europe, in radiology and nuclear medicine.2. To understand the challenges in hybrid imaging, with respect to bothradiology and nuclear medicine.3. To consolidate knowledge of the situation in different parts ofEurope.08:35A-399 Radiological legal matters in eastern EuropeM. Studniarek; Gdansk/PLLearning Objectives:1. To learn about legal matters in multimodality imaging in easternEurope.2. To understand the specific role and diagnostic applications of PET/CT imaging as a result of national guidelines in eastern Europe, withthe example of Poland.3. To consolidate knowledge of the limits of the application ofdiagnostic CT in PET/CT units in radiology and nuclear medicineprocedures listed (officially identified) in Poland.08:53A-400 Legal matters in nuclear medicineG.K. von Schulthess; Zurich/CHLearning Objectives:1. To understand issues facing tracer development and clinical use oftracers.2. To understand the process of getting new tracers approved for clinicaluse.3. To understand the process of getting reimbursement for integratedimaging procedures.09:11A-401 Legal matters in ScandinaviaK. Åhlström Riklund; Umeå/SELearning Objectives:1. To learn about the educational situation in multimodality imaging innorthern Europe.2. To learn about national guidelines for multimodality imaging innorthern Europe.3. To learn what you need to run a PET/CT and cyclotron facility innorthern Europe.09:29A-402 International, regional, national and local frameworkrequirementsA. Perkins; Nottingham/UKLearning Objectives:1. To learn about the origin of the radiation protection framework.2. To appreciate the framework for radiation protection at international,regional and national levels.3. To understand the responsibilities of different parties within theworking environment.Panel discussion:09:47 A discussion with questions from the audience about thedifferences across Europe10:30–12:00 Room BESR meets ChileEM 4 Topics of ongoing radiological researchfrom the AndesWelcome by the ESR President:G.P. Krestin; Rotterdam/NLPresiding:J.I. Bilbao; Pamplona/ESM.A. Pinochet; Santiago/CL10:30A-403 Introduction: Radiology in Chile: reality and challengesP. Soffia; M.A. Pinochet Santiago/CLSession Objectives:1. To learn about some interesting recent and ongoing Chileanradiological research projects in the field of diagnostic imaging.2. To get a glimpse of unique radiological and non-radiological topicsin Chile.10:35A-404 TI-RADS: a US classification of thyroid nodules related tocancer riskE. Horvath; Santiago/CLLearning Objectives:1. To learn about an ultrasonographic-based pattern classification thatenables a cancer risk approach to an accurate selection of thyroidnodules that require fine needle aspiration biopsy (FNAB).2. To understand the description of the 10 US pattern for thyroidnodule classification.3. To correctly classify the pattern into the TIRADS categories.4. To learn how to determine those patterns most closely related withmalignancy.A-394 – A-404Sunday191

Postgraduate Educational ProgrammeA-405 – A-41710:55A-405 Interlude: Chile, land of geographical and culturalcontrastsG. Soto Giordani; Santiago/CL11:00A-406 Neuroimaging in epilepsy: in search of invisible lesionsM. Galvez; Santiago/CLLearning Objective:1. To learn about solutions to improve visualisation of epileptogeniclesions not visible on conventional MRI.11:20A-407 Interlude: Chile, land of wine and poetsG. Soto Giordani; Santiago/CL11:25A-408 MDCT patterns in mesenteric ischaemia: usefulness inpredicting clinical outcomeA. Huete; Santiago/CLLearning Objectives:1. To learn to identify the most frequent patterns of ischaemic bowelwall damage in patients with arterial mesenteric ischaemia usingMDCT angiography.2. To correlate patterns of bowel wall ischaemia on MDCT with clinicaloutcome.3. To identify secondary, non-specific findings of bowel ischaemia onMDCT that signal a potential adverse clinical course.Panel discussion:11:45 Creating networks between Latin American and Europeanradiology: a unique opportunity for collaborative researchprojects10:30–12:00 Room CUrogenital ImagingCC 1321 The female pelvisModerator: E. Sala; New York, NY/US10:30A-409 A. Imaging congenital anomalies of the female genitalsystemK. Kinkel; Chêne-Bougeries/CHLearning Objectives:1. To understand Mullerian duct anomalies through embryology and itsclassification.2. To learn about the indications of MRI or 3D US according to clinicaland sonographic findings.3. To understand imaging technique and report requirements and theimpact of imaging results on treatment options.10:50A-410 B. Benign ovarian massesR. Forstner; Salzburg/ATLearning Objectives:1. To become familiar with common and rare benign adnexal lesions.2. To appreciate the added value of CT and MRI in the differentialdiagnosis of benign adnexal masses.3. To learn about an algorithm for evaluating incidental adnexal masseswith imaging.11:10A-411 C. Imaging the infertile coupleJ. McHugo; Birmingham/UKLearning Objectives:1. To understand the incidence and causes of infertility in female andmale patients.2. To learn about cost-effective strategies for imaging in cases of femaleand male infertility.3. To understand the rationale for best outcomes.11:30A-412 D. Interactive case discussionE. Sala; New York, NY/US10:30–12:00 Room QRTF - Radiology Trainees ForumTF 1 Highlighted LecturesModerators: D. Bulja; Sarajevo/BA, V.H. Koen; Harleem/NL10:30A-413 Emergency radiology management in patients withpolytraumaU. Linsenmaier, L.L. Geyer, S. Wirth; Munich/DELearning Objectives:1. To understand the complex up to date radiological management ofpatients with polytrauma/multiple trauma.2. To become familiar with basic concepts, MDCT protocols and majorfindings in patients with polytrauma/multiple trauma.11:00A-414 Imaging of non-traumatic intracranial haemorrhageZ. Merhemic; Sarajevo/BALearning Objectives:1. To review different underlying pathologies of non-traumaticintracranial haemorrhage.2. To learn how to use CT/CTA, MRI/MRA, and DSA in patients withnon-traumatic intracranial haemorrhage.3. To discuss the value of T2* (GRE/SWI) in evaluation of causes ofintracranial haemorrhage.11:30A-415 Case-based learning in radiologyP. Pokieser; Vienna/ATLearning Objectives:1. To learn about the basics of case based learning.2. To understand the pedagogic potentials of „real world settings“.3. To become familiar with case based ESR learning facilities.12:15–12:45 Room APlenary SessionHL 3 Santiago Ramón y Cajal HonoraryLecturePresiding: J.I. Bilbao; Pamplona/ES12:15A-416 Research and science: from individuals to societies - theRamón y Cajal backgroundL. Martí-Bonmatí; Valencia/ESLearning Objectives:1. To learn about Santiago Ramón y Cajal, a Spanish histologist,neuroscientist, and Nobel laureate.2. To appreciate the change from individual research tomultidisciplinary working groups.3. To understand the concept of science and research, and howcommunication, grouping and socialisation do influence both.12:30–13:30 Room PThe Beauty of Basic Knowledge:Musculoskeletal ImagingMC 25D Neoplastic/non-neoplastic lesions12:30A-417 Neoplastic/non-neoplastic lesionsF.M.H.M. Vanhoenacker; Antwerp/Ghent/Mechelen/BELearning Objectives:1. To understand the basic principles of diagnosing bone and soft tissuetumours.2. To become familiar with the most important entities and their typicalimaging presentations.3. To learn about the specific advantages and weaknesses of the differentimaging modalities.192

Postgraduate Educational Programme12:30–13:30 Room QThe Beauty of Basic Knowledge:Head and NeckMC 24D The suprahyoid neck: anatomy anddiagnostic algorithm of the neck mass12:30A-418 The suprahyoid neck: anatomy and diagnostic algorithmof the neck massA. Trojanowska; Lublin/PLLearning Objectives:1. To become familiar with the compartmental anatomy of thesuprahyoid neck.2. To understand the central role of the parapharyngeal space in thelocalisation of suprahyoid neck masses.3. To be able to localise and provide a useful differential diagnosis of aSHN mass.4. To learn the best imaging approach to the suprahyoid neck.14:00–15:30 Room AInteractive Teaching SessionE³ 1420 Common and uncommon errors in plainfilm and CT imaging of the chest: howto improve your performance14:00A-419 Common and uncommon errors in plain film and CTimaging of the chest: how to improve your performanceD. Tack 1 , N. Howarth 2 ; 1 Baudour/BE, 2 Chêne-Bougeries/CHLearning Objectives:1. To learn about the common reasons for errors in interpretation ofplain film and CT imaging.2. To understand how a side-by-side comparison of chest x-rays andMDCT of missed lesions can help reduce the busy radiologist‘s errorrate.3. To improve the skills required for accurate interpretation of plain filmand CT imaging of the chest.14:00–15:30 Room BNew Horizons SessionNH 14 Imaging of the mind14:00A-420 Chairman‘s introduction: New insights into the state ofconsciousness through neuroimagingS. Sunaert; Leuven/BESession Objectives:1. To become familiar with recent advances in functional brain imaging,and how these lead to ‚the imaging of consciousness‘ and ‚reading themind‘.2. To understand how imaging contributes to the study of the functionalconnectivity and network topology of the human brain.3. To understand how these new techniques and insight lead to (pre-)clinical applications.14:05A-421 Brain wiring: resting state fMRIF. Barkhof; Amsterdam/NLLearning Objectives:1. To understand the basics of resting-state fMRI.2. To become familiar with the organisation of intrinsic connections asdetected with resting state fMRI in the human brain.3. To consolidate the current knowledge of brain networks in aging anddementia, and pharmacology research.14:28A-422 fMRI in disorders of consciousness: diagnostic and legalchallengesC. Di Perri, S. Laureys; Liège/BELearning Objectives:1. To understand the role of structural MRI, DTI and spectroscopy insevere brain injury.2. To become familiar with the role of resting state and activation fMRIin diagnosis and prognosis after coma.3. To understand which fMRI paradigms are „consciousness tests“ incoma and related condition.14:51A-423 fMRI of cognitive functions: discriminating normal aging,minimal cognitive impairment and Alzheimer‘s diseaseA. Falini; Milan/ITLearning Objectives:1. To consolidate knowledge of dementia and Alzheimer’s diseaseclinically.2. To become familiar with common imaging features of dementia andAlzheimer’s disease.3. To appreciate the results from fMRI and DTI and other advancedneuroimaging techniques used in research of dementia andAlzheimer’s disease.Panel discussion:15:14 New insights into the state of consciousness throughneuroimaging. Where are we and where should we go?14:00–15:30 Room CUrogenital ImagingCC 1421 The male genital systemModerator: J.O. Barentsz; Nijmegen/NL14:00A-424 A. Imaging of prostate cancer: an updateJ.J. Fütterer; Nijmegen/NLLearning Objectives:1. To understand multiparametric MR imaging techniques.2. To learn how to interpret prostate MRIs.3. To understand the potential of new MRI developments.14:20A-425 B. Scrotal tumoursP.S. Sidhu; London/UKLearning Objectives:1. To understand the pathological types of primary and secondarytumours of the testis.2. To appreciate the US features of the various histological types oftesticular tumours.3. To appreciate the role of newer US imaging techniques, and the roleof further imaging.14:40A-426 C. The penisM. Bertolotto; Trieste/ITLearning Objectives:1. To learn about the most relevant penile diseases that can bediagnosed by imaging.2. To know the diagnostic roles of US, MRI and other imagingtechniques.3. To understand how imaging influences treatment and follow-up.15:00A-427 D. Interactive case discussionJ.O. Barentsz; Nijmegen/NLA-418 – A-427Sunday193

Postgraduate Educational ProgrammeA-428 – A-43914:00–15:30 Room D1CLICK (Clinical Lessons for Imaging CoreKnowledge): Never without ArteriesCC 1418 Angina, non-occlusive mesentericischaemia (NOMI) and friends: vascularcauses of acute abdomenModerator: O. Chan; London/UK14:00A-428 A. Clinical considerationsP. Rogalla; Toronto, ON/CALearning Objectives:1. To learn about the frequency and importance of the vascular causesof an acute abdomen.2. To learn about the differential diagnosis as well as the differentvascular causes of acute abdomen.3. To learn about prognosis, treatment and outcome of acute abdomencaused by vascular diseases.14:30A-429 B. Imaging techniques and typical findingsM. Prokop; Nijmegen/NLLearning Objectives:1. To learn about the importance of selecting the appropriate imagingtechnique in cases of acute abdomen to detect vascular causes.2. To become familiar with the typical imaging appearance of thedifferent vascular causes of acute abdomen and their most importantdifferential diagnosis.3. To become familiar with potential pitfalls and problems of identifyingvascular causes of acute abdomen.15:00A-430 C. Interactive case discussion: how to proceed?A. Palkó; Szeged/HULearning Objectives:1. To become familiar with typical cases, illustrating the role of imagingmodalities in the diagnosis and differential diagnosis of acuteabdomen.2. To consolidate knowledge of the selection of the appropriateimaging technique, image interpretation and image based treatmentrecommendation.3. To understand the most important information urgently needed fortreatment decisions and planning.14:00–15:30 Room D2Oncologic Imaging: Follow-up of Systemicand Local TherapiesCC 1419 Follow-up of thermal ablation (part I)Moderator: W. Prevoo; Amsterdam/NL14:00A-431 A. The zone of cell death and collateral phenomena oncross-sectional imaging: from histopathology to thestandardisation of termsA. Denys, P. Bize; Lausanne/CHLearning Objectives:1. To understand histopathologic changes after various ablationtechniques.2. To become familiar with post-ablation imaging based on histopathologiccorrelation of ablation zones in various organs.3. To learn about the adequate terms for reporting and publishing onpost-ablation imaging.14:30A-432 B. PET/CT for the evaluation of ablative therapy: Who?Where? When? Does it help?D. Deandreis; Villejuif/FRLearning Objectives:1. To understand who are the best candidates for a PET/CT follow-upof ablation therapies.2. To learn about what is the optimal timing of PET/CT in the followupof ablative therapies.15:00A-433 C. Everyday practice: MR and CT for evaluating responseto thermal ablationC. Dromain, C. Caramella, L. Vilcot, S. Bidault, F. Bidault, F. Deschamps; Villejuif/FRLearning Objectives:1. To become familiar with the imaging aspects of successful ablation.2. To learn about the main pitfalls of post-ablation imaging.3. To consolidate knowledge of the imaging aspects of most commoncomplications.14:00–15:30 Room E1MusculoskeletalRC 1410 How I reportModerator: M. Padrón; Madrid/ES14:00A-434 A. Soft tissue mass: US/MRC. van Rijswijk; Leiden/NLLearning Objectives:1. To become familiar with the strengths/weaknesses of US/MRI inassessing soft tissue tumours.2. To understand the US/MRI specific findings that aid diagnosis.3. To learn a structured approach to reporting.14:30A-435 B. MR of vertebral body collapseR. Lalam; Oswestry/UKLearning Objectives:1. To be able to differentiate benign from malignant causes.2. To learn about the changes of the vertebral body with time, diseaseprogression and therapy.3. To learn a structured reporting approach.15:00A-436 C. MR of the unstable shoulderM. Zanetti; Zurich/CHLearning Objectives:1. To learn about the specific imaging findings of instability.2. To become familiar with the different types of shoulder instability.3. To learn a structured approach to reporting.14:00–15:30 Room E2Oncologic ImagingRC 1416 The essentials of lymph node imagingof solid tumours: what the radiologistneeds to know14:00A-437 Chairman‘s introductionR.G.H. Beets-Tan; Maastricht/NL14:05A-438 A. The current criteria for nodal involvement on CT/MRIW. Schima; Vienna/ATLearning Objectives:1. To become familiar with current criteria.2. To learn about imaging features which are highly specific for nodaldisease.3. To understand the diagnostic performance of cross-sectionalimaging.14:28A-439 B. DWI MR: what does it contribute?H.C. Thoeny; Berne/CHLearning Objectives:1. To understand the principles of DWI of nodes.2. To recognise the imaging appearance of nodes on DWI MRI.3. To become familiar with studies evaluating the diagnosticperformance of DWI MRI.194

Postgraduate Educational Programme14:51A-440 C. Nuclear medicine: PET and other nuclear medicinetechniquesP.L. Choyke; Bethesda, MD/USLearning Objectives:1. To learn which tumours are typically FDG-avid.2. To understand the factors that contribute to the diagnosticperformance of FDG-PET.3. To become familiar with other nuclear imaging techniques for lymphnode imaging.Panel discussion:15:14 When and how could imaging make diagnostic biopsyunnecessary?14:00–15:30 Room F1Special Focus SessionSF 14a Palliative interventional techniquesin cancer14:00A-441 Chairman‘s introductionK.A. Hausegger; Klagenfurt/ATSession Objectives:1. To learn about different palliative techniques in cancer.2. To understand when to indicate different palliative techniques.3. To become familiar with the limitations of palliative techniques.4. To learn when palliation does not help the patient.14:03A-442 Cementoplasty of lytic bone metastasisA. Gangi, J. Garnon, G. Tsoumakidou, I. Enescu; Strasbourg/FRLearning Objective:1. To learn about the indications, techniques, clinical results andcomplications of cementoplasty.14:21A-443 Pleural drainage, pleurodesisF. Gleeson; Oxford/UKLearning Objectives:1. To become familiar with the indication for drainage of malignantpleural effusion.2. To learn about the indications, technique and clinical results ofpleurodesis.14:39A-444 Percutaneous nephrostomy (PCN) and ureteral stentingF. Orsi; Milan/ITLearning Objectives:1. To become familiar with the indication for percutaneousnephrostomy in patients with malignant urinary obstruction.2. To learn about the technique, clinical results and complications ofPCN and antegrade ureteral stenting.14:57A-445 Biliary proceduresM. Krokidis 1 , A.A. Hatzidakis 2 ; 1 Cambridge/UK, 2 Iraklion/GRLearning Objectives:1. To become familiar with the indications for drainage in malignantbiliary obstruction.2. To learn about the technique, clinical results and complications ofpercutaneous cholangiography and biliary stenting.Panel discussion:15:15 How invasive can palliation be? When to say no to palliativetreatment?14:00–15:30 Room F2BreastRC 1402How I reportModerator: A. Tardivon; Paris/FR14:00A-446 A. MammographyE. Azavedo; Stockholm/SELearning Objectives:1. To become familiar with the basic parts of a structured report.2. To understand which information a clinician needs in a report of abreast cancer patient.3. To learn how to compose a report on a patient with a BI-RADS 3lesion.14:30A-447 B. Breast USJ. Camps Herrero; Valencia/ESLearning Objectives:1. To become familiar with BI-RADS categories of breast US.2. To learn how to integrate clinical information and radiologicalfindings.3. To learn how to compose a US report in a breast cancer patient.15:00A-448 C. Breast MRIR.M. Mann; Nijmegen/NLLearning Objectives:1. To understand how to integrate conventional (mammography andUS) findings in a breast MRI report.2. To learn how to include morphological and kinetic information andwhy this needs to be done thoroughly.3. To become familiar with the necessary skills to compose a report on abreast cancer patient (staging, follow-up, relapse, etc).14:00–15:30 Room G/HSpecial Focus SessionSF 14b Comprehensive CT cardiothoracicimaging: a new challenge forradiologists14:00A-449 Chairman‘s introductionL. Bonomo; Rome/ITSession Objectives:1. To understand the importance of looking at the heart on a CT scanof the chest.2. To learn how to optimise integrated cardiothoracic imaging with CT.3. To become familiar with the key imaging findings and learn how toreport.14:05A-450 How to optimise integrated cardiothoracic imaging withCTU.J. Schoepf; Charleston, SC/USLearning Objectives:1. To learn how to select CT protocols that enable assessment of theheart-lung axis with the lowest possible radiation dose.2. To become familiar with the ECG-synchronisation protocols forcardio-thoracic CT image acquisitions.3. To understand strategies for image post-processing and displaying forevaluating diseases affecting the heart-lung axis.A-440 – A-450Sunday195

Postgraduate Educational ProgrammeA-451 – A-46314:28A-451 Coronary artery imaging from a chest CT examination:when and howR. Marano; Rome/ITLearning Objectives:1. To become familiar with the main clinical indications that couldrequire assessment of the heart and coronary arteries in the course ofchest CT.2. To learn how to recognise the normal and abnormal appearance ofheart and coronary arteries commonly observed on chest CT.3. To learn about the acquisition protocol to couple chest CT with ECGgatedcardiac CT.14:51A-452 Cardiopulmonary functional imaging from a chest CTexamination: when and howE.J.R. van Beek; Edinburgh/UKLearning Objectives:1. To understand the feasibility of CT based cardiopulmonaryfunctional imaging.2. To be able to grasp clinical scenarios where cardiopulmonaryfunctional CT imaging may be helpful.3. To be able to set the use of CT within a larger framework of imagingmodalities.Panel discussion:14:14 Is a single CT scan technique and protocol feasible for all thecardiothoracic problems?14:00–15:30 Room I/KGenitourinaryRC 1407 Contrast media safety: update14:00A-453 Chairman‘s introductionP. Reimer; Karlsruhe/DESession Objectives:1. To discuss the safety steps to be taken before contrast administering.2. To present the newest safety guidelines.14:05A-454 A. Acute non-renal reactions to contrast media: newconceptsO. Clément; Paris/FRLearning Objectives:1. To understand what are allergic and non-allergic hypersensitivityreactions.2. To learn the clinical symptoms according to the Ring and Messmerclassification.3. To understand the importance of tryptase sampling and skin testingin the follow-up.14:28A-455 B. Nephrogenic systemic fibrosis: from pathophysiology torecommendationsH.S. Thomsen; Herlev/DKLearning Objectives:1. To understand the underlying pathophysiology.2. To learn about the clinical implications of the recentrecommendations/guidelines.3. To become familiar with legal issues.14:51A-456 C. Contrast medium-induced nephropathy and newguidelinesF. Stacul; Trieste/ITLearning Objectives:1. To become familiar with newest guidelines on contrast inducednephropathy (CIN).2. To understand the future clinical implications of the new guidelines.Panel discussion:15:14 What is the most appropriate radiological approach topatients with falling eGFR and when should contrast media beadministered and when should it not?14:00–15:30 Room L/MPhysics in RadiologyRC 1413 Hybrid imaging systemsModerators: D.G. Sutton; Dundee/UK, J. Votrubová; Prague/CZ14:00A-457 A. Clinical SPECT/CT and PET/CTT. Beyer; Zurich/CHLearning Objectives:1. To review the origins of SPECT/CT and PET/CT imaging systems.2. To understand the basic principles and general clinical applications.3. To speculate on trends in dual-modality PET- and SPECT-basedimaging technology.14:30A-458 B. Clinical MR/PETG. Antoch; Düsseldorf/DELearning Objectives:1. To become acquainted with the origins and evolution of MR/PET.2. To be informed of the current applications.15:00A-459 C. Preclinical hybrid imagingN. Belcari; Pisa/ITLearning Objectives:1. To learn about hybrid imaging tools in animal imaging/pre-clinicalresearch.2. To understand possible clinical applications.14:00–15:30 Room N/OHead and NeckRC 1408 Laryngeal cancer and radiology14:00A-460 Chairman‘s introductionJ.E. Kabala; Bristol/UKSession Objectives:1. To discuss the epidemiology.2. To learn about the available diagnostic imaging modalities.3. To become familiar with the available treatment options.14:05A-461 A. Staging of laryngeal cancer: pearls and pitfallsR. Maroldi; Brescia/ITLearning Objectives:1. To become familiar with the typical findings of T1-T4 laryngealcancer.2. To learn about the patterns of local nodal involvement.3. To understand possible imaging pitfalls in staging.14:28A-462 B. Evaluation after surgery and non-surgical treatment:expected findingsS. Bisdas; Tübingen/DELearning Objectives:1. To appreciate the expected imaging findings after surgery of laryngealcancer.2. To become familiar with imaging findings after non surgicaltreatment.3. To know about the possible imaging pitfalls.14:51A-463 C. Cancer recurrence: how to address clinical dilemmasB. Verbist; Leiden/NLLearning Objectives:1. To understand the limitations of clinical examination.2. To appreciate the value of different imaging techniques in thedetection of recurrence.3. To become familiar with the imaging findings of recurrent laryngealcancer.Panel discussion:15:14 Diagnostic algorithms for diagnosis and follow-up of laryngealcancer196

Postgraduate Educational Programme14:00–15:30 Room PRadiographersRC 1414 Towards advancing and developing therole of radiographers14:00A-464 Chairmen‘s introductionS. Mathers 1 , D. Tscholakoff 2 ; 1 Aberdeen/UK, 2 Vienna/ATSession Objectives:1. To appreciate the potential importance of advancing and developingthe role of radiographers for the profession and for healthcare.2. To become familiar with the level of activity across internationalsocieties in fostering this.3. To understand the importance of such role developments meetingreal clinical needs.14:05A-465 A. The current status: a clinical perspectiveC. McLaren; London/UKLearning Objectives:1. To become familiar with the current status from the perspective of aradiographer in an advanced practice in a paediatric interventionalrole.2. To understand the key factors that facilitate this advanced role, as wellas the challenges faced during implementation.3. To become familiar with the impact that this advanced role has hadon patient care, interprofessional relationships and service delivery, inone institution.14:28A-466 B. The importance of evidence-based practice for thefuture of advanced practice in radiographyA. England; Liverpool/UKLearning Objectives:1. To become familiar with examples of evidence-based practice in thearea of advanced practice and role development in radiography.2. To understand the importance of such an evidence-based approachwhen considering the introduction of advanced roles in a clinicalsetting.3. To gain an insight into the education and training requirements foradvanced practice and role development.14:51A-467 C. The view from the European levelG. Paulo; Coimbra/PTLearning Objectives:1. To understand the influence of evidence-based practice on the futureof the radiography profession in Europe.2. To become familiar with the advantage of advanced practice and roledevelopment in radiography in health systems.3. To understand the benefits of advanced practice and roledevelopment in radiography for the patients.Panel discussion:15:14 How to use the EFRS guidance document on role development14:00–15:30 Room QPaediatricRC 1412 Paediatric emergenciesModerator: V. Donoghue; Dublin/IE14:00A-468 A. The acute non-traumatic neurological patient: CT orMRI?E. Vázquez; Barcelona/ESLearning Objectives:1. To learn about the currently limited role of CT in the non-traumaticacute setting.2. To become familiar with radioprotection strategies and protocolsadapted to children.3. To consolidate the role of MRI as the modality of choice for acutenon-traumatic neurologically ill children, with an emphasis on newertechniques.4. To become familiar with imaging findings and the main differentialdiagnosis of acute neurological conditions in children.14:30A-469 B. Imaging of acute chest pain and/or distress in childrenC.E. de Lange; Oslo/NOLearning Objectives:1. To understand the role of radiographs, US, CT and MRI.2. To become familiar with the most common conditions that causeacute chest pain and/or distress in children.3. To appreciate the different differential diagnoses, depending on theage of the patient.4. To understand the consequences of delaying in their diagnosis andtreatment.15:00A-470 C. The role of the interventional radiologist in paediatrictraumaJ.B. Karani; London/UKLearning Objectives:1. To understand the role of CT, CTA and conventional angiography inthe diagnosis of traumatic vascular complications.2. To understand the importance of vascular and non-vascularintervention following trauma in children.14:00–15:30 Room ZSpecial Focus SessionSF 14c Advances in forensic radiology14:00A-471 Chairman‘s introductionG. Guglielmi; Foggia/ITSession Objectives:1. To become familiar with the role of imaging in forensic pathology.2. To learn how the use of a contrast medium may help the native scanto recognise vascular lesions.3. To learn about the possibilities of MDCT in anthropologicalidentification.14:05A-472 Imaging in forensic medicineM. Thali; Zurich/CHLearning Objectives:1. To learn why imaging methods are becoming essential modalities inforensic medicine.2. To become familiar with the modalities that can be used in forensicimaging.3. To learn what the future developments in forensic radiology andimaging will be.14:23A-473 Advances in post-mortem CT angiographyS. Grabherr; Lausanne/CHLearning Objectives:1. To consolidate knowledge of the advantages and limits of postmortemCT angiography.2. To understand the method of multi-phase post-mortem CTangiography and the indication for its performance.3. To become familiar with the objectives and latest achievements of theTechnical Working Group of Post-mortem Angiography Methods(TWGPAM).14:41A-474 Virtual anthropology and forensic identification usingMDCTF. Dedouit; Toulouse/FRLearning Objectives:1. To learn about the different paleo-pathological diagnoses andanthropological identification of bone lesions with MSCT.2. To learn about the possibilities of MSCT for comparativeidentification.3. To understand reconstructive identification and the main techniquesuseful for age-at-death assessment and sex determination.A-464 – A-474Sunday197

Postgraduate Educational ProgrammeA-475 – A-48514:59A-475 Forensic MR imagingT.D. Ruder; Zurich/CHLearning Objectives:1. To learn about typical post-mortem alterations in MR imaging.2. To become familiar with application of MR imaging in the postmortemsetting.3. To understand the added value of post-mortem cardiac MR in casesof cardiac death.Panel discussion:15:17 Which imaging technique for which forensic scenario?16:00–17:30 Room AInteractive Teaching SessionE³ 1520 Thoracic emergencies16:00A-476 A. VascularE. Castañer; Sabadell/ESLearning Objectives:1. To become familiar with the main causes of thoracic vascularemergencies.2. To understand the role of MDCT angiography in thoracicemergencies.3. To learn about the radiological signs in vascular thoracic emergenciesand its impact on the management of these patients.16:45A-477 B. PulmonaryC.M. Schaefer-Prokop; Amersfoort/NLLearning Objectives:1. To learn about the role of imaging in severe attacks of obstructivelung disease.2. To become familiar with direct and indirect signs of pleural diseasecausing respiratory failure with special emphasis on the intensive carepatient.3. To learn about imaging features that are helpful for the differentialdiagnosis of pulmonary consolidations causing respiratory failure.4. To understand the interaction of comorbidity, age and extent ofpulmonary disease resulting in severe respiratory failure and the roleof imaging in it.16:00–17:30 Room BGI TractRC 1501CT colonography: when the ‚new‘becomes ‚ordinary‘16:00A-478 Chairman‘s introductionA. Laghi; Rome/IT16:05A-479 A. State-of-the-art techniques in 2013T. Mang; Vienna/ATLearning Objectives:1. To become familiar with an optimised technique and how it can beoptimised for specific patient groups.2. To briefly describe basic interpretation and the role of CAD.3. To understand the most common interpretative pitfalls and potentialcomplications, and how they can be avoided.16:28A-480 B. How to set up a serviceP. Lefere; Roeselare/BELearning Objectives:1. To appreciate the need for training prior to CTC and understand therole of training courses and double reporting.2. To become familiar with ways of maximising service efficiency,including cost effectiveness, and how best to replace the barium enema.3. To appreciate the differences in approach from setting up a service forolder symptomatic patients to setting up colorectal cancer screening.4. To learn a basic audit framework.16:51A-481 C. Interaction with gastroenterologists: friends orenemies?A. Graser 1 , C. Hassan 2 ; 1 Munich/DE, 2 Rome/ITLearning Objectives:1. To understand what the gastroenterologists wants to know whenreferring their patients for CTC in both symptomatic and screeningpatients.2. To learn how to formulate local polyp reporting guidelines and howbest to integrate the service with the needs of patients.3. To propose the most effective method for integrating endoscopic andCTC services, minimising competition and maximising cooperation.Panel discussion:17:14 How to create an efficient CTC team?16:00–17:30 Room CUrogenital ImagingCC 1521PaediatricsModerator: M. Claudon; Vandoeuvre-lès-Nancy/FR16:00A-482 A. Imaging strategies for children: urinary tract infectionand vesico-ureteral refluxM. Riccabona; Graz/ATLearning Objectives:1. To learn about the information provided by ultrasonography, MRIand nuclear medicine examinations.2. To become familiar with the technique and indications formicturating cystourethrogram and contrast-enhanced voidingurosonography.3. To become familiar with an imaging algorithm for diagnosticapproaches, and different strategies.16:20A-483 B. Paediatric adrenal tumoursP.-H. Vivier; Rouen/FRLearning Objectives:1. To become familiar with the different adrenal tumours in paediatrics.2. To learn how imaging can help in differentiating neuroblastoma fromWilm’s tumour.3. To understand the value of adequate examinations for the initialworkup of adrenal tumours.16:40A-484 C. Prenatal detection of GU diseasesF.E. Avni; Lille/FRLearning Objectives:1. To learn how to assess the diagnostic criteria of foetal uropathies.2. To learn how to apply a standardised post-natal approach.3. To understand the rationale behind a standardised approach.17:00A-485 D. Interactive case discussionM. Claudon; Vandoeuvre-lès-Nancy/FR198

Postgraduate Educational Programme16:00–17:30 Room D1CLICK (Clinical Lessons for Imaging CoreKnowledge): Never without ArteriesCC 1518 When every step counts: imaging andmanagement of peripheral arterialocclusive disease (PAOD)Moderator: J.F.M. Meaney; Dublin/IE16:00A-486 A. Clinical considerationsM. Schillinger; Vienna/ATLearning Objectives:1. To become familiar with clinical diagnosis and classification ofperipheral arterial occlusive disease.2. To learn about the most important clinical differential diagnosis.3. To learn about the importance of imaging for treatment decisionmakingand planning.16:30A-487 B. Imaging techniques and typical findingsT. Leiner; Utrecht/NLLearning Objectives:1. To learn about state-of-the art MR angiographic imaging of theperipheral arteries (including modern non-enhanced techniques).2. To learn about state-of-the art CT angiographic imaging of theperipheral arteries (including modern dose-saving techniques).3. To become familiar with the appropriate selection of the right patientfor the right imaging test.17:00A-488 C. Interactive case discussion: how to deal with theresults? Typical cases, pitfalls, and what is next?L.P. Lawler; Dublin/IELearning Objectives:1. To become familiar with typical cases illustrating the role of differentimaging modalities in the diagnosis and differential diagnosis ofPAOD.2. To consolidate knowledge of the selection of the appropriateimaging technique, image interpretation and image based treatmentrecommendation.3. To understand the needs and principles in modern multidisciplinarymanagement of PAOD.16:00–17:30 Room D2Oncologic Imaging: Follow-up of Systemicand Local TherapiesCC 1519 Follow-up of thermal ablation (part II)Moderator: P.L. Pereira; Heilbronn/DE16:00A-489 A. Follow-up imaging of thermal ablative therapies forlung tumoursA.R. Gillams; London/UKLearning Objectives:1. To consolidate knowledge of imaging aspect of successful ablation.2. To become familiar with the main pitfalls of post-ablation imaging.3. To learn about the imaging aspects of most common complications.16:30A-490 B. Follow-up imaging of percutaneous local treatment ofbone tumoursF. Deschamps, G. Farouil, T. de Baere; Villejuif/FRLearning Objectives:1. To learn about the post-ablation aspects, according to the ablationtechnique used.2. To consolidate knowledge of the imaging aspects of successfulablation on various types of follow-up imaging, including CT andMRI.17:00A-491 C. Follow-up imaging of thermal ablative therapies forkidney tumoursD.J. Breen; Southampton/UKLearning Objectives:1. To learn about the post-ablation aspects, according to ablationtechnique used.2. To become familiar with the imaging aspect of successful ablation.3. To appreciate the imaging aspect of most common complications.16:00–17:30 Room E1Emergency RadiologyRC 1517 ER: comprehensive imaging of nontraumaticabdominal emergencies16:00A-492 Chairman‘s introduction: logistics and management ofcritical patients with abdominal complaintsS. Wirth, M.F. Reiser; Munich/DESession Objectives:1.To learn about requirements for abdominal imaging for an emergencyradiology department.2. To learn about current developments with a clinical focus on whoshould undergo what and when, what kind of CT exam to use inorder to triage emergency patients to the appropriate therapy options.16:15A-493 A. Imaging of the most frequent emergencies of the upperabdomenC.J. Zech; Basle/CHLearning Objectives:1. To become familiar with dedicated MDCT protocols.2. To learn about other types of imaging such as US and MR.3. To learn about typical and atypical imaging findings.16:35A-494 B. Imaging of the most frequent emergencies of thegastrointestinal tractM. Zins, I. Boulay-Coletta; Paris/FRLearning Objectives:1. To become familiar with dedicated MDCT protocols.2. To learn about other types of imaging such as US and MR.3. To learn about typical and atypical imaging findings.16:55A-495 C. Imaging of the most frequent emergencies of thegenitourinary tractL.E. Derchi; Genoa/ITLearning Objectives:1. To become familiar with dedicated MDCT protocols.2. To learn about other types of imaging such as US and MR.3. To learn about typical and atypical imaging findings.Panel discussion:17:15 How to speed up your diagnoses?16:00–17:30 Room E2State of the Art SymposiumSA 15 Imaging impingement syndromes16:00A-496 Chairman‘s introductionC.W.A. Pfirrmann; Zurich/CHSession Objectives:1. To learn about the role of imaging for the diagnosis of impingementsyndromes.2. To understand what the clinician needs to know from the radiologist.3. To learn the diagnostic value of different imaging modalities toanswer the clinical questions.A-486 – A-496Sunday199

Postgraduate Educational ProgrammeA-497 – A-50816:05A-497 ShoulderP. Robinson; Leeds/UKLearning Objectives:1. To understand impingement mechanisms of the shoulder.2. To become familiar with external and internal shoulderimpingement.3. To learn about the typical imaging findings.4. To appreciate the strength and weaknesses of different imagingmodalities.16:28A-498 AnkleM. Maas; Amsterdam/NLLearning Objectives:1. To understand impingement mechanisms of the ankle.2. To become familiar with anterior and posterior ankle impingement.3. To learn about the typical imaging findings.4. To appreciate the strength and weaknesses of different imagingmodalities.16:51A-499 HipK. Wörtler; Munich/DELearning Objectives:1. To understand impingement mechanisms of the hip.2. To become familiar with cam and pincer type femoroacetabularimpingement (FAI).3. To learn about the typical imaging findings.4. To appreciate the strength and weaknesses of different imagingmodalities.Panel discussion:17:14 Form or function: is impingement a clinical or imagingdiagnosis?16:00–17:30 Room F1Special Focus SessionSF 15a Traumatic brain injury16:00A-500 Chairman‘s introductionA. Rovira-Cañellas; Barcelona/ESSession Objectives:1. To understand the role of neuroradiology in the initial assessment.2. To appreciate the role of conventional and non-conventionalimaging techniques in the diagnosis and monitoring of primary andsecondary traumatic lesions of the brain.3. To learn about the prognostic value of neuroimaging.4. To become familiar with the various types of cerebrovascular traumasand their treatment options.16:05A-501 Acute brain trauma: CT vs MRIM. Muto; Naples/ITLearning Objectives:1. To understand the role of neuroradiology in the management ofbrain trauma patients.2. To learn about the correlation between neuroradiological featuresand clinical findings.3. To understand the importance of imaging follow-up.16:23A-502 New imaging techniques in the detection andquantification of brain damageS. Sunaert; Leuven/BELearning Objectives:1. To consolidate knowledge of new advanced imaging techniques.2. To learn about quantifying brain damage using these techniques.3. To understand the challenges of performing MR examinations inthese patients.16:41A-503 Advanced imaging of brain trauma: outcome predictionD. Galanaud; Paris/FRLearning Objectives:1. To understand the value of diffusion tensor imaging and MRspectroscopy in severe cases.2. To understand the role of these techniques in early- and late-phasediagnosis and treatment follow-up.3. To learn about the lesion patterns associated with favourable andunfavourable outcomes.16:59A-504 Cerebrovascular trauma: diagnosis and therapyT. Krings; Toronto, ON/CALearning Objectives:1. To learn about the classification of the different types ofcerebrovascular trauma.2. To become familiar with vascular emergencies requiring urgenttreatment.3. To become familiar with treatment strategies in cerebrovasculartrauma.Panel discussion:17:17 Role of neuroimaging in traumatic brain injury in 201316:00–17:30 Room F2Special Focus SessionSF 15b Digital breast tomosynthesis16:00A-505 Chairman‘s introductionG. Gennaro; Padua/ITSession Objectives:1. To understand the physical parameters and reconstruction methodswhich determine digital breast tomosynthesis (DBT) image quality.2. To learn about DBT clinical performance and potential clinicalapplications.3. To understand if CAD could be successfully applied compensate forthe time required to review DBT images.16:05A-506 Optimisation of image acquisition and reconstruction inDBTM.J. Yaffe, J.G. Mainprize; Toronto, ON/CALearning Objectives:1. To understand DBT principles.2. To learn about DBT acquisition and optimisation.3. To understand DBT reconstruction algorithms.4. To become familiar with radiation dose from DBT.16:28A-507 Current role of DBT in diagnostic imagingS. Zackrisson, K. Lång, A. Tingberg, P. Timberg, D. Förnvik, M. Dustler, I. Andersson;Malmö/SELearning Objectives:1. To understand the potential impact of DBT on sensitivity andspecificity of breast cancer detection.2. To appreciate limitations of DBT and its impact on imageinterpretation time and effort.3. To understand if DBT is applicable to screening.16:51A-508 Clinical aspects of computer aided detection anddiagnosis in DBTH.-P. Chan; Ann Arbor, MI/USLearning Objectives:1. To learn about the challenges of DBT interpretation in clinicalpractice.2. To understand the potential impact of computer-aided detection onDBT.3. To learn about CAD as a second reader to improve DBT sensitivity.4. To appreciate CAD as a concurrent reader to improve DBT workflow.Panel discussion:17:14 Digital breast tomosynthesis: replacing or just supportingstandard mammography?200

Postgraduate Educational Programme16:00–17:30 Room G/HNeuroRC 1511Epilepsy: a lack of knowledge can bedangerousModerator: M.A. Papathanasiou; Athens/GR16:00A-509 A. Anatomy of the limbic systemT.A. Yousry; London/UKLearning Objectives:1. To learn the components of the limbic system.2. To understand the structure of the hippocampus proper.3. To become familiar with the imaging characteristics at 1.5T, 3T, and9.4T.16:30A-510 B. Temporal lobe epilepsyI.N. Pronin; Moscow/RULearning Objectives:1. To become familiar with MR-characteristics of neoplastic and nonneoplasticcauses of temporal lobe epilepsy.2. To learn about optimised imaging protocol.3. To appreciate the potential impact of modern MR-imagingtechniques to improve visualisation of structural brain changes.17:00A-511 C. fMRI in epilepsyN. Bargalló; Barcelona/ESLearning Objectives:1. To become familiar with the application and limitations of fMRI.2. To appreciate technical aspects and interpretation of fMRI forlanguage localisation and memory testing.3. To consolidate of advanced fMRI applications.16:00–17:30 Room I/KCardiacRC 1503Cardiac CT and MRI in difficult patients:what to do?16:00A-512 Chairman‘s introductionM. Hamilton; Bristol/UK16:05A-513 A. Coronary CTA in patients with severe arrhythmias andhigh heart rateC. Loewe; Vienna/ATLearning Objectives:1. To understand the criteria for optimal patient selection andpreparation to achieve best results.2. To learn about acquisition techniques in patients with arrhythmiasand tachycardia.3. To become familiar with the post-processing techniques available foroptimising images quality following the scan.16:28A-514 B. Severe coronary calcinosis and stents: tips and tricks inimage acquisition and interpretationF. Pugliese 1 , A. Rossi 2 ; 1 London/UK, 2 Trieste/ITLearning Objectives:1. To understand the challenge of calcification and stents whenperforming coronary CTA.2. To become familiar with technical features that maximise imagequality in this patient group.3. To be aware of the accuracy of coronary CTA in stented or calcifiedvessels with the optimum imaging techniques.16:51A-515 C. Cardiac MRI: possible problems and how to avoid themE. Mershina; Moscow/RULearning Objectives:1. To learn the importance of patient selection and preparation inachieving high quality scans.2. To understand the practical techniques available for performing asuccessful scan in difficult patients such as those with arrhythmia orpoor breath-holding ability.3. To learn how imaging parameters can be changed for optimal results.Panel discussion:17:14 When to scan and when not to? How can we make the best ofwhat we have?16:00–17:30 Room L/MPhysics in RadiologyRC 1513 Novel developments in CT and theirimpact on doseModerators: M. Prokop; Nijmegen/NL, V. Tsapaki; Athens/GR16:00A-516 A. Patient dose assessment in CTP.C. Shrimpton; Didcot/UKLearning Objectives:1. To become familiar with technical dose parameters in CT.2. To understand how to assess patient dose.3. To be informed about the role of diagnostic reference levels in CT.16:30A-517 B. New frontiers in CT: functional and spectral imagingN. Pelc; Stanford, CA/USLearning Objectives:1. To learn about new developments in functional and spectral CTimaging.2. To learn about impact on patient dose.17:00A-518 C. New image reconstruction techniquesJ. Sijbers; Antwerp/BELearning Objectives:1. To understand the principles of iterative reconstruction techniquesin CT.2. To learn about novel algorithms.3. To learn about the impact on patient dose.16:00–17:30 Room N/OHead and NeckRC 1508 Performing and reporting head andneck examinations: how should I do it?Moderator: K. Surlan Popovič; Ljubljana/SI16:00A-519 A. Sinonasal CT scans: technique and evaluationH.B. Eggesbø; Oslo/NOLearning Objectives:1. To learn how to perform a state-of-the-art CT examination of thesinuses.2. To understand how to evaluate and what to report on CTexaminations of the sinuses.16:30A-520 B. Temporal bone: CT and MRIM.M. Lemmerling; Gent/BELearning Objectives:1. To learn how to perform a state-of-the art CT and MRI examinationof the temporal bone.2. To learn how to create a complete temporal bone report.A-509 – A-520Sunday201

Postgraduate Educational ProgrammeA-521 – A-52717:00A-521 C. CT and MRI of the neck: how to address key clinicalquestionsD. Farina; Brescia/ITLearning Objectives:1. To understand key clinical questions.2. To learn how to do a structured reading of the CT and MRI scans ofthe head and neck.3. To become familiar with reporting in order to address the needs ofthe clinician.17:00A-527 C. Congenital bone dysplasiasA.C. Offiah; Sheffield/UKLearning Objectives:1. To understand the role of the radiologist in diagnosing congenitalbone dysplasias.2. To understand how to classify bone dysplasias.3. To become familiar with reporting radiological studies related tobone dysplasias.16:00–17:30 Room PRadiographersRC 1514 Hybrid imaging technologiesModerators: C.D. Claussen; Tübingen/DE, C. Malamateniou; London/UK16:00A-522 A. Recent developmentsS. Rep; Ljubljana/SILearning Objectives:1. To become familiar with the basic principles of hybrid imaging.2. To learn about the newest techniques in hybrid imaging.3. To understand the potential technical implications of the use ofhybrid imaging.16:30A-523 B. Clinical applicationsT. Lindner; Ternitz/ATLearning Objectives:1. To become familiar with the major clinical applications of hybridimaging.2. To understand its benefits and drawbacks compared with a singlemodality.3. To become familiar with some case studies.17:00A-524 C. Trends in radiography educationP. Hogg; Manchester/UKLearning Objectives:1. To understand the impact on education.2. To learn how these new requirements can be met by changes in thecurriculum of educational institutions in Europe.3. To understand what further changes in European laws, researchinfrastructure, and collaboration might be required to strengthen andprotect the introduction of hybrid imaging in clinical practice.16:00–17:30 Room QPaediatricRC 1512 Paediatric MSK radiology:what is important?Moderator: M. Raissaki; Iraklion/GR16:00A-525 A. Scoliosis: what the radiologist needs to knowJ.-F. Chateil, S. Missonnier; Bordeaux/FRLearning Objectives:1. To learn about the aetiology of scoliosis.2. To become familiar with imaging findings, measurements andfollow-up.3. To understand how to report imaging findings.16:30A-526 B. Benign bone tumours and pseudotumours in children:the pitfallsK.J. Johnson; Birmingham/UKLearning Objectives:1. To recognise the most common benign bone tumours andpseudotumours.2. To understand the differences between benign bone and pseudotumours and malignancies in children.3. To understand imaging modalities that could help in the differentialdiagnosis of benign bone tumours and pseudo tumours in children.202

Postgraduate Educational Programme08:30–10:00 Room AInteractive Teaching SessionE³ 1620 Acute abdominal inflammatorydisorders08:30A-528 A. Colitis and enterocolitisD.J.M. Tolan; Leeds/UKLearning Objectives:1. To know how to choose the appropriate imaging modality.2. To become familiar with the patterns of distribution and appearancein imaging.3. To learn how to differentiate ischaemia from inflammation.09:15A-529 B. Liver and bile ductsC.D. Becker; Geneva/CHLearning Objectives:1. To know the advantages of each imaging technique.2. To become familiar with the findings in infrequent infections.3. To learn how to study obstructive jaundice.08:30–10:00 Room BSpecial Focus SessionSF 16a My most beautiful mistakes inpaediatric radiology08:30A-530 Chairman‘s introductionP. Tomà; Rome/ITSession Objectives:1. To become familiar with growth and development of newborns toteens.2. To become familiar with the main pitfalls in paediatric radiology.08:35A-531 AbdomenS.G.F. Robben; Maastricht/NLLearning Objectives:1. To become familiar with the most important differential diagnoses.2. To learn about imaging strategies for children.3. To understand the role, importance of, and information obtained,from ultrasonography.08:58A-532 CNSB. Bernardi, T. Verdolotti; Rome/ITLearning Objectives:1. To understand the significance of MR findings in a developing brain.2. To learn how to avoid misinterpretations of easily detectable MRabnormalities.3. To become familiar with the differential diagnosis of uncommondiseases.09:21A-533 MusculoskeletalK. Rosendahl; Bergen/NOLearning Objectives:1. To become familiar with the various controversies regarding USscreening programmes for developmental dysplasia of the hip.2. To understand the value of ultrasonography in the study of themusculoskeletal system.3. To learn how and when to use MRI for investigations and differentialdiagnosis.Panel discussion:09:44 How have you changed or improved yourself after recognisingyour mistakes?08:30–10:00 Room CUrogenital ImagingCC 1621 The usual, the unusualand the dangerousModerator: S.K. Morcos; Sheffield/UK08:30A-534 A. Imaging of renal traumaV. Logager; Copenhagen/DKLearning Objectives:1. To learn how to recognise and describe the different types oftraumatic renal injuries.2. To learn how to correlate these image findings with clinical severity.3. To understand treatment possibilities.08:50A-535 B. Postoperative anatomy and complications after GUinterventionsH.C. Thoeny; Berne/CHLearning Objectives:1. To become familiar with expected imaging findings after (partial)nephrectomy, ileal bladder substitute and radical prostatectomy.2. To understand common complications after surgery.3. To learn where and how to detect tumour recurrence.09:10A-536 C. GU complications in patients with spinal cord damageS. Agarwal; Wrexham/UKLearning Objectives:1. To understand the pathophysiology of urinary tract problems inpatients with spinal cord damage.2. To become familiar with the urinary tract complications associatedwith this group of patients.3. To understand the role of different modalities and common problemsduring imaging.09:30A-537 D. Interactive case discussionS.K. Morcos; Sheffield/UK08:30–10:00 Room D1CLICK (Clinical Lessons for Imaging CoreKnowledge): Never without ArteriesCC 1618 The fast and the furious: vasculartrauma resulting from traffic accidentsModerator: U. Linsenmaier; Munich/DE08:30A-538 A. Clinical considerationsH. Hoppe; Berne/CHLearning Objectives:1. To learn about the frequency and importance of arterial involvementin deceleration trauma.2. To know more about the differential diagnosis as well as the differentlocalisations of arterial lesions.3. To learn about prognosis, treatment and outcome after arterialinvolvement.09:00A-539 B. Imaging techniques and typical findingsH. Alkadhi; Zurich/CHLearning Objectives:1. To learn about the importance of selecting the appropriate imagingtechnique to allow for the detection of arterial involvement in traumapatients.2. To become familiar with the typical image appearance of arterialinvolvement in trauma patients.3. To learn about the most important findings and diagnoses fortreatment planning.A-528 – A-539Monday203

Postgraduate Educational ProgrammeA-540 – A-55109:30A-540 C. Interactive case discussionR. Morgan; London/UKLearning Objectives:1. To become familiar with typical cases illustrating the role ofappropriate imaging modalities in the assessment of patients afterdeceleration trauma.2. To consolidate knowledge of the selection of the appropriateimaging technique, image interpretation and image based treatmentrecommendation.3. To understand the most important information urgently needed fortreatment decisions and planning.08:30–10:00 Room D2Oncologic Imaging: Follow-up of Systemicand Local TherapiesCC 1619 Follow-up of local treatments ofbreast cancerModerator: M.H. Fuchsjäger; Graz/AT08:30A-541 A. MRI-guided HIFU therapies in the breastM. Sklair-Levy; Tel Aviv/ILLearning Objectives:1. To learn about HIFU in breast tumours.2. To become familiar with the post-HIFU aspects of various types ofimaging.09:00A-542 B. Pre- and post- imaging appearance of breast lesionexcision system (BLES) lesionsS.D. Allen; Sutton/UKLearning Objectives:1. To understand the mechanism of the BLES technique.2. To become familiar with the post-BLES aspects of various types ofimaging.09:30A-543 C. Common features and pitfalls in imaging the treatedbreastJ. Camps Herrero; Valencia/ESLearning Objectives:1. To learn about the post-surgical and post-radiation therapies aspectsof the breast and their timing.2. To learn about how to diagnose a recurrence in the treated breast andits differential diagnoses.3. To become familiar with the imaging findings of post-ablation (RFA)of breast.08:30–10:00 Room E1GI TractRC 1601a Diagnosis and staging ofesophageal cancer08:30A-544 Chairman‘s introductionZ. Tarján; Budapest/HU08:35A-545 A. DiagnosisM. Krokidis; Cambridge/UKLearning Objectives:1. To become familiar with the pros and cons of each of the maindiagnostic imaging modalities available when assessing a patient withsuspected esophageal cancer.2. To learn the basic imaging findings of esophageal cancer througheach modality with emphasis on local disease.3. To understand the pitfall in diagnosis and staging of tumours locatedin the gastroesophageal junction.08:58A-546 B. StagingV. Válek; Brno/CZLearning Objectives:1. To learn about optimised EUS, MDCT and PET-CT techniques foresophageal cancer staging.2. To critically review those imaging findings impacting on patientmanagement with regard to palliation, radiation therapy and surgery.3. To understand the potential of imaging prognostic markers.09:21A-547 C. Treatment responseB. Mahon; Birmingham/UKLearning Objectives:1. To learn the normal post-surgical and post-radiation therapy imagingfindings and criteria and to differentiate between these and localrecurrence.2. To become familiar with anatomical and functional imaging criteriato assess treatment response.3. To learn the rationale for follow-up of patients after definitive or neoadjuvantchemoradiotherapy.Panel discussion:09:44 Cross-sectional techniques: developing an integrated imagingalgorithm in oesophageal cancer08:30–10:00 Room E2Oncologic ImagingRC 1616 Complications of cancer treatmentand the detection of recurrences08:30A-548 Chairman‘s introductionM. Laniado; Dresden/DE08:35A-549 A. Head and neck cancerL. Oleaga Zufiría; Barcelona/ESLearning Objectives:1. To learn about the possible range of late toxicity effects after surgeryand chemoradiotherapy of the neck.2. To become familiar with the imaging findings after surgery andchemoradiotherapy.3. To understand which imaging method to use to differentiate betweentreatment sequelae and remaining tumour.08:58A-550 B. Liver and pancreatic cancerC. Catalano; Rome/ITLearning Objectives:1. To become familiar with the imaging of complications followingpancreatic surgery and liver chemotherapy and/or radiotherapy.2. To understand how these changes can conceal or mimic activedisease.3. To learn how to distinguish post-treatment changes from residual orrecurrent disease.09:21A-551 C. Rectal cancerL.C.O. Blomqvist; Stockholm/SELearning Objectives:1. To understand the role of CT, PET and MRI in the surveillance ofpatients after rectal cancer surgery.2. To become familiar with the imaging changes of the irradiated andresected tumour bed.3. To understand the diagnostic algorithm for early detection of a localrecurrence in the treated tumour bed.Panel discussion:09:44 How to differentiate between treatment sequelae and activedisease204

Postgraduate Educational Programme08:30–10:00 Room F1GI TractRC 1601b Abdominal MRI: standard and advancedprotocols in clinical settingsModerator: M.A. Patak; Zurich/CH08:30A-552 A. Fistula in anoA. Gupta; London/UKLearning Objectives:1. To learn optimised MRI state-of-the-art protocols to image patientswith fistula in ano.2. To understand of the role of imaging in fistula classification andstaging, impact on therapeutic decision-making, assessment ofactivity and in treatment monitoring.3. To describe how to provide an optimal MRI fistula report.09:00A-553 B. Pelvic floor diseaseM. Bazot, L. Jarboui, I. Thomassin-Naggara, F. Haab, E. Darai; Paris/FRLearning Objectives:1. To learn the clinical indications and the optimised dynamic MRimaging protocol for investigating pelvic floor disease in patients.2. To understand common and uncommon findings related to theposterior, middle and anterior compartments and how they impacton subsequent patient management.3. To understand how to introduce MRI into a pelvic floor therapy andhow to best integrate with conventional techniques.09:30A-554 C. Suspected biliary tumourC. Matos; Brussels/BELearning Objectives:1. To learn the basic MRI technique for patients with suspected biliarytumour.2. To understand advanced imaging protocols for both structural andfunctional imaging of the bile ducts, and when these are indicated.3. To understand the MR imaging findings which best differentiatebenign from malignant disease, and how to produce an optimisedreport.08:30–10:00 Room G/HNeuroRC 1611Spine: update on postoperativeimaging and minimally invasiveprocedures08:30A-555 Chairman‘s introductionJ. Van Goethem; Antwerp/BE08:35A-556 A. Postoperative spineL. van den Hauwe, J.W. Van Goethem, C. Venstermans, F. De Belder, P.M. Parizel;Antwerp/BELearning Objectives:1. To become familiar with the appropriate imaging technique in thepostoperative spine.2. To learn how to differentiate between normal and abnormalpostoperative findings.3. To recognise the most common postoperative complications.08:58A-557 B. Indications for vertebroplastyA. Gangi, J. Garnon, G. Tsoumakidou, I. Enescu; Strasbourg/FRLearning Objectives:1. To consolidate knowledge of the actual indications for vertebralaugmentation.2. To understand the contraindications and limitations.3. To become familiar with the algorithm of patient selection.4. To understand the best timing for vertebral augmentation.09:21A-558 C. Percutaneous treatment of spinal diseasesM. Muto; Naples/ITLearning Objectives:1. To understand the clinical indications for percutaneous treatment ofspinal diseases.2. To know what diagnostic modality to suggest.3. To become familiar with the different percutaneous techniquesavailable.Panel discussion:09:44 Minimally invasive spinal procedures: the radiologist‘s futurerole?08:30–10:00 Room I/KChestRC 1604Pulmonary embolism: guidelines andbest practice throughout Europe08:30A-559 Chairman‘s introductionM. Rémy-Jardin; Lille/FR08:35A-560 A. Pioped 1-2-3: what have we learned so far?C. Engelke; Göttingen/DELearning Objectives:1. To appreciate the results of Pioped 1-2-3 in the light of technologicalrefinements in 2013.2. To become familiar with the pros and cons of CT versus MR.3. To understand the residual potential indications of scintigraphy.08:58A-561 B. PE in oncologic patientsB. Ghaye; Brussels/BELearning Objectives:1. To learn about the increased risk of venous thromboembolism.2. To understand the means of recognising peripheral PE, includingCAD and new software tools.3. To learn how to deal with clinically unsuspected PE, both forreporting and treatment.09:21A-562 C. PE during pregnancy and puerperiumM.-P. Revel; Paris/FRLearning Objectives:1. To learn more about the increased risk of venous thromboembolism.2. To appreciate the pros and cons of US, CT, MR and scintigraphy.3. To learn about specific diagnostic algorithms.Panel discussion:09:44 Pulmonary embolism work-up in 201308:30–10:00 Room L/MSpecial Focus SessionSF 16c Making homogeneous the readingin HCC08:30A-563 Chairman‘s introductionC. Bartolozzi; Pisa/ITSession Objectives:1. To become familiar with common and uncommon findings in HCCand with updated guidelines in HCC diagnosis and follow-up.2. To understand how interpretation and reporting in HCC influencepatient management.3. To learn about recent developments in computer-aided reporting.A-552 – A-563Monday205

Postgraduate Educational ProgrammeA-564 – A-57408:35A-564 HCC diagnosis: how to report ‚typical‘ findingsC. Ayuso; Barcelona/ESLearning Objectives:1. To learn about AASLD/EASL imaging criteria for non-invasivediagnosis of hepatocellular carcinoma.2. To understand the need for standardised interpretation and reportingin HCC surveillance.3. To learn the current terminology in HCC reporting.08:53A-565 How to interpret and report ‚atypical‘ findingsC.J. Zech; Basle/CHLearning Objectives:1. To learn about common tricks and traps in interpreting atypicalfindings in HCC surveillance.2. To learn about the key elements for homogeneous reading andreporting in ‚atypical‘ HCC.3. To understand the key role that specific findings reported byradiologists have in determining patient management.09:11A-566 How to evaluate tumour response to therapiesJ. Ricke; Magdeburg/DELearning Objectives:1. To understand imaging findings after HCC locoregional and systemictreatments.2. To learn about the current guidelines for defining HCC response totreatment.3. To learn about the key elements of homogeneous reading andreporting after HCC treatment.09:29A-567 Information technology: the practical impact on themanagement of HCC patientsI. Bargellini; Pisa/ITLearning Objectives:1. To understand the need for new systems to improve standardizationof reading and reporting.2. To learn about now tools and software for managing oncologicpatients.3. To understand the added value of computer technology in themanagement of HCC patients.Panel discussion:09:47 Case-based discussion: a practical demonstration of howinterpretation and reporting affect patient management08:30–10:00 Room N/OSpecial Focus SessionSF 16b Head and neck cancer battle:the power of imaging studies08:30A-568 Chairman‘s introductionV. Vandecaveye; Leuven/BESession Objectives:1. To learn how to choose the optimal imaging modality for head andneck cancer staging and detection of tumour recurrence.2. To understand which elements are key to writing a structuredradiological report in diagnosis and staging.3. To become familiar with the imaging features of tumour relapseversus complications in the post-treatment neck.4. To understand the clinical role of imaging in post-treatment patientmanagement.08:35A-569 Building blocks for locoregional staging of head and necktumoursF.A. Pameijer; Utrecht/NLLearning Objectives:1. To learn how to make a choice between CT and MRI.2. To understand which imaging findings should be assessed to obtain aradiological TN-stage.3. To become familiar with structured radiological reporting of headand neck tumours.09:00A-570 Detection of tumour recurrence in head and neck cancer:challenges and pitfallsM. Becker; Geneva/CHLearning Objectives:1. To appreciate the spectrum of expected tissue alterations after therapyand their temporal relationship.2. To understand the imaging aspects of common complications aftertherapy.3. To become familiar with key imaging features of tumour recurrence.4. To learn the potential pitfalls in post-therapeutic image interpretationand how to avoid them.09:20A-571 Locoregional treatment failure in head and neck cancer:causes and clinical implicationsR. Maroldi, P. Nicolai; Brescia/ITLearning Objectives:1. To understand the most frequent causes of local and regional posttreatmentrelapses.2. To become familiar with the indications and options for salvagesurgery and non-surgical procedures.3. To understand the role of imaging in decision-making concerninglocal and regional recurrences.Panel discussion:09:50 Advanced imaging in clinical practice: how does it help thepatient?08:30–10:00 Room PCardiacRC 1603How I reportModerator: R. Vliegenthart; Groningen/NL08:30A-572 A. Chest x-ray in cardiac diseaseM.B. Rubens; London/UKLearning Objectives:1. To be aware of the indications for performing a chest x-ray in patientswith cardiac disease.2. To become familiar with the most important and relevant findings forthe diagnosis of cardiac disease.3. To learn about a structured approach to reading chest x-ray in cardiacpatients.09:00A-573 B. Coronary CTAF. Wolf; Vienna/ATLearning Objectives:1. To appreciate the scope of information needed by a referringphysician from a coronary CTA examination.2. To become familiar with protocols of cardiac CT and imageprocessing.3. To learn a structured approach to reading cardiac CT examinations.09:30A-574 C. Cardiac MRI in ischaemic heart diseaseJ. Bremerich; Basle/CHLearning Objectives:1. To know when to do cardiac MRI in ischaemic heart disease.2. To become familiar with protocols of cardiac MRI and imageprocessing.3. To learn about a structured reporting approach to cardiac MRI.206

Postgraduate Educational Programme08:30–10:00 Room QComputer ApplicationsRC 1605 Improving workflow efficiencyand quality08:30A-575 Chairman‘s introductionD. Caramella; Pisa/ITSession Objectives:1. To highlight the need for IT tools to ensure quality control.2. To understand how to collect data concerning radiation dose.3. To learn about the integration of contrast media injectors into PACS.08:35A-576 A. Improving quality and efficiency of computerised orderentry through decision supportP. Mildenberger; Mainz/DELearning Objectives:1. To understand the relationship of decision support tools andevidence-based medicine.2. To learn how decision support tools can be implemented forrequesting radiological studies.3. To appreciate potential effects of decision support tools on workflowefficiency.08:58A-577 B. Improving quality and efficiency of reporting bystructure and templatesN. Dugar; Doncaster/UKLearning Objectives:1. To learn about clinical requirements for structured reports.2. To become familiar with the IT requirements for report templates.3. To appreciate the potential to generate data for evidence-basedradiology.09:21A-578 C. Improving quality and efficiency of dose managementthrough exchange between modalities and registriesE. Vaño; Madrid/ESLearning Objectives:1. To learn about current European regulation requirements andstandards on patient dosimetry.2. To become familiar with the dose reporting evolution and dosestructured reporting.3. To appreciate the potential for dose analysis and reporting as well asfuture registries.Panel discussion:09:44 Will novel IT tools really improve quality and efficiency in dailyradiological practice?08:30–10:00 Room ZJoint Session of the ESR and EFSUMBAdvances in diagnostic ultrasound: better resultsthrough cooperationModerators: L.E. Derchi; Genoa/IT, F. Piscaglia; Bologna/IT08:30A-579 Introducing the EFSUMB: the world’s largest ultrasoundsocietyN. Gritzmann; Vienna/ATLearning Objectives:1. To learn about the work and responsibility of the differentcommittees.2. To understand the membership basis and objectives of the EFSUMB.3. To learn about the benefits for ultrasound societies and individualmembers.4. To learn about the educational tools of the EFSUMB.08:48A-580 ESR/EFSUMB collaboration: a newly established platformfor joint development of ultrasound in radiology andclinical specialtiesL.E. Derchi; Genoa/ITLearning Objectives:1. To learn about the goals of the ESR Working Group on Ultrasound.2. To understand the cooperative agreement between the ESR andEFSUMB.3. To learn about the initial results of the cooperation between the twosocieties.09:06A-581 Image fusion and interventionT. Lorentzen; Herlev/DKLearning Objectives:1. To understand the technical aspects of image fusion with ultrasound(US) and other imaging modalities (most frequently CT or MRI).2. To learn how to align two sets of data, obtained through differentaxial imaging techniques, with one another and perform live USscanning, where the fused image follows the live US.3. To understand how a lesion, even when invisible, can be targeted forUS-guided, using CT and MRI image fusion.09:24A-582 The EFSUMB non-liver CEUS guidelinesF. Piscaglia, S. Marinelli, E. Terzi; Bologna/ITLearning Objectives:1. To learn about new guidelines and clinical recommendations on theuse of contrast enhanced ultrasound in non-liver applications, whichwere released by the EFSUMB in 2012.2. To learn about the process of producing the document.3. To learn, based on the evidence, which organs are suitable for CEUSin daily practice, and which are only suitable for research usingCEUS.09:42A-583 The EFSUMB/WFUMB liver-CEUS guidelinesM. Claudon; Vandoeuvre-les-Nancy/FRLearning Objectives:1. To learn about the current practice of contrast enhanced ultrasound(CEUS) worldwide.2. To learn how the CEUS international guidelines were established.3. To learn about the main indications for CEUS in cases of liverdisease.10:30–12:00 Room AInteractive Teaching SessionE³ 1720b Musculoskeletal emergencies10:30A-584 A. Axial skeletonE. Llopis; Valencia/ESLearning Objectives:1. To understand the principal indications for emergency spinalimaging.2. To be able to analyse the pros and cons of each imaging modality inspinal trauma: how, why, when?3. To become familiar with key MRI findings in spinal infection,tumour cord compression and other non-traumatic spine disorders.4. To become familiar with the main emergency complicationsfollowing spinal surgery.11:15A-585 B. Peripheral skeletonV.N. Cassar-Pullicino; Oswestry/UKLearning Objectives:1. To learn when and how to use the different imaging modalities inacute skeletal lesions.2. To learn about the US and MRI findings in infection.3. To understand the value of MDCT in acute MSK lesions.A-575 – A-585Monday207

Postgraduate Educational ProgrammeA-586 – A-59510:30–12:00 Room BInteractive Teaching SessionE³ 1720a Pitfalls in pelvic imaging10:30A-586 A. Pitfalls in MRI of the pelvisE. Sala; New York, NY/USLearning Objectives:1. To become familiar with normal variations in MRI appearances offemale pelvis resulting from physiologic conditions (e.g. differentphases of menstrual cycle) and treatments (including exogenoushormone therapy, surgery and radiation) potentially mimickingdisease.2. To discuss the role of correct MR imaging plane in avoiding potentialmis-classification of uterine anomalies and parametrial invasion inpatients with cervical cancer.3. To recognise certain pitfalls related to dynamic contrast-enhancedMRI and diffusion weighted MRI.11:15A-587 B. Pitfalls in pelvic ultrasoundK. Kinkel; Chêne-Bougeries/Geneva/CHLearning Objectives:1. To become familiar with anatomical variants, potentially mimickingdisease.2. To learn about common pitfalls in pelvic ultrasound.12:30–13:30 Room N/OThe Beauty of Basic Knowledge:Head and NeckMC 24E Temporal bone: so beautiful, yet socomplicated12:30A-588 Temporal bone: so beautiful, yet so complicatedB. De Foer; Wilrijk-Antwerp/BELearning Objectives:1. To become familiar with temporal bone anatomy.2. To learn how to choose and tailor imaging techniques according toclinical presentation.3. To appreciate the most common pathologies affecting the three maincompartments of the temporal bone.16:00–17:30 Room CGI TractRC 1901Cross-sectional imaging of colitis16:00A-590 Chairman‘s introductionS.A. Taylor; London/UK16:05A-591 A. What protocol to use?S. Schmidt; Lausanne/CHLearning Objectives:1. To become familiar with the role of colonic distension prior toimaging of suspected or known colitis.2. To understand typical CT, MRI and US protocols.3. To highlight the pros and cons of CT, MRI and US.16:28A-592 B. Differentiating between the causes of colitisB. Gallix; Montpellier/FRLearning Objectives:1. To learn the most common cause of colitis through cross sectionalimaging in both immune competent and immune compromisedpatients.2. To become familiar with differentiating infectious, inflammatory,ischaemic and autoimmune conditions based on cross sectionalimaging criteria.3. To understand the limitations of cross sectional imaging indifferentiating between its causes.16:51A-593 C. The role of cross-sectional imaging in colonicinflammatory bowel diseaseJ. Rimola; Barcelona/ESLearning Objectives:1. To learn the optimised examination protocols for ulcerative colitisand colonic Crohn‘s disease in the acute, subacute and chronicdisease setting.2. To describe criteria for the assessment of disease activity through CT,MRI and ultrasound.3. To outline an integrated approach to the use of cross sectionalimaging in colonic inflammatory bowel disease.Panel discussion:17:14 The role of cross-sectional imaging in the diagnosis andfollow-up of colitis12:30–13:30 Room PThe Beauty of Basic Knowledge:Musculoskeletal ImagingMC 25E Metabolic/endocrine disease12:30A-589 Metabolic/endocrine diseaseJ. Freyschmidt; Bremen/DELearning Objectives:1. To understand the basic pathophysiology of metabolic and endocrinebone diseases.2. To become familiar with the most typical imaging findings ofmetabolic and endocrine diseases.3. To appreciate specific imaging patterns and to discuss the value ofdifferent imaging techniques.20816:00–17:30 Room D2Contrast MediaRC 1906 How I optimise contrast mediaadministrationModerator: W. Semmler; Heidelberg/DE16:00A-594 A. CTP. Leander; Malmö/SELearning Objectives:1. To understand the pharmacokinetics of iodinated contrast media.2. To learn about patient, contrast medium and scanning factorsassociated with contrast enhancement and scan timing.3. To become familiar with protocols for optimised contrastenhancement.16:30A-595 B. MRIG.M. Bongartz; Basle/CHLearning Objectives:1. To understand the differences between iodinated contrast agentsand gadolinium chelates and their impact on contrast mediumadministration.2. To learn about injection and scanning protocols for optimisedvascular and parenchymal enhancement.3. To review the influence of tissue-specific contrast media on theinjection and scanning protocols.

Postgraduate Educational Programme17:00A-596 C. PET/CTX. Montet; Geneva/CHLearning Objectives:1. To become familiar with the role of contrast-enhanced CT in PET/CT.2. To understand the influence of CT contrast-enhancement onattenuation correction of PET images.3. To learn about the importance of adequately timing the injection ofCT and PET agents for optimal PET/CT.16:00–17:30 Room E1MusculoskeletalRC 1910 Intra-articular imaging16:00A-597 Chairman‘s introductionA.H. Karantanas; Iraklion/GR16:05A-598 A. Standard MR techniquesC. Faletti; Turin/ITLearning Objectives:1. To become familiar with the techniques used in standard MR.2. To learn about the strengths/weaknesses of standard MR along withdiagnostic problems related to anatomical variation.16:28A-599 B. CT arthrographyC.W.A. Pfirrmann; Zurich/CHLearning Objectives:1. To become familiar with the techniques used in CT arthrography.2. To learn about the strengths/weaknesses of CT arthrography.16:51A-600 C. MR arthrographyJ. Kramer; Linz/ATLearning Objectives:1. To become familiar with the techniques used in MR arthrography.2. To learn about the strengths/weaknesses of MR arthrography.Panel discussion:17:14 Which imaging technique for which clinical scenario?16:00–17:30 Room E2Oncologic ImagingRC 1916 Gastro-entero-pancreatic neuroendocrinetumours (GEP-NET):a multidisciplinary update16:00A-601 Chairman‘s introductionC. Matos; Brussels/BE16:05A-602 A. Tumour biology, pathogenesis and classificationB. Wiedenmann; Berlin/DELearning Objectives:1. To learn about basic aspects of GEP-NET biology, pathogenesis andclassification.2. To understand the epidemiology and current treatment options.3. To become familiar with rational clinical management.16:28A-603 B. The current role of nuclear medicine techniquesC.M. Deroose; Leuven/BELearning Objectives:1. To learn about the cellular properties of GEP-NET used in molecularimaging.2. To become familiar with the different modalities and new tracersbeing used.3. To learn about the performance of the different methods available.16:51A-604 C. Anatomical imaging: transabdominal US, endoscopicUS, MDCT and MRI. What is the most appropriate imagingapproach?V. Vilgrain, M.-P. Vullierme, P. Ruszniewski, A. Sauvanet; Clichy/FRLearning Objectives:1. To learn how to recognise the specific imaging features of GEP-NET.2. To learn about the strengths and weaknesses of the different imagingmodalities.3. To understand the optimal use of the different imaging modalities inrelation to tumour localisation and staging.Panel discussion:17:14 The future of hybrid imaging16:00–17:30 Room F1Special Focus SessionSF 19 Tablet-computers in radiology: friendor foe?16:00A-605 Chairman‘s introductionE. Neri; Pisa/ITSession Objectives:1. To give an overview of current tablet-computer technology and itspractical use in radiology.2. To discuss the pros and cons of using tablet-computers.3. To analyse specific and critical areas of utilisation (DICOM imagesreading and teleradiology).16:05A-606 Tablet-computers: a technical overviewJ. Fernandez-Bayó; Sabadell/ESLearning Objectives:1. To learn about PC evolution: from desktops, to laptops and tablets.2. To appreciate the portability of a tablet-computer.3. To become familiar with the hardware features with a specific focuson displays and networks.16:23A-607 Radiological features of the tablet-computerP. Sacco 1 , L. Faggioni 2 ; 1 Siena/IT, 2 Pisa/ITLearning Objectives:1. To appreciate the radiological features available on a tablet-computer.2. To become familiar with radiological atlases, databases, socialnetworks.3. To learn how the tablet-computer can help at a congress and preparepresentations.16:41A-608 Reading DICOM images on the tabletO. Ratib; Geneva/CHLearning Objectives:1. To understand the DICOM readers available for tablet-computers.2. To become familiar with the different approaches to DICOM reading(local vs remote) and the PACS/tablets integration.3. To appreciate the pros and cons of DICOM image-reading withtablet-computers in regards to image quality and displays.16:59A-609 Mobile teleradiology with tablet-computers: a criticalappraisalE.R. Ranschaert; ‚s-Hertogenbosch/NLLearning Objectives:1. To learn about mobile teleradiology within and outside the hospital.2. To become familiar with the potential risks of mobile teleradiology(data security, confidentiality, etc.).Panel discussion:17:17 Are we ready and confident enough to use tablet-computers inclinical practice? How and when?A-596 – A-609Monday209

Postgraduate Educational ProgrammeA-610 – A-61916:00–17:30 Room F2BreastRC 1902Breast ultrasoundModerator: M. Müller-Schimpfle; Frankfurt a. Main/DE16:00A-610 A. Physics and practical aspects of high-quality hand-heldand automated breast USM.H. Fuchsjäger; Graz/ATLearning Objectives:1. To understand the physics of hand-held and whole breast US.2. To become familiar with the practical technique of hand-held andwhole breast US.3. To appreciate the clinical applications of hand-held and whole breastUS including automated screening.16:30A-611 B. Complicated cysts and complex-cystic lesions:differentiation and managementG. Rizzatto 1 , C.F. Weismann 2 ; 1 Gorizia/IT, 2 Salzburg/ATLearning Objectives:1. To learn about the US appearance of complicated cysts and complexcysticlesions.2. To consolidate knowledge on differential diagnosis for theserespective lesions.3. To understand the diagnostic algorithm for a work-up of theselesions.17:00A-612 C. The use of ultrasound in the evaluation of the nippleareolarcomplexR. Salvador; Barcelona/ESLearning Objectives:1. To understand the normal anatomy of the nipple-areolar complex.2. To become familiar with conditions commonly affecting the nippleareolarcomplex.3. To appreciate the value of US for diagnosis and management of theseconditions.16:00–17:30 Room G/HNeuroRC 1911Multiple sclerosis: 2013 updateModerator: E. Tali; Ankara/TR16:00A-613 A. Differential diagnosis of multiple T2-HI white matterlesionsA. Rovira-Cañellas; Barcelona/ESLearning Objectives:1. To learn about recognition patterns that might be helpful insuggesting the most likely etiology of brain multifocal T2 lesions.2. To understand the role of spinal cord imaging in the differentialdiagnosis.3. To appreciate a neuroradiologic diagnostic strategy for multiple whitematter lesions of unknown origin.16:30A-614 B. New developments in the diagnosis of multiplesclerosisF. Barkhof; Amsterdam/NLLearning Objectives:1. To understand the 2010 revision of the McDonald criteria for MS.2. To become aware of MRI red-flags in the diagnostic process.3. To become familiar with new developments in pulse-sequences andfield-strength.4. To understand how to use spinal cord imaging in a diagnostic setting.17:00A-615 C. Imaging of MS treatment-related complicationsM.M. Thurnher; Vienna/ATLearning Objectives:1. To become familiar with therapy options in multiple sclerosis (MS).2. To understand therapy induced complications.3. To understand the pathophysiology of immune reconstitutioninflammatory syndrome (IRIS).4. To become familiar with imaging findings in IRIS.16:00–17:30 Room I/KChestRC 1904Phenotypes in obstructive airwaydisease: how should I image, analyseand report?Moderator: P.A. Gevenois; Brussels/BE16:00A-616 A. Asthma and associated conditionsP.-Y. Brillet; Bobigny/FRLearning Objectives:1. To learn more about the imaging findings in asthma and associatedconditions, especially with low-dose and expiratory CT.2. To appreciate the potential to grade the severity of the disease fromCT.3. To learn how to report findings indicative of asthma and associatedconditions.16:30A-617 B. Chronic obstructive pulmonary disease (COPD)N. Sverzellati; Parma/ITLearning Objectives:1. To learn more about the imaging findings in COPD, including lowdose and expiratory CT.2. To become familiar with the concept of CT phenotyping: airwayobstruction vs. alveolar destruction.3. To appreciate the radiological findings of remodelling of airways andpulmonary vasculature.17:00A-618 C. Cystic fibrosis and other bronchiectatic diseasesM.U. Puderbach; Heidelberg/DELearning Objectives:1. To learn more about the imaging findings in bronchiectasis,especially at MRI.2. To appreciate the role of imaging in primary diagnosis, surveillanceand therapy monitoring.3. To become familiar with the role of imaging in surgical planning.16:00–17:30 Room N/OHead and NeckRC 1908 Temporal bone: imaging the mostcommon symptoms and signsModerator: T. Beale; London/UK16:00A-619 A. Conductive hearing loss: what‘s behind it?A. Trojanowska; Lublin/PLLearning Objectives:1. To review the most common causes of conductive hearing loss.2. To become familiar with the imaging findings in patients withconductive hearing loss.3. To differentiate the most frequent causes of conductive hearing loss.210

Postgraduate Educational Programme16:30A-620 B. Sensorineural hearing loss: a challenge for radiologistsJ. Casselman 1 , B. De Foer 2 ; 1 Bruges/BE, 2 Antwerp/BELearning Objectives:1. To learn which imaging techniques should be used.2. To become familiar with the different causes of sensorineural hearingloss.3. To recognise and differentiate the imaging findings in the mostfrequent causes of sensorineural hearing loss.17:00A-621 C. Tinnitus and vertigo: diagnostic algorithmR.B. de Bondt; Zwolle/NLLearning Objectives:1. To learn the most common causes.2. To understand imaging strategies.3. To become familiar with typical imaging findings.16:00–17:30 Room PVascularRC 1915Lower extremity venous insufficiency16:00A-622 Chairman‘s introductionD.J. West; Stoke-on-Trent/UK16:05A-623 A. Venous anatomy and ultrasoundH. Moschouris; Piraeus/GRLearning Objectives:1. To become familiar with normal venous anatomy the indications forimaging and the US techniques.2. To learn about the typical and atypical appearances of venouspathology.3. To understand the potential pitfalls and limitations of US.16:28A-624 B. Rare venous diseases of the lower extremitiesM. Greiner 1 , P. Lemasle 1 , A. Bisdorff-Bresson 2 ; 1 Neuilly sur Seine/FR, 2 Paris/FRLearning Objectives:1. To become familiar with anatomic variants.2. To learn about anatomy with specific congenital disorders, such aspersistent sciatic vein Klippel Trenaunay-Weber syndrome.3. To become familiar with differential diagnosis and pitfalls in thediagnosis of the above conditions.16:51A-625 C. CT venography and MR venographyG. O‘Sullivan, D.G. Lohan; Galway/IELearning Objectives:1. To learn about its indications and pros and cons compared to US.2. To become familiar with imaging parameters, contrast mediaprotocols and flow dependent and flow independent techniques.3. To become familiar with pitfalls and artefacts that affect correctevaluation of imaging findings after endovascular treatments.16:00–17:30 Room QPaediatricRC 1912 Normal variants in paediatric imaging:not to be confused with diseaseModerator: Ø.E. Olsen; London/UK16:00A-626 A. BrainA. Rossi; Genoa/ITLearning Objectives:1. To learn about normal variants in the neonatal and child’s brain.2. To understand the typical imaging characteristics of normal variantsthat should suffice for correct interpretation.3. To become familiar with the differentiation between normal variantsand disease.16:30A-627 B. Chest and abdomenS.G.F. Robben; Maastricht/NLLearning Objectives:1. To learn about normal variants in the neonatal and paediatric chestand abdomen.2. To familiarise oneself with the imaging appearances of commonnormal variants.3. To understand how to differentiate between normal variants anddisease.17:00A-628 C. MusculoskeletalF. Saez; Bilbao/ESLearning Objectives:1. To learn about normal variants in the neonatal and paediatricmusculoskeletal system.2. To familiarise oneself with the imaging appearances of commonnormal variants.3. To understand how to differentiate between normal variants anddisease.4. To learn how to integrate age, location and clinical history with theradiological features before establishing a diagnosis.A-620 – A-628Panel discussion:17:14 Which imaging modality is best for planning endovascularmanagement?Monday211

ScientificSessionsSession numbers are prefixed by SSPresentation numbers are prefixedby the letter B

Scientific SessionsB-0001 – B-001910:30–12:00 Room BCardiacSS 103CT and MRI in preoperative andpostoperative evaluationModerators: G.A. Krombach; Giessen/DE, R. Sanz-Requena; Valencia/ES10:30B-0001 Multiparametric functional MRI for postoperativefollow-up in patients with the ROSS-procedure:comparison of the aortic root replacement versus thesubcoronary implantation techniqueC.O. Ritter 1 , U. Baier 1 , S.P. Sommer 1 , R. Leyh 1 , H. Köstler 1 , D. Hahn 1 , M.J. Beer 2 ;1Würzburg/DE, 2 Graz/AT10:39B-0002 Flow pattern evaluation of apico-aortic conduit(CORREX) in high-risk patients with severe aorticstenosis: a cardiac magnetic resonance (MR)investigationC. Mantini, A.R. Cotroneo, A. Tartaro, E. Di Gianfrancesco, C. Canosa, M. Foschi,D. Marinelli, G. Di Giammarco; Chieti/IT10:48B-0003 Pre- and postinterventional evaluation of cardiacfunction in patients suffering from mitral regurgitationusing cardiac MRIP. Krumm, C.S. Zuern, T.H. Wurster, C. Bretschneider, S. Mangold, B. Klumpp,A. May, C.D. Claussen, U. Kramer; Tübingen/DE10:57B-0004 Pre- and post-interventional analysis of myocardialstrain in patients undergoing mitral valve clippingusing cardiac MRIP. Krumm, C.S. Zuern, T.H. Wurster, A. Seeger, S. Mangold, B. Klumpp,C.D. Claussen, A. May, U. Kramer; Tübingen/DE11:06B-0005 Pressure overloaded right ventricles: importance oftrabeculae in evaluation of RV function by CMRM.M.P. Driessen 1 , V.J.M. Baggen 1 , H.G. Freling 2 , F.J. Meijboom 1 , G.T. Sieswerda 1 ,R.J. Snijder 3 , T. Leiner 1 , T.P. Willems 2 ; 1 Utrecht/NL, 2 Groningen/NL,3Nieuwegein/NL11:15B-0006 Opacification ratios to detect changes in coronary flowby computed tomography angiography – comparisonbetween pre- and post-stented lesionsP.B. Rizzi 1 , R.J. Cerci 1 , P. Lemos 2 , C.E. Rochitte 2 , I. Gottlieb 3 , R.T. George 1 ,J. Texter 1 , A.C. Lardo 1 , J.A.C. Lima 1 ; 1 Baltimore, MD/US, 2 São Paulo/BR,3Rio de Janeiro/BR11:24B-0007 Additional value of cardiac computed tomography toassess prosthetic valvular dysfunctionsA.A. Azarine, N. Hrynchyshyn, A. Samadi, L. Perdrix, G. Ashrafpoor, A. Redheuil,L. Macron, E. Mousseaux, B. Diebold; Paris/FR11:33B-0008 Cardiac computed tomography angiography results indiagnostic and therapeutic change in prosthetic heartvalve endocarditisJ. Habets 1 , W. Tanis 1 , L.A. van Herwerden 1 , W.P.T.M. Mali 1 , R.B.A. van den Brink 2 ,B.A.J.M. de Mol 2 , S.A.J. Chamuleau 1 , R.P.J. Budde 1 ; 1 Utrecht/NL, 2 Amsterdam/NL11:42B-0009 Anatomical variance of coronary venous system indual source computed tomographyM. Krupinski, M. Kuniewicz, J. Lelakowski, M. Irzyk, B. Laskowicz, M. Urbanczyk;Krakow/PL11:51B-0010 Feasibility of MRI in patients with implantedsubcutaneous loop recorder type REVEAL XT®: datafrom the surprise studyL. Christensen, A. Christensen, H. Christensen; Copenhagen/DK10:30–12:00 Room CNeuroSS 111From structure to functionModerators: S.J. Bakke; Oslo/NO, B. Ertl-Wagner; Munich/DE10:30B-0011 Regional cortical thickness is associated withneurocognitive profile in progressive myoclonusepilepsy type 1 (EPM1, Unverricht-Lundborg disease)S. Suoranta 1 , E. Niskanen 2 , M. Äikiä 1 , P. Koskenkorva 1 , M. Könönen 1 ,R. Kälviäinen 1 , R. Vanninen 1 ; 1 Kuopio/FI, 2 Vaasa/FI10:39B-0012 Language impairment and reduced structuralconnectivity in Rolandic epilepsyR. Besseling, J. Jansen, W.H. Backes; Maastricht/NL10:48B-0013 Relative contributory role of Interictal/Ictal SPECT,interictal PET, MR spectroscopy and T2 relaxometryin localisation of seizure focus in temporal lobeepilepsies: a metaanalysis and systematic reviewV. Venugopal 1 , S.K. Puri 1 , I. Afshan 1 , A.D. Prabhu 2 ; 1 New Delhi/IN, 2 Chennai/IN10:57B-0014 Subtle changes in normal appearing white matterprecede development of white matter lesionsB.F.J. Verhaaren, M. de Groot, R. de Boer, S. Klein, A. Hofman, A. van der Lugt,M.A. Ikram, W.J. Niessen, M.W. Vernooij; Rotterdam/NL11:06B-0015 Retrograde degeneration of optic nerve and visualpathway in open angle glaucoma: a morphologicevaluation using 3T MRIS. Sidek, F. A. Rahman, K. Rahmat, N. Mohd Ramli, N. Mohd Ramli;Kuala Lumpur/MY11:15B-0016 High blood pressure and cerebral white matter lesionprogression in the general populationB.F.J. Verhaaren, M.W. Vernooij, R. de Boer, A. Hofman, W.J. Niessen, A. van derLugt, M.A. Ikram; Rotterdam/NL11:24B-0017 MRI texture analysis in Unverricht-Lundborg diseasereveals more complex and heterogeneous texturalappearance in thalami, putamen and amygdala than incontrolsK.K. Holli 1 , S. Suoranta 2 , E. Niskanen 3 , P. Dastidar 1 , H. Eskola 1 , R. Vanninen 2 ;1Tampere/FI, 2 Kuopio/FI, 3 Vaasa/FI11:33B-0018 Structural MRI-assisted diagnosis of major depressivedisorder using surface-based volumetric parameterclassification approachL. Qiu, S. Lui, X. Huang, J. Zhang, X. Yang, Q. Yue, L. Zou, Q. Gong; Chengdu/CN11:42B-0019 Resting-state networks, and peculiarities of the brainmetabolism in patients with Parkinson’s disease (PD)and different level of cognitive impairment (CI): fMRIand 1 H MRS studyZ.Z. Rozhkova, O.M. Omelchenko; Kiev/UA214

Scientific Sessions11:51B-0020 Relationship among fractional anisotropy (FA) values,EEG activity and cognitive status in mild cognitiveimpairment (MCI) and Alzheimer’s disease (AD)patientsF. Pitocco, G. Curcio, F. Scrascia, Y. Errante, A. Giona, C. Mallio, F. Vernieri,B. Beomonte Zobel, C. Quattrocchi; Rome/IT10:30–12:00 Room D1ChestSS 104Lung cancer: from tissuecharacterisation to treatmentModerators: E. Castañer; Sabadell/ES, N. Tacelli; Brussels/BE10:30B-0021 Prognostic value of CT perfusion parameters inpatients with early stage resectable non-small celllung cancerL. Calandriello, A.R. Larici, A. del Ciello, G. Rindi, G. Petrone, L. Bonomo; Rome/IT10:39B-0022 Dynamic volume perfusion CT in patients with lungcancer: baseline perfusion characteristics of differenthistological subtypesJ. Shi 1 , C. Fink 2 , G. Schmid-Bindert 3 , L.R. Pilz 3 , P. Apfaltrer 3 , H. Haubenreisser 3 ,U. Haberland 4 , S.O. Schönberg 3 , T. Henzler 3 ; 1 Shanghai/CN, 2 Celle/DE,3Mannheim/DE, 4 Forchheim/DE10:48B-0023 Correlation between grade and histologicalsubtype of pulmonary adenocarcinoma and [18F]fluorodeoxyglucose standardized uptake value afterevaluation by PET/CTL. Xu, A. Burke, S. Feigenberg; Baltimore, MD/US10:57B-0024 Which response criteria best help predict survivalof patients with EGFR-mutant lung adenocarcinomafollowing EGFR tyrosine kinase inhibitor?J. Lee, H. Lee, J.-H. Kim, M.-J. Ahn, H. Kang, K. Lee; Seoul/KR11:06B-0025 Radiogenomic approach to identify anaplasticlymphoma kinase-positive lung adenocarcinomaC. Jeong, H. Lee, J. Han, J. Jeong, K. Lee, K. Park, M.-J. Ahn, B.-T. Kim; Seoul/KR11:15B-0026 Mucinous vs nonmucinous adenocarcinoma in situ(AIS): imaging features, EGFR mutation and EGFR genecopy number status, and prognosisD. Kim, H.-J. Lee, J. Wi, S. Lee, C. Park, J. Goo; Seoul/KR11:24B-0027 Validation of a computed-tomography-based riskmodel for the prediction of cardiovascular disease in alung cancer screening settingP.M. Jairam, P.A. de Jong, W.P.T.M. Mali, Y. van der Graaf; Utrecht/NL11:33B-0028 Diagnostic accuracy of virtual 18F-FDG PET/CTbronchoscopy for the detection of lymph nodemetastases in non-small cell lung cancer patientsM.C. Herbrik 1 , C. Buchbender 2 , J. Treffert 3 , B. Geiger 4 , V. Hartung-Knemeyer 1 ,H. Kühl 1 , G. Antoch 2 , M. Forsting 1 , T.A. Heusner 2 ; 1 Essen/DE, 2 Düsseldorf/DE,3Knoxville, TN/US, 4 Princeton, NJ/US11:42B-0029 Percutaneous transthoracic CT-guided biopsy usinglarge core needles: initial experienceU.C. Lalji, J.E. Wildberger, M. Bendek, M. Das; Maastricht/NL11:51B-0030 Primary lung cancer treated using radiofrequencyablation: two-year outcome dataJ. Beeson, N. Wickings, V. Anikin, S. Kaul, P. Dalal; London/UK10:30–12:00 Room D2Interventional RadiologySS 109 Chemoembolisation andradioembolisation of liver tumoursModerators: A. Denys; Lausanne/CH, P.M. Paprottka; Munich/DE10:30B-0031 Repeated transarterial chemoembolization in thetreatment of liver metastases of colorectal cancer:local tumour control and survival dataT. Gruber-Rouh, N.N.N. Naguib, M. Beeres, B. Bodelle, S. Zangos, N. Nour Eldin,R. Hammerstingl, T.J. Vogl; Frankfurt/DE10:39B-0032 Holmium-166 radioembolisation: results of a phase 1,dose escalation study in patients with unresectable,chemorefractory liver metastases – the HEPAR trialM.L.J. Smits, J.F.W. Nijsen, M.A.A.J. van den Bosch, M.G.E.H. Lam, M.A.D. Vente,W.P.T.M. Mali, A.D. van het Schip, B.A. Zonnenberg, J.F. Prince; Utrecht/NL10:48B-0033 Repetitive transarterial chemoembolization as apalliative treatment option for liver metastasesfrom cutaneous malignant melanoma: indications,outcomes and role in patient’s managementT. Gruber-Rouh, P. Weisser, N.N.N. Naguib, K. Eichler, M. Harth, S. Zangos, N.-E.A. Nour-Eldin, T.J. Vogl; Frankfurt/DE10:57B-0034 Experimental study on transarterial administrationof survivin siRNA combined with transarterialchemoembolization in rats with hepatocellularcarcinoma (HCC)T.J. Vogl 1 , J. Qian 2 , A. Tran 1 , E. Oppermann 1 , U. Imlau 1 , Y. Hamidavi 1 ,H. Korkusuz 1 , W.O. Bechstein 1 ; 1 Frankfurt a. Main/DE, 2 Wuhan/CN11:06B-0035 Role of transarterial chemoembolization as bridgingstrategy in T2 HCC patients on the waiting listE. Bozzi, I. Bargellini, F. Turini, A. Cicorelli, R. Cioni, C. Bartolozzi; Pisa/IT11:15B-0036 Semi-automatic volumetric tumour segmentation forhepatocellular carcinoma: comparison between C-armcone-beam computed tomography and MRIV. Tacher 1 , M. Lin 2 , M. Chao 1 , L. Gjesteby 1 , N. Bhagat 1 ; 1 Baltimore, MD/US,2Briarcliff Manor, NY/US11:24B-0037 Transcatheter arterial chemoembolisation ofhepatocellular carcinoma in transplant patients:smaller bead diameter and hypervascularity lead tohigher tumour necrosisM. Hakky, S. Amirifeli, C. Wald, C. Molgaard, H. Ahari; Burlington, MA/US11:33B-0038 Initial RECIST tumour reduction as a predictiveparameter for transarterial chemoembolisationtreatment success in patients with hepatocellularcarcinomaD.B. Hasdemir, B.C. Meyer, N. Schweitzer, A. Vogel, C. von Falck, H. Rosenthal,F. Wacker, T. Rodt; Hannover/DEB-0020 – B-0038Thursday215

Scientific SessionsB-0039 – B-005911:42B-0039 Intraprocedural parenchymal blood volumemeasurement using repetitive C-arm CT in patientwith hepatocellular carcinoma and breast cancerduring TACE: therapy response and evaluationT.J. Vogl, S. Blösser, P. Schäfer, E. Mbalisike, S. Zangos; Frankfurt a. Main/DE11:51B-0040 Study on the effect of chemoembolization combinedwith microwave ablation for the treatment ofhepatocellular carcinoma in ratsT.J. Vogl 1 , J. Qian 2 , U. Imlau 1 , Y. Hamidavi 1 , H. Korkusuz 1 , E. Oppermann 1 ,W.O. Bechstein 1 ; 1 Frankfurt a. Main/DE, 2 Wuhan/CN10:30–12:00 Room E1MusculoskeletalSS 110 Shoulder and handModerators: C. Schüller-Weidekamm; Vienna/AT, M. Shahabpour;Brussels/BE10:30B-0041 Diagnosing adhesive capsulitis of shoulder onsonography alone: is it possible?A. Tandon, S. Dewan, S. Bhatt, A.K. Jain; New Delhi/IN10:39B-0042 MR imaging of glenoid bone lossK.R. Lee, J.F. Griffith, W.A. Ng, M. Tong, S. Nimish; Hong Kong/HK10:48B-0043 Rotator cuff tendon tear size and retraction andquantification of muscle fatty infiltration usingchemical shift-based water-fat MR imagingS. Lee, L. Nardo, R. Lucas, D. Karampinos, J. Carballido-Gamio, A. Lai, C.B. Ma,T. Link, R. Krug; San Francisco, CA/US10:57B-0044 Comparison of 3D turbo spin-echo space sequenceswith conventional 2D MRI sequences to assess theshoulder jointJ.K. Kloth 1 , M. Winterstein 1 , M. Akbar 1 , E. Meyer 2 , D. Paul 2 , H.-U. Kauczor 1 , M.-A. Weber 1 ; 1 Heidelberg/DE, 2 Erlangen/DE11:06B-0045 Evaluation of MR-arthrography in identifying bonyBankart lesions: usefulness of thin-slice T1 weightedGRE sequencesG. Foti, E. Oliboni, L. Romano; Negrar/IT11:15B-0046 Superior labral dimension of the glenoid labrum ondirect MR arthrography (MRA): relationship withpresence of SLAPT. Im 1 , J.-A. Choi 1 , G. Lee 1 , J. Oh 1 , S. Hong 2 , H. Kang 1 ; 1 Seongnam/KR, 2 Seoul/KR11:24B-0047 Evaluation of concomitant osseous carpal injuries inpatients with distal radial fractures in MDCTA. von Schneider-Egestorf, C. von Falck, B. Meyer, F. Wacker, H. Rosenthal;Hannover/DE11:33B-0048 Normal anatomy and variants of thetrapeziometacarpal joint at MR imaging inasymptomatic volunteersA. Hirschmann, R. Sutter, A. Schweizer, C.W.A. Pfirrmann; Zurich/CH11:42B-0049 Safety of dorsal wrist arthroscopy portals: a magneticresonance studyR. Cazzato, R. Del Vescovo, F. Giurazza, R.F. Grasso, B. Beomonte Zobel;Rome/IT11:51B-0050 Comparison of three-dimensional indirect isotropic MRarthrography and conventional MR arthrography forthe diagnosis of rotator cuff tearsJ. Lee, Y. Yoon, S. Ji; Seoul/KR10:30–12:00 Room E2GI TractSS 101aAcute bowel diseases: challenges andsolutionsModerators: J. Dormagen; Oslo/NO, S. Leschka; St. Gallen/CH10:30B-0051 The emperor‘s new clothes? An evaluation of theaccuracy of transabdominal ultrasound in diagnosingacute appendicitisP. Yoong 1 , C.A. Johnson 2 , S. Fernando 1 , J.W. Graham 1 ; 1 King‘s Lynn/UK,2London/UK10:39B-0052 Added value of ultrasound re-evaluation for patientswith equivocal CT findings of acute appendicitis: apreliminary studyJ. Sim, H. Kim, J. Yeon, B. Suh, K. Kim, Y. Ha, S. Paik;Sungnam-si, Gyeonggi-do/KR10:48B-0053 Reduced Z-axis coverage at multidetector-row CTto decrease radiation dose and maintain diagnosticaccuracy in adults suspected of acute appendicitisN. Brassart 1 , C. Winant 2 , D. Tack 3 , P. Gevenois 1 , V. de Maertelaer 1 , C. Keyzer 1 ;1Brussels/BE, 2 Mons/BE, 3 Baudour/BE10:57B-0055 The effectiveness of multidetector computedtomography in patients that underwent immediateintestinal resection due to acute abdominal painM. İnci, F. Özkan, S. Bozkurt, M. Yüksel, O. Peker; Kahramanmaraş/TR11:06B-0056 In the evaluation of patients with obscuregastrointestinal bleed, does MDCT angiography have arole?C.B. Kulkarni, S. Moorthy, S.K. Pullara, R.R. Kannan, P.V. Ramchandran,S. Srinivasan; Kochi/IN11:15B-0057 Venous mesenteric ischaemia vs acute arterialmesenteric ischaemia with reperfusion: similaritiesand differencesD. Berritto 1 , F. Iacobellis 1 , M.P. Belfiore 1 , M.A. Mazzei 2 , L. Saba 3 , R. Di Mizio 4 ,S. Cappabianca 1 , A. Rotondo 1 , R. Grassi 1 ; 1 Naples/IT, 2 Siena/IT, 3 Cagliari/IT,4Penne/IT11:24B-0058 Non-occlusive mesenteric ischaemia (NOMI) with andwithout reperfusion: CT features useful for diagnosisand their prognostic valueM.A. Mazzei 1 , G. Imbriaco 1 , S. Guerrini 1 , N. Cioffi Squitieri 1 , E. Foderà 1 ,D. Berritto 2 , P. Mercuri 1 , F.G. Mazzei 1 , L. Volterrani 1 ; 1 Siena/IT, 2 Naples/IT11:33B-0059 Diagnosis of acute arterial mesenteric ischaemia withand without reperfusion using 7T-MRI in an animalmodelD. Berritto 1 , F. Iacobellis 1 , M.P. Belfiore 1 , M.A. Mazzei 2 , L. Saba 3 , M. Scaglione 4 ,S. Cappabianca 1 , A. Rotondo 1 , R. Grassi 1 ; 1 Naples/IT, 2 Siena/IT, 3 Cagliari/IT,4Castel Volturno/IT216

Scientific Sessions11:42B-0060 The potential benefit of abdominal CT to helpdifferentiate between strains of clostridium difficileS.N. Reddy, S. Taori, I.R. Poxton, F. Ewing, D. Brown, J.T. Murchison;Edinburgh/UK10:30–12:00 Room F1Oncologic ImagingSS 116 Perfusion CT and MRI: ready for clinicalpracticeModerators: S. Delorme; Heidelberg/DE, F.A. Gallagher; Cambridge/UK10:30B-0061 Functional MRI changes in follow-up after externalbeam radiation therapy of the prostateA.M. Weidner; Mannheim/DE10:39B-0062 Acute changes in rectal cancer perfusion CTparameters during short-course radiotherapy correlatewith radiological response to therapyJ.M. Franklin, E.J. Hill, T. Pwint, F.V. Gleeson, R.A. Sharma, E.M. Anderson;Oxford/UK10:48B-0063 CT perfusion for evaluation of earlytreatment response of liver metastases after90Y-radioembolisationC.S. Reiner, F. Morsbach, B.-R. Sah, N. Schäfer, T. Pfammatter, H. Alkadhi;Zurich/CH10:57B-0064 First-pass perfusion CT on 256-detector row CT in thequantitative assessment of perfusion map for solidmalignant neoplastic liver lesions: preliminary resultsO. Minutolo, D. Ippolito, A.C. Cadonici, P.A. Bonaffini, C.R.G.L. Talei Franzesi,S. Sironi; Monza/IT11:06B-0065 CT perfusion imaging in stage II-III non-small celllung cancer patients undergoing chemo-radiotherapyevaluationof metabolic tumour activityM. Das, B. Reymen, P. Lambin, H. Sharifi, J.E. Wildberger, D. De Ruysscher,W. van Elmpt; Maastricht/NL11:15B-0066 Imaging of antivascular effects of multikinaseinhibitors (MKI) in patients with metastatic renal cellcancer (mRCC) using dynamic contrast- enhanced CT(DCE-CT, perfusion CT): a pilot studyA. Sterzik, M. Staehler, J. Casuscelli, M. Karpitschka, F. Schwarz, M.F. Reiser,A. Graser; Munich/DE11:24B-0067 Early vs late recurrent glioblastomas: added value ofT1-weighted perfusion MR imaging compared with T2-weighted perfusion MR imagingS.J. Kang, H.S. Kim, S.J. Kim, C.G. Choi; Seoul/KR11:33B-0068 Monitoring the antivascular effects of a novelmultimodal therapy with dynamic contrast-enhancedMRI (DCE-MRI) in an experimental human squamouscell carcinoma modelA. Sterzik, P. Paprottka, P. Zengel, S. Roßpunkt, E. Baloch, M. Moser,M.F. Reiser, K. Nikolaou, C. Cyran; Munich/DE11:42B-0069 Fractional 3D quantification of early contrastenhancingtumour fractions on dynamic MRIacquisitions in soft tissue sarcoma: prospectivecomparison with partial tissue-stained pathologicaltumour viability estimatesA.K. Singh, W. Cai, A. Imanzadeh, S. Saini, G. Harris; Boston, MA/US11:51B-0070 A perfusion CT-derived patient-specific arterial inputfunction for pharmacokinetic modelling of dynamiccontrast-enhanced MRIJ.M. Franklin, M. Enescu, E.J. Hill, R.A. Sharma, J.A. Schnabel, F.V. Gleeson,E.M. Anderson; Oxford/UK10:30–12:00 Room F2BreastSS 102Breast MRI: improving accuracy andtissue characterisationModerators: R. Schulz-Wendtland; Erlangen/DE, M. Telesca; Rome/IT10:30B-0071 BI-RADS®-adapted combined contrast-enhancedmagnetic resonance and diffusion-weighted imagingreading for multiparametric imaging of breast lesionsat 3T improves diagnostic accuracyK. Pinker-Domenig, H. Bickel, T.H. Helbich, S. Gruber, S. Trattnig, W. Bogner;Vienna/AT10:39B-0072 The additional value of expert reading of 3 Teslabreast MRI in patients with microcalcifications onmammographyL.G. Merckel 1 , H.M. Verkooijen 1 , N.H.G.M. Peters 1 , R.M. Mann 2 , W.B. Veldhuis 1 ,K.M. Duvivier 1 , T. van Dalen 1 , P.H.M. Peeters 1 , M.A.A.J. van den Bosch 1 ;1Utrecht/NL, 2 Nijmegen/NL10:48B-0073 Which threshold level is appropriate for analysisof the computer-aided detection system of breastMRI? Effect of pathologic tumour characteristics andbiological markersS. Song 1 , B. Seo 1 , K.-W. Hwang 2 , K. Cho 3 , O. Woo 3 ; 1 Ansan/KR, 2 Incheon/KR,3Seoul/KR10:57B-0074 The additional value of diffusion-weighted imaging(DWI) in MR-mammography: should we still look atcurves?P.A.T. Baltzer 1 , M. Dietzel 2 , J.L. Halder 3 , W.A. Kaiser 3 ; 1 Vienna/AT, 2 Erlangen/DE,3Jena/DE11:06B-0075 Apparent diffusion coefficient (ADC) measurementsof breast lesions: most suspect area versus completelesion assessmentP.A.T. Baltzer 1 , M. Dietzel 2 , J.L. Halder 3 , W.A. Kaiser 3 ; 1 Vienna/AT, 2 Erlangen/DE,3Jena/DE11:15B-0076 Combined contrast-enhanced MRI (CE-MRI) and 3Dmultivoxel proton magnetic resonance spectroscopy(3D-1H-MRSI) at 3 Tesla enables an improvedcharacterization of breast tumoursK. Pinker-Domenig, S. Gruber, W. Bogner, B. Brück, H. Bickel, P.A.T. Baltzer,T. Helbich; Vienna/ATB-0060 – B-0076Thursday217

Scientific SessionsB-0077 – B-009711:24B-0077 Application of breast MRI vs. classical prognosticfactors to predict survival in patients with primarybreast cancerM. Dietzel 1 , P.A.T. Baltzer 2 , R. Zoubi 3 , H. Habrecht 4 , C. Jerowski 4 ,I.B. Runnebaum 4 , W.A. Kaiser 4 ; 1 Erlangen/DE, Jena/DE, 2 Jena/DE, Vienna/AT,3Bielefeld/DE, Jena/DE, 4 Jena/DE11:33B-0079 Diagnosis of breast lesions using proton MRspectroscopyat 1.5 and 3 Tesla: a systematic reviewand meta-analysisP.A.T. Baltzer 1 , M. Dietzel 2 , W.A. Kaiser 3 ; 1 Vienna/AT, 2 Erlangen/DE, 3 Jena/DE11:42B-0080 Volumetric assessment of MRI enhancement kineticsof invasive breast cancers with a post-processingsoftware with correlation of hormonal receptorsubtypesL.C.H. Leong 1 , E. Gombos 2 ; 1 Singapore/SG, 2 Boston, MA/US10:30–12:00 Room G/HGenitourinarySS 107 Prostate imagingModerators: S. Morozov; Moscow/RU, J. Richenberg; Brighton/UK10:30B-0081 Reliability of the PI-RADS scoring system forfunctional prostate MRIM. Quentin, L. Schimmoeller, C. Arsov, R. Rabenalt, R. Lanzman, G. Antoch,P. Albers, D. Blondin; Düsseldorf/DE10:39B-0082 Preoperative multiparametric magnetic resonanceimaging (mp-MRI) reduces positive surgical marginsafter robotic-assisted laparoscopic prostatectomy(RALP): experience in 136 patientsS. Alessi, G. Petralia, G. Musi, A. Alconchel, G. Bardo, S. Raimondi, G. Renne,O. De Cobelli, M. Bellomi; Milan/IT10:48B-0083 The cost-effectiveness of MRI and MR-guided biopsyversus TRUS-guided biopsy in the diagnosis ofprostate cancerS. Crienen, M. de Rooij, J.O. Barentsz, J.A. Witjes, J.P.C. Grutters, M.M. Rovers;Nijmegen/NL10:57B-0084 Quantitative shear wave elastography: detection andcharacterisation of prostate cancer on 105 patientsJ.-M. Correas, A. Khairoune, A.-M. Tissier, V. Vassiliu, A. Méjean, O. Hélénon;Paris/FR11:06B-0085 3T multi-parametric ultrahigh b values (b 2000) MRimaging for detection and localisation of peripheraland transition zone prostate cancerG. Manenti, M. Nezzo, S. Altobelli, M. Antonicoli, S. Capuani, G. Simonetti;Rome/IT11:15B-0086 Analysis of the dependence on b-values of DWI signalmodel outcomes in peripheral healthy and cancerousprostate tissuesS. Lucarini, L.N. Mazzoni, S. Chiti, S. Busoni, C. Gori, I. Menchi; Florence/IT11:24B-0087 Comparison of diffusional kurtosis imaging and monoexponentialDWI model in distinguishing healthy fromcancerous peripheral prostate tissuesS. Lucarini, L.N. Mazzoni, S. Chiti, S. Busoni, C. Gori, I. Menchi; Florence/IT11:33B-0088 MRI+MRSI reliably detects and excludes high-gradeprostate cancer in patients with elevated PSAG.M. Villeirs, J. Schatteman, P.J. De Visschere, G.O. De Meerleer, N. Lumen,W. Oosterlinck; Gent/BE11:42B-0089 Correlation between 1H-MR spectroscopy andhaematochemical evaluation (PSA) in patientsundergoing radiation therapy for prostate cancerF. Barchetti, V. Panebianco, A. Pace, V. Forte, V. Forte, V. Tombolini, C. Catalano;Rome/IT11:51B-0090 The role of 3 T diffusion imaging in prostate cancerrecurrence after radical prostatectomyF. Barchetti, V. Panebianco, V. Forte, A. Pace, V. Tombolini, C. Catalano; Rome/IT10:30–12:00 Room I/KAbdominal VisceraSS 101b Liver fibrosis and cirrhosis:elastography and biomarkersModerators: R. Faschingbauer; Innsbruck/AT, T.J. Kroencke; Berlin/DE10:30B-0091 Estimation of reference values for liver elasticity inbiopsy-proven normal liver using Supersonic ShearWave imaging: measurement reliability and effect ofsteatosisC. Suh, S. Kim, K. Kim; Seoul/KR10:39B-0092 Accuracy of a new real-time shear wave elastographytechnique in the assessment of significant liverfibrosis: preliminary resultsG. Ferraioli, C. Tinelli, B. Dal Bello, R. Lissandrin, M. Zicchetti, C. Filice; Pavia/IT10:48B-0093 MR elastography for predicting progression ofcirrhosisU. Motosugi, T. Takamura, T. Ichikawa, K. Sano, H. Morisaka, S. Ichikawa,T. Araki; Yamanshi/JP10:57B-0094 Evaluation of shear wave elastography for liverfibrosis quantificationA. Guibal, T. Lefort, C. Cohen-Bacrie, G. Renosi, J. Scoazec, J. Dumortier,P. Valette; Lyon/FR11:06B-0095 Evaluation of shear wave elastography to monitordevelopment of fibrosis after liver transplantationO. Kolokythas 1 , R. Bhattacharya 1 , I.W. Liou 1 , A. Kang 1 , P. Bhargava 1 ,L.M. Mitsumori 1 , C. Cuevas 1 , M.F. Bruce 2 ; 1 Seattle, WA/US, 2 Aix-en-Provence/FR11:15B-0096 The efficacy of Gadoxetate Disodium-enhancedmagnetic resonance (MR) imaging in staging liverfibrosisD.S. Feier 1 , C. Balassy 2 , N. Bastati-Huber 2 , J. Stift 2 , R. Badea 1 , A. Ba-Ssalamah 2 ;1Cluj-Napoca/RO, 2 Vienna/AT11:24B-0097 Differential portal venous flow response to terlipressinin normal and cirrhotic rats: non-invasive assessmentusing phase-contrast MRIM. Chouhan, A. Bainbridge, N. Davies, R. Mookerjee, R. Jalan, S. Walker-Samuel,M. Lythgoe, S. Punwani, S.A. Taylor; London/UK218

Scientific Sessions11:33B-0098 Evaluation of T1rho as a potential MR biomarker forliver cirrhosis: comparison of healthy control subjectsand patients with liver cirrhosisI. Rauscher 1 , C. Ganter 1 , P. Martirosian 2 , E.J. Rummeny 1 , K. Holzapfel 1 ;1Munich/DE, 2 Tübingen/DE11:42B-0099 Biomarkers of nonalcoholic fatty liver diseasediagnosed by 1H SRM 3TJ. Martin-Rodriguez, J. Arrebola, J. Gonzalez-Calvin; Granada/ES11:51B-0100 Absolute quantification of phosphorus compounds inthe liver on a clinical 3T scannerA. Laufs 1 , R. Livingstone 2 , S. Kahl 1 , B. Nowotny 1 , B. Klueppelholz 1 , G. Giani 1 ,J. Bunke 3 , J.-H. Hwang 1 , M. Roden 1 ; 1 Düsseldorf/DE, 2 Vellore/IN, 3 Hamburg/DE10:30–12:00 Room L/MPhysics in RadiologySS 113 Multi modality imaging and MR safetyModerators: O. Ciraj-Bjelac; Belgrade/RS, O. Speck; Magdeburg/DE10:30B-0101 MR tumour perfusion measurements: dual echo versusmulti-echo approachV. Hietschold, M. Riebisch, A. Abramyuk, M. Laniado, N. Abolmaali; Dresden/DE10:39B-0102 PET/MR imaging of the pelvis in the presence ofendoprostheses: reducing image artefacts andincreasing accuracy through inpaintingC.N. Ladefoged, F. Andersen, S. Keller, J. Löfgren, A.E. Hansen, S. Holm,L. Hojgaard, T. Beyer; Copenhagen/DK10:48B-0103 Combined PET/MR imaging: the effect of ignoring boneduring MR-based attenuation correction in oncologyimagingJ. Saa, J. Löfgren, R. Sersar, M. Aznar, C. Ladefoged, F. Andersen, R. Larsen,T. Beyer; Copenhagen/DK10:57B-0104 Assessment of the performance of TOF-PET and PETreconstructions on edge definition of cold regions inthe presence of solitary hot spots and low count-ratestudiesY. Bouchareb 1 , M. Masoomi 2 , M. Newell 1 ; 1 London/UK, 2 Portsmouth/UK11:06B-0105 The incidence of biological effects from 3.0 Tesla (T)MRI compared to 1.5 T: an observational study in 911consecutive outpatientsF. Alghamdi, P. Bertrand, L. Barantin, M.A. Lauvin, X. Cazals, F. Domengie,R. Bibi, D. Herbreteau, J.-P. Cottier; Tours/FR11:15B-0106 Static magnetic fields in 1.5 and 3 T MR scanners donot influence perception of pain and touch comparedwith placebo expositionA. Pomschar, K. Kamm, R. Ruscheweyh, R. Laubender, M.F. Reiser, A. Straube,B. Ertl-Wagner; Munich/DE11:24B-0107 Safety and efficiency of low-field magnetic resonanceimaging in patients with cardiac rhythm managementdevicesC. Schukro, M. Lee; Vienna/AT11:33B-0108 Possible hazardous effect of “MR safe” metallicimplants for workersN. Oberhofer 1 , P. Ferrari 2 ; 1 Bolzano/IT, 2 Mattarello/IT11:42B-0109 Swedish national study on modality choice andjustification of CT, MRI and US examinations inchildrenB. Isberg 1 , H. Jorulf 2 , U. Svahn 1 , S. Richter 1 , W. Leitz 1 ; 1 Stockholm/SE,2Uppsala/SE11:51B-0110 In vitro comparison of ultrasound-based elastographytechniquesS. Franchi-Abella 1 , J.-M. Correas 2 , C. Elie 2 ; 1 Le Kremlin-Bicêtre/FR, 2 Paris/FR10:30–12:00 Room N/OVascularSS 115Carotid plaque evaluationModerators: M.A. Aschauer; Graz/AT, D. Filippiadis; Athens/GR10:30B-0111 Arterial stiffness is associated with carotid intraplaquehaemorrhage in the general population: the RotterdamstudyM. Selwaness, Q. van den Bouwhuijsen, F.U.S. Mattace-Raso, G. Verwoert,A. Hofman, O.H. Franco, J.J. Wentzel, J. Witteman, A. van der Lugt;Rotterdam/NL10:39B-0112 Evaluation of carotid atherosclerotic plaque with labbasedX-ray phase-contrast imagingH. Hetterich 1 , S. Fill 1 , M. Willner 2 , F. Bamberg 1 , J. Herzen 2 , A. Hipp 2 , M.F. Reiser 1 ,F. Pfeiffer 2 , T. Saam 1 ; 1 Munich/DE, 2 Garching/DE10:48B-0113 Meta-analysis and systematic review of the predictivevalue of carotid plaque haemorrhage by magneticresonance imaging on cerebrovascular eventsT. Saam 1 , H. Hetterich 1 , V. Hoffmann 2 , C. Yuan 3 , M. Treitl 1 , M. Dichgans 1 ,H. Poppert 1 , M.F. Reiser 1 , F. Bamberg 1 ; 1 Munich/DE, 2 Neuherberg/DE,3Seattle, WA/US10:57B-0114 Genetic loci for coronary calcification and serum lipidsrelate to aortic and carotid calcificationD. Bos, M.A. Ikram, A. Isaacs, B.F.J. Verhaaren, A. Hofman, C.M. van Duijn,J.C.M. Witteman, A. van der Lugt, M.W. Vernooij; Rotterdam/NL11:06B-0115 Is carotid intima-media (IMT) and extra mediathickness (EMT) a surrogate marker of earlyatherosclerosis in patients with inflammatory boweldisease?A. Oikonomou, E. Astrinakis, P. Zezos, N. Courcoutsakis, A. Mpampali,I. Karatzoglou, G. Kouklakis, P. Prassopoulos; Alexandroupolis/GR11:15B-0116 Assessment of microvasculature in atheroscleroticplaque with dynamic contrast-enhanced-MRI: modelcomparison, reproducibility and validation withhistologyM.E. Kooi 1 , M.E. Gaens 1 , R.H.M. van Hoof 1 , J.C. Sluimer 1 , S. Heeneman 1 ,M.J.A.P. Daemen 2 , J.E. Wildberger 1 , R.M. Kwee 1 , W.H. Backes 1 ; 1 Maastricht/NL,2Amsterdam/NL11:24B-0117 Effect of expansive arterial remodelling on clinicalpresentation and plaque composition: an in vivo MRIstudy of the carotid arteriesA. Helck 1 , M. Buchholz 1 , A. Rominger 1 , C. Yuan 2 , M.F. Reiser 1 , K. Nikolaou 1 ,M. Dichgans 1 , A. Karpinska 1 , T. Saam 1 ; 1 Munich/DE, 2 Seattle, WA/USB-0098 – B-0117Thursday219

Scientific SessionsB-0118 – B-013911:33B-0118 Determination of the vascular input function usingmagnitude or phase-based MRI: influence on dynamiccontrast-enhanced MRI model parameters in carotidplaquesR.H.M. van Hoof 1 , M.T.B. Truijman 1 , E. Hermeling 1 , R.J. van Oostenbrugge 1 ,R.J. van der Geest 2 , M.J.A.P. Daemen 3 , J.E. Wildberger 1 , W.H. Backes 1 , M.E. Kooi 1 ;1Maastricht/NL, 2 Leiden/NL, 3 Amsterdam/NL11:42B-0119 Low does CT angiography using iterativereconstruction for the assessment of carotid arterystenosisL. Crush, M. O‘Keeffe, B. Normoyle, F. O‘Neill, E.M. Canniff, P.D. Mc Laughlin,S. O‘Neill, O. O‘Connor, M.M. Maher; Cork/IE11:51B-0120 Determining the vulnerable plaque: correlationbetween 18F-FDG PET and dynamic contrast-enhancedMRI in atherosclerotic plaques of symptomaticpatientsM.T.B. Truijman, R.M. Kwee, R.H.M. van Hoof, R.J. van Oostenbrugge, W.H. Mess,J.E. Wildberger, W.H. Backes, J.A. Bucerius, M.E. Kooi; Maastricht/NL10:30–12:00 Room PEmergency RadiologySS 117 An update on emergency thoracoabdominalimagingModerators: B. Feragalli; Chieti/IT, A. Huete; Santiago/CL10:30B-0121 Emergency CT: what is missed at first reading?A. Platon, G. Varnay, C.D. Becker, P.-A. Poletti; Geneva/CH10:39B-0122 Traumatic aortic injury: what is changing?J.M. Artigas 1 , M. Martí De Gracia 2 , J.A. Soto 3 , A. Garcia-Valiente 1 , M. Marini 4 ,P. Parrilla 1 ; 1 Zaragoza/ES, 2 Madrid/ES, 3 Boston, MA/US, 4 A Coruña/ES10:48B-0123 Comparison between dedicated coronary CTangiogram and triple rule out using 320 multislice CTin cases of acute chest painY. Ragab, H. Hamza, H. Awadalla; Cairo/EG10:57B-0124 Can the presence of active or recent bleeding in CTangio of acute lower intestinal bleeding be predicted?M. Marti de Gracia 1 , J.M. Artigas Martín 2 , J.A. Soto 3 , A. Borobia 1 , A. Vicente 1 ,G. Garzón 1 ; 1 Madrid/ES, 2 Zaragoza/ES, 3 Boston, MA/US11:06B-0125 Accuracy of the AAST organ injury scale as a CTimaging checklist for traumatic liver and spleeninjuriesG. Homann 1 , C.M. Toschke 2 , P. Gaßmann 3 , U. Hanning 1 , W. Heindel 1 , V. Vieth 1 ;1Münster/DE, 2 Ahlen/DE, 3 Mainz/DE11:15B-0126 Comparison of efficacy and safety between distalembolization and augmented embolization techniquesfor treating blunt splenic injuries with activehaemorrhageY.-C. Wong, L.-J. Wang, C.-H. Wu, H.-W. Chen; Taoyuan/TW11:24B-0127 Diagnostic performance of MDCT in the evaluation ofbowel obstruction: can the radiologist‘s experiencemake a difference?A. Ferri, R. Basilico, N. Civitareale, A. Lella, V. Calamita, A. Cotroneo; Chieti/IT11:33B-0128 Diagnosis of bowel obstruction performed by MSCT inemergency department compared with the surgicalfindingsE. Capalbo, F. Sajadidhekrodi, M. Cosentino, M. Peli, M. Lovisatti, A. Kluzer,S. Fornari, M. Cariati; Milan/IT11:42B-0129 Accuracy of ultrasonographic diagnosis of acuteappendicitis in pregnant womenN. Kokhanovsky, A.-R. Zeina, N. Reindorp, A. Levit-Kantor, Y. Glick, A. Nachtigal;Hadera/IL11:51B-0130 Quality assessment of out sourced after-hourscomputed tomography teleradiology reports in acentral London University HospitalJ. Hohmann 1 , P. de Villiers 1 , C. Urigo 2 , D. Sarpi 1 , C. Newerla 3 , J. Brookes 1 ;1London/UK, 2 Lugano/CH, 3 Basle/CH10:30–12:00 Room QRadiographersSS 114 Importance of education in practiceModerators: R. Ribeiro; Lisbon/PT, T. Roding; Haarlem/NL10:30B-0131 Risk management in radiology: applying failuremode effects and criticality analysis in computertomographyM. Antoniutti, C. Maso, N. Vecchiato, S. Doratiotto; Treviso/IT10:39B-0132 How important is the experience in breast imaging forradiographers performing breast-MRI?P. Clauser, V. Londero, C. Molinari, R. Girometti, S. Da Dalt, C. Zuiani,M. Bazzocchi; Udine/IT10:48B-0133 Radiography authorship: a European and internationalreviewB. Snaith; Wakefield/UK10:57B-0134 The influence of clinical placement setting onacademic achievement within an undergraduatediagnostic radiography programmeE. Lewis, M. Hardy; Bradford/UK11:06B-0135 Use of radiation in operating theatres in FinlandP. Heikkilä 1 , A. Henner 1 , P. Tenkanen-Rautakoski 2 , M. Pirinen 2 , S.-M. Ahonen 1 ;1Oulu/FI, 2 Helsinki/FI11:15B-0136 Information-seeking behaviour of radiographersL. Sancho 1 , A.F.C.L. Abrantes 1 , L.P.V. Ribeiro 1 , R.P.P. Almeida 1 , S.I. Rodrigues 1 ,C.A. Silva 2 ; 1 Faro/PT, 2 Evora/PT11:24B-0137 Dose reduction in computer tomography, the effectsof technologist training on the number of extraanatomic imagesT.W.F. Pappot, M.E.J. Pijl; Arnhem/NL11:33B-0138 Evidence-based practice in radiologyM. Dias 1 , A.F.C.L. Abrantes 1 , C.A. Silva 2 , R.P.P. Almeida 1 , L.P.V. Ribeiro 1 ,J. Pinheiro 1 , K.B. Azevedo 1 ; 1 Faro/PT, 2 Evora/PT11:42B-0139 Radiographers quality assurance work: resistance andcooperationR. Gullien, J.G. Andersen, A.E. Haakull; Oslo/NO220

Scientific Sessions11:51B-0140 Radiographers‘ knowledge about adverse reactions toiodinated contrast mediaA. Santos, L. Capitolina, I. Silva, A. Saraiva; Coimbra/PT10:30–12:00 Room ZComputer ApplicationsSS 105 IT infrastructure, learning support andteleradiologyModerators: B. Gibaud; Rennes/FR, A. Simisker; Tartu/EE10:30B-0141 Development of the ViSion ontologyD.J. Vining 1 , U. Salem 1 , C. Popovici 2 , L. Jiang 3 , C. Duran 1 , A. Pitici 2 , I. Aghenitei 2 ,M. Jurca 2 , R. Rosu 2 ; 1 Houston, TX/US, 2 Chapel Hill, NC/US, 3 Beijing/CN10:39B-0142 IT infrastructure to support secondary use of routinelyacquired clinical imaging data for researchK. Leung, F. Van der Lijn, H.A. Vrooman, W.J. Niessen, M.C.J.M. Sturkenboom;Rotterdam/NL10:48B-0143 Interactive methods improve radiology long-termlearningJ.C. Pueyo, J. Etxano, P. Slon, R. Zalazar, J. Ros, L. García del Barrio, G. Bastarrika,A. Villanueva; Pamplona/ES10:57B-0144 The radiology events register (RaER): incidentreporting in radiologyC. Mandel 1 , T. Schultz 2 , N. Hannaford 2 , J. Grimm 3 ; 1 Melbourne/AU, 2 Adelaide/AU,3Sydney/AU11:06B-0145 The liver imaging atlas: an interactive multimodalityweb-based reference and educational resource of liverimagingO. Kolokythas, S. Zaidi, S. Osman, A.P. Tornow, T.T. Pham, S. Bastawrous,G.S. Phillips, P. Bhargava, D.L. Coy; Seattle, WA/US11:15B-0146 Evaluation of teleradiology and telemedicineregarding financial and personnel benefit for regionswith low population densityM.C. Spoerl, N. Hosten; Greifswald/DE11:24B-0147 Fast search for radiology cases in hospital systems viacontent-based image retrievalG. Langs 1 , R. Donner 1 , M. Holzer 1 , D. Markonis 2 , H. Mueller 2 , E. Birngruber 1 ;1Vienna/AT, 2 Sierre/CH11:33B-0148 Internet-based surveys among referring in-hospitalclinicians and radiologists: a useful tool to evaluatereport quality and interdisciplinary co-operationC. Neumann, O. Khalifa, D. Tscholakoff, G. Mostbeck; Vienna/AT11:42B-0149 Cross regional diagnostic radiology network forpreoperative assessment of colorectal cancer:preliminary experiencesL.C.O. Blomqvist 1 , C. Kling-Hassler 1 , A. Sjövall 1 , T. Almqvist 1 , P. Asp 1 ,H. Walfridsson 2 , R. Sundqvist 1 , U. Hertin 1 ; 1 Stockholm/SE, 2 Sollentuna/SE14:00–15:30 Room CHead and NeckSS 208 Head and neck cancer: functionalimaging and hybrid modalitiesModerators: N. Abolmaali; Dresden/DE, S. Steens; Nijmegen/NL14:00B-0150 CT perfusion of head and neck lymph nodes:differentiation between untreated and treatedlymphomaA.M. Tawfik 1 , N.M. Batouty 1 , A.A. Razek 1 , S. Eteiba 1 , M.A. Shaheed 1 , T.J. Vogl 2 ;1Mansoura/EG, 2 Frankfurt am Main/DE14:09B-0151 Prediction of treatment response in head and neckcarcinomas using IVIM-DWI: evaluation of lymph nodemetastasisT. Hauser 1 , M. Essig 2 , F.B. Laun 1 , M. Münter 3 , A. Jensen 1 , K.H. Fritsche 1 ,B. Stieltjes 1 ; 1 Heidelberg/DE, 2 Erlangen/DE, 3 Stuttgart/DE14:18B-0152 Combined perfusion-diffusion-weighted MRI forstaging of recurrent papillary thyroid cancer: afeasibility studyK.N.A. De Paepe, R. Hermans, F. De Keyzer, V. Vander Poorten, S. Nuyts,E. Hauben, B. Decallonne, M. Bex, V. Vandecaveye; Leuven/BE14:27B-0153 Diagnostic evaluation of patients with squamouscell cancer of the head and neck after free flapreconstructions – the usefulness of functionalimaging techniquesM. Członkowski, A. Trojanowska, P. Trojanowski, J. Klatka, A. Drop; Lublin/PL14:36B-0154 The role of MRI and FDG PET/CT imaging in thedetection of unknown primary tumours with cervicalmetastasesA. Lévai; Budapest/HU14:45B-0155 Diffusion-weighted MR imaging in characterization ofhead and neck lesionsF.U. Öztürk, F.Y. Dönmez, F. Kural, S. Çetiner, M. Ağıldere; Ankara/TR14:54B-0156 Comparison of contrast-enhanced PET/CT and PET/MRI with only T2-weighted images in patients withhead and neck cancer – how much MR information isneeded in PET/MRI?F.P. Kuhn, M. Hüllner, S.S. Kollias, G.K. Von Schulthess, P. Veit-Haibach;Zurich/CH15:03B-0157 Comparison of contrast-enhanced PET/MRI andcontrast-enhanced PET/CT in patients with head andneck cancersF.P. Kuhn, M. Hüllner, S.S. Kollias, G.K. Von Schulthess, P. Veit-Haibach;Zurich/CH15:12B-0158 Initial clinical results of simultaneous PET/MRI incomparison with PET/CT in patients with head andneck cancerP. Stumpp, K. Kubiessa, S. Purz, M. Gawlitza, A. Kühn, K.G. Steinhoff, A. Boehm,R. Kluge, T. Kahn; Leipzig/DE15:21B-0159 Diagnostic accuracy of 18 F-FDG-PET/CT and fused18F-FDG-PET-MR images for T and N staging of primaryoral malignanciesP. Heusch 1 , C. Buchbender 1 , C. Sproll 1 , J. Terjung 2 , A. Scherer 1 , G. Antoch 1 ,J. Handschel 1 , T.A. Heusner 1 ; 1 Düsseldorf/DE, 2 Essen/DEB-0140 – B-0159Thursday221

Scientific SessionsB-0160 – B-017914:00–15:30 Room D1ChestSS 204Airways and infiltrative lung diseasesModerators: G.R. Ferretti; Grenoble/FR, C. Mueller-Mang; Vienna/AT14:00B-0160 How does iterative image reconstruction effectemphysema quantification with chest CT?H. Jafarov 1 , C. Fink 2 , H. Haubenreisser 1 , M. Meyer 1 , P. Apfaltrer 1 , S.O. Schönberg 1 ,T. Henzler 1 ; 1 Mannheim/DE, 2 Celle/DE14:09B-0161 Assessing pulmonary perfusion in emphysema:automated quantification of perfused blood volume indual-energy CTPAF.G. Meinel, A. Graef, S.F. Thieme, F. Bamberg, C. Neurohr, M.F. Reiser,T.R.C. Johnson; Munich/DE14:18B-0162 Densitometry on MDCT in cystic fibrosis: radiologicalevidence for emphysemaM.O. Wielpütz 1 , O. Weinheimer 2 , M. Eichinger 1 , M. Wiebel 1 , J. Biederer 1 ,H.-U. Kauczor 1 , C.-P. Heussel 1 , M.A. Mall 1 , M. Puderbach 1 ; 1 Heidelberg/DE,2Mainz/DE14:27B-0163 The effect of inspiration on airway dimensionsmeasured in CT images from the Danish Lung CancerScreening TrialJ. Petersen 1 , M.M.W. Wille 2 , L.H. Thomsen 2 , A. Feragen 1 , A. Dirksen 2 , M. deBruijne 3 ; 1 Copenhagen/DK, 2 Hellerup/DK, 3 Rotterdam/NL14:36B-0164 Chronic bronchitis in large airway: airway wallmeasurements on thin-slice low-dose CTX. Xie, A.E. Dijkstra, J.M. Vonk, M. Oudkerk, H.J.M. Groen, R. Vliegenthart;Groningen/NL14:45B-0165 Value of inspiratory and expiratory lung volume undlung density for detection of bronchiolitis obliteranssyndrome (BOS): a feasibility studyS. Dettmer 1 , O. Otten 1 , C. de Wall 1 , J.-M. Kuhnigk 2 , F. Wacker 1 , H.-O. Shin 1 ;1Hannover/DE, 2 Bremen/DE14:54B-0166 Value of density mappings in computed tomographyfor detection of bronchiolitis obliterans syndrome(BOS)S. Dettmer, T. Kaireit, O. Solyanik, C. de Wall, F. Wacker, H.-O. Shin;Hannover/DE15:03B-0167 Feasibility of krypton ventilation for CT imaging oflung ventilation: preliminary animal dataA.H. Mahnken 1 , G. Jost 2 , H. Pietsch 2 ; 1 Marburg/DE, 2 Berlin/DE15:12B-0168 Quantification of idiopathic pulmonary fibrosis bysemiquantitative HRCT score: correlation betweenradiologists and pulmonary function testsL. Navarro Vilar, M.L. Domingo Montañana, R. Peris Sanchez, E. FernandezFabrellas, C. Ramírez Fuentes, J. Vilar Samper; Valencia/ES15:21B-0169 High-resolution computed tomography (HRCT) of thelungs in brain dead pigs: a feasibility studyG. Bozovic 1 , S. Steen 1 , T. Sjöberg 1 , C. Schaefer-Prokop 2 , J. Verschakelen 3 ,Q. Liao 1 , R. Siemund 1 , I. Björkman-Burtscher 1 ; 1 Lund/SE, 2 Amersfoort/NL,3Leuven/BE14:00–15:30 Room D2Interventional RadiologySS 209 Ablation and biopsy of the prostateand the kidneyModerators: J.J. Fütterer; Nijmegen/NL, J. Kettenbach; Berne/CH14:00B-0170 1.5T magnetic resonance-guided transgluteal biopsiesof the prostate in patients with clinically suspectedprostate cancer: technique and feasibilityB. Bodelle, N.N.N. Naguib, K. Eichler, T.J. Vogl, S. Zangos; Frankfurt/DE14:09B-0171 Magnetic resonance-guided biopsy (MRGB) incombination with multiparametric MRI (mpMRI) afternegative transrectal guided ultrasound (TRUS) biopsyof the prostateS. Polanec, T. Helbich, K. Pinker-Domenig, S. Leitner, P. Brader; Vienna/AT14:18B-0172 MRI-guided biopsy of the prostate: evaluation ofpatient acceptance and adverse effectsT. Franiel, N. Egbers, C. Schwenke, A. Maxeiner, C. Stephan, B. Hamm; Berlin/DE14:27B-0173 MRI+US fusion-guided prostate biopsy and ablationH. Amalou, S. Xu, P. Pinto, B. Wood; Bethesda, MD/US14:36B-0174 Non-invasive focal therapy of organ confined prostatecancer: phase I study using magnetic resonanceguided focused ultrasound technology and excisionpathology for efficacy assessmentA. Napoli, V. Panebianco, M. Anzidei, F. Boni, V. Noce, L. Bertaccini, G. Cartocci,F. Ciolina, C. Catalano; Rome/IT14:45B-0175 Technical challenges, pitfalls and obstacles onperforming prostatic artery embolisation for benignprostatic hyperplasiaH.A.M.R. Rio Tinto, T. Bilhim, L. Fernandes, J. Pereira, J.M. Pisco; Lisbon/PT14:54B-0176 Mid-term results of percutaneous image-guidedradiofrequency ablation of renal tumoursP. Balageas, F. Cornelis, Y. Le Bras, J.-M. Ferrière, A. Ravaud, N. Grenier;Bordeaux/FR15:03B-0177 Retrospective study of renal tumors treated with radiofrequency ablation at Uppsala University Hospitalsince 2007: which factors affect ablation results?V. Acosta Ruiz, A. Magnusson, P. Dahlman, E. Brekkan, M. Lönnemark;Uppsala/SE15:12B-0178 Irreversible electroporation (IRE) of the pig kidneywith involvement of the renal pelvis – technicalaspects, clinical outcome and 3d lesion analysisC.M. Sommer, M.F. Wachter, S. Fritz, D. Vollherbst, U. Stampfl, N. Bellemann,T. Gockner, T. Mokry; Heidelberg/DE15:21B-0179 Retrograde ureteral stent exchange: comparisonbetween the direct grasping and the simple snaretechniqueR. Cazzato, R. Grasso, G. Luppi, E. Faiella, R. Del Vescovo, F. Giurazza,B. Beomonte Zobel; Rome/IT222

Scientific Sessions14:00–15:30 Room E1MusculoskeletalSS 210 Lower limb: tricks for improvedimagingModerators: A. Klauser; Innsbruck/AT, L.M. Sconfienza; Milan/IT14:00B-0180 MR imaging of articular cartilage at the ankle: utilityof axial tractionJ.S. Bauer, P. Jungmann, C. Schäffeler, M. Sauerschnig, A. Mann, T. Baum,E.J. Rummeny, K. Wörtler; Munich/DE14:09B-0181 Do sagittal and coronal alignment of the hindfootchange in upright weight-bearing position?Comparison of upright weight-bearing and supine nonweight-bearingcomputed tomographyA. Hirschmann, C.W.A. Pfirrmann, N. Espinosa, G. Klammer, F.M. Buck; Zurich/CH14:18B-0182 MRI in plantar plate disease evaluation: diagnosticvalue of ‚stress test‘C. Ottonello, I. D‘Ambrosio, P. Giuliani, P. Ronconi; Rome/IT14:27B-0183 Stable or unstable tear of the medial meniscus of theknee: can weight-bearing MRI solve the problem?A. La Marra, S. Mariani, E. Costantini, A. Conchiglia, A. Barile, C. Masciocchi;L‘Aquila/IT14:36B-0184 Periosteal high volume image-guided injection ofrecalcitrant medial collateral ligament injuries: aretrospective case series analysisO. Drumm, O. Chan, P. Malliaras, D. Morrissey, N. Maffulli; London/UK14:45B-0185 Ischiofemoral impingement, do you want to believe?R. Prada, R. Oca, A. Rocha, L. Fernández, M. Costas, G. Tardáguila; Vigo/ES14:54B-0186 US-guided viscosupplementation of the hip:therapeutic efficacy in patients affected by femoroacetabularimpingmentC. Martini 1 , F. Lacelli 2 , E. Fabbro 1 , G. Ferrero 1 , G. Serafini 2 ; 1 Genoa/IT,2Pietra Ligure/IT14:00–15:30 Room E2GI TractSS 201aBowel imaging: protocol optimisationand interventionModerators: V. Cantisani; Rome/IT, P. Popovic; Ljubljana/SI14:00B-0190 Abdominal and pelvic CT: is positive enteric contraststill necessary? Preliminary results of a clinicalinvestigationS. Kammerer, A. Knauer, B. Buerke, C. Schuelke, W.L. Heindel, J. Wessling;Münster/DE14:09B-0191 Value of oral effervescent powder administration formultidetector CT evaluation of the oesophagusK.I. Ringe, S. Meyer, F. Wacker, H.-J. Raatschen; Hannover/DE14:18B-0192 Prospective study of using balloon duodenographycatheters in CT enteroclysis for small bowel diseasesK.C.H. Lau, L.M.F. Tee; Hong Kong/HK14:27B-0193 Role of preoperative imaging with multidetectorcomputed tomography (MDCT) in the management ofpatients with gastroesophageal reflux disease (GERD)symptoms, candidate to sleeve surgical revisionM. Rengo, D. Caruso, F. Vecchietti, M.M. Maceroni, G. Silecchia, A. Laghi;Latina/IT14:36B-0194 Accuracy of MDCT in preoperative definition ofmaximum tumour diameter in patients with gastriccancerM.A. Mazzei, S. Guerrini, N. Salvini, P. Mercuri, A. Parrinello, N. Cioffi Squitieri,D. Marrelli, F.G. Mazzei, L. Volterrani; Siena/IT14:45B-0195 Percutaneous endoscopic gastrostomy (PEG) andjejunostomy (PEJ) placement guided by CT fluoroscopywith or without simultaneous endoscopy in otherwiseuntreatable patientsC.G. Trumm 1 , R.-T. Hoffmann 2 , R.A. Lang 3 , H. Winter 1 , R. Weidenhagen 1 ,K.-W. Jauch 1 , M.F. Reiser 1 , F.W. Spelsberg 1 ; 1 Munich/DE, 2 Dresden/DE,3Ottobeuren/DEB-0180 – B-0199Thursday15:03B-0187 A new way to measure lower limb length andalignment using 3D models based on biplanar linearradiography: a comparison with measurements onsupine CT scans and upright full-length radiographsR. Guggenberger, C.W. Pfirrmann, P. Koch, F. Buck; Zurich/CH15:12B-0188 Dynamic contrast-enhanced MRI can assessvascularity within pseudarthrotic clefts and predictsgood clinical outcomeM.-A. Weber 1 , K. Bloess 1 , I. Burkholder 2 , D. Bender 1 , G. Schmidmaier 1 , H.-U. Kauczor 1 , O. Schoierer 1 ; 1 Heidelberg/DE, 2 Zweibrücken/DE15:21B-0189 Osteoidosteoma – post-procedural MR-imagingcharacteristics following percutaneous MR-guidedlaser ablation in an open 1.0 Tesla MRIS. Fuchs, B. Gebauer, L. Stelter, M. Maurer, D. Renz, P. Schwabe, B. Hamm,F. Streitparth; Berlin/DE14:54B-0196 CT assessment of post-resection arterial stumps forright-sided colorectal cancer: a potential marker ofquality of resection?T.L. Kaye, D.G. Jayne, N.P. West, D.J.M. Tolan; Leeds/UK15:03B-0197 Evaluation of Crohn‘s disease recurrence in patientswith ileocolic anastomosis: value of computedtomography enterography with water enemaF. Paparo, M. Revelli, C. Puppo, I. Garello, L. Bacigalupo, L. Rollandi, R. Piccazzo,A. Garlaschi, G.A. Rollandi; Genoa/IT15:12B-0198 Crohn‘s disease activity: correlation of inflammatorymediators with overall small-bowel motilityS. Bickelhaupt 1 , S. Pazahr 1 , J.M. Froehlich 1 , R. Cattin 2 , H. Bouquet 3 , G. Rogler 1 ,P. Frei 1 , A. Boss 1 , M. Patak 1 ; 1 Zurich/CH, 2 Biel/CH, 3 Berne/CH15:21B-0199 Pilot study to assess the diagnostic performance ofMRI in the identification of adhesions between theabdominal wall and small bowel loops, using a timeefficientprotocolA. Gupta, A. Hansmann, P.F.C. Lung, R. Tandon, R. Ilangovan, M. Marshall;Middlesex/UK223

Scientific SessionsB-0200 – B-021714:00–15:30 Room F1Oncologic ImagingSS 216 New biomarkers for tumourquantificationModerators: C.J. Herold; Vienna/AT, C. Keyzer; Brussels/BE14:00B-0200 3D CT-histogram analysis enables distinguishingaffected and FDG-negative lymph nodes in patientswith lung cancerP. Flechsig 1 , C. Kratochwil 1 , J. Moltz 2 , C.-p. Heussel 1 , R. Talanow 1 , H.-U. Kauczor 1 ,U. Haberkorn 1 , F.L. Giesel 1 ; 1 Heidelberg/DE, 2 Bremen/DE14:09B-0201 Tumour vascularization imaging without contrastagents: the potential of IVIM-MRIM. Iima 1 , O. Reynaud 2 , T. Tsurugizawa 2 , L. Ciobanu 2 , J.-R. Li 2 , F. Geffroy 2 ,B. Djemai 2 , D. Le Bihan 2 ; 1 Kyoto/JP, 2 Gif-sur-Yvette/FR14:18B-0202 Intravoxel incoherent motion (IVIM) diffusionweightedMRI for monitoring the therapeutic efficacyof a vascular disrupting agent (CKD-516) in rabbit VX2liver tumoursI. Joo, J. Lee, J. Han, B. Choi; Seoul/KR14:27B-0203 Texture analysis on contrast-enhanced computedtomography combined with FDG-PET in predicting theresponse to chemotherapy of advanced non-small celllung cancerM. Ravanelli, F. Ferraroni, D. Farina, M. Morassi, P. Tessitore, P. Rossini,R. Maroldi; Brescia/IT14:36B-0204 Texture analysis of advanced non-small cell lungcancer on contrast-enhanced computed tomography:prediction of the response to the first-linechemotherapyM. Ravanelli, M. Morassi, D. Farina, E. Roca, R. Maroldi; Brescia/IT14:45B-0205 Textural analysis of lymphoma on unenhancedcomputed tomography: initial evidence for arelationship with tumour glucose metabolism, stage,end of treatment status and survivalS. Babikir, B. Ganeshan, A.M. Groves, I. Kayani; London/UK14:54B-0206 Improvement in both sensitivity and specificity ofreaders with next generation of mammography CADV. Nikitin, I. Lossev, A. Filatov, N. Bagotskaya; Longmont, CO/US15:03B-0207 Assessing the contribution of hypoxia to R2*differences between cancerous and normal prostatetissueA. Johnson, A. Latifoltojar, V. Hamy, H. Fitzke, K. Shmueli, S. Punwani;London/UK15:12B-0208 Scatter amplitude is a good landmark for tumourlocalisation and treatment assessment in timedomaindiffuse optical tomography during neoadjuvantchemotherapy in breast cancerM. Van de Giessen, B.E. Schaafsma, J.R. Kroep, M.N.J.M. Wasser, C.J.H. Van deVelde, B.P.F. Lelieveldt, J. Dijkstra, A.L. Vahrmeijer; Leiden/NL15:21B-0209 Software validation of metastatic sarcoma lesionassessment using CT volumetric density tumourtrajectoryL.R. Folio 1 , V.M. Derderian 1 , E.C. Jones 1 , M.S. Merchant 1 , A.M. Venkatesan 1 ,E. Lotan 2 ; 1 Bethesda, MD/US, 2 Tel Hashomer/IL14:00–15:30 Room F2BreastSS 202Improvements in preoperative stagingof breast cancerModerators: R.A. Kubik-Huch; Baden/CH, A. Zytoon; Shebin El-Kom/EG14:00B-0210 Usefulness of ultrasonography (US) andultrasonography-guided fine-needle aspiration biopsy(FNAB) for axillary staging in breast cancer: is thebreast imaging reporting and data system (BI-RADS)categorisation applicable?H. Ahn, S. Kim, B. Yun, M. Kim, M. Jang, S. Park, S.-W. Kim, E. Kang;Gyeonggi-do/KR14:09B-0211 Improving diagnostic yield in axillarylymphadenopathy sampling: core biopsy and vacuumassistedcore biopsyR. Salvador, X. Salvador, I. Miranda, O. Dominguez, L. Romero; Barcelona/ES14:18B-0212 Gadofosveset-enhanced axillary MRI for nodal stagingin breast cancerR. Schipper, M.B.I. Lobbes, L.M. van Roozendaal, C.J.G. Castro, B. de Vries,E.M. Heuts, K.B.M.I. Keymeulen, M.L. Smidt, R.G.H. Beets-Tan; Maastricht/NL14:27B-0213 Assessment of 18 Fluorodesoxyglucose positronemission tomography (18FDG PET-CT) vs contrastenhancedmagnetic resonance imaging at 3 Tesla(3T CE-MRI) for lymph node staging in breast cancerpatientsH. Magometschnigg, H. Bickel, G.J. Wengert, G. Karanikas, P. Brader, K. Pinker-Domenig; Vienna/AT14:36B-0214 Imaging of axillary lymph nodes in breast cancerpatients: How do enhancement kinetics of contrastenhancedlymph nodes apparent on dynamic MRmammographycorrelate with standardised uptakevalue of 18F-FDG PET/CT?J. Krammer, C.G. Kaiser, A. Schnitzer, S.O. Schönberg, K. Wasser; Mannheim/DE14:45B-0215 Ultrasound elastography in the diagnostic assessmentof axillary lymph nodes in women presenting to abreast imaging centreL. Sim, L. Leong; Singapore/SG14:54B-0216 The Z011 trial: is this the end of axillary ultrasoundin the pre-operative assessment of breast cancerpatients?T.P. Farrell, M. Stenson, P.A. Carroll, M. Griffin, E.M. Connolly, S.A. O‘Keeffe;Dublin/IE15:03B-0217 Surgical impact of preoperative breast MRI in womenunder 40A. Porto 1 , A. Petrillo 1 , R. Fusco 1 , S. Filice 1 , M. D‘Aiuto 1 , R.M. Trimboli 2 ,F. Sardanelli 2 ; 1 Naples/IT, 2 San Donato Milanese/IT224

Scientific Sessions15:12B-0218 Imaging features in mammography and breastultrasound are related to HER-2 receptor overexpressionof primary invasive breast cancerA. Adams 1 , K.G.A. Gilhuijs 1 , K.E. Pengel 2 , C.E. Loo 2 , W.P.T.M. Mali 1 , S.G. Elias 1 ;1Utrecht/NL, 2 Amsterdam/NL15:12B-0229 3T MRS alterations in brain metabolism in HAARTnaiveHIV infectionA. Trofimova, T. Trofimova, G. Kataeva, S. Medvedev, N. Belyakov, V. Rassokhin,A. Korotkov, E. Malakhova; St. Petersburg/RUB-0218 – B-023715:21B-0219 Is availability of breast MRI-guided interventionassociated with improved results of breast MRIscreening of the contralateral breast in women withnewly diagnosed breast carcinoma?V. Freitas 1 , S. Kulkarni 2 , S. Ghai 2 , R. Fleming 2 , A. Scaranelo 2 , P. Crystal 2 ;1Rio De Janeiro/BR, 2 Toronto, ON/CA14:00–15:30 Room G/HNeuroSS 211Infection and inflammationModerators: E. Marco de Lucas; Sancibrian/ES, G. Schroth; Berne/CH14:00B-0220 Evaluation of plaque detection and optimum time ofenhancement in acute attack multiple sclerosis aftercontrast injectionH. Hashemi, H. Ghanaati, S. Behzadi, M. Harirchian, M. Yaghoobi, M. Shakiba,A. Jalali, K. Firouznia; Tehran/IR14:09B-0221 Respiratory syncytial virus-related encephalitis: brainMR study with diffusion imagingA. Pak, S. Suh, G. Son, Y. Lee, H. Seo, K. Kim, B. Eun, N. Lee, H. Seol; Seoul/KR14:18B-0222 Cortical-juxtacortical lesions in clinically isolatedsyndromes: distribution and diagnostic valueJ.P. Salazar, C. Auger, D. Pareto, R. Mitjana, M. Tintore, J. Corral; Barcelona/ES14:27B-0223 Regional MRI perfusion measures predict motor/executive function in patients with clinically isolatedsyndromeE. Papadaki, P. Simos, T. Panou, V. Mastorodemos, E. Amanakis, T. Maris,A. Karantanas, A. Plaitakis; Iraklion/GR14:36B-0224 The “central vein sign”: is there a place forsusceptibility-weighted imaging in possible multiplesclerosis?T. Kau, M. Taschwer, M. Schönfelder, J.R. Weber, K.A. Hausegger; Klagenfurt/AT14:45B-0225 Single- and multi-voxel proton spectroscopy inpatients with pyogenic brain abscessP.-H. Lai, C.-W. Ko, S.-H. Hsu, J.-H. Fu, P.-C. Wang, H.-B. Pan; Kaohsiung/TW14:54B-0227 Directional diffusivity changes describing microstructuraldamage in normal appearing and lesionedcervical cord white matter in multiple sclerosisN. Berkovitz, P. Gottlieb, S. Tal; Zrifin/IL15:03B-0228 Cognitive deficits in clinically isolated syndromecorrelate with perfusion changes indicative ofinflammationE. Papadaki, P. Simos, T. Panou, V. Mastorodemos, E. Amanakis, T. Maris,A. Karantanas, A. Plaitakis; Iraklion/GR14:00–15:30 Room I/KAbdominal VisceraSS 201b Hepatocellular carcinoma: diagnosisand managementModerators: G. Brancatelli; Palermo/IT, M. Bruegel; Munich/DE14:00B-0230 Intravoxel incoherent motion diffusion-weighted MRimaging of hepatocellular carcinoma: correlation withenhancement degree and histological gradeS. Woo, J. Lee, J.-H. Yoon, I. Joo, J. Han, B. Choi; Seoul/KR14:09B-0231 Accuracy of contrast-enhanced imaging in thepretransplantation staging of hepatocellularcarcinoma (HCC) and pathologic predictive factors ofHCC recurrence after liver transplantation (LT)G. Besutti, A. Pecchi, M. De Santis, G. Tarantino, F. Di Benedetto, P. Torricelli;Modena/IT14:18B-0232 Detection of HCC and liver metastases with BR14:final results of a multicentre phase IIA studyJ. Hohmann 1 , A. Müller 2 , J. Skrok 3 , K.-J. Wolf 2 , A. Martegani 4 , C.F. Dietrich 5 ,T. Albrecht 2 ; 1 Basle/CH, 2 Berlin/DE, 3 Baltimore, MD/US, 4 Como/IT,5Bad Mergentheim/DE14:27B-0233 Integrating contrast-enhanced sonography (CEUS)in the follow-up algorithm of patients withpercutaneously ablated hepatocellular carcinoma(HCC)O. Catalano, P. Vallone, V. Granata, F. Izzo, V. Albino, A. Nunziata, A. Petrillo;Naples/IT14:36B-0234 Hepatocellular carcinoma (HCC) treated withtransarterial chemoembolization (TACE): volume CTperfusion (VCTP) imaging in the detection of earlychanges – preliminary resultsJ. Steiner, T. Wimmer, D. Bohlsen, F. Quehenberger, H. Schöllnast; Graz/AT14:45B-0235 Role of dynamic contrast-enhanced perfusion MRimaging in monitoring of patients with HCC lesionstreated by radiofrequency ablation or transarterialchemoembolizationC. Trattenero, D. Ippolito, M. Colombo, P.A. Bonaffini, R. Corso, S. Sironi; Milan/IT14:54B-0236 Diagnostic efficacy of combined dynamic perfusionMRI with ADC mapping in the assessment oftherapeutic effects of HCC-treated lesions: preliminaryresultsD. Ippolito, C. Trattenero, P. Bonaffini, C. Capraro, R. Corso, S. Sironi; Monza/IT15:03B-0237 Recurrence patterns of hepatocellular carcinoma(HCC) after liver transplantation (LT) and variations indynamic imaging and histopathological characteristicsbetween the primary and the intrahepatic recurrentHCCG. Besutti, A. Pecchi, M. De Santis, G. Tarantino, F. Di Benedetto, P. Torricelli;Modena/ITThursday225

Scientific SessionsB-0238 – B-025615:12B-0238 Accuracy of mRECIST versus RECIST 1.1 in predictingoutcome in hepatocellular carcinoma treated withSorafenibG. Gallusi, M. Di Martino, C. Lombardo, M. Del Monte, R. Di Miscio, A.F. Attili,C. Catalano; Rome/IT15:21B-0239 Could antiplatelet therapy prevent hepatocellularcarcinoma? 7 Tesla liver magnetic resonance imagingstudy in a mouse model of hbv-related chronichepatitisP. Marra, A. Esposito, G. Sitia, A. Palmisano, T. Canu, F. De Cobelli, L.G. Guidotti,A. Del Maschio; Milan/IT14:00–15:30 Room L/MPhysics in RadiologySS 213 Innovations in CT technology and dataprocessingModerators: C. Leidecker; Forchheim/DE, R. Padovani; Udine/IT14:00B-0240 Performance evaluation of a new CT detector withminimal electronic noise for low dose abdominalperfusion imagingE. Klotz, U. Haberland, B. Schmidt; Forchheim/DE14:09B-0241 Performance of a next-generation solid-state detectorwith fully integrated readout electronics for MDCT:quantitative analysis of image quality and radiationexposure reduction potential in comparison with itspredecessorG. Pahn, L.-S. Veloza, H.-P. Schlemmer, H.-U. Kauczor, W. Stiller; Heidelberg/DE14:18B-0242 Integrated circuit detector technology in abdominalcomputed tomography: value in obese patientsF. Morsbach 1 , S. Bickelhaupt 1 , S. Raetzer 1 , B. Schmidt 2 , H. Alkadhi 1 ; 1 Zurich/CH,2Forchheim/DE14:27B-0243 Comparison of filtered back projection (FBP) withhybrid and iterative reconstruction algorithms (HIRand IR) in low dose protocols including high andlow kV settings in CT angiography by testing thedetectability of simulated endoleak and thrombus in aphantom studyZ. Deák, J. Grimm, F. Mück, M. Treitl, M.F. Reiser, S. Wirth; Munich/DE14:36B-0244 Influence of sinogram affirmed iterative reconstructionof CT data on image noise characteristics and lowcontrastdetectability in comparison with filtered backprojection: an objective approachC. von Falck 1 , V. Bratanova 1 , T. Rodt 1 , B. Meyer 1 , S. Waldeck 2 , F. Wacker 1 , H.-o. Shin 1 ; 1 Hannover/DE, 2 Koblenz/DE14:45B-0245 CTDI measurements using radiochromic filmsN. Tomic, N. Sharoubim, F. DeBlois, J. Seuntjens; Montreal, QC/CA14:54B-0246 Physical characterization of iterative reconstructionalgorithms in computed tomography and assessmentof image quality for the optimization of a dual-energyabdominal protocolL. Berta, L. Mascaro, M. Cataldo, R. Maroldi; Brescia/IT15:03B-0248 The impact of tube voltage, scan direction and beamcollimation on the performance of automatic tubecurrent modulation systems in paediatric and adult CTN. Buls 1 , J. Schoenaers 2 , G. Van Gompel 1 , K. Nieboer 1 , J. de Mey 1 ; 1 Jette/BE,2Hasselt/BE15:12B-0249 3D spatial resolution evaluation of clinical CT using aspherical phantomT. Mäkelä, V. Sairanen, J.I. Peltonen, M. Kortesniemi; Helsinki/FI14:00–15:30 Room N/OVascularSS 215Major vessel imagingModerators: W.R. Jaschke; Innsbruck/AT, O. Pellerin; Paris/FR14:00B-0250 Low dose runoff CTA: what protocol is preferredwithout special reconstruction algorithms?E. Kondratyev, G. Karmazanovsky; Moscow/RU14:09B-0251 Value of contrast-enhanced MRA of the peripheralarteries at 3T: results of a large European multicentretrial comparing meglumine gadoterate to gadobutrol-MRA with DSAC. Loewe 1 , J. Arnaiz 2 , D. Krause 3 , L. Marti Bonmati 4 , M. Aschauer 5 , A. Tartaro 6 ,M. Lombardi 7 , M. Burrel 8 , R. Izzillo 9 ; 1 Vienna/AT, 2 Santander/ES, 3 Dijon/FR,4Valencia/ES, 5 Graz/AT, 6 Chieti/IT, 7 Pisa/IT, 8 Barcelona/ES, 9 Saint-Denis/FR14:18B-0252 Nonenhanced quiescent-interval single-shot (QISS)MRA in assessment of peripheral artery disease:comparison with digital subtraction angiography (DSA)R.S. Lanzman 1 , P. Heusch 1 , J. Aissa 1 , P. Schmitt 2 , J. Klasen 1 , D. Blondin 1 ,G. Antoch 1 , P. Kröpil 1 ; 1 Düsseldorf/DE, 2 Erlangen/DE14:27B-0253 Magnetic resonance thrombus characterisationcan identify patients with rapid abdominal aorticaneurysm expansionV.L. Nguyen 1 , T. Leiner 2 , M.C.J. Wishaupt 1 , F.A.M.V. Hellenthal 1 , R.J. van derGeest 3 , E.M. Kooi 1 , G.W.H. Schurink 1 ; 1 Maastricht/NL, 2 Utrecht/NL, 3 Leiden/NL14:36B-0254 CT angiography of abdominal aorta with low kVCT protocol and low contrast medium volume: afeasibility studyC.R.G.L. Talei Franzesi, D. Ippolito, P. Bonaffini, A.C. Cadonici, A. Masetto,S. Sironi; Monza/IT14:45B-0255 An international multi-centre comparison of thenon-contrast MR angiography technique time-spatiallabelling inversion pulse (time-SLIP) against contrastenhancedCT angiography for assessing renal arterystenosis: the renal artery contrast-free trial (REACT)T.S.E. Albert 1 , I. Parienty 2 , V. Catala 3 , H. Xue 4 , V. Katabathina 5 , J.E. Lopera 5 ,Z.Y. Jin 4 , N. Yellin 1 , M. Akahane 6 ; 1 Monterey, CA/US, 2 Antony/FR, 3 Barcelona/ES,4Beijing/CN, 5 San Antonio, TX/US, 6 Tokyo/JP14:54B-0256 Zonal variations in the size of the atheroscleroticaortic arch during cardiac cycle and their implicationson endovascular stentingS. Puppala, A. Shah, C. Dadnam; Leeds/UK226

Scientific Sessions15:03B-0257 CT angiography for the evaluation of the thoracicaorta: dynamic changes in the cardiac cycle withimplications for thoracic endograft treatmentJ. Vallejos, C. Capunay, P. Carrascosa, J.C. Parodi, M.I. Sagarduy, P. Cortines;Vicente López/AR15:12B-0258 Peripheral artery occlusion disease (PAOD):comparison of CE-MRA versus DSA in grading ofstenosis and planning therapyT.J. Vogl, C. Wurz, S. Zangos, A. Thalhammer, T. Schmitz-Rixen;Frankfurt a. Main/DE15:21B-0259 Iodine load reduction in CT aorta angiography withgemstone spectral imaging: comparison with standardCT aorta angiographyX. Luo, J. Wu, J. Sun, M. Chen; Yangzhou/CN14:00–15:30 Room PCardiacSS 203Planning cardiac interventionsModerators: I. Arkhipova; Moscow/RU, P. Mildenberger; Mainz/DE14:00B-0260 Anatomical angulation between the long axis of theleft ventricle and left ventricular outflow tract aspossible predictor of postprocedural complicationsin patients undergoing transapical aortic valveimplantationB. Foldyna, M. Haensig, C. Lücke, D. Holzhey, S. Nitzsche, M. Borger, F.W. Mohr,M. Gutberlet, L. Lehmkuhl; Leipzig/DE14:09B-0261 Temporal dynamics of the aortic root and the aorticvalve: implications for transcatheter aortic valveimplantationT. Jurencak, B. Kietselaer, C. Mihl, V. Van Ommen, L. van Garsse, J. Wildberger,M. Das; Maastricht/NL14:18B-0262 Aortic annulus area assessment by multidetectorcomputed tomography for predicting paravalvularregurgitation in patients undergoing balloonexpandabletranscatheter aortic valve implantation– a comparison with transthoracic andtransoesophageal echocardiographyG. Pontone, D. Andreini, E. Bertella, S. Mushtaq, S. Cortinovis, A. Annoni,A. Formenti, G. Ballerini, M. Pepi; Milan/IT14:27B-0263 Transcatheter aortic valve replacement: performanceof an aortic valvular complex model for semiautomatedquantification of aortic annulus dimensionsat cardiac CTP. Blanke 1 , E.-M. Spira 1 , D. Bernhardt 2 , R. Ionasec 3 , U. Ebersberger 4 , T. Flohr 2 ,M. Langer 1 , U.J. Schoepf 5 ; 1 Freiburg/DE, 2 Forchheim/DE, 3 Princeton, NJ/US,4Munich/DE, 5 Charleston, SC/US14:36B-0264 Dimensions of the aortic root and the aortic valvefor transcatheter aortic valve implantation: non-ECG-triggered multi-detector CT high-pitch scanscompared with retrospectively ECG-gated low-pitchcardiac scansT. Jurencak, B. Kietselaer, C. Mihl, P. Nelemans, V. Van Ommen, L. van Garsse,J. Wildberger, M. Das; Maastricht/NL14:45B-0265 Is aortic valve calcium distribution a predictorfor outcome after transcutaneous aortic valveimplantation?P. Apfaltrer 1 , G. Schymik 2 , T. Germann 1 , H. Schroefel 2 , M. Meyer 1 , C. Fink 1 ,S.O. Schönberg 1 , T. Henzler 1 ; 1 Mannheim/DE, 2 Karlsruhe/DE14:54B-0266 Influence of observer experience and training onproficiency in cardiac CT interpretationJ.M. Kerl 1 , U.J. Schoepf 2 , R.W. Bauer 1 , P. Costello 2 , T.J. Vogl 1 , C. Herzog 1 ;1Frankfurt a. Main/DE, 2 Charleston, SC/US15:03B-0267 Utility of cardiac magnetic resonance in theidentification of patients eligible for earlyimplantation of cardioverter defibrillator after acutemyocardial infarctionE. Belloni 1 , E. Emanuele 2 , G. Marchesi 3 , D. Aschieri 3 , S. Ferraro 3 , E. Michieletti 3 ,G.Q. Villani 3 , P. Scagnelli 1 ; 1 Castel San Giovanni/IT, 2 Robbio/IT, 3 Piacenza/IT15:12B-0268 Optimisation of contrast injection protocol for CTangiography in transcatheter aortic valve implantation(TAVI): preliminary resultsD. Di Marco 1 , M. Giglio 2 , R. Fachechi 1 , S. Sironi 1 , P. Spagnolo 2 ; 1 Monza/IT,2Milan/IT15:21B-0269 Assessment of aortic valve area in patients withsevere aortic stenosis using cardiac dual-sourcecomputed tomography: comparison with transthoracicechocardiography and cardiac magnetic resonanceH. An, S. Ko, H. Hwang, M. Song, J. Choi, J. Shin; Seoul/KR14:00–15:30 Room QRadiographersSS 214 Managing quality and dose in CTModerators: E. Agadakos; Athens/GR, A. Yule; Cardiff/UK14:00B-0270 Personalised low dose chest CT applying adaptiveiterative dose reduction algorithm (AIDR 3D)integrated automatic exposure control techniqueswith 320-slice MDCT: initial clinical trialX. Chen; Guangzhou/CN14:09B-0271 Feasibility of low dose protocol at 640-slice dynamicvolume CT for diagnosing central airways narrowingZ.-X. Ding, Z. Wang; Hangzhou/CN14:18B-0272 Conducting a national diagnostic reference levelsurvey for computed tomography examinations: thePortuguese experienceJ. Santos 1 , S. Foley 2 , G. Paulo 1 , M.F. McEntee 3 , L. Rainford 2 ; 1 Coimbra/PT,2Dublin/IE, 3 Sydney/AU14:27B-0273 Comparison of image quality between left andright arm injection of contrast agent in computedtomography of carotid arteriesD. Hribar, N. Djuric, S. Sterzaj, T. Holc, M. Kovacic, A. Janezic; Ljubljana/SI14:36B-0274 Dose assessment in paediatric head computedtomography examinationsC.L.D.C. Fernandes, S.I. Rodrigues, A.F.C.L. Abrantes, L.P.V. Ribeiro,R.P.P. Almeida, C.A. Silva, K.B. Azevedo; Faro/PTB-0257 – B-0274Thursday227

Scientific SessionsB-0275 – B-028914:45B-0275 Dose values in eye lens in paediatric brain computedtomography: influence of different protocolsC. Carriço 1 , M. Inácio 1 , A. Kristiansen 2 , M. Larsen 2 , J. Santos 1 , S. Holm 2 , G. Paulo 1 ;1Coimbra/PT, 2 Odense/DK14:54B-0276 Influence of different arm positioning of MSCT of chestby apply automatic tube current modulation techniqueZ.-X. Ding, Z. Wang; Hangzhou/CN15:03B-0277 The effectiveness of lead apron for radiationprotection in CTN. Weber, P. Monnin, C. Elandoy, S. Ding; Lausanne/CH15:12B-0278 Optimisation of local diagnostic reference levels inhead computed tomographyM. Monteiro, A. Carvalho, J. Matias, J. Santos; Coimbra/PT15:21B-0279 Comparison of radiation dose and image qualitybetween sequential and spiral brain CTI. Pace, F. Zarb; Msida/MT14:54B-0286 A patient dose managing solution identifies erroneousparameter settings in CT acquisition protocols, andcontributes towards lowering radiation exposureT. De Bondt 1 , Q. Collier 1 , R. Salgado 1 , M. Geldof 1 , F. Deferme 1 , J. Valette 2 ,A. Jomier 2 , W. Van Hecke 1 , P.M. Parizel 1 ; 1 Antwerp/BE, 2 Mutzig/FR15:03B-0287 Evaluation of the quality of abdominal computedtomography images reconstructed with iterativereconstruction techniqueL. Henriksson, A. Persson, M. Sandborg; Linköping/SE15:12B-0288 Improved image quality of virtual non-contrast dualenergyCT images using a new iodine subtractionalgorithmA. Helck, N. Hummel, F. Meinel, S.F. Thieme, M.F. Reiser, A. Graser,T.R.C. Johnson; Munich/DE15:21B-0289 Image quality of monoenergetic low-keV datasets forlower extremity dual-energy CT angiographyS. Sudarski, D. Schneider, P. Apfaltrer, S.O. Schönberg, T. Henzler;Mannheim/DE14:00–15:30 Room ZComputer ApplicationsSS 205 Quantitative image analysis andoptimisationModerators: L. Faggioni; Pisa/IT, M. Fatehi; Tehran/IR14:00B-0280 Consistent automatic adipose tissue quantification inMR abdomen imagesD. Smeets, W. Van Hecke, D. Loeckx; Leuven/BE14:09B-0281 Computational texture analysis in interstitial lungdisease: comparison of descriptors and classificationaccuracyJ. Ofner 1 , C. Mueller-Mang 1 , A. Burner 1 , D. Markonis 2 , A. Depeursinge 2 ,H. Mueller 2 , G. Langs 1 ; 1 Vienna/AT, 2 Sierre/CH14:18B-0282 Quantification of correlations between somatostatinreceptors expression in biopsies from neuroendocrinetumours and PET/CT uptake values in the context ofpersonalised medicineM. Athelogou 1 , D. Kaemmerer 2 , A. Lupp 3 , V. Prasad 4 , R. Schoenmeyer 1 ,G. Binnig 1 , R. Baum 2 ; 1 Munich/DE, 2 Bad Berka/DE, 3 Jena/DE, 4 Berlin/DE14:27B-0283 3D analysis CT software in volumetric anddensitometric analysis of urinary stonesM. Moschetta, A. Scardapane, M. Telegrafo, G. Angelelli, A.A. Stabile Ianora;Bari/IT14:36B-0284 The 3DSlicer open-source platform for segmentation,registration, quantitative imaging and 3D visualizationof biomedical image dataS. Pujol 1 , S. Pieper 2 , R. Kikinis 1 ; 1 Boston, MA/US, 2 Cambridge, MA/US14:45B-0285 Can the CT acquisition protocol be used incombination with the study description to optimisepatient dose tracking for CT examinations?T. De Bondt 1 , Q. Collier 1 , R. Salgado 1 , M. Geldof 1 , F. Deferme 1 , J. Valette 2 ,A. Jomier 2 , W. Van Hecke 1 , P.M. Parizel 1 ; 1 Antwerp/BE, 2 Mutzig/FR228

Scientific Sessions10:30–12:00 Room D1ChestSS 504Lung nodulesModerators: S. Diederich; Düsseldorf/DE, N. Karabulut; Denizli/TR10:30B-0290 70kV computed tomography of the thorax: valence forcomputer-assisted nodule evaluation and radiationdose – first clinical resultsB. Schulz 1 , B. Bodelle 1 , T. Lehnert 1 , F. Al-Butmeh 1 , M. Sedlmair 2 , R. Banckwitz 2 ,D. Klement 1 , T.J. Vogl 1 , M.J. Kerl 1 ; 1 Frankfurt a. Main/DE, 2 Erlangen/DE10:39B-0291 Improved accuracy of lung cancer diagnosis for fastgrowinglung nodules in CT lung cancer screening byoptimisation of volume-doubling time cut-offM.A. Heuvelmans 1 , M. Oudkerk 1 , G.H. De Bock 1 , X. Xie 1 , P.M.A. Van Ooijen 1 ,M.J.W. Greuter 1 , P.A. De Jong 2 , H.J.M. Groen 1 , R. Vliegenthart 1 ; 1 Groningen/NL,2Utrecht/NL10:48B-0292 AIDR improves characterisation of sub-centimetrepulmonary GGO on low dose HRCTS. Hashemi Amroabadi 1 , H. Mehrez 2 , R.S. Cobbold 1 , N.S. Paul 1 ; 1 Toronto, ON/CA,2Markham, ON/CA10:57B-0293 Comparison of capabilities for differentiatingmalignant SPNs from benign SPNs among dynamicfirst-pass perfusion area-detector CT, dynamic firstpassMRI and FDG-PET/CTY. Ohno 1 , S. Seki 1 , M. Nishio 1 , H. Koyama 1 , T. Yoshikawa 1 , S. Matsumoto 1 ,Y. Fujisawa 2 ; 1 Kobe/JP, 2 Ohtawara/JP11:06B-0294 Can dual-energy index help to differentiate malignantand benign lesions of lung?A. Kannivelu, S. Srinivasan, H.S. Teh, H.T. Koay, C.H.A. Tan, T.W. Choy, K.K. Yeow,S.K.J. Lim; Singapore/SG11:15B-0295 Features of resolving and non-resolving indeterminatepulmonary nodules on follow-up CT: the NELSON studyY. Zhao, M. Dorrius, M. Heuvelmans, P. van Ooijen, M. Oudkerk, R. Vliegenthart;Groningen/NL11:24B-0296 Stratification of pure ground-glass opacity (GGO)nodular lung adenocarcinoma using quantitativeanalysis of CT imaging metrics to select patients forlimited-resection more preciselyJ. Son, H. Lee, J. Kim, J. Han, K. Lee, O. Kwon, B. Kim, H. Kim, Y. Shim; Seoul/KR11:33B-0297 Non-solid, part-solid or solid? Classification ofpulmonary nodules in thoracic CT by radiologists and acomputer-aided diagnosis systemC. Jacobs 1 , E.M. van Rikxoort 2 , J.-M. Kuhnigk 1 , E.T. Scholten 3 , P.A. de Jong 4 ,C. Schaefer-Prokop 5 , M. Prokop 2 , B. van Ginneken 2 ; 1 Bremen/DE, 2 Nijmegen/NL,3Haarlem/NL, 4 Utrecht/NL, 5 Amersfoort/NL11:42B-0298 Solid pulmonary nodules detected by low-dose CT:effect of semi-automatic software on volumetry invitro and in vivoY. Zhao, M. Dorrius, P. van Ooijen, M. Oudkerk, R. Vliegenthart; Groningen/NL11:51B-0299 Feasibility of training radiographers to detect nodulesin CT lung cancer screeningA. Nair 1 , N. Gartland 1 , B. Barton 1 , E. Ifeakor 1 , J. Hodgkinson 1 , R. Vliegenthart 2 ,P.A. de Jong 3 , M. Prokop 4 , A. Devaraj 1 ; 1 London/UK, 2 Groningen/NL, 3 Utrecht/NL,4Nijmegen/NL10:30–12:00 Room D2Interventional RadiologySS 509 Neurovascular and spine interventionsModerators: E.R. Gizewski; Innsbruck/AT, L. Pierot; Reims/FR10:30B-0300 Carotid artery stenting: results and analysis of asingle-centre experience after 12 yearsF. Fanelli, A. Cannavale, E. Boatta, M. Corona, C. Cirelli, F.M. Salvatori; Rome/IT10:39B-0301 Additional value of mechanical thrombectomydevices in thrombo-embolic complications duringendovascular occlusion of intracranial aneurysmsM.H.J. Voormolen, T. van der Zijden, T. Menovsky, P.N.M. Parizel; Antwerp/BE10:48B-0302 Stent-assisted endovascular occlusion of intracranialaneurysmsM.H.J. Voormolen, T. Van der Zijden, T. Menovsky, P. Parizel; Antwerp/BE10:57B-0303 Long-term results of microsurgical and endovasculartherapy of intracranial aneurysms in patientsfollowing subarachnoid haemorrhageK. Bojanowski 1 , J. Baron 2 , B. Kostkiewicz 1 , M. Zawadzki 1 , J. Walecki 1 ;1Warsaw/PL, 2 Katowice/PL11:06B-0304 Embolisation of cerebral aneurysms with hydrogelcoatedcoils: systematic review and meta-analysisA. Pałys, Z. Serafin, W. Lasek; Bydgoszcz/PL11:15B-0305 Effect of antiplatelet therapy on radiographic outcomeof positivity on diffusion-weighted imaging in electiveendovascular coiling of unruptured cerebral aneurysmT. Matsushige, K. Shinagawa, Y. Akiyama, T. Okazaki, S. Sakamoto, Y. Kiura,K. Sugiyama, K. Kurisu; Hiroshima/JP11:24B-0306 MR-guided lumbosacral nerve root injection therapyusing an open 1.0 Tesla MRI system: a clinicalinvestigationF. Streitparth 1 , M. De Bucourt 1 , T. Hartwig 1 , T. Walter 1 , M. Maurer 1 , D. Renz 1 ,B. Gebauer 1 , B. Hamm 1 , U. Teichgräber 2 ; 1 Berlin/DE, 2 Jena/DE11:33B-0307 Vertebral split fractures: the role of percutaneousvertebroplastyL. Huwart 1 , O. Hauger 2 , P.-Y. Marcy 1 , P. Foti 1 , M.-E. Amoretti 1 , P. Brunner 3 ,N. Amoretti 1 ; 1 Nice/FR, 2 Bordeaux/FR, 3 Monaco/MC11:42B-0308 Percutaneous vertebroplasty in vertebra plana:does the presence of intravertebral cleft impact theefficiency of the procedure?L. Huwart 1 , P.-Y. Marcy 1 , P. Foti 1 , M.-E. Amoretti 1 , O. Hauger 2 , P. Brunner 3 ,N. Amoretti 1 ; 1 Nice/FR, 2 Bordeaux/FR, 3 Monaco/MC11:51B-0309 Percutaneous ablation of spinal osteoid osteoma:report of 37 patientsG. Tsoumakidou, J. Garnon, I. Enescu, X. Buy, A. Gangi; Strasbourg/FRB-0290 – B-0309Friday229

Scientific SessionsB-0310 – B-032910:30–12:00 Room E1MusculoskeletalSS 510 Tendon, muscle and tissuecompositionModerators: J. Healy; London/UK, A. Mileto; Durham, NC/US10:30B-0310 Efficacy of intra-tendinous injection of plateletrichplasma to treat tendinosis: comprehensiveassessment on a murine modelB. Dallaudiere 1 , M. Lempicki 1 , L. Pesquer 2 , P. Meyer 2 , E. Schouman-Claeys 1 ,J.-M. Serfaty 1 ; 1 Paris/FR, 2 Bordeaux/FR10:39B-0311 High volume image-guided injections in patellartendinopathyS.L. Morton, O. Chan, D. Morrissey, J. King, T. Crisp, N. Maffulli; London/UK10:48B-0312 Biomechanical properties of the calcaneal tendon invivo assessed by transient shear wave elastographyS. Aubry 1 , J.-R. Risson 1 , A. Kastler 2 , B. Barbier-Brion 1 , M. Runge 1 , B. Kastler 1 ;1Besancon/FR, 2 Clermont-Ferrand/FR10:57B-0313 Muscle elastography in patients affected by multiplesclerosisG. Illomei, G. Spinicci, M. Arru, M. Marrosu; Cagliari/IT11:06B-0314 Dixon-based MRI for assessment of muscle-fatcontent in-vitro and in patients with achillodynia incomparison to healthy volunteersM.A.F. Fischer, C.W.A. Pfirrmann, N. Espinosa, D.A. Raptis, F.M. Buck; Zurich/CH11:15B-0315 Postmortal 31P magnetic resonance spectroscopy ofthe skeletal muscle: a-ATP/Pi ratio as a forensic tool?J. Yamamura 1 , T.M. Schidt 1 , R. Fischer 1 , Z.J. Wang 2 , M. Lorenzen 1 ; 1 Hamburg/DE,2Dallas, TX/US11:24B-0316 Visceral fat by DXA: current methods and potentialclinical implicationsA. Bazzocchi, D. Diano, F. Ponti, A. Andreone, C. Sassi, U. Albisinni, G. Battista;Bologna/IT11:33B-0317 Post-exercise intramyocellular acetylcarnitinelevels in endurance trained and sedentary subjectsmeasured with 1 H-MRSL. Lindeboom, B.M.W. Brouwers, T. van de Weijer, C.I.H.C. Nabuurs, M.E. Kooi,M.K.C. Hesselink, P. Schrauwen, J.E. Wildberger, V.B. Schrauwen-Hinderling;Maastricht/NL11:42B-0318 In vivo differentiation of muscle precursor cells usingMR relaxometryN.C. Chuck, F. Azzabi Zouraq, D. Eberli, A. Boss; Zurich/CH11:51B-0319 MRI findings of the bone marrow related to unloadingwith longitudinal follow-upL. Nardo 1 , D. Sandman 1 , W. Virayavanich 1 , S. Lee 1 , A. Lai 1 , L. Zhang 2 , R. Souza 1 ,M. Guindani 2 , T. Link 1 ; 1 San Francisco, CA/US, 2 Houston, TX/US10:30–12:00 Room F1Oncologic ImagingSS 516 Cutting edge imaging in oncology:when and how?Moderators: K. Coenegrachts; Bruges/BE, E.J. Rummeny; Munich/DE10:30B-0320 Virtual 3D 18F-FDG PET/CT panendoscopy forassessing the upper airways of head and neck cancerpatients: initial resultsP. Heusch 1 , C. Buchbender 1 , B. Geiger 2 , J. Treffert 3 , T. Lauenstein 4 ,M. Forsting 4 , G. Antoch 1 , T.A. Heusner 1 ; 1 Duesseldorf/DE, 2 Princeton, NJ/US,3Knoxville, TN/US, 4 Essen/DE10:39B-0321 18F-FLT- PET in the diagnosis of gastric cancerT. Staniuk 1 , M. Studniarek 2 , W. Zegarski 1 , E. Srutek 1 , B. Malkowski 1 ;1Bydgoszcz/PL, 2 Bojano/PL10:48B-0322 First clinical experience in restaging of patientswith recurrent prostate cancer by 11C-choline-PET/MR: comprehensive diagnostic MR protocol andcomparison with 11C-choline-PET/CTM. Eiber, M. Souvatzoglou, E.J. Rummeny, M. Schwaiger, A.J. Beer; Munich/DE10:57B-0323 Apparent diffusion coefficient for evaluating earlytumour response to neoadjuvant chemo-radiotherapyin locally advanced cervical cancer: correlation withhistopathology. Preliminary resultsM. Miccò, A.L. Valentini, B. Gui, A.M. De Gaetano, M. Iacobucci, L. Bonomo;Rome/IT11:06B-0324 The value of DWI in differentiating ocular tumoursfrom retinal detachmentK. Erb, G. Willerding, M. Taupitz, B. Hamm, P. Asbach; Berlin/DE11:15B-0325 Dosimetric impact of MR vs CT delineation of boostvolume in breast cancerM. Betti, L. Orlandini, C. Biagini, M. de Liguoro, F. Mungai, L. Natale, L. Cionini;Sesto Fiorentino/IT11:24B-0326 PET/MR vs PET/CT in lung cancer N staging: initialexperience with a three-segment model attenuationcorrectionA. Kohan, C. Rubbert, J.L. Vercher Conejero, S. Partovi, R. Jones, K. Herrmann,P. Faulhaber; Cleveland, OH/US11:33B-0327 Incidental findings in the general adult populationusing whole body MRI as a screening methodS. Ulus, E. Karaarslan; Istanbul/TR11:42B-0328 Bone metastasis at a glance: a new advancedvisualization algorithm for fast and easy detection inthoracoabdominal CTD.F. Toth, M. Toepker, M.E. Mayerhoefer, J. Furtner, U. Asenbaum, G. Karanikas,M. Weber, C. Czerny, H. Ringl; Vienna/AT11:51B-0329 Comparison of the utility of whole body MRI with andwithout contrast-enhanced quick 3D and double RF fatsuppression techniques, conventional whole body MRI,PET/CT and conventional examination for assessmentof recurrence in NSCLC patientsY. Ohno 1 , S. Seki 1 , M. Nishio 1 , H. Koyama 1 , T. Yoshikawa 1 , S. Matsumoto 1 ,S. Satou 2 , K. Sugimura 1 ; 1 Kobe/JP, 2 Ohtawara/JP230

Scientific Sessions10:30–12:00 Room F2BreastSS 502Elastography and other advances inbreast ultrasoundModerators: D. Djilas-Ivanovic; Sremska Kamenica/RS, P. Skaane; Oslo/NO10:30B-0330 Quantitative shear wave elastography: evaluatingan additional use with conventional ultrasound indiagnosis of breast lesionsJ. Moon, K.-S. Jung, S. Koh, J.-Y. Jung; Anyang-si/KR10:39B-0331 Quantitative ShearWave ultrasound elastography:initial experience in palpable breast massesS. Hari, S. Naga, A. Dhar, M. Jana; New Delhi/IN10:48B-0332 Can the ring sign improve the performance ofshearwave elastography in benign/malignantdifferentiation of screen detected solid breastmasses?M. Szewcyk-Bieda, A. Evans, S. Vinnicombe, P. Whelehan, K. Thomson;Dundee/UK10:57B-0334 Influence of menopause in women on breastelasticity measured by elasticity parameters withsonoelastographyX. Wang, Y. Wang, P. Xu; Shanghai/CN11:06B-0335 Stiffness measured by Shear Wave elastography: abiomarker of the early chemotherapy response in ahuman breast cancer model?F. Chamming‘s, M. Le Frère-Belda, v. Fitoussi, L. Pidial, H. Latorre-Ossa, J.-L. Gennisson, O. Clément, C.-A. Cuenod, L.S. Fournier; Paris/FR11:15B-0336 SONAZOID® (perflubutane) microbubble-enhancedultrasound for differential diagnosis of breast lesions:pooled analysis of phase 2 and 3 clinical studiesY. Miyamoto 1 , T. Ito 2 , E. Takada 3 , T. Hirai 4 , K. Omoto 5 , R. Sekiguchi 3 , T. Okuno 6 ,S. Kanazawa 1 , F. Moriyasu 1 ; 1 Tokyo/JP, 2 Osaka/JP, 3 Tochigi/JP, 4 Nara/JP,5Saitama/JP, 6 Kobe/JP11:24B-0337 US-based automated breast volume scanner (ABVS):improvement of breast lesion detection in 51 patients– initial studyX. Wang, Y. Wang, P. Xu; Shanghai/CN11:33B-0338 Useful of real-time virtual sonography (RVS) on theevaluation of MRI-detected lesions of the breast insecond-look sonographyS. Nakano, K. Fujii, M. Yoshida, J. Kousaka, Y. Mori, T. Ando, R. Tetsuka,T. Fukutomi, T. Ishiguchi; Nagakute/JP11:42B-0339 Targeting accuracy of real-time virtual sonography(RVS) in sonographic identification of enhancinglesions in breast MRIS. Nakano, K. Fujii, M. Yoshida, J. Kousaka, Y. Mori, T. Ando, R. Tetsuka,T. Fukutomi, T. Ishiguchi; Nagakute/JP10:30–12:00 Room G/HGenitourinarySS 507 New frontiers in GU imagingModerators: G. Hagen; Oslo/NO, C.M.A. Hoeks; Nijmegen/NL10:30B-0340 Functional evaluation of transplanted kidneys usingarterial spin labelling (ASL) MRI at 1.5T and 3T:results in 105 patientsR.S. Lanzman, D. Blondin, P. Heusch, P. Bilk, P. Kröpil, F. Miese, G. Antoch, H.-J. Wittsack; Düsseldorf/DE10:39B-0341 Assessment of novel chemokine-directed therapy ofrenal allograft rejection in a murine animal model withmultiparametric functional MRIM. Notohamiprodjo, A. Kalnins, M. Kolb, A. Wagner, M.F. Reiser, K. Nikolaou,J. Andrassy; Munich/DE10:48B-0342 Assesment cisplatin-induced interstitial nephropathyusing diffusion-weighted MRIR. Del Vescovo, F. Giurazza, R.L. Cazzato, C.L. Piccolo, R.F. Grasso, B. BeomonteZobel; Rome/IT10:57B-0343 Value of diffusion-weighted-MR-imaging for thedetection of nephritisH.J. Michaely 1 , M. Reichert 1 , B. Henninger 2 , S. Haneder 1 , S.O. Schönberg 1 ;1Mannheim/DE, 2 Innsbruck/AT11:06B-0344 DCE-MRI assessment of kidney function and renalmasses: single slice versus whole organ/tumourM. Notohamiprodjo, A.D. Helck, S. Winter, M. Staehler, M. Braunagel,M. Ingrisch, M.F. Reiser, K. Nikolaou; Munich/DE11:15B-0345 In vivo sodium (23Na) imaging of the human kidneysat 7.0T: preliminary resultsS. Haneder 1 , V. Juras 2 , H.J. Michaely 1 , S.O. Schönberg 1 , S. Trattnig 2 , Š. Zbýň 2 ;1Mannheim/DE, 2 Vienna/AT11:24B-0346 Arterial spin labelling for the prostate: initialexperience at 3T MRIS. Takahashi 1 , N. Aoyama 1 , T. Kimura 2 , K. Kitajima 1 , Y. Ueno 1 , S. Sato 3 ,K. Sugimura 1 ; 1 Kobe/JP, 2 Otawara/JP, 3 Osaka/JP11:33B-0347 A new look at the female pelvis: ultra-high-field (7T)MR imagingL. Umutlu, O. Kraff, A. Fischer, S. Kinner, S. Maderwald, M. Forsting, M.E. Ladd,T.C. Lauenstein; Essen/DE11:42B-0348 Bridging septa in T2-weighted MRI of healthyvolunteers: is there an association with the peri- andpararenal fat thickness?B. Mensel, R. Bülow, F. Weber, J.-P. Kühn, N. Hosten, K. Hegenscheid;Greifswald/DE11:51B-0349 Feasibility of 3T MR diffusion tensor imaging (DTI) forreconstructing anatomic connectivity of sacral plexusV. Iotti 1 , A. Pecchi 1 , L. Nocetti 1 , F. Fiocchi 1 , C. Alboni 2 , P. Torricelli 1 ; 1 Modena/IT,2Sassuolo/ITB-0330 – B-0349Friday231

Scientific SessionsB-0350 – B-036910:30–12:00 Room L/MNeuroSS 511Stroke-related arterial diseaseModerators: E. Avdagic; Sarajevo/BA, P. Barsi; Budapest/HU10:30B-0350 Atherosclerotic calcification is related to cognitivedecline: the Rotterdam studyD. Bos, M.W. Vernooij, A. Hofman, G.P. Krestin, J.C.M. Witteman, A. van der Lugt,M.A. Ikram; Rotterdam/NL10:39B-0351 Does clinical severity in acute stroke reliably predictlarge vessel occlusion? Results from a prospectivecohort study of CT angiography (CTA) in hyper-acutestrokeC. Hansen, C. Ovesen, H. Christensen, I. Havsteen, J. Nielsen, A. Christensen;Copenhagen/DK10:48B-0352 Value of monoenergetic low KV dual-energy CTdatasets for improved image quality of cervical andcerebral CT-angiographyD. Schneider, P. Apfaltrer, H. Haubenreisser, M. Meyer, S. Sudarski, C. Fink,S.O. Schönberg, T. Henzler; Mannheim/DE10:57B-0353 Black blood MRI in patients with and withoutsuspected primary angiitis of the central nervoussystemT. Saam, T. Pfefferkorn, M. Habs, C. Opherk, A. Straube, M. Dichgans, M.F. Reiser,K. Nikolaou, J. Linn; Munich/DE11:06B-0354 3T MRI reveals extra- and intracranial involvement ingiant cell arteritis (GCA)S. Siemonsen, C. Brekenfeld, T. Klink, J. Fiehler, T. Bley; Hamburg/DE11:15B-0355 BOLD fMRI of cerebrovascular reserve in patientswith severe stenosis of the middle cerebral artery:preliminary resultsA. Krainik, A. Attye, M. Villien, K. Boubagra, K. Garambois, J. Bouvier, J. Warnking,F. Tahon, O. Detante; Grenoble/FR11:24B-0356 Intracranial artery calcification on CT predicts pooroutcome after stroke: results from a prospectivecohort studyC. Ovesen, H. Christensen, A.-M. Abild, C. Hansen, I. Havsteen, J. Nielsen,A. Christensen; Copenhagen/DK11:33B-0357 Intracranial artery stenosis on CT angiography (CTA)predicts poor outcome after stroke: results from aprospective cohort studyC. Ovesen, H. Christensen, A.-M. Abild, C. Hansen, I. Havsteen, J. Nielsen,A. Christensen; Copenhagen/DK11:42B-0358 Contribution of the temporal maximum intensityprojection (tMIP) datasets for measurement of themiddle cerebral artery (MCA) occlusion and predictivevalue for results of systemic thrombolytic therapyJ. Baxa, R. Tupý, V. Rohan, B. Kreuzberg, J. Ferda; Pilsen/CZ11:51B-0359 MRI findings in small vessel disease and theirrelationship to cognitive impairmentP. Benjamin, A.J. Lawrence, B. Patel, A.W. Chung, T.R. Barrick, A.D. Mackinnnon,R. Morris, H.S. Markus; London/UK10:30–12:00 Room N/OVascularSS 515Novel tools for blood flow evaluationModerators: J. Barkhausen; Lübeck/DE, F. Garaci; Rome/IT10:30B-0361 Assessment of blood flow haemodynamics of livercirrhosis patients after treatment with a TIPS stentgraftusing a flowsensitive 4D MRI imaging at 3 TeslaZ. Stankovic 1 , M.F. Russe 2 , B. Jung 2 , W. Euringer 2 , Z. Csatari 2 , L. Stehlin 2 ,M. Langer 2 , M. Markl 1 ; 1 Chicago, IL/US, 2 Freiburg/DE10:39B-0362 Evaluation of atherosclerosis and endothelialfunctions in nonalcoholic hepatosteatosis patients:comparison with ultrasound and biochemical markersM.G. Yilmabasar, A. Hayirlioglu, U. Ozdamarlar, I. Kuru; Istanbul/TR10:48B-0363 CT angiography in renal donors using automated kVpselection in combination with sinogram-affirmediterative reconstruction: evaluation of radiation doseand image qualityM.P.F. Botelho, F.D. Gonzalez-Guindalini, P. Entezari, H. Chalian, V. Yaghmai;Chicago, IL/US10:57B-0364 Comparison of high pitch (3) and standard pitch (0.6)CT angiography using 128-slice dual-source CT inpatients with peripheral arterial diseaseK. Choo, J. Park, J. Kim, J. Roh; Busan/KR11:06B-0365 Differential diagnosis of cervical artery dissection andintra-arterial thrombosis using MRI and MRAM. Dreval, M. Krotenkova, L. Kalashnikova, L. Dobryinina, R. Konovalov;Moscow/RU11:15B-0366 Impact of organ-specific dose reduction on imagequality of head and neck CT-angiographyR.S. Lanzman, L. Schimmöller, P. Heusch, S. Dietrich, F. Miese, J. Aissa,T.A. Heusner, G. Antoch, P. Kröpil; Düsseldorf/DE11:24B-0367 Precision of pulmonary vein diameter measurementsassessed by CE-MRA and steady-state-free precessionimagingF. Henes, P. Bannas, M. Regier, J. Buhk, K. Müllerleile, G. Adam, M. Groth;Hamburg/DE11:33B-0368 The application of CT angiography with whole brainperfusion imaging in the evaluation of patients withtransient ischaemic attackH. Shi, F. Yang, X. Ma, W. Guo, S. Dong, M. Qiao; Beijing/CN11:42B-0369 Multicentre, intra-individual comparison of singledose gadobenate dimeglumine and double dosegadopentetate dimeglumine for MR angiography ofthe peripheral arteriesR. Iezzi 1 , J. Wang 2 , F. Yan 2 , J. Liu 3 , D. Li 4 , X. Wang 3 , Y. Li 2 , F. De Cobelli 5 ,G. Pirovano 6 ; 1 Rome/IT, 2 Shanghai/CN, 3 Peking/CN, 4 Hefei/CN, 5 Milan/IT,6Princeton, NJ/US232

Scientific Sessions10:30–12:00 Room PCardiacSS 503Advances in coronary CT angiographyModerators: S. Bohata; Brno/CZ, L. Natale; Sesto Fiorentino/IT10:30B-0370 Evaluation of a novel algorithm for coronary motioncompensation in prospective and retrospectivecoronary CT angiography (CCTA)J.-L. Sablayrolles 1 , J. Feignoux 1 , P. Ayestaran 2 , A. Sagniez 2 ; 1 Saint Denis/FR,2Buc/FR10:30–12:00 Room QRadiographersSS 514 The radiographer‘s role as health careteam memberModerators: V. Syrgiamiotis; Athens/GR, C. Vandulek; Kaposvár/HU10:30B-0380 How do radiographers interact with children in theradiographic examination?B. Björkman 1 , K. Enskär 1 , M. Golsäter 1 , R.J. Simeonsson 2 ; 1 Jönköping/SE,2Chapel Hill, NC/USB-0370 – B-038910:39B-0371 Estimating effective dose for cardiac CT with patientspecificdose maps in comparison with DLP conversion(„k factor“) methodJ.H. Yanof 1 , C. Thompson 1 , J. Wiegert 2 , K. Yaddanapudi 1 , S. Halliburton 1 ;1Cleveland, OH/US, 2 Hamburg/DE10:48B-0372 Impact of a new detector technology (Stellar, SiemensHealthcare) on image noise in coronary CTAS.D.C. Deseive 1 , A.-L. Menges 1 , S. Martinoff 1 , M. Hadamitzky 1 , T. Flohr 2 ,B. Schmidt 2 , C. Thierfelder 2 , T. Allmendinger 2 , J. Hausleiter 1 ; 1 Munich/DE,2Erlangen/DE10:57B-0373 Radiation dose reduction in computed tomographymyocardial perfusion imaging using iterativereconstruction and patient-tailored imagingM. Williams 1 , S. Golay 1 , N.W. Weir 1 , S. Mirsadraee 1 , E.J.R. Van Beek 1 , J. Reid 2 ,G. McKillop 1 , N. Uren 1 , D.E. Newby 1 ; 1 Edinburgh/UK, 2 Melrose/UK11:06B-0374 Radiation dose reduction in cardiac CTA using a noveliterative reconstruction algorithm in 320-row detectorCTT. Durmus 1 , R. Luhur 1 , J. Blobel 2 , J. Mews 2 , A. Lembcke 1 ; 1 Berlin/DE, 2 Neuss/DE11:15B-0375 Computed tomography coronary angiography with aconsistent dose below 2 mSv using double high-pitchspiral acquisition in patients with atrial fibrillationQ. Wang, Y. Chen, B. He; Beijing/CN11:24B-0376 Coronary artery calcium scoring from dual-sourcechest CT: potentials for ungated, high-pitch scantechnique in routine clinical practiceF. Molinari, A. Hutt, M. Rémy-Jardin, J.-B. Faivre, A. Simeone, E. Algeri, J. Rémy;Lille/FR11:33B-0377 Diagnostic accuracy of free-breathing coronaryCTA using dual-source CT high-pitch acquisition:comparison of single and double scans withconventional angiographyM.C. So 1 , W.L. Chin 2 , C.M. Wong 1 , C.W. Tai 1 , M.W. Leung 1 ; 1 Hong Kong/HK,2Singapore/SG11:42B-0378 One beat coronary CT angiography using 640 slicesmultidetector CT scanner in patients with atrialfibrillationA. Gennarelli, A. Di Sibio, M. Perri, F. Di Stasio, V. Felli, M. Di Luzio, A.V. Giordano,E. Di Cesare, C. Masciocchi; L‘Aquila/IT11:51B-0379 Influence of AIDR on accuracy of plaquecharacterisation and lumen assessment during CTcoronary angiographyA. Ursani, H. Mehrez, H. Kashani, N. Paul; Toronto, ON/CA10:39B-0381 Requesting x-rays at the right time to utilise thecapacity of the radiology department: an everydaychallengeM. Mowinckel-Nilsen; Os/NO10:48B-0382 Risk management in computed tomography using anincident reporting systemM. Antoniutti, S. Doratiotto; Treviso/IT10:57B-0383 Is a radiographer-led immediate reporting servicefor emergency department referrals a cost-effectiveinitiative?M. Hardy 1 , B. Snaith 2 ; 1 Bradford/UK, 2 Wakefield/UK11:06B-0384 An investigation into the ability of Irish radiographers:in the identification of wrist and scaphoid fracturesA.P. Tyrrell 1 , L. Rainford 2 ; 1 Kilkenny/IE, 2 Dublin/IE11:15B-0385 Workloads of reporting radiographers andsonographers: cost-effectiveness compared withconsultant radiologistW.P. Hedges 1 , S.H. Khan 2 ; 1 Lancaster/UK, 2 Blackburn/UK11:24B-0386 Radiographer‘s expectations for role development:a national survey in view of radiography students infinal year of graduationC.M. Mendes, A.F.C.L. Abrantes, R.P.P. Almeida, L.P.V. Ribeiro, S.I. Rodrigues;Faro/PT11:33B-0387 Job satisfaction among radiographers in Switzerland:a national surveyN. Richli Meystre, P. Lehmann, N. Mamboury; Lausanne/CH11:42B-0388 Progression of quality improvement works inradiography by radiographersR. Gullien, J.G. Andersen, A.E. Haakull; Oslo/NO11:51B-0389 Radiographer contribution to the interpretation oftrauma radiographs: a survey of UK practiceB. Snaith 1 , M. Hardy 2 , E. Lewis 1 ; 1 Wakefield/UK, 2 Bradford/UKFriday233

Scientific SessionsB-0390 – B-040914:00–15:30 Room AGenitourinarySS 607 Female pelvis imagingModerators: L.S. Fournier; Paris/FR, A.G. Rockall; London/UK14:00B-0390 Diagnostic and prognostic value of 18 F-FDG PET/MR over MR and PET/CT in recurrent gynaecologicmalignancies prior to pelvic exenterationI.A. Burger 1 , H.A. Vargas 2 , O.F. Donati 2 , V. Andikyan 2 , H. Schoder 2 , D. Chi 2 ,E. Sala 2 , H. Hricak 2 ; 1 Zurich/CH, 2 New York, NY/US14:09B-0391 Diagnostic value of quantitative measurement ofmicrovascular changes achieved using perfusionMR imaging in the assessment of tumour grading inendometrial carcinomaO. Minutolo, D. Ippolito, A.C. Cadonici, P.A. Bonaffini, C. Capraro, S. Sironi;Monza/IT14:18B-0392 Influence of pathophysiological parameters withkinematic MRI in evaluation of female pelvic floorM. Palumbo, S. Carbone, L.S. Maltese, D. D‘Elia, A. Luceri, V. Ricci, L. Volterrani;Siena/IT14:27B-0393 Origin of the uterine artery in females using threedimensionalreconstructed contrast-enhanced MRangiography before uterine artery embolisation: whereto look for itN.N.N. Naguib, N.-E.A. Nour-Eldin, T. Lehnert, B. Schulz, S. Zangos, T.J. Vogl;Frankfurt a. Main/DE14:36B-0394 Fibre tracking evaluation of sacral nervous pathways3D architecture in women affected by endometriosisM. Sergi, V. Vinci, S. Bernardo, P. Sollazzo, M. Saldari, L. Manganaro; Rome/IT14:45B-0395 How to improve magnetic resonance accuracy indetection of deep infiltrating colorectal endometriosis:correlation with laparoscopy and histopathologyM. Miccò, A.L. Valentini, B. Gui, V. Ninivaggi, M. Marino, L. Bonomo; Rome/IT14:54B-0396 Preliminary functional study with MR defecography inpatients suffering from deep endometriosisP. Sollazzo, S. Bernardo, M. Sergi, V. Vinci, M. Saldari, L. Manganaro; Rome/IT15:03B-0397 Diffusion-weighted magnetic resonance imaging ofthe female pelvis: do apparent diffusion coefficientvalues of the fat tissue change over the menstrualphases?F. Fornasa, A. Gasparini, F. Pantalone, M. Bellotti, A. Dibenedetto, C. Cicciò;San Bonifacio/IT15:12B-0398 Effect of different birthing positions on pelvic bonydimensions in healthy women and pregnant patientsin MR pelvimetryS. Zangos, K. Eichler, A. Schollenberger, A. Reitter, F. Louwen, P. Siebenhandl,T. Gruber-Rouh, T.J. Vogl; Frankfurt a. Main/DE15:21B-0399 Retrospective analysis of elements that can predictshort- and long-term outcome in patients affected byuterine leiomyomas and treated with MRgFUSF. Ciolina, A. Napoli, F. Zaccagna, F. Boni, L. Bertaccini, V. Noce, B. CavalloMarincola, C. Catalano; Rome/IT14:00–15:30 Room BNeuroSS 611Alzheimer‘s and Parkinson‘sModerators: B. Góraj; Nijmegen/NL, T. Meindl; Landshut/DE14:00B-0400 MCI to AD conversion and the role of myoinositol (MI)and N-acetylaspertate (NAA) as biomarkers for thisprocessJ. Walecki, M. Barcikowska, J.B. Ćwikła, T. Gabrylewicz, T. Bulski; Warsaw/PL14:09B-0401 Evaluation of posterior cingulate region with FDG-PETand MR advanced techniques (MRS, PWI and DTI) inpatients with MCI – correlation of the methodsA. Zimny, J. Bladowska, A. Macioszek, P. Szewczyk, E. Trypka, R. Wojtynska,J. Leszek, M.J. Sasiadek; Wroclaw/PL14:18B-0402 The relation of uric acid with brain atrophy andcognition: the Rotterdam scan studyB.F.J. Verhaaren, M.W. Vernooij, A. Dehghan, H. Vrooman, R. de Boer,W.J. Niessen, A. van der Lugt, M.A. Ikram; Rotterdam/NL14:27B-0403 MR spectroscopy in mild and moderate cognitiveimpairment as illness outcome predictor: preliminaryexperienceJ. Forner Giner 1 , A. Alberich-Bayarri 1 , G. Garcia Marti 1 , A. Pomar-Nadal 1 , J. Rayón-Aledo 2 , L. Martí-Bonmatí 1 ; 1 Valencia/ES, 2 Madrid/ES14:36B-0404 Differentiating multiple system atrophy andParkinson’s disease on 3T MRI: a novel use of decisiontreeS. Rajandran Nair, L.K. Tan, N. Ramli, S.Y. Lim, K. Rahmat, H. Mohd Nor;Kuala Lumpur/MY14:45B-0405 Subthalamic nuclei 3 Tesla T2-relaxometry correlatedto UPDRS scores in pre-deep brain stimulation (DBS)patients with Parkinson disease with consideration tothe laterality of the diseaseT.M.L. Lönnfors-Weitzel, T. Weitzel, J. Slotboom, C. Kiefer, A. Kaelin-Lang,C. Pollo, R. Wiest; Berne/CH14:54B-0406 Increased regional grey matter volume in Parkinson’sdisease patients with excessive daytime sleepiness:an MRI studyM. Chondrogiorgi, L.C. Tzarouchi, A. Zikou, P. Kosta, M.I. Argyropoulou,S. Konitsiotis; Ioannina/GR15:03B-0407 Olfactory tract evaluation in patients with Parkinsondisease (PD) and hyposmia: a diffusion tensor imaging(DTI) studyF. Pitocco, L. Di Biase, A. Giona, L. Scarciolla, C. Mallio, Y. Errante, J. Melgari,B. Beomonte Zobel, C. Quattrocchi; Rome/IT15:12B-0408 The neural correlates of anomia in the conversionfrom mild cognitive impairment to Alzheimer’s diseaseE. Pravata‘ 1 , J. Tavernier 1 , R. Parker 2 , H. Vavro 3 , J.E. Mintzer 1 , M. Spampinato 1 ;1Charleston, SC/US, 2 Gainesville, FL/US, 3 Zagreb/HR15:21B-0409 Gender differences in grey matter atrophy patterns inthe mild cognitive and early Alzheimer’s diseaseM. Spampinato 1 , E. Pravata‘ 1 , B. Langdon 1 , K. Patrick 1 , R. Parker 2 ;1Charleston, SC/US, 2 Gainesville, FL/US234

Scientific Sessions14:00–15:30 Room CCardiacSS 603aCT and MRI: risk stratificationModerators: E.A. Mershina; Moscow/RU, M.R. Rees; Gwynedd/UK14:00B-0410 Updated algorithms using „in-office-evaluation“and calcium score may reduce referral of stableangina patients to computed tomography coronaryangiographyA.S. Dharampal, A. Rossi, A. Dedic, S.L. Papadopoulou, A. Weustink, K. Nieman,E. Boersma, P.J. de Feijter, G.P. Krestin; Rotterdam/NL14:09B-0411 Dynamic CT perfusion imaging for the detection ofmyocardial ischaemia: a first experience with a 3Dsemi-automated evaluation softwareU. Ebersberger 1 , R.P. Marcus 2 , U.J. Schoepf 1 , P. Blanke 1 , Y. Wang 3 , L. Geyer 1 ,A.D. McQuiston 1 , D. Bernhardt 4 , F. Bamberg 2 ; 1 Charleston, SC/US, 2 Munich/DE,3Beijing/CN, 4 Forchheim/DE14:18B-0412 Quantitative evaluation of myocardial perfusionreserve at 3 and 1.5 Tesla in comparison to invasivemeasurement of fractional flow reserve for detectionof coronary artery diseaseT. Walcher, K. Ikuye, W. Rottbauer, J. Woehrle, P. Bernhardt; Ulm/DE14:27B-0413 Dynamic stress computed tomography perfusionimaging for the detection of functionally significantcoronary lesionsA. Rossi 1 , A. Dharampal 1 , S.E. Petersen 2 , E. Klotz 3 , G.P. Krestin 1 ,K. Gruszczynska 4 , E. Capuano 2 , P.J. de Feyter 1 , F. Pugliese 2 ; 1 Rotterdam/NL,2London/UK, 3 Forchheim/DE, 4 Katowice/PL14:36B-0414 In vivo quantification of total atherosclerotic burden:prognostic accuracy of whole body CTA in relationto traditional cardiovascular risk index and 5-yearfollow-upF. Zaccagna, A. Napoli, G. Cartocci, V. Noce, F. Boni, C. Catalano; Rome/IT14:45B-0415 Diagnostic performance of computed tomographycoronary angiography to detect or excludeangiographic ‚high-risk-CAD‘A.S. Dharampal, S.L. Papadopoulou, A. Rossi, W.B. Meijboom, E. Boersma,K. Nieman, P.J. de Feijter, G.P. Krestin; Rotterdam/NL14:54B-0416 Cost effectiveness and rule-out strategy of MDCT-CA in patients with undifferentiated chest pain inemergency departmentR. Malago, M. Tezza, C. Barbiani, A. Pezzato, G. Sala, G. Taioli, R. Pozzi Mucelli;Verona/IT15:03B-0417 Transient ischaemic dilation of the left ventricleon SPECT: correlation with findings at coronary CTangiographyU. Ebersberger, W.T. Halligan, P.B. Morris, B.T. Mischen, S.A. Chiaramida,U.J. Schoepf; Charleston, SC/US15:12B-0418 Relationship between myocardial scar and coronaryartery plaque in diabetes patients: from preliminaryresults of assessment with cardiac computedtomography angiography and magnetic resonanceimaging in patients with type 2 diabetes for detectionof unrecognised myocardial scar in subclinicalcoronary atherosclerosis (ACCREDIT) studyJ.-W. Kang 1 , S. Choi 2 , S. Ko 1 , Y. Choe 1 , B. Choi 1 , W. Lee 1 , T.-H. Lim 1 ; 1 Seoul/KR,2Seongnam/KR15:21B-0419 Epicardial fat volume and coronary artery disease atCT: racial differences in African American and whitepatients with acute chest painP. Apfaltrer 1 , A. Schindler 2 , U.J. Schoepf 2 , J. Nance 2 , U. Ebersberger 2 ,R. Vliegenthart 2 ; 1 Mannheim/DE, 2 Charleston, SC/US14:00–15:30 Room D2Interventional RadiologySS 609a Oncologic ablation and guidedinterventionsModerators: P. Almeida; Coimbra/PT, A. Basile; Catania/IT14:00B-0420 Radiation exposure in CT-guided interventionsR. Kloeckner, D. Pinto dos Santos, C. Düber, M. Pitton; Mainz/DE14:09B-0421 Percutaneous image-guided cryotherapy: a newtherapeutic possibility for local recurrence of softtissue sarcomas?N. Lippa, A. Italiano, P. Sargos, M. Kind, E. Stoeckle, B. N‘Guyen Bui, F. Cornelis;Bordeaux/FR14:18B-0422 Robot-assisted radiofrequency ablation of livertumours: early experienceB.J.J. Abdullah, C.H. Yeong, K.L. Goh, B.K. Yoong, G.F. Ho, C. Yim;Kuala Lumpur/MY14:27B-0423 Image-guided percutaneous thermal ablation ofhepatic and renal tumours using high-frequency jetventilation to minimise respiratory motionD.M.L. Tse, D.Y.F. Chung, S. Scott, P. Boardman, F.V. Gleeson, E.M. Anderson;Oxford/UK14:36B-0424 Radiofrequency ablation of hepatocellular carcinomaassociated with chronic liver disease withoutcirrhosis: long-term experienceL. Sottocornola, A. Salmi, A. Rossini, R. Maroldi, P. Cabassa; Brescia/IT14:45B-0425 Safety and efficacy of sonographically guidedpercutaneous radiofrequency ablation of left lobehepatocellular carcinomaM.I.M.A. Ibrahim; Sohag/EG14:54B-0426 Percutaneous, ultrasound-guided IRE ablations ofunresectable pancreatic cancerA. Nilsson, C. Månsson, J. Krause, R. Brahmstaedt, P. Nygren, B.-M. Karlson;Uppsala/SEB-0410 – B-0426Friday235

Scientific SessionsB-0427 – B-044615:03B-0427 High-intensity focused ultrasound ablation ofpancreatic cancer: a totally non-invasive treatmentfor tumour control of locally advanced lesions (stageIII)F. Zaccagna, A. Napoli, G. Cartocci, G. Brachetti, L. DI Mare, F. Boni, V. Noce,L. Bertaccini, C. Catalano; Rome/IT15:12B-0428 Fusion imaging-guided percutaneous biopsy of focalhepatic lesions with poor conspicuity on conventionalultrasonographyH. Park, M. Lee, M. Kim, M. Lee, J. Hwang, T. Kang, S. Lim, H. Lim, H. Lim;Seoul/KR15:21B-0429 CTNAV: a prospective randomised clinical trial of anavigation system for computer assisted CT guidedinterventionsP. Durand, A. Moreau-Gaudry, J. Frandon, M. Medici, E. Chipon, C. Sengel,I. Bricault; Grenoble/FR14:00–15:30 Room E1MusculoskeletalSS 610a Musculoskeletal tumoursModerators: E. Quaia; Trieste/IT, R. Lalam; Oswestry/UK14:00B-0430 Magnetic resonance imaging parameters predictive formalignancy: a prospective study of 100 consecutivesoft-tissue musculoskeletal massesV. Vasilevska Nikodinovska, M. Samargiski, V. Janevska, S. K.Kunovska;Skopje/MK14:09B-0431 Evaluation of features and role of ultrasound andMR imaging in large lipomas and well-differentiatedliposarcomasH. Gupta 1 , V. Bhat 2 , S. Edward 1 , E. Hensor 1 , P. Robinson 1 ; 1 Leeds/UK, 2 Cardiff/UK14:18B-0432 Comparison of efficacy of surgical-, CT- and PET-CTguidedbiopsy in musculoskeletal lesionsJ.L.M.A. Gielen, A.M. De Schepper, S. Ceyssens, D.H. Creytens, J. Somville, P. VanDyck, P. Pauwels, M. Peeters, P.M. Parizel; Antwerp/BE14:27B-0433 CT evaluation of thoracic bone metastasis: comparisonof 3D volume-rendered images and combined axialand coronal multiplanar reconstruction imagesK. Doo 1 , E.-Y. Kang 1 , H. Yong 1 , O. Woo 1 , K. Lee 2 , Y.-W. Oh 1 ; 1 Seoul/KR, 2 Ansan/KR14:36B-0434 DCE-MRI for assessment of vessel remodellingassociated with bone defect healing in experimentallytic bone metastasesD. Komljenovic, W. Semmler, T. Bäuerle; Heidelberg/DE14:45B-0435 View-angle tilting (VAT) and slice-encoding metalartifact correction (SEMAC) for MR imaging oforthopaedic tumor prosthesesP.M. Jungmann 1 , C. Ganter 1 , F. Pohlig 1 , C. Schaeffeler 1 , J.S. Bauer 1 , M. Nittka 2 ,E.J. Rummeny 1 , H. Rechl 1 , K. Woertler 1 ; 1 Munich/DE, 2 Erlangen/DE14:54B-0436 Association of QCT bone mineral density and bonestructure with vertebral fractures in patients withmultiple myelomaJ. Borggrefe 1 , S. Giravent 2 , F. Thomsen 2 , J. Peña 2 , A. Wulff 2 , A. Günther 1 ,M. Heller 2 , C.C. Glüer 1 ; 1 Cologne/DE, 2 Kiel/DE15:03B-0437 Imaging patterns in multiple myeloma: observationsat whole body MRIN.M. Long, O.M. Drumm, P. O‘ Gorman, S.J. Eustace; Dublin/IE15:12B-0438 Efficacy of whole body low-dose CT (WBLDCT) in thestaging of patients with early multiple myeloma:comparison with whole body magnetic resonanceimaging (WBMRI)V. Besostri, D. Ippolito, P.A. Bonaffini, A. Masetto, A. Cuccia, S. Sironi; Milan/IT15:21B-0439 Role of apparent diffusion coefficient (ADC) maps inthe evaluation of tumour response in chemotherapy inpatients with multiple myelomaP.A. Bonaffini, D. Ippolito, V. Besostri, A. Casiraghi, A. Di Lelio, S. Sironi; Monza/IT14:00–15:30 Room F1Abdominal VisceraSS 601 Liver steatosis: imaging andquantificationModerators: I. Bargellini; Pisa/IT, B. Van Beers; Clichy/FR14:00B-0440 Presence/absence of hepatic steatosis afterpercutaneous intraportal pancreatic islettransplantation in 108 allo- and auto-transplantedpatients: can ultrasound predict the clinical outcome?G. Agostini, M. Venturini, G. Querques, P. Maffi, C. Gremizzi, A. Palmisano, F. DeCobelli, A. Secchi, A. Del Maschio; Milan/IT14:09B-0441 Phosphorus magnetic resonance spectroscopy(31P-MRS) in non-alcoholic fatty liver disease(NAFLD)J.M. Abrigo, V.-S. Wong, D.-W. Yeung, G.-H. Wong, A.-h. Chan, H.-Y. Chan, W.-W. Chu; Shatin/HK14:18B-0442 Clinical implications of fatty liver on hepatic diffusionweightedimaging studied in healthy subjectsH. Dijkstra, A. Handayani, P. Kappert, M. Oudkerk, P.E. Sijens; Groningen/NL14:27B-0443 Liver fat volume fraction quantification in patientswith chronic liver diseases with separated estimationof fat and water relaxation times at 1.5 and 3.0TB. Leporq, F. Pilleul, O. Beuf; Villeurbanne/FR14:36B-0444 Combination of liver intravoxel incoherent motionimaging with MR fat quantification at 3.0T todistinguish between pure steatosis and NASHB. Leporq 1 , F. Pilleul 1 , J. Dumortier 2 , O. Guillaud 2 , T. Lefort 2 , O. Beuf 1 ;1Villeurbanne/FR, 2 Lyon/FR14:45B-0445 Quantification of steatosis hepatitis and liver ironoverload in a population-based study using magneticresonance imagingJ.P. Kühn 1 , D. Hernando 2 , H. Völzke 1 , S.B. Reeder 2 , N. Hosten 1 , B. Mensel 1 ,K. Hegenscheid 1 , M. Evert 1 , S. Baumeister 1 ; 1 Greifswald/DE, 2 Madison, WI/US14:54B-0446 Effect of Gd-EOB-DTPA on hepatic fat quantificationusing high-speed T2-corrected multiecho acquisition(HISTO) at 1H MR spectroscopyY. Park 1 , C. Lee 1 , I. Kim 1 , B. Kiefer 2 , K. Kim 1 , J. Choi 1 , J. Lee 1 , C. Park 1 ; 1 Seoul/KR,2Erlangen/DE236

Scientific Sessions15:03B-0447 Brown adipose tissue influences body fat compositionand hepatic steatosisM.K. Werner, S. Ripkens, M. Schmadl, I. Stef, A. Deckert, C.D. Claussen,C. Würslin, N. Stefan, C. Pfannenberg; Tübingen/DE15:12B-0448 In-phase/opposed-phase MRI and MR spectroscopicmeasurements for the quantification of liver fatcontent in morbidly obese patientsH.H. Bertram 1 , G. Thörmer 2 , N. Garnov 2 , T. Schütz 2 , V. Peter 2 , T. Kahn 2 , H. Busse 2 ;1Munich/DE, 2 Leipzig/DE15:21B-0449 Dynamic contrast enhanced-MRI (DCE-MRI) functionalassessment of vascular events occurring during theintra-hepatic engraftment of pancreatic islets maypredict long-term outcome of islets transplantationA. Palmisano, A. Esposito, G. Ironi, P. Maffi, F. De Cobelli, T. Canu, A. Secchi,A. Del Maschio; Milan/IT14:00–15:30 Room F2BreastSS 602Breast imaging after neoadjuvanttherapy and surgeryModerators: G. Gennaro; Padua/IT, P. Martinez-Miravete; Logroño/ES14:00B-0450 Early response monitoring of neoadjuvantchemotherapy in breast cancer patients usingmagnetic resonance imaging: a systematic reviewM. Lobbes 1 , R. Prevos 1 , M. Smidt 1 , V. Tjan-Heijnen 1 , M. van Goethem 2 ,R.G.H. Beets-Tan 1 , J. Wildberger 1 ; 1 Maastricht/NL, 2 Antwerp/BE14:09B-0451 The role of magnetic resonance imaging in assessingresidual disease and pathologic complete responsein breast cancer patients receiving neoadjuvantchemotherapy: a systematic reviewR. Prevos 1 , M. Smidt 1 , V. Tjan-Heijnen 1 , M. van Goethem 2 , R.-J. Schipper 1 ,R.G.H. Beets-Tan 1 , J. Wildberger 1 , M. Lobbes 1 ; 1 Maastricht/NL, 2 Antwerp/BE14:18B-0452 Radiological evaluation of complete pathologicalresponse after neoadjuvant chemotherapy treatmentof breast carcinomaN.M.A. Abdel Razek, H.A. El Ghazaly, O.Z. Yousef; Cairo/EG14:27B-0453 Breast MRI at 3T: a pilot study estimating the roleof unenhanced MRI (DWI combined with T2 IDEALsequence) vs CE-MRI in the assessment of response toneo-adjuvant chemotherapyF. Vasselli, F. Pediconi, M. Telesca, M. Luciani, V. Casali, E. Miglio, A. Castrignanò,C. Catalano; Rome/IT14:36B-0454 Radiological findings in breast autologous fatinjection: a retrospective review in 12-year follow-upL. Camera, I. Baglio, G. Barbazeni, A. Bianchin, M. Valdo, S. Montemezzi;Verona/IT14:45B-0455 Invasive ductal carcinoma with marked necrosis onneoadjuvant chemotherapy: RECIST or mRECIST in MRIassessment of tumour response?M.M. Nadrljanski, Z.C. Milosevic; Belgrade/RS14:54B-0456 CAD-based assessment of therapy monitoring inneoadjuvant chemotherapy of breast cancerJ.S. Grueneisen 1 , S. Maderwald 1 , T. Heusner 2 , S. Kuemmel 1 , E.A. Hauth 1 ,M. Forsting 1 , T.C. Lauenstein 1 , L. Umutlu 1 ; 1 Essen/DE, 2 Düsseldorf/DE15:03B-0457 Breast MRI for assessment of primary systemicchemotherapy (PSC): computer assisted diagnosis(CAD) predicts degree of tissue response and residualtumour massP.A.T. Baltzer 1 , M. Dietzel 2 , W.A. Kaiser 3 ; 1 Vienna/AT, 2 Erlangen/DE, 3 Jena/DE15:12B-0458 Evaluation of residual breast tissue post-mastectomyusing breast MRIV. Tsehmaister Abitbol, A. Rundstein, A. Shalmon, E. Konen, M. Sklair-Levy;Tel Hashomer/IL15:21B-0459 Breast cancer recurrence in DIEP flap reconstructedbreasts: a 12-year retrospective studyJ.A. Farras Roca, A. Luciani, R. Bosc, E. Meyblum, P. Beaussart, F. Pigneur,Y. Belkacemi, A. Rahmouni, T.-H. Dao; Créteil/FR14:00–15:30 Room G/HCardiacSS 603bCardiomyopathy and fibrosisModerators: P. Donato; Coimbra/PT, R. Maksimović; Belgrade/RS14:00B-0460 Potential value of fibrosis quantification in dilatedcardiomyopathyA. Jacquier, A. Kallifatidis, B. Maurel, A. Flavian, J. Gaubert, J. Bartoli, G. Moulin;Marseille/FR14:09B-0461 Potential value of fibrosis quantification inhypertrophic cardiomyopathyA. Jacquier, A. Kallifatidis, B. Maurel, A. Flavian, J. Gaubert, J. Bartoli, G. Moulin;Marseille/FR14:18B-0462 Extent of myocardial scar detected by late Gadoliniumenhancement-cardiac magnetic resonance (LGE-CMR)as a predictor of major adverse cardiac events (MACE)in HCM patientsS. Bertugno, G. Ligabue, F. Fiocchi, L. Nocetti, S. Vasaturo, V. Morini, A. Barbieri,R. Lugli; Modena/IT14:27B-0463 Myocardial scar extension detected by late Gadoliniumenhancement-cardiovascular magnetic resonance(LGE-CMR) for arrhythmic risk stratification of HCMpatientsS. Bertugno, G. Ligabue, F. Fiocchi, L. Nocetti, S. Vasaturo, V. Morini, A. Barbieri ,R. Lugli, P. Torricelli; Modena/IT14:36B-0464 Prognostic value of RV remodelling in pulmonaryhypertension: cardiac magnetic resonance studyN. Galea, M. Francone, I. Carbone, I. Iacucci, P. David, C. Vizza, C. Catalano;Rome/IT14:45B-0465 Evaluation of Brugada syndrome by cardiac magneticresonanceL. Salvatori 1 , C. Tessa 1 , i. Del Meglio 1 , S. Diciotti 2 , C. Vignali 1 , G. Casolo 1 ;1Lido di Camaiore/IT, 2 Firenze/ITB-0447 – B-0465Friday237

Scientific SessionsB-0466 – B-048614:54B-0466 Sensitivity of cardiac magnetic resonance varieswith clinical presentation of biopsy-proven acutemyocarditis: correlation with necrosis/apoptosispatterns of viral aetiologyG. Cannavale, M. Francone, R. Rosati, P. David, A. Frustaci, C. Catalano; Rome/IT15:03B-0467 Cardiac magnetic resonance vs echocardiography forthe assessment of cardiac volumes and function inthalassemia intermedia patientsC. Tudisca 1 , A. Meloni 2 , C. Ascioti 3 , S. Renne 3 , V. Santamaria 4 ; 1 Palermo/IT,2Pisa/IT, 3 Lamezia Terme/IT, 4 Vibo Valentia/IT15:12B-0468 Right heart involvement in thalassaemia major (TM)patients: a cardiac MR (CMR) assessmentF. Pitocco, I. Di Giampietro, A. De Vivo, P. Cianciulli, C. Liguori, B. BeomonteZobel; Rome/IT15:21B-0469 β-thalassaemia as a new potential risk factor forleft ventricular noncompaction (LVNC): a cardiac MRIevaluationC. Liguori, I. Di Giampietro, F. Pitocco, P. Cianciulli, B. Beomonte Zobel; Rome/IT14:00–15:30 Room L/MHead and NeckSS 608 Technical innovations, TMJ disease andrare entitiesModerators: J. Frühwald-Pallamar; Vienna/AT, J. Widelec; Brussels/BE14:00B-0470 CT numbers of CBCT regarding position dependence ondifferent size of field-of-viewM. Imura 1 , T. Todoroki 2 ; 1 Kyoto/JP, 2 Osaka/JP14:09B-0471 Dual-source 128-slice MDCT neck: radiation dose andimage quality estimation of a clinically relevant dualenergy,high-pitch, standard single-energy protocolJ. Paul, E. Mbalisike, T.J. Vogl; Frankfurt a. Main/DE14:18B-0472 Performance of filtered back-projection (FBP),statistical (ASIR) and model-based (VEO) iterativereconstruction of neck CT staging examinationsF.G. Mück, L. Geyer, J. Grimm, Z. Deak, M.F. Reiser, S. Wirth; Munich/DE14:27B-0473 Maxillary sinus pyocele: a new radiological entityA. Lacan-Melki, S. Espinoza-Boireau, I. Khettab, P. Halimi; Paris/FR14:36B-0474 Carotid blowout syndrome in patients withnasopharyngeal carcinoma treated with radiotherapy:a review of 12-year experienceV.K. Fung, J.S. Shum, B.M. Lai, C. Chu, W.K. Kan; Hong Kong/HK14:45B-0475 Nasal-type NK/T-cell lymphoma of the nasal cavityand PNS: CT and MR imaging findingsK. Kang 1 , S. Suh 1 , K. Kim 1 , K. Son 1 , Y. Lee 2 , H. Seo 2 , N. Lee 1 , H. Seol 1 ; 1 Seoul/KR,2Ansan/KR14:54B-0476 Temporomandibular joint internal derangement:correlation of MRI findings with clinical symptomsK. Šurlan Popovič, U. Lamot, M. Vrabec, R. Klavžar; Ljubljana/SI15:03B-0477 An investigation of relative signal intensity of MRimages in retrodiscal tissue and lateral pterygoidmuscle in patients with temporomandibular jointdisorder and its relation with MRI findingsZ. Ghoncheh, M. Panjnosh, H. Banihashemi; Tehran/IR15:12B-0478 High resolution 3D MR imaging of thetemporomandibular joint: feasibility and comparisonwith 2D sequencesU. Navarro, M. Ravanelli, D. Farina, E. Botturi, R. Maroldi; Brescia/IT15:21B-0479 Radiological anatomy of the ethmoidal arteries: acone beam CT studyL. Sottocornola, M. Dal Corso, M. Ravanelli, L. Pianta, R. Maroldi; Brescia/IT14:00–15:30 Room N/OMusculoskeletalSS 610b Cartilage: advanced imagingModerators: A. Karpenko; St. Petersburg/RU, P. Omoumi; Brussels/BE14:00B-0480 Direct comparison of MR imaging at 1.5- and 3.0-T forevaluating the articular cartilage of the kneeP. Van Dyck 1 , C. Kenis 1 , V. Lambrecht 2 , K. Wouters 1 , F.M.H.M. Vanhoenacker 1 ,J.L. Gielen 1 , P.M. Parizel 1 ; 1 Antwerp/BE, 2 Gent/BE14:09B-0481 Biochemical imaging of the knee’s cartilage:comparison of three techniques at 3 TeslaC. Rehnitz 1 , J. Kupfer 1 , N. Streich 1 , I. Burkholder 2 , B. Schmitt 3 , L. Lauer 3 , H.-U. Kauczor 1 , M.-A. Weber 1 ; 1 Heidelberg/DE, 2 Zweibrücken/DE, 3 Erlangen/DE14:18B-0482 High-resolution flat-panel CT arthrography forcartilage defect detection: comparison to multidetectorCTR. Guggenberger 1 , S. Winklhofer 1 , T. Redel 2 , J. Korporaal 2 , A. Meier 2 , J. vonSpiczak 1 , G. Andreisek 1 , H. Alkadhi 1 ; 1 Zurich/CH, 2 Forchheim/DE14:27B-0483 Longitudinal evaluation of T2 relaxation time inrelation to baseline volume of femorotibial cartilage –data from the osteoarthritis initiativeP. Beringer 1 , L. Nardo 1 , H. Liebl 1 , U.R. Heilmeier 1 , A. Lai 1 , F. Liu 1 , G.B. Joseph 1 ,F. Eckstein 2 , T.M. Link 1 ; 1 San Francisco, CA/US, 2 Salzburg/AT14:36B-0484 Longitudinal increase of T2 relaxation time innormal subjects indicating physiological aging of thecollagen network and cartilage matrix: data from theosteoarthritis initiative (OAI)U.R. Heilmeier, P. Beringer, L. Nardo, H. Liebl, S. Lee, G. Joseph, C.E. McCulloch,M.C. Nevitt, T.M. Link; San Francisco, CA/US14:45B-0485 3D delayed gadolinium-enhanced MRI of cartilage(dGEMRIC) at 3T used to evaluate the effectof hyaluronic acid on cartilage quality in kneeosteoarthritis patientsJ. van Tiel, M. Reijman, K. Bos, J. Verhaar, G.P. Krestin, S. Bierma - Zeinstra,H. Weinans, G. Kotek, E. Oei; Rotterdam/NL14:54B-0486 T2* mapping and delayed gadolinium-enhancedmagnetic resonance imaging in cartilage (dGEMRIC) ofglenohumeral cartilage in asymptomatic volunteers at3TB. Bittersohl 1 , F.R. Miese 1 , C. Dekkers 1 , H. Senyurt 1 , J. Kircher 2 , H.-J. Wittsack 1 ,G. Antoch 1 , R. Krauspe 1 , C. Zilkens 1 ; 1 Düsseldorf/DE, 2 Cologne/DE238

Scientific Sessions15:03B-0487 Validity of gradient-echo three-dimensional delayedgadolinium-enhanced magnetic resonance imaging ofhip joint cartilage: a histologically controlled studyC. Zilkens 1 , F.R. Miese 1 , M. Herten 1 , S. Kurzidem 1 , M. Jäger 2 , D. König 3 ,G. Antoch 1 , R. Krauspe 1 , B. Bittersohl 1 ; 1 Düsseldorf/DE, 2 Essen/DE, 3 Viersen/DE15:12B-0488 In-vivo sodium magnetic resonance (MR) imaging ofhealthy intervertebral discs during unloadingK.M. Friedrich, J. Wimmer, V. Juras, S. Zbyn, I. Nöbauer-Huhmann, S. Trattnig;Vienna/AT15:21B-0489 T2 mapping for assessment of lumbar disc repair afterautologous disc-derived chondrocyte transplantation(ADCT)M. Glowacki, M. Ostrowska, W. Gradkowski, J. Walecki; Warsaw/PL15:03B-0497 Uterine artery embolization for management ofsecondary postpartum haemorrhage associated withplacenta accretaZ. Wang, Z. Jin, X. Li; Beijing/CN15:12B-0498 Placenta percreta: role of bilateral occlusion balloonsinsertion in to internal iliac arteries to preventhaemorrhage and hysterectomyM. Teixidor Viñas, A.-M. Belli, E. Chandraharan; London/UK15:21B-0499 Efficacy of bilateral uterine artery embolization asa first-line therapeutic option for acquired uterinearteriovenous malformationsJ. Shin, H.-K. Yoon, G.-Y. Ko, D.-I. Gwon; Seoul/KRB-0487 – B-050614:00–15:30 Room PInterventional RadiologySS 609b Gynaecological and obstetricinterventionsModerators: P. Andersen; Odense/DK, R. Nijenhuis; Maastricht/NL14:00B-0490 Non-invasive treatment of uterine fibroids using MRguidedhigh-intensity focused ultrasound: results onquality of life, non-perfused volume ratio and sizereduction over 12 monthsF. Ciolina, A. Napoli, B. Cavallo Marincola, F. Boni, F. Zaccagna, V. Noce,L. Bertaccini, C. Catalano; Rome/IT14:09B-0491 MRI-guided focused ultrasound treatment ofsymptomatic uterine fibroids: impact of technologyadvancement on ablation volumes in 115 patientsC.G. Trumm 1 , R. Stahl 1 , D.-A. Clevert 1 , P. Herzog 2 , I. Mindjuk 2 , S. Kornprobst 2 , R.-T. Hoffmann 3 , M.F. Reiser 1 , M. Matzko 2 ; 1 Munich/DE, 2 Dachau/DE, 3 Dresden/DE14:18B-0492 Efficacy of MRI-guided focused ultrasound (MRgFUS)treatment of uterine fibroids: evaluation of nonperfusedvolume (NPV), fibroid shrinkage and clinicalimprovement at 6-month follow-upI. Invernizzi 1 , M. Vaiani 1 , P. Colombo 1 , F. Zucconi 1 , S. Sironi 2 , C. Ticca 1 ; 1 Milan/IT,2Monza/IT14:27B-0493 Uterine adenomyosis treated by MRgFUS: technicalapproach and clinical resultsF. Ferrari, A. Miccoli, F. Arrigoni, A.V. Giordano, E. Fascetti, G. Mascaretti,C. Masciocchi; L‘Aquila/IT14:36B-0494 Is uterine artery embolisation in large sized myomaas efficient as in normal sized myoma: a retrospectivecomparative study in 263 patientsH. Choi 1 , G. Jeon 1 , M. Kim 2 , J. Lee 1 , J. Yoon 1 , S. Hwang 1 ; 1 Seongnam/KR,2Seoul/KR14:45B-0495 Usefulness of pelvic artery embolisation: acomparison between caesarean section and vaginaldelivery in 176 patientsH. Lee, G. Jeon; Seongnam-si/KR14:54B-0496 Transarterial embolization in the treatment ofpostpartum haemorrhageZ. Wang, X. Li, Z. Jin; Beijing/CN14:00–15:30 Room ZMolecular ImagingSS 606 MR/PET and PET/CTModerators: N. Belcari; Pisa/IT, P.R. Ros; Cleveland, OH/US14:00B-0500 Simultaneous 68 Ga-DOTATOC PET/MRI for whole bodystaging in patients with neuroendocrine tumours:preliminary resultsK.J. Beiderwellen 1 , T.D. Poeppel 1 , V. Hartung-Knemeyer 1 , C. Buchbender 2 ,H. Kuehl 1 , A. Bockisch 1 , T.C. Lauenstein 1 ; 1 Essen/DE, 2 Düsseldorf/DE14:09B-0501 Diffusion-weighted imaging as part of hybrid FDG-PET/MRI protocols for whole body cancer staging: does itbenefit lesion detection?T.A. Heusner 1 , P. Heusch 1 , V. Hartung-Knemeyer 2 , K. Beiderwellen 2 ,T. Lauenstein 2 , M. Forsting 2 , G. Antoch 1 , C. Buchbender 1 ; 1 Düsseldorf/DE,2Essen/DE14:18B-0502 Molecular imaging of the prostate usingmultiparametric functional [11C]-acetate PET/MRI:proof of conceptS. Polanec, T. Helbich, K. Pinker-Domenig, S. Leitner, B. Füger, G. Karanikas,M. Margreiter, S. Kommata, P. Brader; Vienna/AT14:27B-0503 PET/CT guided therapy planning in prostate cancerpatients eligible for radiotherapy: results from abicentric clinical studyE. Lopci 1 , B.A. Jereczek-Fossa 2 , M. Rodari 1 , G. Pepe 1 , C. Fodor 2 , D. Zerini 2 , O. DeCobelli 2 , R. Orecchia 2 , A. Chiti 1 ; 1 Rozzano/IT, 2 Milan/IT14:36B-0504 Detection of lung nodules in an integrated whole bodyMR/PET scanner: comparison to PET/CTN.F. Schwenzer, C. Schraml, S. Gatidis, C. Brendle, H. Schmidt, C. Pfannenberg,C.D. Claussen; Tübingen/DE14:45B-0505 Assessment of tumour aggressiveness withquantitative perfusion imaging and tumour volume inpatients with lung cancer: correlation with metabolicparameters of 18 FDG-PET/CTD. Fior, D. Ippolito, P.A. Bonaffini, C. Capraro, C. Messa, S. Sironi; Monza/IT14:54B-0506 FDG-PET/CT for the early prediction ofhistopathological complete response to neoadjuvantchemotherapy in breast cancer patientsT.A. Heusner 1 , C. Riegger 1 , S. Kuemmel 2 , M. Forsting 2 , V. Hartung-Knemeyer 2 ,G. Antoch 1 , C. Buchbender 1 ; 1 Düsseldorf/DE, 2 Essen/DEFriday239

Scientific SessionsB-0507 – B-050815:03B-0507 Diagnostic accuracy of 11C-choline PET (CHO-PET) inpatient affected by hepatocellular carcinoma (HCC):comparison with CT/MRIE. Lopci, G. Torzilli, A. Palmisano, M. Scorsetti, A. Chiti; Rozzano/IT15:12B-0508 PIB-PET as a pathological and functional marker inAlzheimer‘s diseaseV. Abreu 1 , A. Nordberg 2 ; 1 Lorenskog/NO, 2 Stockholm/SE240

Scientific Sessions10:30–12:00 Room CNeuroSS 911New insights into brain gliomasModerators: L.C. Tzarouchi; Ioannina/GR, P. Vilela; Almada/PT10:30B-0509 Data-driven grading of brain gliomas: amultiparametric MRI studyV. Panara, D. Tortora, P. Mattei, S. Salice, C. Briganti, A. Cotroneo, A. Tartaro,M. Caulo; Chieti/IT10:39B-0510 Combining diffusion kurtosis imaging, dynamicsusceptibility-weighted MR imaging and short echotime chemical shift imaging for grading gliomasS. Van Cauter 1 , F. De Keyzer 1 , D. Sima 1 , J. Veraart 2 , F. D‘Arco 1 , R. Peeters 1 , S. VanGool 1 , S. Sunaert 1 , U. Himmelreich 1 ; 1 Leuven/BE, 2 Antwerp/BE10:48B-0511 Dynamic contrast-enhanced (DCE) MRI of cerebralgliomas: assessment of tumoral angiogenesis withlow gadolinium-based contrast agent doseD. Gadda, L. Mazzoni, M. Moretti, S. Chiti, G. Giordano; Firenze/IT10:57B-0512 Correction of CBV perfusion maps from T1 leakageeffect allows a better correlation of perfusion DSC MRimaging with histopathologic glioma grading and anestimation of vascular permeabilityF. Viry 1 , D. Galanaud 1 , A. Mitulescu 2 , Y. Chaibi 2 , V. Reina 1 , D. Leclercq 1 ,D. Dormont 1 ; 1 Paris/FR, 2 La Ciotat/FR11:06B-0513 Paradoxical imaging features of high-grade gliomaswith oligodendroglial component: quantitativeanalysis on diffusion and DSC perfusion MR imagingL. Sunwoo, S. Choi, T. Kim, S.-H. Lee, C.-K. Park, J.-H. Kim, C.-H. Sohn, S.-H. Park,I. Kim; Seoul/KR11:15B-0514 Survival predictive value of perfusion-weighted MRIrelative cerebral blood volume (rCBV) in glioblastomamultiforme adjusted by multiple biomarkers includingMGMT promoter methylationG. Viteri, P. Slon, J. Etxano, G. Aldave, R. García-Eulate, J.L. Zubieta, S. Tejada,R. Díez-Valle, P.D. Dominguez; Pamplona/ES11:24B-0515 Additive value of arterial spin labeling indifferentiating primary central nervous systemlymphoma from glioblastoma multiforme: an observerperformance studyK. Yamashita, T. Yoshiura, A. Hiwatashi, O. Togao, K. Kikuchi, K. Yoshimoto,H. Honda; Fukuoka/JP11:33B-0516 Glioma grading using pharmacokinetic parameters inT1-weighted dynamic contrast-enhanced perfusion MRS.C. Jung, S. Choi, S. Kim, H. Shin, J. Yeom, I. Ryoo; Seoul/KR11:42B-0517 Intravoxel incoherent motion MR imaging withbiexponential and stretched-exponential model ingrading cerebral gliomasY. Bai 1 , D. Shi 1 , S. Dou 1 , F. Sun 2 , M. Wang 1 ; 1 Zhengzhou/CN, 2 Beijing/CN11:51B-0518 Apparent diffusion coefficient obtained by magneticresonance imaging as a prognostic marker inglioblastomas: correlation with MGMT promotermethylation statusL. Calabria 1 , M. Rossi Espagnet 1 , F. Tavanti 1 , A. Boellis 1 , V. Coppola 2 , M. Federici 1 ,A. Romano 1 , L. Fantozzi 1 , A. Bozzao 1 ; 1 Rome/IT, 2 Ronciglione/IT10:30–12:00 Room D1ChestSS 904Image quality and dose reductionModerators: P.A. Grenier; Paris/FR, J. Vlahos; London/UK10:30B-0519 Clinical evaluation of an automatic tube voltageselection in chest CT angiographyT. Niemann, S. Henry, F. Pontana, K. Yasunaga, J.-B. Faivre, J. Rémy, M. Rémy-Jardin; Lille/FR10:39B-0520 Organ-based tube-current modulation: impact ofbreast position in clinical practiceS. Taylor 1 , D. Tack 2 , V. De Maertelaer 3 , P. Gevenois 3 ; 1 Montigny-le-Tilleul/BE,2Baudour/BE, 3 Brussels/BE10:48B-0521 Reduced radiation exposure of the female breastduring low-dose chest CT using an organ-based tubecurrentmodulation and bismuth shield: comparison ofimage quality and radiation doseY. Kim, Y. Sung, E. Kim, H. Kim, J. Choi; Incheon/KR10:57B-0522 Evaluation of automated attenuation-based tubepotential selection in combination with organ-specificdose reduction for clinical chest CTP. Kröpil, L. Schimmöller, S. Dietrich, P. Heusch, J. Aissa, G. Antoch,R.S. Lanzman; Düsseldorf/DE11:06B-0523 Thoracic imaging with low-dose MDCT at low tubevoltages using iterative image reconstruction: whereis the limit of diagnostic confidence compared to theclinical standard?W. Stiller 1 , G. Pahn 1 , J.L. Mayer 1 , M. Dadrich 1 , J. Hirsch 2 , S. Böhme 3 ,K. Markstaller 3 , G. Szabó 1 , H.-U. Kauczor 1 ; 1 Heidelberg/DE, 2 Witten/DE,3Vienna/AT11:15B-0524 Effect of acquisition parameters and reconstructionalgorithm on lesion conspicuity in low-dose MDCT ofthe thoraxV. Yaghmai, H.G. Töre, M.P.F. Botelho, F.D. Gonzalez-Guindalini, S.K. Patel,K. Dill, C.B. Harmath; Chicago, IL/US11:24B-0525 Evaluation of an iterative reconstruction algorithm(iDose) to reduce image noise and improve imagequality in submillisievert CT scans of the thoraxM. Henninger, A.A. Fingerle, C. Markus, T. Zahel, P.B. Noël, E.J. Rummeny,M. Dobritz; Munich/DE11:33B-0526 Phantom study for adaptive iterative dose reduction3D (AIDR 3D) for low-dose chest CT examination:utility for identification of pulmonary ground glassopacity and nodule on 320-detector row CT usingdifferent scanning methodsS. Seki 1 , H. Koyama 1 , Y. Ohno 1 , M. Nishio 1 , T. Yoshikawa 1 , S. Matsumoto 1 ,N. Sugihara 2 , H. Inokawa 2 , K. Sugimura 1 ; 1 Kobe/JP, 2 Ohtawara/JP11:42B-0527 The lateral scan projection radiograph (topogram) inCT pulmonary angiography: the effect on scan lengthand radiation doseJ.C.L. Rodrigues, I. Negus, N.E. Manghat, M.C.K. Hamilton; Bristol/UKB-0509 – B-0527Saturday241

Scientific SessionsB-0528 – B-054811:51B-0528 Accuracy of lung nodule volumetry using adaptiveiterative dose reduction 3D for ultra-low dose of320-detector row CT: a phantom studyK. Doo 1 , E.-Y. Kang 1 , H. Yong 1 , O. Woo 1 , K. Lee 2 , Y.-W. Oh 1 ; 1 Seoul/KR, 2 Ansan/KR11:51B-0538 Endovascular treatment of haemoptysis of pulmonaryartery origin: a single-centre experienceA. Khalil, S. Haddad, M. Tassart, A. Parrot, M.-F. Carette; Paris/FR10:30–12:00 Room D2Interventional RadiologySS 909 Thoracic interventionsModerators: J. Tacke; Passau/DE, K. Zelenak; Martin/SK10:30B-0529 CT-guided lung biopsy: core needle coaxial techniquewith autologous blood needle tract embolisationcompared with fine needle aspiration in diagnosticyield and post-biopsy pneumothorax rateS. Lee 1 , A. Montaser 2 , L. Nardo 1 , U.R. Heilmeier 1 , B.A. Aronson 2 ;1San Francisco, CA/US, 2 Canton, OH/US10:39B-0530 Computed tomography-guided lung biopsy with thepatient in lateral position and the biopsy side down:effect on pneumothorax rate and clinical significanceG. Velonakis, D. Filippiadis, A. Mazioti, S.I. Argentos, K. Malagari, A. Kelekis,N. Kelekis; Athens/GR10:48B-0531 C-arm cone-beam computed tomography (CBCT)needle path overlay for percutaneous biopsy ofpulmonary nodulesC. Floridi, F. Fontana, A. Ierardi, G. DeMarchi, L. Nocchi-Cardim, C. Pellegrino,G. Carrafiello, C. Fugazzola; Varese/IT10:57B-0532 Computed tomography guided trans-thoracic fineneedle aspiration biopsy of pulmonary nodule:pulmonary haemorrhage, complication or advantage?M. De Filippo, L. Saba, G. Concari, C. Rossi; Parma/IT11:06B-0533 Feasibility and safety of CT-guided percutaneousradiofrequency, microwave or cryoablation of thepulmonary and mediastinal unresectable tumoursadjacent to the heart and large vesselsC. Pusceddu, L. Melis, G. Meloni; Cagliari/IT11:15B-0534 Factors influencing local tumour control in patientswith neoplastic pulmonary nodules treated withmicrowave ablation (MWA): a risk factor analysisT.J. Vogl, T.S. Worst, N.N.N. Naguib, N.-E.A. Nour-Eldin; Frankfurt a. Main/DE11:24B-0535 Percutaneous microwave ablation of lung tumoursC. Pusceddu, L. Melis, G. Meloni; Cagliari/IT11:33B-0536 MRI chest parameters used in the assessmentof tumour response post microwave ablation ofpulmonary metastasesN.-E.A. Nour-Eldin, N.N.N. Naguib, T. Gruber-Rouh, T. Lehnert, M. Sadegi,T.J. Vogl; Frankfurt a. Main/DE11:42B-0537 Transpulmonary chemoembolisation (TPCE) andtranspulmonary chemoperfusion (TPCP) as atreatment for unresectable primary and secondarylung tumours: local tumour control and survivalT.J. Vogl, A. Müller, S. Zangos, T. Lehnert; Frankfurt a. Main/DE10:30–12:00 Room E1MusculoskeletalSS 910 Spine: advancing the use of CT and MRIModerators: P.M. Cunningham; Navan/IE, J. Labuscagne; Bunbury, WA/AU10:30B-0539 Cervical nerve root infiltration under CT and MRIguidance: a cost comparisonM.H. Maurer, M. deBucourt, T. Hartwig, B. Hamm, F. Streitparth; Berlin/DE10:39B-0540 Fast inner volume imaging of the lumbar spine with azoomed SPACE sequence using parallel transmitP. Riffel 1 , S. Kannengiesser 2 , D. Paul 2 , S.O. Schönberg 1 , H.J. Michaely 1 ;1Mannheim/DE, 2 Erlangen/DE10:48B-0541 The importance of ispection of true FISP sequencesduring MRI of the lumbar spineM. Papavasilopoulou, M. Raissaki, C. Voulgaris, A. Karantanas; Iraklion/GR10:57B-0542 Computed tomography of the cervical spine:comparison of image quality between standarddosefiltered back-projection and low-dose iterativereconstruction protocolsF. Becce 1 , Y. Ben Salah 2 , F.R. Verdun 1 , B.C. Vande Berg 2 , F.E. Lecouvet 2 ,R. Meuli 1 , P. Omoumi 2 ; 1 Lausanne/CH, 2 Brussels/BE11:06B-0543 Imaging quality of reduced radiation dose lumbarspine CT with iterative reconstructionC.-J. Lin, S. Hung, W. Guo, T. Wu; Taipei/TW11:15B-0544 Multidetector computed tomography of the cervicalspine: optimisation of iterative reconstructionstrength levelsP. Omoumi 1 , F.R. Verdun 2 , Y. Ben Salah 1 , B.C. Vande Berg 1 , F.E. Lecouvet 1 ,R. Meuli 2 , F. Becce 2 ; 1 Brussels/BE, 2 Lausanne/CH11:24B-0545 Relationship among facet joint fluid (FJF) at MRI, age,and disk degeneration in patients affected with lowback painC. Ottonello 1 , A. Giardino 2 , G.D.E. Papini 3 , A. Sharipova 3 , G. Di Leo 3 , F. Sardanelli 3 ;1Pomezia/IT, 2 Milan/IT, 3 San Donato Milanese/IT11:33B-0546 Typification of posterior instability in patients withspondylolysis or isthmic spondylolisthesisP. Niggemann 1 , J. Kuchta 2 , H. Urbach 2 , H.H. Schild 2 ; 1 Mannheim/DE, 2 Bonn/DE11:42B-0547 Differentiation of benign and malignant vertebral bodyfractures with dynamic contrast-enhanced MRIT. Geith 1 , A. Biffar 1 , G. Schmidt 1 , S. Sourbron 2 , H.R. Duerr 1 , M.F. Reiser 1 , A. Baur-Melnyk 1 ; 1 Munich/DE, 2 Leeds/UK11:51B-0548 Trabecular bone structure analysis of the spine usingclinical MDCT: can it predict vertebral bone strength?T. Baum 1 , M. Gräbeldinger 1 , E. Grande Garcia 1 , R. Burgkart 1 , J. Patsch 2 ,E.J. Rummeny 1 , T.M. Link 3 , J.S. Bauer 1 ; 1 Munich/DE, 2 Vienna/AT,3San Francisco, CA/US242

Scientific Sessions10:30–12:00 Room F1Oncologic ImagingSS 916 Whole-body imaging: how to do itModerators: T.F. Hany; Zurich/NL, D.M.J. Lambregts; Maastricht/NL10:30B-0549 Cross over PET/MRI vs PET/CT study in oncologicalpatients: does it change management?J. Al-Kalbani, K. Alnabhani, A. Afaq, R. Syed, C. O‘Meara, A. Barnes, J. Boumanji;London/UK10:39B-0550 Whole body magnetic resonance imaging, includingdiffusion-weighted imaging, for staging malignantlymphoma: comparison to computed tomography in135 patientsT.C. Kwee 1 , M.A. Vermoolen 1 , E.A. Akkerman 2 , M. Kersten 2 , R. Fijnheer 3 ,F.J. Beek 1 , M.S. van Leeuwen 1 , M.B. Bierings 1 , R.A.J. Nievelstein 1 ; 1 Utrecht/NL,2Amsterdam/NL, 3 Amersfoort/NL10:48B-0551 Combination of continuously moving table MRI andPET including image fusion: improved lesion detectionin local and distant recurrence of rectal cancerT. Baumann, A.-O. Schäfer, M. Langer; Freiburg/DE10:57B-0552 Does positron emission tomography data acquisitionimpact simultaneous diffusion-weighted imaging in awhole body PET/MRI system?R.S. Lanzman 1 , C. Buchbender 1 , P. Heusch 1 , V. Hartung-Knemeyer 2 ,T. Lauenstein 2 , M. Forsting 2 , G. Antoch 1 , T. Heusner 1 ; 1 Düsseldorf/DE, 2 Essen/DE11:06B-0553 Standardised uptake values for [18F]-FDG in normalorgan tissues: comparison of whole body PET/CT andPET/MRIC. Buchbender 1 , P. Heusch 1 , V. Hartung-Knemeyer 2 , H. Kühl 2 , T. Lauenstein 2 ,M. Forsting 2 , G. Antoch 1 , T.A. Heusner 1 ; 1 Düsseldorf/DE, 2 Essen/DE11:15B-0554 Impact of FDG PET-CT on patient management andradiotherapy treatment planning in locally advancedcervical carcinomaS. Fleming, R. Cooper, S. Swift, F. Chowdhury, A. Scarsbrook, C. Patel; Leeds/UK11:24B-0555 Is there a role for standard uptake value in theprognostic evaluation of lung nodules?A. Bazzocchi, S. Brocchi, G. Facchini, V. Ambrosini, S. Ascanio, G. Battista,S. Fanti; Bologna/IT11:33B-0556 Detection of underlying malignancy in patients withparaneoplastic neurological syndromes: comparison of18F-FDG-PET/CT and contrast-enhanced CTN. Schramm, A. Rominger, C. Schmidt, C. Schmid-Tannwald, F.G. Meinel,M.F. Reiser, C. Rist; Munich/DE11:42B-0557 FDG-avid duodenal lesions: a retrospective analysis oftheir significance in oncology practiceS. Puri, L. Jones, J. Strang; Rochester, NY/US11:51B-0558 Feasibility and first clinical experiences withsimultaneous PET/MR imaging of cervical cancer:comparison of image quality with MRI and PET/CTP. Brandmaier, S. Purz, M. Reinhardt, M. Gawlitza, H. Barthel, O. Sabri, T. Kahn,R. Kluge, P. Stumpp; Leipzig/DE10:30–12:00 Room F2BreastSS 902Increased risk of breast cancerModerators: L.A. Carbonaro; San Donato Milanese/IT, L. Ollivier; Paris/FR10:30B-0559 Individual radiosensitivity: a key-issue to reconsiderhigh breast cancer risk patient screening modalitiesC. Colin 1 , N. Foray 2 , F. De Vathaire 3 , M. Bourguignon 4 , P.-J. Valette 1 ;1Pierre-Bénite/FR, 2 Lyon/FR, 3 Villejuif/FR, 4 Paris/FR10:39B-0560 Which screenings program should be offered towomen with BRCA1 or BRCA2 mutations? A simulationof comparative cost-effectivenessG.H. De Bock 1 , K.M. Vermeulen 1 , L. Jansen 1 , J.C. Oosterwijk 1 , S. Siesling 1 ,T. Feenstra 1 , N. Houssami 2 , M.J.W. Greuter 1 ; 1 Groningen/NL, 2 Syndey/AU10:48B-0561 MRI of hereditary breast cancer: can hyper T2 signalintensity be considered as a new semeiotic parameterof higher aggressiveness?G. Trecate, R. Agresti, S. Viganò, L. Suman, D. Vergnaghi, C. Ferranti,M. Marchesini, G. Scaperotta, P. Panizza; Milan/IT10:57B-0562 Fully automated MRI breast density (BD)measurement: comparison to standard mammographicdensity estimationG.J. Wengert, W.-D. Vogl, T.H. Helbich, H. Bickel, W. Bogner, K. Pinker-Domenig;Vienna/AT11:06B-0563 Fully automated quantitative MRI breast density (BD)measurement confirms higher breast density in breastcancer patientsK.J. Pinker-Domenig, G.J. Wengert, H. Bickel, H.F. Magomatschnigg, M. Curda,T.H. Helbich; Vienna/AT11:15B-0564 To excise or not to excise? Management of high-riskbreast lesions in a symptomatic populationJ.D. Cunningham, A. Corr, E. Kelliher, A. O‘Shea, J. Kerr, D. Duke, N. Hambly;Dublin/IE11:24B-0565 The diagnostic value of 3 Tesla breast MRI in thediagnosis of in situ and invasive breast cancerL.G. Merckel 1 , H.M. Verkooijen 1 , N.H.G.M. Peters 1 , R.M. Mann 2 , W.B. Veldhuis 1 ,T. van Dalen 1 , W.P.T.M. Mali 1 , P.H.M. Peeters 1 , M.A.A.J. van den Bosch 1 ;1Utrecht/NL, 2 Nijmegen/NL11:33B-0566 Positive enhancement integral values in diagnosticmagnetic resonance imaging of breast carcinoma:ductal carcinoma in situ (DCIS) vs invasive ductalcarcinoma (IDC)M.M. Nadrljanski, O.S. Radulovic, Z.C. Milosevic; Belgrade/RS11:42B-0567 DCIS at image-guided needle biopsy: can breast MRIpre-operatory predict invasivity?M. Marcon, V. Bertani, P. Clauser, E. Di Gaetano, V. Londero, A. Linda,R. Girometti, C. Zuiani, M. Bazzocchi; Udine/IT11:51B-0568 Breast dynamic MRI in patient with DCIS percutaneousbiopsy diagnosis: are different grades associated withspecific features?V. Bertani, M. Marcon, P. Clauser, A. Linda, V. Londero, R. Girometti, C. Zuiani,M. Bazzocchi; Udine/ITB-0549 – B-0568Saturday243

Scientific SessionsB-0569 – B-058712:00B-0569 Triple negative breast cancers (TNBCs) versus nontriplenegative breast cancers (non-TNBCs) diagnosedduring a high-risk screening program: sensitivity ofimaging modalities and patient outcomeR.M. Trimboli 1 , F. Podo 2 , F. Santoro 2 , F. Sardanelli 3 ; 1 San Donato Milanese/IT,2Rome/IT, 3 Milan/IT10:30–12:00 Room I/KAbdominal VisceraSS 901 Cross-sectional pancreatic imagingand biomarkersModerators: B. Marincek; Cleveland, OH/US, G.A. Zamboni; Verona/IT10:30B-0570 Dynamic contrast MR imaging of the pancreasunder free breathing in combination with navigatortechniqueT. Masui 1 , M. Katayama 1 , K. Sato 1 , K. Terauchi 1 , K. Tsukamoto 1 , K. Mizuki 1 ,Y. Iwadate 2 , H. Sakahara 1 , H. Kabasawa 2 ; 1 Hamamatsu/JP, 2 Hino/JP10:39B-0571 Diffusion-weighted magnetic resonance imaging ofhealthy pancreas: a study to investigate the effect ofage on apparent diffusion coefficient valuesC. Ma, C. Pan, H. Zhang, H. Wang, J. Wang, S. Chen, J. Lu; Shanghai/CN10:48B-0572 Pancreatic cystic lesion fluid content virtual analysisby means of acoustic radiation force impulse (ARFI)ultrasound imaging: fact or fiction?S. Canestrini, M. D‘Onofrio, R. De Robertis, S. Crosara, E. Demozzi, G. Puntel,R. Pozzi Mucelli; Verona/IT10:57B-0573 Role of perfusion CT in the evaluation of pancreaticmassesR. Vasudevan, M. Kang, R. Gupta, D. Bhasin, S. Rana, N. Khandelwal;Chandigarh/IN11:06B-0574 Comparison between CT and CEUS in the diagnosis ofpancreatic adenocarcinomaS. Crosara, M. D‘Onofrio, R. De Robertis, S. Canestrini, R. Pozzi Mucelli; Verona/IT11:15B-0575 High-resolution diffusion-weighted imaging ofpancreatic ductal adenocarcinoma using 2D reducedfield of view single-shot echo planar imaging at 3.0TeslaC. Ma, Y. Li, H. Wang, S. Chen, J. Lu; Shanghai/CN11:24B-0576 Imaging features of acinar cell cystadenoma: can wedifferentiate them from branch duct IPMNs?C. Delavaud 1 , G. D‘Assignies 1 , J. Cros 1 , P. Ruszniewski 1 , P. Hammel 1 ,A. Couvelard 2 , V. Vilgrain 1 , M.-P. Vullierme 1 ; 1 Clichy sur Seine/FR, 2 Paris/FR11:33B-0577 Diffusion-weighted 3T MR imaging with b-multiple SE-EPI in the differential diagnosis of cystic pancreaticlesionsP. Boraschi, F. Donati, R. Gigoni, G. Gherarducci, U. Boggi, F. Falaschi,C. Bartolozzi; Pisa/IT11:42B-0578 Cystic fibrosis in juveniles and adults: association offatty involution of the pancreas at MDCT with CFTRgenetic mutation and insulin-dependent diabetesmellitusU.G. Mueller-Lisse, N. Ashoori, H.A. Strube, M. Schmitz, R. Fischer, R.M. Huber,M.F. Reiser, E.M. Coppenrath; Munich/DE11:51B-0579 Pancreatic atrophy in β-thalassaemia population:morphological MR evaluation and correlation withpancreatic functional parametersC. Liguori, F. Pitocco, I. Di Giampietro, P. Cianciulli, B. Beomonte Zobel; Rome/IT10:30–12:00 Room N/OCardiacSS 903Myocardial perfusion and coronaryartery diseaseModerators: F. Cademartiri; Monastier di Treviso/IT,G.I. Kirova-Nedialkova; Sofia/BG10:30B-0580 Dual bolus dynamic contrast-enhanced cardiacperfusion imaging: comparison of eight reportedanalysis methodsB.M. Müller-Bierl, K. Tanaka, N. Buls, Y. Fierens, T. van Cauteren, I. Willekens,R. Luypaert, J. De Mey; Brussels/BE10:39B-0581 Image quality and radiation exposure of low-dosedual-source dynamic CT stress myocardial perfusionImaging: a randomized study comparing 80-kVp/370-mAs and 100-kVp/300-mAs protocolsM. Fujita, K. Kitagawa, T. Ito, Y. Shiraishi, Y. Kurobe, M. Nagata, M. Ishida,H. Sakuma, K. Dohi; Tsu/JP10:48B-0582 Feasibility of CT-based dynamic stress perfusionimaging to differentiate ischaemic and infarctedmyocardium as compared with magnetic resonanceimagingF. Bamberg, R. Marcus, K. Hildebrandt, F. Schwarz, D. Theisen, K. Bauner,A. Becker, T. Johnson, K. Nikolaou; Munich/DE10:57B-0583 Adenosine perfusion and late gadoliniumenhancement at 3 Tesla in comparison to 1.5 Tesla forthe detection of coronary artery stenosisT. Walcher, K. Ikuye, W. Rottbauer, J. Woehrle, P. Bernhardt; Ulm/DE11:06B-0584 Myocardial perfusion defects and late gadoliniumenhancement in asymptomatic subjects withsubclinical atherosclerosis and mild coronarycalcifications – results of the Heinz Nixdorf recall MRIsubstudyT. Schlosser, K. Nassenstein, P. Hunold, K.-H. Joeckel, J. Barkhausen, R. Erbel,B. Sievers; Essen/DE11:15B-0585 Late enhancement multidetector computedtomography (LE-MDCT) assessment of scar substratein recurrent ventricular tachycardia (VT)C. Colantoni, A. Esposito, A. Palmisano, F. De Cobelli, F. Baratto, G. Maccabelli,P. Della Bella, A. Del Maschio; Milan/IT11:24B-0586 Dynamic CT perfusion imaging of the myocardiumusing a wide detector CT scanner: stress/rest or stressonlyA.M. Huber 1 , V. Leber 1 , B. Gramer 1 , M. Vembar 2 , A. Leber 1 , E. Hoffmann 1 ,E.J. Rummeny 1 ; 1 Munich/DE, 2 Cleveland, OH/US11:33B-0587 Advanced age and apnoea-hypopnoea indexpredict subclinical atherosclerosis in patients withobstructive sleep apnoea syndromeB. Arık 1 , C. Gümüş 1 , M. İnci 2 , M. Ege 3 , A. Zorlu 4 , K. Varol 1 , Ö. Doğan 1 ; 1 Sivas/TR,2Kahramanmaraş/TR, 3 Ankara/TR, 4 Malatya/TR244

Scientific Sessions11:42B-0588 Prevalence of severe subclinical coronary arterydisease on cardiac CT and MRI in patients with extracardiacarterial diseaseM.A.M. den Dekker 1 , J.J.A.M. van den Dungen 1 , I.F.J. Tielliu 1 , R.A. Tio 1 ,R.M.J.J. Jaspers 2 , M. Oudkerk 1 , R. Vliegenthart 1 ; 1 Groningen/NL, 2 Deventer/NL11:51B-0589 Dual-energy CT with non-linear image blendingimproves visualization of delayed myocardial contrastenhancement in acute myocardial infarctionA.H. Mahnken 1 , P. Bruners 2 , K. Kartje 2 , B. Schmidt 3 ; 1 Marburg/DE, 2 Aachen/DE,3Forchheim/DE10:30–12:00 Room PPaediatricSS 912 Paediatric body and bonesModerators: K.J. Johnson; Birmingham/UK, L.-S. Ording-Müller; Tromsø/NO10:30B-0590 Accuracy of ultrasound using a computerisedtechnique to evaluate nonalcoholic fatty liver diseasein obese and eutrophic adolescents as compared withMRIJ.H.R.N. Nascimento, R.B.S. Soder, M.E. Epifanio, M.B. Baldisserotto;Porto Alegre/BR10:39B-0591 Can ultrasonography reliably differentiate betweenileo-colic and small bowel intussusception?N. Simanovsky 1 , N. Lioubashevsky 2 , K. Rozovsky 2 , N. Hiller 2 ; 1 Beth Horon/IL,2Jerusalem/IL10:48B-0593 Early-stage disease activity of the wrist in juvenileidiopathic arthritis: assessment with MRI in a pilotstudyC.M. Nusman, R. Hemke, D. Schonenberg, J.M. van den Berg, K.M. Dolman,T.W. Kuijpers, M.A.J. van Rossum, M. Maas; Amsterdam/NL10:57B-0594 Clavicle radiographs in children: a waste of time andradiation?M.R. Jackson, M.-P. Lirette, P. Leonard; Edinburgh/UK11:06B-0595 A follow-up study of a delayed approach to managingdevelopmental hip dysplasia (DDH)L. Woods, M. Khalil, A. Witwit, S. Manickam, M. Churchill, V. Cook; London/UK11:15B-0596 Value of lower-limb MRI in the staging and re-stagingof post-treatment osteonecrosis in paediatric patientswith lymphoproliferative diseaseA. Masetto, D. Ippolito, P.A. Bonaffini, L. Longoni, A. Sala, A. Rovelli, S. Sironi;Monza/IT11:24B-0597 Painful paediatric hip: frog-leg lateral view only!J. Bomer, F. Klerx, H.C. Holscher; Den Haag/NL11:33B-0598 DXA as a key instrument for the evaluation and thefollow-up of adolescents affected by anorexia nervosaF. Ciccarese, G. Facchini, E. Di Pietro, F. Moscano, L. Iero, E. Franzoni, G. Battista,A. Bazzocchi; Bologna/IT11:42B-0599 Replacing conventional spine radiographs with dualenergyX-ray absorptiometry (DXA) in children withsuspected reduction in bone densityE. Adiotomre, L. Summers, P. Broadley, I. Lang, G. Morrison, A. Offiah;Sheffield/UK10:30–12:00 Room QRadiographersSS 914 Dose optimisation as daily challengeModerators: P. Blackburn Andersen; Kolding/DK, A. Petakovic;Novo Mesto/SI10:30B-0600 Estimating organs cancer incidence related to patientradiation exposure following PCI for acute and chroniccoronary total occlusionD. Maccagni; Milan/IT10:39B-0601 Project retake: quality assurance of radiation hygieneby maintaining image qualityS.M. Khan; Oslo/NO10:48B-0602 Implementation of a quality control program in aradiology departmentM. Leão, L.P.V. Ribeiro, A.F.C.L. Abrantes, J. Pinheiro, R.P.P. Almeida,K.B. Azevedo, S.I. Rodrigues; Faro/PT10:57B-0603 Assessment of radiological imaging conformitiesbased in quality control chartsS. Cândido, A.M. Ribeiro, L.P.V. Ribeiro, A.F.C.L. Abrantes, J. Pinheiro,K.B. Azevedo, R.P.P. Almeida; Faro/PT11:06B-0604 A review of diagnostic imaging frequency to aidresearch exploring the issue of consent for higherdose paediatric examinationsJ.L. Portelli 1 , J. McNulty 2 , S. Mohan 2 , P. Bezzina 1 , L. Rainford 2 ; 1 Msida/MT,2Dublin/IE11:15B-0605 An approach for Portuguese diagnostic referencelevels for bedside chest radiographyA. Sousa, S. Serém, J. Santos, G. Paulo; Coimbra/PT11:24B-0606 An investigation into the relationship between theexposure index value and image qualityM.-L. Butler, L. Rainford; Dublin/IE11:33B-0607 Attenuation of anode heel effect with an aluminumfilter and their influence on patient dose in lumbarspine radiographyJ. Soares, R. Dores, P. Sousa, S.I. Rodrigues, L.P.V. Ribeiro, A.F.C.L. Abrantes,R.P.P. Almeida; Faro/PT11:42B-0608 Antero-posterior (AP) pelvic radiography: collimatorerrors and their effects on radiation doseH. Brookfield 1 , A.S. Manning-Stanley 2 , A. England 1 ; 1 Liverpool/UK, 2 Salford/UK11:51B-0609 Breast shielding significantly reduces breast doseduring lumbar spine radiographyN. Mekiš, D. Žontar, D. Škrk; Ljubljana/SIB-0588 – B-0609Saturday245

Scientific SessionsB-0610 – B-061910:30–12:00 Room ZComputer ApplicationsSS 905 Computer-aided diagnosisModerators: T. Mang; Vienna/AT, D. Regge; Turin/IT10:30B-0610 Automated characterization of pulmonary nodulesin thoracic CT images using a segmentation-basedclassification systemC. Jacobs 1 , E.M. van Rikxoort 2 , J.-M. Kuhnigk 1 , E.T. Scholten 3 , P.A. de Jong 4 ,C. Schaefer-Prokop 5 , M. Prokop 2 , B. van Ginneken 2 ; 1 Bremen/NL, 2 Nijmegen/NL,3Haarlem/NL, 4 Utrecht/NL, 5 Amersfoort/NL10:39B-0611 Semiautomatic estimation of right ventricularparameters from MR images: a new stereologicalapproachM. Mazonakis, K. Pagonidis, C. Varveris, J. Damilakis; Iraklion/GR10:48B-0612 Automated computerized software for diameter andvolume measurements of pulmonary metastaticdisease: preliminary evaluationE. Lotan, D. Aharoni, S. Raskin, B. Boursi, R. Berger, E. Konen; Ramamt Gan/IL10:57B-0613 Computerised morphological estimation of sex andage – from subjective investigation to computerassistedanalysisA. Vlcek, F. Kanz, W. Weninger, J. Streicher, D. Risser, F. Kainberger; Vienna/AT11:06B-0614 Semiautomatic evaluation of quantitativepharmacokinetic parameters – systematic evaluationof a new CAD-tool and evaluation of clinicalperformance at high field 3T MRIM. Dietzel, A. Dörfler; Erlangen/DE11:15B-0615 Rapid semi-automated volumetry of pleural effusion inMDCTM.P.F. Botelho, F.D. Gonzalez-Guindalini, H. Chalian, V. Yaghmai; Chicago, IL/US11:24B-0616 Software-supported evaluation of small-bowelmotility using free-breathing cine MRIS. Bickelhaupt 1 , R. Cattin 2 , S. Raible 2 , J.M. Froehlich 1 , H. Bouquet 3 , U. Bill 3 ,M.A. Patak 1 ; 1 Zurich/CH, 2 Biel/CH, 3 Berne/CH11:33B-0617 Automated system for CT carotid plaquecharacterisation into symptomatic and asymptomaticclassesL. Saba 1 , U. Acharia 2 , M. Anzidei 3 , M. Piga 1 , J.S. Suri 4 ; 1 Cagliari/IT, 2 Singapore/SG,3Rome/IT, 4 Pocatello, ID/US11:42B-0618 Automated labelling framework applied on full andpartial spine CT scansD. Major, J. Hladuvka, F. Schulze, K. Bühler; Vienna/AT11:51B-0619 Segmentation-free scheme for computer-assistedimage interpretation: application to CT colonographyF. Chandelier 1 , T. Cabrera 2 , P. Kocsis 1 , L. Stein 2 , V. Demers 2 ; 1 Granby, QC/CA,2Montreal, QC/CA246

Scientific Sessions10:30–12:00 Room AOncologic ImagingSS 1316 Rectal cancer imaging: the next stepModerators: L. Curvo-Semedo; Coimbra/PT, C. Hoeffel; Reims/FR10:30B-0620 Predictive value of combined quantitative parametersobtained with ADC map and 18-FDG/PET study inassessment of treatment response of patients withadvanced rectal cancer: histopathologic correlationD. Ippolito, A. Cadonici, C. Trattenero, L. Monguzzi, C. Capraro, S. Sironi;Monza/IT10:39B-0621 Intrinsic gradient of the vascular function in rectaltumoursM.H. Martens, E. Kluza, S. Subhani, M. Maas, C. Jeukens, G.L. Beets,R.G.H. Beets-Tan; Maastricht/NL10:48B-0622 Enhanced vascular structure and function in thetumour-surrounding mesorectum: potential riskfactors for patients with rectal cancerM.H. Martens, E. Kluza, J.-P.J.E. Kleijnen, M. Maas, C.R.L.P. Jeukens, W.H. Backes,G.L. Beets, R.G.H. Beets-Tan; Maastricht/NL10:57B-0623 Value of 3D FSE Cube sequence at 3T MRI inpreoperative local staging of rectal cancerR. Scandiffio, P. Vagli, P. Bemi, A. Mantarro, L. Faggioni, R. Balestri, P. Buccianti,E. Neri, C. Bartolozzi; Pisa/IT11:06B-0624 Prediction of subsequent metastatic disease bydynamic contrast MRI in locally advanced rectalcancerE.M. Anderson, J.M. Franklin, L. Tanner, M. Brady, F.V. Gleeson; Oxford/UK11:15B-0625 Features on MRI after transanal endoscopicmicrosurgery in patients with rectal cancerL.A. Heijnen 1 , M. Maas 1 , M.H. Martens 1 , D.M.J. Lambregts 1 , J.W.A. Leijtens 2 ,W. Deserno 2 , G.L. Beets 1 , R.G.H. Beets-Tan 1 ; 1 Maastricht/NL, 2 Roermond/NL11:24B-0626 Role of perfusional MRI and DWI to predictpathological complete response to neoadjuvantchemoradiotherapy in rectal cancerC.N. De Cecco, M. Ciolina, M.M. Maceroni, G. Muscogiuri, F. Iafrate, A. Laghi;Rome/IT11:33B-0627 Additional value of diffusion-weighted (DWI) MRI forpredicting complete tumour response (T0N0) in rectalcancer treated with neo-adjuvant chemoradiationtherapy (CRT)S. Sassen 1 , M. de Booij 1 , M.N. Sosef 1 , G. Lammering 2 , C.M.M. Bakker 1 , R. Clarijs 1 ,R.C.M. Berendsen 1 , J. Wals 1 , R.F.A. Vliegen 1 ; 1 Heerlen/NL, 2 Maastricht/NL11:42B-0628 Advanced characterisation of rectal cancer priorsurgery: preliminary results on the evaluation ofmultimodality functional MRI techniques in correlationto histopathologyD. Hausmann, D. Dinter, P. Kienle, F. Doyan, S.O. Schönberg, U.I. Attenberger;Mannheim/DE11:51B-0629 ColoCare: compartmental quantification of obesity onCT as risk factor for colorectal cancerJ. Welzel, H. Hogenauer, J. Staffa, D. Scherer, L. Grenacher, C. Ulrich, H.-U. Kauczor; Heidelberg/DE10:30–12:00 Room D1ChestSS 1304CTPA techniques in lung perfusion andpulmonary hypertensionModerators: I. Hartmann; Rotterdam/NL, E.J. Stern; Seattle, WA/US10:30B-0630 Impact of iterative reconstructions on the diagnosisof acute pulmonary embolism (PE) on low-dose CTangiograms: clinical experience in 53 patientsF. Pontana, S. Henry, J.-B. Faivre, N. Tacelli, S. Bendaoud, M. Rémy-Jardin,J. Rémy; Lille/FR10:39B-0631 Comparison of image quality and radiation dosebetween 64-MDCT and high pitch 128-DSCT protocolsin triple rule-out studiesA. Fernandez del Valle, C. Delgado, R. Oca, N. Silva, G. Tardáguila; Vigo/ES10:48B-0632 Sinogram-affirmed iterative reconstructed simulatedECG-gated ultra high pitch CT pulmonary angiographyin the acute setting: effect on dose and image qualityS.J. Co 1 , S. Nicolaou 1 , J. Mayo 1 , T. Liang 1 , D. Hou 1 , K. Krzymyk 2 ;1Vancouver, BC/CA, 2 Topanga, CA/US10:57B-0633 70 kV CT pulmonary angiography in clinical routine:initial experience, radiation dose and image qualityR.W. Bauer, F. Al-Butmeh, C. Frellesen, J.A. Wichmann, T. Lehnert, T.J. Vogl,M. Kerl; Frankfurt am Main/DE11:06B-0634 Automated quantification of pulmonary perfusedblood volume in acute pulmonary embolism usingdual-energy CTPAF.G. Meinel, A. Graef, F. Bamberg, S.F. Thieme, C. Neurohr, C. Kupatt, M.F. Reiser,T.R.C. Johnson; Munich/DE11:15B-0635 Dual-source CT perfusion maps: do they increase thediagnostic confidence in the diagnosis of pulmonaryembolism by CT?E. Stiefsohn, S. Scharer, H. Prosch, C. Neumann, K. Osinger, M. Weber,G. Mostbeck; Vienna/AT11:24B-0636 CT-pulmonary angiography follow-up in acutepulmonary embolism: resolution of emboli and changeof CT signs of right heart dilatation and pulmonaryhypertensionC. Neumann, H. Prosch, K. Osinger, D. Vedrilla, M. Weber, G. Mostbeck;Vienna/AT11:33B-0637 Clinical significance of high density thrombi onnon-enhanced CT scan in patients with pulmonarythromboembolismK.S. Beck, B. Lee, H. Kim, D. Han; Seoul/KR11:42B-0638 Automated quantification of pulmonary perfusedblood volume by dual-energy CTPA in chronicthromboembolic pulmonary hypertensionF.G. Meinel, A. Graef, M. Armbruster, C. Neurohr, M.F. Reiser, T.R.C. Johnson;Munich/DE11:51B-0639 Non-invasive diagnosis of pulmonary hypertensionwith dynamic contrast-enhanced computedtomographyM. Pienn 1 , G. Kovacs 1 , M. Tscherner 1 , T.R.C. Johnson 2 , P. Kullnig 1 , R. Stollberger 1 ,A. Olschewski 1 , H. Olschewski 1 , Z. Bálint 1 ; 1 Graz/AT, 2 Munich/DEB-0620 – B-0639Sunday247

Scientific SessionsB-0640 – B-065910:30–12:00 Room D2Interventional RadiologySS 1309 Skeletal and endocrinologicinterventionsModerators: L. Crocetti; Pisa/IT, D.K. Tsetis; Iraklion/GR10:30B-0640 Selective arterial embolisation for bone tumoursG. Rossi 1 , E. Rimondi 1 , A.F. Mavrogenis 2 , A. Andreone 1 , P. Spinnato 1 , G. Garzillo 1 ,P. Ruggieri 1 , D. Vanel 1 , A. Bazzocchi 1 ; 1 Bologna/IT, 2 Athens/GR10:39B-0641 Radiofrequency ablation of osteoid osteoma:technique with special tricks for difficult anatomicallocations and atypical nidusA.K. Janu, B. Jankharia, K. Pilania, P. Thakrar; Mumbai/IN10:48B-0642 Osteoid osteomas of the elbow: a challenging locationA. Bazzocchi, G. Facchini, G. Bettelli, E. Castiello, M. Cavaciocchi, R. Rotini,U. Albisinni; Bologna/IT10:57B-0643 MR-guided high-intensity focused ultrasound for noninvasivetreatment of osteoid osteomaM. Anzidei, A. Napoli, G. Brachetti, B. Cavallo Marincola, G. Cartocci, F. Boni,V. Noce, L. Bertaccini, C. Catalano; Rome/IT11:06B-0644 MR-guided focused ultrasound ablation on bonemetastases: role of dynamic contrast-enhanced MRI inthe evaluation of treatment responseA. Napoli, V. Noce, M. Anzidei, F. Boni, G. Brachetti, G. Cartocci, L. Bertaccini,C. Catalano, F. Ciolina; Rome/IT11:15B-0645 Palliative treatment of bone metastases: analysis ofbiological effects of MR-guided focused ultrasound(MRgFUS) versus external beam radiation therapy(EBRT). A randomised comparative trial usingfunctional diffusion maps as molecular activityindicatorA. Napoli, G. Brachetti, D.S. De Oliveira, G. Cartocci, F. Boni, V. Noce,C. Marsecano, V. Tombolini, C. Catalano; Rome/IT11:24B-0646 Percutaneous laser ablation of metastatic lymphnodes in the neck from papillary thyroid carcinoma:1-year resultsG. Mauri 1 , T. Tondolo 1 , L. Cova 1 , T. Ierace 1 , N.S. Goldberg 2 , L. Solbiati 1 ;1Busto Arsizio/IT, 2 Jerusalem/IL11:33B-0648 Arterial spin labelling (ASL) MRI for monitoring kidneyperfusion before and after renal denervation: initialresultsC. Schleich, D. Blondin, P. Kröpil, O. Vonend, P. Heusch, H.-J. Wittsack,G. Antoch, R.S. Lanzman; Düsseldorf/DE11:42B-0649 Reliable and reproducible sampling of adrenal veins inthe management of hyperaldosteronism, a technicallydemanding yet feasible procedure: an institutionalexperienceC.H. Lam, H.L. Chow, S.H. Chiu, H.Y. Cho, S. Lau; Hong Kong/HK10:30–12:00 Room E1MusculoskeletalSS 1310 Arthritis and metabolic bone diseaseModerators: A.J. Grainger; Leeds/UK, A. Plagou; Athens/GR10:30B-0650 Radiological peripheral involvement in a cohort ofpolyarticular juvenile idiopathic arthritis at adulthoodA. Feydy, R. Bazeli, V. Freire, M. Elhai, J. Wipff, C. Job-Deslandre, A. Kahan,J.-L. Drapé; Paris/FR10:39B-0651 Monitoring of initial methotrexate therapy effect oncartilage composition in early rheumatoid arthritiswith biochemical MRI of finger cartilageC. Schleich, B. Ostendorf, C. Buchbender, C. Nowak, P. Sewerin, M. Schneider,G. Antoch, A. Scherer, F. Miese; Düsseldorf/DE10:48B-0652 Quantification of synovitis in the cranio-cervicalregion in early rheumatoid arthritis using dynamiccontrast-enhanced (DCEI) and diffusion-weighted(DWI) magnetic resonance imaging (MRI)M. Jeromel 1 , V. Jevtič 1 , M. Tomšič 1 , I. Pisanec 2 , J. Markota 1 , I. Serša, 1 ,A. Ambrožič 1 ; 1 Ljubljana/SI, 2 Celje/SI10:57B-0653 Slow radiographic progression of bone destructionin the hands in early psoriatic arthritis withoutcorrelation to clinical disease activityM. Geijer 1 , U. Lindqvist 2 , T. Husmark 3 , G.-M. Alenius 4 , P.T. Larsson 5 , A. Teleman 6 ,E. Theander 7 ; 1 Lund/SE, 2 Uppsala/SE, 3 Falun/SE, 4 Umeå/SE, 5 Stockholm/SE,6Oskarström/SE, 7 Malmö/SE11:06B-0654 Role of dynamic MRI in predicting outcome of patientsaffected with early stage arthritisC.A. Mattiuz 1 , L.M. Sconfienza 1 , M. Cimmino 2 , G. Garlaschi 2 , G. Di Leo 1 ,F. Sardanelli 1 ; 1 Milan/IT, 2 Genoa/IT11:15B-0655 Association of trochlear dysplasia with degenerativeabnormalities in the knee: data from the osteoarthritisinitiativeP.M. Jungmann 1 , S.-C. Tham 2 , H. Liebl 3 , M. Nevitt 3 , C.E. McCulloch 3 , J. Lynch 3 ,T.M. Link 3 ; 1 Munich/DE, 2 Singapore/SG, 3 San Francisco, CA/US11:24B-0656 Reliability of tomosynthesis for semiquantitativeassessment of knee osteoarthritis features byradiologists with different levels of expertiseD. Hayashi 1 , L. Xu 1 , J. Gusenburg 1 , F.W. Roemer 1 , D.J. Hunter 2 , L. Li 1 ,A. Guermazi 1 ; 1 Boston, MA/US, 2 Sydney/AU11:33B-0657 Scoring hip abnormalities using MR images (SHAMRI):a novel hip whole joint osteoarthritis evaluationsystemS. Lee 1 , L. Nardo 1 , A. Lai 1 , D. Kumar 1 , C.R. Wyatt 1 , R.B. Souza 1 , N.E. Lane 2 ,S. Majumdar 1 , T.M. Link 1 ; 1 San Francisco, CA/US, 2 Sacramento, CA/US11:42B-0658 Cortical thickness mapping reveals effects of age,weight and osteophytes in the proximal femurT.D. Turmezei, G.M. Treece, A.H. Gee, C.J. Tonkin, K.E.S. Poole; Cambridge/UK11:51B-0659 Multifocal endosteal thickening of the femur inpatients on long-term bisphosphonate therapypresenting with atypical femoral fracturesM.A. Png, P.C. Mohan, J.S.B. Koh, T.S. Howe; Singapore/SG248

Scientific Sessions10:30–12:00 Room E2CardiacSS 1303Towards improved image quality anddetectionModerators: G. Feuchtner; Innsbruck/AT, C. Herzog; Munich/DE10:30B-0660 Stenosis quantification in coronary CT angiography:impact of an integrated circuit detector with iterativereconstructionF. Morsbach 1 , L. Desbiolles 2 , A. Plass 1 , S. Leschka 2 , B. Schmidt 3 , V. Falk 1 ,H. Alkadhi 1 , P. Stolzmann 1 ; 1 Zurich/CH, 2 St. Gallen/CH, 3 Forchheim/DE10:39B-0661 CT coronary angiography: effect of iodineCONcentration on vascular attenuation. The CT-CONmulticentric study preliminary resultsM. Rengo 1 , A.S. Dharampal 2 , D. Caruso 1 , K. Nieman 2 , A. Laghi 1 , G.P. Krestin 2 ;1Latina/IT, 2 Rotterdam/NL10:48B-0662 MDCT coronary angiography evolution of phasiccritical stenosis in myocardial bridgesR. Malago, M. Tezza, G. Sala, A. Pezzato, C. Barbiani, R. Pozzi Mucelli; Verona/IT10:57B-0663 Quantitative CT coronary angiography: does it predictfunctionally significant coronary stenoses?A. Rossi 1 , S. Papadopoulou 1 , F. Pugliese 2 , B. Russo 1 , A. Dharampal 1 ,P.H. Kitslaar 3 , S.E. Petersen 2 , P. de Feyter 1 , G.P. Krestin 1 ; 1 Rotterdam/NL,2London/UK, 3 Leiden/NL11:06B-0664 Impact of iterative CT image reconstruction oncalcium score measurementsJ.A.C. van Osch 1 , M. Mouden 1 , J.A. van Dalen 1 , J.R. Timmer 1 , S. Reiffers 1 ,M.J.W. Greuter 2 , J.P. Ottervanger 1 , S. Knollema 1 , P.L. Jager 1 ; 1 Zwolle/NL,2Groningen/NL11:15B-0665 Accuracy of prospectively ECG-triggered ultra lowdosecoronary dual-source CT angiography usingiterative reconstructionM. Lell, C. Layritz, T. Pflederer, W. Wuest, S. Achenbach, M. Uder; Erlangen/DE11:24B-0666 Influence of iterative reconstruction on coronarycalcium score in cardiac computed tomographyK. Jaspers 1 , J.A.C. Van Osch 2 , J.M. Groen 1 , M.J.W. Greuter 1 ; 1 Groningen/NL,2Zwolle/NL11:33B-0667 Magnetic resonance velocity mapping-basedevaluation of elevated mean pulmonary arterialpressure: the impact of visualisation techniquesU. Reiter 1 , G. Reiter 1 , G. Kovacs 1 , A. Stalder 2 , M.A. Gulsun 3 , A. Greiser 2 ,H. Olschewski 1 , M.H. Fuchsjäger 1 ; 1 Graz/AT, 2 Erlangen/DE, 3 Princeton, NJ/US11:42B-0668 Undersampled real time cine SSFP with through-timeradial GRAPPA: evaluation of RV function in breathholdand free breathingB.J. Wintersperger 1 , A. Pellow 1 , G. Bastarrika 1 , M.A. Griswold 2 , N. Seiberlich 2 ,M. Sussman 1 ; 1 Toronto, ON/CA, 2 Cleveland, OH/US11:51B-0669 Diagnostic accuracy of delayed phase dual-energyCT for the detection of chronic myocardial infarctioncompared to 3-T MRI late gadolinium enhancementJ.L. Wichmann, J.M. Kerl, T. Lehnert, M. Doss, T.J. Vogl, R.W. Bauer;Frankfurt am Main/DE10:30–12:00 Room F1NeuroSS 1311Brain tumours: imaging and therapyModerators: X. Golay; London/US; A. Zimny; Wroclaw/PL10:30B-0670 Intra-arterial ophthalmic artery chemotherapy forgroup D retinoblastoma in children: 4-years LausanneexperienceS. Binaghi, J.-B. Zerlauth, M. Beck-Popovic, F. Munier, R. Meuli; Lausanne/CH10:39B-0671 Neurocutaneous melanosis in children with giantcongenital melanocytic neviO. Szczygielski, M. Boczar, E. Sawicka, M. Bekiesinska-Figatowska, J. Madzik,A. Romaniuk-Doroszewska, M. Uliasz, T. Klepacka, E. Michalak; Warsaw/PL10:48B-0672 Surveillance neuroimaging in patients withmedulloblastoma should include diffusion-weightedimagingL. van den Hauwe, C. Gidding, E. van Lindert, P. Wesseling, B. Goraj;Nijmegen/NL10:57B-0673 Preoperative evaluation of consistency ofmeningiomas: diagnostic efficacy of MRIA. Hiwatashi, T. Yoshiura, O. Togao, K. Yamashita, K. Kikuchi, K. Yoshimoto,M. Mizoguchi, S.O. Suzuki, H. Honda; Fukuoka/JP11:06B-0674 Radiation-induced telangiectasia in the long-termsurvivors of intracranial germ cell tumours: wholeventriclevs whole-brain radiationL. Li, S. Mugikura, T. Murata, T. Kumabe, K. Jingu, T. Fujii, E. Mori, S. Takahashi;Sendai/JP11:15B-0675 Dynamic sequences in Intraoperative MRI duringtranssphenoidal resection of pituitary adenomas:quantitative analysisM. Rossi Espagnet 1 , A. Boellis 1 , V. Coppola 2 , A. Romano 1 , S. Pugliese 1 ,F. Tavanti 1 , L. Calabria 1 , L. Fantozzi 1 , A. Bozzao 1 ; 1 Rome/IT, 2 Ronciglione/IT11:24B-0676 Preoperative classification of cerebral tumours byapplying whole brain VPCT: which parameter to use inorder to achieve the highest prognostic value?A. Xyda 1 , E. Klotz 2 , U. Haberland 2 , R. Schramm 3 , M. Knauth 3 , P. Schramm 3 ;1Iraklion/GR, 2 Forchheim/DE, 3 Göttingen/DE11:33B-0677 Apparent diffusion coefficient in determination ofhistological subtype of meningiomaD.A. Stojanov; Nis/RS11:42B-0678 Evaluation of diffusivity in pituitary adenoma in theSella Turcica with 3D turbo field echo with diffusionsensitizeddriven-equilibrium preparation: initialexperienceA. Hiwatashi 1 , T. Yoshiura 1 , O. Togao 1 , K. Yamashita 1 , K. Kikuchi 1 , H. Honda 1 ,M. Obara 2 ; 1 Fukuoka/JP, 2 Tokyo/JPB-0660 – B-0678Sunday249

Scientific SessionsB-0679 – B-069610:30–12:00 Room F2BreastSS 1302How to get more from breast imagingmodalitiesModerators: N. Houssami; Sydney/AU, M. Nadrljanski; Belgrade/RS10:30B-0679 Magnetic resonance imaging of fibroadenomas inthe female breast: new insights on dynamic andmorphologic profiles and differential diagnosis frommalignant breast lesionsM. Dietzel 1 , P.A.T. Baltzer 2 , W.A. Kaiser 3 ; 1 Erlangen, Jena/DE,2Jena/DE, Vienna/AT, 3 Jena/DE10:39B-0680 Texture analysis of malignant breast tumours: is adifferentiation of ductal carcinoma in situ, invasiveductal and invasive lobular breast cancer possible?T. Knogler 1 , K. Pinker-Domenig 1 , N. Perry 2 , S. Milner 2 , K. Mokbel 2 ,M.E. Mayerhoefer 1 ; 1 Vienna/AT, 2 London/UK10:48B-0681 Variation of apparent diffusion coefficients (ADC)measured in the normal breast using diffusionweightedMR mammography: effects of menopausalstatus, anthropometric measures and hormone intakeK. Hegenscheid, R. Seipel, R. Laqua, C.O. Schmidt, H. Völzke, N. Hosten,B. Mensel; Greifswald/DE10:57B-0682 Second-look US with MR volume navigation (V Nav) ofbreast lesions: a way to make it objectiveA. Fausto, P. Mercuri, L. Mantovani, L. Volterrani; Siena/IT11:06B-0683 Dense breasts as a new standard indication forMR mammography: prospective analysis of 1488consecutive patientsC.G. Kaiser 1 , C. Reich 2 , K. Wasser 1 , S.O. Schönberg 1 , W.A. Kaiser 2 ; 1 Mannheim/DE,2Jena/DE11:15B-0684 Is 2D central projection obtained with digital breasttomosynthesis qualitatively equivalent to digitalmammmography?P. Clauser 1 , V. Londero 1 , C. Molinari 1 , R. Girometti 1 , A. Taibi 2 , S. Vecchio 3 ,C. Zuiani 1 , M. Bazzocchi 1 ; 1 Udine/IT, 2 Ferrara/IT, 3 Bologna/IT11:24B-0685 The role of additional ultrasound and tomosynthesisafter normal digital mammography: comparisonbetween both techniquesP. Slon, J. Etxano, I. Simon-Yarza, G. Viteri, A. Elizalde, L.J. Pina Insausti;Pamplona/ES11:33B-0686 Lesion detection and characterization of one-viewdigital breast tomosynthesis combined with one-viewmammography compared to two-view mammographyG. Gennaro 1 , E.R. Hendrick 2 , A. Toledano 3 , R. Chersevani 4 , C. di Maggio 1 ,M. La Grassa 5 , L. Pescarini 1 , I. Polico 1 , A. Proietti 1 ; 1 Padua/IT, 2 Denver, CO/US,3Washington, DC/US, 4 Gorizia/IT, 5 Aviano/IT11:42B-0687 Does the adjunct of digital breast tomosynthesis(DBT) increase inter-reader reproducibility of twodimensionaldigital mammography (2D-DM)?G. Di Leo 1 , L.A. Carbonaro 1 , M. Bazzocchi 2 , V. Londero 2 , A. Dal Col 2 ,R.M. Trimboli 1 , F. Sardanelli 1 ; 1 San Donato Milanese/IT, 2 Udine/IT11:51B-0688 One-to-one comparison between digitalmammography and digital breast tomosynthesisusing a fully automated software: breast densityunderestimation on digital breast tomosynthesisvaries in different BI-RADS classesA. Tagliafico, S. Airaldi, F. Cavagnetto, B. Bingotti, S. Tosto, D. Astengo,M. Calabrese; Genoa/IT10:30–12:00 Room G/HGenitourinarySS 1307 The bladder and belowModerators: M. Baramia; Tbilisi/GE, R.H. Oyen; Leuven/BE10:30B-0689 The role of CT as a staging tool and prognosticbiomarker in the pretreatment evaluation of intradiverticularbladder tumoursP.L. Di Paolo, H.A. Vargas, H. Hricak; New York, NY/US10:39B-0690 Usefulness of diffusion-weighted magnetic resonanceimaging in patients with muscle-invasive bladdercancer selected for radical cystectomy: lymph nodestaging prospective study and comparison with CTscanJ. Borrego Gómez, J. Martel Villagrán, E. De la Peña, J. Culebras, C. Llorente;Madrid/ES10:48B-0691 Use of FLAIR sequences for detection and localstaging of bladder tumours with MRIM. Di Girolamo, G. Muscogiuri, M. Cappucci, V. Catena, R. Persechino, V. David;Rome/IT10:57B-0692 Magnetic resonance virtual cystoscopy versusconventional cystoscopy in the detection of urinarybladder cancerS. Elangovan; Puducherry/IN11:06B-0693 Voiding MR cystourethrography: a new diagnosticimaging technique for the evaluation of male lowerurinary tractM. Di Girolamo, C. Cantone, E.M. Pandolfi, R. Persechino, F. Caporilli Razza,V. David; Rome/IT11:15B-0694 Micturition MRI: voiding assessment in continent ilealurinary reservoirJ. Lopater 1 , A. Scherrer 1 , V. Delmas 2 , S. Gey 2 , Y. Neuzillet 1 , T. Lebret 1 ;1Suresnes/FR, 2 Paris/FR11:24B-0695 Clinical relevance of magnetic resonance dynamicspongiourethrotomography of male urethral stricturedetectionE. Banchik, V. Dombrovsky, M. Kogan, V. Mitusov; Rostov-on-Don/RU11:33B-0696 Urinary bladder neck dysfunction in male patients:evaluation with MRI and with voiding MRcystourethrographyM. Di Girolamo, A. Trucchi, S. Mariani, G. Muscogiuri, I. Casazza, V. David;Rome/IT250

Scientific Sessions11:42B-0697 MRI findings of radiation-induced changes in theurethra and periurethral tissues in patients withprostate cancerC. Marigliano 1 , O.F. Donati 2 , O. Akin 2 , D. Goldman 2 , J. Eastham 2 ; 1 Rome/IT,2New York, NY/US11:51B-0698 MRI anatomic evaluation in patients with persistenturinary incontinence after advance male sling: a workin progress study with a 3T systemV. Zampa, D. Pistolesi, S. Ortori, L. Faggioni, M. Marletta, C. Bartolozzi; Pisa/IT10:30–12:00 Room I/KAbdominal VisceraSS 1301 Abdominal CT: dose reduction andtechnical improvementsModerators: D. Tack; Baudour/BE, A. Taibbi; Palermo/IT10:30B-0699 Hybrid iterative reconstruction for abdominal CT: canthe radiation dose be decreased while preserving thelow-contrast detectability?S.T. Schindera 1 , D. Odedra 2 , S. Arsalan Raza 2 , T.K. Kim 2 , H.-J. Jang 2 , Z. Szucs-Farkas 3 , P. Rogalla 2 ; 1 Basle/CH, 2 Toronto, ON/CA, 3 Biel/CH10:39B-0700 Image quality on liver CT based on sinogram-affirmediterative reconstruction algorithmB. Schulz, B. Bodelle, P. Siebenhandl, M. Beeres, F. Al-Butmeh, C. Frellesen,T.J. Vogl; Frankfurt a. Main/DE10:48B-0701 Efficacy of a liver detection algorithm for noisereduction in abdominal CTN. Ardley 1 , K. Buchan 2 , K. Lau 1 ; 1 Clayton/AU, 2 Melbourne/AU10:57B-0702 Impact of modified abdominal CT protocols for obesepatients with filtered back projection and hybriditerative reconstruction technique on image quality,radiation dose and low-contrast detectability: aphantom studyS.T. Schindera 1 , D. Odedra 2 , D. Mercer 2 , S. Thipphavong 2 , P. Chou 2 , Z. Szucs-Farkas 3 , P. Rogalla 2 ; 1 Basle/CH, 2 Toronto, ON/CA, 3 Biel/CH11:06B-0703 Automated attenuation-based tube potential selectionfor abdominal CT examinations: impact on imagequality and dose reductionP. Kröpil, P. Heusch, L. Schimmöller, F. Miese, S. Dietrich, G. Antoch,R.S. Lanzman; Düsseldorf/DE11:15B-0704 Second generation dual-energy CT of the abdomen:radiation dose comparison with 64- and 128-rowsingle energy acquisitionC.N. De Cecco, A. Darnell, N. Macias, G. Muscogiuri, C. Ayuso, A. Laghi; Rome/IT11:24B-0705 Can iterative reconstructions improve the detectionof small hypervascular liver nodules with dual-energyCT?L. Facchetti 1 , L. Berta 2 , L. Mascaro 1 , F. Pittiani 1 , L. Romanini 1 , R. Maroldi 1 ;1Brescia/IT, 2 Milan/IT11:33B-0706 Low-voltage CT of the abdomen: correlation betweenpatient diameters and subjective image quality,toward identifying cutoff patient diameters for patientselection.G.A. Zamboni, M. Ambrosetti, R. Pozzi Mucelli; Verona/IT11:42B-0707 Preliminary application of spectral CT imaging in thedifferentiation of hepatic tumoursW. Chen, X. Ye, C. Zhou; Beijing/CN11:51B-0708 Ultra-high-field imaging of the biliary tract at 7 Tesla:initial results of Gd-EOB-DTPA-enhanced magneticresonance cholangiographyA. Fischer, O. Kraff, S. Orzada, F. Nensa, L.C. Schäfer, M.E. Ladd, L. Umutlu,T.C. Lauenstein; Essen/DE10:30–12:00 Room L/MHead and NeckSS 1308 Advanced imaging of the ear, orbit andglandsModerators: R. Elias; Rotterdam/NL, B.F. Schuknecht; Zurich/CH10:30B-0709 Volume-rendering 3D-MRI for detection of auditorypathways in children under evaluation for cochlearimplantationI. Burck, N.N. Nagy, M. Harth, T. Stöver, T.J. Vogl, S. Strieth; Frankfurt a. Main/DE10:39B-0710 Congenital sensorineural hearing loss and ABI surgery:pre-operative radiological protocol and considerationsafter 12 years of experienceM. Barillari, R. Cerini, F. Spagnolli, N. Cardobi, M. Carner, L. Colletti, V. Colletti,R. Pozzi Mucelli; Verona/IT10:48B-0711 Three dimensional and multiplanar reconstruction ofthe internal auditory canal using high-resolution MRimaging before cochlear implantation: does the sizeof the cochlear nerve affect the results of speechrecognition outcome after implantation?N.N.N. Naguib, N.-E.A. Nour-Eldin, T. Lehnert, T. Lehnert, M. Harth, T.J. Vogl,C. Hey; Frankfurt a. Main/DE10:57B-0712 Local tumour control in uveal melanoma (UM)after gamma knife radiosurgery (GKR): quantitativeassessment of tumour response with contrastenhancedultrasound (CEUS)C. Colantoni, M. Venturini, G. Modorati, A. Colucci, M. Di Nicola, G. Agostini, F. DeCobelli, F. Bandello, A. Del Maschio; Milan/IT11:06B-0713 Evaluation of lacrimal drainage system obstructionusing combined multidetector CT and instillationdacryocystographyM. Shweel, A. ElShafaey, M. Nasar, R. MohyElDien; ElMinia/EG11:15B-0714 Parotid gland tumours shear wave elastography: apreliminary studyS. Espinoza-Boireau, I. Khettab, A. Lacan Melki, P. Halimi; Paris/FRB-0697 – B-0714Sunday251

Scientific SessionsB-0715 – B-073511:24B-0715 Does heterogeneous echogenicity of the thyroidparenchyma influence the detection of multifocalityand bilaterality for papillary thyroid carcinoma onpreoperative ultrasound staging?S. Herh, E.-K. Kim, H. Moon, J. Kwak; Seoul/KR11:33B-0716 Role of elastography in the characterisation of thyroidnodulesF. Sogaro, P. Tessitore, A. Scrimieri, F. Pittiani, A. Borghesi, R. Maroldi; Brescia/IT11:42B-0717 The new approach to thyroid elastosonography –time-strain curves – may aid the differentiation ofnodulesR.Z. Slapa, B. Migda, W.S. Jakubowski, J. Bierca, J. Slowinska-Srzednicka;Warsaw/PL11:51B-0718 Semiquantitative strain elastography for theevaluation of chronic thyroiditisF. Ozkan, M. Sahin, K. Gul, M.F. Inci, M. Yuksel; Kahramanmaras/TR10:30–12:00 Room N/OEmergency RadiologySS 1317 Technical issues and clinical resultsModerators: M. Brink; Nijmegen/NL, G. Schueller; Bülach/CH10:30B-0719 Advanced visualisation of intracranial hematomas ofcranial computed tomographyH. Ringl, F. Stiassny, W. Schima, M. Toepker, C. Czerny, G. Schueller,U. Asenbaum, J. Furtner, C.J. Herold; Vienna/AT10:39B-0720 Simple and easy way using time-intensity curve ofperfusion-weighted images to find penumbra in strokepatients within 4.5 hours of onset due to the carotidartery occlusionT. Mori, T. Iwata, Y. Miyazaki, M. Nakazaki, Y. Takahashi; Kamakura/JP10:48B-0721 CT imaging in an emergency setting is notsubstantially delayed by iterative reconstructionM.J. Willemink, A.M.R. Schilham, T. Leiner, W.P.T.M. Mali, P.A. de Jong,R.P.J. Budde; Utrecht/NL10:57B-0722 Patient-tailored automatic kVp selection withsinogram-affirmed iterative reconstruction (SAFIRE)to reduce dose in patients undergoing emergentCT imaging of abdomen and pelvis: an intra-patientcomparisonF.D. Gonzalez-Guindalini, M.P.F. Botelho, H. Chalian, V. Yaghmai; Chicago, IL/US11:06B-0723 Automated selection of tube potential in thoracoabdominaltrauma CT results in significant dosesavingsC. Frellesen, J. Kerl, T. Lehnert, M. Harth, B. Schulz, B. Bodelle, M. Beeres,T.J. Vogl, R.W. Bauer; Frankfurt/DE11:15B-0724 Usefulness of low-dose CT with or without adaptivestatistical iterative reconstruction (ASIR) in thediagnosis of acute appendicitisJ.J. Fondevila, M.S. Carreras, I. Arrieta, J. Mesa, A.R. Gil, T. Marquina, A. Castrillo,I. Aguirregoicoa, L. Martinez; Barakaldo/ES11:24B-0725 The diagnostic yield of MSCT in the detection ofobscure infection focusesS. Schleder, L. Luerken, L.-M. Dendl, P. Wiggermann, C. Stroszczynski,A. Schreyer; Regensburg/DE11:33B-0726 Impact and appropriateness of emergency departmentultrasonography requests: a prospective studyE.S. Ventura, Y. Costa, F.V. Gomes; Faro/PT11:42B-0727 Post mortem computed tomography (PMCT) qualitymanagement in critical care?S. Kirchhoff, M.F. Reiser, O. Peschel, M. Graw, K.-G. Kanz; Munich/DE11:51B-0728 Portrayal of radiology in major medical televisionseries: does it influence the perception of radiology inthe general population?T. Heye 1 , E.M. Merkle 2 , J.R. Leyendecker 3 , D.T. Boll 1 , R.T. Gupta 1 ;1Durham, NC/US, 2 Basle/CH, 3 Winston-Salem, NC/US10:30–12:00 Room PPaediatricSS 1312 Chest, heart and radiation awarenessModerators: W. Hirsch; Leipzig/DE, P.D. Humphries; London/UK10:30B-0729 Radiation dose levels in paediatric chest CT:experience in 506 children evaluated with dual-sourceCTT. Santangelo, L. Colas, T. Niemann, A. Simeone, M. Rémy-Jardin, J. Rémy;Lille/FR10:39B-0730 Multi-detector CT studies in children: a comparison ofradiation doses between paediatric and non-paediatricradiology units. Results from the first 2011 ItalianSIRM surveyC. Granata 1 , F. Palorini 2 , D. Origgi 2 , D. Matranga 3 , S. Salerno 3 ; 1 Genoa/IT,2Milan/IT, 3 Palermo/IT10:48B-0731 Is paediatric chest CT achievable at 70 kV? Afeasibility study in 130 childrenT. Niemann, S. Henry, L. Colas, J.-B. Faivre, T. Santangelo, J. Rémy, M. Rémy-Jardin; Lille/FR10:57B-0732 Anthropometry of children and mathematicalphantoms applied to dose reconstruction in paediatricradiologyM.C. Seidenbusch, K. Schneider; Munich/DE11:06B-0733 Radiation exposure during scanograms (scoutviews)in paediatric computed tomography (CT)K. Schneider, V. Teusch, M.C. Seidenbusch; Munich/DE11:15B-0734 Reference values for cardiac valve diameters inextreme preterm infantsA. Adams, N. Wesseling, J.L.M. Strengers, W.B. de Vries, M.C. Molenschot;Utrecht/NL11:24B-0735 Asymmetric lung perfusion in congenital heartdisease: impact of differential pulmonary arterialanatomy and pulmonary vascular resistanceO. Kondrachuk, T. Yalynska, R. Tammo, I. Iershova, N. Rokytska; Kiew/UA252

Scientific Sessions11:33B-0736 Whole heart 4D haemodynamics in patients withtransposition of the great arteries after switchprocedureJ. Geiger 1 , M. Markl 2 , D. Hirtler 1 , B. Jung 1 , B. Stiller 1 , M. Langer 1 ; 1 Freiburg/DE,2Chicago, IL/US11:42B-0737 Chest-CT protocol standardization for multicentre trialin cystic fibrosis (CF) infantsP. Ciet 1 , K. Gonzalez Graniel 1 , S. Stick 2 , M. de Bruijne 1 , H.A.W.M. Tiddens 1 , M. Vanstraten 1 ; 1 Rotterdam/NL, 2 Perth/AU11:51B-0738 Cystic fibrosis lung disease in children: correlationbetween MRI and HRCT scoresC. Sileo, H. Corvol, P.-Y. Boelle, E. Blondiaux, A. Clement, H. Ducou Le Pointe;Paris/FR11:33B-0746 CT coronary angiography with low concentration (240mg Iodine/ml) contrast materialC. Mihl 1 , J.F. Kalafut 2 , M. Yanniello 2 , G. Muehlenbruch 3 , F.F. Behrendt 3 ,J.E. Wildberger 1 , M. Das 1 ; 1 Maastricht/NL, 2 Pittsburgh, PA/US, 3 Aachen/DE11:42B-0747 The impact of MR contrast agent concentration onbolus geometryG. Jost, H. Pietsch; Berlin/DE11:51B-0748 Transarterial chemoembolization (TACE) in malignantliver metastases: evaluation of a fast C-arm CTacquisition protocol with a robotic multi-axis C-armsystemT.J. Vogl 1 , M. von Roden 2 , E. Mbalisike 1 , S. Zangos 1 ; 1 Frankfurt a. Main/DE,2Forchheim/DEB-0736 – B-074810:30–12:00 Room ZContrast MediaSS 1306 New agents and protocolsModerators: L. Grazioli; Brescia/IT, T.C. Lauenstein; Essen/DE10:30B-0739 Magnetic resonance imaging diagnosis ofmetastatic lymph nodes: efficacy of the novelultrasmall superparamagnetic iron oxide agent withmonodisperse iron oxide core and multiple-interactionligandsR.-E. Yoo 1 , S. Choi 1 , H. Cho 1 , E.-g. Kim 2 , J. Park 2 , W.-J. Myeong 2 ; 1 Seoul/KR,2Daejeon/KR10:39B-0740 Gold as a potential contrast agent for dual-energy CTR. Krissak, M. Elgert, B. Kusch, R. Hünerbein; Bad Langensalza/DE10:48B-0741 Potential use of intra-articular diluted high-relaxivitygadolinium-based contrast agent for magneticresonance arthrography (MRA): an in-vitro studyL.M. Sconfienza, A. Aliprandi, P. Cannaò, S. Sdao, M. Bandirali, F. Sardanelli;Milan/IT10:57B-0742 Feasibility of contrast agent volume reduction on640-slice CT coronary angiography in patients withlow heart rateZ.-X. Ding, Z. Wang; Hangzhou/CN11:06B-0743 The influence of the contrast media protocol and thescan mode on arterial enhancement in cardiac CTE. Talakic, D. Stocker, P. Täubl, R. Maderthaner, F. Quehenberger,H. Schoellnast, M. Tillich; Graz/AT11:15B-0744 Multislice CT angiography with direct intra-arterialultra-low-dose-contrast injection for the evaluation ofrenal graft failure: initial studyM. Guzinski, J. Kurcz, J. Garcarek, M. Sasiadek; Wrocław/PL11:24B-0745 Feasibility in low kV CT angiography of the abdominalaorta: assessment of image quality, radiationexposure and contrast material volumeC.R.G.L. Talei Franzesi, D. Ippolito, P.A. Bonaffini, V. Bartolo, C. Trattenero,S. Sironi; Monza/ITSunday253

Scientific Session254

Scientific Sessions10:30–12:00 Room CNeuroSS 1711Brain ischaemia: perfusion anddiffusionModerators: L. Oleaga Zufiría; Bilbao/ES, M. Vernooij; Rotterdam/NL10:30B-0749 Prognostic impact of perfusion CT data in the earlyperiod after subarachnoid haemorrhageC. Mathys, D. Martens, D.C. Reichelt, J. Aissa, K. Rybacki, K.-G. Klein, G. Antoch,B. Turowski; Düsseldorf/DE10:39B-0750 Advanced MRI sequences in the acute evaluationof transient ischaemic attack (TIA). A comparisonbetween DTI, DWI and ASL including 8 weeks followupscans: preliminary results from the CopenhagenTIA-MRI-studyA. Christensen, C. Ovesen, J. Damm, J. Nielsen, H. Christensen; Copenhagen/DK10:48B-0751 Normal laterality index of cerebrovascular reserve ofthe middle cerebral artery: a 100 volunteers‘ BOLDfMRI studyA. Krainik, A. Attye, I. Tropres, L. Lamalle, J.-F. Le Bas; Grenoble/FR10:57B-0752 In-vivo validation of velocity measurements byquantitative phase contrast MR angiography of thebrain supplying arteries: a comparison with DopplersonographyK.W. Hsieh, F. Kellner-Weldon, C. Zubler, R. Verma, M.-L. Mono, M. Reinert,J. Gralla, G. Schroth, M. El-Koussy; Berne/CH11:06B-0754 Eligibility of 3-dimensional CT perfusion blood flowvolumemismatch to predict time from symptom onsetin acute ischemic strokeK.M. Thierfelder, L. von Baumgarten, F.G. Meinel, A.B. Baumann, K. Nikolaou,M.F. Reiser, W.H. Sommer; Munich/DE11:15B-0755 Whole brain CT perfusion: volumetric assessmentof perfusion deficits in patients with acute ischemicstrokeK.M. Thierfelder 1 , L. von Baumgarten 1 , E. Klotz 2 , A.B. Baumann 1 , K. Nikolaou 1 ,M.F. Reiser 1 , W.H. Sommer 1 ; 1 Munich/DE, 2 Erlangen/DE11:24B-0756 Time-to-peak (TTP) maps using whole brain CTperfusion in minor stroke: a diagnostic tool beyondpenumbra measurementS. Chakraborty, M.E. Ahmad, J.K. Wasserman, K. Keyhanian, D. Dowlatshahi,G. Stotts; Ottawa, ON/CA11:33B-0757 Reliability of flow-volume mismatch assessment inwhole brain coverage CT perfusion in acute strokepatientsK.M. Thierfelder, L. von Baumgarten, F.G. Meinel, K. Nikolaou, F.F. Strobl,M.F. Reiser, W.H. Sommer; Munich/DE11:42B-0758 Influence of temporal sampling rate of CTPacquisitions on cerebral perfusion maps using a digitalphantomM. Oei 1 , R. van den Boom 1 , L.J. Oostveen 1 , H.O.A. Laue 2 , B. van Ginneken 1 ,R. Manniesing 1 , M. Prokop 1 ; 1 Nijmegen/NL, 2 Bremen/DE10:30–12:00 Room D1ChestSS 1704Technological refinements: from x-raysto micro-imagingModerators: A.P. Parkar; Bergen/NO, C.M. Schaefer-Prokop;Amersfoort/NL10:30B-0759 Evaluation of pulmonary nodules by serial radiographsobtained by a flat-panel detectorY. Nakano, K. Maeda, S. Kitahara, T. Toyama, M. Kuwabara; Kusatsu/JP10:39B-0760 Function ventilation analysis in dynamic chestx-ray examination: in comparison with 133Xe lungventilation scintigraphyT. Abe, T. Izuka, N. Motohashi, Y. Shiraishi, N. Koyanagi, A. Kurosaki, M. Ito,H. Ogata, S. Kudou; Kiyose, Tokyo/JP10:48B-0761 Performance evaluation of automatic chest radiographreading for detection of tuberculosis (TB): acomparative study with clinical officers and certifiedreaders on TB suspects in sub-Saharan AfricaP. Maduskar 1 , L. Hogeweg 1 , B. van Ginneken 1 , H. Ayles 2 ; 1 Nijmegen/NL,2London/UK10:57B-0762 Diagnostic imaging costs before and afterdigital tomosynthesis implementation in patientmanagement after suspected thoracic lesions onchest radiographyE. Quaia, E. Baratella, G. Grisi, R. Cuttin, G. Poillucci, S. Kus, M. Cova; Trieste/IT11:06B-0763 Lung ultrasound in the elderly population:investigating the limit between physiological andpathological patternsA. Chiesa, F. Ciccarese, G. Gardelli, F. Feletti, U. Regina, M. Zompatori;Bologna/IT11:15B-0764 Digital X-ray optical densitometry in assessmentof respiratory function in patients with COPDexacerbationN. Gorbunov, V. Laptev; Novosibirsk/RU11:24B-0765 Diffusion-weighted echo-planar MRI with multipleb-values in primary lung cancer: a new approachto the non-invasive differentiation of histologicalsubtypes?M. Regier, D. Schwarz, A. Laqmani, F.O.G. Henes, G. Adam; Hamburg/DE11:33B-0766 Non-contrast-enhanced perfusion MRI for preoperativeassessment of lung function in patients with nonsmall-celllung cancer (NSCLC)G. Sommer, G. Bauman, C. Draenkow, C.-P. Heussel, H.-U. Kauczor, H.-P. Schlemmer, M. Puderbach; Heidelberg/DE11:42B-0767 Comparison of assessment of preoperative pulmonaryvasculature in non-small cell lung cancer patients bynon-contrast-enhanced and 4D contrast-enhanced MRangiography at 3T and by contrast-enhanced thinsectionMDCT using a 64-detector row systemY. Ohno 1 , S. Seki 1 , M. Nishio 1 , H. Koyama 1 , T. Yoshikawa 1 , S. Matsumoto 1 ,S. Satou 2 , K. Sugimura 1 ; 1 Kobe/JP, 2 Ohtawara/JPB-0749 – B-0767Monday255

Scientific SessionsB-0768 – B-078711:51B-0768 In vivo micro-CT and 18 F-FDG micro-PET imaging ofSPC-raf and SPC-myc transgenic mouse models oflung adenocarcinomaT. Rodt, C. von Falck, M. Luepke, K. Hueper, R. Halter, S. Dettmer, C. Boehm,J. Borlak, F. Wacker; Hannover/DE11:51B-0778 Comparison of outcomes of endovascular treatmentwith stent placement in patients with early and latehepatic venous outflow obstruction (HVOO)G. Viteri, J. Etxano, P. Slon, F. Rotellar, J.I. Herrero, A. Benito, J.I. Bilbao;Pamplona/ES10:30–12:00 Room D2Interventional RadiologySS 1709 Abdominal interventions: from TIPS tobile ductsModerators: R.F. Dondelinger; Liège/BE, B. Sekovsky; Split/HR10:30B-0769 Clinical relevance and interventional-radiologicalmanagement of early complications after pancreaticsurgery: a 12-year single-centre experience on 1285patientsG. Agostini, M. Venturini, F. De Cobelli, S. Cappio, M. Salvioni, E. Di Rosa,G. Balzano, P. Maffi, A. Del Maschio; Milan/IT10:39B-0770 Management of post-surgical biliary leakage withretrievable covered stent: preliminary resultsA. Gioppo, A. Campari, J. Parraga, C. Michelozzi, L. Rahali, A. Sacrini,F. Melchiorre, G. Cornalba; Milan/IT10:48B-0771 Bioabsorbable biliary stent in the percutaneoustreatment of benign biliary stricture: preliminaryexperienceG. Mauri, C. Michelozzi, V. Pedicini, D. Poretti, M. Tramarin, F. Melchiorre,G. Cornalba, G. Brambilla; Milan/IT10:57B-0772 Patient doses in liver-transplanted children withbiliary strictures treated with interventional radiologyprocedures: a single centre surveyL. Maruzzelli, G. Mamone, R. Miraglia, L. Indovina, A. Luca; Palermo/IT11:06B-0773 Endoluminal RFA with subsequent ductoplastyfor biliary and pancreatic duct malignant blockrecanalisationM. Mizandari 1 , N. Habib 2 ; 1 Tbilisi/GE, 2 London/UK11:15B-0774 Effectiveness of therapeutic lymphography onlymphatic leakageT. Gruber-Rouh, N.N.N. Naguib, T. Lehnert, A. Thalhammer, S. Zangos, B. Schulz,V. Jacobi, T.J. Vogl; Frankfurt/DE11:24B-0775 Tips for TIPS: 12-year experienceC. Zini, F. Fanelli, M. Bezzi, E. Boatta, M. Corona, P. Lucatelli, A. Cannavale,C. Cirelli, F.M. Salvatori; Rome/IT11:33B-0776 A new trial with a newly designed Y-shaped coveredstent for the palliative treatment of hilar malignantobstruction of liver: mid-term resultB. Kang 1 , G. Jung 2 ; 1 Seoul/KR, 2 Busan/KR11:42B-0777 The comparison of balloon-occluded retrogradetransvenous obliteration for gastric varices usingliquid and foam sclerosantsJ. Koizumi 1 , K. Myojin 1 , C. Itou 1 , N. Mori 1 , T. Sekiguchi 1 , T. Hara 1 , T. Ichikawa 1 ,Y. Imai 1 , B. Janne d’Othée 2 ; 1 Isehara/JP, 2 Baltimore, MD/US10:30–12:00 Room E1MusculoskeletalSS 1710 Hip: CT and MRI applicationsModerators: M.H. Maurer; Berlin/DE, A. Vieira; Porto/PT10:30B-0779 Retrospective analysis of CT as secondary imaging inthe diagnosis of occult femoral neck fractureK.J. Partington, P. Robinson, H. Gupta; Leeds/UK10:39B-0780 MRI or CT for occult hip fracture: Do either missclinically relevant fractures?K. Sneddon, H. Rehman, Z. Davis, F. Perks, T.O. White, R.G.E. Clement;Edinburgh/UK10:48B-0781 Digital tomosynthesis in diagnosis of occult hipfracturesM. Geijer 1 , D. Collin 2 , J.H. Göthlin 2 ; 1 Lund/SE, 2 Mölndal/SE10:57B-0782 Advanced core decompression for patients withavascular necrosis of the hip: therapeutic successmonitored by MRIA. Lazik, O. Kraff, T. Claßen, S. Landgraeber, F. Grabellus, T.C. Lauenstein,J.M. Theysohn; Essen/DE11:06B-0783 Lower-limb MRI examination as a predictive factor ofarticular collapse in haematological young patientswith femoral head osteonecrosis: lesion surfaceversus lesion volumeA. Masetto, D. Ippolito, P.A. Bonaffini, D. Fior, A.S. Casiraghi, S. Sironi; Monza/IT11:15B-0784 Alpha angles and herniation pits: revisited on MRI in80 asymptomatic hip jointsE. Lee, J.-A. Choi, G. Lee, H. Kang; Seongnam-si/KR11:24B-0785 Gluteus tendinopathy in femoroacetabularimpingement (FAI): findings with MR-artrography ofthe hipE. Lanza 1 , G. Pozzi 1 , C. Garcia Parra 2 , R. Bisogno 1 , A. Zerbi 1 ; 1 Milan/IT,2Bergamo/IT11:33B-0786 Evaluation of a new method for the assessment ofanterior acetabular coverage and hip joint spacenarrowingR. Ferré, E. Gibon, A. Feydy, H. Guerini, R. Campana, N. Zee, C. Bourdet,M. Hammadouche, J.-l. Drapé; Paris/FR11:42B-0787 Diagnostic value of MR enterography (MRE), afteroral administration of glucose-polyethylene, in thedetermination of the activity of disease in patientswith known Crohn‘s disease: a prospective singlecentre studyV. Bartolo, D. Ippolito, C. Trattenero, P.A. Bonaffini, V. Besostri, S. Sironi;Monza/IT256

Scientific Sessions11:51B-0788 Metal artefact reduction in hip prosthesis withiterative reconstructionsF. Morsbach 1 , S. Bickelhaupt 1 , G. Wanner 1 , A. Krauss 2 , B. Schmidt 2 , H. Alkadhi 1 ;1Zurich/CH, 2 Forchheim/DE10:30–12:00 Room E2GI TractSS 1701a CT/MR colonography: technical issuesand clinical studiesModerators: D. Cano; Pamplona/ES, D.Z. Saranovic; Belgrade/RS10:30B-0789 CT colonography: accurate registration of prone andsupine endoluminal surfaces of the colonT.E. Hampshire, H.R. Roth, E. Helbren, A. Plumb, D. Boone, G. Slabaugh,S. Halligan, D.J. Hawkes; London/UK10:39B-0790 A multi-centre randomised double-blind placebocontrolledtrial to evaluate the value of a single bolusintravenous alfentanil in CT colonographyT.N. Boellaard, M.P. van der Paardt, M.W. Hollmann, S. Eberl, J. Peringa,G. Kavaliauskiene, J.H. Runge, J.A.W. Tielbeek, J. Stoker; Amsterdam/NL10:48B-0791 The possible role of contrast material-enhancedcomputed tomographic colonography (CTC) in thesurveillance after surgery for colorectal cancerM. Morone, G. Mazza, T. Natilla, G. Baiocchi, M. Ghedi, E. Dettori, B. Frittoli,L. Grazioli; Brescia/IT10:57B-0792 CT colonography: comparative study of experiencedvs non-experienced radiologists using 3D flythroughapproach with and without CAD softwareF. Vecchietti, M. Rengo, D. Caruso, C.N. De Cecco, D. Bellini, A. Laghi; Latina/IT11:06B-0793 CT colonography bowel preparation: influence of alaxative agent on a fluid tagging preparationM. Rengo, D. Bellini, M.M. Maceroni, F. Vecchietti, D. Caruso, P. Lucchesi,A. Laghi; Latina/IT11:15B-0794 Flat lesions: CTC with and without CADG. Mazza, T. Natilla, M. Morone, B. Frittoli, G. Baiocchi, L. Grazioli; Brescia/IT11:24B-0795 MR colonography to screen for colorectal neoplasia inasymptomatic adultsA. Graser, A. Melzer, E. Lindner, P. Stieber, M.F. Reiser, B. Göke, F.T. Kolligs;Munich/DE11:33B-0796 Retrospective evaluation of diverticular disease ina large cohort of 1091 patients who underwent CTcolonographyM. Ciolina 1 , C. De Cecco 2 , P. Baldassari 1 , M. Iannitti 1 , A. Pichi 1 , F. Iafrate 1 ,A. Laghi 2 ; 1 Rome/IT, 2 Latina/IT11:42B-0797 Accuracy of water enema-MDCT in colon cancerstaging: a prospective studyC. Ridereau-Zins 1 , E. Sibileau 1 , A. Pavageau 1 , D. Vanel 2 , E. Lermite 1 , E. Metivier-Cesbron 1 , C. Aube 1 ; 1 Angers/FR, 2 Bologna/IT11:51B-0798 Feasibility study of low-dose CT colonography usingmodel-based iterative reconstruction: preliminaryfindings in 20 patientsV. Vardhanabhuti, C. Roobottom; Plymouth/UK10:30–12:00 Room F1Oncologic ImagingSS 1716 Response evaluation in oncology:beyond RECISTModerators: T. Denecke; Berlin/DE, M.I. Furmanek; Warsaw/PL10:30B-0799 Calibration of computed tomography (CT) volumetricmeasurements for assessing tumour response to drugtherapy in a randomised multicentre oncology studyR. Avila 1 , D. Yankelevitz 2 , V. Archer 3 , G. Zahlmann 4 ; 1 Clifton Park, NY/US,2New York, NY/US, 3 Welwyn Garden City/UK, 4 Basle/CH10:39B-0800 Evaluating the agreement between tumour volumetryand the estimated volumes of tumour lesions using analgorithmM. D‘Anastasi, R.P. Laubender, V. Heinemann, M.F. Reiser, M. Schlichting,A. Graser; Munich/DE10:48B-0801 Chemotherapy response evaluation with magneticresonance (MR) and FDG-PET/CT in gastroesophagealtumours (GT): apparent diffusion coefficient (ADC) andstandardised uptake volume (SUV) changes comparedwith tumour regression grade (TRG) at histologyF. Giganti, F. De Cobelli, C. Canevari, E. Orsenigo, L. Albarello, E. Mazza,C. Staudacher, L. Gianolli, A. Del Maschio; Milan/IT10:57B-0802 Treatment response assessment in Hodgkinlymphoma: in search for morphological correlates ofmetabolic activityT. Knogler, G. Karanikas, M. Weber, K. El-Rabadi, M.E. Mayerhoefer; Vienna/AT11:06B-0803 Predictive values of MRI parameters for theprogression-free survival after radioembolisation inpatients with metastases of neuroendocrine tumoursW.H. Sommer, F. Ceelen, P. Paprottka, M.F. Reiser, D. Theisen; Munich/DE11:15B-0804 One-month apparent diffusion coefficientdeterminedresponse at diffusion-weighted MRI is anindependent predictor of response to transarterialchemoembolization for hepatocellular carcinomaV. Vandecaveye, K. Michielsen, F. De Keyzer, W. Laleman, M. Komuta,F. Nevens, T. Roskams, C. Verslype, G. Maleux; Leuven/BE11:24B-0805 Real-time imaging of the therapeutic responseof tumours to anti-vascular treatment in mice bygadofosveset-enhanced MRIA.J. Höink 1 , T. Persigehl 2 , J. Ring 1 , R.M. Mesters 1 , W.E. Berdel 1 , W.L. Heindel 1 ,C. Bremer 1 , C. Schwöppe 1 ; 1 Münster/DE, 2 Cologne/DE11:33B-0806 Reproducibility of therapy response evaluationbetween experienced and less experienced readers ofpleural mesothelioma by mRECIST, RECIST 1.0, RECIST1.1, and WHOL. Stahlhut 1 , A. Bunck 1 , Y. Tan 2 , M. Steen 1 , X. Guo 2 , D. Maintz 1 , L. Schwartz 2 ,B. Zhao 2 , T. Persigehl 1 ; 1 Cologne/DE, 2 New York, NY/US11:42B-0807 Use of multimedia structured reporting for tumourresponse assessmentD.J. Vining 1 , A. Pitici 2 , I. Aghenitei 2 , C. Popovici 2 , M. Jurca 2 , R. Rosu 2 ,A. Tsimberidou 1 ; 1 Houston, TX/US, 2 Chapel Hill, NC/USB-0788 – B-0807Monday257

Scientific SessionsB-0808 – B-082711:51B-0808 Comparison of breast-MRI vs. standard prognosticfactors for the prediction of local recurrence aftertreatment of primary breast cancerP.A.T. Baltzer 1 , M. Dietzel 2 , H. Habrecht 3 , R. Zoubi 4 , C. Jerowski 3 ,I.B. Runnebaum 3 , W.A. Kaiser 3 ; 1 Jena/DE, Vienna/AT, 2 Erlangen/DE, Jena/DE,3Jena/DE, 4 Bielefeld/DE, Jena/DE10:30–12:00 Room F2BreastSS 1702Tomosynthesis: a role in clinicalpractice?Moderators: S. Allen; Sutton/UK, E.M. Jung; Regensburg/DE10:30B-0809 The role of additional tomosynthesis combined withdigital mammographyP. Martínez 1 , J. Echano 2 , M. Sainz 1 , I. Simon 2 , G. Viteri 2 , A. Garcia Lallana 1 ,C. Minguillon 1 , L. Pina 2 ; 1 Zaragoza/ES, 2 Pamplona/ES10:39B-0810 Does breast tomosynthesis combined with 2D digitalmammography increase the detection rate of breastcancer?R. Saiz-Mendiguren 1 , C. Marginet-Mangas 1 , A. Garcia-Lallana 2 ,E. Martinez 1 , C. Ibarburen 1 , L. Pina Insausti 3 ; 1 Palma de Mallorca/ES,2Santurce/ES, 3 Pamplona/ES10:48B-0811 Detection rate for suspicious lesions of digitalbreast tomosynthesis in combination with digitalmammography or 2D central projection imagingC. Zuiani 1 , P. Clauser 1 , V. Londero 1 , C. Molinari 1 , R. Girometti 1 , A. Taibi 2 ,S. Vecchio 3 , M. Bazzocchi 1 ; 1 Udine/IT, 2 Ferrara/IT, 3 Bologna/IT10:57B-0812 Digital mammography in comparison with digitalbreast tomosynthesis in detection of multicentricbreast cancerN. Prvulovic, D. Djilas, M. Prvulovic, D. Bogdanovic, K. Koprivsek; Novi Sad/RS11:06B-0813 The role of tomosynthesis after normal mammographyaccording to ACR density patternsJ. Etxano, P. Slon, I. Simon-Yarza, R. Zalazar, A. Elizalde, L. Pina; Pamplona/ES11:15B-0814 Influence of breast density on diagnostic performanceof digital breast tomosynthesis (DBT) after digitalmammography (DM) focusing on recall rate reductionL.A. Carbonaro 1 , R.M. Trimboli 1 , N. Verardi 1 , M. Fedeli 2 , G. Di Leo 1 , F. Sardanelli 1 ;1San Donato Milanese/IT, 2 Milan/IT11:24B-0815 Recall rate reduction by adding double reading digitalbreast tomosynthesis (DBT) to digital mammography(DM)L.A. Carbonaro 1 , R.M. Trimboli 1 , N. Verardi 1 , K. Khouri Chalouhi 2 , G. Di Leo 1 ,F. Sardanelli 1 ; 1 San Donato Milanese/IT, 2 Milan/IT11:33B-0816 Breast tomosynthesis versus digital mammography:evaluation of diagnostic potential in women withabnormal screening mammogramsM.A. Shaaban; Cairo/EG11:42B-0817 Analysis of discordant screening-detected cancersat FFDM (2D) versus 2D plus tomosynthesis (combomode) in a population-based screening program:results from the Oslo tomosynthesis screening trialP. Skaane, R. Gullien, M. Krager, U. Haakenaasen, M. Izadi, I.N. Jebsen, U. Ekseth,E.B. Eben; Oslo/NO11:51B-0818 The STORM trial of screening mammography:screening with tomosynthesis or standardmammographyS. Ciatto (posthumous) 1 , N. Houssami 2 , D. Bernardi 1 , F. Caumo 3 , P. Macaskill 2 ;1Trento/IT, 2 Sydney/AU, 3 Verona/IT10:30–12:00 Room G/HGenitourinarySS 1707 Hints on haematuria and adrenals forallModerators: O. Nikolic; Novi Sad/RS, H. Sugimura; Miyazaki/JP10:30B-0819 Impact of patient mobilisation on interpretationof upper urinary tract filling defects seen on MDCTurographyJ.M. Froehlich, A. Joeres, P.J. Probst, F. Nussberger, H.C. Thoeny; Berne/CH10:39B-0820 Evaluation of diagnostic strategies for hematuriausing risk stratificationN.C. Cowan; Birmingham/UK10:48B-0821 Use of novel iterative reconstruction in CT KUB:approach on improving image qualityV. Vardhanabhuti, C. Roobottom, S. Ilyas; Plymouth/UK10:57B-0822 Renal cell carcinoma subtype differentiation onsingle-phase contrast-enhanced CTF. Veloso Gomes 1 , J. Palas 2 , A. Matos 2 , V. Mascarenhas 3 , V. Herédia 4 , S. Duarte 3 ,M. Ramalho 2 ; 1 Faro/PT, 2 Almada/PT, 3 Lisbon/PT, 4 Évora/PT11:06B-0823 To assess parameters within CT findings to aiddistinction of histological subtype of renal cellcarcinoma within our instituteM.J. Conneely, D. Ferguson, C. Donagh, M. Quinlan, T. McHale, P. McCarthy;Galway/IE11:15B-0824 MDCT in differentiating pT1-2 from pT3 tumours inclear cell RCCO. Le, C. Wood, P. Tamboli, R. Vikram; Houston, TX/US11:24B-0825 Reader variability in urinary stone size estimation:training does not helpM. Lidén, T. Andersson, H. Geijer; Örebro/SE11:33B-0826 Contrast-enhanced CT and chemical shift MRI:accuracy for lipid-poor adenoma characterizationY.A. Choi, B.K. Park, J.M. Seo, S.Y. Park, C.K. Kim; Seoul/KR11:42B-0827 Functional MRI with diffusion-weighted imaging andADC map in characterization of undetermined adrenallesions: comparison with chemical shift imagingC.R.G.L. Talei Franzesi, D. Ippolito, P.A. Bonaffini, C. Capraro, V. Besostri, S. Sironi;Monza/IT258

Scientific Sessions11:51B-0828 Non-contrast-enhanced MR adrenal venography foradrenal venous samplingH. Ota, K. Takase, N. Satani, T. Kimura, K. Seiji, Y. Ono, R. Morimoto, F. Sato,S. Takahashi; Sendai/JP10:30–12:00 Room I/KAbdominal VisceraSS 1701b DWI in pancreatic and hepatobiliarydiseasesModerators: G.J. Munneke; London/UK, D. Weishaupt; Zurich/CH10:30B-0829 Feasibility of abdominal diffusion Kurtosis imagingcompared to standard diffusion weighted imaging at1.5 and 3 TeslaJ. Hansmann, A. Lemke, J. Wambsganss, S.O. Schönberg, U. Attenberger;Mannheim/DE10:39B-0830 Differential diagnosis of benign from malignant distalbiliary strictures: value of adding diffusion-weightedimaging to conventional magnetic resonancecholangiopancreatographyR.-E. Yoo, J. Lee, J. Yoon, J. Kim, J. Han, B. Choi; Seoul/KR10:48B-0831 Correlation of measurements of diffusion-weightedMR imaging and Gd-EOB-DTPA-enhanced MR imagingin hepatic malignant tumours: ADC versus signalintensity on hepatobiliary phaseS. Choi, Y. Park, C. Lee, K. Kim, J. Choi, J. Lee, C. Park; Seoul/KR10:57B-0832 Non-invasive assessment of solid benign andmalignant focal liver lesions by quantitative analysisof functional MRI with diffusion-weighted imagingM. Colombo, D. Ippolito, P.A. Bonaffini, C. Trattenero, V. Bartolo, S. Sironi;Monza/IT11:06B-0833 Quantitative data analysis of the diffusion-weightedMR-images in the differential diagnosis of metastaticliver disease of colorectal and pancreatic aetiologyY. Savchenkov, S. Bagnenko, G. Trufanov, V. Fokin; St. Petersburg/RU11:15B-0834 Does the ADC-map eradicate the T2-shine-througheffect affecting DW images of focal liver lesions? Astudy with exponential ADC-mapsR. Girometti, M. Maieron, S. Pullini, E. Minighin, L. Cereser, G. Como,M. Bazzocchi, C. Zuiani; Udine/IT11:24B-0835 Prevalence of the T2-shine-through effect on DWimages of focal liver lesions: a study with exponentialADC-maps at 1.5TR. Girometti, M. Maieron, E. Minighin, S. Pullini, L. Cereser, G. Como,M. Bazzocchi, C. Zuiani; Udine/IT11:33B-0836 DWI magnetic resonance imaging in the evaluation ofHCC recurrence after trans-arterial chemoembolization(TACE): comparison with contrast-enhanced MRimagingM. Di Martino, R. Di Miscio, M. Del Monte, C. Lombardo, D. Geiger, C. Catalano;Rome/IT11:42B-0837 MRI of pancreatic adenocarcinoma including diffusionweightedimaging: assessment of tumour conspicuityand pathologic correlationL. Legrand, V. Duchatelle, V. Molinié, I. Boulay-Coletta, E. Sibileau, M. Zins;Paris/FR11:51B-0838 Evaluation of diffusion-weighted MR imaging fordetection of infection in acute pancreatic collectionsand/or necrosis: preliminary resultsF. Islim, A.E. Salik, S. Bayramoglu, K. Guven, H. Alis, A.N. Turhan; Istanbul/TR10:30–12:00 Room L/MPhysics in RadiologySS 1713 Breast imaging and novel CTtechniquesModerators: N. Karssemeijer; Nijmegen/NL, M. Koutalonis; Colchester/UK10:30B-0839 Comparative detector evaluation of full field digitalmammography (FFDM) systems using the Fourierdefinition of the Hotelling-observer signal-to-noiseratio (SNR)R. Wise, I. Delakis, E. Kulama, D. McRobbie; London/UK10:39B-0840 Spectral reconstruction algorithm for digital breasttomosynthesisI. Sechopoulos, V. Mejia-Bustamante, S.S.J. Feng, J. Nagy; Atlanta, GA/US10:48B-0841 Contrast-detail visibility analysis for digital breasttomosynthesis versus digital mammographyS. Elie, W.J.H. Veldkamp, R.E. van Engen, M.J.M. Broeders; Nijmegen/NL10:57B-0842 Can a colour representation of grey-scale imagesimprove object detectability in mammography?E. Salvagnini 1 , L. Cockmartin 1 , K. Michielsen 1 , J. Jacobs 2 , N.W. Marshall 1 ,L. Struelens 3 , H. Bosmans 1 ; 1 Leuven/BE, 2 Heverlee/BE, 3 Mol/BE11:06B-0843 Volumetric breast-density measurement usingspectral mammographyA. Gooßen 1 , M. Lundqvist 2 , K. Erhard 1 , E. Fredenberg 2 ; 1 Hamburg/DE, 2 Solna/SE11:15B-0844 Monochromatic dual-energy X-rays for precisemeasurement of bone mineral density: preliminaryresultsC.-H. Lee, K.-H. Yoon, Y.-H. Lee, E. Kang, D. Kang; Iksan/KR11:24B-0845 Phase contrast imaging using grating interferometer:preliminary resultsD. Kang, K.-H. Yoon, Y.-H. Lee, E. Kang, C.-H. Lee; Iksan/KR11:33B-0846 First in-vitro results of microbubbles as a scatteringcontrast agent for X-ray dark-field imaging measuredat a first pre-clinical X-ray phase-contrast and darkfieldCT scannerA. Velroyen 1 , M. Bech 1 , A. Tapfer 1 , M. Ingrisch 2 , C.C. Cyran 2 , S. Auweter 2 ,K. Nikolaou 2 , M.F. Reiser 2 , F. Pfeiffer 1 ; 1 Garching/DE, 2 Munich/DE11:42B-0847 In vivo urinary stones chemical compoundidentification using dual-energy CTT. Kraśnicki, M. Guziński, P. Podgórski, J. Bladowska, A. Czarnecka,K. Tupikowski, M. Sąsiadek; Wrocław/PLB-0828 – B-0847Monday259

Scientific SessionsB-0848 – B-086511:51B-0848 Value of monoenergetic low-keV dual-energy CTdatasets for improved image quality of abdominal CTangiographyS. Sudarski, D. Schneider, P. Apfaltrer, S.O. Schönberg, T. Henzler;Mannheim/DE10:30–12:00 Room N/OCardiacSS 1703Biomarkers, tissue characterisationand remodellingModerators: M. Das; Maastricht/NL, K. Gruszczynska; Katowice/PL10:30B-0849 Biomarkers of atherosclerotic and myocardialremodelling: correlation with plaque volume in cardiacCTL.L. Geyer 1 , A. Krazinski 1 , J.R. Silverman 1 , F. Bamberg 2 , U. Ebersberger 2 ,P. Costello 1 , U.J. Schoepf 1 ; 1 Charleston, SC/US, 2 Munich/DE10:39B-0850 Morpho-functional and metabolic assessment of theheart in adult-onset growth hormone (GH) deficiencypatients with cardiac magnetic resonance (CMR) and31P MR spectroscopy (31P-MRS)M. Cava, F. De Cobelli, A. Esposito, G. Perseghin, A. Rossini, R. Lanzi, M. Losa,T. Canu, A. Del Maschio; Milan/IT10:48B-0851 Right ventricular remodelling after ST-elevationmyocardial infarctionM. Tille, M. Gutberlet, H. Thiele, M. Grothoff; Leipzig/DE10:57B-0852 Influence of periprocedural myonecrosis assessed bymagnetic resonance delayed enhancement in patientswith bifurcation lesions angioplasty on prognosis atone-year follow-upR. Gil, J. Walecki, D. Vassilev, M. Furmanek, A. Michałek, M. Odyniec-Nowacka,A.J. Piliszek; Warsaw/PL11:06B-0853 Exposure to a high fat diet during early developmentincreases the susceptibility to cardiac lipidaccumulationP.A. van Ewijk, S. Paglialunga, J. Slenter, J.E. Wildberger, J. Glatz,M.K.C. Hesselink, P. Schrauwen, V.B. Schrauwen-Hinderling, M.E. Kooi;Maastricht/NL11:15B-0854 Cardiac and hepatic iron and heart function by MR inthalassaemia major patients treated with combineddeferiprone and desferrioxamine regimen versusmonotherapies: a multi-centre, observational andprospective studyC. Tudisca 1 , P. Ricchi 2 , A. Meloni 3 , E. Grassedonio 1 , M. Santodirocco 4 ;1Palermo/IT, 2 Naples/IT, 3 Pisa/IT, 4 San Giovanni Rotondo/IT11:24B-0855 Are the preferential patterns of myocardial ironoverload preserved at the CMR follow-up?C. Tudisca 1 , A. Meloni 2 , G. Giuffrida 3 , E. Grassedonio 1 , E. Chiodi 4 ,A. Pietrapertosa 5 , M. Lombardi 2 , M. Midiri 1 , A. Pepe 2 ; 1 Palermo/IT, 2 Pisa/IT,3Catania/IT, 4 Ferrara/IT, 5 Bari/IT11:33B-0856 The effect of partial volume averaging on peakvelocity measurements in phase contrast magneticresonance angiography (PCMRA)J.C.L. Rodrigues 1 , K. Minhas 1 , G. Pieles 1 , C. Bucciarelli-Ducci 1 , R. Tulloh 1 ,N.E. Manghat 1 , C.J. Occleshaw 2 , M.C.K. Hamilton 1 ; 1 Bristol/UK, 2 Auckland/NZ11:42B-0857 Different patterns of delayed cardiac enhancementin symptomatic patients with post-total correctionof tetralogy of fallot assessed by cardiac MRI and itscorrelation with right ventricular function: a reportfrom IranF. Akhavan, M. Motevalli, N. Abolfat-h-Zadeh Ghale Joughi; Tehran/IR11:51B-0858 Diastolic versus systolic acquisition of T1 mapsof normal human myocardium at 1.5T magneticresonance imagingU. Reiter 1 , G. Reiter 1 , K. Dorr 1 , A. Greiser 2 , R. Maderthaner 1 , M.H. Fuchsjäger 1 ;1Graz/AT, 2 Erlangen/DE10:30–12:00 Room PPaediatricSS 1712 Foetal and neonatal imagingModerators: N. De Graaf; Rotterdam/NL, H. Ringertz; Linköping/SE10:30B-0859 Antenatal blood flow quantification by phase-contrastMRI using a new triggering method: comparison withDoppler ultrasound in a sheep modelB.P. Schönnagel, C. Much, J. Yamamura, G. Adam, F. Ueberle, M. Tavares deSousa, H. Kooijman, U. Wedegärtner; Hamburg/DE10:39B-0860 Relationship between body growth and regional brainvolume changes in extremely premature small forgestational age babiesL.C. Tzarouchi, A. Drougia, A. Zikou, A. Charisiadi, P. Kosta, L. Astrakas,S. Andronikou, M.I. Argyropoulou; Ioannina/GR10:48B-0861 Do vascular events impact brain maturation oftwin pregnancies complicated with twin-to-twintransfusion syndrome?S. Bargy; Paris/FR10:57B-0862 Microstructural changes of white matter tractsin small for gestational age very preterm infantsevaluated at term equivalent ageL.C. Tzarouchi, A. Drougia, A. Zikou, P. Kosta, L. Astrakas, S. Andronikou,M.I. Argyropoulou; Ioannina/GR11:06B-0863 The “tail sign” in the differential diagnosis of vermianpathologies in foetuses under 24 weeks: role of foetalMRIP. Sollazzo, M. Sergi, V. Vinci, S. Bernardo, M. Saldari, L. Manganaro; Rome/IT11:15B-0864 Real time cine-MRI in children and foetuses with headand neck pathologyT. Feygin, A. Pollock, J. Stein, T. Victoria; Philadelphia, PA/US11:24B-0865 Magnetic-resonance-imaging-based ratio of fetal lungvolume to foetal body volume as a new prognosticmarker in congenital diaphragmatic herniaM. Weidner, C. Hagelstein, A. Debus, A. Walleyo, S.O. Schönberg, T. Schaible,K.A. Büsing, S. Kehl, K.W. Neff; Mannheim/DE260

Scientific Sessions11:33B-0866 Repetitive MR measurements of lung volume infoetuses with congenital diaphragmatic hernia toinvestigate the individual development of pulmonaryhypoplasia during pregnancyC. Hagelstein, M. Weidner, A. Debus, A. Walleyo, S.O. Schönberg, T. Schaible,S. Kehl, K.A. Büsing, K.W. Neff; Mannheim/DE11:42B-0867 Periventricular nodular heterotopia: prenatalultrasound findingsE. Blondiaux, C. Sileo, C. Nahama-Allouche, M.-L. Moutard, A. Gelot, J.-M. Jouannic, H. Ducou le Pointe, C. Garel; Paris/FR11:51B-0868 Role of foetal MR in the evaluation of gastrointestinaltract anomaliesS. Bernardo, V. Vinci, P. Sollazzo, M. Sergi, M. Saldari, L. Manganaro; Rome/IT10:30–12:00 Room QRadiographersSS 1714MammographyModerators: S.J. Foley; Dublin/IE, P. Vahtramae; Pärnu/EE10:30B-0869 Online portfolio for radiographers attending thebreast cancer screening mammography certificate inSwitzerlandN. Richli Meystre, L. Flaction, R. Le Coultre; Lausanne/CH10:39B-0870 Inter-observer agreement among PGMI radiographer inCambridge/UK and Oslo/NO in assessing each other’sand their own mammography screening examsR. Gullien 1 , E. Rostad 1 , A.E. Haakull 1 , R.L. Hammond 1 , M. Hauge 1 , K. Taylor 2 ,J.G. Andersen 1 ; 1 Oslo/NO, 2 Cambridge/UK10:48B-0871 Radiation dose levels assessment in mammographyC. Lourenço, P. Sousa, S.I. Rodrigues, A.F.C.L. Abrantes, L.P.V. Ribeiro,K.B. Azevedo, R.P.P. Almeida; Faro/PT10:57B-0872 Quality control in digital mammography: radiographerspractice at 5 hospitals of LisbonC. Tomás, C. Gonçalves, C.I.S. Reis; Lisbon/PT11:06B-0873 An investigation into the psychological anxiety ofMaltese women before and after a mammogramC. Falzon; Sta Lucija/MT11:15B-0874 Ergonomic and environmental assessment in digitalmammography room: impact on radiographers’ activityS. Costa, E. Oliveira, F. Serranheira, S. Viegas, C.I.S. Reis; Lisbon/PT11:24B-0875 Accuracy of students, and radiographers, withand without, mammography post-graduation ininterpretation of mammography imagesR.B.J. Cópio 1 , K.B. Azevedo 1 , A.F.C.L. Abrantes 1 , L.P.V. Ribeiro 1 , R.P.P. Almeida 1 ,C.A. Silva 2 ; 1 Faro/PT, 2 Evora/PT11:33B-0876 Patient satisfaction assessment in mammographyexamsL. Borralho, L.P.V. Ribeiro, C.A. Silva, A.F.C.L. Abrantes, J. Pinheiro,R.P.P. Almeida; Faro/PT11:42B-0877 Impacts of digital mammography in radiographerspracticeL. Painho, T. Fernandes, C.I.S. Reis; Lisbon/PT11:51B-0878 Imaging ethicsB. Hofmann; Oslo/NO10:30–12:00 Room ZMolecular ImagingSS 1706 Molecular imaging in cancer anddegenerative diseasesModerators: J. Hakumäki; Kuopio/FI, E. Lopci; Rozzano/IT10:30B-0879 Improving current preclinical therapy monitoringmethods by multiparametric MR using a hNISexpressingtumour xenograft mouse modelE.J. Koziolek 1 , I. Apostolova 2 , A. Tarkowska 1 , U. Schumacher 1 , W. Brenner 2 ,G. Adam 1 , M.G. Kaul 1 ; 1 Hamburg/DE, 2 Berlin/DE10:39B-0880 In vivo assessment of the anti-apoptotic effect ofc-kit+ pluripotent bone marrow cells on ischaemicmyocardium in mice with hybrid fluorescencemolecular tomography – x-ray computed tomographyM. Wildgruber, A. Ale, K. Kosanke, R. Braren, R. Meier, E.J. Rummeny,V. Ntziachristos; Munich/DE10:48B-0881 Magnetic resonance imaging of murine myocardialinfarction with an elastin-binding contrast agentM. Wildgruber 1 , M. Settles 1 , I. Bielicki 1 , K. Kosanke 1 , A.M. Huber 1 , E.J. Rummeny 1 ,R.M. Botnar 2 ; 1 Munich/DE, 2 London/DE10:57B-0882 Comparison of nanobodies and conventionalmonoclonal antibodies for in vivo fluorescenceimaging of lymphomasP. Bannas, A. Lenz, V. Kunick, W. Danquah, F. Haag, M. Trepel, G. Adam,H. Ittrich, F. Koch-Nolte; Hamburg/DE11:06B-0883 The design of a dual-functional imaging contrastagent for targeting to tumour endothelial marker(TEM8)Q. Quan 1 , X. Huang 2 , J. Xie 2 , Y. Yan 3 , H. Gao 2 , G. Zhang 1 , X. Chen 2 ; 1 Shanghai/CN,2Bethesda, MD/US, 3 Madison, WI/US11:15B-0884 Folic acid-modified dendrimer-entrapped goldnanoparticles as nanoprobes for targeted computedtomography imaging of human lung adenocarcinomaL.-F. Zheng, H. Wang, C. Peng, M.-W. Shen, X.-Y. Shi, G.-X. Zhang; Shanghai/CN11:24B-0885 Imaging of the therapeutic efficiency of photodynamictherapy with a new designed fluorescence opticalannexin probeK. Haedicke, S. Gräfe, F. Lehmann, W.A. Kaiser, I. Hilger; Jena/DE11:33B-0886 Bimodal NIRF nanoparticles as an optical and MRIcontrast agent for imaging cells of the mononuclearphagocyte systemJ. Domey 1 , C. Bergemann 2 , I. Krumbein 1 , J.R. Reichenbach 1 , S. Bremer-Streck 1 ,W.A. Kaiser 1 , I. Hilger 1 ; 1 Jena/DE, 2 Berlin/DEB-0866 – B-0886Monday261

Scientific SessionsB-0887 – B-090711:42B-0887 Assessment of in vivo cell viability of Gd or SPIO cellsusing MRI and BLIJ. Guenoun, A. Ruggiero, G. Doeswijk, R. Janssens, G.A. Koning, G. Kotek,G.P. Krestin, M.R. Bernsen; Rotterdam/NL11:51B-0888 Interaction of magnetically labelled multipotentmesenchymal stromal cells and E-/P-selectinsmonitored by magnetic resonance imaging in miceJ. Salamon, K. Peldschus, D. Wicklein, C. Lange, H. Ittrich, U. Schumacher,G. Adam; Hamburg/DE15:12B-0897 Intra- and inter-scanner test-retest reliability ofwhole-brain arterial spin labeling perfusion MRIB. Wu, X. Wu, X. Lou, M. Ge, L. Ma; Beijing/CN15:21B-0898 Software for the radiological view: fully automatedCT-based quantification of microangiopathic densityreduction in white matter in comparison to goldstandard MRIU. Hanning 1 , I. Noelte 2 , G. Homann 1 , T. Niederstadt 1 , V. Hesselmann 1 ,W. Heindel 1 , A. Kemmling 3 ; 1 Münster/DE, 2 Mannheim/DE, 3 Hamburg/DE14:00–15:30 Room BNeuroSS 1811a Latest developments in neuroimagingModerators: S. Haller; Geneva/CH, E. Papadaki; Iraklion/GR14:00B-0889 Improved image quality for higher diagnostic accuracyof cranial computed tomography using iterative imagereconstructionH. Haubenreisser 1 , C. Fink 2 , P. Apfaltrer 1 , B. Schmidt 3 , M. Sedlmair 3 ,S.O. Schönberg 1 , T. Henzler 1 ; 1 Mannheim/DE, 2 Celle/DE, 3 Forchheim/DE14:09B-0890 Synchrotron radiation micro-CT imaging of the mousebrainA. Chabrol 1 , H. Rositi 1 , M. Marinescu 1 , M. Langer 2 , C. Olivier 2 , F. Peyrin 2 ,C. Frindel 1 , M. Wiart 1 , Y. Berthezène 1 ; 1 Lyon/FR, 2 Grenoble/FR14:18B-0891 Effect of dose reduction on cerebral CT perfusionmaps: results from a hybrid digital perfusion phantomR. van den Boom 1 , M. Oei 1 , L.J. Oostveen 1 , H. Laue 2 , B. van Ginneken 1 ,R. Manniesing 1 , M. Prokop 1 ; 1 Nijmegen/NL, 2 Bremen/DE14:27B-0892 iDose hybrid iterative reconstruction algorithmimproves image quality in brain CT and partlycompensates for radiation dose reductionA. Löve, R. Siemund, P. Höglund, D. van Westen, L. Stenberg, C. Petersen,I.M. Björkman-Burtscher; Lund/SE14:36B-0893 MRI susceptibility-weighted imaging (SWI): role in thedifferentiation of inflammatory pathologies from highgradegliomaS. Chu 1 , Y. Wang 1 , Z. Yang 1 , F. Xv 1 , O. Boyko 2 ; 1 Shanghai/CN, 2 Los Angeles, CA/US14:45B-0894 Inter-session reproducibility of cerebral blood flow(CBF) in the primary motor cortex as assessed in theVESPA (vendor-specific features of ASL-MRI) studyR.M.E. Steketee 1 , H.-J.M.M. Mutsaerts 2 , G.C. Houston 3 , C.B.L.M. Majoie 2 ,A.J. Nederveen 2 , M. Smits 1 ; 1 Rotterdam/NL, 2 Amsterdam/NL, 3 Zeist/NL14:54B-0895 Are quantitative pharmacokinetic data of dynamiccontrast-enhanced MRI influenced by observer-relatedbias? New data with special focus on reproducibility,precision, accuracy, reliability, repeatability andsystematic biasM. Dietzel 1 , M. Saake 1 , P.A.T. Baltzer 2 , S. Lang 1 , B. Volbers 1 , T. Struffert 1 ,T. Engelhorn 1 , A. Dörfler 1 ; 1 Erlangen/DE, 2 Vienna/AT15:03B-0896 MR elastography (MRE) for non-invasivedifferentiation of intracranial tumours: results of ahistology correlated studyM. Simon 1 , J. Guo 2 , M. Bonsanto 1 , D. Petersen 1 , I. Sack 2 , J. Würfel 3 ; 1 Lübeck/DE,2Berlin/DE, 3 Göttingen/DE14:00–15:30 Room CNeuroSS 1811b Spinal imagingModerators: M. Buruian; Targu-Mures/RO, A. Cianfoni; Lugano/CH14:00B-0899 Diagnosis of lumbosacral transitional vertebrae onlumbar MRI: role of spinal and paraspinal anatomicmarkers and value of additional whole-spine localizerN. Tokgoz, M. Ucar, B. Erdogan Sendur, K. Kılıc, C. Ozcan; Ankara/TR14:09B-0900 Intravertebral gas in the cervical spineP. Slon, J. Etxano, G. Viteri, I. Simón-Yarza, M. Páramo, P. García, J.C. Pueyo,J. Larrache; Pamplona/ES14:18B-0901 The importance of craniovertebral andcervicomedullary angle on cervicogenic headacheG. Çoban 1 , I. Çöven 1 , E.B. Çifçi 1 , E. Yıldırım 1 , C.A. Yazıcı 2 , B. Horasanlı 1 ; 1 Konya/TR,2Ankara/TR14:27B-0902 Acute low back/leg pain due to lumbar disc herniation:intradiscal and intraforaminal injections of oxygenozonevs steroid and anaestheticsA. Alexandre 1 , G. Izzo 1 , G.G. Giardina 1 , L. Coro‘ 2 , A. Alexandre 2 ; 1 Rome/IT,2Treviso/IT14:36B-0903 Optimising a BLADE sequence for T2-weighted MRI ofthe cervical spine in transverse orientation: is there achance for artefact reduction?C. Fellner 1 , C.M. Wendl 1 , C. Stroszczynski 1 , T. Finkenzeller 2 ; 1 Regensburg/DE,2Nürnberg/DE14:45B-0904 Role of 3D MRI with ProSet technique in theevaluation of lumbar radiculopathyD. Grasso, C. Borreggine, C. Bristogiannis, L.P. Stoppino, D. Melchionda,L. Macarini; Foggia/IT14:54B-0905 Assessing severity of peripheral neuropathy with DTIC. Mathys, J. Aissa, G. Meyer zu Hörste, D.C. Reichelt, G. Antoch, B. Turowski,H.-P. Hartung, K.A. Sheikh, H.C. Lehmann; Düsseldorf/DE15:03B-0906 Leukodystrophy with brainstem and spinal cordinvolvement and lactate elevation (LBSL): assessmentof the involved white matter tracts by MRIH.M.H. Kassem 1 , S. Radwan 1 , M.H.I. Elmahdy 1 , A.A.S.W. Wafae 2 , H.R.S. Farghaly 1 ;1Riyadh/SA, 2 Cairo/EG15:12B-0907 Diffusion tensor imaging of the spondylotic cervicalspinal cord: a new biomarker in cervical spinal cordmyelopathy? A preliminary studyF.W. Cartes-Zumelzu, S. Ingorokva, H. Kostron, G.M. Feuchtner, C. Kremser,R. Granata, G. Broessner, C. Thomé; Innsbruck/AT262

Scientific Sessions15:21B-0908 Diffusion tensor imaging and magnetisation transferimaging of spinal cord in MS patientsM. Gencturk, Y. Anik, H. Efendi, A. Demirci; Kocaeli/TR14:00–15:30 Room D1CardiacSS 1803Cardiac imaging: into the futureModerators: R.W. Bauer; Frankfurt a. Main/DE, E. Canet Soulas; Bron/FR14:00B-0909 Ablation of atrial flutter guided by magneticresonance imagingM. Grothoff, P. Sommer, C. Piorkowski, J. Hoffmann, G. Hindricks, M. Gutberlet;Leipzig/DE14:09B-0910 Quantitative BOLD response of the left ventricularmyocardium to hyperoxic respiratory challenge at 1.5T and 3.0T cardiac magnetic resonance imagingS. Winklhofer, S. Pazahr, R. Manka, H. Alkadhi, A. Boss, P. Stolzmann; Zurich/CH14:18B-0911 High-resolution susceptibility-weighted magneticresonance imaging of rat heart microvasculatureE. Blondiaux, L. Pidial, G. Autret, D. Balvay, C.-A. Cuenod, H. Ducou le Pointe,O. Clément; Paris/FR14:27B-0912 T2-weighted dark blood cardiac imaging using a dualsourceparallel radiofrequency transmission with RFshimming at 3 T compared with standard MR imagingat 3 TM. Rasper, M. Settles, B. Gramer, M. Souvatzoglou, E.J. Rummeny, A. Huber;Munich/DE14:36B-0913 Myocardial T1-mapping and myocardial extracellularvolume (ECV) fraction: intraindividual comparison ofgadobutrol and gadoterate meglumine in an animalmodelK.U. Bauner 1 , T. Sander 1 , D. Theisen 1 , H. Pietsch 2 , G. Jost 2 , M.F. Reiser 1 ,K. Nikolaou 1 , B.J. Wintersperger 3 ; 1 Munich/DE, 2 Berlin/DE, 3 Toronto, ON/CA14:45B-0914 Noninvasive diagnosis of pulmonary hypertension viamagnetic resonance vortex flow detection: definitionof cut-off criteriaG. Reiter 1 , U. Reiter 1 , G. Kovacs 1 , A. Stalder 2 , M.A. Gulsun 3 , A. Greiser 2 ,H. Olschewski 1 , M.H. Fuchsjäger 1 ; 1 Graz/AT, 2 Erlangen/DE, 3 Princeton, NJ/US14:54B-0915 Feasibility study for an image-based enhancementof low-dose intra-procedural 4D C-arm cardiac flatdetectorCT (4D-FD-CT)Y. Kyriakou 1 , C. Koehler 1 , S. de Buck 2 , D. Nuyens 2 , H. Heidbuchel 2 ;1Forchheim/DE, 2 Leuven/BE15:03B-0916 Assessment of HU-value stability in dynamic CT-scansfor quantitative estimation of myocardial perfusionM. Handler 1 , T. Rienmüller 1 , P. Ourednicek 2 , V. Makarenko 3 , L. Bockeria 3 ,S. Zhorzholiani 3 , I. Krestinich 3 , R. Rienmüller 4 , C. Baumgartner 1 ; 1 Hall in Tirol/AT,2Prague/CZ, 3 Moscow/RU, 4 Graz/AT15:12B-0917 Impact of iterative image reconstruction algorithmson the feasibility of automated plaque assessment incoronary computed tomographic angiographyS. Puchner, M. Ferencik, M. Károlyi, S. Do, P. Maurovich-Horvat, U. Hoffmann,C. Schlett; Boston, MA/US15:21B-0918 Calcium score of small coronary calcifications onmulti detector computed tomography: a phantomstudyJ.M. Groen 1 , K.F. Kofoed 2 , M. Zacho 2 , R. Vliegenthart 1 , T.P. Willems 1 ,M.J.W. Greuter 1 ; 1 Groningen/NL, 2 Copenhagen/DK14:00–15:30 Room D2Interventional RadiologySS 1809 New approaches to aortic andperipheral interventionsModerators: S. Kudrnova; Budapest/HU, R. Morgan; London/UK14:00B-0919 Paclitaxel-coated balloons for the failing dialysisaccess: a prospective randomized controlled trialP.M. Kitrou, K. Katsanos, S. Spiliopoulos, N. Cristeas, M. Kuriakopoulou,D. Karnabatidis, D. Siablis; Patras/GR14:09B-0920 Lower limb multilevel treatment with drug elutingballoon: 12-month results from the “DEBELLUM” trialF. Fanelli, A. Cannavale, P. Lucatelli, A. Wlderk, C. Cirelli, F.M. Salvatori,L. Scarciolla; Rome/IT14:18B-0921 Directional atherectomy of chronic totalfemoropopliteal occlusions: middle-term outcomesM. Rossi, G.M. Varano, F. Laurino, G. Orgera, A. Zolovkins, N. Maltzeff, M. Citone,V. David; Rome/IT14:27B-0922 Predictive value of angiographic scores for theintegrated management of the ischaemic diabetic footF.M. Turini, I. Bargellini, A. Piaggesi, A. Cicorelli, R. Cervelli, E. Iacopi, R. Cioni,C. Bartolozzi; Pisa/IT14:36B-0923 12 months results of a randomised trial comparingmono- or dual-antiplatelet therapy in interventionallytreated patients with peripheral arterial diseaseF.F. Strobl 1 , J. Schmehl 2 , K. Brechtel 2 , T. Zeller 3 , C.D. Claussen 2 , G. Tepe 4 ;1Munich/DE, 2 Tübingen/DE, 3 Bad Krozingen/DE, 4 Rosenheim/DE14:45B-0924 Comparing 2D angiography, 3D rotational angiography,and pre-procedural CT image fusion with 2Dfluoroscopy for endovascular repair of thoracoabdominalaortic aneurysmV. Tacher 1 , M. Lin 2 , P. Desgranges 1 , T. Grünhagen 3 , A. Luciani 1 , J.-P. Becquemin1, J.-F. Deux 1 , A. Rahmouni 1 ; 1 Creteil/FR, 2 Briarcliff Manor, NY/US, 3 Best/NL14:54B-0925 Endoleak complications of thoracic endovascularaortic repair (TEVAR): long-term outcomes andsurvivalA. Rampoldi, P. Fratto, M. Solcia, R. Vercelli, C. Migliorisi, F. Barbosa, D. Foresti,M. Nichelatti, G. Cornalba; Milan/IT15:03B-0926 Selective coverage of the left subclavian arterywithout recanalization in patients with patentvertebro-vertebral arterial communications duringTEVAR: a single centre studyM. Lee; Seoul/KRB-0908 – B-0926Monday263

Scientific SessionsB-0927 – B-094515:12B-0927 Completely CT-guided treatment of lumbar artery fedtype 2 endoleaks after stent graft repair of abdominalaortic aneurysms with direct sac puncture andembolization with the liquid embolic agent ethylenevinyl alcohol copolymer (Onyx)M. Treitl 1 , M. Sadeghi 2 , K. Eberhardt 1 , D. Maxien 1 , M.F. Reiser 1 ; 1 Munich/DE,2Erding/DE15:21B-0928 Endovascular treatment of type 1 endoleaks afterstent graft repair of aortic aneurysms: effectivenessand safety of the ethylene vinyl alcohol copolymerOnyx as liquid embolic agentM. Treitl 1 , M. Sadeghi 2 , K. Eberhardt 1 , D. Maxien 1 , M.F. Reiser 1 ; 1 Munich/DE,2Erding/DE14:00–15:30 Room E1MusculoskeletalSS 1810 Knee: new horizonsModerators: M. Aparisi Gomez; Valencia/ES, A. Cotten; Lille/FR14:00B-0929 PCL index as an objective MRI tool to evaluateanatomic ACL reconstruction during functionalactivitiesA. Ntoulia 1 , F. Zampeli 1 , E. Pappas 2 , S. Ristanis 1 , A. Georgoulis 1 ; 1 Ioannina/GR,2Brooklyn, NY/US14:09B-0930 Microstructural evaluation of the cruciate ligamentswith MR diffusion tensor imaging (DTI): correlationswith knee stabilityL. Di Clemente 1 , D. Tortora 1 , V. Panara 1 , M. Savastano 1 , V. Calvisi 2 , P. Palumbo 2 ,A. Tartaro 1 , A.R. Cotroneo 1 , M. Caulo 1 ; 1 Chieti/IT, 2 L‘Aquila/IT14:18B-0931 Dynamic contrast-enhanced imaging for detection ofcomplications after double-bundle reconstruction ofthe anterior cruciate ligamentY.-C. Lin 1 , Y.-H. Juan 1 , Y.-C. Cheung 1 , W.-L. Yeh 1 , C.-H. Chiu 1 , C.-F. Tan 1 , C.-M. Kuo 2 ; 1 Taoyuan/TW, 2 Ilan/TW14:27B-0932 Susceptibility artifacts on knee MRI: their frequency,change over time, and their relation with radiographydetectedcalcifications and joint space narrowing, andMR-detected meniscal tearsM. Jarraya 1 , D. Hayashi 1 , A. Guermazi 1 , C.K. Kwoh 2 , M.J. Hannon 2 , C.E. Moore 3 ,J.M. Jakicic 2 , S.M. Green 2 , F.W. Roemer 4 ; 1 Boston, MA/US, 2 Pittsburgh, PA/US,3Houston, TX/US, 4 Augsburg/DE14:36B-0933 Meniscal pathology demonstraded by MRI andlow level laser therapy: a double-blinded placebocontrolled trialO. Kiritsi 1 , N. Malliaropoulos 2 , K. Tsitas 2 , K. Omar 1 ;1Gorleston on sea, Great Yarmouth/UK, 2 Thessaloniki/GR14:45B-0934 Meniscal tears are associated with adjacenttibiofemoral cartilage degeneration assessed using 3TMRI T2 relaxation timeH. Alizai, W. Lin, H. Liebl, L. Nardo, C. McCulloch, J. Lynch, M. Nevitt;San Francisco, CA/US14:54B-0935 Articular depression assessed by MDCT as a predictorof soft-tissue injuries in tibial plateau fractures:intraindividual correlation to findings at magneticresonance imagingM. Regier, A. Spiro, F.O.G. Henes, G. Adam; Hamburg/DE15:03B-0936 Anatomical risk factors in patients after patellardislocation: a case-control study using MRIT. Köhlitz, S. Scheffler, T. Jung, E. Wiener, B. Vollnberg, G. Diederichs; Berlin/DE15:12B-0937 Early changes of trabecular bone structure inasymptomatic subjects with knee malalignmentT. Baum, J. Penzel, M. Sauerschnig, E.J. Rummeny, K. Wörtler, J.S. Bauer;Munich/DE15:21B-0938 Total knee arthroplasty MR imaging with theWARP-technique, featuring slice-encoding metalartefact correction (SEMAC) and view-angle tilting(VAT): reduction of metal artefacts for STIR andintermediate-weighted sequencesR. Sutter, R. Hodek, S.F. Fucentese, C.W.A. Pfirrmann; Zurich/CH14:00–15:30 Room E2GI TractSS 1801a Colorectal cancer: diagnosticbiomarkers and response assessmentModerators: A. Filippone; Chieti/IT, J. Husty; Brno/CZ14:00B-0939 MR imaging evaluation of rectal cancer before andafter chemoradiation therapyR. Cazzato, C.L. Piccolo, R. Del Vescovo, F. Giurazza, R.F. Grasso, B. BeomonteZobel; Rome/IT14:09B-0940 MRI-based selection of clinical complete and goodresponders after chemoradiation for rectal cancerallows for successful minimal invasive treatmentL. Heijnen 1 , M. Maas 1 , M.H. Martens 1 , D.M.J. Lambregts 1 , J.W.A. Leijtens 2 ,R.G.H. Beets-Tan 1 , G.L. Beets 1 ; 1 Maastricht/NL, 2 Roermond/NL14:18B-0941 Diffusion-weighted-based volumetry in theassessment of response in patients with rectal cancertreated with neo-adjuvant therapy: feasibility studyS.F. Carbone, M. Palumbo, V. Ricci, L. Pelliccia, E. Cacchiarelli, L. Volterrani;Siena/IT14:27B-0942 Therapy response assessment in locally advancedrectal cancer: comparison between functionaldynamic and diffusion parameters in MRIR. Fusco, V. Granata, M. Petrillo, M. Sansone, A. Petrillo; Naples/IT14:36B-0943 Reproducibility of MRI texture analysis in primaryrectal cancerS. Gourtsoyianni 1 , G. Ljungqvist 1 , A. Khan 2 , R. Glynne- Jones 2 , B. Ganeshan 3 ,K. Miles 3 , V. Goh 1 ; 1 London/UK, 2 Northwood/UK, 3 Falmer/UK14:45B-0944 Predictors of mesorectal fascia infiltration on spectralpre-saturation inversion-recovery (SPIR) MR imagingsequence after gadolinium injection in patients withrectal carcinoma after neoadjuvant chemo- andradiation therapyE. Quaia, L. De Paoli, A. Gennari, B. Cabibbo, M. Cova; Trieste/IT14:54B-0945 Neoadjuvant therapy in locally advanced colon cancer:the role of MDCTI. Gonzalez Crespo, D. Cano, J. Etxano, P. Slon, J. Arredondo; Pamplona/ES264

Scientific Sessions15:03B-0946 Assessment of the variation in the contrast-to-noiseratio across a range of CT scanners in a multicentreperfusion CT study of colorectal cancer (PROSpeCT): aphantom studyM. Lewis, V.J. Goh; London/UK15:12B-0947 Diffusion-weighted-based MRI: volumetry andapparent diffusion coefficientS.F. Carbone, M. Palumbo, T. Carfagno, V. Ricci, L. Pirtoli, L. Volterrani; Siena/IT15:21B-0948 Computed tomography of the bowel: a prospectivecomparison study between four techniquesM. Revelli, F. Paparo, L. Bacigalupo, A. Garlaschi, L. Cevasco, E. Biscaldi,G. Rollandi; Genoa/IT14:00–15:30 Room F1BreastSS 1802a Newer techniques in breast imagingand therapyModerators: F. Chamming‘s; Paris/FR, M. Sklair-Levy; Tel Aviv/IL14:00B-0949 The impact of contrast-enhanced digitalmammography on the characterization of breastlesionsM.H. Helal, R.M.K. Fouad, M.A. Aly, R. Wessam, I. Gouda, N. AbdelShafi,O.M. Nada, S. Mansour, M. Elbadawy; Cairo/EG14:09B-0950 Clinical feasibility of contrast-enhanced dual-energymammography (CEDEM) with a tungsten (W)/titanium(Ti) anode/filter combination: a prototype reportT. Knogler 1 , R. Leithner 1 , M. Hörnig 2 , F. Semturs 1 , M. Waitzbauer 1 , G. Langs 1 ,P. Homolka 1 , K. Pinker-Domenig 1 , T.H. Helbich 1 ; 1 Vienna/AT, 2 Erlangen/DE14:18B-0951 Comparison of contrast-enhanced dual-energymammography (CEDEM) with contrast-enhancedmagnetic resonance imaging (CE-MRI) in breastlesions: a prototype reportT. Knogler 1 , R. Leithner 1 , M. Hörnig 2 , M. Waitzbauer 1 , F. Semturs 1 , G. Langs 1 ,P. Homolka 1 , K. Pinker-Domenig 1 , T.H. Helbich 1 ; 1 Vienna/AT, 2 Erlangen/DE14:27B-0952 Metabolic imaging of breast tumours with dedicatedbreast 18F-FDG PET-CT: comparison with contrastenhancedMRI at 3T (3T CE-MRI)H.F. Magometschnigg, T.H. Helbich, H. Bickel, G. Wengert, B. Brück, K. Pinker-Domenig; Vienna/AT14:36B-0953 High spatial and temporal resolution breast imagingat 7 Tesla goes clinicalK. Pinker-Domenig, P.A.T. Baltzer, T. Helbich, S. Gruber, W. Bogner, O. Zaric,L. Minarikova, H. Moosbauer, S. Trattnig; Vienna/AT14:45B-0954 Evaluation of T1/T2 ratios in a pilot study as apotential biomarker of biopsy: proven benignand malignant breast lesions in correlation withhistopathological disease stageM.A. Malikova, J.N. Tkacz, P.J. Slanetz, A. Aakil, C.-Y. Guo, H. Jara; Boston, MA/US14:54B-0955 Improved differentiation of breast tumours usingnovel imaging system based on co-registered optoacoustictomography and ultrasoundP. Otto 1 , K. Kist 1 , N.C. Dornbluth 1 , T. Stavros 1 , D. Herzog 1 , B. Clingman 1 ,J. Zalev 1 , P. Lavin 2 , A. Oraevsky 3 ; 1 San Antonio, TX/US, 2 Southborough, MA/US,3Houston, TX/US15:03B-0956 Breast lesion excision system (BLES) – innovativebreast biopsy technology: experience understerotactic guidance in small microcalcificationclustersS. Vigano‘, G.P. Scaperrotta, C. Ferranti, L. Suman, M. Marchesini, E. Capalbo,P. Panizza; Milan/IT15:12B-0957 Percutaneous breast lesion excision system (BLES):a new tool for complete closed excision of high risklesionsN.M. Abdel Razek; Cairo/EG15:21B-0958 Cryoablation as local therapy for patients with breastcancer bone metastases (BCBM)C. Pusceddu 1 , S. Pilleri 2 , G. Amucano 1 , L. Melis 1 , G. Meloni 2 ; 1 Cagliari/IT,2Sassari/IT14:00–15:30 Room F2BreastSS 1802b Maximising cancer detection in breastscreeningModerators: M. Álvarez-Benito; Córdoba/ES, E. Szabó; Szeged/HU14:00B-0959 Breast cancer prediction modelling based on commonmammographic findings in screeningJ. Timmers 1 , A.L.M. Verbeek 1 , R.M. Pijnappel 2 , J. in ‚t Hout 1 , M.J.M. Broeders 1 ,G.J. den Heeten 3 ; 1 Nijmegen/NL, 2 Utrecht/NL, 3 Amsterdam/NL14:09B-0960 Non-blinded versus blinded double reading ofscreening mammograms in the Netherlands: apopulation-based studyL.E.M. Duijm 1 , G.J. den Heeten 2 , J. Nederend 1 , M.J.M. Broeders 2 ; 1 Eindhoven/NL,2Nijmegen/NL14:18B-0961 Discrepant screening mammography assessments atdouble reading: impact of arbitration by a third readeron screening outcomeL.E.M. Duijm 1 , G.J. den Heeten 2 , J. Nederend 1 , M.J.M. Broeders 2 ; 1 Eindhoven/NL,2Nijmegen/NL14:27B-0962 First experiences with a self-test for Dutch breastscreening radiologists as a quality assurance toolJ. Timmers 1 , A. Verbeek 1 , R. Pijnappel 2 , M. Broeders 1 , G. den Heeten 3 ;1Nijmegen/NL, 2 Utrecht/NL, 3 Amsterdam/NL14:36B-0963 Transition from analogue to digital screeningmammography significantly increases the proportionof women referred twice for the same lesionL.E.M. Duijm, H. Wiersma; Eindhoven/NL14:45B-0964 Audits as part of quality assurance in the Dutch breastcancer screening programmeT.D. Geertse, R. Holland, C.G.C.M. van Landsveld-Verhoeven, J.M.H. Timmers,K.H. Schuur, R. Pijnappel, F. Jansen, M.J.M. Broeders, G.J. den Heeten;Nijmegen/NLB-0946 – B-0964Monday265

Scientific SessionsB-0965 – B-098414:54B-0965 Avoidable surgical consultations in women with apositive screening mammogram: experience froma southern region of the Dutch breast screeningprogrammeI.L. Schreutelkamp, R.M. Kwee, M. de Booij, M.E.A.P. Adriaensen van Roij;Heerlen/NL15:03B-0966 BI-RADS 3 category, a pain in the neck for theradiologist: which technique detects more cases?J. Etxano, I. Simon-Yarza, G. Viteri, M. Paramo, A. Elizalde, L.J. Pina Insausti;Pamplona/ES15:12B-0967 Adding 3D automated breast ultrasound (ABUS) toservice screening mammography in dense breastsB. Wilczek, K. Hågemo, B. Adalsteisson, M. Janicijevic, K. Thorneman, C. Hinzer,K. Leifland; Stockholm/SE15:21B-0968 Feasibility of automated 3D breast ultrasoundscanning in screening of women with high riskJ.C.M. van Zelst, R.D.M. Mus, T. Tan, N. Karssemeijer, R.M. Mann; Nijmegen/NL14:54B-0975 Perfusion and permeability DCE-MRI measurementsin renal cell carcinoma and metastases: effect ofROI size and positioning on inter- and intraobservervariabilityM. Braunagel, E. Radler, M. Ingrisch, M. Staehler, A. Crispin, K. Nikolaou,M.F. Reiser, M. Notohamiprodjo; Munich/DE15:03B-0976 Can a contrast-enhanced ultrasound nephrostogrambe used instead of a fluoroscopic nephrostogram:preliminary findingsM. Daneshi, K. Patel, D. Huang, M. Sellars, P. Sidhu; London/UK15:12B-0977 Vena cava anomalies associated with horseshoekidney on MDCTT. Ichikawa, J. Koizumi, S. Kawada, Y. Imai; Isehara/JP15:21B-0978 Comparison of dynamic transperineal ultrasoundwith evacuation proctography for the evaluation ofpatients with posterior compartment pelvic disordersM.J. Webb, Y. Ron, S. Zelber-Sagi, E. Tiomni, Z. Halpern, E. Santo; Tel Aviv/IL14:00–15:30 Room G/HGenitourinarySS 1807 Mixed modalities in GU imagingModerators: A.J. Beer; Munich/DE, I. Vivas; Pamplona/ES14:00B-0969 Simultaneous [18F] choline PET/MRI of the prostate:initial resultsA. Wetter, C. Lipponer, F. Nensa, T. Olbricht, H. Rübben, A. Bockisch,T. Lauenstein; Essen/DE14:09B-0970 Advantage of hybrid whole body 3T PET-MRI scannerfor prostate cancer imagingT. de Perrot, O. Rager, M. Pusztaszeri, L. Koehl, A. Figueiral, M.-F. Pelte, C. Iselin,O. Ratib, J.-P. Vallee; Geneva/CH14:18B-0971 Renal cell carcinoma subtype differentiation: CT vsMRIF. Veloso Gomes 1 , A. Matos 2 , J. Palas 2 , V. Herédia 3 , V. Mascarenhas 4 ,M. Ramalho 2 ; 1 Faro/PT, 2 Almada/PT, 3 Évora/PT, 4 Lisboa/PT14:27B-0972 Characterization of complex cystic renal massesaccording to the Bosniak criteria: results after a5-year follow-up with CEUSM. Bertolotto, V. Savoca, W. Toscano, S. Kus, C. Cercato, M.A. Cova; Trieste/IT14:36B-0973 Differentiation between benign Leydig cell andmalignant germ cell testicular tumours withqualitative and quantitative contrast-enhancedultrasound assessmentsD.Y. Huang, R.J. Eckersly, M.E. Sellars, P.S. Sidhu; London/UK14:45B-0974 US and colour-Doppler findings in testicular lymphomaand their mimicsM. Bertolotto 1 , L.E. Derchi 2 , M. Secil 3 , M. Valentino 4 , P. Pavlica 5 , M.A. Cova 1 ;1Trieste/IT, 2 Genova/IT, 3 Izmir/TR, 4 Tolmezzo/IT, 5 Bologna/IT14:00–15:30 Room I/KAbdominal VisceraSS 1801b Liver volume, function and focallesionsModerators: B. Choi; Seoul/KR, C.M. Nyhsen; Sunderland/UK14:00B-0979 ROC curve analysis of diagnostic confidence of CT andMR in focal liver pathologyL. Saba 1 , M. Di Martino 2 , C. Catalano 2 , M. Piga 1 ; 1 Cagliari/IT, 2 Rome/IT14:09B-0980 Diagnostic accuracy of dynamic gadoxetic-acidenhancedMRI and PET-CT in patients with livermetastases from neuroendocrine neoplasmsW.H. Sommer 1 , C. Zech 1 , S. Sourbron 2 , M. Armbruster 1 , M.F. Reiser 1 ; 1 Munich/DE,2Leeds/UK14:18B-0981 The LiMAx test as adjunct to CT for assessing liverfunction after portal vein embolizationA.H. Mahnken 1 , A. Roeth 2 , P.H. Alizai 2 , C. Kuhl 2 , R.M. van Dam 3 , U. Neumann 2 ,M. Schmeding 2 ; 1 Marburg/DE, 2 Aachen/DE, 3 Maastricht/NL14:27B-0982 Future remnant liver function after portal veinocclusion measured with 99mTc-mebrofenin SPECT/CTI. Dudás, T. Györke, C. Korom, P. Pajor, A. Zsirka-Klein, E. Horvath, A. Bozó,P. Kupcsulik, O. Hahn; Budapest/HU14:36B-0983 Comparison of percutaneous portal vein embolization,portal vein ligation and portal vein occlusioncombined with ipsilateral hepatic artery cannulaimplantation prior to major liver resectionP. Pajor, I. Dudás, A. Zsirka Klein, P. Kupcsulik, J. Tamás, O. Hahn; Budapest/HU14:45B-0984 Hepatic parenchymal and vascular contrastimprovement in super-delayed phase images of Gd-EOB-DTPA-enhanced MRIS. Kobayashi, O. Matsui, T. Gabata, W. Koda, T. Minami, K. Kozaka, A. Kitao;Kanazawa/JP266

Scientific Sessions14:54B-0985 Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced MR imagingM. Haimerl, N. Verloh, C. Fellner, C. Nießen, C. Stroszczynski, P. Wiggermann;Regensburg/DE15:03B-0986 Liver dysfunction induced by amiodarone therapy:evaluation by sequential CT studiesY. Sonoyama, T. Tajima, T. Shiga, N. Hagiwara, S. Sakai; Tokyo/JP15:12B-0987 Feasibility of a volumetric measurement of the leftliver lobe with 3D ultrasound compared with MRIE. Danse, O. Lebecque, N. Michoux, R. Reding; Brussels/BE15:21B-0988 An accurate formula for a quick estimate of livervolume in polycystic liver diseaseM. Chrispijn, T.J.G. Gevers, J.P.H. Drenth; Nijmegen/NL14:00–15:30 Room L/MPhysics in RadiologySS 1813 Patient dose management and dosesurveysModerators: H. Bosmans; Leuven/BE, W. Stiller; Heidelberg/DE14:00B-0989 European population dose and differences inradiological procedures between European countriesR. Bly 1 , A. Jahnen 2 , H. Olerud 3 , J. Vassileva 4 , H. Järvinen 1 , S. Vogiatzi 5 ; 1 Helsinki/FI,2Luxembourg/LU, 3 Østerås/NO, 4 Sofia/BG, 5 Athens/GR14:09B-0990 Radiation dose from multidetector CT examinations inadults in Italy: result of the first Italian surveyS. Salerno 1 , C. Granata 2 , D. Matranga 1 , F. Palorini 3 , D. Origgi 3 ; 1 Palermo/IT,2Genoa/IT, 3 Milan/IT14:18B-0991 Patient-specific whole body voxel model for accurateMonte Carlo CT dose estimationN. Saltybaeva, Y. Smal, D. Kolditz, W. Kalender; Erlangen/DE14:27B-0992 A simple algorithm for dose estimation in CT imagingconsidering patient sizeY. Smal, N. Saltybaeva, W. Kalender; Erlangen/DE14:36B-0993 Monte Carlo tool for 3D-dose simulation in computedtomography taking into account tube currentmodulationN. Saltybaeva 1 , D. Kolditz 1 , B. Schmidt 2 , W. Kalender 1 ; 1 Erlangen/DE,2Forchheim/DE14:45B-0994 Evaluation of patient dose reduction after introductionof iterative reconstruction in routine MDCTD. Defez 1 , P. Coulon 2 , P.C. Douek 3 , L. Boussel 4 ; 1 Pierre Benite/FR, 2 Suresnes/FR,3Bron/FR, 4 Lyon/FR14:54B-0995 Adjusting and measuring CT dose in severely obesepatientsR. Marcus, F. Bamberg, K. Neumaier, M.F. Reiser, T.R.C. Johnson; Munich/DE15:03B-0996 The effects of head size/shape, head positioning, andbow-tie filter selection on peak tissue doses frombrain perfusion 256-slice CTK. Perisinakis 1 , I. Seimenis 2 , A. Tzedakis 1 , A.E. Papadakis 1 , J. Damilakis 1 ;1Iraklion/GR, 2 Alexandroupolis/GR15:12B-0997 Detector dose vs image quality in radiography withdigital detectors: a visual grading analysisR. Decoster, H. Mol, D. Smits; Brussels/BE15:21B-0998 Active personal dosimeters to support optimisation ofradiation protection in interventional radiologyR. Padovani, F. Bonutti, A. Trianni, G. Bernardi; Udine/IT14:00–15:30 Room N/OVascularSS 1815Vascular researchModerators: S. Kuribayashi; Tokyo/JP, A. Pellegrin; Trieste/IT14:00B-0999 Hybrid-MRA steady state VIBE imaging – a delayedcloser look at the vessels: evaluation of the additionaldiagnostic benefit in patients who undergo aperipheral magnetic resonance angiographic protocolM. Ong, K. Hausotter, S.O. Schönberg, H.J. Michaely; Mannheim/DE14:09B-1000 Multimodal imaging of atherosclerotic plaquesusing SPIO and quantum dot labelled high densitylipoproteins in ApoE-/- miceC.S.L. Jung, H. Ittrich, M.G. Kaul, T. Ducic, O. Bruns, B. Freund, J. Hereren,G. Adam; Hamburg/DE14:18B-1001 Skin autofluorescence, a non-invasive marker for AGEaccumulation, is elevated in subjects with evidencefor subclinical atherosclerosisM.A.M. den Dekker, M. Zwiers, E.R. van den Heuvel, L.C. de Vos, A.J. Smit,M. Oudkerk, R. Vliegenthart, J.D. Lefrandt, D.J. Mulder; Groningen/NL14:27B-1002 Vascular enhancement and image quality of lowerextremityCT venography using 100 kVp and ultrahighpitch: comparison of conventional lower-extremity CTvenography using 120 kVp and standard pitchK. Choo, J. Park, J. Kim, J. Roh, C. Park; Busan/KR14:36B-1003 CT textural analysis of culprit lesions in transientischaemic attack and/or stroke: correlation withimmunohistochemistryE. Barden 1 , L. Menezes 1 , B. Ganeshan 1 , M. Rodriguez-Justo 1 , R. Endozo 1 ,C.W. Kotze 2 , S.W. Yusuf 2 , A.M. Groves 1 ; 1 London/UK, 2 Brighton/UK14:45B-1004 Non-contrast-enhanced MR angiography combinedwith peripheral cardiac gating at 3T: comparison ofrespiratory triggered and breath held techniqueT. Masui 1 , M. Katayama 1 , K. Sato 1 , K. Terauchi 1 , N. Takei 2 , K. Tsukamoto 1 ,K. Mizuki 1 , M. Miyoshi 2 , H. Sakahara 1 ; 1 Hamamatsu/JP, 2 Hino/JP14:54B-1005 Low kV settings CT-angiography with ultra lowcontrast medium volume for the assessment ofthoracic and abdominal aorta disease: a feasibilitystudyC.R.G.L. Talei Franzesi, D. Ippolito, P.A. Bonaffini, D. Fior, O. Minutolo, S. Sironi;Monza/IT15:03B-1006 X-ray phase-contrast imaging of arterial vesselwall: translation from synchrotron radiation to aconventional lab-based X-ray sourceH. Hetterich 1 , M. Willner 2 , S. Fill 1 , F. Bamberg 1 , J. Herzen 2 , M. Stockmar 2 ,F. Pfeiffer 2 , M.F. Reiser 1 , T. Saam 1 ; 1 Munich/DE, 2 Garching/DEB-0985 – B-1006Monday267

Scientific SessionsB-1007 – B-102815:12B-1007 Single contrast medium dose peripheral MRangiography is feasible without subtraction using twopointDixon fat saturationT. Leiner 1 , J. Habets 1 , B. Versluis 2 , L. Geerts 3 , J. Hendrikse 1 , E.-J. Vonken 1 ,H. Eggers 4 ; 1 Utrecht/NL, 2 Maastricht/NL, 3 Best/NL, 4 Hamburg/DE15:21B-1008 Correlation of cardiovascular risk factors and occultatherosclerotic findings using whole body magneticresonance imaging of the vascular system in anasymptomatic patient collective: initial resultsS. Mangold, E. Randrianarisoa, P. Krumm, C. Bretschneider, A. Seeger, K. Rittig,B. Balletshofer, C.D. Claussen, U. Kramer; Tübingen/DE14:00–15:30 Room PPaediatricSS 1812 Paediatric brainModerators: M.A. Lucic; Sremska Kamenica/RS, M. Stenzel; Jena/DE14:00B-1010 Ultra-low-dose CT of the inner ear with adaptivestatistical image reconstruction in infants candidateto cochlear prosthesis implantation: preliminaryexperienceL. Faggioni, E. Neri, L. Bruschini, V. Seccia, S. Sellari Franceschini, C. Bartolozzi;Pisa/IT14:09B-1011 Traumatic subdural hygromas in children between 0and 2 years: a retrospective CT and MRI studyM.L. Hahnemann 1 , A. Schmeling 2 , M. Schlamann 1 , M. Forsting 1 , H. Pfeiffer 2 ,D. Wittschieber 2 ; 1 Essen/DE, 2 Münster/DE14:18B-1012 Apparent kurtosis coefficient (AKC) in brain: afeasibility study in paediatric populationsI. D‘Errico, A. Ciccarone, M. Esposito, M. Mortilla, C. Fonda; Florence/IT14:27B-1013 Which T1 pulse should be used to study the pretermbrain with a 3 Tesla scanner?D. Tortora, V. Panara, P.A. Mattei, S. Salice, M. Tagliamonte, C. Briganti,A.R. Cotroneo, A. Tartaro, M. Caulo; Chieti/IT14:36B-1014 Paediatric brain tumour classification by quantitativemethods of magnetic resonance imaging: combinationof DTI, PWI and MRSS. Chełstowska, E. Jurkiewicz, I. Pakuła-Kościesza, K. Nowak, K. Malczyk,S. Rączkowska, M. Armata, J. Walecki; Warsaw/PL14:45B-1015 Perfusion parameters of pilocytic astrocytomas:additional oddities of these tumoursM. Martucci, S. Gaudino, E. Gangemi, R. Colantonio, G. Di Lella, C. Colosimo;Rome/IT14:54B-1016 Evaluation of metabolic changes within the normalappearing grey and white matters in children withgrowth hormone deficiency: magnetic resonancespectroscopy and hormonal correlationJ. Bladowska, A. Zimny, A. Zacharzewska, T.M. Gondek, A. Banaszek, T. Żak,A. Noczyńska, M. Sąsiadek; Wroclaw/PL15:03B-1017 Functional correlation of the spastic hemiplegicpatients with MR findingsK. Hayakawa, S. Yoshida, H. Tatekawa, Y. Yamori, T. Kanda, N. Yoshida, H. Hirota,M. Iwami, K. Nakamura; Kyoto/JP15:12B-1018 Diffusion tensor tractography and fractionalanisotropy in paediatric cortical abnormalitiesevaluation with TBSS analysisA. Ciccarone, I. D‘Errico, M. Esposito, M. Mortilla, C. Fonda; Florence/IT14:00–15:30 Room QRadiographersSS 1814 Challenges of different imagingtechniquesModerators: H.H. Hjemly; Olso/NO, J. McNulty; Dublin/IE14:00B-1019 Occupational exposition to electromagnetic fields inMR: understanding the discussion around the directive2004/40/ECC.S.L. Santos, D.P. Rocha, M.M.C.P. Ribeiro; Lisbon/PT14:09B-1020 Radiographers perceptions of magnetic resonanceimaging: a study of the causes that lead to therepetition of examsT.R. Filipe 1 , L.P.V. Ribeiro 1 , R.P.P. Almeida 1 , S.I. Rodrigues 1 , K.B. Azevedo 1 ,C.A. Silva 2 , A.F.L. Abrantes 1 ; 1 Faro/PT, 2 Évora/PT14:18B-1021 Functional mapping of the visual word form area withfrequent words of the Portuguese lexicon: an fMRIstudyC. Ferreira 1 , P. Martins 2 , G. Cunha 1 , N. Canário 1 , C. Nunes 1 , A.C. Miranda 2 ,J. Ribeiro 2 , S. Afonso 2 , M. Castelo-Branco 1 ; 1 Coimbra/PT, 2 Aveiro/PT14:27B-1022 A survey of the various methods and techniquesemployed in myocardial stress testingK. Borg Grima 1 , L. Rainford 2 , P. Bezzina 1 , D. O‘Leary 2 ; 1 Msida/MT, 2 Dublin/IE14:36B-1023 Importance of scout imaging in neuroradiologicstudiesD.C. Martin, S.H. Erbay, M. Hakky, K.D. Erbay, N. Erbay, D. Marrero;Burlington, MA/US14:45B-1024 Comparison of a 12-channel- with a 32-channel headcoil using SNR measurementsC. Vandulek, D. Kaczur, E. Vinczen, I. Repa; Kaposvár/HU14:54B-1025 Psychological effect of chronic exposure to highmagnetic field on MRI technologistsN.M. Mishah, W. Hamed; Jeddah/SA15:03B-1026 Development and implementation of a syntheticdata evaluation scenario for image fusion algorithmsbased on discrete wavelet transform and principalcomponent analysisV. Weiss; Wiener Neustadt/AT15:12B-1027 Image registration and fusion of CT and micro-CT of asheep‘s cochleaS. Leitner; Berndorf/AT15:21B-1028 Evaluation of image quality optimisation using VGCand ordinal regression analysisF. Zarb 1 , M.F. McEntee 2 , S. Foley 3 , L. Rainford 3 ; 1 Msida/MT, 2 Sydney/AU,3Dublin/IE268

Scientific Sessions14:00–15:30 Room ZContrast MediaSS 1806 Functional studies and safetyModerators: T. Gleeson; Wexford/UK, E.M. Merkle; Basle/CH14:00B-1029 Measuring hepatic functional reserve using lowtemporal resolution Gd-EOB-DTPA dynamic contrastenhancedMRI: a comparison study with galactosylhumanserum albumin scintigraphy and indocyaninegreen retentionK. Saito 1 , J.R. Ledsam 2 , S.P. Sourbron 2 , T. Hashimoto 1 , Y. Araki 1 , S. Akata 1 ,K. Tokuuye 1 ; 1 Tokyo/JP, 2 Leeds/UK14:09B-1030 Dynamic enhancement pattern of Gd-EOB-DTPAcompared to gadobutrol in patients with HCCS. Kinner, C. Kloeters, L. Umutlu, N. Sippel, T.C. Lauenstein; Essen/DE14:18B-1031 Gadoxetic acid-enhanced hepatobiliary phase MRI andhigh b-value diffusion-weighted imaging (DWI) in thedifferential diagnosis between benign to malignantliver lesionsP. Arcuri, G. Fodero, S. Roccia, S. Molica, V. Arcuri; Catanzaro/IT14:27B-1032 Gadoxetic acid-enhanced MRI of the liver: correlationbetween Gadoxetic acid uptake and serum hepaticenzymes levelsE. Talakic, H. Schoellnast, T. Wimmer, J. Steiner, F. Quehenberger, U. Reiter;Graz/AT14:36B-1033 MRCP using hepatospecific contrast media (GD-EOB-DTPA) in biliary leaksR. Faletti, M. Fronda, F. Barisone, C. Bogetti, A. Dominguez, A. Rapellino,L. Marchisio, P. Fonio, G. Gandini; Turin/IT14:45B-1034 N-acetylcysteine for the prevention of contrastinducednephropathy in ratsM.F. İnci 1 , I. Şalk 2 , O. Solak 2 , Ü. Vurdem 3 , R. İnci 1 ; 1 Kahramanmaraş/TR,2Sivas/TR, 3 Kayseri/TRB-1029 – B-103814:54B-1035 Evaluation of enhancement properties of gadoliniumlabellednanoparticles for contrast-enhanced MRI inrats with experimental liver tumours at 9.4 TP. Fries 1 , D. Morr 1 , A. Müller 1 , F. Lux 2 , O. Tillement 2 , J. Palm 1 , G. Schneider 1 ,R. Seidel 1 , A. Buecker 1 ; 1 Homburg/DE, 2 Lyon/FR15:03B-1036 Regorafenib monotherapy effects on experimentalhuman colon carcinoma xenografts monitored by DCE-CT with immunohistochemical validationP.M. Kazmierczak, H. Hirner, L. Havla, M. Schneider, O. Dietrich, C. Bruns,M.F. Reiser, K. Nikolaou, C.C. Cyran; Munich/DE15:12B-1037 Contrast-induced nephropathy in patients undergoingintravenous contrast-enhanced computed tomographyand the relationship with risk factors: a meta-analysisS.I. Moos, J. Stoker, S. Bipat; Amsterdam/NL15:21B-1038 Renal MR angiography at 7 Tesla: how muchgadolinium do we need?L. Umutlu, A. Fischer, M. Forsting, M.E. Ladd, S. Maderwald, O. Kraff,T.C. Lauenstein; Essen/DEMonday269

List ofAuthors &Co-Authors

List of Authors and Co-AuthorsAA. Rahman F.: B-0015Aakil A.: B-0954Abdel Razek N.M.: B-0957Abdel Razek N.M.A.: B-0452Abdel Rehim M.: A-021AbdelShafi N.: B-0949Abdullah B.J.J.: B-0422Abe T.: B-0760Abild A.-M.: B-0356, B-0357Abolfat-h-Zadeh Ghale Joughi N.: B-0857Abolmaali N.: B-0101Abramyuk A.: B-0101Abrantes A.F.C.L.: B-0136, B-0138, B-0274, B-0386,B-0602, B-0603, B-0607, B-0871, B-0875, B-0876Abrantes A.F.L.: B-1020Abreu V.: B-0508Abrigo J.M.: B-0441Acharia U.R.: B-0617Achenbach S.: B-0665Acosta Ruiz V.: B-0177Adalsteisson B.: B-0967Adam A.: A-104Adam G.: B-0367, B-0765, B-0859, B-0879, B-0882,B-0888, B-0935, B-1000Adam E.J.: A-280Adams A.: B-0218, B-0734Adiotomre E.: B-0599Adriaensen van Roij M.E.A.P.: B-0965Afaq A.: B-0549Afonso S.: B-1021Afshan I.: B-0013Agarwal S.: A-536Aghenitei I.: B-0141, B-0807Ağıldere M.: B-0155Agostini G.: B-0440, B-0712, B-0769Agresti R.: B-0561Aguirregoicoa I.: B-0724Ahari H.: B-0037Aharoni D.: B-0612Åhlström Riklund K.: A-398, A-401Ahmad M.E.: B-0756Ahn H.S.: B-0210Ahn M.-J.: B-0024, B-0025Ahonen S.-M.: B-0135Äikiä M.: B-0011Airaldi S.: B-0688Aissa J.: B-0252, B-0366, B-0522, B-0749, B-0905Akahane M.: B-0255Akata S.: B-1029Akbar M.: B-0044Akhavan F.: B-0857Akin O.: B-0697Akiyama Y.: B-0305Akkerman E.A.: B-0550Albarello L.: B-0801Alberich-Bayarri A.: B-0403Albers P.: B-0081Albert T.S.E.: B-0255Albino V.: B-0233Albisinni U.: B-0316, B-0642Alboni C.: B-0349Albrecht T.: B-0232Al-Butmeh F.: B-0290, B-0633, B-0700Alconchel A.: B-0082Alcorn D.: SK 27Aldave G.: B-0514Ale A.: B-0880Alenius G.-M.: B-0653Alessi S.: B-0082Alexandre A.: B-0902Alfayate Sáez E.: A-285Algeri E.: B-0376Alghamdi F.: B-0105Aliprandi A.: B-0741Alis H.: B-0838Alizai H.: B-0934Alizai P.H.: B-0981Alkadhi H.: A-037, A-218, A-539, B-0063, B-0242,B-0482, B-0660, B-0788, B-0910, SY 10Al-Kalbani J.: B-0549Aleksandrova-Moiseja M.: Rising StarsAllen S.D.: A-542Allmendinger T.: B-0372Almeida P.: SK 27Almeida R.P.P.: B-0136, B-0138, B-0274, B-0386,B-0602, B-0603, B-0607, B-0871, B-0875, B-0876,B-1020Almqvist T.: B-0149Alnabhani K.: B-0549Altobelli S.: B-0085Aly M.A.: B-0949Amalou H.: B-0173Amanakis E.: B-0223, B-0228Ambrosetti M.C.: B-0706Ambrosini V.: B-0555Ambrožič A.: B-0652Amirifeli S.: B-0037Amoretti M.-E.: B-0307, B-0308Amoretti N.: B-0307, B-0308Amucano G.: B-0958An H.S.: B-0269Andersen F.: B-0102, B-0103Andersen J.G.: B-0139, B-0388, B-0870Anderson E.M.: B-0062, B-0070, B-0423, B-0624,SK 27Andersson I.: A-507Andersson T.: B-0825Andikyan V.: B-0390Ando T.: B-0338, B-0339Andrassy J.: B-0341Andreini D.: B-0262Andreisek G.: B-0482Andreone A.: B-0316, B-0640Andronikou S.: B-0860, B-0862Angelelli G.: B-0283Anik Y.: B-0908Anikin V.: B-0030Annet L.: A-196Annoni A.: B-0262Antoch G.: A-383, A-458, B-0028, B-0081, B-0159,B-0252, B-0320, B-0340, B-0366, B-0486, B-0487,B-0501, B-0506, B-0522, B-0552, B-0553, B-0648,B-0651, B-0703, B-0749, B-0905Antonicoli M.: B-0085Antoniutti M.: B-0131, B-0382Anzidei M.: B-0174, B-0617, B-0643, B-0644Aoyama N.: B-0346Apfaltrer P.: B-0022, B-0160, B-0265, B-0289,B-0352, B-0419, B-0848, B-0889Apostolova I.: B-0879Araki T.: B-0093Araki Y.: B-1029Archer V.: B-0799Arcuri P.P.: B-1031Arcuri V.: B-1031Ardies P.: SY 21Ardley N.: B-0701Argentos S.I.: B-0530Argyropoulou M.I.: A-119, A-252, B-0406, B-0860,B-0862Arık B.: B-0587Armata M.: B-1014Armbruster M.: B-0638, B-0980Arnaiz J.: B-0251Aronson B.A.: B-0529Arrebola J.P.: B-0099Arredondo J.: B-0945Arrieta I.: B-0724Arrigoni F.: B-0493Arru M.: B-0313Arsalan Raza S.: B-0699Arsov C.: B-0081Artigas J.M.: B-0122Artigas Martín J.M.: B-0124Asbach P.: B-0324Ascanio S.: B-0555Aschauer M.: B-0251Aschieri D.: B-0267Ascioti C.: B-0467Asenbaum U.: B-0328, B-0719Ashoori N.: B-0578Ashrafpoor G.: B-0007Asp P.: B-0149Astengo D.: B-0688Astrakas L.: B-0860, B-0862Astrinakis E.: B-0115Athanasiou A.: A-028Athelogou M.: B-0282Attenberger U.: B-0829Attenberger U.I.: B-0628Attili A.F.: B-0238Attye A.: B-0355, B-0751Aube C.: B-0797Aubry S.: B-0312Auger C.: B-0222Auriol J.: A-244Autret G.: B-0911Auweter S.: B-0846Avila R.: B-0799Avni F.E.: A-484Awadalla H.: B-0123Ayestaran P.: B-0370Ayles H.: B-0761Ayuso C.: A-111, A-360, A-564, B-0704Azarine A.A.: B-0007Azavedo E.: A-446Azevedo K.B.: B-0138, B-0274, B-0602, B-0603,B-0871, B-0875, B-1020Aznar M.: B-0103Azzabi Zouraq F.: B-0318BBabikir S.: B-0205Bacigalupo L.: B-0197, B-0948Backes W.H.: B-0012, B-0116, B-0118, B-0120,B-0622Badea R.: B-0096Baggen V.J.M.: B-0005Baglio I.: B-0454Bagnenko S.: B-0833272

List of Authors and Co-AuthorsBagotskaya N.: B‐0206Bai Y.: B‐0517Baier U.: B‐0001Bailly P.: A‐268Bainbridge A.: B‐0097Baiocchi G.: B‐0791, B‐0794Bakker C.M.M.: B‐0627Balageas P.: B‐0176Balassy C.: B‐0096Baldassari P.: B‐0796Baldisserotto M.B.: B‐0590Bale R.: SK 27Balestri R.: B‐0623Bálint Z.: B‐0639Ballerini G.: B‐0262Balletshofer B.: B‐1008Balleyguier C.S.: A‐027, A‐296Baloch E.: B‐0068Baltzer P.A.T.: A‐029, B‐0074, B‐0075, B‐0076,B‐0077, B‐0079, B‐0457, B‐0679, B‐0808, B‐0895,B‐0953Balvay D.: B‐0911Balzano G.: B‐0769Bamberg F.: B‐0112, B‐0113, B‐0161, B‐0411,B‐0582, B‐0634, B‐0849, B‐0995, B‐1006Banaszek A.: B‐1016Banchik E.: B‐0695Banckwitz R.: B‐0290Bandello F.: B‐0712Bandirali M.: B‐0741Banihashemi H.: B‐0477Bannas P.: B‐0367, B‐0882Barantin L.: B‐0105Baratella E.: B‐0762Baratto F.: B‐0585Barbazeni G.: B‐0454Barbiani C.: B‐0416, B‐0662Barbier-Brion B.: B‐0312Barbieri A.: B‐0462, B‐0463Barbosa F.: B‐0925Barchetti F.: B‐0089, B‐0090Barcikowska M.: B‐0400Barden E.: B‐1003Bardo G.: B‐0082Barentsz J.O.: A‐136, A‐427, B‐0083Bargalló N.: A‐511Bargellini I.: A‐567, B‐0035, B‐0922Bargy S.: B‐0861Barile A.: B‐0183Barillari M.: B‐0710Barisone F.: B‐1033Barkhausen J.: B‐0584Barkhof F.: A‐165, A‐421, A‐614Barnes A.: B‐0549Baron J.: B‐0303Baron R.L.: A‐135Barrau V.: A‐021Barrick T.R.: B‐0359Barrington S.F.: A‐301Barthel H.: B‐0558Bartoli J.M.: B‐0460, B‐0461Bartolo V.: B‐0745, B‐0787, B‐0832Bartolozzi C.: A‐563, B‐0035, B‐0577, B‐0623,B‐0698, B‐0922, B‐1010Barton B.: B‐0299Basilico R.: B‐0127Ba-Ssalamah A.: B‐0096Bastarrika G.: A‐184, A‐201, B‐0143, B‐0668Bastati-Huber N.: B‐0096Bastawrous S.: B‐0145Båth M.: A‐236Batouty N.M.: B‐0150Battista G.: B‐0316, B‐0555, B‐0598Bauer J.S.: B‐0180, B‐0435, B‐0548, B‐0937Bauer P.: A‐343Bauer R.W.: B‐0266, B‐0633, B‐0669, B‐0723Bauerfeind P.: A‐147Bäuerle T.: B‐0434Baum R.: B‐0282Baum T.: B‐0180, B‐0548, B‐0937Bauman G.: B‐0766Baumann A.B.: B‐0754, B‐0755Baumann T.: B‐0551Baumeister S.: B‐0445Baumgartner C.: B‐0916Bauner K.: B‐0582Bauner K.U.: B‐0913Baur-Melnyk A.: B‐0547Baxa J.: B‐0358Bayramoglu S.: B‐0838Bazeli R.: B‐0650Bazot M.: A‐553Bazzocchi A.: B‐0316, B‐0555, B‐0598, B‐0640,B‐0642Bazzocchi M.: B‐0132, B‐0567, B‐0568, B‐0684,B‐0687, B‐0811, B‐0834, B‐0835Beaussart P.: B‐0459Becce F.: B‐0542, B‐0544Bech M.: B‐0846Bechstein W.O.: B‐0034, B‐0040Beck K.S.: B‐0637Becker A.: B‐0582Becker C.D.: A‐529, B‐0121Becker H.-C.:Becker M.: A‐274, A‐570Beck-Popovic M.: B‐0670Becquemin J.-P.: B‐0924Beek F.J.: B‐0550Beer A.J.: B‐0322Beer M.J.: B‐0001Beeres M.: B‐0031, B‐0700, B‐0723Beeson J.: B‐0030Beets G.L.: B‐0621, B‐0622, B‐0625, B‐0940Beets-Tan R.G.H.: A‐007, A‐141, A‐175, A‐437,B‐0212, B‐0450, B‐0451, B‐0621, B‐0622, B‐0625,B‐0940Behrendt F.F.: B‐0746Behzadi S.: B‐0220Beiderwellen K.: B‐0501Beiderwellen K.J.: B‐0500Beigelman C.: A‐333Bekiesinska-Figatowska M.: B‐0671Belcari N.: A‐459Belfiore M.P.: B‐0057, B‐0059Belghiti J.: A‐019Belkacemi Y.: B‐0459Bellemann N.: B‐0178Belli A.-M.: A‐388, B‐0498Bellin M.-F.: A‐176Bellini D.: B‐0792, B‐0793Bellomi M.: B‐0082Belloni E.: B‐0267Bellotti M.: B‐0397Belyakov N.: B‐0229Bemi P.: B‐0623Ben Lakhdar Z.: A‐021Ben Salah Y.: B‐0542, B‐0544Bendaoud S.: B‐0630Bendek M.: B‐0029Bender D.: B‐0188Beningfield S.: A‐262Benito A.: A‐076, B‐0778Benjamin P.: B‐0359Beomonte Zobel B.: B‐0020, B‐0049, B‐0179, B‐0342,B‐0407, B‐0468, B‐0469, B‐0579, B‐0939Berdel W.E.: B‐0805Berendsen R.C.M.: B‐0627Berg W.A.: A‐154Bergemann C.: B‐0886Berger R.: B‐0612Beringer P.: B‐0483, B‐0484Berkouk K.: A-291, EIBIRBerkovitz N.: B‐0227Bernardi B.: A‐532Bernardi D.: B‐0818, SY 17Bernardi G.: B‐0998Bernardo S.: B‐0394, B‐0396, B‐0863, B‐0868Bernhardt D.: B‐0263, B‐0411Bernhardt P.: B‐0412, B‐0583Bernsen M.R.: B‐0887Berritto D.: B‐0057, B‐0058, B‐0059Berta L.: B‐0246, B‐0705Bertaccini L.: B‐0174, B‐0399, B‐0427, B‐0490,B‐0643, B‐0644Bertani V.: B‐0567, B‐0568Bertella E.: B‐0262Berthezène Y.: B‐0890Bertolotto M.: A‐426, B‐0972, B‐0974Bertram H.H.: B‐0448Bertrand P.: B‐0105Bertugno S.: B‐0462, B‐0463Besostri V.: B‐0438, B‐0439, B‐0787, B‐0827Besseling R.: B‐0012Besutti G.: B‐0231, B‐0237Bettelli G.: B‐0642Betti M.: B‐0325Beuf O.: B‐0443, B‐0444Bex M.: B‐0152Beyer T.: A‐457, B‐0102, B‐0103Bezzi M.: A‐340, B‐0775Bezzina P.: B‐0604, B‐1022Bhagat N.: B‐0036Bhargava P.: B‐0095, B‐0145Bhasin D.: B‐0573Bhat V.: B‐0431Bhatt S.: B‐0041Bhattacharya R.: B‐0095Biagini C.: B‐0325Bianchin A.L.: B‐0454Bibi R.: B‐0105Bick U.: A‐063Bickel H.: B‐0071, B‐0076, B‐0213, B‐0562, B‐0563,B‐0952Bickelhaupt S.: B‐0198, B‐0242, B‐0616, B‐0788Bidault F.: A‐433Bidault S.: A‐433Biederer J.: A‐082, A‐380, B‐0162Bielicki I.: B‐0881Bierca J.: B‐0717Bierings M.B.: B‐0550Bierma - Zeinstra S.: B‐0485273

List of Authors and Co-AuthorsBiffar A.: B-0547Bilbao J.I.: A-077, A-233, B-0778Bilhim T.: B-0175Bilk P.: B-0340Bill U.: B-0616Binaghi S.: B-0670Bingotti B.: B-0688Binnig G.: B-0282Bipat S.: B-1037Birngruber E.: B-0147Biscaldi E.: B-0948Bisdas S.: A-462Bisdorff-Bresson A.: A-624Bisogno R.: B-0785Bittersohl B.: B-0486, B-0487Bize P.: A-189, A-431Björkman B.: B-0380Björkman-Burtscher I.: B-0169Björkman-Burtscher I.M.: B-0892Bladowska J.: B-0401, B-0847, B-1016Blanke P.: B-0263, B-0411Bley T.: B-0354Blobel J.: B-0374Bloess K.: B-0188Blomqvist L.C.O.: A-551, B-0149Blondiaux E.: B-0738, B-0867, B-0911Blondin D.: B-0081, B-0252, B-0340, B-0648Blösser S.: B-0039Bly R.: B-0989Boardman P.: B-0423Boatta E.: B-0300, B-0775Bockeria L.: B-0916Bockisch A.: B-0500, B-0969Boczar M.: B-0671Bodelle B.: B-0031, B-0170, B-0290, B-0700, B-0723Boehm A.: B-0158Boehm C.: B-0768Boellaard T.N.: B-0790Boelle P.-Y.: B-0738Boellis A.: B-0518, B-0675Boersma E.: B-0410, B-0415Bogaert J.: A-092, A-370Bogdanovic D.: B-0812Bogetti C.: B-1033Boggi U.: B-0577Bogner W.: B-0071, B-0076, B-0562, B-0953Bohlsen D.: B-0234Böhme S.: B-0523Bojanowski K.: B-0303Bojarovska J.: Rising StarsBoland G.: A-270Boll D.T.: B-0728Bolle N.: SY 12Bomer J.: B-0597Bonaffini P.: B-0254Bonaffini P.A.: B-0064, B-0235, B-0236, B-0391,B-0438, B-0439, B-0505, B-0596, B-0745, B-0783,B-0787, B-0827, B-0832, B-1005Bonanno E.: SK 27Bongartz G.M.: A-595Boni F.: B-0174, B-0399, B-0414, B-0427, B-0490,B-0643, B-0644, B-0645Bonomo L.: A-381, A-449, B-0021, B-0323, B-0395Bonsanto M.: B-0896Bonutti F.: B-0998Boone D.: B-0789Boraschi P.: B-0577Borg Grima K.: B-1022Borger M.: B-0260Borges A.: A-001, A-310Borggrefe J.: B-0436Borghesi A.: B-0716Borlak J.: B-0768Borobia A.: B-0124Borralho L.: B-0876Borreggine C.: B-0904Borrego Gómez J.: B-0690Bos D.: B-0114, B-0350Bos K.: B-0485Bosc R.: B-0459Bosmans H.: B-0842Bosmans J.M.L.: A-272Boss A.: B-0198, B-0318, B-0910Botelho M.P.F.: B-0363, B-0524, B-0615, B-0722Botnar R.M.: B-0881Botturi E.: B-0478Boubagra K.: B-0355Bouchareb Y.: B-0104Boulay-Coletta I.: A-494, B-0837Boumanji J.: B-0549Bouquet H.: B-0198, B-0616Bourdet C.: B-0786Bourguignon M.: B-0559Boursi B.: B-0612Boussel L.: B-0994Bouvier J.: B-0355Boyko O.B.: B-0893Bozkurt S.: B-0055Bozó A.: B-0982Bozovic G.: B-0169Bozzao A.: B-0518, B-0675Bozzi E.: B-0035Brachetti G.: B-0427, B-0643, B-0644, B-0645Brader P.: A-095, B-0171, B-0213, B-0502Brady M.: B-0624Brahmstaedt R.: B-0426Brambilla G.: B-0771Brandmaier P.: B-0558Braren R.: B-0880Brassart N.: B-0053Bratanova V.: B-0244Braunagel M.: B-0344, B-0975Brechtel K.: B-0923Breen D.J.: A-491, SK 27Breikss M.: Rising StarsBrekenfeld C.: B-0354Brekkan E.: B-0177Bremer C.: B-0805Bremerich J.: A-324, A-574Bremer-Streck S.: B-0886Brendle C.: B-0504Brenner W.: B-0879Bretschneider C.: B-0003, B-1008Bricault I.: B-0429Briganti C.: B-0509, B-1013Brkljacic B.: SK 27Brillet P.-Y.: A-616Bristogiannis C.: B-0904Britton P.D.: A-374Broadley P.: B-0599Brocchi S.: B-0555Broeders M.: B-0962Broeders M.J.M.: B-0841, B-0959, B-0960, B-0961,B-0964Broessner G.: B-0907Brookes J.: B-0130Brookfield H.: B-0608Brouwer P.A.: SY 19Brouwers B.M.W.: B-0317Brown D.: B-0060Bruce M.F.: B-0095Brück B.: B-0076, B-0952Bruners P.: B-0589Brunner P.: B-0307, B-0308Bruno O.: A-109Bruns C.: B-1036Bruns O.: B-1000Bruschini L.: B-1010Buccianti P.: B-0623Bucciarelli-Ducci C.: B-0856Bucerius J.A.: B-0120Buchan K.: B-0701Buchbender C.: B-0028, B-0159, B-0320, B-0500,B-0501, B-0506, B-0552, B-0553, B-0651Buchholz M.: B-0117Buck F.: B-0187Buck F.M.: B-0181, B-0314Budde R.P.J.: B-0008, B-0721Buecker A.: B-1035Buerke B.: B-0190Buhk J.: B-0367Bühler K.: B-0618Bülow R.: B-0348Buls N.: B-0248, B-0580Bulski T.: B-0400Bunck A.: B-0806Bunke J.: B-0100Burck I.: B-0709Burger I.A.: B-0390Burgkart R.: B-0548Burke A.: B-0023Burkholder I.: B-0188, B-0481Burner A.: B-0281Burrel M.: A-116, B-0251Büsing K.A.: B-0865, B-0866Busoni S.: B-0086, B-0087Busse H.: B-0448Butler M.-L.: B-0606Buy X.: B-0309, SK 27CCabassa P.: B-0424Cabibbo B.: B-0944Cabrera T.: B-0619Cacchiarelli E.: B-0941Cáceres J.: A-254Cademartiri F.: A-249Cadonici A.: B-0620Cadonici A.C.: B-0064, B-0254, B-0391Cai W.: B-0069Calabrese M.: B-0688Calabria L.F.: B-0518, B-0675Calamita V.: B-0127Calandriello L.: B-0021Calvisi V.: B-0930Camera L.: B-0454Campana R.: B-0786Campari A.: B-0770Camps Herrero J.: A-447, A-543Canale S.: A-027Canário N.: B-1021274

List of Authors and Co-AuthorsCândido S.: B‐0603Canestrini S.: B‐0572, B‐0574Canevari C.: B‐0801Cannaò P.: B‐0741Cannavale A.: B‐0300, B‐0775, B‐0920Cannavale G.: B‐0466Canniff E.M.: B‐0119Cano D.: B‐0945Canosa C.: B‐0002Cantone C.: B‐0693Canu T.: B‐0239, B‐0449, B‐0850Capalbo E.: B‐0128, B‐0956Capitolina L.: B‐0140Caporilli Razza F.: B‐0693Cappabianca S.: B‐0057, B‐0059Cappio S.: B‐0769Cappucci M.: B‐0691Capraro C.: B‐0236, B‐0391, B‐0505, B‐0620, B‐0827Capuani S.: B‐0085Capuano E.: B‐0413Capunay C.: B‐0257Caramella C.: A‐433Caramella D.: A‐575Carballido-Gamio J.: B‐0043Carbonaro L.A.: B‐0687, B‐0814, B‐0815Carbone I.: B‐0464Carbone S.F.: B‐0392, B‐0941, B‐0947Cardobi N.: B‐0710Carette M.-F.: B‐0538Carfagno T.: B‐0947Cariati M.: B‐0128Carner M.: B‐0710Carrafiello G.: B‐0531Carrascosa P.: B‐0257Carreras M.S.: B‐0724Carriço C.: B‐0275Carroll P.A.: B‐0216Cartes-Zumelzu F.W.: B‐0907Cartocci G.: B‐0174, B‐0414, B‐0427, B‐0643, B‐0644,B‐0645Caruso D.: B‐0193, B‐0661, B‐0792, B‐0793Carvalho A.: B‐0278Casali V.: B‐0453Casazza I.: B‐0696Caseiro-Alves F.: A‐070, A‐122Casiraghi A.: B‐0439Casiraghi A.S.: B‐0783Casolo G.: B‐0465Cassar-Pullicino V.N.: A‐149, A‐275, A‐585Casselman J.W.: A‐620Castañer E.: A‐476Castelo-Branco M.: B‐1021Castiello E.: B‐0642Castrignanò A.: B‐0453Castrillo A.: B‐0724Castro C.J.G.: B‐0212Casuscelli J.: B‐0066Catala V.: B‐0255Catalano C.: A‐127, A‐185, A‐550, B‐0089, B‐0090,B‐0174, B‐0238, B‐0399, B‐0414, B‐0427, B‐0453,B‐0464, B‐0466, B‐0490, B‐0643, B‐0644, B‐0645,B‐0836, B‐0979Catalano O.: B‐0233Cataldo M.: B‐0246Catena V.: B‐0691Cattin R.: B‐0198, B‐0616Caulo M.: B‐0509, B‐0930, B‐1013Caumo F.: B‐0818Cava M.: B‐0850Cavaciocchi M.: B‐0642Cavagnetto F.: B‐0688Cavallo Marincola B.: B‐0399, B‐0490, B‐0643Cazals X.: B‐0105Cazzato R.L.: B‐0049, B‐0179, B‐0342, B‐0939Ceelen F.: B‐0803Cercato C.: B‐0972Cerci R.J.: B‐0006Cereser L.: B‐0834, B‐0835Cerini R.: B‐0710Cervelli R.: B‐0922Çetiner S.: B‐0155Cevasco L.: B‐0948Ceyssens S.: B‐0432Chabrol A.: B‐0890Chaibi Y.: B‐0512Chakraborty S.: B‐0756Chalian H.: B‐0363, B‐0615, B‐0722Chamming’s F.: B‐0335Chamuleau S.A.J.: B‐0008Chan A.W.-H.: B‐0441Chan H.L.-Y.: B‐0441Chan H.-P.: A‐508Chan O.: B‐0184, B‐0311Chandelier F.: B‐0619Chandraharan E.: B‐0498Chao M.: B‐0036Charisiadi A.: B‐0860Chateil J.-F.: A‐525Chełstowska S.: B‐1014Chen H.-W.: B‐0126Chen M.: B‐0259Chen S.: B‐0571, B‐0575Chen W.: B‐0707Chen X.: B‐0270, B‐0883Chen Y.: B‐0375Chersevani R.: B‐0686Cheung Y.-C.: B‐0931Chi D.: B‐0390Chiaramida S.A.: B‐0417Chiesa A.M.: B‐0763Chin W.L.: B‐0377Chiodi E.: B‐0855Chipon E.: B‐0429Chiti A.: B‐0503, B‐0507Chiti S.: B‐0086, B‐0087, B‐0511Chiu C.-H.: B‐0931Chiu S.H.: B‐0649Cho H.R.: B‐0739Cho H.Y.: B‐0649Cho K.R.: B‐0073Choe Y.H.: B‐0418Choi B.I.: B‐0202, B‐0230, B‐0830Choi B.W.: B‐0418Choi C.G.: B‐0067Choi H.J.: B‐0494Choi J.-A.: B‐0046, B‐0784Choi J.H.: B‐0521Choi J.W.: B‐0269, B‐0446, B‐0831Choi S.H.: B‐0513, B‐0516, B‐0739, B‐0831Choi S.I.: B‐0418Choi Y.A.: B‐0826Chondrogiorgi M.: B‐0406Choo K.S.: B‐0364, B‐1002Chou P.: B‐0702Chouhan M.: B‐0097Chow H.L.: B‐0649Chowdhury F.: B‐0554Choy T.W.: B‐0294Choyke P.L.: A‐014, A‐440Chrispijn M.: B‐0988Christensen A.: B‐0010, B‐0351, B‐0356, B‐0357,B‐0750Christensen H.: B‐0010, B‐0351, B‐0356, B‐0357,B‐0750Christensen L.: B‐0010Chu C.: B‐0474Chu S.: B‐0893Chu W.C.-W.: B‐0441Chuck N.C.: B‐0318Chung A.W.: B‐0359Chung D.Y.F.: B‐0423Churchill M.: B‐0595Cianciulli P.: B‐0468, B‐0469, B‐0579Ciatto (posthumous) S.: B‐0818Ciccarese F.: B‐0598, B‐0763Ciccarone A.: B‐1012, B‐1018Cicciò C.: B‐0397Cicorelli A.: B‐0035, B‐0922Ciet P.: B‐0737Çifçi E.B.: B‐0901Cimmino M.: B‐0654Ciobanu L.: B‐0201Cioffi Squitieri N.: B‐0058, B‐0194Ciolina F.: B‐0174, B‐0399, B‐0490, B‐0644Ciolina M.: B‐0626, B‐0796Cioni R.: B‐0035, B‐0922Cionini L.: B‐0325Cirelli C.: B‐0300, B‐0775, B‐0920Citone M.: B‐0921Civitareale N.: B‐0127Clarijs R.: B‐0627Claßen T.: B‐0782Claudon M.: A‐108, A‐485, A‐583Claus F.: A‐353Clauser P.: B‐0132, B‐0567, B‐0568, B‐0684, B‐0811Claussen C.D.: B‐0003, B‐0004, B‐0447, B‐0504,B‐0923, B‐1008Clavien P.-A.: A‐144Clement A.: B‐0738Clément O.: A‐454, B‐0335, B‐0911Clement R.G.E.: B‐0780Clevert D.-A.: B‐0491, SY 23Clingman B.: B‐0955Co S.J.: B‐0632Çoban G.: B‐0901Cobbold R.S.: B‐0292Coche E.E.J.G.: MSY 1Cockmartin L.: B‐0842Cohen-Bacrie C.: B‐0094Colantoni C.: B‐0585, B‐0712Colantonio R.: B‐1015Colas L.: B‐0729, B‐0731Colin C.: B‐0559Colletti L.: B‐0710Colletti V.: B‐0710Collier Q.: B‐0285, B‐0286Collin D.: B‐0781Colombo M.: B‐0235, B‐0832Colombo P.: B‐0492Colosimo C.: B‐1015Colucci A.: B‐0712Como G.: B‐0834, B‐0835Concari G.: B‐0532Conchiglia A.: B‐0183275

List of Authors and Co-AuthorsConlon K.: A-144, A-148Conneely M.J.: B-0823Connolly E.M.: B-0216Cook V.: B-0595Cooper R.: B-0554Cópio R.B.J.: B-0875Coppenrath E.M.: B-0578Coppola V.: B-0518, B-0675Cornalba G.: B-0771, B-0925Cornalba G.P.: B-0770Cornelis F.: B-0176, B-0421Coro’ L.: B-0902Coroiu R.: Rising StarsCorona M.: B-0300, B-0775Corr A.: B-0564Corral J.F.: B-0222Correas J.-M.: B-0084, B-0110, SK 26Corso R.: B-0235, B-0236Cortines P.: B-0257Cortinovis S.: B-0262Corvol H.: B-0738Cosentino M.: B-0128Cossu E.: SK 27Costa S.: B-0874Costa Y.: B-0726Costantini E.: B-0183Costas M.: B-0185Costello P.: B-0266, B-0849Cotroneo A.: B-0509Cotroneo A.R.: B-0002, B-0127, B-0930, B-1013Cotten A.: A-314Cottier J.-P.: B-0105Cotton M.: A-262Coulon P.: B-0994Courcoutsakis N.: B-0115Couvelard A.: B-0576Cova L.: B-0646Cova M.A.: B-0762, B-0944, B-0972, B-0974Çöven I.: B-0901Cowan N.C.: A-305, A-379, B-0820Coy D.L.: B-0145Cras P.: A-306Creytens D.H.: B-0432Crienen S.: B-0083Crisp T.: B-0311Crispin A.: B-0975Cristeas N.: B-0919Crocetti L.: SK 27Croisille P.: A-371Cros J.: B-0576Crosara S.: B-0572, B-0574Crush L.: B-0119Crystal P.: B-0219Csatari Z.: B-0361Cuccia A.: B-0438Cuenod C.-A.: B-0335, B-0911Cuevas C.: B-0095Culebras J.: B-0690Cunha G.: B-1021Cunningham J.D.: B-0564Curcio G.: B-0020Curda M.: B-0563Curvo-Semedo L.: A-009Cuttin R.: B-0762Ćwikła J.B.: B-0400Cyran C.C.: B-0068, B-0846, B-1036Czarnecka A.: B-0847Czerny C.: B-0328, B-0719Członkowski M.: B-0153DDa Dalt S.: B-0132Dadnam C.: B-0256Dadrich M.: B-0523Daemen M.J.A.P.: B-0116, B-0118Dahlman P.: B-0177D’Aiuto M.: B-0217Dal Bello B.: B-0092Dal Col A.: B-0687Dal Corso M.: B-0479Dalal P.: B-0030Dallaudiere B.: B-0310D’Ambrosio I.: B-0182Damilakis J.: A-051, B-0611, B-0996Damm J.: B-0750D‘Anastasi M.: B-0800Daneshi M.: B-0976Danquah W.: B-0882Danse E.: A-196, B-0987, SY 23Danza F.M.: A-351Dao T.-H.: B-0459Daouk J.: A-268Dappa E.: Rising StarsDarai E.: A-553D’Arco F.: B-0510Darnell A.: B-0704Das M.: B-0029, B-0065, B-0261, B-0264, B-0746D‘Assignies G.: B-0576Dastidar P.: B-0017David P.: B-0464, B-0466David V.: B-0691, B-0693, B-0696, B-0921Davies N.: B-0097Davis Z.: B-0780de Baere T.: A-490De Belder F.: A-131, A-264, A-346, A-365, A-556De Bock G.H.: B-0291, B-0560de Boer R.: B-0014, B-0016, B-0402de Bondt R.B.-J.: A-621De Bondt T.: B-0285, B-0286de Booij M.: B-0627, B-0965de Bruijne M.: B-0163, B-0737de Buck S.: B-0915De Bucourt M.: B-0306De Cecco C.N.: B-0626, B-0704, B-0792, B-0796De Cobelli F.: B-0239, B-0369, B-0440, B-0449,B-0585, B-0712, B-0769, B-0801, B-0850De Cobelli O.: B-0082, B-0503de Feijter P.J.: B-0410, B-0415de Feyter P.: B-0663de Feyter P.J.: B-0413De Filippo M.: B-0532De Foer B.: A-588, A-620De Gaetano A.M.: B-0323de Groot M.: B-0014de Jong P.A.: B-0027, B-0291, B-0297, B-0299,B-0610, B-0721De Jonge M.C.: A-362de Kerviler E.: A-103, A-298De Keyzer F.: B-0152, B-0510, B-0804de Koning H.J.: A-064De la Peña E.: B-0690de Lange C.E.: A-469de Liguoro M.: B-0325de Maertelaer V.: B-0053, B-0520De Meerleer G.O.: B-0088de Mey J.: B-0248, B-0580de Mol B.A.J.M.: B-0008De Oliveira D.S.: B-0645De Paepe K.N.A.: B-0152De Paoli L.: B-0944de Perrot T.: B-0970De Robertis R.: B-0572, B-0574de Rooij M.: B-0083de Roos A.: A-039, A-250De Ruysscher D.: B-0065De Santis M.: B-0231, B-0237De Schepper A.M.: B-0432De Vathaire F.: B-0559de Villiers P.: B-0130De Visschere P.J.: B-0088De Vivo A.E.: B-0468de Vos L.C.: B-1001de Vries B.: B-0212de Vries W.B.: B-0734de Wall C.: B-0165, B-0166De Wever L.: A-353De Wever W.F.M.: A-382Deák Z.: B-0243, B-0472Deandreis D.: A-432DeBlois F.: B-0245deBucourt M.: B-0539Debus A.: B-0865, B-0866Decallonne B.: B-0152Deckert A.: B-0447Decoster R.: B-0997Dedic A.: B-0410Dedouit F.: A-474Deferme F.: B-0285, B-0286Defez D.: B-0994Dehghan A.: B-0402Dekkers C.: B-0486del Ciello A.: B-0021del Cura J.L.: A-024, A-187Del Maschio A.: B-0239, B-0440, B-0449, B-0585,B-0712, B-0769, B-0801, B-0850, SY 16Del Meglio I.: B-0465Del Monte M.: B-0238, B-0836Del Vescovo R.: B-0049, B-0179, B-0342, B-0939Delakis I.: B-0839Delavaud C.: B-0576Delgado C.: B-0631D’Elia D.: B-0392Della Bella P.: B-0585Delmas V.: B-0694DeMarchi G.: B-0531Demers V.: B-0619Demeter Z.: Rising StarsDemirci A.: B-0908Demozzi E.: B-0572den Dekker M.A.M.: B-0588, B-1001den Heeten G.: B-0962den Heeten G.J.: B-0959, B-0960, B-0961, B-0964Dendl L.-M.: B-0725Denecke T.: A-056, A-318Denjoy N.: EIBIRDenys A.: A-189, A-431Depeursinge A.: B-0281Deray G.: SY 14Derchi L.E.: A-495, A-580, B-0974Derderian V.M.: B-0209Deroose C.M.: A-603276

List of Authors and Co-AuthorsD’Errico I.: B-1012, B-1018Desai S.R.: A-238Desbiolles L.: B-0660Deschamps F.: A-433, A-490, SK 26Deseive S.D.C.: B-0372Deserno W.: B-0625Desgranges P.: B-0924deSouza N.M.: A-096Detante O.: B-0355Dettmer S.: B-0165, B-0166, B-0768Dettori E.: B-0791Deux J.-F.: B-0924Devaraj A.: B-0299Dewan S.: B-0041Dhar A.: B-0331Dharampal A.: B-0413, B-0663Dharampal A.S.: B-0410, B-0415, B-0661Di Benedetto F.: B-0231, B-0237Di Biase L.: B-0407Di Cesare E.: B-0378Di Clemente L.: B-0930Di Gaetano E.: B-0567Di Giammarco G.: B-0002Di Giampietro I.: B-0468, B-0469, B-0579Di Gianfrancesco E.: B-0002Di Girolamo M.: B-0691, B-0693, B-0696Di Lelio A.: B-0439Di Lella G.M.: B-1015Di Leo G.: B-0545, B-0654, B-0687, B-0814, B-0815,EuroAIMDi Luzio M.: B-0378di Maggio C.: B-0686Di Marco D.: B-0268DI Mare L.: B-0427Di Martino M.: B-0238, B-0836, B-0979Di Miscio R.: B-0238, B-0836Di Mizio R.: B-0057Di Nicola M.: B-0712Di Paolo P.L.: B-0689Di Perri C.: A-422Di Pietro E.: B-0598Di Rosa E.: B-0769Di Sibio A.: B-0378Di Stasio F.: B-0378Diano D.: B-0316Dias M.: B-0138Dibenedetto A.: B-0397Dichgans M.: B-0113, B-0117, B-0353Diciotti S.: B-0465Diebold B.: B-0007Diederich S.: A-003Diederichs G.: B-0936Dietrich C.F.: B-0232Dietrich O.: B-1036Dietrich S.: B-0366, B-0522, B-0703Dietzel M.: B-0074, B-0075, B-0077, B-0079, B-0457,B-0614, B-0679, B-0808, B-0895Díez-Valle R.: B-0514Dijkstra A.E.: B-0164Dijkstra H.: B-0442Dijkstra J.: B-0208Dill K.: B-0524Ding S.: B-0277Ding Z.-X.: B-0271, B-0276, B-0742Dinter D.: B-0628Dirksen A.: B-0163Djemai B.: B-0201Djilas D.: B-0812Djuric N.: B-0273Do S.: B-0917Dobritz M.: B-0525Dobryinina L.: B-0365Doeswijk G.: B-0887Doğan Ö.T.: B-0587Dohi K.: B-0581Dolman K.M.: B-0593Dombrovsky V.: B-0695Domengie F.: B-0105Domey J.: B-0886Domingo Montañana M.L.: B-0168Dominguez A.: B-1033Dominguez O.: B-0211Dominguez P.D.: B-0514Donagh C.: B-0823Donati F.: B-0577Donati O.F.: B-0390, B-0697Dong S.: B-0368Dönmez F.Y.: B-0155Donner R.: B-0147D‘Onofrio M.: B-0572, B-0574Donoso L.: A-279Doo K.W.: B-0433, B-0528Doratiotto S.: B-0131, B-0382Dores R.: B-0607Dörfler A.: A-308, B-0614, B-0895Dormont D.: B-0512Dornbluth N.C.: B-0955Dorr K.: B-0858Dorrius M.: B-0295, B-0298Doss M.: B-0669Dou S.: B-0517Douek P.C.: B-0994Dousset V.: A-166Dowlatshahi D.: B-0756Doyan F.: B-0628Draenkow C.: B-0766Dragean A.: A-196Drapé J.-L.: B-0650, B-0786Drenth J.P.H.: B-0988Dreval M.: B-0365Driessen M.M.P.: B-0005Dromain C.: A-027, A-433Drop A.: B-0153Drougia A.: B-0860, B-0862Drumm O.M.: B-0184, B-0437Duarte S.: B-0822Düber C.: B-0420Duchatelle V.: B-0837Ducic T.: B-1000Ducou Le Pointe H.: B-0738, B-0867, B-0911Dudás I.: B-0982, B-0983Duerr H.R.: B-0547Dugar N.: A-577Duijm L.E.M.: B-0960, B-0961, B-0963Duke D.: B-0564Dumortier J.: B-0094, B-0444Duprez T.P.J.: A-309Duran C.: B-0141Durand P.: B-0429Durmus T.: B-0374Dustler M.: A-507Duvivier K.M.: B-0072EEastham J.A.: B-0697Eben E.B.: B-0817Eberhardt K.M.: B-0927, B-0928Eberl S.: B-0790Eberli D.: B-0318Ebersberger U.: B-0263, B-0411, B-0417, B-0419,B-0849Echano J.: B-0809Eckersly R.J.: B-0973Eckstein F.: B-0483Edjlali-Goujon M.: A-283Edward S.: B-0431Efendi H.: B-0908Egbers N.: B-0172Ege M.R.: B-0587Eggers H.: B-1007Eggesbø H.B.: A-519Eibel R.: A-033Eiber M.: B-0322Eichinger M.: B-0162Eichler K.: B-0033, B-0170, B-0398Ekseth U.: B-0817El Ghazaly H.A.: B-0452Elandoy C.: B-0277Elangovan S.: B-0692Elbadawy M.: B-0949Elgert M.: B-0740Elhai M.: B-0650Elias S.G.: B-0218Elie C.: B-0110Elie S.: B-0841Elizalde A.: B-0685, B-0813, B-0966El-Koussy M.: B-0752Elmahdy M.H.I.: B-0906El-Rabadi K.: B-0802ElShafaey A.: B-0713Emanuele E.: B-0267Emich H.: Rising StarsEndozo R.: B-1003Enescu I.: A-043, A-442, A-557, B-0309Enescu M.: B-0070Engelhorn T.: A-206, B-0895Engelke C.: A-560England A.: A-466, B-0608Enskär K.: B-0380Entezari P.: B-0363Epifanio M.E.: B-0590Erb K.: B-0324Erbay K.D.: B-1023Erbay N.: B-1023Erbay S.H.: B-1023Erbel R.: B-0584Erdogan Sendur B.: B-0899Erhard K.: B-0843Errante Y.: B-0020, B-0407Ertl-Wagner B.: A-085 A-278, B-0106Eskola H.: B-0017Espinosa N.: B-0181, B-0314Espinoza-Boireau S.: B-0473, B-0714Esposito A.: B-0239, B-0449, B-0585, B-0850Esposito M.: B-1012, B-1018Essig M.: A-203, A-347, B-0151Eteiba S.: B-0150Etxano J.: B-0143, B-0514, B-0685, B-0778, B-0813,B-0900, B-0945, B-0966Eun B.: B-0221277

List of Authors and Co-AuthorsEuringer W.: B-0361Eustace S.J.: A-361, B-0437Evans A.: B-0332Evert M.: B-0445Ewing F.: B-0060FFabbro E.: B-0186Facchetti L.: B-0705Facchini G.: B-0555, B-0598, B-0642Fachechi R.: B-0268Faggioni L.: A-607, B-0623, B-0698, B-1010Faiella E.: B-0179Faivre J.-B.: B-0376, B-0519, B-0630, B-0731Faivre S.: A-020, A-358Falaschi F.: B-0577Faletti C.: A-598Faletti R.: B-1033Falini A.: A-423Falk V.: B-0660Fallenberg E.: A-027Fallenberg E.M.:Falzon C.: B-0873Fanelli F.: A-246, B-0300, B-0775, B-0920Fanti S.: B-0555Fantozzi L.M.: B-0518, B-0675Farghaly H.R.S.: B-0906Farina D.: A-521, B-0203, B-0204, B-0478Farouil G.: A-490Farras Roca J.A.: B-0459Farrell T.P.: B-0216Fascetti E.: B-0493Faulhaber P.: B-0326Fausto A.: B-0682Fedeli M.P.: B-0814Federici M.: B-0518Feenstra T.: B-0560Feier D.S.: B-0096Feigenberg S.: B-0023Feignoux J.: B-0370Feletti F.: B-0763Felli V.: B-0378Fellner C.: B-0903, B-0985Feng S.S.J.: B-0840Feragen A.: B-0163Ferda J.: B-0358Ferencik M.: B-0917Ferguson D.: B-0823Fernandes C.L.D.C.: B-0274Fernandes L.: B-0175Fernandes T.: B-0877Fernandez del Valle A.: B-0631Fernandez Fabrellas E.: B-0168Fernández L.: B-0185Fernandez-Bayó J.: A-606Fernando S.: B-0051Ferraioli G.: B-0092, SY 23Ferranti C.: B-0561, B-0956Ferrari F.: B-0493Ferrari P.: B-0108Ferrari V.: A-049Ferraro S.: B-0267Ferraroni F.: B-0203Ferré R.: B-0786Ferreira C.: B-1021Ferrero G.: B-0186Ferretti G.R.: A-240Ferri A.: B-0127Ferrière J.-M.: B-0176Feuchtner G.M.: B-0907Feydy A.: B-0650, B-0786Feygin T.: B-0864Fiehler J.: B-0354Fierens Y.: B-0580Figueiral A.: B-0970Fijnheer R.: B-0550Filatov A.: B-0206Filice C.: B-0092, SY 23Filice S.: B-0217Filipe T.R.: B-1020Filippiadis D.: B-0530Fill S.: B-0112, B-1006Fingerle A.A.: B-0525Fink C.: B-0022, B-0160, B-0265, B-0352, B-0889Finkenzeller T.: B-0903Fiocchi F.: B-0349, B-0462, B-0463Fior D.: B-0505, B-0783, B-1005Firouznia K.: B-0220Fischer A.: B-0347, B-0708, B-1038Fischer M.A.F.: B-0314Fischer R.: B-0315, B-0578Fischer T.:Fishman E.K.: A-123Fitoussi V.: B-0335FitzGerald R.: A-293Fitzke H.: B-0207Flaction L.: B-0869Flavian A.: B-0460, B-0461Flechsig P.: B-0200Fleming R.: B-0219Fleming S.: B-0554Flohr T.: B-0263, B-0372Floridi C.: B-0531Foderà E.: B-0058Fodero G.: B-1031Fodor C.: B-0503Fokin V.: B-0833Foldyna B.: B-0260Foley S.: A-392, B-0272, B-1028Folio L.R.: B-0209Fonda C.: B-1012, B-1018Fondevila J.J.: B-0724Fonio P.: B-1033Fontana F.: B-0531Foray N.: B-0559Foresti D.: B-0925Formenti A.: B-0262Fornari S.: B-0128Fornasa F.: B-0397Forner Giner J.: B-0403Förnvik D.: A-507Forrai G.: A-297Forsting M.: B-0028, B-0320, B-0347, B-0456,B-0501, B-0506, B-0552, B-0553, B-1011, B-1038Forstner R.: A-410Forte V.: B-0089, B-0090Foschi M.: B-0002Foti G.: B-0045Foti P.: B-0307, B-0308Fouad R.M.K.: B-0949Fournier L.S.: B-0335Fraile Moreno E.: A-113Franchi-Abella S.: B-0110Franco O.H.: B-0111Francone M.: A-202, B-0464, B-0466, Rising StarsFrandon J.: B-0429Franiel T.: B-0172Franklin J.M.: B-0062, B-0070, B-0624Franquet T.: A-335Fransen H.: SY 19Franzoni E.: B-0598Fratto P.: B-0925Fredenberg E.: B-0843Frei P.: B-0198Freire V.: B-0650Freitas V.: B-0219Freling H.G.: B-0005Frellesen C.: B-0633, B-0700, B-0723Freund B.: B-1000Freyschmidt J.: A-589Friedrich K.M.: B-0488Fries P.: B-1035Frigerio A.: A-155Frindel C.: B-0890Fritsche K.H.: B-0151Frittoli B.: B-0791, B-0794Fritz S.: B-0178Froehlich J.M.: B-0198, B-0616, B-0819Fronda M.: B-1033Frouin F.: A-216Frustaci A.: B-0466Fu J.-H.: B-0225Fucentese S.F.: B-0938Fuchs S.: B-0189Fuchsjäger M.H.: A-610, B-0667, B-0858, B-0914,SK 27Fugazzola C.: B-0531Füger B.: B-0502Fujii K.: B-0338, B-0339Fujii T.: B-0674Fujisawa Y.: B-0293Fujita M.: B-0581Fukutomi T.: B-0338, B-0339Fung V.K.: B-0474Furmanek M.: B-0852Furtner J.: B-0328, B-0719Fusco R.: B-0217, B-0942Fütterer J.J.: A-378, A-424GGabata T.: B-0984Gabrylewicz T.: B-0400Gadda D.: B-0511Gaens M.E.: B-0116Galanaud D.: A-503, B-0512Gale A.G.: A-271Galea N.: B-0464Gallagher F.A.: A-015Gallix B.: A-592Gallucci M.: A-042Gallusi G.: B-0238Galvez M.: A-406Gamhewage G.: A-387Ganai B.: Rising StarsGandini G.: B-1033Ganeshan B.: B-0205, B-0943, B-1003Gangemi E.: B-1015Gangi A.: A-043, A-442, A-557, B-0309Ganter C.: B-0098, B-0435Gao H.: B-0883Garambois K.: B-0355278

List of Authors and Co-AuthorsGarcarek J.: B‐0744García del Barrio L.: B‐0143Garcia Lallana A.: B‐0809, B-0810Garcia Marti G.: B‐0403García P.: B‐0900Garcia Parra C.: B‐0785García-Eulate R.: B‐0514Garcia-Valiente A.: B‐0122Gardelli G.: B‐0763Garel C.: A‐121, B‐0867Garello I.: B‐0197Garlaschi A.: B‐0197, B‐0948Garlaschi G.: B‐0654Garnon J.: A‐043, A‐442, A‐557, B‐0309Garnov N.: B‐0448Gartland N.: B‐0299Garzillo G.: B‐0640Garzón G.: B‐0124Gasparini A.: B‐0397Gasparotti R.: A‐074Gaßmann P.: B‐0125Gatidis S.: B‐0504Gaubert J.Y.: B‐0460, B‐0461Gaudino S.: B‐1015Gawlitza M.: B‐0158, B‐0558Ge M.: B‐0897Gebauer B.: A‐320, B‐0189, B‐0306Gee A.H.: B‐0658Geers-van Gemeren S.: A‐191Geerts L.: B‐1007Geertse T.D.: B‐0964Geffroy F.: B‐0201Geiger B.: B‐0028, B‐0320Geiger D.: B‐0836Geiger J.: B‐0736Geijer H.: B‐0825Geijer M.: B‐0653, B‐0781Geith T.: B‐0547Geldof M.: B‐0285, B‐0286Gelot A.: B‐0867Gencturk M.: B‐0908Gennarelli A.: B‐0378Gennari A.: B‐0944Gennaro G.: A‐505, B‐0686Gennisson J.-L.: B‐0335George R.T.: B‐0006Georgoulis A.: B‐0929Gerevini S.: A‐161Germann T.: B‐0265Geschwind J.-F.: A‐273Gevenois P.A.: B‐0053, B‐0520Gevers T.J.G.: B‐0988Gey S.: B‐0694Geyer L.: B‐0411, B‐0472Geyer L.L.: A‐221, A‐413, B‐0849Ghai S.: B‐0219Ghanaati H.: B‐0220Ghaye B.: A‐561Ghedi M.: B‐0791Gherarducci G.: B‐0577Ghoncheh Z.: B‐0477Giani G.: B‐0100Gianolli L.: B‐0801Giardina G.G.: B‐0902Giardino A.: B‐0545Gibaud B.: A‐050Gibon E.: B‐0786Gibson R.N.: A‐023Gidding C.: B‐0672Gielen J.L.: B‐0480Gielen J.L.M.A.: B‐0432Giesel F.L.: B‐0200Giganti F.: B‐0801Giglio M.: B‐0268Gigoni R.: B‐0577Gil A.R.: B‐0724Gil R.: B‐0852Gilbert F.J.: A‐156, A‐225Gilca G.-E.: Rising StarsGilhuijs K.G.A.: B‐0218Gillams A.R.: A‐489Gillard J.H.: A‐241Giona A.: B‐0020, B‐0407Gioppo A.: B‐0770Giordano A.V.: B‐0378, B‐0493Giordano G.P.: B‐0511Giravent S.: B‐0436Girometti R.: B‐0132, B‐0567, B‐0568, B‐0684,B‐0811, B‐0834, B‐0835Giuffrida G.: B‐0855Giuliani P.: B‐0182Giurazza F.: B‐0049, B‐0179, B‐0342, B‐0939Gjesteby L.: B‐0036Glaser C.: A‐152Glatz J.: B‐0853Gleeson F.: A‐004, A‐443Gleeson F.V.: B‐0062, B‐0070, B‐0423, B‐0624Glick Y.: B‐0129Glowacki M.: B‐0489Glüer C.C.: B‐0436Glynne- Jones R.: B‐0943Gockner T.: B‐0178Goffette P.P.: A‐341Goh K.L.: B‐0422Goh V.: B‐0943Goh V.J.: A‐010, A‐171, B‐0946Göke B.: B‐0795Golay S.: B‐0373Goldberg N.S.: B‐0646Golding S.J.: A‐022Goldman D.: B‐0697Golsäter M.: B‐0380Golubnitschaja O.: A‐326Gombos E.: B‐0080Gomes F.V.: B‐0726Gómez-Ansón B.: A‐222, Rising StarsGonçalves C.: B‐0872Gondek T.M.: B‐1016Gong Q.: B‐0018Gonzalez Crespo I.: B‐0945Gonzalez Graniel K.: B‐0737Gonzalez-Calvin J.L.: B‐0099Gonzalez-Guindalini F.D.: B‐0363, B‐0524, B‐0615,B‐0722Goo J.M.: B‐0026Gooßen A.: B‐0843Goraj B.: B‐0672Gorbunov N.: B‐0764Gore R.M.: A‐090Gori C.: B‐0086, B‐0087Göthlin J.H.: B‐0781Gottlieb I.: B‐0006Gottlieb P.: B‐0227Gouda I.: B‐0949Gourtsoyianni S.: A‐008, A‐071, B‐0943Gourtsoyiannis N.: A‐138Gräbeldinger M.: B‐0548Grabellus F.: B‐0782Grabherr S.: A‐473Gradkowski W.: B‐0489Graef A.: B‐0161, B‐0634, B‐0638Gräfe S.: B‐0885Graham J.W.: B‐0051Graif M.: A-282Gralla J.: B‐0752Gramer B.: B‐0586, B‐0912Granata C.: B‐0730, B‐0990Granata R.: B‐0907Granata V.: B‐0233, B‐0942Grande Garcia E.: B‐0548Grant D.: Rising StarsGraser A.: A‐481, B‐0066, B‐0288, B‐0795, B‐0800Grass M.: A‐337Grassedonio E.: B‐0854, B‐0855Grassi R.: B‐0057, B‐0059Grasso D.: B‐0904Grasso R.F.: B‐0049, B‐0179, B‐0342, B‐0939Graw M.: B‐0727Grazioli L.: B‐0791, B‐0794Green S.M.: B‐0932Greiner M.: A‐624Greiser A.: B‐0667, B‐0858, B‐0914Gremizzi C.: B‐0440Grenacher L.: B‐0629Grenier N.: B‐0176Greuter M.J.W.: B‐0291, B‐0560, B‐0664, B‐0666,B‐0918Greutmann M.: A‐322Griffin M.: B‐0216Griffith J.F.: B‐0042Grimm J.: B‐0144, B‐0243, B‐0472Grischenko V.I.: SY 20Grisi G.: B‐0762Griswold M.A.: B‐0668Gritzmann N.: A‐579Groen H.J.M.: B‐0164, B‐0291Groen J.M.: B‐0666, B‐0918Groth M.: B‐0367Grothoff M.: B‐0851, B‐0909Groves A.M.: B‐0205, B‐1003Gruber S.: B‐0071, B‐0076, B‐0953Gruber-Rouh T.: B‐0031, B‐0033, B‐0398, B‐0536,B‐0774Grueneisen J.S.: B‐0456Grünhagen T.: B‐0924Gruszczynska K.: B‐0413Grutters J.P.C.: B‐0083Guenoun J.: B‐0887Guerini H.: B‐0786Guermazi A.: B‐0656, B‐0932Guerrini S.: B‐0058, B‐0194Guggenberger R.: B‐0187, B‐0482Guglielmi G.: A‐471Gui B.: B‐0323, B‐0395Guibal A.: B‐0094Guidotti L.G.: B‐0239Guillaud O.: B‐0444Guindani M.: B‐0319Gul K.: B‐0718Gullien R.: B‐0139, B‐0388, B‐0817, B‐0870Gulsun M.A.: B‐0667, B‐0914279

List of Authors and Co-AuthorsGümüş C.: B-0587Günther A.: B-0436Guo C.-Y.: B-0954Guo J.: B-0896Guo W.: B-0368Guo W.Y.: B-0543Guo X.: B-0806Gupta A.: A-552, B-0199Gupta H.: B-0431, B-0779Gupta R.: B-0573Gupta R.T.: B-0728Gusenburg J.: B-0656Gutberlet M.: A-091, A-321, B-0260, B-0851, B-0909Guven K.: B-0838Guzinski M.: B-0744, B-0847Gwon D.-I.: B-0499Györke T.: B-0982HHa Y.R.: B-0052Haab F.: A-553Haag F.: B-0882Haakenaasen U.: B-0817Haakull A.E.: B-0139, B-0388, B-0870Haberkorn U.: B-0200Haberland U.: B-0022, B-0240, B-0676Habets J.: B-0008, B-1007Habib N.: B-0773Habrecht H.: B-0077, B-0808Habs M.: B-0353Hadamitzky M.: B-0372Hadaschik B.A.: A-059Haddad S.: B-0538Haedicke K.: B-0885Haensig M.: B-0260Hagelstein C.: B-0865, B-0866Hågemo K.: B-0967Hagiwara N.: B-0986Hahn D.: B-0001Hahn G.: A-397Hahn O.: B-0982, B-0983Hahnemann M.L.: B-1011Haimerl M.: B-0985Hakky M.: B-0037, B-1023Halder J.L.: B-0074, B-0075Halimi P.: B-0473, B-0714Halliburton S.: B-0371Halligan S.: B-0789Halligan W.T.: B-0417Halpern Z.: B-0978Halter R.: B-0768Hambly N.: B-0564Hamed W.: B-1025Hamidavi Y.: B-0034, B-0040Hamilton M.: A-512Hamilton M.C.K.: B-0527, B-0856Hamm B.: A-207, A-316, B-0172, B-0189, B-0306,B-0324, B-0539Hammadouche M.: B-0786Hammel P.: B-0576Hammerstingl R.: B-0031Hammond R.L.: B-0870Hampshire T.E.: B-0789Hamy V.: B-0207Hamza H.: B-0123Han D.H.: B-0637Han J.: B-0025Han J.H.: B-0296Han J.K.: B-0202, B-0230, B-0830Handayani A.: B-0442Handler M.: B-0916Handschel J.: B-0159Haneder S.: B-0343, B-0345Hanelore H.A.: Rising StarsHannaford N.: B-0144Hanning U.: B-0125, B-0898Hannon M.J.: B-0932Hansen A.E.: B-0102Hansen C.: B-0351, B-0356, B-0357Hansmann A.: B-0199Hansmann J.: B-0829Hany T.F.: A-158Hara T.: B-0777Hardy M.: B-0134, B-0383, B-0389Hari S.: B-0331Harirchian M.H.: B-0220Harmath C.B.: B-0524Harris G.: B-0069Harth M.: B-0033, B-0709, B-0711, B-0723Hartmann A.: SY 4Hartung H.-P.: B-0905Hartung-Knemeyer V.: B-0028, B-0500, B-0501,B-0506, B-0552, B-0553Hartwig T.: B-0306, B-0539Hasdemir D.B.: B-0038Hashemi Amroabadi S.: B-0292Hashemi H.: B-0220Hashimoto T.: B-1029Hassan C.: A-481Hatzidakis A.A.: A-339, A-445Hauben E.: B-0152Haubenreisser H.: B-0022, B-0160, B-0352, B-0889Hauge M.: B-0870Hauger O.: B-0307, B-0308Hausegger K.A.: A-441, B-0224Hauser T.: B-0151Hausleiter J.: B-0372Hausmann D.: B-0628Hausmann R.:Hausotter K.: B-0999Haustermans K.: A-174Hauth E.A.: B-0456Havla L.: B-1036Havsteen I.: B-0351, B-0356, B-0357Hawkes D.J.: B-0789Hayakawa K.: B-1017Hayashi D.: B-0656, B-0932Hayirlioglu A.: B-0362He B.: B-0375Hedges W.P.: B-0385Heeneman S.: B-0116Hegenscheid K.: B-0348, B-0445, B-0681Heidbuchel H.: B-0915Heijnen L.: B-0940Heijnen L.A.: B-0625Heikkilä P.: B-0135Heilmeier U.R.: B-0483, B-0484, B-0529Heindel W.: B-0125, B-0898Heindel W.L.: B-0190, B-0805Heinemann V.: B-0800Heinz-Peer G.: A-030, A-302Helal M.H.: B-0949Helbich T.: B-0076, B-0953Helbich T.H.: A-064, A-228, B-0071, B-0171, B-0502,B-0562, B-0563, B-0950, B-0951, B-0952Helbren E.: B-0789Helck A.: B-0117, B-0288Helck A.D.: B-0344Hélénon O.: A-032, B-0084Hellenthal F.A.M.V.: B-0253Heller M.: B-0436Helmberger T.: SK 27Hemke R.: B-0593Hendrick E.R.: B-0686Hendrikse J.: B-1007Henes F.O.: B-0367Henes F.O.G.: B-0765, B-0935Henner A.: B-0135Hennig J.: EIBIRHenninger B.: B-0343Henninger M.: B-0525Henriksson L.: B-0287Henry S.: B-0519, B-0630, B-0731Hensor E.: B-0431Henzler T.: B-0022, B-0160, B-0265, B-0289, B-0352,B-0848, B-0889Herbreteau D.: B-0105Herbrik M.C.: B-0028Herédia V.: B-0822, B-0971Hereren J.: B-1000Herh S.J.: B-0715Hermans J.: SY 18Hermans R.: A-118, B-0152Hermeling E.: B-0118Hernando D.: B-0445Herold C.J.: A-089, B-0719Herrero J.I.: B-0778Herrmann K.: B-0326Herten M.: B-0487Hertin U.: B-0149Herzen J.: B-0112, B-1006Herzog C.: B-0266Herzog D.: B-0955Herzog P.: B-0491Hesselink M.K.C.: B-0317, B-0853Hesselmann V.: B-0898Hetterich H.: B-0112, B-0113, B-1006Heusch P.: B-0159, B-0252, B-0320, B-0340, B-0366,B-0501, B-0522, B-0552, B-0553, B-0648, B-0703Heusner T.: B-0456, B-0552Heusner T.A.: B-0028, B-0159, B-0320, B-0366,B-0501, B-0506, B-0553Heussel C.-P.: A-334, B-0162, B-0200, B-0766Heuts E.M.: B-0212Heuvelmans M.: B-0295Heuvelmans M.A.: B-0291Hewlett R.: A-259Hey C.: B-0711Heye T.: B-0728Heywang-Köbrunner S.H.: SY 5Hietschold V.: B-0101Hildebrandt K.: B-0582Hilger I.: B-0885, B-0886Hill E.J.: B-0062, B-0070Hillengass J.: A-300Hiller N.: B-0591Hillman B.J.: A-277Himmelreich U.: B-0510Hindricks G.: B-0909Hinzer C.: B-0967280

List of Authors and Co-AuthorsHipp A.: B-0112Hirai T.: B-0336Hirner H.: B-1036Hirota H.: B-1017Hirsch J.: B-0523Hirschmann A.: B-0048, B-0181Hirtler D.: B-0736Hitendu D.: A-322Hiwatashi A.: B-0515, B-0673, B-0678Hizhnyak A.: Rising StarsHladuvka J.: B-0618Ho G.F.: B-0422Hoare T.: SY 24Hodek R.: B-0938Hodgkinson J.: B-0299Hoffmann C.: A-087Hoffmann E.: B-0586Hoffmann J.: B-0909Hoffmann P.: A-245Hoffmann R.-T.: B-0195, B-0491Hoffmann U.: B-0917Hoffmann V.: B-0113Hofman A.: B-0014, B-0016, B-0111, B-0114, B-0350Hofmann B.: B-0878Hogenauer H.: B-0629Hogeweg L.: B-0761Hogg P.: A-524Höglund P.: B-0892Hohmann J.: B-0130, B-0232Höink A.J.: B-0805Hojgaard L.: B-0102Holc T.: B-0273Holland R.: B-0964Holli K.K.: B-0017Hollmann M.W.: B-0790Holm S.: B-0102, B-0275Holscher H.C.: B-0597Holzapfel K.: B-0098Holzer M.: B-0147Holzhey D.: B-0260Homann G.: B-0125, B-0898Homolka P.: B-0950, B-0951Hompes D.: A-353Honda H.: B-0515, B-0673, B-0678Hong S.H.: B-0046Hoppe H.: A-538Horasanlı B.: B-0901Horner K.: A-338Hörnig M.: B-0950, B-0951Horvath E.: A-404, B-0982Hosten N.: B-0146, B-0348, B-0445, B-0681Hou D.: B-0632Houssami N.: A-130, B-0560, B-0818Houston G.C.: B-0894Howarth N.: A-419Howe T.S.: B-0659Hribar D.: B-0273Hricak H.: A-061, A-124, B-0390, B-0689Hrynchyshyn N.: B-0007Hsieh K.W.-V.: B-0752Hsu S.-H.: B-0225Huang D.: B-0976Huang D.Y.: B-0973Huang X.: B-0018, B-0883Huber A.: B-0912Huber A.M.: B-0586, B-0881Huber R.M.: B-0578Hübler M.: A-322Hueper K.: B-0768Huete A.: A-408Hüllner M.: B-0156, B-0157Hummel N.: B-0288Hünerbein R.: B-0740Hung S.C.: B-0543Hunink M.G.M.: EuroAIMHunold P.: B-0584Hunter D.J.: B-0656Husmark T.: B-0653Hutt A.: B-0376Huwart L.: B-0307, B-0308Hwang H.K.: B-0269Hwang J.: B-0428Hwang J.-H.: B-0100Hwang K.-W.: B-0073Hwang S.M.: B-0494IIacoban C.G.: Rising StarsIacobellis F.: B-0057, B-0059Iacobucci M.: B-0323Iacopi E.: B-0922Iacucci I.: B-0464Iafrate F.: B-0626, B-0796Iannitti M.: B-0796Ibarburen C.: B-0810Ibrahim M.I.M.A.: B-0425Ichikawa S.: B-0093Ichikawa T.: B-0093, B-0777, B-0977Ierace T.: B-0646Ierardi A.M.: B-0531Iero L.: B-0598Iershova I.: B-0735Iezzi R.: A-355, B-0369Ifeakor E.: B-0299Iima M.: B-0201Ikram M.A.: B-0014, B-0016, B-0114, B-0350, B-0402Ikuye K.: B-0412, B-0583Ilangovan R.: B-0199Illing R.: SK 27Illomei G.: B-0313Ilyas S.: B-0821Im T.S.: B-0046Imai Y.: B-0777, B-0977Imanzadeh A.: B-0069Imbriaco G.: B-0058Imlau U.: B-0034, B-0040Imura M.: B-0470in ‘t Hout J.: B-0959Inácio M.: B-0275İnci M.F.: B-0055, B-0587, B-0718, B-1034İnci R.: B-1034Indovina L.: B-0772Ingorokva S.: B-0907Ingrisch M.: B-0344, B-0846, B-0975Inokawa H.: B-0526Invernizzi I.: B-0492Ionasec R.: B-0263Iotti V.: B-0349Ippolito D.: B-0064, B-0235, B-0236, B-0254, B-0391,B-0438, B-0439, B-0505, B-0596, B-0620, B-0745,B-0783, B-0787, B-0827, B-0832, B-1005Ironi G.: B-0449Irzyk M.: B-0009Isaacs A.: B-0114Isberg B.: B-0109Iselin C.: B-0970Ishida M.: B-0581Ishiguchi T.: B-0338, B-0339Islim F.: B-0838Italiano A.: B-0421Ito M.: B-0760Ito T.: B-0336, B-0581Itou C.: B-0777Ittrich H.: B-0882, B-0888, B-1000Ivanac G.: SY 2, SK 27Iwadate Y.: B-0570Iwami M.: B-1017Iwata T.: B-0720Izadi M.: B-0817Izuka T.: B-0760Izzillo R.: B-0251Izzo F.: B-0233Izzo G.: B-0902JJackson M.R.: B-0594Jackson S.A.: A-229Jacobi V.: B-0774Jacobs C.: B-0297, B-0610Jacobs J.: B-0842Jacquet L.: A-196Jacquier A.: B-0460, B-0461Jafarov H.: B-0160Jäger H.R.: A-046, Rising StarsJäger M.: B-0487Jager P.L.: B-0664Jahnen A.: B-0989Jain A.K.: B-0041Jairam P.M.: B-0027Jakicic J.M.: B-0932Jakubowski W.S.: B-0717Jalali A.H.: B-0220Jalan R.: B-0097Jana M.: B-0331Janevska V.: B-0430Janezic A.: B-0273Jang H.-J.: B-0699Jang M.: B-0210Janicijevic M.: B-0967Jankharia B.: B-0641Janne d’Othée B.: B-0777Janse van Rensburg P.: A-259Jansen F.: B-0964Jansen J.: B-0012Jansen L.: B-0560Janssens R.: B-0887Janu A.K.: B-0641Jara H.: B-0954Jarboui L.: A-553Jargiello T.: A-044Jarraya M.: B-0932Järvinen H.: B-0989Jaspers K.: B-0666Jaspers R.M.J.J.: B-0588Jauch K.-W.: B-0195Jayne D.G.: B-0196Jebsen I.N.: B-0817Jensen A.: B-0151Jeon G.S.: B-0494, B-0495Jeong C.J.: B-0025Jeong J.Y.: B-0025281

List of Authors and Co-AuthorsJereczek-Fossa B.A.: B-0503Jeromel M.: B-0652Jerowski C.: B-0077, B-0808Jeukens C.: B-0621Jeukens C.R.L.P.: B-0622Jevtič V.: B-0652Ji S.K.: B-0050Jiang L.: B-0141Jin Z.: B-0496, B-0497Jin Z.Y.: B-0255Jingu K.: B-0674Job-Deslandre C.: B-0650Joeckel K.-H.: B-0584Joeres A.: B-0819Johnson A.: B-0207Johnson C.A.: B-0051Johnson K.J.: A-526Johnson T.: B-0582Johnson T.R.C.: A-357, B-0161, B-0288, B-0634,B-0638, B-0639, B-0995Jomier A.: B-0285, B-0286Jones E.C.: B-0209Jones L.: B-0557Jones R.: B-0326Joo I.: B-0202, B-0230Jorulf H.: B-0109Joseph G.: B-0484Joseph G.B.: B-0483Jost G.: B-0167, B-0747, B-0913Jouannic J.-M.: B-0867Juan Y.-H.: B-0931Jung B.: B-0361, B-0736Jung C.S.L.: B-1000Jung E.M.: SY 24Jung G.S.: B-0776Jung J.-Y.: B-0330Jung K.-S.: B-0330Jung S.C.: B-0516Jung T.: B-0936Jungmann P.: B-0180Jungmann P.M.: B-0435, B-0655Juras V.: B-0345, B-0488Jurca M.: B-0141, B-0807Jurencak T.: B-0261, B-0264Jurkiewicz E.: B-1014KK.Kunovska S.: B-0430Kabala J.E.: A-460Kabasawa H.: B-0570Kachelrieß M.: A-336Kaczur D.: B-1024Kaelin-Lang A.: B-0405Kaemmerer D.: B-0282Kahan A.: B-0650Kahl S.: B-0100Kahn T.: B-0158, B-0448, B-0558Kainberger F.: B-0613Kaireit T.: B-0166Kaiser C.G.: B-0214, B-0683Kaiser W.A.: A-128, B-0074, B-0075, B-0077, B-0079,B-0457, B-0679, B-0683, B-0808, B-0885, B-0886Kalafut J.F.: B-0746Kalashnikova L.: B-0365Kalender W.: B-0991, B-0992, B-0993Kalender W.A.: A-106Kallifatidis A.: B-0460, B-0461Kalnins A.: B-0341Kälviäinen R.: B-0011Kamm K.: B-0106Kammerer S.: B-0190Kan W.K.: B-0474Kanazawa S.: B-0336Kanda T.: B-1017Kang A.: B-0095Kang B.C.: B-0776Kang D.M.: B-0844, B-0845Kang E.G.: B-0844, B-0845Kang E.Y.: B-0210Kang E.-Y.: B-0433, B-0528Kang H.: B-0024Kang H.S.: B-0046, B-0784Kang J.-W.: B-0418Kang K.W.: B-0475Kang M.: B-0573Kang S.J.: B-0067Kang T.W.: B-0428Kannan R.R.: B-0056Kannengiesser S.: B-0540Kannivelu A.: B-0294Kanz F.: B-0613Kanz K.-G.: B-0727Kappert P.: B-0442Karaarslan E.: B-0327Karampinos D.: B-0043Karani J.B.: A-470Karanikas G.: B-0213, B-0328, B-0502, B-0802Karantanas A.: B-0223, B-0228, B-0541Karantanas A.H.: A-597Karatzoglou I.: B-0115Karlson B.-M.: B-0426Karmazanovsky G.: B-0250Karnabatidis D.: B-0919Károlyi M.: B-0917Karpinska A.: B-0117Karpitschka M.: B-0066Karssemeijer N.: B-0968Kartje K.: B-0589Kashani H.: B-0379Kassarjian A.: A-002Kassem H.M.H.: B-0906Kastler A.: B-0312Kastler B.: B-0312Katabathina V.: B-0255Kataeva G.: B-0229Katayama M.: B-0570, B-1004Katsanos K.: B-0919Kau T.: B-0224Kauczor H.-U.: A-080, A-181, A-234, B-0044, B-0162,B-0188, B-0200, B-0241, B-0481, B-0523, B-0629,B-0766Kaufmann P.A.: A-013Kaul M.G.: B-0879, B-1000Kaul S.: B-0030Kavaliauskiene G.: B-0790Kawada S.: B-0977Kayani I.: B-0205Kaye T.L.: B-0196Kazmierczak P.M.: B-1036Keeling A.: A-389Kehl S.: B-0865, B-0866Kelekis A.: B-0530Kelekis A.D.: A-040Kelekis N.L.: A-038, B-0530Keller S.: B-0102Kelliher E.: B-0564Kellner-Weldon F.: B-0752Kemmling A.: B-0898Kemp M.: A-053Kenis C.: B-0480Kerbaol A.: A-109Kerl J.: B-0723Kerl J.M.: B-0266, B-0669Kerl M.: B-0633Kerl M.J.: B-0290Kerr J.: B-0564Kersten M.J.: B-0550Keyhanian K.: B-0756Keymeulen K.B.M.I.: B-0212Keyzer C.: A-035, B-0053Khairoune A.: B-0084Khalifa O.: B-0148Khalil A.: B-0538Khalil M.: B-0595Khan A.: B-0943Khan S.H.: B-0385Khan S.M.: B-0601Khandelwal N.: B-0573Khettab I.: B-0473, B-0714Khouri Chalouhi K.: B-0815Kiefer B.: B-0446Kiefer C.: B-0405Kienle P.: B-0628Kiessling F.M.A.: A-016, A-328Kietselaer B.: B-0261, B-0264Kikinis R.: B-0284Kikuchi K.: B-0515, B-0673, B-0678Kilborn T.: A-261Kılıc K.: B-0899Kim B.T.: B-0296Kim B.-T.: B-0025Kim C.K.: B-0826Kim D.H.: B-0026Kim E.-G.: B-0739Kim E.-K.: B-0715Kim E.Y.: B-0521Kim H.J.: B-0052Kim H.K.: B-0296Kim H.L.: B-0637Kim H.S.: B-0067, B-0521Kim I.H.: B-0513Kim I.S.: B-0446Kim J.H.: B-0296, B-0830Kim J.-H.: B-0024, B-0513Kim J.W.: B-0364, B-1002Kim K.: B-0221Kim K.A.: B-0446, B-0831Kim K.H.: B-0052Kim K.M.: B-0475Kim K.W.: B-0091Kim M.D.: B-0494Kim M.S.: B-0210Kim M.Y.: B-0428Kim S.C.: B-0516Kim S.J.: B-0067Kim S.M.: B-0210Kim S.-W.: B-0210Kim S.Y.: B-0091Kim T.K.: B-0699Kim T.M.: B-0513Kim Y.K.: B-0521282

List of Authors and Co-AuthorsKimura T.: B-0346, B-0828Kind M.: B-0421King J.: B-0311Kinkel K.: A-409, A-587Kinner S.: B-0347, B-1030Kircher J.: B-0486Kirchhoff S.: B-0727Kiritsi O.: B-0933Kist K.: B-0955Kitagawa K.: B-0581Kitahara S.: B-0759Kitajima K.: B-0346Kitao A.: B-0984Kitrou P.M.: B-0919Kitslaar P.H.: B-0663Kiura Y.: B-0305Klammer G.: B-0181Klasen J.: B-0252Klatka J.: B-0153Klavžar R.: B-0476Kleijnen J.-P.J.E.: B-0622Klein K.-G.: B-0749Klein S.: B-0014Klement D.: B-0290Klepacka T.: B-0671Klerx F.: B-0597Kling-Hassler C.: B-0149Klink T.: B-0354Kloeckner R.: B-0420Kloeters C.: B-1030Kloth J.K.: B-0044Klotz E.: B-0240, B-0413, B-0676, B-0755Klueppelholz B.: B-0100Kluge R.: B-0158, B-0558Klumpp B.: B-0003, B-0004Kluza E.: B-0621, B-0622Kluzer A.: B-0128Knauer A.: B-0190Knauth M.: B-0676Knogler T.: B-0680, B-0802, B-0950, B-0951Knollema S.: B-0664Ko C.-W.: B-0225Ko G.-Y.: B-0499Ko S.M.: B-0269, B-0418Koay H.T.: B-0294Kobayashi S.: B-0984Koch P.: B-0187Koch-Nolte F.: B-0882Kocsis P.: B-0619Koda W.: B-0984Koehl L.: B-0970Koehler C.: B-0915Kofoed K.F.: B-0918Kogan M.: B-0695Koh D.-M.: ESOR CourseKoh J.S.B.: B-0659Koh S.H.: B-0330Kohan A.: B-0326Köhlitz T.: B-0936Koizumi J.: B-0777, B-0977Kokhanovsky N.: B-0129Kolb M.: B-0341Kolditz D.: B-0991, B-0993Kollias S.S.: B-0156, B-0157Kolligs F.T.: B-0795Kolokythas O.: B-0095, B-0145Kolossvary M.: Rising StarsKomljenovic D.: B-0434Kommata S.: B-0502Komuta M.: B-0804Kondrachuk O.: B-0735Kondratyev E.: B-0250Konen E.: B-0458, B-0612König D.: B-0487Koning G.A.: B-0887Konitsiotis S.: B-0406Könönen M.: B-0011Konovalov R.: B-0365Kooi E.M.: B-0253Kooi M.E.: B-0116, B-0118, B-0120, B-0317, B-0853Kooijman H.: B-0859Kool D.R.: A-066Kopf H.: SK 26Koprivsek K.: B-0812Korkusuz H.: B-0034, B-0040Körner M.: A-065Kornprobst S.: B-0491Korom C.: B-0982Korotkov A.: B-0229Korporaal J.G.: B-0482Kortesniemi M.: B-0249Kosanke K.: B-0880, B-0881Koskenkorva P.: B-0011Kosta P.: B-0406, B-0860, B-0862Kostkiewicz B.: B-0303Köstler H.: B-0001Kostron H.: B-0907Kotek G.: B-0485, B-0887Kotze C.W.: B-1003Kouklakis G.: B-0115Kousaka J.: B-0338, B-0339Kovacic M.: B-0273Kovacs G.: B-0639, B-0667, B-0914Koyama H.: B-0293, B-0329, B-0526, B-0767Koyanagi N.: B-0760Kozaka K.: B-0984Koziolek E.J.: B-0879Kraff O.: B-0347, B-0708, B-0782, B-1038Krager M.: B-0817Krainik A.: B-0355, B-0751Kramer J.: A-600Kramer U.: B-0003, B-0004, B-1008Krammer J.: B-0214Kraśnicki T.: B-0847Kratochwil C.: B-0200Krause D.: B-0251Krause J.: B-0426Krauspe R.: B-0486, B-0487Krauss A.: B-0788Krazinski A.: B-0849Kremser C.: B-0907Krestin G.P.: A-137, A-325, B-0350, B-0410, B-0413,B-0415, B-0485, B-0661, B-0663, B-0887Krestinich I.: B-0916Kreuzberg B.: B-0358Krings T.: A-504Krissak R.: B-0740Kristiansen A.: B-0275Kroep J.R.: B-0208Krokidis M.: A-339, A-445, A-545Kröpil P.: B-0252, B-0340, B-0366, B-0522, B-0648,B-0703Krotenkova M.: B-0365Krug R.: B-0043Krumbein I.: B-0886Krumm P.: B-0003, B-0004, B-1008Krupinski M.: B-0009Krzymyk K.: B-0632Kubiessa K.: B-0158Kuchta J.: B-0546Kudou S.: B-0760Kuehl H.: B-0500Kuemmel S.: B-0456, B-0506Kuhl C.: B-0981Kuhl C.K.: A-227Kühl H.: B-0028, B-0553Kühn A.: B-0158Kuhn F.P.: B-0156, B-0157Kühn J.P.: B-0445Kühn J.-P.: B-0348Kuhnigk J.-M.: B-0165, B-0297, B-0610Kuijpers T.W.: B-0593Kulama E.: B-0839Kulkarni C.B.: B-0056Kulkarni S.: B-0219Kullnig P.: B-0639Kumabe T.: B-0674Kumar D.: B-0657Kunick V.: B-0882Kuniewicz M.: B-0009Kuo C.-M.: B-0931Kupatt C.: B-0634Kupcsulik P.K.: B-0982, B-0983Kupfer J.: B-0481Kural F.: B-0155Kurcz J.: B-0744Kuriakopoulou M.: B-0919Kurisu K.: B-0305Kurobe Y.: B-0581Kurosaki A.: B-0760Kuru I.: B-0362Kurzidem S.: B-0487Kus S.: B-0762, B-0972Kusch B.: B-0740Kuwabara M.: B-0759Kwak J.Y.: B-0715Kwee R.M.: B-0116, B-0120, B-0965Kwee T.C.: A-299, B-0550Kwoh C.K.: B-0932Kwon O.J.: B-0296Kyriakou Y.: B-0915LLa Grassa M.: B-0686La Marra A.: B-0183Lacan Melki A.: B-0714Lacan-Melki A.: B-0473Lacelli F.: B-0186Ladd M.E.: B-0347, B-0708, B-1038Ladefoged C.: B-0103Ladefoged C.N.: B-0102Laghi A.: A-478, B-0193, B-0626, B-0661, B-0704,B-0792, B-0793, B-0796Lai A.: B-0043, B-0319, B-0483, B-0657Lai B.M.: B-0474Lai P.-H.: B-0225Lalam R.: A-435Laleman W.: B-0804Lalji U.C.: B-0029Lam C.H.S.: B-0649Lam M.G.E.H.: B-0032283

List of Authors and Co-AuthorsLamalle L.: B‐0751Lamb H.J.: A‐213Lambin P.: B‐0065Lambrecht V.: B‐0480Lambregts D.M.J.: B‐0625, B‐0940Lammering G.: B‐0627Lamot U.: B‐0476Landgraeber S.: B‐0782Lane N.E.: B‐0657Lang I.: B‐0599Lång K.: A‐507Lang R.A.: B‐0195Lang S.: B‐0895Langdon B.: B‐0409Lange C.: B‐0888Langer M.: B‐0263, B‐0361, B‐0551, B‐0736, B‐0890Langs G.: B‐0147, B‐0281, B‐0950, B‐0951Laniado M.: A‐548, B‐0101Lantuejoul S.: A‐240Lanza E.: B‐0785Lanzi R.: B‐0850Lanzman R.S.: B‐0081, B‐0252, B‐0340, B‐0366,B‐0522, B‐0552, B‐0648, B‐0703Laptev V.: B‐0764Laqmani A.: B‐0765Laqua R.: B‐0681Lardo A.C.: B‐0006Larici A.R.: B‐0021Larrache J.: B‐0900Larsen M.: B‐0275Larsen R.: B‐0103Larsson P.T.: B‐0653Lasek W.: B‐0304Laskowicz B.: B‐0009Laterre P.-F.: A‐196Latifoltojar A.: B‐0207Latorre-Ossa H.: B‐0335Lau K.: B‐0701Lau K.C.H.: B‐0192Lau S.: B‐0649Laubender R.: B‐0106Laubender R.P.: B‐0800Laue H.: B‐0891Laue H.O.A.: B‐0758Lauenstein T.: B‐0320, B‐0501, B‐0552, B‐0553,B‐0969Lauenstein T.C.: B‐0347, B‐0456, B‐0500, B‐0708,B‐0782, B‐1030, B‐1038Lauer L.: B‐0481Laufs A.: B‐0100Laun F.B.: B‐0151Laureys S.: A‐422Laurino F.: B‐0921Lauvin M.A.: B‐0105Lavin P.: B‐0955Law M.: A‐330Lawler L.P.: A‐488Lawrence A.J.: B‐0359Layritz C.: B‐0665Lazik A.: B‐0782Le Bas J.-F.: B‐0751Le Bihan D.: B‐0201Le Bras Y.: B‐0176Le Coultre R.: B‐0869Le Frère-Belda M.A.: B‐0335Le O.: B‐0824Leander P.: A‐594Leão M.: B‐0602Lebecque O.: B‐0987Leber A.: B‐0586Leber V.: B‐0586Lebret T.: B‐0694Leclercq D.: B‐0512Lecouvet F.E.: B‐0542, B‐0544Ledsam J.R.: B‐1029Lee B.Y.: B‐0637Lee C.H.: B‐0446, B‐0831Lee C.-H.: B‐0844, B‐0845Lee E.: B‐0784Lee G.Y.: B‐0046, B‐0784Lee H.J.: B‐0495Lee H.-J.: B‐0026Lee H.Y.: B‐0024, B‐0025, B‐0296Lee J.: B‐0831, Rising StarsLee J.H.: B‐0024, B‐0050Lee J.L.: B‐0446Lee J.M.: B‐0202, B‐0230, B‐0830Lee J.T.: B‐0494Lee K.L.R.: B‐0042Lee K.S.: B‐0024, B‐0025, B‐0296Lee K.Y.: B‐0433, B‐0528Lee M.: B‐0107, B‐0926Lee M.H.: B‐0428Lee M.W.: B‐0428Lee N.: B‐0221Lee N.J.: B‐0475Lee S.: B‐0043, B‐0319, B‐0484, B‐0529, B‐0657Lee S.-H.: B‐0513Lee S.M.: B‐0026Lee W.: B‐0418Lee Y.: B‐0221Lee Y.H.: B‐0475Lee Y.-H.: B‐0844, B‐0845Lefere P.: A‐480Lefort T.: B‐0094, B‐0444Lefrandt J.D.: B‐1001Legrand L.: B‐0837Lehmann F.: B‐0885Lehmann H.C.: B‐0905Lehmann P.: B‐0387Lehmkuhl L.: B‐0260Lehnert T.: B‐0290, B‐0393, B‐0536, B‐0537, B‐0633,B‐0669, B‐0711, B‐0723, B‐0774Leifland K.: B‐0967Leijtens J.W.A.: B‐0625, B‐0940Leiner T.: A‐243, A‐487, B‐0005, B‐0253, B‐0721,B‐1007Leithner R.: B‐0950, B‐0951Leitner S.: B‐0171, B‐0502, B‐1027Leitz W.: B‐0109Lelakowski J.: B‐0009Lelieveldt B.P.F.: B‐0208Lell M.: B‐0665Lella A.: B‐0127Lemasle P.: A‐624Lembcke A.: B‐0374Lemke A.: B‐0829Lemke H.U.: A‐047Lemmerling M.M.: A‐520Lemos P.: B‐0006Lempicki M.: B‐0310Lenz A.: B‐0882Leonard P.: B‐0594Leong L.: B‐0215Leong L.C.H.: B‐0080Leporq B.: B‐0443, B‐0444Lermite E.: B‐0797Lesaru M.: A‐373Leschka S.: B‐0660Leszek J.: B‐0401Leung K.Y.E.: B‐0142Leung M.W.: B‐0377Lévai A.: B‐0154Levit-Kantor A.: B‐0129Lewis E.: B‐0134, B‐0389Lewis M.: B‐0946Leyendecker J.R.: B‐0728Leyh R.: B‐0001Li D.: B‐0369Li J.-R.: B‐0201Li L.: B‐0656, B‐0674Li X.: B‐0496, B‐0497Li Y.: B‐0369, B‐0575Liang T.: B‐0632Liao Q.: B‐0169Lidén M.: B‐0825Liebl H.: B‐0483, B‐0484, B‐0655, B‐0934Ligabue G.: B‐0462, B‐0463Liguori C.: B‐0468, B‐0469, B‐0579Lim H.: B‐0428Lim H.K.: B‐0428Lim S.: B‐0428Lim S.K.J.: B‐0294Lim S.Y.Y.: B‐0404Lim T.-H.: B‐0418Lima J.A.C.: B‐0006Lin C.-J.: B‐0543Lin M.: B‐0036, B‐0924Lin W.: B‐0934Lin Y.-C.: B‐0931Linda A.: B‐0567, B‐0568Lindeboom L.: B‐0317Lindner E.: B‐0795Lindner T.: A‐523Lindqvist U.: B‐0653Link T.: B‐0043, B‐0319Link T.M.: A‐125, B‐0483, B‐0484, B‐0548, B‐0655,B‐0657Linn J.: B‐0353Linsenmaier U.: A‐197, A‐221, A‐413Lions C.: A‐244Liou I.W.: B‐0095Lioubashevsky N.: B‐0591Lippa N.: B‐0421Lipponer C.: B‐0969Lirette M.-P.: B‐0594Lissandrin R.: B‐0092Liu F.: B‐0483Liu J.: B‐0369Liu Y.: A‐095Livingstone R.: B‐0100Ljungqvist G.: B‐0943Llopis E.: A‐584Llorente C.: B‐0690Lobbes M.: B‐0450, B‐0451Lobbes M.B.I.: B‐0212Lockhat Z.: A‐258, A‐260Loeckx D.: B‐0280Loewe C.: A‐183, A‐513, B‐0251Löfgren J.: B‐0102, B‐0103Loft A.: A‐173284

List of Authors and Co-AuthorsLogager V.: A-534Lohan D.G.: A-625Lombard C.: A-262Lombardi M.: B-0251, B-0855Lombardo C.V.: B-0238, B-0836Londero V.: B-0132, B-0567, B-0568, B-0684, B-0687,B-0811Long N.M.: B-0437Longoni L.: B-0596Lönnemark M.: B-0177Lönnfors-Weitzel T.M.L.: B-0405Loo C.E.: B-0218Lopater J.: B-0694Lopci E.: B-0503, B-0507Lopera J.E.: B-0255Lorentzen T.: A-581Lorenzen M.: B-0315Losa M.: B-0850Lossev I.: B-0206Lotan E.: B-0209, B-0612Lou X.: B-0897Lourenço C.: B-0871Louwen F.: B-0398Lovblad K.-O.: A-366Löve A.: B-0892Lovisatti M.: B-0128Lu J.: B-0571, B-0575Luca A.: B-0772Lucarini S.: B-0086, B-0087Lucas R.: B-0043Lucatelli P.: B-0775, B-0920Lucchesi P.: B-0793Luceri A.M.: B-0392Luciani A.: B-0459, B-0924Luciani M.L.: B-0453Lucidarme O.: A-216Lücke C.: B-0260Luepke M.: B-0768Luerken L.: B-0725Lugli R.: B-0462, B-0463Luhur R.: B-0374Lui S.: B-0018Lukianchenko A.:Lumen N.: B-0088Lundqvist M.: B-0843Lung P.F.C.: B-0199Luo X.: B-0259Lupp A.: B-0282Luppi G.: B-0179Lux F.: B-1035Luypaert R.: B-0580Lynch J.: B-0655, B-0934Lythgoe M.: B-0097MMa C.: B-0571, B-0575Ma C.B.: B-0043Ma L.: B-0897Ma X.: B-0368Maas M.: A-102, A-253, A-498, B-0593, B-0621,B-0622, B-0625, B-0940Macarini L.: B-0904Macaskill P.: B-0818Maccabelli G.: B-0585Maccagni D.: B-0600Maccioni F.: A-230Maceroni M.M.: B-0193, B-0626, B-0793Macho J.: A-112Macias N.: B-0704Macioszek A.: B-0401Mack M.G.: A-126Mackinnnon A.D.: B-0359Macron L.: B-0007Maderthaner R.: B-0743, B-0858Maderwald S.: B-0347, B-0456, B-1038Madureira A.J.B.S.: A-036, Rising StarsMaduskar P.: B-0761Madzik J.: B-0671Maeda K.: B-0759Maffi P.: B-0440, B-0449, B-0769Maffulli N.: B-0184, B-0311Magnusson A.: A-304, B-0177Magomatschnigg H.F.: B-0563Magometschnigg H.: B-0213Magometschnigg H.F.: B-0952Maher M.M.: B-0119Mahnken A.H.: B-0167, B-0589, B-0981Mahon B.: A-547Maieron M.: B-0834, B-0835Mainprize J.G.: A-506Maintz D.: B-0806Majoie C.B.L.M.: B-0894Major D.: B-0618Majós C.: A-159Majumdar S.: B-0657Makarenko V.: B-0916Mäkelä T.: B-0249Malagari K.: B-0530Malago R.: B-0416, B-0662Malakhova E.: B-0229Malczyk K.: B-1014Maleux G.: B-0804Mali W.P.T.M.: B-0008, B-0027, B-0032, B-0218,B-0565, B-0721Malich A.: SK 27Malikova M.A.: B-0954Malkowski B.: B-0321Mall M.A.: B-0162Malliaras P.: B-0184Malliaropoulos N.: B-0933Mallio C.A.: B-0020, B-0407Maltese L.S.: B-0392Maltzeff N.: B-0921Maly Sundgren P.C.: A-072, A-194, A-332Mamboury N.: B-0387Mamone G.: B-0772Mandel C.: B-0144Manenti G.: A-376, B-0085Manfredi R.: A-110Mang T.: A-479Manganaro L.: B-0394, B-0396, B-0863, B-0868Manghat N.E.: B-0527, B-0856Mangold S.: B-0003, B-0004, B-1008Manickam S.: B-0595Manka R.: B-0910Mann A.: B-0180Mann R.M.: A-448, B-0072, B-0565, B-0968Manniesing R.: B-0758, B-0891Manning-Stanley A.S.: B-0608Mansour S.: B-0949Månsson C.: B-0426Mantarro A.: B-0623Mantini C.: B-0002Mantovani L.: B-0682Marano R.: A-451Marchesi G.: B-0267Marchesini M.: B-0561, B-0956Marchisio L.: B-1033Marcon M.: B-0567, B-0568Marcus R.: B-0582, B-0995Marcus R.P.: B-0411Marcy P.-Y.: B-0307, B-0308Marginet-Mangas C.: B-0810Margreiter M.: B-0502Mariani S.: B-0183, B-0696Marigliano C.: B-0697Marinelli D.: B-0002Marinelli S.: A-582Marinescu M.: B-0890Marini M.: B-0122Marino M.: B-0395Maris T.: B-0223, B-0228Markl M.: B-0361, B-0736Markonis D.: B-0147, B-0281Markota J.: B-0652Markstaller K.: B-0523Markus C.: B-0525Markus H.S.: B-0359Marletta M.: B-0698Maroldi R.: A-461, A-571, B-0203, B-0204, B-0246,B-0424, B-0478, B-0479, B-0705, B-0716Marquina T.: B-0724Marra P.: B-0239Marrelli D.: B-0194Marrero D.: B-1023Marrosu M.G.: B-0313Marsecano C.: B-0645Marshall M.: B-0199Marshall N.W.: B-0842Martegani A.: B-0232, SY 23Martel Villagrán J.: B-0690Marten-Engelke K.: A-239Martens D.: B-0749Martens M.H.: B-0621, B-0622, B-0625, B-0940Marti Bonmati L.: B-0251Martí De Gracia M.: B-0122, B-0124Martí-Bonmatí L.: A-115, A-139, A-416, B-0403, ESORCourse, EIBIRMartin D.C.: B-1023Martin D.F.: A-342Martinez de Vega V.: SY 13Martinez E.: B-0810Martinez L.: B-0724Martínez P.: B-0809Martínez Rodrigo J.J.: A-114Martini C.: B-0186Martinoff S.: B-0372Martinoli C.: A-163Martin-Rodriguez J.L.: B-0099Martins P.: B-1021Martirosian P.: B-0098Martucci M.: B-1015Maruzzelli L.: B-0772Mascarenhas V.: B-0822, B-0971Mascaretti G.: B-0493Mascaro L.: B-0246, B-0705Masciocchi C.: B-0183, B-0378, B-0493Masetto A.: B-0254, B-0438, B-0596, B-0783Maso C.: B-0131Masoomi M.: B-0104Mastorodemos V.: B-0223, B-0228285

List of Authors and Co-AuthorsMasui T.: B‐0570, B‐1004Mátéka I.: A‐026Mathers S.: A‐464Mathys C.: B‐0749, B‐0905Matias J.M.: B‐0278Matos A.: B‐0822, B‐0971Matos C.: A‐554, A‐601Matranga D.: B‐0730, B‐0990Matsui O.: B‐0984Matsumoto S.: B‐0293, B‐0329, B‐0526, B‐0767Matsushige T.: B‐0305Mattace-Raso F.U.S.: B‐0111Mattei P.A.: B‐0509, B‐1013Mattiuz C.A.: B‐0654Matzko M.: B‐0491Maurel B.: B‐0460, B‐0461Maurer M.: B‐0189, B‐0306Maurer M.H.: B‐0539Mauri G.: B‐0646, B‐0771, SK 26Maurovich-Horvat P.: B‐0917Mavrogenis A.F.: B‐0640Maxeiner A.: B‐0172Maxien D.: B‐0927, B‐0928May A.: B‐0003, B‐0004Mayer J.L.: B‐0523Mayerhoefer M.E.: B‐0328, B‐0680, B‐0802Mayo J.: B‐0632Mazioti A.: B‐0530Mazonakis M.: B‐0611Mazza E.: B‐0801Mazza G.: B‐0791, B‐0794Mazzei F.G.: B‐0058, B‐0194Mazzei M.A.: B‐0057, B‐0058, B‐0059, B‐0194Mazzoni L.: B‐0511Mazzoni L.N.: B‐0086, B‐0087Mbalisike E.: B‐0039, B‐0471, B‐0748Mc Laughlin P.D.: B‐0119McCarthy P.: B‐0823McCulloch C.: B‐0934McCulloch C.E.: B‐0484, B‐0655McEntee M.F.: B‐0272, B‐1028McHale T.: B‐0823McHugo J.: A‐411McKillop G.: B‐0373McLaren C.: A‐465McNulty J.: A‐344, B‐0604McQuiston A.D.: B‐0411McRobbie D.: B‐0839Medici M.: B‐0429Medvedev S.: B‐0229Mehrez H.: B‐0292, B‐0379Meier A.K.: B‐0482Meier R.: B‐0880Meijboom F.J.: B‐0005Meijboom W.B.: B‐0415Meinel F.: B‐0288Meinel F.G.: B‐0161, B‐0556, B‐0634, B‐0638,B‐0754, B‐0757Méjean A.: B‐0084Mejia-Bustamante V.: B‐0840Mekiš N.: B‐0609Melchionda D.: B‐0904Melchiorre F.: B‐0770, B‐0771Melgari J.M.: B‐0407Melis L.: B‐0533, B‐0535, B‐0958Meloni A.: B‐0467, B‐0854, B‐0855Meloni G.B.: B‐0533, B‐0535, B‐0958Melzer A.: B‐0795Menchi I.: B‐0086, B‐0087Mendes C.M.: B‐0386Mendes Pereira V.: A‐366Menezes L.: B‐1003Menges A.-L.: B‐0372Menovsky T.: A‐306, B‐0301, B‐0302Mensel B.: B‐0348, B‐0445, B‐0681Menu Y.: A‐068, A‐134, A‐157, A-281Mercer D.: B‐0702Merchant M.S.: B‐0209Merckel L.G.: B‐0072, B‐0565Mercuri P.: B‐0058, B‐0194, B‐0682Merhemic Z.: A‐414Merkle E.M.: B‐0728Merran S.: A‐352Mershina E.: A‐515Mershina E.A.:Mertelmeier T.: SY 5Mesa J.: B‐0724Mess W.H.: B‐0120Messa C.: B‐0505Mesters R.M.: B‐0805Metivier-Cesbron E.: B‐0797Meuli R.: B‐0542, B‐0544, B‐0670Mews J.: B‐0374Meyblum E.: B‐0459Meyer B.: B‐0047, B‐0244Meyer B.C.: B‐0038Meyer E.: B‐0044Meyer M.: B‐0160, B‐0265, B‐0352Meyer M.-E.: A‐268Meyer P.: B‐0310Meyer S.: B‐0191Meyer zu Hörste G.: B‐0905Miccò M.: B‐0323, B‐0395Miccoli A.: B‐0493Michaely H.J.: A‐242, B‐0343, B‐0345, B‐0540,B‐0999, SY 12Michalak E.: B‐0671Michałek A.: B‐0852Michelozzi C.: B‐0770, B‐0771Michieletti E.: B‐0267Michielsen K.: B‐0804, B‐0842Michoux N.: B‐0987Midiri M.: B‐0855Miese F.: B‐0340, B‐0366, B‐0651, B‐0703Miese F.R.: B‐0486, B‐0487Migda B.: B‐0717Miglio E.: B‐0453Migliorisi C.: B‐0925Mihl C.: B‐0261, B‐0264, B‐0746Mildenberger P.: A‐576Miles K.: B‐0943Milner S.: B‐0680Milosevic Z.C.: B‐0455, B‐0566Minami T.: B‐0984Minar E.: A‐212Minarikova L.: B‐0953Mindjuk I.: B‐0491Minguillon C.: B‐0809Minhas K.: B‐0856Minighin E.: B‐0834, B‐0835Mintzer J.E.: B‐0408Minutolo O.: B‐0064, B‐0391, B‐1005Miraglia R.: B‐0772Miranda A.C.: B‐1021Miranda I.: B‐0211Mirsadraee S.: B‐0373Mischen B.T.: B‐0417Mishah N.M.: B‐1025Missonnier S.: A‐525Mitjana R.: B‐0222Mitsumori L.M.: B‐0095Mitulescu A.: B‐0512Mitusov V.: B‐0695Miyamoto Y.: B‐0336Miyazaki Y.: B‐0720Miyoshi M.: B‐1004Mizandari M.: B‐0773Mizoguchi M.: B‐0673Mizuki K.: B‐0570, B‐1004Mngomezulu V.: A‐257Modorati G.: B‐0712Mohan P.C.: B‐0659Mohan S.: B‐0604Mohd Nor H.: B‐0404Mohd Ramli N.: B‐0015Mohr F.W.: B‐0260MohyElDien R.: B‐0713Mokbel K.: B‐0680Mokrane F.: A‐244Mokry T.: B‐0178Mol H.: B‐0997Molenschot M.C.: B‐0734Molgaard C.: B‐0037Molica S.: B‐1031Molinari C.: B‐0132, B‐0684, B‐0811Molinari F.: B‐0376Molinié V.: B‐0837Mollet N.R.: A‐249Moltz J.: B‐0200Monguzzi L.: B‐0620Monnin P.: B‐0277Mono M.-L.: B‐0752Montaser A.: B‐0529Monteiro M.: B‐0278Montemezzi S.: B‐0454Montet X.: A‐596Mookerjee R.: B‐0097Moon H.J.: B‐0715Moon J.H.: B‐0330Moore C.E.: B‐0932Moorthy S.: B‐0056Moos S.I.: B‐1037Moosbauer H.: B‐0953Morana G.: A‐006Morassi M.: B‐0203, B‐0204Morcos S.K.: A‐537Moreau-Gaudry A.: B‐0429Moretti M.: B‐0511Morgan R.: A‐247, A‐540, Rising StarsMori E.: B‐0674Mori N.: B‐0777Mori T.: B‐0720Mori Y.: B‐0338, B‐0339Morimoto R.: B‐0828Morini V.: B‐0462, B‐0463Morisaka H.: B‐0093Moriyasu F.: B‐0336Morone M.: B‐0791, B‐0794Morr D.: B‐1035Morris P.B.: B‐0417Morris R.: B‐0359286

List of Authors and Co-AuthorsMorrison G.: B-0599Morrissey D.: B-0184, B-0311Morsbach F.: B-0063, B-0242, B-0660, B-0788Mortilla M.: B-1012, B-1018Morton S.L.: B-0311Morvay Z.: A-026Moscano F.: B-0598Moschetta M.: B-0283Moschouris H.: A-623Moser M.: B-0068Mostbeck G.: B-0148, B-0636, B-0635, SK 26Motevalli M.: B-0857Motohashi N.: B-0760Motosugi U.: B-0093Mouden M.: B-0664Moulin G.: B-0460, B-0461Moussa S.: A-303Mousseaux E.: B-0007Moutard M.-L.: B-0867Mowinckel-Nilsen M.L.: B-0381Mpampali A.: B-0115Much C.: B-0859Mück F.: B-0243Mück F.G.: B-0472Muehlenbruch G.: B-0746Mueller H.: B-0147, B-0281Mueller-Lisse U.G.: A-177, A-354, B-0578Mueller-Mang C.: B-0281Mugikura S.: B-0674Mulder D.J.: B-1001Müller A.: B-0232, B-0537, B-1035Müller-Bierl B.M.: B-0580Müllerleile K.: B-0367Mundinger A.: SY 13Mungai F.: B-0325Munier F.: B-0670Münter M.: B-0151Murata T.: B-0674Murchison J.T.: B-0060Mus R.D.M.: B-0968Muscogiuri G.: B-0626, B-0691, B-0696, B-0704Mushtaq S.: B-0262Musi G.: B-0082Muto M.: A-501, A-558Mutsaerts H.-J.M.M.: B-0894Myeong W.-J.: B-0739Myojin K.: B-0777NNabuurs C.I.H.C.: B-0317Nachtigal A.: B-0129Nada O.M.: B-0949Nadrljanski M.M.: B-0455, B-0566Naga S.: B-0331Nagata M.: B-0581Naguib N.N.N.: B-0031, B-0033, B-0170, B-0393,B-0534, B-0536, B-0711, B-0774Nagy E.: A-026Nagy J.: B-0840Nagy N.N.: B-0709Nahama-Allouche C.: B-0867Nair A.: B-0299Nakamura K.: B-1017Nakano S.: B-0338, B-0339Nakano Y.: B-0759Nakazaki M.: B-0720Nance J.W.: B-0419Napoli A.: B-0174, B-0399, B-0414, B-0427, B-0490,B-0643, B-0644, B-0645Nardo L.: B-0043, B-0319, B-0483, B-0484, B-0529,B-0657, B-0934Nasar M.: B-0713Nascimento J.H.H.R.N.: B-0590Nassenstein K.: B-0584Natale L.: A-372, B-0325Natilla T.: B-0791, B-0794Navarro U.: B-0478Navarro Vilar L.: B-0168Nechaev V.: Rising StarsNederend J.: B-0960, B-0961Nederveen A.J.: B-0894Neff K.W.: B-0865, B-0866Negus I.: B-0527Nelemans P.: B-0264Nensa F.: B-0708, B-0969Neri E.: A-605, B-0623, B-1010Nestle U.: A-099Neubauer B.J.: Rising StarsNeuhaus P.: A-317Neumaier K.: B-0995Neumann C.: B-0148, B-0635, B-0636Neumann U.: B-0981Neurohr C.: B-0161, B-0634, B-0638Neuzillet Y.: B-0694Nevens F.: B-0804Nevitt M.: B-0655, B-0934Nevitt M.C.: B-0484Newby D.E.: B-0373Newell M.: B-0104Newerla C.: B-0130Nezzo M.: B-0085Ng W.H.A.: B-0042N’Guyen Bui B.: B-0421Nguyen V.L.L.: B-0253Nica I.: A-196Nichelatti M.: B-0925Nicolai P.: A-571Nicolaou S.: B-0632Nieboer K.: B-0248Niederstadt T.: B-0898Nielsen J.: B-0351, B-0356, B-0357, B-0750Nieman K.: B-0410, B-0415, B-0661Niemann T.: B-0519, B-0729, B-0731Nießen C.: B-0985Niessen W.J.: B-0014, B-0016, B-0142, B-0402Nievelstein R.A.J.: B-0550Niggemann P.: B-0546Nijsen J.F.W.: B-0032Nikitin V.: B-0206Nikolaou K.: A-012, B-0068, B-0117, B-0341, B-0344,B-0353, B-0582, B-0754, B-0755, B-0757, B-0846,B-0913, B-0975, B-1036Nilsson A.: B-0426, SY 9Nimish S.: B-0042Ninivaggi V.: B-0395Nishio M.: B-0293, B-0329, B-0526, B-0767Niskanen E.: B-0011, B-0017Nittka M.: B-0435Nitzsche S.: B-0260Nöbauer-Huhmann I.: B-0488Nocchi-Cardim L.: B-0531Noce V.: B-0174, B-0399, B-0414, B-0427, B-0490,B-0643, B-0644, B-0645Nocetti L.: B-0349, B-0462, B-0463Noczyńska A.: B-1016Noël P.B.: B-0525Noelte I.: B-0898Nordberg A.: B-0508Normoyle B.: B-0119Notohamiprodjo M.: B-0341, B-0344, B-0975Nour Eldin N.E.: B-0031Nour-Eldin N.-E.A.: B-0033, B-0393, B-0534, B-0536,B-0711Nowak C.: B-0651Nowak K.: B-1014Nowotny B.: B-0100Ntoulia A.: B-0929Ntziachristos V.: B-0880Nunes C.: B-1021Nunziata A.: B-0233Nusman C.M.: B-0593Nussberger F.: B-0819Nuyens D.: B-0915Nuyts S.: B-0152Nygren P.: B-0426OO’ Gorman P.: B-0437Obara M.: B-0678Oberhofer N.: B-0108Oca R.: B-0185, B-0631Occleshaw C.J.: B-0856O’Connor O.: B-0119O’Connor P.J.: A-363O’Connor S.: A-192Odedra D.: B-0699, B-0702Odyniec-Nowacka M.: B-0852Oei E.: B-0485Oei M.: B-0758, B-0891Offiah A.: B-0599Offiah A.C.: A-527Ofner J.: B-0281Ogata H.: B-0760Oh J.H.: B-0046Oh Y.-W.: B-0433, B-0528Ohno Y.: B-0293, B-0329, B-0526, B-0767Oikonomou A.: A-237, B-0115Okada T.: SY 19Okazaki T.: B-0305O’Keeffe M.: B-0119O’Keeffe S.A.: B-0216Okuno T.: B-0336Olbricht T.: B-0969Oleaga Zufiría L.: A-549O’Leary D.: B-1022Olerud H.: B-0989Oliboni E.: B-0045Oliveira E.: B-0874Olivier C.: B-0890Olschewski A.: B-0639Olschewski H.: B-0639, B-0667, B-0914Omar K.: B-0933O‘Meara C.: B-0549Omelchenko O.M.: B-0019Omoto K.: B-0336Omoumi P.: B-0542, B-0544O’Neill F.: B-0119O’Neill S.: B-0119Ong M.: B-0999Ono Y.: B-0828Oosterlinck W.: B-0088287

List of Authors and Co-AuthorsOosterwijk J.C.: B-0560Oostveen L.J.: B-0758, B-0891Op de Beeck B.J.: A-055Opherk C.: B-0353Oppermann E.: B-0034, B-0040Oraevsky A.: B-0955Orecchia R.: B-0503Orgera G.: B-0921Origgi D.: B-0730, B-0990Orlandini L.C.: B-0325Orsenigo E.: B-0801Orsi F.: A-188, A-444Ortori S.: B-0698Orzada S.: B-0708O‘Shea A.: B-0564Osinger K.: B-0635, B-0636Osman S.: B-0145Ostendorf B.: B-0651Ostrowska M.: B-0489O’Sullivan G.: A-625Ota H.: B-0828Otten O.: B-0165Ottervanger J.P.: B-0664Otto P.: B-0955Ottonello C.: B-0182, B-0545Oudkerk M.: B-0164, B-0291, B-0295, B-0298,B-0442, B-0588, B-1001Ourednicek P.: B-0916Ovesen C.: B-0351, B-0356, B-0357, B-0750Owens C.: A-105, A-107, A-267Oyen R.H.: A-353Ozcan C.: B-0899Ozdamarlar U.: B-0362Ozdoba C.: A-142Ozgen Mocan B.: A-251Özkan F.: B-0055, B-0718Özsunar Y.: A-331Öztürk F.U.: B-0155PPace A.: B-0089, B-0090Pace I.: B-0279Paci E.: A-062Padhani A.R.: A-060, A-329, ESOR CoursePadovani R.: B-0998Padrón M.: SY 8Paglialunga S.: B-0853Pagonidis K.: B-0611Pahn G.: B-0241, B-0523Paik S.Y.: B-0052Painho L.: B-0877Pajor P.: B-0982, B-0983Pak A.: B-0221Pakuła-Kościesza I.: B-1014Palas J.: B-0822, B-0971Palkó A.: A-193, A-430Palm J.: B-1035Palmisano A.: B-0239, B-0440, B-0449, B-0507,B-0585Palorini F.: B-0730, B-0990Palumbo M.: B-0392, B-0941, B-0947Palumbo P.: B-0930Pałys A.: B-0304Pameijer F.A.: A-117, A-569Pan C.: B-0571Pan H.-B.: B-0225Panara V.: B-0509, B-0930, B-1013Pandolfi E.M.: B-0693Panebianco V.: B-0089, B-0090, B-0174Panicek D.M.: A-088Panizza P.: B-0561, B-0956, SY 16Panjnosh M.: B-0477Panou T.: B-0223, B-0228Pantalone F.: B-0397Papadaki E.: B-0223, B-0228Papadakis A.E.: B-0996Papadopoulou S.L.: B-0410, B-0415, B-0663Paparo F.: B-0197, B-0948Papathanasiou M.A.: A-265Papavasilopoulou M.: B-0541Papini G.D.E.: B-0545Pappas E.: B-0929Pappot T.W.F.: B-0137Paprottka P.: B-0068, B-0803Páramo M.: B-0900, B-0966Pardo F.: A-078Pareto D.: B-0222Parienty I.: B-0255Parizel P.: A-264, B-0302Parizel P.M.: A-055, A-131, A-205, A-306, A-346,A-365, A-556, B-0285, B-0286, B-0432, B-0480Parizel P.N.M.: B-0301Park B.K.: B-0826Park C.K.: B-1002Park C.-K.: B-0513Park C.M.: B-0026, B-0446, B-0831Park H.J.: B-0428Park J.: B-0739Park J.H.: B-0364, B-1002Park K.: B-0025Park S.-H.: B-0513Park S.Y.: B-0210, B-0826Park Y.S.: B-0446, B-0831Parker R.: B-0408, B-0409Parodi J.C.: B-0257Parraga J.: B-0770Parrilla P.: B-0122Parrinello A.: B-0194Parrot A.: B-0538Partington K.J.: B-0779Partovi S.: B-0326Patak M.: B-0198Patak M.A.: B-0616Patel B.: B-0359Patel C.: B-0554Patel K.: B-0976Patel S.K.: B-0524Patrick K.: B-0409Patsch J.: B-0548Paul D.: B-0044, B-0540Paul J.: B-0471Paul N.: B-0379Paul N.S.: B-0292Paulo C.: Rising StarsPaulo G.: A-284, A-467, B-0272, B-0275, B-0605Pauwels P.: B-0432Pavageau A.H.: B-0797Pavlica P.: B-0974Pazahr S.: B-0198, B-0910Pecchi A.: B-0231, B-0237, B-0349Pedicini V.: B-0771Pediconi F.: B-0453Peeters M.: B-0432Peeters P.H.M.: B-0072, B-0565Peeters R.: B-0510Peeters R.R.: A-386Pekarovic D.: A-167Peker O.: B-0055Pelage J.-P.: A-390Pelc N.: A-517Peldschus K.: B-0888Peli M.: B-0128Pellegrino C.: B-0531Pelliccia L.: B-0941Pellot Barakat C.: A-216Pellow A.: B-0668Pelte M.-F.: B-0970Peltonen J.I.: B-0249Peña Fernández M.P.: A-286Peña J.: B-0436Peng C.: B-0884Pengel K.E.: B-0218Penzel J.: B-0937Pepe A.: B-0855Pepe G.: B-0503Pepi M.: B-0262Perdrix L.: B-0007Pereira J.: B-0175Pereira P.L.: SK 27Perez-Rodrigo S.: A-375Peri A.: A-049Peringa J.: B-0790Peris Sanchez R.: B-0168Perisinakis K.: B-0996Perkins A.: A-402Perks F.: B-0780Perri M.: B-0378Perry N.: B-0680Persechino R.: B-0691, B-0693Perseghin G.: B-0850Persigehl T.: B-0805, B-0806Persson A.: B-0287Pescarini L.: B-0686Peschel O.: B-0727Pesquer L.: B-0310Peter V.: B-0448Peters N.H.G.M.: B-0072, B-0565Petersen C.: B-0892Petersen D.: B-0896Petersen J.: B-0163Petersen S.E.: B-0413, B-0663Petralia G.: B-0082Petrillo A.: B-0217, B-0233, B-0942Petrillo M.: B-0942Petrone G.: B-0021Peynircioglu B.: A-178Peyrin F.: B-0890Pezzato A.: B-0416, B-0662Pfammatter T.: B-0063Pfannenberg C.: B-0447, B-0504Pfefferkorn T.: B-0353Pfeiffer F.: B-0112, B-0846, B-1006Pfeiffer H.: B-1011Pfirrmann C.W.: B-0187Pfirrmann C.W.A.: A-496, A-599, B-0048, B-0181,B-0314, B-0938Pflederer T.: B-0665Pham T.T.: B-0145Phillips G.S.: B-0145Piaggesi A.: B-0922Piano M.: A-045288

List of Authors and Co-AuthorsPianta L.: B-0479Piccazzo R.: B-0197Piccolo C.L.: B-0342, B-0939Pichi A.: B-0796Pidial L.: B-0335, B-0911Pieles G.: B-0856Pienn M.: B-0639Pieper S.: B-0284Pierot L.: A-132Pietrabissa A.: A-049Pietrapertosa A.: B-0855Pietsch H.: B-0167, B-0747, B-0913Piga M.: B-0617, B-0979Pigneur F.: B-0459Pijl M.E.J.: B-0137Pijnappel R.: B-0962, B-0964Pijnappel R.M.: B-0959Pilania K.: B-0641Piliszek A.J.: B-0852Pilleri S.: B-0958Pilleul F.: B-0443, B-0444Pilz L.R.: B-0022Pina Insausti L.: B-0810Pina Insausti L.J.: B-0685, B-0966Pina L.: B-0809Pina L.J.: B-0813Pinheiro J.: B-0138, B-0602, B-0603, B-0876Pinker-Domenig K.: B-0071, B-0076, B-0171, B-0213,B-0502, B-0562, B-0680, B-0950, B-0951, B-0952,B-0953Pinker-Domenig K.J.: B-0563Pinochet M.A.: A-403Pinto dos Santos D.: B-0420Pinto P.: B-0173Piorkowski C.: B-0909Pirinen M.: B-0135Pirovano G.: B-0369Pirtoli L.: B-0947Pisanec I.: B-0652Piscaglia F.: A-582Pisco J.M.: B-0175Pistolesi D.: B-0698Pitcher R.: A-262Pitici A.: B-0141, B-0807Pitocco F.: B-0020, B-0407, B-0468, B-0469, B-0579Pittiani F.: B-0705, B-0716Pitton M.: B-0420Plaitakis A.: B-0223, B-0228Plass A.: B-0660Platon A.: B-0121Plug G.: A-170Plumb A.: B-0789Png M.A.: B-0659Podgórski P.: B-0847Podo F.: B-0569Poeppel T.D.: B-0500Pohlig F.: B-0435Poillucci G.: B-0762Pokieser P.: A-415Pokieser W.: SK 26Polanec S.: B-0171, B-0502Poletti P.-A.: B-0121Polico I.: B-0686Pollo C.: B-0405Pollock A.: B-0864Pomar-Nadal A.: B-0403Pomschar A.: B-0106Pontana F.: B-0519, B-0630Ponti F.: B-0316Pontone G.: B-0262Poole K.E.S.: B-0658Popovici C.: B-0141, B-0807Poppert H.: B-0113Poretti D.: B-0771Portelli J.L.: B-0604Porto A.: B-0217Postema S.: SY 1Poxton I.R.: B-0060Pozzi G.: B-0785Pozzi Mucelli R.: B-0416, B-0572, B-0574, B-0662,B-0706, B-0710Pozzi-Mucelli R.: A-031Prabhu A.D.: B-0013Prada R.: B-0185Prasad V.: B-0282Prassopoulos P.: B-0115Pravata’ E.: B-0408, B-0409Precht H.: A-393Prevos R.: B-0450, B-0451Prieto J.M.: A-054Prince J.F.: B-0032Probst P.J.: B-0819Proietti A.: B-0686Prokop M.: A-429, B-0297, B-0299, B-0610, B-0758,B-0891Pronin I.N.: A-510Prosch H.: B-0635, B-0636Provenzale J.: SY 6Pruvo J.-P.: A-364Prvulovic M.: B-0812Prvulovic N.: B-0812Puchner S.: B-0917Puderbach M.: B-0162, B-0766Puderbach M.U.: A-083, A-618Pueyo J.C.: B-0143, B-0900Pugliese F.: A-514, B-0413, B-0663Pugliese L.: A-049Pugliese S.: A-346, B-0675Pujol S.: B-0284Puliti D.: A-062Pullara S.K.: B-0056Pullini S.: B-0834, B-0835Puntel G.: B-0572Punwani S.: B-0097, B-0207, SY 15Puppala S.: B-0256Puppo C.: B-0197Puri S.: B-0557Puri S.K.: B-0013Purz S.: B-0158, B-0558Pusceddu C.: B-0533, B-0535, B-0958Pusztaszeri M.: B-0970Pwint T.: B-0062QQian J.: B-0034, B-0040Qiao M.: B-0368Qiu L.: B-0018Quaia E.: B-0762, B-0944Quan Q.: B-0883Quattrocchi C.C.: B-0020, B-0407Quehenberger F.: B-0234, B-0743, B-1032Quentin M.: B-0081Querques G.: B-0440Quinlan M.: B-0823RRaatschen H.-J.: B-0191Rabenalt R.: B-0081Rączkowska S.: B-1014Radler E.: B-0975Radulovic O.S.: B-0566Radwan S.: B-0906Raetzer S.: B-0242Ragab Y.: B-0123Rager O.: B-0970Rahali L.: B-0770Rahmat K.: B-0015, B-0404Rahmouni A.: B-0459, B-0924Raible S.: B-0616Raimondi S.: B-0082Rainford L.: B-0272, B-0384, B-0604, B-0606,B-1022, B-1028Raissaki M.: B-0541Rajandran Nair S.: B-0404Ramalho M.: B-0822, B-0971Ramchandran P.V.: B-0056Ramírez Fuentes C.: B-0168Ramli N.: B-0404Rampoldi A.: B-0925Rana S.: B-0573Randrianarisoa E.: B-1008Ranschaert E.R.: A-290, A-609Rapellino A.: B-1033Raptis D.A.: B-0314Raskin S.: B-0612Rasper M.: B-0912Rassokhin V.: B-0229Ratib O.: A-210, A-608, B-0970Raupach J.: A-245Rauscher I.: B-0098Ravanelli M.: B-0203, B-0204, B-0478, B-0479Ravaud A.: B-0176Raymond E.: A-358Rayón-Aledo J.C.: B-0403Razek A.A.: B-0150Rechl H.: B-0435Reddy S.N.: B-0060Redel T.: B-0482Redheuil A.: B-0007Reding R.: B-0987Reeder S.B.: B-0445Reekers J.A.: A-100, A-101Regier M.: B-0367, B-0765, B-0935Regina U.M.V.: B-0763Rehani M.M.: A-384Rehman H.: B-0780Rehnitz C.: B-0481Reich C.: B-0683Reichelt D.C.: B-0749, B-0905Reichenbach J.R.: B-0886Reichert M.: B-0343Reid J.: B-0373Reiffers S.: B-0664Reijman M.: B-0485Reimer P.: A-453Reina V.: B-0512Reindorp N.: B-0129Reiner C.S.: B-0063Reinert M.: B-0752Reinhardt M.: B-0558Reis C.I.S.: B-0872, B-0874, B-0877289

List of Authors and Co-AuthorsReiser M.F.: A-180, A-492, B-0066, B-0068, B-0106,B-0112, B-0113, B-0117, B-0161, B-0195, B-0243,B-0288, B-0341, B-0344, B-0353, B-0472, B-0491,B-0547, B-0556, B-0578, B-0634, B-0638, B-0727,B-0754, B-0755, B-0757, B-0795, B-0800, B-0803,B-0846, B-0913, B-0927, B-0928, B-0975, B-0980,B-0995, B-1006, B-1036Reiter G.: B-0667, B-0858, B-0914Reiter U.: B-0667, B-0858, B-0914, B-1032Reitter A.: B-0398Remedios D.: A-292Rémy J.: B-0376, B-0519, B-0630, B-0729, B-0731Rémy-Jardin M.: A-559, B-0376, B-0519, B-0630,B-0729, B-0731Renc O.: A-245Rengo M.: B-0193, B-0661, B-0792, B-0793Renne G.: B-0082Renne S.: B-0467Renosi G.: B-0094Renoux J.: A-160Renz D.: B-0189, B-0306Rep S.: A-522Repa I.: B-1024Reponen J.: A-048Retico A.: A-266Revel M.-P.: A-562Revelli M.: B-0197, B-0948Reymen B.: B-0065Reynaud O.: B-0201Ribeiro A.M.: B-0603Ribeiro J.: B-1021Ribeiro L.P.V.: B-0136, B-0138, B-0274, B-0386,B-0602, B-0603, B-0607, B-0871, B-0875, B-0876,B-1020Ribeiro M.M.C.P.: B-1019Ribeiro R.T.: A-169Riccabona M.: A-482Ricchi P.: B-0854Ricci V.: B-0392, B-0941, B-0947Richli Meystre N.: B-0387, B-0869Richter S.: B-0109Ricke J.: A-566Ridereau-Zins C.: B-0797Riebisch M.: B-0101Rieger M.: A-067Riegger C.: B-0506Rienmüller R.: B-0916Rienmüller T.: B-0916Riess H.: A-319Riffel P.: B-0540Rimola J.: A-593Rimondi E.: B-0640Rindi G.: B-0021Ring J.: B-0805Ringe K.I.: B-0191Ringl H.: B-0328, B-0719Rio Tinto H.A.M.R.: B-0175Ripkens S.: B-0447Risser D.U.: B-0613Risson J.-R.: B-0312Rist C.: B-0556Ristanis S.: B-0929Ritter C.O.: B-0001Rittig K.: B-1008Rizzatto G.: A-611Rizzi P.B.: B-0006Robben S.G.F.: A-531, A-627Robinson P.: A-497, B-0431, B-0779Roca E.: B-0204Roccia S.: B-1031Rocha A.: B-0185Rocha D.P.: B-1019Rochitte C.E.: B-0006Rockall A.G.: A-377Rodari M.: B-0503Roden M.: B-0100Roditi G.: A-182Rodrigues J.C.L.: B-0527, B-0856Rodrigues S.I.: B-0136, B-0274, B-0386, B-0602,B-0607, B-0871, B-1020Rodriguez-Justo M.: B-1003Rodt T.: B-0038, B-0244, B-0768Roebuck D.: A-394, A-396Roemer F.W.: B-0656, B-0932Roeth A.: B-0981Rogalla P.: A-231, A-428, B-0699, B-0702Rogler G.: B-0198Roh J.: B-0364, B-1002Rohan V.: B-0358Rokytska N.: B-0735Rollandi G.A.: B-0197, B-0948Rollandi L.: B-0197Romanini L.: B-0705Romaniuk-Doroszewska A.: B-0671Romano A.: B-0518, B-0675Romano L.: B-0045Romano S.: A-349Romero L.: B-0211Rominger A.: B-0117, B-0556Ron Y.: B-0978Ronconi P.: B-0182Ronot M.: A-109, A-358Roobottom C.: B-0798, B-0821Ros J.: B-0143Rosati R.: B-0466Rosen B.R.: A-209Rosendahl K.: A-533Rosenthal H.: B-0038, B-0047Rositi H.: B-0890Roskams T.: B-0804Rossi A.: A-086, A-120, A-514, A-626, B-0410,B-0413, B-0415, B-0663Rossi C.: B-0532Rossi Espagnet M.C.: B-0518, B-0675Rossi G.: B-0640Rossi M.: B-0921Rossini A.: B-0424, B-0850Rossini P.: B-0203Roßpunkt S.: B-0068Rostad E.: B-0870Rosu R.: B-0141, B-0807Rotellar F.: B-0778Roth H.R.: B-0789Rotini R.: B-0642Rotondo A.: B-0057, B-0059Rottbauer W.: B-0412, B-0583Rousseau H.: A-244Rovelli A.: B-0596Rovers M.M.: B-0083Rovira-Cañellas A.: A-500, A-613Rozhkova Z.Z.: B-0019Rozovsky K.: B-0591Rübben H.: B-0969Rubbert C.: B-0326Rubens M.B.: A-572Ruder T.D.: A-475Rüfenacht D.A.: A-133Ruggieri P.: B-0640Ruggiero A.: B-0887Ruiz Blanco C.: A-284, A-287Rummeny E.J.: B-0098, B-0180, B-0322, B-0435,B-0525, B-0548, B-0586, B-0880, B-0881, B-0912,B-0937Rundstein A.: B-0458Runge J.H.: B-0790Runge M.: B-0312Runnebaum I.B.: B-0077, B-0808Ruscheweyh R.: B-0106Russe M.F.: B-0361Russo B.: B-0663Ruszniewski P.: A-604, B-0576Rutten M.J.C.M.: SY 4Rybacki K.: B-0749Ryoo I.: B-0516SSaa J.: B-0103Saake M.: B-0895Saam T.: B-0112, B-0113, B-0117, B-0353, B-1006Saba L.: B-0057, B-0059, B-0532, B-0617, B-0979Sablayrolles J.-L.: B-0370Sabri O.: A-208, B-0558Sacco P.: A-607Sack I.: B-0896Sacrini A.: B-0770Sadeghi M.: B-0927, B-0928Sadegi M.: B-0536Saez F.: A-628Sagarduy M.I.: B-0257Sagniez A.: B-0370Sah B.-R.: B-0063Sahin M.: B-0718Saini S.: B-0069Sainz M.: B-0809Sairanen V.: B-0249Saito K.: B-1029Saiz-Mendiguren R.: B-0810Sajadidhekrodi F.: B-0128Sakahara H.: B-0570, B-1004Sakai S.: B-0986Sakamoto S.: B-0305Sakuma H.: B-0581Sala A.: B-0596Sala E.: A-412, A-586, B-0390Sala G.: B-0416, B-0662Salamon J.: B-0888Salazar J.P.: B-0222Saldari M.: B-0394, B-0396, B-0863, B-0868Salem R.: A-359Salem U.: B-0141Salerno S.: B-0730, B-0990Salgado R.: A-055, A-205, A-365, B-0285, B-0286Salice S.: B-0509, B-1013Salik A.E.: B-0838Şalk I.: B-1034Salmi A.: B-0424Saltybaeva N.: B-0991, B-0992, B-0993Salvador R.: A-612, B-0211Salvador X.: B-0211Salvagnini E.: B-0842Salvatori F.M.: B-0300, B-0775, B-0920290

List of Authors and Co-AuthorsSalvatori L.: B‐0465Salvini N.: B‐0194Salvioni M.: B‐0769Samadi A.R.: B‐0007Samargiski M.: B‐0430Sancho L.: B‐0136Sandborg M.: B‐0287Sander T.: B‐0913Sandman D.: B‐0319Sangro B.: A‐075, A‐079Sano K.: B‐0093Sansone M.: B‐0942Santamaria V.: B‐0467Santangelo T.: B‐0729, B‐0731Santo E.: B‐0978Santodirocco M.: B‐0854Santoro F.: B‐0569Santos A.: B‐0140Santos C.S.L.: B‐1019Santos J.: B‐0272, B‐0275, B‐0278, B‐0605Saraiva A.: B‐0140Sardanelli F.: A‐130, B‐0217, B‐0545, B‐0569,B‐0654, B‐0687, B‐0741, B‐0814, B‐0815Sargos P.: B‐0421Sarpi D.: B‐0130Sasiadek M.: B‐0744, B‐0847, B‐1016Sasiadek M.J.: B‐0401Sassen S.: B‐0627Sassi C.: B‐0316Satani N.: B‐0828Sato F.: B‐0828Sato K.: B‐0570, B‐1004Sato S.: B‐0346Satou S.: B‐0329, B‐0767Sauerschnig M.: B‐0180, B‐0937Sauvanet A.: A‐604Savastano M.: B‐0930Savchenkov Y.: B‐0833Savoca V.: B‐0972Sawicka E.: B‐0671Scaglione M.: A‐220, B‐0059Scagnelli P.: B‐0267Scandiffio R.: B‐0623Scaperotta G.: B‐0561Scaperrotta G.P.: B‐0956Scaranelo A.: B‐0219Scarciolla L.: B‐0407, B-0020Scardapane A.: B‐0283Scarsbrook A.: B‐0554Schaafsma B.E.: B‐0208Schaefer-Prokop C.: B‐0169, B‐0297, B‐0610Schaefer-Prokop C.M.: A‐195, A‐477Schaeffeler C.: B‐0435Schäfer A.-O.: B‐0551Schäfer F.K.W.: SY 2Schäfer L.C.: B‐0708Schäfer N.: B‐0063Schäfer P.: B‐0039Schäffeler C.: B‐0180Schaible T.: B‐0865, B‐0866Scharer S.: B‐0635Schatteman J.: B‐0088Scheffler S.: B‐0936Scherer A.: B‐0159, B‐0651Scherer D.: B‐0629Scherrer A.: B‐0694Schidt T.M.: B‐0315Schild H.H.: B‐0546Schilham A.M.R.: B‐0721Schillinger M.: A‐486Schima W.: A‐005, A‐438, B‐0719Schimmoeller L.: B‐0081Schimmöller L.: B‐0366, B‐0522, B‐0703Schindera S.T.: B‐0699, B‐0702Schindler A.: B‐0419Schipper R.J.: B‐0212Schipper R.-J.: B‐0451Schlamann M.: B‐1011Schleder S.: B‐0725Schleich C.: B‐0648, B‐0651Schlemmer H.-P.: A‐058, A‐211, B‐0241, B‐0766Schlett C.: B‐0917Schlichting M.: B‐0800Schlosser T.: B‐0584Schmadl M.: B‐0447Schmeding M.: B‐0981Schmehl J.: B‐0923Schmeling A.: B‐1011Schmid-Bindert G.: B‐0022Schmidmaier G.: B‐0188Schmidt B.: B‐0240, B‐0242, B‐0372, B‐0589,B‐0660, B‐0788, B‐0889, B‐0993Schmidt C.: B‐0556Schmidt C.O.: B‐0681Schmidt G.: B‐0547Schmidt H.: B‐0504Schmidt S.: A‐591Schmid-Tannwald C.: B‐0556Schmitt B.: A‐153, B‐0481Schmitt P.: B‐0252Schmitz M.: B‐0578Schmitz-Rixen T.: B‐0258Schnabel J.A.: A‐235, B‐0070Schneider D.: B‐0289, B‐0352, B‐0848Schneider G.: B‐1035Schneider J.F.: A‐224Schneider K.: B‐0732, B‐0733Schneider M.: B‐0651, B‐1036Schnitzer A.: B‐0214Schoder H.: A‐179, B‐0390Schoellnast H.: B‐0743, B‐1032Schoenaers J.: B‐0248Schoenmeyer R.: B‐0282Schoepf U.J.: A‐450, B‐0263, B‐0266, B‐0411, B‐0417,B‐0419, B‐0849, Rising StarsSchoierer O.: B‐0188Schollenberger A.: B‐0398Schöllnast H.: B‐0234, SK 27Scholten E.T.: B‐0297, B‐0610Schönberg S.O.: B‐0022, B‐0160, B‐0214, B‐0265,B‐0289, B‐0343, B‐0345, B‐0352, B‐0540, B‐0628,B‐0683, B‐0829, B‐0848, B‐0865, B‐0866, B‐0889,B‐0999Schonenberg D.: B‐0593Schönfelder M.: B‐0224Schönnagel B.P.: B‐0859Schouman-Claeys E.: B‐0310Schraml C.: B‐0504Schramm N.: B‐0556Schramm P.: B‐0676Schramm R.: B‐0676Schrauwen P.: B‐0317, B‐0853Schrauwen-Hinderling V.B.: B‐0317, B‐0853Schreutelkamp I.L.: B‐0965Schreyer A.: B‐0725Schroefel H.: B‐0265Schroth G.: B‐0752Schuelke C.: B‐0190Schueller G.: A‐219, B‐0719Schukro C.: B‐0107Schultz T.: B‐0144Schulz B.: B‐0290, B‐0393, B‐0700, B‐0723, B‐0774Schulze F.: B‐0618Schulz-Menger J.: SY 6Schumacher U.: B‐0879, B‐0888Schurink G.W.W.H.: B‐0253Schuster H.: SK 26Schütz T.: B‐0448Schuur K.H.: B‐0964Schwabe P.: B‐0189Schwaiger M.: B‐0322Schwartz L.: B‐0806Schwarz D.: B‐0765Schwarz F.: B‐0066, B‐0582Schweiger M.: A‐322Schweitzer N.: B‐0038Schweizer A.: B‐0048Schwenke C.: B‐0172Schwenzer N.F.: B‐0504Schwöppe C.: B‐0805Schymik G.: B‐0265Scoazec J.Y.: B‐0094Sconfienza L.M.: B‐0654, B‐0741, EuroAIMScorsetti M.: B‐0507Scott S.: B‐0423Scrascia F.: B‐0020Scrimieri A.: B‐0716Sdao S.: B‐0741Secchi A.: B‐0440, B‐0449Seccia V.: B‐1010Sechopoulos I.: B‐0840Secil M.: B‐0974Sedlacek S.: SY 5Sedlmair M.: B‐0290, B‐0889Seeger A.: B‐0004, B‐1008Seiberlich N.: B‐0668Seidel R.: B‐1035Seidenbusch M.C.: B‐0732, B‐0733Seiji K.: B‐0828Seimenis I.: B‐0996Seipel R.: B‐0681Seker F.: Rising StarsSeki S.: B‐0293, B‐0329, B‐0526, B‐0767Sekiguchi R.: B‐0336Sekiguchi T.: B‐0777Sellari Franceschini S.: B‐1010Sellars M.: B‐0976Sellars M.E.: B‐0973Selwaness M.: B‐0111Semmler W.: B‐0434Semturs F.: B‐0950, B‐0951Sengel C.: B‐0429Senol U.: A-294Senyurt H.: B‐0486Seo B.K.: B‐0073Seo H.: B‐0221Seo H.S.: B‐0475Seo J.M.: B‐0826Seol H.: B‐0221Seol H.Y.: B‐0475Serafin Z.: B‐0304291

List of Authors and Co-AuthorsSerafini G.: B‐0186Serém S.: B‐0605Serfaty J.-M.: B‐0310Sergi M.E.: B‐0394, B‐0396, B‐0863, B‐0868Serranheira F.: B‐0874Serša, I.: B‐0652Sersar R.: B‐0103Settles M.: B‐0881, B‐0912Seuntjens J.: B‐0245Sewerin P.: B‐0651Shaaban M.A.: B‐0816Shah A.: B‐0256Shaheed M.A.: B‐0150Shakiba M.: B‐0220Shalmon A.: B‐0458Sharifi H.: B‐0065Sharipova A.: B‐0545Sharma R.A.: B‐0062, B‐0070Sharoubim N.: B‐0245Sharp P.: A‐233Sheikh K.A.: B‐0905Shen M.-W.: B‐0884Shi D.: B‐0517Shi H.: B‐0368Shi J.: B‐0022Shi X.-Y.: B‐0884Shiga T.: B‐0986Shim Y.M.: B‐0296Shin H.-O.: B‐0165, B‐0166, B‐0244Shin H.S.: B‐0516Shin J.H.: B‐0499Shin J.K.: B‐0269Shinagawa K.: B‐0305Shiraishi Y.: B‐0581, B‐0760Shmueli K.: B‐0207Shrimpton P.C.: A‐516Shum J.S.: B‐0474Shweel M.: B‐0713Siablis D.: B‐0919Sibert A.: A‐021Sibileau E.: B‐0797, B‐0837Sidek S.: B‐0015Sidhu P.S.: A‐425, B‐0973, B‐0976Siebenhandl P.: B‐0398, B‐0700Siemonsen S.: B‐0354Siemund R.: A‐204, B‐0169, B‐0892Siesling S.: B‐0560Sieswerda G.T.: B‐0005Sievers B.: B‐0584Sijbers J.: A‐518Sijens P.E.: B‐0442Silecchia G.: B‐0193Sileo C.: B‐0738, B‐0867Silva C.A.: B‐0136, B‐0138, B‐0274, B‐0875, B‐0876,B‐1020Silva I.: B‐0140Silva N.: B‐0631Silverman J.R.: B‐0849Silvers R.: A‐090Sim J.Y.: B‐0052Sim L.: B‐0215Sima D.: B‐0510Simanovsky N.: B‐0591Simeone A.: B‐0376, B‐0729Simeonsson R.J.: B‐0380Simon I.: B‐0809Simon M.: B‐0896Simonetti G.: A‐376, B‐0085Simon-Yarza I.: B‐0685, B‐0813, B‐0900, B‐0966Simos P.: B‐0223, B‐0228Singh A.K.: B‐0069Sinitsyn V.E.: A‐094Sipola P.: A‐093Sippel N.: B‐1030Sirlin C.B.: A‐217Sironi S.: B‐0064, B‐0235, B‐0236, B‐0254, B‐0268,B‐0391, B‐0438, B‐0439, B‐0492, B‐0505, B‐0596,B‐0620, B‐0745, B‐0783, B‐0787, B‐0827, B‐0832,B‐1005Sitia G.: B‐0239Sjöberg T.: B‐0169Sjövall A.: B‐0149Skaane P.: B‐0817, SY 17Skehan S.: A‐146Sklair-Levy M.: A‐541, B‐0458Škrk D.: B‐0609Skrok J.: B‐0232Slabaugh G.: B‐0789Slanetz P.J.: B‐0954Slapa R.Z.: B‐0717Slenter J.: B‐0853Slon P.: B‐0143, B‐0514, B‐0685, B‐0778, B‐0813,B‐0900, B‐0945Slotboom J.: B‐0405Slowinska-Srzednicka J.: B‐0717Sluimer J.C.: B‐0116Smal Y.: B‐0991, B‐0992Smeets D.: B‐0280Smets A.M.J.B.: A‐395Smidt M.: B‐0450, B‐0451Smidt M.L.: B‐0212Smit A.J.: B‐1001Smith A.: SY 17Smits D.: B‐0997Smits M.: A‐098, B‐0894Smits M.L.J.: B‐0032Snaith B.: B‐0133, B‐0383, B‐0389Sneddon K.: B‐0780Snijder R.J.: B‐0005Snoeckx A.: A‐055So M.C.: B‐0377Soares J.: B‐0607Soder R.B.S.: B‐0590Soens J.: SY 1Soffia P.: A‐403Sogaro F.: B‐0716Sohn C.-H.: B‐0513Solak O.: B‐1034Solbiati L.: B‐0646, SK 26Solcia M.: B‐0925Sollazzo P.: B‐0394, B‐0396, B‐0863, B‐0868Solyanik O.: B‐0166Sommer C.M.: B‐0178Sommer G.: B‐0766Sommer P.: B‐0909Sommer S.P.: B‐0001Sommer W.H.: B‐0754, B‐0755, B‐0757, B‐0803,B‐0980Somville J.: B‐0432Son G.: B‐0221Son J.Y.: B‐0296Son K.R.: B‐0475Song K.: Rising StarsSong M.G.: B‐0269Song S.E.: B‐0073Sonoyama Y.: B‐0986Soria Jerez J.A.: A‐288Sosef M.N.: B‐0627Soto García M.R.: A‐289Soto Giordani G.: A‐405, A‐407Soto J.A.: B‐0122, B‐0124Sottocornola L.: B‐0424, B‐0479Sourbron S.: B‐0547, B‐0980Sourbron S.P.: B‐1029Sousa A.: B‐0605Sousa P.: B‐0607, B‐0871Souvatzoglou M.: B‐0322, B‐0912Souza R.: B‐0319Souza R.B.: B‐0657Spagnolli F.: B‐0710Spagnolo P.: B‐0268Spampinato M.V.: B‐0408, B‐0409Spelsberg F.W.: B‐0195Sperryn C.W.: A‐256Spiliopoulos S.: B‐0919Spinhoven M.: A‐055Spinicci G.: B‐0313Spinnato P.: B‐0640Spira E.-M.: B‐0263Spiro A.: B‐0935Spoerl M.C.: B‐0146Sproll C.: B‐0159Srinivasan S.: B‐0056, B‐0294Srutek E.: B‐0321Stabile Ianora A.A.: B‐0283Stacul F.: A‐456Stadler A.: A‐248Staehler M.: B‐0066, B‐0344, B‐0975Staffa J.: B‐0629Stahl R.: B‐0491Stahlhut L.: B‐0806Stajgis M.: A‐143Stalder A.: B‐0667, B‐0914Stampfl U.: B‐0178Staniuk T.: B‐0321Stankovic Z.: B‐0361Stanton M.T.: A‐168Staudacher C.: B‐0801Stavros T.: B‐0955Steen M.: B‐0806Steen S.: B‐0169Stef I.: B‐0447Stefan N.: B‐0447Stehlin L.: B‐0361Stein J.: B‐0864Stein L.: B‐0619Steiner J.: B‐0234, B‐1032Steinhoff K.G.: B‐0158Steketee R.M.E.: B‐0894Stelter L.: B‐0189Stenberg L.: B‐0892Stenson M.: B‐0216Stephan C.: B‐0172Sterzaj S.: B‐0273Sterzik A.: B‐0066, B‐0068Stiassny F.: B‐0719Stick S.: B‐0737Stieber P.: B‐0795Stiefsohn E.: B‐0635Stieltjes B.: B‐0151Stift J.: B‐0096292

List of Authors and Co-AuthorsStiller B.: B-0736Stiller W.: B-0241, B-0523Stocker D.: B-0743Stockmar M.: B-1006Stoeckle E.: B-0421Stojanov D.A.: B-0677Stoker J.: B-0790, B-1037Stollberger R.: B-0639Stolzmann P.: B-0660, B-0910Stoppino L.P.: B-0904Stork A.: SY 13Stotts G.: B-0756Stöver T.: B-0709Strang J.: B-0557Straube A.: B-0106, B-0353Streich N.: B-0481Streicher J.: B-0613Streitparth F.: B-0189, B-0306, B-0539Strengers J.L.M.: B-0734Strieth S.: B-0709Strobl F.F.: B-0757, B-0923Stroszczynski C.: B-0725, B-0903, B-0985Strube H.A.: B-0578Struelens L.: B-0842Struffert T.: B-0895Studniarek M.: A-399, B-0321Stumpp P.: B-0158, B-0558Sturkenboom M.C.J.M.: B-0142Subhani S.: B-0621Sudarski S.: B-0289, B-0352, B-0848Sugihara N.: B-0526Sugimura K.: B-0329, B-0346, B-0526, B-0767Sugiyama K.: B-0305Suh B.S.: B-0052Suh C.: B-0091Suh S.: B-0221Suh S.I.: B-0475Suman L.: B-0561, B-0956Summers L.: B-0599Sun F.: B-0517Sun J.: B-0259Sunaert S.: A-420, A-502, B-0510Sundqvist R.: B-0149Sung Y.M.: B-0521Sunwoo L.: B-0513Suoranta S.: B-0011, B-0017Suri J.S.: B-0617Šurlan Popovič K.: B-0476Suryanarayanan S.: SY 16Sussman M.: B-0668Sutter R.: B-0048, B-0938Suzuki S.O.: B-0673Svahn U.: B-0109Sverzellati N.: A-617Swift S.: B-0554Syed R.: B-0549Syrgiamiotis V.: A-345Szabó E.: A-026Szabó G.: B-0523Szczerbo-Trojanowska M.: A-391Szczygielski O.: B-0671Szewcyk-Bieda M.: B-0332Szewczyk P.: B-0401Szucs-Farkas Z.: B-0699, B-0702TTacelli N.: B-0630Tacher V.: B-0036, B-0924Tack D.: A-419, B-0053, B-0520Tacke J.: SK 27Tagliafico A.: A-163, B-0688Tagliamonte M.: B-1013Tahon F.: B-0355Tai C.W.: B-0377Taibi A.: B-0684, B-0811Taioli G.: B-0416Tajima T.: B-0986Takada E.: B-0336Takahashi S.: B-0346, B-0674, B-0828Takahashi Y.: B-0720Takamura T.: B-0093Takase K.: B-0828Takei N.: B-1004Tal S.: B-0227Talakic E.: B-0743, B-1032Talanow R.: B-0200Talei Franzesi C.R.G.L.: B-0064, B-0254, B-0745,B-0827, B-1005Tali E.T.: A-164Tamás J.: B-0983Tamboli P.: B-0824Tammo R.: B-0735Tan C.-F.: B-0931Tan C.H.A.: B-0294Tan L.K.K.: B-0404Tan T.: B-0968Tan Y.: B-0806Tanaka K.: B-0580Tandon A.: B-0041Tandon R.: B-0199Tanghe H.: A-311Tanis W.: B-0008Tanner L.: B-0624Taori S.: B-0060Taourel P.: A-350Tapfer A.: B-0846Tarantino G.: B-0231, B-0237Tardáguila G.: B-0185, B-0631Tardivon A.: A-156Tarján Z.: A-544Tarkowska A.: B-0879Tartaro A.: B-0002, B-0251, B-0509, B-0930, B-1013Taschwer M.: B-0224Taşkın F.: SY 5Tassart M.: B-0538Tatekawa H.: B-1017Täubl P.: B-0743Taupitz M.: B-0324Tavanti F.: B-0518, B-0675Tavares de Sousa M.: B-0859Tavernier J.: B-0408Tawfik A.M.: B-0150Taylor A.M.: A-323Taylor K.: B-0870Taylor S.: B-0520Taylor S.A.: A-232, A-590, B-0097Tee L.M.F.: B-0192Teh H.S.: B-0294Teichgräber U.: B-0306Teixidor Viñas M.: B-0498Tejada S.: B-0514Telegrafo M.: B-0283Teleman A.: B-0653Telesca M.: B-0453Tenkanen-Rautakoski P.: B-0135Tepe G.: B-0923Terauchi K.: B-0570, B-1004Terjung J.: B-0159Terzi E.: A-582Tessa C.: B-0465Tessitore P.: B-0203, B-0716Tetsuka R.: B-0338, B-0339Teusch V.: B-0733Texter J.: B-0006Tezza M.: B-0416, B-0662Thakrar P.: B-0641Thalhammer A.: B-0258, B-0774Thali M.: A-472Tham S.-C.: B-0655Theander E.: B-0653Theisen D.: B-0582, B-0803, B-0913Theysohn J.M.: B-0782Thiele H.: B-0851Thieme S.F.: B-0161, B-0288, B-0634Thierfelder C.: B-0372Thierfelder K.M.: B-0754, B-0755, B-0757Thipphavong S.: B-0702Thoeny H.C.: A-069, A-439, A-535, B-0819Thomassin-Naggara I.: A-553Thomé C.: B-0907Thompson C.: B-0371Thomsen F.: B-0436Thomsen H.S.: A-455Thomsen L.H.: B-0163Thomson K.: B-0332Thörmer G.: B-0448Thorneman K.: B-0967Thurnher M.M.: A-263, A-615, Rising StarsTicca C.: B-0492Tiddens H.A.W.M.: B-0737Tielbeek J.A.W.: B-0790Tielliu I.F.J.: B-0588Tille M.: B-0851Tillement O.: B-1035Tillich M.: B-0743Timberg P.: A-507Timmer J.R.: B-0664Timmers J.: B-0959, B-0962Timmers J.M.H.: B-0964Tinelli C.: B-0092Tingberg A.: A-507Tinozzi F.P.: A-049Tintore M.: B-0222Tio R.A.: B-0588Tiomni E.: B-0978Tissier A.-M.: B-0084Tjan-Heijnen V.: B-0450, B-0451Tkacz J.N.: B-0954Todoroki T.: B-0470Toepker M.: B-0328, B-0719Togao O.: B-0515, B-0673, B-0678Tokgoz N.: B-0899Tokuuye K.: B-1029Tolan D.J.M.: A-348, A-528, B-0196Toledano A.: B-0686Tomà P.: A-530Tomás C.: B-0872Tombolini V.: B-0089, B-0090, B-0645Tomic N.: B-0245293

List of Authors and Co-AuthorsTomšič M.: B-0652Tondolo T.: B-0646Tong M.P.: B-0042Tonkin C.J.: B-0658Töre H.G.: B-0524Tornow A.P.: B-0145Torres-Tabanera M.: A-375Torricelli P.: B-0231, B-0237, B-0349, B-0463Tortora D.: B-0509, B-0930, B-1013Torzilli G.: B-0507Toscano W.: B-0972Toschke C.M.: B-0125Tosto S.: B-0688Toth D.F.: B-0328Toyama T.: B-0759Tramarin M.: B-0771Tran A.: B-0034Trattenero C.: B-0235, B-0236, B-0620, B-0745,B-0787, B-0832Trattnig S.: A-140, A-150, A-151, ESOR Course,B-0071, B-0345, B-0488, B-0953Trecate G.: B-0561Treece G.M.: B-0658Treffert J.: B-0028, B-0320Trefois P.: A-196Treitl M.: B-0113, B-0243, B-0927, B-0928Trepel M.: B-0882Trianni A.: B-0998Triantopoulou C.: A-057Trimboli R.M.: B-0217, B-0569, B-0687, B-0814,B-0815, EuroAIMTrofimova A.: B-0229Trofimova T.: B-0229Trojanowska A.: A-418, A-619, B-0153Trojanowski P.: B-0153Tropres I.: B-0751Trucchi A.: B-0696Trufanov G.: B-0833Truijman M.T.B.: B-0118, B-0120Trumm C.G.: B-0195, B-0491Trypka E.: B-0401Tscherner M.: B-0639Tscholakoff D.: A-464, B-0148Tse D.M.L.: B-0423Tsehmaister Abitbol V.: B-0458Tsimberidou A.: B-0807Tsitas K.: B-0933Tsoumakidou G.: A-043, A-442, A-557, B-0309Tsukamoto K.: B-0570, B-1004Tsurugizawa T.: B-0201Tudisca C.: B-0467, B-0854, B-0855Tulloh R.: B-0856Tupikowski K.: B-0847Tupý R.: B-0358Turhan A.N.: B-0838Turini F.: B-0035Turini F.M.: B-0922Turmel-Rodrigues L.: A-198Turmezei T.D.: B-0658Turowski B.: B-0749, B-0905Tyrrell A.P.: B-0384Tzarouchi L.C.: B-0406, B-0860, B-0862Tzedakis A.: B-0996UUberoi R.: A-200Ucar M.: B-0899Uder M.: B-0665Ueberle F.: B-0859Ueno Y.: B-0346Uhlenbrock D.: SY 4Uliasz M.: B-0671Ulrich C.: B-0629Ulus S.: B-0327Umutlu L.: B-0347, B-0456, B-0708, B-1030, B-1038Urbach H.: B-0546Urbanczyk M.: B-0009Uren N.: B-0373Urigo C.: B-0130Ursani A.: B-0379VVagli P.: B-0623Vahrmeijer A.L.: B-0208Vaiani M.: B-0492Valdo M.: B-0454Válek V.: A-186, A-546Valentini A.L.: B-0323, B-0395Valentini V.: A-172Valentino M.: B-0974Valette J.: B-0285, B-0286Valette P.J.: B-0094Valette P.-J.: B-0559Vallée J.-P.: A-369, B-0970, ESOR CourseVallejos J.: B-0257Vallone P.: B-0233Valvassori L.: A-045van Beek E.J.R.: A-084, A-452, B-0373Van Beers B.: A-097, A-215, ESOR Coursevan Buchem M.A.: SY 15Van Cauter S.: B-0510van Cauteren T.: B-0580van Dalen J.A.: B-0664van Dalen T.: B-0072, B-0565van Dam R.M.: B-0981Van de Giessen M.: B-0208Van de Velde C.J.H.: B-0208van de Weijer T.: B-0317van den Berg J.M.: B-0593van den Boom R.: B-0758, B-0891van den Bosch M.A.A.J.: B-0032, B-0072, B-0565,Rising Starsvan den Bouwhuijsen Q.: B-0111van den Brink R.B.A.: B-0008van den Dungen J.J.A.M.: B-0588van den Hauwe L.: A-131, A-205, A-264, A-346, A-365,A-556, B-0672van den Heuvel E.R.: B-1001van der Geest R.J.: B-0118, B-0253van der Graaf Y.: B-0027Van der Lijn F.: B-0142van der Lugt A.: A-214, A-368, B-0014, B-0016,B-0111, B-0114, B-0350, B-0402van der Paardt M.P.: B-0790Van der Zijden T.: A-131, A-205, A-306, A-346, A-365,B-0301, B-0302van Duijn C.M.: B-0114Van Dyck P.: A-313, B-0432, B-0480van Elmpt W.: B-0065van Engen R.E.: B-0841van Ewijk P.A.: B-0853van Garsse L.: B-0261, B-0264van Ginneken B.: B-0297, B-0610, B-0758, B-0761,B-0891Van Goethem J.: A-131, A-264, A-365, A-555Van Goethem J.W.: A-205, A-346, A-556van Goethem M.: B-0450, B-0451Van Gompel G.: B-0248Van Gool S.: B-0510Van Hecke W.: B-0280, B-0285, B-0286van Herwerden L.A.: B-0008van het Schip A.D.: B-0032van Hoof R.H.M.: B-0116, B-0118, B-0120van Landsveld-Verhoeven C.G.C.M.: B-0964van Leeuwen M.S.: B-0550van Lindert E.: B-0672van Mourik J.H.: Rising StarsVan Ommen V.: B-0261, B-0264Van Ongeval C.: SY 1van Ooijen P.: B-0295, B-0298Van Ooijen P.M.A.: B-0291van Oostenbrugge R.J.: B-0118, B-0120van Osch J.A.C.: B-0664, B-0666van Rijswijk C.: A-434van Rikxoort E.M.: B-0297, B-0610van Roozendaal L.M.: B-0212van Rossum M.A.J.: B-0593Van Steen A.: SY 1Van straten M.: B-0737van Tiel J.: B-0485van Westen D.: B-0892van Zelst J.C.M.: B-0968Vande Berg B.C.: B-0542, B-0544Vandecaveye V.: A-568, B-0152, B-0804Vander Poorten V.: B-0152Vandulek C.: B-1024Vanel D.: B-0640, B-0797Vanhoenacker F.M.H.M.: A-312, A-417, B-0480Vanninen R.: B-0011, B-0017Vaño E.: A-385, A-578Varano G.M.: B-0921Vardhanabhuti V.: B-0798, B-0821Vargas H.A.: B-0390, B-0689Varnay G.: B-0121Varol K.: B-0587Varveris C.: B-0611Vasaturo S.: B-0462, B-0463Vasilevska Nikodinovska V.: B-0430Vasselli F.: B-0453Vassilev D.: B-0852Vassileva J.: B-0989Vassiliu V.: B-0084Vasudevan R.: B-0573Vaudano E.: EIBIRVavro H.: B-0408Vázquez E.: A-468Vecchiato N.: B-0131Vecchietti F.: B-0193, B-0792, B-0793Vecchio S.: B-0684, B-0811Vedrilla D.: B-0636Veillon F.: A-073Veit-Haibach P.: B-0156, B-0157Veldhuis W.B.: B-0072, B-0565Veldkamp W.J.H.: B-0841Velonakis G.: B-0530Veloso Gomes F.: B-0822, B-0971Veloza L.-S.: B-0241Velroyen A.: B-0846294

List of Authors and Co-AuthorsVeltman J.: A-226Vembar M.: B-0586Venkatesan A.M.: B-0209Venstermans C.: A-131, A-264, A-346, A-365, A-556Vente M.A.D.: B-0032Ventura E.S.: B-0726Venturini M.: B-0440, B-0712, B-0769Venugopal V.: B-0013Veraart J.: B-0510Verardi N.: B-0814, B-0815Verbeek A.: B-0962Verbeek A.L.M.: B-0959Verbeke C.: A-145Verbist B.: A-463Vercelli R.: B-0925Vercher Conejero J.L.: B-0326Verdolotti T.: A-532Verdun F.R.: B-0542, B-0544Vergnaghi D.: B-0561Verhaar J.: B-0485Verhaaren B.F.J.: B-0014, B-0016, B-0114, B-0402Verkooijen H.M.: B-0072, B-0565Verloh N.: B-0985Verma R.: B-0752Vermeulen K.M.: B-0560Vermoolen M.A.: B-0550Vernieri F.: B-0020Vernooij M.: A-327Vernooij M.W.: B-0014, B-0016, B-0114, B-0350,B-0402Verschakelen J.: B-0169Versluis B.: B-1007Verslype C.: B-0804Verstraete K.L.A.: A-025Verwoert G.: B-0111Vicente A.: B-0124Victoria T.: B-0864Viegas S.: B-0874Vieth V.: B-0125Viganò S.: B-0561Vigano’ S.: B-0956Vignali C.: B-0465Vikram R.: B-0824Vilanova J.C.: A-315Vilar J.: A-255Vilar Samper J.: B-0168Vilcot L.: A-433Vilela P.: A-367Vilgrain V.: A-017, A-018, A-021, A-109, A-167, A-358,A-604, B-0576Villani G.Q.: B-0267Villanueva A.: B-0143Villeirs G.M.: B-0088Villien M.: B-0355Vinci V.: B-0394, B-0396, B-0863, B-0868Vinczen E.: B-1024Vining D.J.: B-0141, B-0807Vinnicombe S.: B-0332Virayavanich W.: B-0319Viry F.: B-0512Viteri G.: B-0514, B-0685, B-0778, B-0809, B-0900,B-0966Vivier P.-H.: A-483Vizza C.D.: B-0464Vlcek A.: B-0613Vliegen R.F.A.: B-0627Vliegenthart R.: B-0164, B-0291, B-0295, B-0298,B-0299, B-0419, B-0588, B-0918, B-1001Vock P.: A-052, A-384Voelckel S.: A-067Vogel A.: B-0038Vogiatzi S.: B-0989Vogl T.J.: B-0031, B-0033, B-0034, B-0039, B-0040,B-0150, B-0170, B-0258, B-0266, B-0290, B-0393,B-0398, B-0471, B-0534, B-0536, B-0537, B-0633,B-0669, B-0700, B-0709, B-0711, B-0723, B-0748,B-0774, SY 12Vogl W.-D.: B-0562Volbers B.: B-0895Vollherbst D.: B-0178Vollnberg B.: B-0936Volterrani L.: B-0058, B-0194, B-0392, B-0682,B-0941, B-0947Völzke H.: B-0445, B-0681von Baumgarten L.: B-0754, B-0755, B-0757von Falck C.: B-0038, B-0047, B-0244, B-0768von Roden M.: B-0748von Schneider-Egestorf A.: B-0047von Schulthess G.K.: A-400, B-0156, B-0157von Spiczak J.: B-0482Vonend O.: B-0648Vonk J.M.: B-0164Vonken E.-J.: B-1007Voormolen M.: A-131, A-205, A-306, A-346, A-365Voormolen M.H.J.: B-0301, B-0302Vorwerk D.: A-199Voulgaris C.: B-0541Vrabec M.: B-0476Vrooman H.: B-0402Vrooman H.A.: B-0142Vullierme M.-P.: A-604, B-0576Vurdem Ü.E.: B-1034Vymazal J.: A-307WWachter M.F.: B-0178Wacker F.: B-0038, B-0047, B-0165, B-0166, B-0191,B-0244, B-0768Wafae A.A.S.W.: B-0906Wagner A.: B-0341Wagner M.: A-216Waitzbauer M.: B-0950, B-0951Walcher T.: B-0412, B-0583Wald C.: B-0037Waldeck S.: B-0244Walecki J.: B-0303, B-0400, B-0489, B-0852, B-1014Walfridsson H.: B-0149Walker-Samuel S.: B-0097Walleyo A.: B-0865, B-0866Wallis M.G.: A-129, SY 16Wals J.: B-0627Walter T.: B-0306Wambsganss J.: B-0829Wang H.: B-0571, B-0575, B-0884Wang J.: B-0369, B-0571Wang L.-J.: B-0126Wang M.: B-0517Wang P.-C.: B-0225Wang Q.: B-0375Wang X.: B-0334, B-0337, B-0369Wang Y.: B-0334, B-0337, B-0411, B-0893Wang Z.: B-0271, B-0276, B-0496, B-0497, B-0742Wang Z.J.: B-0315Wanke I.: A-133Wanner G.: B-0788Warnking J.: B-0355Wasser K.: B-0214, B-0683Wasser M.N.J.M.: B-0208Wasserman J.K.: B-0756Webb M.J.: B-0978Weber F.: B-0348Weber J.R.: B-0224Weber M.: B-0328, B-0635, B-0636, B-0802Weber M.-A.: B-0044, B-0188, B-0481Weber N.: B-0277Wedegärtner U.: B-0859Weidenhagen R.: B-0195Weidner A.M.: B-0061Weidner M.: B-0865, B-0866Weinans H.: B-0485Weinheimer O.: B-0162Weir N.W.: B-0373Weishaupt D.: A-162Weismann C.F.: A-611Weiss V.: B-1026Weisser P.: B-0033Weitzel T.: B-0405Welsch G.: A-151Welzel J.: B-0629Wendl C.M.: B-0903Wengert G.: B-0952Wengert G.J.: B-0213, B-0562, B-0563Weninger W.: B-0613Wenkel E.: SY 1Wentzel J.J.: B-0111Werner M.K.: B-0447Wessam R.: B-0949Wesseling N.: B-0734Wesseling P.: B-0672Wessling J.: B-0190West D.J.: A-622West N.P.: B-0196Wetter A.: B-0969Weustink A.: B-0410Whelehan P.: B-0332White T.O.: B-0780Wi J.Y.: B-0026Wiart M.: B-0890Wichmann J.A.: B-0633Wichmann J.L.: B-0669Wickings N.: B-0030Wicklein D.: B-0888Wiebel M.: B-0162Wiedenmann B.: A-602Wiegert J.: B-0371Wielpütz M.O.: B-0162Wiener E.: B-0936Wiersma H.: B-0963Wiest R.: B-0405Wiggermann P.: B-0725, B-0985Wilczek B.: B-0967Wild J.M.: A-081, A-269Wildberger J.: B-0261, B-0264, B-0450, B-0451Wildberger J.E.: A-034, B-0029, B-0065, B-0116,B-0118, B-0120, B-0317, B-0746, B-0853, SY 10Wildgruber M.: B-0880, B-0881Wille M.M.W.: B-0163Willekens I.: B-0580Willemink M.J.: B-0721Willems T.P.: B-0005, B-0918295

List of Authors and Co-AuthorsWillerding G.: B-0324Williams M.: B-0373Willner M.: B-0112, B-1006Wilson D.J.: A-041Wimmer J.: B-0488Wimmer T.: B-0234, B-1032Winant C.: B-0053Winklhofer S.: B-0482, B-0910Winter H.: B-0195Winter S.: B-0344Wintersperger B.J.: A-011, B-0668, B-0913Winterstein M.: B-0044Wipff J.: B-0650Wirth S.: A-413, A-492, B-0243, B-0472Wise R.: B-0839Wishaupt M.C.J.: B-0253Witjes J.A.: B-0083Witteman J.: B-0111Witteman J.C.M.: B-0114, B-0350Wittsack H.-J.: B-0340, B-0486, B-0648Wittschieber D.: B-1011Witwit A.: B-0595Wlderk A.: B-0920Woehrle J.: B-0412, B-0583Woertler K.: B-0435Wojtynska R.: B-0401Wolf F.: A-356, A-573Wolf K.-J.: B-0232Wong C.M.: B-0377Wong G.L.-H.: B-0441Wong V.W.-S.: B-0441Wong Y.-C.: B-0126Woo O.H.: B-0073, B-0433, B-0528Woo S.: B-0230Wood B.: B-0173Wood C.: B-0824Wood P.: A-190Woods L.: B-0595Worst T.S.: B-0534Wörtler K.: A-499, B-0180, B-0937Wouters K.: B-0480Wu B.: B-0897Wu C.-H.: B-0126Wu J.: B-0259Wu T.H.: B-0543Wu X.: B-0897Wuest W.: B-0665Wulff A.: B-0436Wulz-Horber S.: SY 5Würfel J.: B-0896Würslin C.: B-0447Wurster T.H.: B-0003, B-0004Wurz C.: B-0258Wüstner M.: SY 24Wyatt C.R.: B-0657XXie J.: B-0883Xie X.: B-0164, B-0291Xu L.: B-0023, B-0656Xu P.: B-0334, B-0337Xu S.: B-0173Xue H.: B-0255Xv F.: B-0893Xyda A.: B-0676YYaddanapudi K.: B-0371Yaffe M.J.: A-506Yaghmai V.: B-0363, B-0524, B-0615, B-0722Yaghoobi M.: B-0220Yalynska T.: B-0735Yamamura J.: B-0315, B-0859Yamashita K.: B-0515, B-0673, B-0678Yamori Y.: B-1017Yan F.: B-0369Yan Y.: B-0883Yang F.: B-0368Yang X.: B-0018Yang Z.: B-0893Yankelevitz D.: B-0799Yanniello M.: B-0746Yanof J.H.: B-0371Yasunaga K.: B-0519Yazıcı C.A.: B-0901Ye X.: B-0707Yeh W.-L.: B-0931Yellin N.: B-0255Yeom J.A.: B-0516Yeon J.W.: B-0052Yeong C.H.: B-0422Yeow K.K.: B-0294Yeung D.K.-W.: B-0441Yıldırım E.: B-0901Yilmabasar M.G.: B-0362Yim C.: B-0422Yong H.S.: B-0433, B-0528Yoo R.-E.: B-0739, B-0830Yoon H.-K.: B-0499Yoon J.H.: B-0494, B-0830Yoon J.-H.: B-0230Yoon K.-H.: B-0844, B-0845Yoon Y.C.: B-0050Yoong B.K.: B-0422Yoong P.: B-0051Yoshida M.: B-0338, B-0339Yoshida N.: B-1017Yoshida S.: B-1017Yoshikawa T.: B-0293, B-0329, B-0526, B-0767Yoshimoto K.: B-0515, B-0673Yoshiura T.: B-0515, B-0673, B-0678Yousef O.Z.: B-0452Yousry T.A.: A-223, A-509Yuan C.: B-0113, B-0117Yue Q.: B-0018Yüksel M.: B-0055, B-0718Yun B.L.: B-0210Yusuf S.W.: B-1003ZZaccagna F.: B-0399, B-0414, B-0427, B-0490Zacharzewska A.: B-1016Zacho M.: B-0918Zackrisson S.: A-507Zahel T.: B-0525Zahlmann G.: B-0799Zaidi S.: B-0145Żak T.: B-1016Zalazar R.: B-0143, B-0813Zalev J.: B-0955Zamboni G.A.: B-0706Zampa V.: B-0698Zampeli F.: B-0929Zanetti M.: A-436Zangos S.: B-0031, B-0033, B-0039, B-0170, B-0258,B-0393, B-0398, B-0537, B-0748, B-0774Zappa M.: A-358Zar H.: A-262Zarb F.: B-0279, B-1028Zaric O.: B-0953Zawadzki M.: B-0303Zbýň Š.: B-0345, B-0488Zech C.: B-0980Zech C.J.: A-493, A-565Zee N.: B-0786Zegarski W.: B-0321Zeina A.-R.: B-0129Zelber-Sagi S.: B-0978Zeller T.: B-0923Zengel P.: B-0068Zerbi A.: B-0785Zerini D.: B-0503Zerlauth J.-B.: B-0670Zezos P.: B-0115Zhang G.: B-0883Zhang G.-X.: B-0884Zhang H.: B-0571Zhang J.: B-0018Zhang L.: B-0319Zhao B.: B-0806Zhao Y.R.: B-0295, B-0298Zheng L.-F.: B-0884Zhorzholiani S.: B-0916Zhou C.: B-0707Zicchetti M.: B-0092Zikou A.: B-0406, B-0860, B-0862Zilkens C.: B-0486, B-0487Zimny A.: B-0401, B-1016Zini C.: B-0775Zins M.: A-494, B-0837Zizka J.: A-245Zolovkins A.: B-0921Zompatori M.: B-0763Zonnenberg B.A.: B-0032Žontar D.: B-0609Zorlu A.: B-0587Zou L.: B-0018Zoubi R.: B-0077, B-0808Zoumpoulis P.S.: SY 2Zsirka Klein A.: B-0983Zsirka-Klein A.: B-0982Zubieta J.L.: B-0514Zubler C.: B-0752Zucconi F.: B-0492Zuern C.S.: B-0003, B-0004Zuiani C.: B-0132, B-0567, B-0568, B-0684, B-0811,B-0834, B-0835Zwiers M.: B-1001296

List ofModeratorsThis part lists all moderators followedby the session number in italic letters.

List of ModeratorsAAbolmaali N.: SS 208Adam E.J.: RC 714, Standards and AuditAgadakos E.: SS 214Alguersuari A.: JIIQAllen S.: SS 1702Almeida P.: SS 609aÁlvarez-Benito M.: SS 1802bAndersen P.E.: SS 609bAparisi Gomez M.P.: SS 1810Argyropoulou M.I.: FC Self-Assessment TestArkhipova I.: SS 203Aschauer M.A.: SS 115Avdagic E.: SS 511Ayuso C.: EM 1BBakke S.J.: SS 111Baramia M.: SS 1307Barentsz J.O.: CC 1421Bargellini I.: SS 601Barkhausen J.: SS 515, SY 4Barsi P.: SS 511Basile A.: SS 609aBauer R.W.: SS 1803Beale T.: RC 1908Beer A.J.: SS 1807Belcari N.: SS 606Bilbao J.I.: EM 1, EM 2, EM 3, EM 4Bilecen D.: RC 815Blackburn Andersen P.: SS 914Bohata S.: SS 503Bosmans H.: SS 1813Brader P.: EIBIR/EORTC Joint WorkshopBrambs H.-J.: RC 401Brancatelli G.: SS 201bBrink M.: SS 1317Brkljacic B.: RC 307Brountzos E.: CC 1218Brouwer P.A.: SY 19Bruegel M.: SS 201bBulja D.: TF 1Buruian M.: SS 1811bCCáceres J.: RC 304Cademartiri F.: SS 903Camps Herrero J.: SY 3Canet Soulas E.: SS 1803Cano D.: SS 1701aCantisani V.: SS 201aCarbonaro L.A.: SS 902Caseiro-Alves F.: SY 6Castañer E.: SS 104Catalano C.: MC 722Chamming’s F.: SS 1802aChan O.: CC 1418Choi B.I.: SS 1801bCianfoni A.: SS 1811bCiraj-Bjelac O.: RC 1113, SS 113Claudon M.: CC 1521Claussen C.D.: RC 1514Clavien P.-A.: EM 2Clément O.: RC 306Coenegrachts K.: SS 516Cotten A.: SS 1810Cowan N.C.: CC 1121Crocetti L.: SS 1309Cunningham P.M.: SS 910Curvo-Semedo L.: SS 1316DDamilakis J.: ESR Radiation Protection SessionD' Anastasi M.: 6 th Post-Processing Face-Off SessionDanielsson M.: SY 16Das M.: SS 1703de Bruijne M.: EIBIR presents IMAGINE WorkshopDe Foer B.: E³ 420De Graaf N.: SS 1712de Koning H.J.: MC 423de Roos A.: MC 322De Vries L.: MSY 1Delorme S.: SS 116Denecke T.: SS 1716Denys A.: SS 109Derchi L.E.: Joint Session of the ESR and EFSUMB,EPOS DiscussionsDeutschmann H.A.: RC 715Di Cesare E.: RC 303Diederich S.: SS 504Djilas-Ivanovic D.: SS 502Donato P.: SS 603bDondelinger R.F.: SS 1709Donoghue V.: RC 1412Dormagen J.B.: SS 101aEElias R.: SS 1308Elliott S.T.: SY 23Ertl-Wagner B.: SS 111Esen G.: RC 302FFaggioni L.: SS 205Faschingbauer R.: SS 101bFatehi M.: SS 205Feragalli B.: SS 117Ferretti G.R.: SS 204Feuchtner G.: SS 1303Filippiadis D.: SS 115Filippone A.: SS 1801aFoley S.J.: SS 1714Fournier L.S.: SS 607Frija G.: RC 1214, MIR 2Frühwald-Pallamar J.: SS 608Fuchsjäger M.H.: CC 1619Furmanek M.I.: SS 1716Fütterer J.J.: SS 209GGallagher F.A.: SS 116Garaci F.G.: SS 515Gennaro G.: SS 602Gevenois P.A.: RC 1904Gibaud B.: SS 105Gilbert F.J.: MC 723Girard N.: E³ 920bGizewski E.R.: SS 509Gleeson F.: RC 1104Gleeson T.: SS 1806Golay X.: SS 1311Góraj B.: SS 611Gouliamos A.D.: E³ 720bGourtsoyiannis N.: ESOR SessionGrainger A.J.: SS 1310Graser A.: 6th Post Processing Face-Off SessionGrazioli L.: SS 1306Grenier P.A.: SS 904Gruszczynska K.: SS 1703Grzycka-Kowalczyk L.: RC 1108HHagen G.: SS 507Hakumäki J.: SS 1706Haller K.: RC 1114Haller S.: SS 1811aHamm B.: SY 18Hany T.F.: SS 916Hartley T.: SY 1Hartmann I.: SS 1304Healy J.: SS 510Helbich T.H.: MC 423, SY 5Hendrikse J.: RC 315Hennig J.: EIBIRHerold C.J.: SS 216Herzog C.: SS 1303Hirsch W.: SS 1312Hjemly H.H.: SS 1814Hoeffel C.: SS 1316Hoeks C.M.A.: SS 507Houssami N.: MC 623, SS 1302Hricak H.: MC 528Huete A.: SS 117Humphries P.D.: SS 1312Hunink M.G.M.: EuroAIMHusty J.: SS 1801aJJaschke W.R.: SS 215Johnson K.J.: SS 912Jung E.M.: SS 1702KKarabulut N.: SS 504Karpenko A.: SS 610bKarssemeijer N.: SS 1713Kellenberger C.J.: RC 812Kettenbach J.: SS 209Keyzer C.: SS 216Kirova-Nedialkova G.I.: SS 903Klauser A.: SS 210Koen V.H.: TF 1Koh D.-M.: CC 819Kornienko V.N.: SY 20Koutalonis M.: SS 1713Krestin G.P.: ESOR Session, EIBIRKroencke T.J.: SS 101bKrombach G.A.: SS 103Kubik-Huch R.A.: SS 202Kudrnova S.: SS 1809Kuribayashi S.: SS 1815LLabuscagne J.: SS 910Lalam R.: SS 610aLambregts D.M.J.: SS 916Lauenstein T.C.: SS 1306Lehéricy S.: E³ 820bLeidecker C.: SS 213Lencioni R.: CC 1219Leschka S.: SS 101aLinsenmaier T.: CC 1618Liu Y.: EIBIR/EORTC Joint WorkshopLlopis E.: RC 1210Loewe C.: EPOS DiscussionsLonn L.: CC 818Lopci E.: SS 1706Lucic M.A.: SS 1812298

List of ModeratorsMMagnusson A.: RC 707Maksimović R.: SS 603bMalamateniou C.: RC 1514Mang T.: SS 905Marco de Lucas E.: SS 211Marincek B.: SS 901Martí-Bonmatí L.: RC 1114, ESOR CourseMartinez-Miravete P.: SS 602Matos C.: ESOR CourseMaurer M.H.: SS 1710McNulty J.: SS 1814Meaney J.F.M.: CC 1518Meindl T.: SS 611Menu Y.: MC 628, MIR 1Merhemic Z.: RC 1111Merkle E.M.: SS 1806Mershina E.A.: SS 603aMildenberger P.: MIR 1, SS 203Mileto A.: SS 510Molyneux A.: E³ 620Morcos S.K.: CC 1621Morgan R.: SS 1809Morozov S.: SS 107Mostbeck G.H.: SY 24Mueller-Lisse T.G.: CC 1221Mueller-Mang C.: SS 204Müller-Schimpfle M.: RC 1902Munneke G.J.: SS 1701bNNadrljanski M.: SS 1302Natale L.: SS 503Nijenhuis R.: SS 609bNikolic O.: SS 1707Nyhsen C.M.: SS 1801bOOleaga Zufiría L.: SS 1711Ollivier L.: SS 902Olsen Ø.E.: RC 1912Omoumi P.: SS 610bOrding-Müller L.-S.: SS 912Oyen R.H.: SS 1307PPadovani R.: SS 213Padrón M.: RC 1410Panicek D.M.: MC 428Papadaki E.: SS 1811aPapathanasiou M.A.: RC 1511Paprottka P.M.: SS 109Parkar A.P.: SS 1704Patak M.A.: RC 1601bPaulo G.: EM 5Peebles C.: RC 803Pekarovic D.: RC 1214Pellegrin A.: SS 1815Pellerin O.: SS 215Pereira P.L.: CC 1519Petakovic A.: SS 914Pickuth D.: SY 8Pierot L.: SS 509Pinochet M.A.: EM 4Piscaglia F.: Joint Session of the ESR and EFSUMBPlagou A.: SS 1310Popovic P.: SS 201aPrayer D.: E³ 520cPrevoo W.: CC 1419Prokop M.: RC 1513, SY 11Pronk-Larive D.: RC 714QQuaia E.: SS 610aRRaissaki M.: RC 1512Rees M.R.: SS 603aRegge D.: SS 905Reiser M.F.: MC 728Ribeiro R.: SS 114Richenberg J.: SS 107Ringertz H.: SS 1712Rockall A.G.: SS 607Roding T.: SS 114Rollandi G.A.: RC 1201Ros P.R.: SS 606, EPOS DiscussionsRossi A.: EPOS DiscussionsRuiz Blanco C.: EM 5Rummeny E.J.: SS 516SSala E.: CC 1321Sanz-Requena R.: SS 103Saranovic D.Z.: SS 1701aSardanelli F.: MC 623, EuroAIMSchaefer-Prokop C.M.: SS 1704Schillebeeckx J.: MIR 2Schönberg S.O.: SY 14Schroth G.: SS 211Schueller G.: SS 1317Schuknecht B.F.: SS 1308Schüller-Weidekamm C.: SS 110Schulz-Wendtland R.: SS 102Schwarz F.: 6th Post Processing Face-Off SessionSconfienza L.M.: SS 210Sekovsky B.: SS 1709Semmler W.: RC 1906Shahabpour M.: SS 110Sharp P.: EF 1Sidhu P.S.: SY 9Sigal R.C.: SY 13Simisker A.: SS 105Sinitsyn V.E.: MC 422, SY 21, EPOS DiscussionsSkaane P.: SS 502Sklair-Levy M.: SS 1802aSmith A.: SY 17Souquet J.: SY 2Speck O.: SS 113Sperryn C.W.: EM 3Steens S.: SS 208Stenzel M.: SS 1812Stern E.J.: SS 1304Stiller W.: SS 1813Sugimura H.: SS 1707Šurlan Popovič K.: RC 1508Sutton D.G.: RC 1413Syrgiamiotis V.: SS 514Szabó E.: SS 1802bTTacelli N.: SS 104Tack D.: SS 1301Tacke J.: SS 909Taibbi A.: SS 1301Tali E.T.: RC 1911Tardivon A.: MC 723, RC 1402Telesca M.: SS 102Thurnher M.M.: CC 1118Torresin A.: EF 2Trianni A.: RC 1113Tsapaki V.: RC 1513Tsetis D.K.: SS 1309Tyurin I.E.: SY 20Tzarouchi L.C.: SS 911VVahtramae P.: SS 1714Valdés Solís P.: RC 417Van Beers B.: SS 601van der Putten W.J.M.: EF 1Vandulek C.: SS 514van den Heuvel J.: SY 15van Persijn van Meerten E.L.: CC 719van Rijn R.R.: EPOS DiscussionsVassileva J.N.: EF 2Venstermans C.: RC 411Vernooij M.: SS 1711Vieira A.: SS 1710Vilela P.: SS 911Villeirs G.M.: RC 1207Vivas I.: SS 1807Vlahos J.: SS 904Vliegenthart R.: RC 1603Vock P.: ESR Radiation Protection SessionVogl T.J.: SY 12Vorwerk D.: IIQVotrubová J.: RC 1413WWeishaupt D.: SS 1701bWidelec J.: SS 608Wildberger J.E.: SY 10YYule A.: SS 214ZZamboni G.A.: SS 901Zelenak K.: SS 909Zimny A.: SS 1311Zytoon A.A.: SS 202299

CreditsCoordination:ESR Office | Neutorgasse 9 | 1010 Vienna, AustriaPhone: (+43 1) 533 40 64-0 | Fax: (+43 1) 533 40 64-441E-mail: communications@myESR.orgmyESR.orgManaging Editor: Julia PatuzziLayout: ESR Graphic Department, Philipp StöhrPhoto Credits:Unless otherwise indicated all pictures © ESR – European Society of RadiologyPrinted by Holzhausen, Vienna, 2013All data as per date of printing: February 2013ESR accepts no responsibility for errors or misprints.Printed on enviromental friendly paper300